Citrus Sinensis ID: 004869
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 726 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.694 | 0.677 | 0.45 | 1e-110 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.517 | 0.531 | 0.450 | 3e-90 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.469 | 0.447 | 0.481 | 2e-89 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.539 | 0.575 | 0.435 | 4e-88 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.444 | 0.708 | 0.504 | 4e-87 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.391 | 0.435 | 0.530 | 7e-83 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.461 | 0.471 | 0.467 | 5e-82 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.498 | 0.705 | 0.452 | 5e-82 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.438 | 0.441 | 0.501 | 1e-81 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.455 | 0.850 | 0.457 | 3e-81 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 399 bits (1026), Expect = e-110, Method: Compositional matrix adjust.
Identities = 243/540 (45%), Positives = 319/540 (59%), Gaps = 36/540 (6%)
Query: 146 LSPDSSDC---CKPDTVLKRASHGCHCVYPIKLDLVL--LNVSQNPNWNLFLEELASQLG 200
+SP S DC C C CV+P+K+ L+L S P N E+A+
Sbjct: 91 VSPSSHDCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTY 150
Query: 201 LRVSQIELINFYVLSLSQLNISMDIT-PHTGISFSASDASAINFSLTTHKVHFDSTLVGD 259
L SQ++++ S +Q +DI G F + A+ I KV + T+ GD
Sbjct: 151 LEQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGD 210
Query: 260 YKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNK--GKHSNLILIFGIGTG 317
Y++ + ++ P PS +P AP P ++++ +NK G I I +
Sbjct: 211 YEVTHISY--PGIPSSSP-NGDVTGDAPGGLPIPINATTFANKSQGIGFRTIAIIALSGF 267
Query: 318 LLITAIISVL-IICSCAFRGRKSKA-----SPKETAKPRTADAVTLGGSLPHPT------ 365
+LI ++ + II G+ S A +P +P +
Sbjct: 268 VLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARSSGSDSLMSSM 327
Query: 366 -----STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD 420
S + EL++AT+ F +LGEGGFGRV++G + DGT VA+K LT Q D
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 421 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 480
+EF+ EVEMLSRLHHRNLVKL+G + L YELV NGS+ES LH LD
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGI--CIEGRTRCLIYELVHNGSVESHLH-----EGTLD 440
Query: 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
W+ R+KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F KV+DFGLA++A EG +
Sbjct: 441 WDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-S 499
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
++STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVT
Sbjct: 500 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVT 559
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
WARP+L +++ LE+L DP L G Y +D +V IA+ CV E + RP MGEVVQ+LK++
Sbjct: 560 WARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 184/408 (45%), Positives = 252/408 (61%), Gaps = 32/408 (7%)
Query: 277 PLASSPPMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRG 336
P +++P PT R + +ST+N G + ++ + L++ + + + C
Sbjct: 249 PGSNNPSQNNPTLRPPLDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREK 308
Query: 337 RKSKASPKE-TAKPRTADAVT------LGGSLPHPTSTR----------------FLAYE 373
R S S + T P ++ A + + S P S R +YE
Sbjct: 309 RLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYE 368
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
EL +ATN F ++LGEGGFG V+KG+L DG VA+K+L GG QGD+EF EVE LSR+
Sbjct: 369 ELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRI 428
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
HHR+LV +VG+ S D + LL Y+ V N L LHG V LDW TR+KIA AAR
Sbjct: 429 HHRHLVSIVGHCISGD--RRLLIYDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAAR 483
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GLAYLHED P +IHRD K+SNILLE+NF A+V+DFGLA+ A + T +++TRV+GTFGY
Sbjct: 484 GLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGY 542
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKD 610
+APEYA +G L KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP++ + +
Sbjct: 543 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETE 602
Query: 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ LADP+LGG Y + + R+ A ACV A +RP MG++V++ +
Sbjct: 603 EFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 184/382 (48%), Positives = 238/382 (62%), Gaps = 41/382 (10%)
Query: 309 ILIFGIGTGLLITAIISVLIICSCAFRGRKSKAS----------PKETAKPRTADAVT-- 356
++ IG L++ +I V++ C + RK + S P E++ PR+ A+
Sbjct: 330 VVGVSIGVALVLLTLIGVVV---CCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKT 386
Query: 357 ----------------LGGSLP--HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK 398
L S P S +YEEL ATN F ++LGEGGFGRV+K
Sbjct: 387 QSSAPLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYK 446
Query: 399 GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458
GVL D VA+K+L GG QGD+EF EV+ +SR+HHRNL+ +VGY S + + LL Y+
Sbjct: 447 GVLPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISEN--RRLLIYD 504
Query: 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 518
VPN +L LH LDW TR+KIA AARGLAYLHED P +IHRD K+SNILL
Sbjct: 505 YVPNNNLYFHLHA--AGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 562
Query: 519 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 578
ENNFHA V+DFGLAK A + T +++TRVMGTFGY+APEYA +G L KSDV+S+GVVLL
Sbjct: 563 ENNFHALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 621
Query: 579 ELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE---LADPRLGGKYPKEDFIRVCTI 635
EL+TGRKPVD SQP G E+LV WARP+L + EE LADP+LG Y + R+
Sbjct: 622 ELITGRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEA 681
Query: 636 AAACVAPEANQRPTMGEVVQSL 657
AAAC+ A +RP M ++V++
Sbjct: 682 AAACIRHSATKRPRMSQIVRAF 703
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 194/445 (43%), Positives = 258/445 (57%), Gaps = 53/445 (11%)
Query: 283 PMKAPTHRAS-------PSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFR 335
P+ PT AS PSSS S G + I+ G+ GL+ +S+ ++ R
Sbjct: 207 PIAKPTGPASNNGNNTLPSSSPGKSEVG--TGGIVAIGVIVGLVF---LSLFVMGVWFTR 261
Query: 336 GRKSK---------ASPKETAKPRTADAVTLGGSLPHPTSTR------------------ 368
RK K P + P+ +D V P R
Sbjct: 262 KRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVS 321
Query: 369 ----FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL 424
+ +Y+EL + T+ F ++LGEGGFG V+KGVLSDG VA+K+L GG QG++EF
Sbjct: 322 NQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWET 483
EVE++SR+HHR+LV LVGY S QH LL Y+ VPN +L LH P + WET
Sbjct: 382 AEVEIISRVHHRHLVTLVGYCISE---QHRLLVYDYVPNNTLHYHLHAP--GRPVMTWET 436
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-Y 542
R+++A AARG+AYLHED P +IHRD K+SNILL+N+F A VADFGLAK A E N +
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 543 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602
+STRVMGTFGY+APEYA +G L K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WA
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWA 556
Query: 603 RPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659
RP+L + + +EL DPRLG + + R+ AAACV A +RP M +VV++L
Sbjct: 557 RPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDT 616
Query: 660 VQRVIECQDPTLTSSNNRANLRQSS 684
++ + + + + RQ S
Sbjct: 617 LEEATDITNGMRPGQSQVFDSRQQS 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 167/331 (50%), Positives = 216/331 (65%), Gaps = 8/331 (2%)
Query: 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVE 428
A+ EL AT NF P + LGEGGFGRV+KG L S G VA+K+L G QG++EFLVEV
Sbjct: 74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
MLS LHH NLV L+GY + D Q LL YE +P GSLE LH LDW RMKIA
Sbjct: 134 MLSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
AA+GL +LH+ + P VI+RDFK+SNILL+ FH K++DFGLAK P G +++STRVM
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
GT+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D P G++NLV WARP+ D
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFND 311
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668
+ + +LADPRL G++P + +A+ C+ +A RP + +VV +L + + D
Sbjct: 312 RRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYD 369
Query: 669 PTLTSSNNRANLRQS---STTFDSDGTSSMF 696
P+ S + R + + D G+ S F
Sbjct: 370 PSKDDSRRNRDERGARLITRNDDGGGSGSKF 400
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 155/292 (53%), Positives = 206/292 (70%), Gaps = 8/292 (2%)
Query: 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 429
YEEL ATN F A++LG+GGFG V KG+L G VA+K+L G QG++EF EVE+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
+SR+HHR+LV L+GY + Q LL YE VPN +LE LHG ++W TR+KIAL
Sbjct: 328 ISRVHHRHLVSLIGYCMA--GVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIAL 383
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+A+GL+YLHED P +IHRD KASNIL++ F AKVADFGLAK A + T ++STRVMG
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMG 442
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-- 607
TFGY+APEYA +G L KSDV+S+GVVLLEL+TGR+PVD + ++LV WARP+L
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502
Query: 608 -DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
++ E LAD ++G +Y +E+ R+ AAACV A +RP M ++V++L+
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 171/366 (46%), Positives = 228/366 (62%), Gaps = 31/366 (8%)
Query: 353 DAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL 412
D+ +G H T YEEL + T F +ILGEGGFG V+KG L+DG VA+K+L
Sbjct: 330 DSAVMGSGQTHFT------YEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQL 383
Query: 413 TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG- 471
G QGD+EF EVE++SR+HHR+LV LVGY + S+ LL YE VPN +LE LHG
Sbjct: 384 KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIA--DSERLLIYEYVPNQTLEHHLHGK 441
Query: 472 --PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529
P+ L+W R++IA+ +A+GLAYLHED P +IHRD K++NILL++ F A+VADF
Sbjct: 442 GRPV-----LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADF 496
Query: 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 589
GLAK +T ++STRVMGTFGY+APEYA +G L +SDV+S+GVVLLEL+TGRKPVD
Sbjct: 497 GLAKLNDSTQT-HVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555
Query: 590 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 646
QP G+E+LV WARP+L + EL D RL Y + + R+ AAACV +
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615
Query: 647 RPTMGEVVQSLKMVQRVIECQDPTLTS----------SNNRANLRQSSTTFDSDGTSSMF 696
RP M +VV++L + + + +N+ R+ + FD S M+
Sbjct: 616 RPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMY 675
Query: 697 SSGPYS 702
SG YS
Sbjct: 676 -SGDYS 680
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 178/393 (45%), Positives = 239/393 (60%), Gaps = 31/393 (7%)
Query: 271 PAPSQAPLASSP--PMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLI 328
P P +P P P P SP S S S + ++ IG G+ + +I
Sbjct: 91 PPPPASPSGQEPTTPTMTPGFSLSPPSPSRLS-----TGAVVGISIGGGVFVLTLI--FF 143
Query: 329 ICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASIL 388
+C R R KA P +G L ST Y EL ATN F A++L
Sbjct: 144 LCKKK-RPRDDKALP-----------APIGLVLGIHQST--FTYGELARATNKFSEANLL 189
Query: 389 GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448
GEGGFG V+KG+L++G VA+K+L G QG+KEF EV ++S++HHRNLV LVGY +
Sbjct: 190 GEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIA- 248
Query: 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 508
+Q LL YE VPN +LE LHG ++W R+KIA+ +++GL+YLHE+ P +IH
Sbjct: 249 -GAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIH 305
Query: 509 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 568
RD KA+NIL++ F AKVADFGLAK A + T ++STRVMGTFGY+APEYA +G L KS
Sbjct: 306 RDIKAANILIDFKFEAKVADFGLAKIALDTNT-HVSTRVMGTFGYLAPEYAASGKLTEKS 364
Query: 569 DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL---RDKDRLEELADPRLGGKYP 625
DVYS+GVVLLEL+TGR+PVD + ++LV WARP+L ++ E LAD +L +Y
Sbjct: 365 DVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYD 424
Query: 626 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+E+ R+ AAACV A +RP M +VV+ L+
Sbjct: 425 REEMARMVACAAACVRYTARRRPRMDQVVRVLE 457
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 172/343 (50%), Positives = 224/343 (65%), Gaps = 25/343 (7%)
Query: 351 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIK 410
T D+ LG H +YEEL E T F +ILGEGGFG V+KG L DG VA+K
Sbjct: 346 TPDSAILGSGQTH------FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVK 399
Query: 411 RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWL 469
+L G QGD+EF EVE++SR+HHR+LV LVGY S QH LL YE V N +LE L
Sbjct: 400 QLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIS---DQHRLLIYEYVSNQTLEHHL 456
Query: 470 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529
HG G+ L+W R++IA+ +A+GLAYLHED P +IHRD K++NILL++ + A+VADF
Sbjct: 457 HGK-GLPV-LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADF 514
Query: 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 589
GLA+ +T ++STRVMGTFGY+APEYA +G L +SDV+S+GVVLLEL+TGRKPVD
Sbjct: 515 GLARLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQ 573
Query: 590 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 646
+QP G+E+LV WARP+L + L EL D RL +Y + + R+ AAACV +
Sbjct: 574 TQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPK 633
Query: 647 RPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDS 689
RP M +VV R ++C + SN + Q STT+DS
Sbjct: 634 RPRMVQVV-------RALDCDGDSGDISNG-IKIGQ-STTYDS 667
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 162/354 (45%), Positives = 226/354 (63%), Gaps = 23/354 (6%)
Query: 336 GRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGR 395
G K ++ + PRT + +L + + ELK AT NF P S++GEGGFG
Sbjct: 28 GSKGSSTASFSYMPRTEGEILQNANLKN------FSLSELKSATRNFRPDSVVGEGGFGC 81
Query: 396 VFKGVLSD----------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
VFKG + + G +A+KRL G QG +E+L E+ L +L H NLVKL+GY
Sbjct: 82 VFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGY- 140
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
+ LL YE + GSLE+ L L W TR+++AL AARGLA+LH ++QP
Sbjct: 141 -CLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQ 198
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
VI+RDFKASNILL++N++AK++DFGLA+ P G +++STRVMGT GY APEY TGHL
Sbjct: 199 VIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLS 258
Query: 566 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 625
VKSDVYS+GVVLLELL+GR+ +D +QP G+ NLV WARP L +K RL + DPRL G+Y
Sbjct: 259 VKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYS 318
Query: 626 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK--MVQRVI--ECQDPTLTSSN 675
+++ +A C++ +A RPTM E+V++++ +Q+ E Q+P ++ N
Sbjct: 319 LTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDN 372
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 726 | ||||||
| 225437589 | 707 | PREDICTED: receptor-like serine/threonin | 0.951 | 0.977 | 0.782 | 0.0 | |
| 147821305 | 707 | hypothetical protein VITISV_041991 [Viti | 0.951 | 0.977 | 0.782 | 0.0 | |
| 449484209 | 723 | PREDICTED: receptor-like serine/threonin | 0.986 | 0.990 | 0.750 | 0.0 | |
| 449469022 | 723 | PREDICTED: receptor-like serine/threonin | 0.986 | 0.990 | 0.748 | 0.0 | |
| 297814127 | 725 | kinase family protein [Arabidopsis lyrat | 0.993 | 0.994 | 0.717 | 0.0 | |
| 255548425 | 711 | kinase, putative [Ricinus communis] gi|2 | 0.968 | 0.988 | 0.739 | 0.0 | |
| 30679031 | 725 | protein kinase family protein [Arabidops | 0.994 | 0.995 | 0.710 | 0.0 | |
| 3912917 | 707 | putative NAK-like ser/thr protein kinase | 0.966 | 0.992 | 0.728 | 0.0 | |
| 356503938 | 720 | PREDICTED: receptor-like serine/threonin | 0.980 | 0.988 | 0.722 | 0.0 | |
| 357511391 | 725 | Receptor-like protein kinase [Medicago t | 0.976 | 0.977 | 0.688 | 0.0 |
| >gi|225437589|ref|XP_002270928.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2 [Vitis vinifera] gi|297743991|emb|CBI36961.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1119 bits (2894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/704 (78%), Positives = 603/704 (85%), Gaps = 13/704 (1%)
Query: 36 ANLADNLLKETSVSPSQAPLVAPAIPDLPLPANLPLFRRSRRKHLLPHG------APAHP 89
A+L DN L+ VSP+ APL PA+PDLPLP+NLPL+ R ++KH +P AP+ P
Sbjct: 4 ADLPDNQLEAPLVSPTSAPLATPALPDLPLPSNLPLYHRRKQKHPMPSHVPKRVLAPSQP 63
Query: 90 PFCGPHITSRQPPTSSSLSKPLMKRSALEPPSAGLA-----NISPAQFSTGTVPSGLAEP 144
P GP +TS PPTSS LSKP MKR L P GL +I+P Q + G +P GLA+P
Sbjct: 64 PDYGPLVTSAHPPTSSRLSKPSMKRGGLVSPGTGLVPPHLEDIAPMQSNAGPIPVGLAQP 123
Query: 145 PLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVS 204
PLSP S+CC+PD VLK+ SHGCHCVYPIK+DLVLLNVSQNPNW LFLEELA+QLGLRVS
Sbjct: 124 PLSPSDSNCCEPDMVLKQGSHGCHCVYPIKVDLVLLNVSQNPNWKLFLEELATQLGLRVS 183
Query: 205 QIELINFYVLSLSQLNISMDITPHTGISFSASDASAINFSLTTHKVHFDSTLVG--DYKL 262
QIELINFY+LSLS+LNISMDI PHTGISFSASDAS IN SL H VH D T VG DYKL
Sbjct: 184 QIELINFYLLSLSRLNISMDIIPHTGISFSASDASKINSSLAAHMVHLDPTSVGVGDYKL 243
Query: 263 LNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITA 322
LN TWF+PP PS APL ++ PM+AP ++ S S+S SNK KH NL+LI GI G+L A
Sbjct: 244 LNVTWFKPPVPSPAPLVATSPMEAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVA 303
Query: 323 IISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNF 382
II V+++ CA +K+K SP+E KP TAD V + GSLPHPTSTRFLAYEELKEATNNF
Sbjct: 304 IICVIMVSLCASCRKKTKPSPEENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNF 363
Query: 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
EPASILGEGGFGRVFKGVLSDGTAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLV
Sbjct: 364 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLV 423
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
GYYS+RDSSQ+LLCYELVPNGSLE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDS
Sbjct: 424 GYYSNRDSSQNLLCYELVPNGSLEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDS 483
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
QPCVIHRDFKASNILLENNFHAKVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTG
Sbjct: 484 QPCVIHRDFKASNILLENNFHAKVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTG 543
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622
HLLVKSDVYSYGVVLLELLTGR+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL G
Sbjct: 544 HLLVKSDVYSYGVVLLELLTGRRPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAG 603
Query: 623 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQ 682
KYPKEDF+RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV+E QD LTSSN R NLRQ
Sbjct: 604 KYPKEDFVRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQ 663
Query: 683 SSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR 726
SSTTF+SDGTSS+FSSGPYSGLSAFDN+N+SRTAVFSEDLHEGR
Sbjct: 664 SSTTFESDGTSSIFSSGPYSGLSAFDNDNISRTAVFSEDLHEGR 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147821305|emb|CAN74588.1| hypothetical protein VITISV_041991 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1118 bits (2891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/704 (78%), Positives = 603/704 (85%), Gaps = 13/704 (1%)
Query: 36 ANLADNLLKETSVSPSQAPLVAPAIPDLPLPANLPLFRRSRRKHLLPHG------APAHP 89
A+L DN L+ VSP+ APL A+PDLPLP+NLPL+ R ++KH +P AP+ P
Sbjct: 4 ADLPDNQLEAPLVSPTSAPLATXALPDLPLPSNLPLYHRRKQKHPMPSHVPKRVLAPSQP 63
Query: 90 PFCGPHITSRQPPTSSSLSKPLMKRSALEPPSAGLA-----NISPAQFSTGTVPSGLAEP 144
P GP +TS PPTSS LSKP MKR L P GL +I+P Q + G +P GLA+P
Sbjct: 64 PDYGPLVTSAHPPTSSRLSKPSMKRGGLVSPGTGLVPPHLEDIAPMQSNAGPIPVGLAQP 123
Query: 145 PLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVS 204
PLSP S+CC+PD VLK+ SHGCHCVYPIK+DLVLLNVSQNPNW LFLEELA+QLGLRVS
Sbjct: 124 PLSPSDSNCCEPDMVLKQRSHGCHCVYPIKVDLVLLNVSQNPNWKLFLEELATQLGLRVS 183
Query: 205 QIELINFYVLSLSQLNISMDITPHTGISFSASDASAINFSLTTHKVHFDSTLVG--DYKL 262
QIELINFY+LSLS+LNISMDI PHTGISFSASDAS IN SL H VH D T VG DYKL
Sbjct: 184 QIELINFYLLSLSRLNISMDIIPHTGISFSASDASKINSSLAAHMVHLDPTSVGVGDYKL 243
Query: 263 LNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITA 322
LN TWF+PP PS APL ++ PM+AP ++ S S+S SNK KH NL+LI GI G+L A
Sbjct: 244 LNVTWFKPPVPSPAPLVATSPMEAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVA 303
Query: 323 IISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNF 382
IISV+++ CA +K+K SP+E KP TAD V + GSLPHPTSTRFLAYEELKEATNNF
Sbjct: 304 IISVIMVSLCASCRKKTKPSPEENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNF 363
Query: 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
EPASILGEGGFGRVFKGVLSDGTAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLV
Sbjct: 364 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLV 423
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
GYYS+RDSSQ+LLCYELVPNGSLE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDS
Sbjct: 424 GYYSNRDSSQNLLCYELVPNGSLEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDS 483
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
QPCVIHRDFKASNILLENNFHAKVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTG
Sbjct: 484 QPCVIHRDFKASNILLENNFHAKVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTG 543
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622
HLLVKSDVYSYGVVLLELLTGR+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL G
Sbjct: 544 HLLVKSDVYSYGVVLLELLTGRRPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAG 603
Query: 623 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQ 682
KYPKEDF+RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV+E QD LTSSN R NLRQ
Sbjct: 604 KYPKEDFVRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQ 663
Query: 683 SSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR 726
SSTTF+SDGTSS+FSSGPYSGLSAFDN+N+SRTAVFSEDLHEGR
Sbjct: 664 SSTTFESDGTSSIFSSGPYSGLSAFDNDNISRTAVFSEDLHEGR 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449484209|ref|XP_004156817.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1074 bits (2778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 550/733 (75%), Positives = 608/733 (82%), Gaps = 17/733 (2%)
Query: 1 MSVLTVSDTTGLLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAI 60
MSV S T G+L++ + P+ L +L ++ T+A++A+ L P VAPA
Sbjct: 1 MSVPAASFTAGILEQVSFQFPKQLILLWFVITVTNADVANVL---------PTPFVAPAT 51
Query: 61 PDLPLPANLPLFRRSRRKHLLPHGAP------AHPPFCGPHITSRQPPTSSSLSKPLMKR 114
D+PLPA LPL + RK++ P AP + PP+ G ITS PPTSS+ SKPLMK
Sbjct: 52 RDIPLPAKLPLHQHHHRKYMSPQSAPEAGLAPSSPPYFGNLITSGHPPTSSNFSKPLMK- 110
Query: 115 SALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRAS-HGCHCVYPI 173
S PP L NI+P Q + G +PSGLA+PPLSP ++DCCKPD VLKR S CHCVYPI
Sbjct: 111 SGSAPPDDRLENIAPIQSTAGAIPSGLAQPPLSPIAADCCKPDMVLKRGSGDDCHCVYPI 170
Query: 174 KLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISF 233
K+DL+LLN+SQNPNW LFLEELAS+LGLRVSQIELINFYVLSLS+LNISMD+TPHTGISF
Sbjct: 171 KIDLLLLNISQNPNWKLFLEELASELGLRVSQIELINFYVLSLSRLNISMDVTPHTGISF 230
Query: 234 SASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASP 293
SA+DASAIN SLT HKV D TLVGDY LLN TWF+PP PSQAP+AS+ P+ AP +
Sbjct: 231 SAADASAINSSLTMHKVRLDPTLVGDYSLLNITWFKPPPPSQAPIASASPVAAPAYHFPA 290
Query: 294 SSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTAD 353
S+S ++ +KG HSNL L+ GIG G L AI+ VLIIC C K++A P T KPR D
Sbjct: 291 STSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHFGKTEAPPLVTEKPRVED 350
Query: 354 AVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT 413
V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIKRLT
Sbjct: 351 KVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIKRLT 410
Query: 414 CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 473
GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLHGPL
Sbjct: 411 SGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLHGPL 470
Query: 474 GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533
GVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK
Sbjct: 471 GVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 530
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 593
QAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS
Sbjct: 531 QAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 590
Query: 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
GQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTMGEV
Sbjct: 591 GQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTMGEV 650
Query: 654 VQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVS 713
VQSLKMVQRV E QD + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+NVS
Sbjct: 651 VQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDNDNVS 710
Query: 714 RTAVFSEDLHEGR 726
RTA+FSEDLHEGR
Sbjct: 711 RTAIFSEDLHEGR 723
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469022|ref|XP_004152220.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/733 (74%), Positives = 607/733 (82%), Gaps = 17/733 (2%)
Query: 1 MSVLTVSDTTGLLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAI 60
MSV S T G+L++ + P+ L +L ++ T+A++A+ L P APA
Sbjct: 1 MSVPAASFTAGILEQVSFRFPKQLILLWFVITVTNADVANVL---------PTPFFAPAT 51
Query: 61 PDLPLPANLPLFRRSRRKHLLPHGAP------AHPPFCGPHITSRQPPTSSSLSKPLMKR 114
D+PLPA LPL + RK++ P AP + PP+ G ITS PPTSS+ SKPLMK
Sbjct: 52 RDIPLPAKLPLHQHHHRKYMSPQSAPEAGLAPSSPPYFGNLITSGHPPTSSNFSKPLMK- 110
Query: 115 SALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRAS-HGCHCVYPI 173
S PP L NI+P Q + G +PSGLA+PPLSP ++DCCKPD VLKR S CHCVYPI
Sbjct: 111 SGSAPPDDRLENIAPIQSTAGAIPSGLAQPPLSPIAADCCKPDMVLKRGSGDDCHCVYPI 170
Query: 174 KLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISF 233
K+DL+LLN+SQNPNW LFLEELAS+LGLRVSQIELINFYVLSLS+LNISMD+TPHTGISF
Sbjct: 171 KIDLLLLNISQNPNWKLFLEELASELGLRVSQIELINFYVLSLSRLNISMDVTPHTGISF 230
Query: 234 SASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASP 293
SA+DASAIN SLT HKV D TLVGDY LLN TWF+PP PSQAP+AS+ P+ AP +
Sbjct: 231 SAADASAINSSLTMHKVRLDPTLVGDYSLLNITWFKPPPPSQAPIASASPVAAPAYHFPA 290
Query: 294 SSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTAD 353
S+S ++ +KG HSNL L+ GIG G L AI+ VLIIC C K++A P T KPR D
Sbjct: 291 STSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHCGKTEAPPLVTEKPRVED 350
Query: 354 AVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT 413
V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIKRLT
Sbjct: 351 KVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIKRLT 410
Query: 414 CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 473
GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLHGPL
Sbjct: 411 SGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLHGPL 470
Query: 474 GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533
GVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK
Sbjct: 471 GVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 530
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 593
QAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS
Sbjct: 531 QAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 590
Query: 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
GQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTMGEV
Sbjct: 591 GQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTMGEV 650
Query: 654 VQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVS 713
VQSLKMVQRV E QD + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+NVS
Sbjct: 651 VQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDNDNVS 710
Query: 714 RTAVFSEDLHEGR 726
RTA+FSEDLHEGR
Sbjct: 711 RTAIFSEDLHEGR 723
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814127|ref|XP_002874947.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320784|gb|EFH51206.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/730 (71%), Positives = 596/730 (81%), Gaps = 9/730 (1%)
Query: 1 MSVLTVSDTTGLLKKA-QYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPA 59
MS+ +++ ++G + + L +LF+ C +V LAD + +SP+ +P +PA
Sbjct: 1 MSIFSLASSSGSQRDILRMALKPVLFVYC-VVSLVSVLLADAQHEGLPISPTLSPSTSPA 59
Query: 60 IPDLPLPANLPLFRRSRRKHLLPHG--APAHPPFCGPHITSRQPPTSSSLSKPLMKRSAL 117
I DLPLPA P F R K+ P AP HPP + S PPT+S SKP MK++A
Sbjct: 60 ISDLPLPAEFPRFHR---KYFAPQQTEAPEHPPPFSRLVASVHPPTNSHFSKPSMKKNA- 115
Query: 118 EPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDL 177
+ P AGL +I+PAQ S +P L +PPLSP S+CCK D VLKR S GCHCVYPIKLD+
Sbjct: 116 QSPGAGLVDIAPAQSSNSALPDALTQPPLSPSISNCCKADMVLKRRSIGCHCVYPIKLDI 175
Query: 178 VLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISFSASD 237
+LLNVS+ P+WN+FL E A+QLGL QIELINFYVLSLS++NISMDITPH+GISFSAS
Sbjct: 176 LLLNVSETPSWNMFLNEFATQLGLLPHQIELINFYVLSLSRMNISMDITPHSGISFSASQ 235
Query: 238 ASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSS 297
ASAIN SL +HK+ F TLVGDYKLLN TWFE PAPSQAPL +S P KAP+ +S S+S
Sbjct: 236 ASAINSSLISHKIQFSPTLVGDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGSSASTSV 295
Query: 298 STSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTL 357
+ K KH NLILIF I G+LI AII+VL+ICSCA R K+ KET KPR DA ++
Sbjct: 296 RSPGKKKHPNLILIFAIAAGVLILAIITVLVICSCALREEKAPDPHKETVKPRNLDAGSV 355
Query: 358 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ 417
GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+LT GG
Sbjct: 356 GGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGP 415
Query: 418 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 477
QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC
Sbjct: 416 QGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNC 475
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+AKVADFGLAKQAPE
Sbjct: 476 PLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPE 535
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
GR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN
Sbjct: 536 GRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 595
Query: 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
LVTW RPILRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSL
Sbjct: 596 LVTWTRPILRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSL 655
Query: 658 KMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 716
KMVQRV+E QDP L +SN R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+EN++RT
Sbjct: 656 KMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHENITRTT 715
Query: 717 VFSEDLHEGR 726
VFSEDLHEGR
Sbjct: 716 VFSEDLHEGR 725
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548425|ref|XP_002515269.1| kinase, putative [Ricinus communis] gi|223545749|gb|EEF47253.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/734 (73%), Positives = 603/734 (82%), Gaps = 31/734 (4%)
Query: 1 MSVLTVSDTTG--LLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAP 58
MSVL V+ TG + +K L +IL + C + TDA+ D L K SPS+AP +P
Sbjct: 1 MSVLPVAIGTGAEVSRKVCCFLLQILVVSCYVNPITDAD--DQLFKAPITSPSRAPSASP 58
Query: 59 AIPDLPLPANLPLFRRSRRKHLLPHGAP------AHPPFCGPHITSRQPPTSSSLSKPLM 112
AIPDLPLPA+LP F + RKH P GAP A PP GP ITS PTSS SKP M
Sbjct: 59 AIPDLPLPAHLPSFHKPHRKHFAPLGAPLVGVSPAEPPNYGPLITSSHAPTSSRFSKPSM 118
Query: 113 KRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYP 172
K++AL PPS GL +I+P + S G +GLA+PPLSP SDCCKPD VLKR S+ CHCVYP
Sbjct: 119 KKNALVPPSVGLVDIAPTRSSEGANATGLAQPPLSPQISDCCKPDMVLKRGSNDCHCVYP 178
Query: 173 IKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGIS 232
IKLDL+L+NVSQNP+WN FL++LASQLGLRVSQIELINFYVLSLS+LNISMDITPHTGIS
Sbjct: 179 IKLDLLLVNVSQNPSWNKFLQDLASQLGLRVSQIELINFYVLSLSRLNISMDITPHTGIS 238
Query: 233 FSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRAS 292
FS SDAS IN SL HKVHFDS+LVGDY+LLN TWFEPPAPSQAP+A+S P++AP+H+++
Sbjct: 239 FSGSDASFINSSLALHKVHFDSSLVGDYRLLNLTWFEPPAPSQAPVAASSPVEAPSHQSA 298
Query: 293 PSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTA 352
SSS STSN+GK SNLILI IG G++I A++++L+ICSCAFR K K SPKE+ KPRT
Sbjct: 299 TSSSVSTSNRGKRSNLILILCIGAGIIIIAVVTMLVICSCAFREWKPKGSPKESVKPRTV 358
Query: 353 DAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL 412
DAV+ GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL
Sbjct: 359 DAVSAGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL 418
Query: 413 TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 472
T GGQQGDKEFLVEVEMLS L+ V D S P
Sbjct: 419 TNGGQQGDKEFLVEVEMLSSFTWTRLMGTVHVKGPNDLS--------------------P 458
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
LGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA
Sbjct: 459 LGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 518
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
KQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP
Sbjct: 519 KQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 578
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
SGQENLVTWARPILRDKDRLEELAD +L GKYPK+DF+RVCTIAAACVAPEANQRPTMGE
Sbjct: 579 SGQENLVTWARPILRDKDRLEELADTKLKGKYPKDDFVRVCTIAAACVAPEANQRPTMGE 638
Query: 653 VVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENV 712
VVQSLKMVQR+ E QD ++++SN R N+RQSSTTF+SDGTSS+FSSGPYSGLSAFDN+N+
Sbjct: 639 VVQSLKMVQRITEYQD-SMSASNARPNMRQSSTTFESDGTSSIFSSGPYSGLSAFDNDNI 697
Query: 713 SRTAVFSEDLHEGR 726
SRTAVFSEDLHEGR
Sbjct: 698 SRTAVFSEDLHEGR 711
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30679031|ref|NP_192110.2| protein kinase family protein [Arabidopsis thaliana] gi|21928159|gb|AAM78107.1| AT4g02010/T10M13_2 [Arabidopsis thaliana] gi|32815839|gb|AAP88328.1| At4g02010/T10M13_2 [Arabidopsis thaliana] gi|332656711|gb|AEE82111.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1048 bits (2709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/729 (71%), Positives = 590/729 (80%), Gaps = 7/729 (0%)
Query: 1 MSVLTVSDTTGLLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAI 60
MS+ +++ ++ + + + + I+ +V LAD + VSP+ +P +P I
Sbjct: 1 MSIFSLASSSDSQRDDLIMALKAVVIVYCVVSLVSVQLADAQHEGLPVSPTLSPSTSPVI 60
Query: 61 PDLPLPANLPLFRRSRRKHLLPHGA--PAHPPFCGPHITSRQPPTSSSLSKPLMKRSALE 118
DLPLPA P F R K+ P A P H P + S PPTSS SKP MKR+A +
Sbjct: 61 TDLPLPAEFPRFHR---KYFAPQQAEAPQHSPPYSRLVASDHPPTSSHFSKPSMKRNA-Q 116
Query: 119 PPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLV 178
P AGLA+I+PAQ S G +P L +PPLSP S+CCK D VLKR S GCHCVYPIKLD++
Sbjct: 117 SPGAGLADIAPAQSSNGVLPDALTQPPLSPSISNCCKSDMVLKRRSIGCHCVYPIKLDIL 176
Query: 179 LLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISFSASDA 238
LLNVS+ P+WN+FL E A+QLGL QIELINFYVLSLS++NISMDITPH+GISFSAS A
Sbjct: 177 LLNVSETPSWNMFLNEFATQLGLLPHQIELINFYVLSLSRMNISMDITPHSGISFSASQA 236
Query: 239 SAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSS 298
SAIN SL +HK+ F TLVGDYKLLN TWFE PAPSQAPL +S P KAP+ +S ++S
Sbjct: 237 SAINSSLISHKIQFSPTLVGDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGSSATTSVR 296
Query: 299 TSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLG 358
+ K +H NLILIF I G+LI AII+VL+ICS A R K+ KE KPR DA + G
Sbjct: 297 SPGKKRHPNLILIFSIAAGVLILAIITVLVICSRALREEKAPDPHKEAVKPRNLDAGSFG 356
Query: 359 GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ 418
GSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+LT GG Q
Sbjct: 357 GSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQ 416
Query: 419 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 478
GDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC
Sbjct: 417 GDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP 476
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+AKVADFGLAKQAPEG
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 598
R N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL
Sbjct: 537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596
Query: 599 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
VTW RP+LRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSLK
Sbjct: 597 VTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLK 656
Query: 659 MVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAV 717
MVQRV+E QDP L +SN R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+EN++RT V
Sbjct: 657 MVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHENITRTTV 716
Query: 718 FSEDLHEGR 726
FSEDLHEGR
Sbjct: 717 FSEDLHEGR 725
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3912917|gb|AAC78693.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana] gi|7268585|emb|CAB80694.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/710 (72%), Positives = 581/710 (81%), Gaps = 8/710 (1%)
Query: 20 LPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAIPDLPLPANLPLFRRSRRKH 79
L ++ + C +V LAD + VSP+ +P +P I DLPLPA P F R K+
Sbjct: 3 LKAVVIVYC-VVSLVSVQLADAQHEGLPVSPTLSPSTSPVITDLPLPAEFPRFHR---KY 58
Query: 80 LLPHGA--PAHPPFCGPHITSRQPPTSSSLSKPLMKRSALEPPSAGLANISPAQFSTGTV 137
P A P H P + S PPTSS SKP MKR+A + P AGLA+I+PAQ S G +
Sbjct: 59 FAPQQAEAPQHSPPYSRLVASDHPPTSSHFSKPSMKRNA-QSPGAGLADIAPAQSSNGVL 117
Query: 138 PSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLVLLNVSQNPNWNLFLEELAS 197
P L +PPLSP S+CCK D VLKR S GCHCVYPIKLD++LLNVS+ P+WN+FL E A+
Sbjct: 118 PDALTQPPLSPSISNCCKSDMVLKRRSIGCHCVYPIKLDILLLNVSETPSWNMFLNEFAT 177
Query: 198 QLGLRVSQIELINFYVLSLSQLNISMDITPHTGISFSASDASAINFSLTTHKVHFDSTLV 257
QLGL QIELINFYVLSLS++NISMDITPH+GISFSAS ASAIN SL +HK+ F TLV
Sbjct: 178 QLGLLPHQIELINFYVLSLSRMNISMDITPHSGISFSASQASAINSSLISHKIQFSPTLV 237
Query: 258 GDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTG 317
GDYKLLN TWFE PAPSQAPL +S P KAP+ +S ++S + K +H NLILIF I G
Sbjct: 238 GDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGSSATTSVRSPGKKRHPNLILIFSIAAG 297
Query: 318 LLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKE 377
+LI AII+VL+ICS A R K+ KE KPR DA + GGSLPHP STRFL+YEELKE
Sbjct: 298 VLILAIITVLVICSRALREEKAPDPHKEAVKPRNLDAGSFGGSLPHPASTRFLSYEELKE 357
Query: 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 437
AT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+LT GG QGDKEF VE++MLSRLHHRN
Sbjct: 358 ATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRN 417
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
LVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC LDW+TRMKIALDAARGLAY
Sbjct: 418 LVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIALDAARGLAY 477
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
LHEDSQP VIHRDFKASNILLENNF+AKVADFGLAKQAPEGR N+LSTRVMGTFGYVAPE
Sbjct: 478 LHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPE 537
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617
YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW RP+LRDKDRLEEL D
Sbjct: 538 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDRLEELVD 597
Query: 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN- 676
RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSLKMVQRV+E QDP L +SN
Sbjct: 598 SRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKA 657
Query: 677 RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR 726
R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+EN++RT VFSEDLHEGR
Sbjct: 658 RPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHENITRTTVFSEDLHEGR 707
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503938|ref|XP_003520756.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2643), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/725 (72%), Positives = 589/725 (81%), Gaps = 13/725 (1%)
Query: 9 TTGLLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAIPDLPLPAN 68
+ G+LKK Q L+ + + IL +V +A D ++ S+ S++PL + DLPL AN
Sbjct: 2 SIGILKKVQGLVLKWILILSCLVYMIEAGENDKTMEPPSLYDSRSPLAFVVVHDLPLTAN 61
Query: 69 LPLFRRSRRKHLLPHGAP------AHPPFCGPHITSRQPPTSSSLSKPLMKRSALEPPSA 122
+ KH+L HGAP +PP GP ++ P SS LS P K+S ++PP +
Sbjct: 62 HHVL-----KHVLSHGAPIAALSTVNPPLYGPFTSNGHSPASSHLSIPFKKKSEVKPPIS 116
Query: 123 GLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLVLLNV 182
NI+P + PS LA+PPLSP +S+CCK D VLKR S CHC YPIKLDL L NV
Sbjct: 117 VFKNIAPVHSTAAAGPSALAQPPLSPYASNCCKQDMVLKRGSKDCHCAYPIKLDLFLSNV 176
Query: 183 SQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISFSASDASAIN 242
SQNP+WN FLEELA+QLGLR +QIELINFYVLSLS LNISM+ITPH GISFSA++ S IN
Sbjct: 177 SQNPSWNDFLEELATQLGLRNTQIELINFYVLSLSTLNISMNITPHKGISFSANEVSRIN 236
Query: 243 FSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNK 302
SL+ HKV D LVG YKLLN TWFEPP PSQAP ++ P+ P H + S+SSS+S K
Sbjct: 237 SSLSMHKVQLDPGLVGGYKLLNLTWFEPPPPSQAPTLAASPVNTPLHHSPTSTSSSSSPK 296
Query: 303 -GKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSL 361
G+HSNL LI GI G++ AIISVLI C C F K+K P ET KPRT A++ GSL
Sbjct: 297 RGRHSNLFLILGIAIGIIFIAIISVLIFCLCTFLS-KAKTPPIETEKPRTESAISTVGSL 355
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK 421
PHPTSTRF+AYEELKEATNNFEPAS+LGEGGFGRVFKGVL+DGT VAIKRLT GGQQGDK
Sbjct: 356 PHPTSTRFIAYEELKEATNNFEPASVLGEGGFGRVFKGVLNDGTHVAIKRLTNGGQQGDK 415
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 481
EFLVEVEMLSRLHHRNLVKLVGY+S+RDSSQ++LCYELVPNGSLE+WLHGPLG+NC LDW
Sbjct: 416 EFLVEVEMLSRLHHRNLVKLVGYFSNRDSSQNVLCYELVPNGSLEAWLHGPLGINCPLDW 475
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
+TRMKIALDAARGL+YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR+N
Sbjct: 476 DTRMKIALDAARGLSYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRSN 535
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601
YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP+GQENLVTW
Sbjct: 536 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPTGQENLVTW 595
Query: 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661
ARPILRDKDRLEE+ADPRLGGKYPKEDF+RVCTIAAACVA EANQRPTMGEVVQSLKMVQ
Sbjct: 596 ARPILRDKDRLEEIADPRLGGKYPKEDFVRVCTIAAACVALEANQRPTMGEVVQSLKMVQ 655
Query: 662 RVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSED 721
RV E QD L SSN R NLRQSS+TF+ DGTSSMFSSGPYSGLSAFDN+N+SRT VFSED
Sbjct: 656 RVTEYQDSVLASSNARPNLRQSSSTFEFDGTSSMFSSGPYSGLSAFDNDNISRTVVFSED 715
Query: 722 LHEGR 726
L EGR
Sbjct: 716 LCEGR 720
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357511391|ref|XP_003625984.1| Receptor-like protein kinase [Medicago truncatula] gi|355500999|gb|AES82202.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2595), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/723 (68%), Positives = 573/723 (79%), Gaps = 14/723 (1%)
Query: 12 LLKKAQYLLPEILFILCSIVIFTDANLADNLLKETSVSPSQAPLVAPAIPDLPLPANLPL 71
+ KK Q L + + IL +V ++ + D L+ +S +++PL A + DLPLP N
Sbjct: 9 IFKKIQGSLMKWMLILSYLVFMIESGVHDKTLEPPLLSAARSPLAAVFVHDLPLPGN--- 65
Query: 72 FRRSRRKHLLPHGAPA------HPPFCGPHITSRQPPTSSSLSKPLMKRSALEPPSAGLA 125
K+ L GAP P GP I QPP SS S P KRS + P +G
Sbjct: 66 --SHGSKYALSRGAPIATLSLDSSPSYGPFINPGQPPKSSHFSIPFKKRSEWKLPISGFK 123
Query: 126 NISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPIKLDLVLLNVSQN 185
NI+P + PS L +PPL+ +S+CCK D VLKR S GCHCVYPIK+D++LLNVSQN
Sbjct: 124 NIAPIHSTEAAAPSALPQPPLTHHASNCCKQDMVLKRGSKGCHCVYPIKIDILLLNVSQN 183
Query: 186 PNWNLFLEELASQLGLRV-SQIELINFYVLSLSQLNISMDITPHTGISFSASDASAINFS 244
P+W+ FL+ELA QLGL+ +QI+LINFYV++ S LNISMDITPH GISFSA++AS IN S
Sbjct: 184 PDWDKFLDELAGQLGLQNNTQIDLINFYVINFSTLNISMDITPHKGISFSANEASRINSS 243
Query: 245 LTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKGK 304
L+ HKV D LVG YKLLN WFEPP P+QAP ++ P KAP + + ++S S+S +G
Sbjct: 244 LSMHKVRLDPRLVGGYKLLNIIWFEPPPPTQAPTLTASPEKAPLYHSPTATSPSSSTRGG 303
Query: 305 HSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHP 364
HSNL LI GI G+L AI+S+LI C C RK K P ET KPR AV+ GGS+ HP
Sbjct: 304 HSNLFLILGIAIGMLFIAIVSILIFCLCTLL-RKEKTPPIETEKPRIESAVSAGGSISHP 362
Query: 365 TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL 424
TSTRF+AYEEL+EATNNFE AS+LGEGGFG+VFKG+LSDGT+VAIKRLT GGQQGDKEFL
Sbjct: 363 TSTRFIAYEELREATNNFESASVLGEGGFGKVFKGILSDGTSVAIKRLTNGGQQGDKEFL 422
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
EVEMLSRLHHRNLVKLVGYYS+R+SSQ+LLCYELVPNGSLE+WLHGP+G+NC LDW+TR
Sbjct: 423 AEVEMLSRLHHRNLVKLVGYYSNRESSQNLLCYELVPNGSLEAWLHGPMGINCPLDWDTR 482
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
MKIALDAARGL+YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG NYLS
Sbjct: 483 MKIALDAARGLSYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGGANYLS 542
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604
TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR PVDMSQP GQENLVTWARP
Sbjct: 543 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRTPVDMSQPGGQENLVTWARP 602
Query: 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664
ILRDKDRL+E+ADP+L GKYPKEDF+RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR+
Sbjct: 603 ILRDKDRLDEIADPKLEGKYPKEDFVRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRIT 662
Query: 665 ECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLS-AFDNENVSRTAVFSEDLH 723
E D L SSN + NLRQSS+TF+ DGTSS+FSSGPYSGLS AFDN+N+SRT VFSEDLH
Sbjct: 663 EYNDSVLASSNTQTNLRQSSSTFEFDGTSSVFSSGPYSGLSAAFDNDNISRTVVFSEDLH 722
Query: 724 EGR 726
EGR
Sbjct: 723 EGR 725
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 726 | ||||||
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.553 | 0.554 | 0.808 | 1.7e-246 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.395 | 0.385 | 0.637 | 3.2e-102 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.417 | 0.272 | 0.616 | 6.6e-102 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.431 | 0.442 | 0.523 | 1.8e-88 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.393 | 0.375 | 0.571 | 9.2e-86 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.402 | 0.428 | 0.549 | 5e-85 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.388 | 0.432 | 0.537 | 2.2e-82 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.402 | 0.417 | 0.518 | 5.1e-81 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.417 | 0.664 | 0.530 | 2.9e-80 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.438 | 0.447 | 0.496 | 9.5e-80 |
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1698 (602.8 bits), Expect = 1.7e-246, Sum P(2) = 1.7e-246
Identities = 326/403 (80%), Positives = 352/403 (87%)
Query: 325 SVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP 384
+VL+ICS A R K+ KE KPR DA + GGSLPHP STRFL+YEELKEAT+NFE
Sbjct: 323 TVLVICSRALREEKAPDPHKEAVKPRNLDAGSFGGSLPHPASTRFLSYEELKEATSNFES 382
Query: 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
ASILGEGGFG+V++G+L+DGTAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGY
Sbjct: 383 ASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGY 442
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
YSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP
Sbjct: 443 YSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQP 502
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
VIHRDFKASNILLENNF+AKVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHL
Sbjct: 503 SVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHL 562
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 624
LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW RP+LRDKDRLEEL D RL GKY
Sbjct: 563 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDRLEELVDSRLEGKY 622
Query: 625 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQX 683
PKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSLKMVQRV+E QDP L +SN R N RQ
Sbjct: 623 PKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQS 682
Query: 684 XXXXXXXXXXXXXXXXPYSGLSAFDNENVSRTAVFSEDLHEGR 726
PYSGLSAFD+EN++RT VFSEDLHEGR
Sbjct: 683 SATFESEVTSSMFSSGPYSGLSAFDHENITRTTVFSEDLHEGR 725
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.2e-102, Sum P(2) = 3.2e-102
Identities = 188/295 (63%), Positives = 227/295 (76%)
Query: 366 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 425
S + EL++AT+ F +LGEGGFGRV++G + DGT VA+K LT Q D+EF+
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
EVEMLSRLHHRNLVKL+G + L YELV NGS+ES LH G LDW+ R+
Sbjct: 393 EVEMLSRLHHRNLVKLIGICI--EGRTRCLIYELVHNGSVESHLHE--GT---LDWDARL 445
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F KV+DFGLA++A EG + ++ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHIST 504
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605
RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVTWARP+
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
L +++ LE+L DP L G Y +D +V IA+ CV E + RP MGEVVQ+LK++
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
Identities = 190/308 (61%), Positives = 227/308 (73%)
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK 421
P S + E+ +ATNNF+ + +LGEGGFGRV++GV DGT VA+K L QQG +
Sbjct: 703 PFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSR 762
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 481
EFL EVEMLSRLHHRNLV L+G D ++ L+ YEL+PNGS+ES LHG + LDW
Sbjct: 763 EFLAEVEMLSRLHHRNLVNLIGI-CIEDRNRSLV-YELIPNGSVESHLHGIDKASSPLDW 820
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
+ R+KIAL AARGLAYLHEDS P VIHRDFK+SNILLEN+F KV+DFGLA+ A + N
Sbjct: 821 DARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDN 880
Query: 542 -YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
++STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP GQENLV+
Sbjct: 881 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVS 940
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
W RP L + L + D LG + + +V IA+ CV PE + RP MGEVVQ+LK+V
Sbjct: 941 WTRPFLTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLV 1000
Query: 661 QRVIECQD 668
EC +
Sbjct: 1001 SN--ECDE 1006
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 1.8e-88, Sum P(3) = 1.8e-88
Identities = 170/325 (52%), Positives = 224/325 (68%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 396
R ++P +K R+ + G L + S +YEEL +ATN F ++LGEGGFG V
Sbjct: 335 RMQSSAPVGASK-RSGSYQSQSGGLGN--SKALFSYEELVKATNGFSQENLLGEGGFGCV 391
Query: 397 FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456
+KG+L DG VA+K+L GG QGD+EF EVE LSR+HHR+LV +VG+ S D + LL
Sbjct: 392 YKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD--RRLLI 449
Query: 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516
Y+ V N L LHG V LDW TR+KIA AARGLAYLHED P +IHRD K+SNI
Sbjct: 450 YDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 506
Query: 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 576
LLE+NF A+V+DFGLA+ A + T +++TRV+GTFGY+APEYA +G L KSDV+S+GVV
Sbjct: 507 LLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVV 565
Query: 577 LLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVC 633
LLEL+TGRKPVD SQP G E+LV WARP++ + + + LADP+LGG Y + + R+
Sbjct: 566 LLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMI 625
Query: 634 TIAAACVAPEANQRPTMGEVVQSLK 658
A ACV A +RP MG++V++ +
Sbjct: 626 EAAGACVRHLATKRPRMGQIVRAFE 650
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 9.2e-86, Sum P(2) = 9.2e-86
Identities = 168/294 (57%), Positives = 209/294 (71%)
Query: 366 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 425
S +YEEL ATN F ++LGEGGFGRV+KGVL D VA+K+L GG QGD+EF
Sbjct: 414 SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKA 473
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
EV+ +SR+HHRNL+ +VGY S + + LL Y+ VPN +L LH G LDW TR+
Sbjct: 474 EVDTISRVHHRNLLSMVGYCISEN--RRLLIYDYVPNNNLYFHLHAA-GTP-GLDWATRV 529
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
KIA AARGLAYLHED P +IHRD K+SNILLENNFHA V+DFGLAK A + T +++T
Sbjct: 530 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HITT 588
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605
RVMGTFGY+APEYA +G L KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP+
Sbjct: 589 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 648
Query: 606 LRDKDRLEE---LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656
L + EE LADP+LG Y + R+ AAAC+ A +RP M ++V++
Sbjct: 649 LSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 5.0e-85, Sum P(2) = 5.0e-85
Identities = 166/302 (54%), Positives = 215/302 (71%)
Query: 369 FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE 428
+ +Y+EL + T+ F ++LGEGGFG V+KGVLSDG VA+K+L GG QG++EF EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
++SR+HHR+LV LVGY S QH LL Y+ VPN +L LH P G + WETR+++
Sbjct: 386 IISRVHHRHLVTLVGYCISE---QHRLLVYDYVPNNTLHYHLHAP-GRPV-MTWETRVRV 440
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 546
A AARG+AYLHED P +IHRD K+SNILL+N+F A VADFGLAK A E N ++STR
Sbjct: 441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
VMGTFGY+APEYA +G L K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WARP+L
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560
Query: 607 R---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663
+ + +EL DPRLG + + R+ AAACV A +RP M +VV++L ++
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEA 620
Query: 664 IE 665
+
Sbjct: 621 TD 622
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 2.2e-82, Sum P(3) = 2.2e-82
Identities = 156/290 (53%), Positives = 207/290 (71%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLS 431
YEEL ATN F A++LG+GGFG V KG+L G VA+K+L G QG++EF EVE++S
Sbjct: 270 YEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIIS 329
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
R+HHR+LV L+GY + Q LL YE VPN +LE LHG G ++W TR+KIAL +
Sbjct: 330 RVHHRHLVSLIGYCMA--GVQRLLVYEFVPNNNLEFHLHGK-G-RPTMEWSTRLKIALGS 385
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
A+GL+YLHED P +IHRD KASNIL++ F AKVADFGLAK A + T ++STRVMGTF
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGTF 444
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---D 608
GY+APEYA +G L KSDV+S+GVVLLEL+TGR+PVD + ++LV WARP+L +
Sbjct: 445 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 504
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ E LAD ++G +Y +E+ R+ AAACV A +RP M ++V++L+
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 5.1e-81, Sum P(3) = 5.1e-81
Identities = 158/305 (51%), Positives = 207/305 (67%)
Query: 362 PHPT-----STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG 416
PHP+ + YEEL AT F +LG+GGFG V KG+L +G +A+K L G
Sbjct: 311 PHPSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGS 370
Query: 417 QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 476
QG++EF EVE++SR+HHR+LV LVGY S+ Q LL YE +PN +LE LHG G
Sbjct: 371 GQGEREFQAEVEIISRVHHRHLVSLVGYCSNA-GGQRLLVYEFLPNDTLEFHLHGKSGTV 429
Query: 477 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
+DW TR+KIAL +A+GLAYLHED P +IHRD KASNILL++NF AKVADFGLAK +
Sbjct: 430 --MDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQ 487
Query: 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596
+ T ++STRVMGTFGY+APEYA +G L KSDV+S+GV+LLEL+TGR PVD+S ++
Sbjct: 488 DNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-ED 545
Query: 597 NLVTWARPI-LRDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
+LV WARP+ +R E EL DP L +Y + R+ AAA V +RP M ++
Sbjct: 546 SLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQI 605
Query: 654 VQSLK 658
V++L+
Sbjct: 606 VRTLE 610
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 164/309 (53%), Positives = 209/309 (67%)
Query: 371 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEM 429
A+ EL AT NF P + LGEGGFGRV+KG L S G VA+K+L G QG++EFLVEV M
Sbjct: 75 AFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLM 134
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
LS LHH NLV L+GY + D Q LL YE +P GSLE LH LDW RMKIA
Sbjct: 135 LSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAA 192
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
AA+GL +LH+ + P VI+RDFK+SNILL+ FH K++DFGLAK P G +++STRVMG
Sbjct: 193 GAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMG 252
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609
T+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D P G++NLV WARP+ D+
Sbjct: 253 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDR 312
Query: 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 669
+ +LADPRL G++P + +A+ C+ +A RP + +VV +L + + DP
Sbjct: 313 RKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYDP 370
Query: 670 TLTSSN-NR 677
+ S NR
Sbjct: 371 SKDDSRRNR 379
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 9.5e-80, Sum P(2) = 9.5e-80
Identities = 165/332 (49%), Positives = 214/332 (64%)
Query: 334 FRGRKSKASPKETAKPRTADAVTLGGSLPHPT-----STRFLAYEELKEATNNFEPASIL 388
+ ++ S R T GS P T F YEEL + T F +IL
Sbjct: 301 YNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHF-TYEELTDITEGFSKHNIL 359
Query: 389 GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448
GEGGFG V+KG L+DG VA+K+L G QGD+EF EVE++SR+HHR+LV LVGY +
Sbjct: 360 GEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIA- 418
Query: 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 508
S+ LL YE VPN +LE LHG G L+W R++IA+ +A+GLAYLHED P +IH
Sbjct: 419 -DSERLLIYEYVPNQTLEHHLHGK-GRPV-LEWARRVRIAIGSAKGLAYLHEDCHPKIIH 475
Query: 509 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 568
RD K++NILL++ F A+VADFGLAK +T ++STRVMGTFGY+APEYA +G L +S
Sbjct: 476 RDIKSANILLDDEFEAQVADFGLAKLNDSTQT-HVSTRVMGTFGYLAPEYAQSGKLTDRS 534
Query: 569 DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYP 625
DV+S+GVVLLEL+TGRKPVD QP G+E+LV WARP+L + EL D RL Y
Sbjct: 535 DVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYV 594
Query: 626 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+ + R+ AAACV +RP M +VV++L
Sbjct: 595 ENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 726 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 85/279 (30%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 386 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 439
LGEG FG V+KG L VA+K L +Q +EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
KL+G + + E + G L S+L L + AL ARG+ YL
Sbjct: 65 KLLGV--CTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLE 119
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
S+ IHRD A N L+ N K++DFGL++ + Y ++APE
Sbjct: 120 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESL 175
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
G KSDV+S+GV+L E+ T G +P G N L++ RL P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRL-----P 223
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+ P + + C A + RPT E+V+ L
Sbjct: 224 Q-----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 3e-51
Identities = 85/279 (30%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 386 SILGEGGFGRVFKGVLSDG-----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 439
LGEG FG V+KG L VA+K L +Q +EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
KL+G + ++ E +P G L +L L + AL ARG+ YL
Sbjct: 65 KLLGV--CTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLE 120
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
S+ IHRD A N L+ N K++DFGL++ + Y ++APE
Sbjct: 121 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESL 176
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
G KSDV+S+GV+L E+ T G +P G N L+ RL + +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPKPPNC 229
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
P E + + C A + RPT E+V+ L
Sbjct: 230 ------PPELY----KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 89/282 (31%), Positives = 131/282 (46%), Gaps = 42/282 (14%)
Query: 388 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG V+KG L T VA+K L G ++ +EFL E ++ +L H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G + + E +P G L +L L + +++AL A+G+ YL
Sbjct: 67 LGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLE-- 119
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYA 559
S+ +HRD A N L+ N K++DFGL++ E +Y R G ++APE
Sbjct: 120 SKNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLPIKWMAPESL 176
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 615
G KSDV+S+GV+L E+ T G +P MS E ++ L D RL E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEL----LEDGYRLPRPEN 228
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
L Y + C A + RPT E+V+ L
Sbjct: 229 CPDEL---Y---------ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 73/197 (37%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVKLVGYY 445
LGEGGFG V+ G VAIK + E L E+E+L +L+H N+VKL G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
+ L E GSL+ L L + ++I L GL YLH S
Sbjct: 61 EDENH--LYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH--SNG- 112
Query: 506 VIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
+IHRD K NILL +N K+ADFGL+K L ++GT Y+APE +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 565 L-VKSDVYSYGVVLLEL 580
KSD++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 84/278 (30%), Positives = 120/278 (43%), Gaps = 32/278 (11%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLV 439
+E LGEG FG+V+ G VAIK + + D+E L E+++L +L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L + D + L E G L L L + L YLH
Sbjct: 61 RLYDVF--EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLH 114
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
++HRD K NILL+ + H K+ADFGLA+Q L+T V GT Y+APE
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVL 168
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
+ D++S GV+L ELLTG+ P G + L+ + I + K P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIGKPK-----PPFPP 218
Query: 620 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
E D IR + + +R T E +Q
Sbjct: 219 PEWDISPEAKDLIR------KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 82/286 (28%), Positives = 123/286 (43%), Gaps = 39/286 (13%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 441
LGEG FG V+KG L T VA+K L + + K+FL E ++ +L H N+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-----LDWETRMKIALDAARGLA 496
+G + + L E + G L +L V L + + A+ A+G+
Sbjct: 62 LGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YL S+ V HRD A N L+ + K++DFGL++ + T ++AP
Sbjct: 120 YLA--SKKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE- 613
E G KSDV+S+GV+L E+ T G P +S LR RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYRLPK 228
Query: 614 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
E L Y + +C + RPT E+V+ L+
Sbjct: 229 PEYCPDEL---Y---------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 92/287 (32%), Positives = 128/287 (44%), Gaps = 42/287 (14%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNL 438
+E LG G FG V+K G VA+K L + + D+ E+ +L RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
V+L+ + D L E G L +L L + KIAL RGL YL
Sbjct: 61 VRLIDAF--EDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYL 114
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 557
H + +IHRD K NILL+ N K+ADFGLAK+ + ++ +T V GT Y+APE
Sbjct: 115 HSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFV-GTPWYMAPEV 169
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617
K DV+S GV+L ELLTG+ P IL + +
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPF-------------SGENILDQLQLIRRILG 216
Query: 618 PRLGGKYPKE--------DFIRVCTIAAACVAPEANQRPTMGEVVQS 656
P L PK D I+ C+ + ++RPT E++Q
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKK------CLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 387 ILGEGGFGRVFKGVLSD-GTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
+LG G FG V+ + D G +A+K L+ ++ + E+ +LS L H N+V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 500
+ + + E V GSL S L G L E ++ GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-------EPVIRKYTRQILEGLAYLHS 119
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+ ++HRD K +NIL++++ K+ADFG AK+ + T + V GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKP 586
+D++S G ++E+ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 85/286 (29%), Positives = 120/286 (41%), Gaps = 27/286 (9%)
Query: 388 LGEGGFGRVFKG---VLSDGTA--VAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+V L D T VA+K L G +Q +F E+E+L L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 499
G L E +P+GSL +L H ++ + + + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLG 126
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE 557
IHRD A NIL+E+ K++DFGLAK PE + Y F Y APE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
T SDV+S+GV L EL T G P + + RL EL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 617 DPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
G + P+ V + C E RP+ +++ + +
Sbjct: 240 KE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 382 FEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
FE +G+GGFG V+K G VAIK + ++ ++ + E+++L + H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM-KIALDAARGLAYLH 499
G Y +D + E GSL+ L E+++ + + +GL YLH
Sbjct: 62 YYGSYLKKDELW--IVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLH 115
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ +IHRD KA+NILL ++ K+ DFGL+ Q + + ++GT ++APE
Sbjct: 116 SNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVI 169
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKP 586
K+D++S G+ +EL G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V++G+ ++ T VA+K L G K+FL E +++ +L H L++L Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVC 70
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ EL+ GSL +L G G L + +A A G+AYL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YI 125
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD A N+L+ N KVADFGLA+ E + R F + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L E++T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 95/313 (30%), Positives = 142/313 (45%), Gaps = 58/313 (18%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEV 427
LKE E +LG G FG V+KGV + +G VAIK L + +KE L E
Sbjct: 3 ILKET--ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETR 484
+++ + H ++V+L+G S SQ L +L+P G L ++ +G L+W +
Sbjct: 61 YVMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ 117
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ A+G++YL E ++HRD A N+L++ H K+ DFGLAK Y +
Sbjct: 118 I------AKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 603
++A E + KSDV+SYGV + EL+T G KP + P A
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP---------AV 218
Query: 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTI-----AAACVAPEANQRPTMGEVVQSL- 657
I D LE+ G + P+ +CTI C +A RPT E++
Sbjct: 219 EI---PDLLEK------GERLPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266
Query: 658 KMVQRVIECQDPT 670
KM +DP
Sbjct: 267 KM------ARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 74/213 (34%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRN 437
N++ ++G G FG V+KG+ L G VAIK+++ + + K + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 438 LVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-DAAR 493
+VK Y S ++S L E NGSL + GP E+ + + + +
Sbjct: 61 IVK---YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQ 110
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GLAYLHE VIHRD KA+NIL + K+ADFG+A + + + S V+GT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+APE SD++S G ++ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 83/277 (29%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKE-FLVEVEMLSRLHHRNLVKLVGY 444
+G+G FG V+KGVL T VA+K TC K FL E E+L + H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ ELVP GSL ++L L + ++++LDAA G+ YL
Sbjct: 61 --CVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE---SK 112
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
IHRD A N L+ N K++DFG++++ G + APE G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 565 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623
+SDV+SYG++L E + G P G N T ++R+E G +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPY-----PGMSNQQT--------RERIES------GYR 213
Query: 624 YPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 658
P + + C A + RP+ E+ L+
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 72/195 (36%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V++G+ + VAIK L ++F EV+ L RL H++L+ L S
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ EL+ GSL ++L P G L + + +A A G+AYL E + I
Sbjct: 74 --GEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAYLEEQN---SI 126
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 567
HRD A NIL+ + KVADFGLA+ E YLS+ + + APE A G K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 568 SDVYSYGVVLLELLT 582
SDV+S+G++L E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 6e-30
Identities = 88/351 (25%), Positives = 138/351 (39%), Gaps = 29/351 (8%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRL-HHR 436
++ LGEG FG V+ D VA+K L + KE FL E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
N+VKL ++ +D L E V GSLE L + E I L
Sbjct: 59 NIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALE 115
Query: 497 YLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRT----NYLSTRVMGTF 551
YLH +IHRD K NILL + K+ DFGLAK P+ + L + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 552 GYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
GY+APE + + SD++S G+ L ELLTG P + + + T +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELP 231
Query: 609 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666
L P K D ++ +A + R + + + ++
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
Query: 667 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAV 717
D + + + + S + S +S SG +++ +
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 71/205 (34%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V+ G + T VA+K L G + FL E +++ +L H LV+L S
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 448 RDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ Y E + GSL +L G L + +A A G+AYL +
Sbjct: 73 EEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESRN-- 123
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTG 562
IHRD A NIL+ N K+ADFGLA+ + + + R F + APE A G
Sbjct: 124 -YIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYG 179
Query: 563 HLLVKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L E++T GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+ +G+G FG V G G VA+K L FL E +++ L H NLV+L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGV- 68
Query: 446 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
+ + E + GSL +L G + ++ ALD G+ YL E +
Sbjct: 69 -VLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEKN- 122
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 561
+HRD A N+L+ + AKV+DFGLAK+A +G+ + G + APE
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALRE 173
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+G++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 74/241 (30%), Positives = 101/241 (41%), Gaps = 54/241 (22%)
Query: 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 428
++F+ I+GEG F V AIK L DK L+ E E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKE 53
Query: 429 MLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRM 485
+L+RL H ++KL YY+ +D E PNG L ++ G L C TR
Sbjct: 54 VLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-----TRF 106
Query: 486 KIA--LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------Q 534
A L A L YLH +IHRD K NILL+ + H K+ DFG AK
Sbjct: 107 YAAEILLA---LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 535 APEGRTNYLSTR---------VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 585
TN S +GT YV+PE SD+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 586 P 586
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 96/282 (34%), Positives = 125/282 (44%), Gaps = 21/282 (7%)
Query: 388 LGEGGFGRVF---KGVLSDGTA--VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+V +DGT VA+K L GQQ + E+ +L L+H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G S + L E VP GSL +L L+ + A G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 558
IHRD A N+LL+N+ K+ DFGLAK PEG Y R G F Y A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWY-AVEC 181
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
SDV+S+GV L ELLT S P E ++ + + RL EL +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQM-TVVRLIELLER 239
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
+ PK V + C EA RPT ++ LK +
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 92/304 (30%), Positives = 131/304 (43%), Gaps = 56/304 (18%)
Query: 375 LKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
L + T FE ++GEG +G+V+K G VAIK + + ++E E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 434 -HHRNLVKLVGYYSSRDSS----QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
+H N+ G + ++ Q L EL GS+ + G L E I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTR 546
+ RGLAYLHE+ VIHRD K NILL N K+ DFG++ Q + GR N
Sbjct: 120 RETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----T 172
Query: 547 VMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVT 600
+GT ++APE +SDV+S G+ +EL G+ P+ DM P
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPM------- 224
Query: 601 WARP---ILRDKDRLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMG 651
R I R+ P L K P+ DFI C I QRP M
Sbjct: 225 --RALFKIPRNP-------PPTL--KSPENWSKKFNDFISECLIK------NYEQRPFME 267
Query: 652 EVVQ 655
E+++
Sbjct: 268 ELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRN 437
+FE + +G+G FG VFK V +D A+K+ L+ ++ +E + E +L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLD--WETRMKIALDAARG 494
+++ YY S L + E NG L L G D W ++I L G
Sbjct: 61 IIR---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----G 113
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
LA+LH ++HRD K+ N+ L+ + K+ D G+AK + ++GT Y+
Sbjct: 114 LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYL 168
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
+PE KSDV++ GVVL E TG+ P D N I+R
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRGV----- 217
Query: 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 648
P + Y ++ + + C+ + QRP
Sbjct: 218 --FPPVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 55/286 (19%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G+G FG+V+ SDG +K L+ ++ ++ L EV++L +L+H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 445 YSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+ + LC E G L + E + + L YLH
Sbjct: 68 FEEKGK----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE----- 557
++HRD K NI L +N K+ DFG++K + T V GT Y++PE
Sbjct: 124 ---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYLSPELCQNK 178
Query: 558 -YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
Y KSD++S G VL EL T + P + + L ELA
Sbjct: 179 PYN------YKSDIWSLGCVLYELCTLKHPF--------------------EGENLLELA 212
Query: 617 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656
L G+YP + + + + + + +RP++ +++QS
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 75/199 (37%), Positives = 108/199 (54%), Gaps = 14/199 (7%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVG 443
+LG+G FG VFKG L D T VA+K TC Q+ +FL E +L + H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
+ R + ELVP G S+L L + +K ALDAA G+AYL +S+
Sbjct: 60 VCTQRQPI--YIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYL--ESK 112
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
C IHRD A N L+ N K++DFG+++Q +G + + + + APE G
Sbjct: 113 NC-IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170
Query: 564 LLVKSDVYSYGVVLLELLT 582
+SDV+SYG++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHR 436
+E + +GEG +G+V+K G VA+K++ + + F + E+++L +L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR--- 493
N+V+L +S+ + +E + + L L P +K +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-----------VKFTESQIKCYM 106
Query: 494 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRV 547
GL YLH + ++HRD K SNIL+ N+ K+ADFGLA +Y + RV
Sbjct: 107 KQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRV 162
Query: 548 MGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGR 584
+ T Y PE LL+ + D++S G +L EL G+
Sbjct: 163 I-TLWYRPPE------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/215 (34%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V+ G + T VAIK L G + FL E ++ +L H LV+L Y+
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL---YAV 69
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ E + NGSL +L P G+ L + +A A G+A++ + I
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +A+NIL+ K+ADFGLA+ N + R F + APE G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 566 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 598
+KSDV+S+G++L E++T GR P M+ P +NL
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 86/280 (30%), Positives = 130/280 (46%), Gaps = 45/280 (16%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKL 441
LG G FG V++G+ L DG A+K ++ GQ+ K+ E+ +LS+L H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---GLA 496
+G + R+ + ELVP GSL L +G I L + GL
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSF---------PEPVIRLYTRQILLGLE 116
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YLH+ + +HRD K +NIL++ N K+ADFG+AKQ E + G+ ++AP
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAP 170
Query: 557 EYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
E G + +D++S G +LE+ TG KP P Q V I R K+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATG-KP-----PWSQLEGVAAVFKIGRSKELPPIP 224
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
K DFI C+ + + RPT E+++
Sbjct: 225 DHLSDEAK----DFILK------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 87/285 (30%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 388 LGEGGFGRVFKGV--LSDGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLV 442
LG G FG V KGV + G VA+K L G KEFL E ++++L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHE 500
G +L EL P G L +L + + A A G+AYL
Sbjct: 63 GVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-----YVA 555
+HRD A N+LL N AK++DFG+++ G Y +T T G + A
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLE 613
PE G KSDV+SYGV L E + G KP +M G E +L +RL
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAE-----VIAMLESGERLP 218
Query: 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
P+E + +I +C RPT E+ + +
Sbjct: 219 R----------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 89/294 (30%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 386 SILGEGGFGRVFK---GVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
LG+G FG V L D T VA+K+L + ++F E+E+L L H N+VK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 499
G S L E +P GSL +L + LD + A +G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYL- 124
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAP 556
S+ V HRD NIL+E+ K+ DFGL K P+ + Y R G F Y AP
Sbjct: 125 -GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-AP 180
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT----GRKP----VDMSQPSGQENLVTWAR-PILR 607
E V SDV+S+GVVL EL T P + M Q ++ + +L+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661
+ RL P G P E + I C + +QRP+ E+ ++ ++
Sbjct: 241 NNGRL-----PAPPG-CPAE----IYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 81/262 (30%), Positives = 114/262 (43%), Gaps = 21/262 (8%)
Query: 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 437
S LGEG G V K L + G A+K +T K+ L E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+VK G + SS + E GSL+S + + KIA +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
LH +IHRD K SNILL K+ DFG++ + N L+ GT Y+APE
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFTGTSFYMAPE 173
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPV--DMSQPSGQENLVTW--ARPILRDKDRLE 613
+ SDV+S G+ LLE+ R P + P G L+++ P KD
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD--- 230
Query: 614 ELADPRLGGKYPKE--DFIRVC 633
+P G K+ +E DFI+ C
Sbjct: 231 ---EPGNGIKWSEEFKDFIKQC 249
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 388 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVK 440
LGEG FG+VF G D VA+K L K+F E E+L+ H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-------LGVNC-HLDWETRMKIALD 490
G + + ++ +E + +G L +L HGP L ++IA+
Sbjct: 73 FYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
A G+ YL SQ V HRD N L+ + K+ DFG+++ T+Y RV G
Sbjct: 131 IASGMVYL--ASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYT--TDYY--RVGGH 183
Query: 551 ----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++ PE M +SDV+S+GVVL E+ T G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG+G FG V+ G + T VAIK L G + FL E +++ +L H LV+L Y+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 69
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ E + GSL +L G +G +L + +A A G+AY+ + +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 124
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +A+NIL+ N KVADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L EL T GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V+ G + T VA+K L G + FL E +++ +L H LV+L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ E + GSL +L G L M A A G+AY+ + I
Sbjct: 73 EPI---YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIERMN---YI 124
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +++NIL+ + K+ADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L EL+T GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 58/296 (19%)
Query: 388 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
LG+G FG V++G+ T VAIK + ++ EFL E ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHL----DWETRMKIALDAARG 494
L+G S L+ EL+ G L+S+L P N + +++A + A G
Sbjct: 74 LLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--------LSTR 546
+AYL +HRD A N ++ + K+ DFG+ + E T+Y L R
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPI 605
M APE G KSDV+S+GVVL E+ T QP G N
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSN-------- 227
Query: 606 LRDKDRLEELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
EE+ + G + P+ ++ + C RPT E+V SLK
Sbjct: 228 -------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 43/283 (15%)
Query: 388 LGEGGFGRVFKGVLSDGTA----VAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLV 442
LG+G FG V +G S VA+K L +FL E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLH----GPLGVNCHLDWETRMKIALDAARGLAYL 498
G ++ EL P GSL L G ++ D+ A+ A G+ YL
Sbjct: 63 GVV--LTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYL 113
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---RVMGTFGYVA 555
S+ IHRD A NILL ++ K+ DFGL + P+ +Y+ +V F + A
Sbjct: 114 E--SKRF-IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
PE T SDV+ +GV L E+ T G +P + SG + L + I ++ +RLE
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQIL----KKIDKEGERLER 222
Query: 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
P+ + + C A RPT + + L
Sbjct: 223 ----------PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 86/273 (31%), Positives = 132/273 (48%), Gaps = 33/273 (12%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG+G FG V+ G + T VAIK L G + FL E +++ +L H LV L Y+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPL---YAV 69
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ E + GSL +L G +L + +A A G+AY+ + I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +A+NIL+ +N K+ADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 566 VKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 624
+KSDV+S+G++L EL+T GR P G N R +L +R + P+ G
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY-----PGMVN-----REVLEQVERGYRMPCPQ-GCPE 230
Query: 625 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+ +++C + ++RPT E +QS
Sbjct: 231 SLHELMKLCW------KKDPDERPTF-EYIQSF 256
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 49/285 (17%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G FG+V+ V L G +A+K R+ + KE E+++L L H NLVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
R+ + + E G+LE L G LD L GLAYLH
Sbjct: 68 EVHRE--KVYIFMEYCSGGTLEELLEH--GRI--LDEHVIRVYTLQLLEGLAYLHSHG-- 119
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE---YA 559
++HRD K +NI L++N K+ DFG A + T + GT Y+APE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA---------RPILRDKD 610
+D++S G V+LE+ TG++P S +N + +P + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW-----SELDN--EFQIMFHVGAGHKPPIPDSL 231
Query: 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+L +DF+ C + + +RPT E++Q
Sbjct: 232 QLSPEG----------KDFLDRCLES------DPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 387 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
++G G FG V +G L VAIK L G + +FL E ++ + H N+++L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G + S ++ E + NGSL+ +L G + + A G+ YL
Sbjct: 71 EGVVTK--SRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYL--- 122
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
S+ +HRD A NIL+ +N KV+DFGL+++ + Y + + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 590
SDV+S+G+V+ E+++ G +P DMS
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRN 437
++ E +LG+G G V+K G A+K++ G + K+ L E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 438 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 494
+VK G +Y + S + E + GSL L G + IA +G
Sbjct: 61 VVKCYGAFYKEGEIS---IVLEYMDGGSLADLLKKVGKIPEPV------LAYIARQILKG 111
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L YLH +IHRD K SN+L+ + K+ADFG++K + +GT Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
+PE +D++S G+ LLE G+ P P GQ + + I
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDG------ 218
Query: 615 LADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 656
P L ++ E DFI +AC+ + +RP+ E++Q
Sbjct: 219 -PPPSLPAEEFSPEFRDFI------SACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 32/265 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRN 437
++ E LG G G V K + G +A+K + + K+ L E+++L + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 438 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
+V G +Y++ D S +C E + GSL+ L G + KIA+ +GL
Sbjct: 61 IVGFYGAFYNNGDIS---ICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLT 114
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YLHE + +IHRD K SNIL+ + K+ DFG++ Q N L+ +GT Y+AP
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAP 168
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
E VKSD++S G+ L+EL TGR P P + L+ +
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIV 217
Query: 617 D---PRL-GGKYPKE--DFIRVCTI 635
+ PRL GK+ + DF+ +C I
Sbjct: 218 NEPPPRLPSGKFSPDFQDFVNLCLI 242
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIK---RLTCGGQQGDKEFLVEVEMLSRLHHR 436
+FE ++G+G FG+V D A+K + C + + L E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGL 495
LV L +YS +D L +L+ G L H L E ++K + L
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLR--YH--LSQKVKFS-EEQVKFWICEIVLAL 113
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
YLH +IHRD K NILL+ H + DF +A + L+T GT GY+A
Sbjct: 114 EYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMA 167
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE V D +S GV E L G++P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
+G G FG V+ G + VAIK + G +++F+ E +++ +L H LV+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
R S L +E + +G L +L G ET + + LD G+AYL VI
Sbjct: 71 R--SPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NVI 122
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 564
HRD A N L+ N KV+DFG+ + + + Y S+ GT + +PE
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSST--GTKFPVKWSSPEVFSFSKY 178
Query: 565 LVKSDVYSYGVVLLELLT-GRKPVD 588
KSDV+S+GV++ E+ + G+ P +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
I+GEG FG V +G + G VA+K + C + FL E ++++LHH+NLV+L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 446 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
+ +++ EL+ G+L ++L G V+ ++ +LD A G+ YL
Sbjct: 69 --LHNGLYIV-MELMSKGNLVNFLRTRGRALVSV----IQLLQFSLDVAEGMEYLESKK- 120
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
++HRD A NIL+ + AKV+DFGLA+ G N + APE
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKHKK 173
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP 586
KSDV+SYGV+L E+ + GR P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 437
N E +GEG G V+K + G VAIK++ Q KE ++ E+ ++ H N
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPN 76
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL-HGPLGVNCHLDWETRMK-IALDAARG 494
+V Y D L + E + GSL + + +N E ++ + + +G
Sbjct: 77 IVDYYDSYLVGD---ELWVVMEYMDGGSLTDIITQNFVRMN-----EPQIAYVCREVLQG 128
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L YLH SQ IHRD K+ NILL + K+ADFG A Q + ++ S V+GT ++
Sbjct: 129 LEYLH--SQNV-IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWM 183
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
APE Y K D++S G++ +E+ G P
Sbjct: 184 APEVIKRKDYGP------KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 67/298 (22%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
+E +G G +G V+K ++ G VAIK + + E+ ML H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIAL---DAARG 494
G Y RD + + E GSL+ GPL + ++IA + +G
Sbjct: 65 YFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPL---------SELQIAYVCRETLKG 113
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 552
LAYLHE IHRD K +NILL + K+ADFG++ Q T ++ R +GT
Sbjct: 114 LAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPY 166
Query: 553 YVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVD----------MSQPSGQENLV 599
++APE A G K D+++ G+ +EL + P+ +S+ +
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--- 223
Query: 600 TWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
P L+DK+ K+ DFI+ C + +RPT +++Q
Sbjct: 224 ----PKLKDKE------------KWSPVFHDFIKKCLTK------DPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 84/315 (26%), Positives = 128/315 (40%), Gaps = 70/315 (22%)
Query: 380 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH 434
N +E ++GEG +G V K + G VAIK+ + D++ L EV++L +L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLR 58
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
H N+V L + + + L +E V LE P G L + +
Sbjct: 59 HENIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQA 112
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR----TNYLSTRVMGT 550
+AY H + +IHRD K NIL+ + K+ DFG A+ T+Y++TR
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---- 165
Query: 551 FGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ------- 591
Y APE LLV DV++ G ++ ELL G P+ D+ Q
Sbjct: 166 -WYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKC 217
Query: 592 -----PSGQENLVTWAR------PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 640
PS QE + R P + LE +YP + AC+
Sbjct: 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER--------RYPGKVSSPALDFLKACL 269
Query: 641 APEANQRPTMGEVVQ 655
+ +R T E++Q
Sbjct: 270 RMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 83/266 (31%), Positives = 117/266 (43%), Gaps = 63/266 (23%)
Query: 388 LGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLV---EVEM-------LSRLHH 435
LG+G FG+V V G A+K L K+ ++ EVE LSR++H
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINH 52
Query: 436 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK-----I 487
+VKL +Y+ + L L E P G L S L G E R + I
Sbjct: 53 PFIVKL--HYAFQTEE-KLYLVLEYAPGGELFSHLSKEGRFS-------EERARFYAAEI 102
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
L L YLH +I+RD K NILL+ + H K+ DFGLAK+ + +T
Sbjct: 103 VL----ALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC 154
Query: 548 MGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605
GT Y+APE + G+ K+ D +S GV+L E+LTG+ P ++ + + I
Sbjct: 155 -GTPEYLAPEVLLGKGY--GKAVDWWSLGVLLYEMLTGKPPFY-----AEDRKEIYEK-I 205
Query: 606 LRDKDRLEELADPRLGGKYPKEDFIR 631
L+D R E P D I
Sbjct: 206 LKDPLRFPEFLSPEA------RDLIS 225
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 78/279 (27%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
F+ LGEG +G V+K + G VAIK + +E + E+ +L + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 441 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
YY S + L + E GS+ + N L E I +GL YLH
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ IHRD KA NILL AK+ADFG++ Q + T V+GT ++APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVI 171
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEELADP 618
K+D++S G+ +E+ G+ P P ++ P L DP
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS---------DP 222
Query: 619 RLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
K+ E DF++ C + + +RP+ +++Q
Sbjct: 223 ---EKWSPEFNDFVKKCLVK------DPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 61/217 (28%), Positives = 114/217 (52%), Gaps = 30/217 (13%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRL----TCGGQQGDKEFLV------EVEMLSRLHH 435
++G+G +GRV+ + ++ G +A+K++ T G+ ++ + E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL--DA 491
N+V+ +G+ ++ + L E VP GS+ S L +G +E ++
Sbjct: 68 LNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGR--------FEEQLVRFFTEQV 117
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
GLAYLH ++HRD KA N+L++ + K++DFG++K++ + N + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 552 GYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKP 586
++APE + K D++S G V+LE+ GR+P
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 381 NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 437
+F+ LG+G +G V+K LSD A+K + G Q ++E V E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 438 LVKLVGYY-SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
++ Y + D ++ + E P G L + + + +I + RGL
Sbjct: 61 II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
LHE ++HRD K++NILL N K+ D G++K ++ +GT Y+AP
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
E KSD++S G +L E+ T P + AR +++L
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARS-------MQDLR 210
Query: 617 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656
GKYP +D + + + RP +++ S
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 44/289 (15%)
Query: 388 LGEGGFGRVFKGVLS--DGTA----VAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVK 440
LG G FG V++G+ DG A VA+K L +Q + +FL+E ++S+ +H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CHLDWETRMKIALDAARGLAY 497
L+G S + + EL+ G L+S+L P L + + A D A+G Y
Sbjct: 74 LIGV--SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 498 LHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLST--RVMGTFG 552
L E+ IHRD A N LL AK+ADFG+A+ R +Y R M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIK 186
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611
++ PE + G K+DV+S+GV+L E+ + G P P +++
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----------------PGRTNQEV 230
Query: 612 LEELADPRLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+E + GG+ PK V I C RP +++ ++
Sbjct: 231 MEFVT---GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 29/222 (13%)
Query: 380 NNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-H 434
N+ + ++GEG FG+V K + DG + AIKR+ + D ++F E+E+L +L H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-------GPLGVNCH-----LDWE 482
H N++ L+G R L E P+G+L +L P + L +
Sbjct: 67 HPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
+ A D ARG+ YL SQ IHRD A NIL+ N+ AK+ADFGL++ G+ Y
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177
Query: 543 LSTRVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
+ + MG ++A E SDV+SYGV+L E+++
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V G VAIK + G D +F+ E +++ +L H NLV+L G +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ + E + NG L ++L G L E + + D + YL + I
Sbjct: 71 Q--RPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESN---GFI 122
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 564
HRD A N L+ + KV+DFGLA+ + + Y S+ GT + PE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSS--QGTKFPVKWAPPEVFDYSRF 178
Query: 565 LVKSDVYSYGVVLLELLTGRK 585
KSDV+S+GV++ E+ + K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 388 LGEGGFGRVF------KGVLSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVK 440
LGEG FG+V +G + G VA+K L G + E+E+L L+H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
G + + L E +P+GSL+ +L P N ++ + ++K A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN-KINLKQQLKYAVQICKGMDYLGS 127
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEY 558
+HRD A N+L+E+ K+ DFGL K + + F Y APE
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT 582
+ + SDV+S+GV L ELLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 391 GGFGRVF---KGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGY 444
G +GRVF K S G AIK + + L E ++LS+ +VKL Y
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--Y 59
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
YS + L E +P G L S L V LD + + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLEN---VGS-LDEDVARIYIAEIVLALEYLHSNG-- 113
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS------TRVMGTFGYVAPEY 558
+IHRD K NIL+++N H K+ DFGL+K R L+ R++GT Y+APE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 559 AMTGHLLVKS-----DVYSYGVVLLELLTGRKP 586
+L + D +S G +L E L G P
Sbjct: 173 -----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 388 LGEGGFGRVFKGVL------SDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 439
LGEG FG+V+KG L T+VAIK L + EF E E++S L H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPNIV 71
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL-GVNCHLDWETRMK---------I 487
L+G + + L +E + +G L +L + P V ET I
Sbjct: 72 CLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
A+ A G+ YL S +HRD A N L+ K++DFGL++ + ++
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ ++ PE + G +SD++S+GVVL E+ + G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-CGGQQGDKEFLV-----EVEMLSRL 433
+ LG G F ++ + GT +A+K++T ++E +V E+ +++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 491
+H ++++++G ++ + S L E + GS+ L G +
Sbjct: 61 NHPHIIRMLG--ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA------VIINYTEQL 112
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ--APEGRTNYLSTRVM 548
RGL+YLHE+ +IHRD K +N+L+++ ++ADFG A + A +++
Sbjct: 113 LRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT ++APE DV+S G V++E+ T + P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 86/306 (28%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHR 436
+E ++GEG +G V K + G VAIK+ K + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
NLV L+ + R + L +E V + L+ P G LD K RG+
Sbjct: 61 NLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIE 114
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAP-EGRTNYLSTRVMGTFGY 553
+ H + +IHRD K NIL+ + K+ DFG A+ AP E T+Y++TR Y
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WY 166
Query: 554 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ----PSGQEN 597
APE LLV D+++ G ++ E+LTG +P+ D+ Q N
Sbjct: 167 RAPE------LLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGN 219
Query: 598 LVTWARPILRDKD------RLEELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650
L+ + I K+ RL E+ + L ++PK + V +A C+ + + RP+
Sbjct: 220 LIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGL-VLDLAKQCLRIDPDDRPSS 277
Query: 651 GEVVQS 656
+++
Sbjct: 278 SQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 79/289 (27%), Positives = 117/289 (40%), Gaps = 41/289 (14%)
Query: 388 LGEGGFGRVFKG------VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP----------LGVNCHLDWETRMKIAL 489
G D ++ +E + +G L +L HGP L + IA
Sbjct: 73 YGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
A G+ YL +HRD N L+ N K+ DFG+++ + M
Sbjct: 131 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 608
++ PE M +SDV+S+GV+L E+ T G++P + +T R + R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER- 246
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
PR+ PKE V I C E QR + E+ + L
Sbjct: 247 ---------PRV---CPKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 76/224 (33%), Positives = 112/224 (50%), Gaps = 36/224 (16%)
Query: 387 ILGEGGFGRVFKG----VLSDGTA---VAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNL 438
LG G FG V++G +L G+ VA+K L G Q KEFL E ++S +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--------PLGVNCHLDWETRMKIALD 490
VKL+G + ++ EL+ G L S+L PL L + + I LD
Sbjct: 62 VKLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPL-----LTLKELLDICLD 114
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHA----KVADFGLAKQAPEGRTNYLST 545
A+G YL E IHRD A N L+ E + A K+ DFGLA+ +++Y
Sbjct: 115 VAKGCVYL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRK 169
Query: 546 RVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
G ++APE + G +SDV+S+GV++ E+LT G++P
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYY 445
LG G G V K + GT +A K + G + K+ L E++++ H +V +Y
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFY 69
Query: 446 SSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+ + ++ +C E + GSL+ GP+ V E KIA+ GL YL+
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV------EILGKIAVAVVEGLTYLYNVH 123
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
+ ++HRD K SNIL+ + K+ DFG++ + N ++ +GT Y++PE G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFVGTSTYMSPERIQGG 177
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622
VKSDV+S G+ ++EL G+ P S IL ++ + PRL
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG--ILDLLQQIVQEPPPRL-- 233
Query: 623 KYPKEDFIRVCT-IAAACVAPEANQRPTMGEVVQSLKMVQ 661
P DF AC+ + +RPT ++ +Q
Sbjct: 234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 19/221 (8%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGG-QQGDKEFLV-EV 427
YE L+ +G+G FG V K V SDG + K + G + +K+ LV EV
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
+L L H N+V+ R + + E G L + +++ E +I
Sbjct: 51 NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110
Query: 488 ALDAARGLAYLH--EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
L H D V+HRD K +NI L+ N + K+ DFGLAK G + +
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAK 168
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+GT Y++PE KSD++S G ++ EL P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V+ G ++ T VA+K L G + FL E ++ L H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ + E + GSL +L G L + + A G+AY+ + I
Sbjct: 73 EEPI--YIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 125
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +A+N+L+ + K+ADFGLA+ + N + R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L E++T G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 388 LGEGGFGRVFKGVL-SDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G FG VF G L +D T VA+K R T K FL E +L + H N+V+L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+ + + ELV G ++L GP L + +++ +AA G+ YL
Sbjct: 62 CTQKQPI--YIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK- 113
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 560
IHRD A N L+ K++DFG++++ +G Y ST M + APE
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 561 TGHLLVKSDVYSYGVVLLE 579
G +SDV+S+G++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 48/237 (20%)
Query: 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLS 431
++E LGEG FG V+K + G VA+K++ +K+ F L E+++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62
Query: 432 RLHHRNLVKLVGY---YSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHL---DWET 483
+L H N+V L+ + + Y + P + L L P + L +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKC 119
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 533
M L+ G+ YLHE+ ++HRD KA+NIL++N K+ADFGLA+
Sbjct: 120 YMLQLLE---GINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 534 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 584
G Y T ++ T Y PE + T + D++ G V E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRL---TCGGQQGDKEFLV---EVEMLSRLHHRNLVK 440
+LG+G +G V+ G+ + G +A+K++ T +KE+ EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLG--VNCHLDWETRMKIALDAARGLA 496
+G + D + + E VP GS+ S L+ GPL V C K G+A
Sbjct: 67 YLG--TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC--------KYTKQILDGVA 116
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ----APEGRTNYLSTRVMGTFG 552
YLH + CV+HRD K +N++L N K+ DFG A++ G + + + GT
Sbjct: 117 YLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
++APE KSD++S G + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 434
+E LGEG + V+K G VAIK++ G ++ K+ L E+++L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE------SWLHGPLGVNCHLDWETRMKIA 488
H N++ L+ + + + L +E + LE S + P + + M +
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMT 111
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
L RGL YLH + ++HRD K +N+L+ ++ K+ADFGLA+ + +V+
Sbjct: 112 L---RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV 164
Query: 549 GTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 586
T Y APE LL + D++S G + ELL R P
Sbjct: 165 -TRWYRAPE------LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 73/236 (30%), Positives = 109/236 (46%), Gaps = 32/236 (13%)
Query: 388 LGEGGFGRVFK-GVLSDGTAVAIKRL-----TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LG GGFGRV V S A+K + GQQ + E E+L +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 442 VGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYL 498
+ +D +++ + E G L + L G ++ R IA YL
Sbjct: 59 YRTF--KDK-KYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIAC-VVLAFEYL 109
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H +I+RD K N+LL++N + K+ DFG AK+ G+ + T GT YVAPE
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEI 163
Query: 559 AMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613
+ G+ D +S G++L ELLTGR P ++ + + IL+ +LE
Sbjct: 164 ILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDD---EDPMEIYND-ILKGNGKLE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 94/332 (28%), Positives = 145/332 (43%), Gaps = 52/332 (15%)
Query: 368 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAV----AIKRLT-CGGQQGDK 421
R L ELK +LG G FG V+KG+ + +G V AIK L G + +
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 478
EF+ E +++ + H +LV+L+G S L +L+P+G L ++H +G
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLL 111
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
L+W + A+G+ YL E ++HRD A N+L+++ H K+ DFGLA+
Sbjct: 112 LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
Query: 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 597
Y + ++A E +SDV+SYGV + EL+T G KP D
Sbjct: 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------G 214
Query: 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+ T P L +K E L P + I V + C +A+ RP E+
Sbjct: 215 IPTREIPDLLEKG--ERLPQPPICT-------IDVYMVMVKCWMIDADSRPKFKELAAEF 265
Query: 658 KMVQR------VIECQDPTLTSSNNRANLRQS 683
+ R VI+ D S N + Q+
Sbjct: 266 SRMARDPQRYLVIQGDDRMKLPSPNDSKFFQN 297
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 387 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 441
++G G FG VF+G+L AVAIK L G ++ ++FL E ++ + H N+++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL--DAARGLAYLH 499
G + + ++ E + NG+L+ +L G ++ + + + A G+ YL
Sbjct: 72 EGVVTKFKPA--MIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLS 124
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAP 556
+ + +HRD A NIL+ +N KV+DFGL++ PEG Y ++ + AP
Sbjct: 125 DMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAP 179
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 590
E SDV+S+G+V+ E+++ G +P DMS
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+++ E + GSL +L G + L + +K +LD + YL ++
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLRSR-GRSV-LGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVAPEYAMTGHLL 565
+HRD A N+L+ + AKV+DFGL K+A + T L + + APE
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+G++L E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 387 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 441
++G G FG V +G L VAIK L G ++ ++FL E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G + S ++ E + NG+L+S+L G + ++ A G+ YL E
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 558
+ +HRD A NIL+ +N KV+DFGL++ + ++ T +G + APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 590
SDV+SYG+V+ E+++ G +P DMS
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 75/252 (29%), Positives = 110/252 (43%), Gaps = 25/252 (9%)
Query: 388 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGV-------NCHLDWETRMKIALDAA 492
G D ++ +E + +G L +L HGP V L + IA A
Sbjct: 73 YGVCVEGDPL--IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
G+ YL +HRD N L+ N K+ DFG+++ + M
Sbjct: 131 AGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL--VTWARPILRDK 609
++ PE M +SDV+S GVVL E+ T G++P Q S E + +T R + R +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECITQGRVLQRPR 245
Query: 610 DRLEELADPRLG 621
+E+ D LG
Sbjct: 246 TCPKEVYDLMLG 257
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 78/312 (25%), Positives = 130/312 (41%), Gaps = 52/312 (16%)
Query: 381 NFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL 433
N LGEG FG+V K + T VA+K L + ++ L E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GPLGVNCHLDWETR---- 484
+H +++KL G S LL E GSL S+L GP + + +
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 485 -----------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533
+ A +RG+ YL E ++HRD A N+L+ K++DFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 592
E + ++ ++A E +SDV+S+GV+L E++T G P P
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
E L +L+ R+E P+ + + C E ++RPT +
Sbjct: 236 ---ERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPTFAD 278
Query: 653 VVQSLK--MVQR 662
+ + L+ MV+
Sbjct: 279 ISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 381 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLH 434
++ P +LG+G FG + L D + V K LT ++ ++ L E+ +LS L
Sbjct: 1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 435 HRNLVKLVGYYSSRDSSQHLLC-YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H N++ YY+ LL E G+L + G + E +
Sbjct: 58 HPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVS 112
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
++Y+H+ ++HRD K NI L K+ DFG++K G ++ V+GT Y
Sbjct: 113 AVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYY 167
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
++PE KSD+++ G VL ELLT ++ D + P NLV
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 35/285 (12%)
Query: 387 ILGEGGFGRVFKGVLS--DGTA--VAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
ILGEG FG V +G LS DG+ VA+K +L +EFL E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 441 LVGY-YSSRDSSQ---HLLCYELVPNGSLESWL-HGPLGVNC-HLDWETRMKIALDAARG 494
L+G + + + ++ + +G L S+L + LG L +T +K +D A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGY 553
+ YL S IHRD A N +L + VADFGL+K+ G Y R+ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVKW 181
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612
+A E KSDV+++GV + E+ T G+ P G EN + LR +RL
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-----PGVENHEIYD--YLRHGNRL 234
Query: 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
K P++ + + +C + RPT ++ + L
Sbjct: 235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 80/305 (26%), Positives = 133/305 (43%), Gaps = 46/305 (15%)
Query: 368 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTA----VAIKRLT-CGGQQGDK 421
R L EL++ +LG G FG V KG+ + +G + VAIK + G+Q +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 478
E + + L H +V+L+G + L +L P GSL + L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
L+W + A+G+ YL E ++HR+ A NILL+++ ++ADFG+A
Sbjct: 112 LNW------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 597
Y + ++A E + G +SDV+SYGV + E+++ G +P +P +
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
Query: 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
L+ ++ E LA P++ I V + C + N RPT E+
Sbjct: 223 LL----------EKGERLAQPQICT-------IDVYMVMVKCWMIDENVRPTFKELANEF 265
Query: 658 KMVQR 662
+ R
Sbjct: 266 TRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKE-------FLVEVEMLSRLHH 435
+++G G FG V+ G+ S G +A+K+ L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 436 RNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMK-IALDA 491
N+V+ Y S + HL + E VP GS+ + L +G ET ++
Sbjct: 66 ENIVQ---YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-------ETLVRNFVRQI 115
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR----- 546
+GL YLH +IHRD K +NIL++N K++DFG++K+ N LST+
Sbjct: 116 LKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGAR 169
Query: 547 --VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQ 591
+ G+ ++APE K+D++S G +++E+LTG+ P D +Q
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 433
N+ +LG+G FGRV+ D G +A+K++ + + V E+++L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 490
H +V+ YY + L + E +P GS++ L +G L TR K
Sbjct: 62 QHERIVQ---YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV-----TR-KYTRQ 112
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVM 548
G+ YLH + ++HRD K +NIL ++ + K+ DFG +K Q + + V
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VT 168
Query: 549 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 586
GT +++PE ++G K+DV+S G ++E+LT + P
Sbjct: 169 GTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V G VAIK + G D EF+ E +++ +L H LV+L G +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ + E + NG L ++L +++ D G+AYL E Q I
Sbjct: 71 QRPI--YIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYL-ESKQ--FI 122
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 564
HRD A N L+++ KV+DFGL++ + Y S+ +G+ + PE +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSS--VGSKFPVRWSPPEVLLYSKF 178
Query: 565 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623
KSDV+++GV++ E+ + G+ P + S V+ + R P L +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----------PHLASE 228
Query: 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+V I +C +A +RPT +++ S+
Sbjct: 229 -------KVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
LG+GGFG V + G A K+L ++G++ L E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 444 YYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARGLAYL 498
+ ++D LC L+ G L+ + G G E R A GL +L
Sbjct: 61 AFETKDD----LCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHL 111
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H+ +++RD K N+LL+++ + +++D GLA + G+ GT GY+APE
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEV 165
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
D ++ G L E++ GR P
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 444
+GEG +G V+K G VAIK++ + K L E+++L L+H N++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 445 YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+ + +L+ Y+L+ + P + ++ +GLA+
Sbjct: 67 FRHKGDL-YLVFEFMDTDLYKLIKDRQR----GLPESLIKSYLYQL--------LQGLAF 113
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGR--TNYLSTRVMGTFGYV 554
H ++HRD K N+L+ K+ADFGLA+ R T+Y+ TR Y
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165
Query: 555 APE--YAMTGHLLVKSDVYSYGVVLLELLTGR 584
APE G+ D++S G + ELL+ R
Sbjct: 166 APELLLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 388 LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 443
LG G FG V KGV VAIK L ++ + E + E E++ +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
++ +L E+ G L +L G + +++ + G+ YL +
Sbjct: 63 VC---EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN- 115
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 561
+HRD A N+LL N +AK++DFGL+K A +Y R G + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP 586
+SDV+SYG+ + E + G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 4e-18
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-------FLVEVEMLSRL 433
+E LGEG +G V+K G VA+K++ + D E L E+ +L L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM--KIALDA 491
H N+VKL+ + + +L+ E L+ +L + I
Sbjct: 56 KHPNIVKLLDVIHT-ERKLYLVF-EYCDM-DLKKYLD-----KRPGPLSPNLIKSIMYQL 107
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMG 549
RGLAY H ++HRD K NIL+ + K+ADFGLA+ P + V+
Sbjct: 108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP---LRTYTHEVV- 160
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
T Y APE +L+ S YS V + E++TG+
Sbjct: 161 TLWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G FG V+K + VAIK + + + E + E++ LS+ + K YY
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---YY 65
Query: 446 SS--RDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
S + S ++ E GS L G L D I + GL YLHE+
Sbjct: 66 GSFLKGSKLWII-MEYCGGGSCLDLLKPGKL------DETYIAFILREVLLGLEYLHEEG 118
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
IHRD KA+NILL K+ADFG++ Q + +T V GT ++APE
Sbjct: 119 ---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFV-GTPFWMAPEVIKQS 173
Query: 563 HLLVKSDVYSYGVVLLELLTGRKP 586
K+D++S G+ +EL G P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-18
Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
ELK+ ++FE S LG G G V K + ++L + + + L L
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-IRELQVL 57
Query: 434 HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
H N +VG+Y + S + +C E + GSL+ L + E K+++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVL 113
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
RGLAYL E Q ++HRD K SNIL+ + K+ DFG++ Q + N +GT
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRS 167
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
Y++PE H V+SD++S G+ L+EL GR P+ P +E + RP++
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 39/294 (13%)
Query: 375 LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
L++ FE ++G G +G+V+KG + G AIK + G + ++E E+ ML +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 434 -HHRNLVKLVGYYSSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
HHRN+ G + ++ Q L E GS+ + G +W I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 546
+ RGL++LH+ VIHRD K N+LL N K+ DFG++ Q GR N
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 171
Query: 547 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601
+GT ++APE KSD++S G+ +E+ G P+ P
Sbjct: 172 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------- 221
Query: 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+R + PRL K + F + +C+ +QRPT ++++
Sbjct: 222 ----MRALFLIPRNPAPRLKSKKWSKKFQ---SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 387 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 441
++GEG FG+V + ++ DG + AIK L + D ++F E+E+L +L HH N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 489
+G +R + E P G+L +L G L + ++ A
Sbjct: 69 LGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
D A G+ YL E IHRD A N+L+ N +K+ADFGL++ G Y+ + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178
Query: 550 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++A E KSDV+S+GV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 388 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+VF D VA+K L + ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP--------LGVNC-HLDWETRMKIALD 490
G + + L+ +E + +G L +L HGP V L + IA
Sbjct: 73 YGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
A G+ YL + +HRD N L+ K+ DFG+++ + R M
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++ PE + +SD++S+GVVL E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G G V+ + L + VAIKR+ Q + L EV+ +S+ +H N+VK YY
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK---YY 65
Query: 446 SSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+S L L + GSL + P G T +K L +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNG 122
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAM 560
Q IHRD KA NILL + K+ADFG++ +G R +GT ++APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 561 TGH-LLVKSDVYSYGVVLLELLTGRKP 586
H K+D++S+G+ +EL TG P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 88/333 (26%), Positives = 143/333 (42%), Gaps = 47/333 (14%)
Query: 375 LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 428
LKE F+ +LG G FG V+KG+ + +G VAIK L + +KE L E
Sbjct: 4 LKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 485
+++ + + ++ +L+G + S L +L+P G L ++ +G L+W
Sbjct: 62 VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 114
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
+ A+G+ YL E ++HRD A N+L++ H K+ DFGLAK Y +
Sbjct: 115 --CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604
++A E + +SDV+SYGV + EL+T G KP D S +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------- 222
Query: 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR-- 662
IL +RL + P I V I C +A+ RP E++ + R
Sbjct: 223 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272
Query: 663 ----VIECQDPTLTSSNNRANLRQSSTTFDSDG 691
VI+ + S +N ++ +
Sbjct: 273 QRYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 305
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLS 431
+E +G G +G V V G VAIK+++ F L E+++L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLR 54
Query: 432 RLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 487
L H N++ L + S + + + EL +E+ LH + L + ++
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DDHIQYF 108
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA------PEGRTN 541
RGL YLH + VIHRD K SNIL+ +N K+ DFGLA+ T
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
Y+ TR Y APE ++ K+ D++S G + ELLT +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 380 NNFEPASILGEGGFGRVFK----GVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSR 432
NN E +G+G FGRVF+ G+L T VA+K L +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 433 LHHRNLVKLVGYYSS--------------------RDSSQHLLCYELVPNGSLESWLHGP 472
H N+VKL+G + R S C S P
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
L ++C ++ IA A G+AYL E +HRD N L+ N K+ADFGL+
Sbjct: 125 LPLSC----TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ S ++ PE +SDV++YGVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+LG+G +G V+ LS +AIK + + + E+ + S L HRN+V+ +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 446 SSRDSSQHLLCY-ELVPNGSLESWLH---GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 500
S + E VP GSL + L GPL N E + GL YLH+
Sbjct: 75 SENG---FFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEGLKYLHD 126
Query: 501 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 557
+ ++HRD K N+L+ N + K++DFG +K+ N + GT Y+APE
Sbjct: 127 NQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV 180
Query: 558 --YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 592
G+ +D++S G ++E+ TG+ P +++ +P
Sbjct: 181 IDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 71/235 (30%), Positives = 101/235 (42%), Gaps = 54/235 (22%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLV----------EV 427
++FE LG G FGRV V G+ A+K L K +V E
Sbjct: 1 DDFEFIKTLGTGSFGRVML-VRHKGSGKYYALKIL-------SKAKIVKLKQVEHVLNEK 52
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
+L + H LV L Y S +D S L E VP G L S L +
Sbjct: 53 RILQSIRHPFLVNL--YGSFQDDSNLYLVMEYVPGGELFSHL-----RKSG-------RF 98
Query: 488 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539
AR L YLH +++RD K N+LL+++ + K+ DFG AK+ +GR
Sbjct: 99 PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGR 154
Query: 540 TNYLSTRVMGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQP 592
T L GT Y+APE + G+ K+ D ++ G+++ E+L G P P
Sbjct: 155 TYTLC----GTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 388 LGEGGFGRVFKGVL-----SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGE FG+++KG L VAIK L Q EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG--------VNCHLDWETRMKIA 488
+G + L +E + G L +L H +G V LD + IA
Sbjct: 73 LGVVTQEQPVCML--FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
+ A G+ YL S +H+D A NIL+ H K++D GL+++ + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++ PE M G SD++S+GVVL E+ + G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 55/286 (19%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+G G FG V K + GT +A+KR+ ++ K L++++++ R + +V +Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKFY 69
Query: 446 ----SSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIALDAARGLAYL 498
D +C EL+ + SL+ + ++ L + E KIA+ + L YL
Sbjct: 70 GALFREGDC---WICMELM-DISLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYL 123
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
E+ + +IHRD K SNILL+ N + K+ DFG++ Q + + TR G Y+APE
Sbjct: 124 KEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPER 178
Query: 559 AMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
V+SDV+S G+ L E+ TG+ P W D+L ++
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF----DQLTQV 223
Query: 616 AD---PRLGGKYPKE------DFIRVCTIAAACVAPEANQRPTMGE 652
P L +E +FI +C I + ++RP E
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIK------DESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 24/214 (11%)
Query: 382 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 437
F +LG+GGFG V V + G A K+L ++G+ L E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 438 LVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAA 492
+V L Y ++D+ LC L+ G L+ ++ G G E R A +
Sbjct: 62 VVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEIC 112
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
GL LH++ +++RD K NILL+++ H +++D GLA PEG+T + RV GT G
Sbjct: 113 CGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y+APE D ++ G +L E++ G+ P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 368 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDK 421
R L ELK+ +LG G FG V+KG+ + DG VAIK L + +K
Sbjct: 2 RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 478
E L E +++ + + +L+G + S L +L+P G L ++ +G
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
L+W + A+G++YL E ++HRD A N+L+++ H K+ DFGLA+
Sbjct: 112 LNW------CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162
Query: 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 597
T Y + ++A E + +SDV+SYGV + EL+T G KP D
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP------ 216
Query: 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
AR I ++ E L P + I V I C ++ RP E+V
Sbjct: 217 ----AREIPDLLEKGERLPQPPICT-------IDVYMIMVKCWMIDSECRPRFRELVDEF 265
Query: 658 KMVQR 662
+ R
Sbjct: 266 SRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 380 NNFEPASILGEGGFGRVFKGV---LSDGTA---VAIKRLTCGGQQGDKEFLV-EVEMLSR 432
NN LG G FG+V + LS A VA+K L ++E L+ E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 433 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
L +H N+V L+G + L+ E G L ++L L E + +
Sbjct: 95 LGNHENIVNLLG--ACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQV 150
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL---STRVM 548
A+G+A+L S+ C IHRD A N+LL + K+ DFGLA+ +NY+ + R+
Sbjct: 151 AKGMAFL--ASKNC-IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARL- 205
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++APE +SDV+SYG++L E+ +
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-17
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E+ + +L H N+VKL+G R L +E + +L L L WE R
Sbjct: 733 EIADMGKLQHPNIVKLIG--LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
KIA+ A+ L +LH P V+ + I+++ + L ++S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605
YVAPE T + KSD+Y +G++L+ELLTG+ P D ++ ++V WAR
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYC 895
Query: 606 LRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
D L+ DP + G + + + V +A C A + RP +V+++L+ R
Sbjct: 896 YSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 387 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 441
++GEG FG+V K + DG + AIKR+ + D ++F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 489
+G R L E P+G+L +L L + + A
Sbjct: 62 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
D ARG+ YL + IHRD A NIL+ N+ AK+ADFGL++ G+ Y+ + MG
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMG 171
Query: 550 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++A E SDV+SYGV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 381 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRL 433
N + + LG G FG VF T V +K L + EF E++M +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLGVNCHLDWETRMKIA 488
H+N+V+L+G R++ H + E G L+ +L L + ++ +
Sbjct: 66 SHKNVVRLLGL--CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
A G+ +L S +HRD A N L+ + KV+ L+K Y +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNAL 179
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
++APE KSDV+S+GV++ E+ T + P L D
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----LPFYG----------LSD 224
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
++ L L +L P+ R+ + C A RP+ E+V +L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 74/217 (34%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 382 FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHR 436
+E S +GEG +G VFK + G VAIK+ + D K L E+ ML +L H
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHP 60
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
NLV L+ + R HL+ +E + L P GV HL KI + +
Sbjct: 61 NLVNLIEVFR-RKRKLHLV-FEYCDHTVLNELEKNPRGVPEHL----IKKIIWQTLQAVN 114
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGR-TNYLSTRVMGTFGY 553
+ H C IHRD K NIL+ K+ DFG A+ P T+Y++TR Y
Sbjct: 115 FCH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166
Query: 554 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTG 583
APE LLV DV++ G V ELLTG
Sbjct: 167 RAPE------LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)
Query: 388 LGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 444
+GEG G VFK G VA+K++ +G + L E++ L H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL--- 64
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD-----WETR--MKIALDAARGLAY 497
D H + LV +E V + + + M++ L G+AY
Sbjct: 65 ---LDVFPHGSGFVLV----MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAY 114
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAP 556
+H + ++HRD K +N+L+ + K+ADFGLA+ + E Y S +V T Y AP
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAP 169
Query: 557 EYAMTGHLLVKS-------DVYSYGVVLLELLTGR 584
E LL + D+++ G + ELL G
Sbjct: 170 E------LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V+ + T VA+K + G + FL E ++ L H LVKL +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ E + GSL +L G L + + A G+A++ + + I
Sbjct: 73 EPI---YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 124
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 565
HRD +A+NIL+ + K+ADFGLA+ + N + R F + APE G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 566 VKSDVYSYGVVLLELLT-GRKPV-DMSQP 592
+KSDV+S+G++L+E++T GR P MS P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 375 LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
L++ FE ++G G +G+V+KG + G AIK + + ++E +E+ ML +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69
Query: 434 -HHRNLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
HHRN+ G + + H L E GS+ + G DW I
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--IC 127
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 546
+ RGLA+LH VIHRD K N+LL N K+ DFG++ Q GR N
Sbjct: 128 REILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 181
Query: 547 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPV-DM 589
+GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 182 -IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 77/305 (25%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 388 LGEGGFGRV----------------FKGVLSDGTA-VAIKRLTCGG-QQGDKEFLVEVEM 429
LGEG FG V + +D VA+K L ++FL EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 430 LSRLHHRNLVKLVG-------------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 476
LSRL N+ +L+G Y + D +Q L + +G +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS------ 126
Query: 477 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
L + T + +A A G+ YL +HRD N L+ N+ K+ADFG+++
Sbjct: 127 --LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVD-MSQPS 593
+ R ++A E + G KSDV+++GV L E+LT +P + ++
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
EN A RD R L P PK+ + + C + RPT E+
Sbjct: 242 VIEN----AGHFFRDDGRQIYLPRPPN---CPKDIYELMLE----CWRRDEEDRPTFREI 290
Query: 654 VQSLK 658
L+
Sbjct: 291 HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 72/234 (30%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 436
+G+GG+G+VF D G VA+KR+ K L E ++L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK-------KSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARG 494
LVKL Y+ +D L E VP G + L+ G L + + M A+DA
Sbjct: 62 WLVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L Y IHRD K N L++ + H K+ DFGL+K + V+G+ Y+
Sbjct: 120 LGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYM 165
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTW 601
APE Y T D +S G +L E L G P S P+ ENL W
Sbjct: 166 APEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 387 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 438
LGEG FG+V K + VA+K L + D + + E+EM+ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------MK 486
+ L+G +++ +++ E +G+L +L P G D +
Sbjct: 79 INLLGV-CTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
A ARG+ +L S+ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 137 FAYQVARGMEFL--ASKKC-IHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKT 191
Query: 547 VMGTFGY--VAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
G +APE +SDV+S+GV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 382 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 437
F +LG+GGFG V V + G A KRL ++G+ L E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 438 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
+V L Y ++D+ LC L + G L+ ++ +G N + E + A + GL
Sbjct: 62 VVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFEEERALFYAAEILCGL 115
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
LH ++ ++RD K NILL++ H +++D GLA + PEG + + RV GT GY+A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE + D + G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 39/283 (13%)
Query: 388 LGEGGFGRVFKGVLSDGTAVA---IKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG 443
+G G FG+V G G + A +K L FL EV+ L+H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDS 502
+S +LL E P G L+++L G V + ++A + A GL +LH+
Sbjct: 63 --QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRVMGTFG--YVAPEYA 559
IH D N L + K+ D+GLA +Q PE +Y T+ ++APE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE---DYYITKDCHAVPLRWLAPELV 174
Query: 560 MTGH--LLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611
LL KS+++S GV + EL T +P S ++ L + ++R++D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSDEQVL----KQVVREQDI 228
Query: 612 LEELADPRLGGKYPKEDFIRVCTIAAAC-VAPEANQRPTMGEV 653
+L P+L KY R + C + PE RPT EV
Sbjct: 229 --KLPKPQLDLKYSD----RWYEVMQFCWLDPE--TRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 437
+ +E LG+G FG+V+K G A K + ++ ++F+VE+++LS H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIAL---DA 491
+V L Y + L+ E G+L+S L L T +I
Sbjct: 64 IVGLYEAYFYENKLWILI--EFCDGGALDSIMLELERGL---------TEPQIRYVCRQM 112
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
L +LH VIHRD KA NILL + K+ADFG++ A T +GT
Sbjct: 113 LEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTP 167
Query: 552 GYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 586
++APE K+D++S G+ L+EL P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G FG VFKG+ + VAIK + + + E + E+ +LS+ + K G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 504
+D+ ++ L +L+ GPL ET++ L + +GL YLH + +
Sbjct: 72 L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 122
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
IHRD KA+N+LL + K+ADFG+A Q + T +GT ++APE
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 624
K+D++S G+ +EL G P P L+ P P L G Y
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 225
Query: 625 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
P ++F+ AC+ E + RPT E+++
Sbjct: 226 SKPLKEFVE------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 383 EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 437
+GEG FG V++GV ++ AVA+K +E FL E ++ + H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLA 496
+VKL+G + + EL P G L S+L VN + LD + + + + LA
Sbjct: 69 IVKLIGVITENPV---WIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALA 121
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YL S+ V HRD A N+L+ + K+ DFGL++ E + Y +++ ++AP
Sbjct: 122 YLE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAP 177
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
E SDV+ +GV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 382 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 437
F +LG+GGFG V V + G A K+L ++G+ L E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 438 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
+V L Y ++D+ LC L + G L+ ++ +G N D + + A + GL
Sbjct: 62 VVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFDEQRAIFYAAELCCGL 115
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
L + +++RD K NILL++ H +++D GLA Q PEG T + RV GT GY+A
Sbjct: 116 EDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMA 169
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE D + G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 71
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 503
+R+ +++ E + G+L +L C+ ++ + +A + + YL + +
Sbjct: 72 TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
IHRD A N L+ N KVADFGL++ G T + APE
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQ 591
+KSDV+++GV+L E+ T G P +D+SQ
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 16/251 (6%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 433
ELK+ ++FE S LG G G VFK V + + + R + + L L
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 434 HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
H N +VG+Y + S + +C E + GSL+ L + + K+++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVI 113
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
+GL YL E + ++HRD K SNIL+ + K+ DFG++ Q + N +GT
Sbjct: 114 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRS 167
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612
Y++PE H V+SD++S G+ L+E+ GR P+ P +E + + P+ D
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI--PPPDAKELELMFGCPVEGDPAES 225
Query: 613 EELADPRLGGK 623
E PR G+
Sbjct: 226 ETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 35/231 (15%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-FLV----EVEM 429
K + F+ +GEG +G+V+K D G VA+K++ +KE F + E+++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKI 59
Query: 430 LSRLHHRNLVKLVGYYSS--------RDSSQHLLCYELVPN---GSLESWLHGPLGVNCH 478
L +L+HRN+V L + +D L +E + + G LES L V+
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFS 114
Query: 479 LDW-ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
D ++ MK L+ GL Y H+ + +HRD K SNILL N K+ADFGLA+
Sbjct: 115 EDHIKSFMKQLLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 587
+ + +V+ T Y PE + + DV+S G +L EL T +KP+
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 51/257 (19%)
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGP-------LGVNCHLDW 481
L LH N +VG+Y + S + +C E + GSL+ L LG
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG------- 102
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
KI++ RGL YL E + ++HRD K SNIL+ + K+ DFG++ Q +
Sbjct: 103 ----KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 152
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601
++ +GT Y++PE H V+SD++S G+ L+E+ GR P+ E +
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 602 ARPILRDKDRLE----------------ELAD-------PRLGGKYPKEDFIRVCTIAAA 638
K+ EL D P+L ++F
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF---QDFVDK 269
Query: 639 CVAPEANQRPTMGEVVQ 655
C+ +R + E+ +
Sbjct: 270 CLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 33/292 (11%)
Query: 382 FEPASILGEGGFGRVFKGVL--SDGT--AVAIKRLTCG--GQQGDKEFLVEVEMLSRLHH 435
F +LG+G FG V + L DG+ VA+K L +EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 436 RNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL-HGPLGVN-CHLDWETRMKIAL 489
N++KL+G + L + + +G L ++L +G L +T ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
D A G+ YL S IHRD A N +L N VADFGL+K+ G
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 608
++A E SDV+++GV + E++T G+ P +G EN + I
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLI--- 229
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
RL K P + V + C +PE RP+ + L+++
Sbjct: 230 -------KGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSR 432
+ +++E +G G +G V+K L G A+K + + GD L++ E M+
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKE 62
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALD 490
H N+V G Y SR+ + +C E GSL+ H GPL + + R +
Sbjct: 63 CKHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----E 114
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VM 548
+GLAYLH + +HRD K +NILL +N K+ADFG+A + T ++ R +
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFI 167
Query: 549 GTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPV 587
GT ++APE A G D+++ G+ +EL + P+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 36/220 (16%)
Query: 382 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 437
F +LG+GGFG V V + G A K+L ++G+ L E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 438 LVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAAR 493
+V L Y ++D+ LC L+ G L+ ++ G G D E + A +
Sbjct: 62 VVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITC 113
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GL LH + +++RD K NILL++ H +++D GLA + PEG T + RV GT GY
Sbjct: 114 GLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGY 167
Query: 554 VAPEYAMTGHLLVKSDVYSY-------GVVLLELLTGRKP 586
+APE +VK++ Y++ G ++ E++ G+ P
Sbjct: 168 MAPE-------VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 16/240 (6%)
Query: 363 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 421
P ++ L E L + T+ +E +G+G +G+V+K DG+ A+K L D+
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDE 63
Query: 422 EFLVEVEMLSRL-HHRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 477
E E +L L +H N+VK G + D Q L EL GS+ + G L
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
LD I A GL +LH + +IHRD K +NILL K+ DFG++ Q
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 592
R ++ +GT ++APE + DV+S G+ +EL G P+ P
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 391 GGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFL-VEVE---MLSRLHHRNLVKLVGY 444
G FG V+ K + G AIK L + V+ E M+ + + KL
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL--- 62
Query: 445 YSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHED 501
Y S S +L L E + G S + G L DW + IA + G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP----EDW-AKQYIA-EVVLGVEDLHQR 116
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
+IHRD K N+L++ H K+ DFGL+ R + + +GT Y+APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILG 167
Query: 562 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
SD +S G V+ E L G P P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 48/292 (16%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 437
++ E LG G +G V K + GT +A+KR+ Q K L+++++ R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-- 58
Query: 438 LVKLVGYYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
V +Y + R+ +C E++ + SL+ + + + KIA+ + L
Sbjct: 59 CPYTVTFYGALFREGDV-WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYV 554
YLH + VIHRD K SN+L+ N K+ DFG++ + ++ T G Y+
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKPYM 170
Query: 555 APEY----AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
APE VKSDV+S G+ ++EL TGR P D +W P + K
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPFQQLKQ 219
Query: 611 RLEELADPRLGGKYPKE-------DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+EE P+L P E DF+ C +RP E++Q
Sbjct: 220 VVEE-PSPQL----PAEKFSPEFQDFVNKCLKK------NYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 441
++G+G FG V+ G L D A+K L + ++FL E ++ H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARG 494
+G + S ++ L HG L + ET + L A+G
Sbjct: 62 LGICLPSEGSPLVV---------LPYMKHGDL--RNFIRSETHNPTVKDLIGFGLQVAKG 110
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVMGT 550
+ YL +HRD A N +L+ +F KVADFGLA+ + Y S T
Sbjct: 111 MEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGAKLP 165
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++A E T KSDV+S+GV+L EL+T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 444
++G G +G V++G + G VA+K + D + EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 445 YSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARGLAYLH 499
Y S L + E GS+ + + GP+ I++ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---------ISVIIREVLVALKYIH 118
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ VIHRD KA+NIL+ N + K+ DFG+A + + ST V GT ++APE
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVI 173
Query: 560 MTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
G K+D++S G+ + E+ TG P L+ ++P P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------P 220
Query: 619 RL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 656
RL Y K +F+ AAC+ E +R + E+++S
Sbjct: 221 RLEDNGYSKLLREFV------AACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 34/244 (13%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---EVEMLSRLHHR 436
+FE +G G +G V+K ++ G AIK + + ++F V E+ M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHS 66
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMK-IALDAAR 493
N+V G Y RD + +C E GSL+ H GPL E+++ ++ + +
Sbjct: 67 NIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYHVTGPLS-------ESQIAYVSRETLQ 117
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTF 551
GL YLH + +HRD K +NILL +N H K+ADFG++ Q T ++ R +GT
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTP 170
Query: 552 GYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---WARPI 605
++APE A G D+++ G+ +EL + P+ P L+T + P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
Query: 606 LRDK 609
L+DK
Sbjct: 231 LKDK 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 387 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 441
++G G FG V G L VAIK L G ++ ++FL E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G + S ++ E + NGSL+++L G + + A G+ YL +
Sbjct: 71 EGVVTK--SKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM 125
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEY 558
+HRD A NIL+ +N KV+DFGL++ PE Y + + APE
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 180
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 590
SDV+SYG+V+ E+++ G +P +MS
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 35/304 (11%)
Query: 364 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQQGDK 421
P S + + ++ + ++ +E +G+G +G+VFK VL+ +G+ A+K L D+
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILD-PIHDIDE 59
Query: 422 EFLVEVEMLSRLH-HRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 477
E E +L L H N+VK G Y +D Q L EL GS+ + G L
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
++ I +A GL +LH + IHRD K +NILL K+ DFG++ Q
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 592
R ++ +GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
Query: 593 SGQENLVTWARPILR-DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 651
R + + ++ L P L DFIR C+ + +RPT+
Sbjct: 235 ---------MRALFKIPRNPPPTLHQPELWSN-EFNDFIR------KCLTKDYEKRPTVS 278
Query: 652 EVVQ 655
+++Q
Sbjct: 279 DLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 388 LGEGGFGRVFKGVLSDGT------AVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVK 440
LGE FG+V+KG L AVAIK L + +EF E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG-------VNCHLDWETRMKIA 488
L+G + + Y + L +L H +G V L+ + I
Sbjct: 73 LLGVVTKEQPLSMIFSY--CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
A G+ +L S V+H+D N+L+ + + K++D GL ++ L +
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+++PE M G + SD++SYGVVL E+ + G +P
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 388 LGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
LG+GGFG V V + G A K+L + G+K L+E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 444 YYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHE 500
+ +S HL L L+ G L+ ++ G G L+ E + + G+ +LH
Sbjct: 61 AF---ESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHS 113
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+++RD K N+LL++ + +++D GLA + +G+T T+ GT GY+APE
Sbjct: 114 MD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILK 167
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILRDKDRLE 613
D ++ G + E++ GR P D + +E L R L D+ + E
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTLEDEVKFE 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 39/274 (14%)
Query: 388 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G FG V+KG+ + VAIK + + + E + E+ +LS+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 446 SSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQ 503
++ + E + GS L GPL ET + L + +GL YLH + +
Sbjct: 72 LK--GTKLWIIMEYLGGGSALDLLKPGPLE-------ETYIATILREILKGLDYLHSERK 122
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
IHRD KA+N+LL K+ADFG+A Q + T +GT ++APE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 564 LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623
K+D++S G+ +EL G P P L+ P P L G+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 224
Query: 624 Y--PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
Y P ++F+ AC+ + RPT E+++
Sbjct: 225 YSKPFKEFVE------ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 387 ILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVK 440
+L EG FGR+F G+L D V +K + + L E +L L H+N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLA 496
++ D + Y + G+L+ +L G L + + +A+ A G++
Sbjct: 73 ILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YLH+ VIH+D A N +++ K+ D L++ + L ++A
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
E + SDV+S+GV+L EL+T G+ P P + + L+D RL +
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LKDGYRLAQP 241
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+ P E F + A C A + +RP+ ++VQ L
Sbjct: 242 IN------CPDELF----AVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 388 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
LG+G FG V+ KGV+ D T VAIK + ++ EFL E ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGVNCHLDWETRMKIALDAARG 494
L+G S + L+ EL+ G L+S+L V + +++A + A G
Sbjct: 74 LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 552
+AYL+ + +HRD A N ++ +F K+ DFG+ + E T+Y G
Sbjct: 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
+++PE G SDV+S+GVVL E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 62/234 (26%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-------CGGQQGDKEFLVEVEMLSR 432
++ S +GEG +G V G VAIK+++ C + L E+++L R
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC------QRTLREIKILRR 59
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM------- 485
H N++ + +++ S ES + V + ET +
Sbjct: 60 FKHENIIGI---------------LDIIRPPSFES-FNDVYIVQELM--ETDLYKLIKTQ 101
Query: 486 KIALDAA--------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-P 536
++ D RGL Y+H + V+HRD K SN+LL N K+ DFGLA+ A P
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 537 EGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
E T Y++TR Y APE + K+ D++S G +L E+L+ R
Sbjct: 159 EHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 6e-15
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 437
LG+G FG V+ G VAIK++ K+F L EV+ L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSL----ESWLHGPLGVNCHLDWETRMK-IALDAA 492
+VKL R++ + +E + G+L + P E+ ++ I
Sbjct: 60 IVKL--KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-------ESVIRSIIYQIL 109
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-----TNYLSTRV 547
+GLA++H+ HRD K N+L+ K+ADFGLA+ E R T+Y+STR
Sbjct: 110 QGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR- 162
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYS-------YGVVLLELLTGR 584
Y APE +L++S YS G ++ EL T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 388 LGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
LGEG FG V +G L+ AV ++ + ++FL E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 443 GYYSSRDSSQH----LLCYELVPNGSLESWL-HGPLGVNCHLDWETRM--KIALDAARGL 495
G S+ ++ + +G L S+L + LG +C T+M K D A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGM 125
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYV 554
YL S IHRD A N +L N + VADFGL+K+ G Y R+ ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVKWI 181
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 613
A E KSDV+S+GV + E+ T G+ P G EN + LR +RL+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIY--DYLRQGNRLK 234
Query: 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ D L G Y ++ ++C RP+ + L+
Sbjct: 235 QPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 74/269 (27%), Positives = 113/269 (42%), Gaps = 49/269 (18%)
Query: 388 LGEGGFGRV---------------FKGVLSDGTA--VAIKRLTCGGQQGDK-EFLVEVEM 429
LGEG FG V F + G VA+K L + + +FL EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH---------------GP 472
LSRL N+++L+G D LC E + NG L +L P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
+ + + + +AL A G+ YL S +HRD N L+ N K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
+ G + R + ++A E + G SDV+++GV L E+L + QP
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241
Query: 593 SGQ---ENLVTWARPILRDKDRLEELADP 618
G+ E ++ A RD+ R L P
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRP 270
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 48/228 (21%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---F----LVEVEMLSR 432
+E + + EG +G V++ G VA+K+L + +KE F L E+ +L +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLK 60
Query: 433 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPNG--SLESWLHGPLGVNCHLDWETRMK 486
L H N+V + VG + + + E V + SL + P + + + M
Sbjct: 61 LQHPNIVTVKEVVVG----SNLDKIYMVMEYVEHDLKSLMETMKQPFLQS---EVKCLML 113
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
L G+A+LH++ ++HRD K SN+LL N K+ DFGLA++ Y T+
Sbjct: 114 QLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQ 165
Query: 547 VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPV 587
++ T Y APE LL+ D++S G + ELLT +KP+
Sbjct: 166 LVVTLWYRAPE------LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 388 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF---LVEVEMLSRLHHRNLVKLVG 443
+G G FG V F + VAIK+++ G+Q ++++ + EV L +L H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 502
Y ++ ++ Y L + PL E + I A +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQ-------EVEIAAICHGALQGLAYLHSH- 134
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE--YAM 560
IHRD KA NILL K+ADFG A + +GT ++APE AM
Sbjct: 135 --ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAM 186
Query: 561 -TGHLLVKSDVYSYGVVLLELLTGRKP 586
G K DV+S G+ +E L RKP
Sbjct: 187 DEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 47/225 (20%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-------FLVEVEMLSR 432
FE + +GEG +G V++ + G VA+K++ + D E L E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLN 62
Query: 433 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWE 482
L H N+V+L VG +HL LV SL + P E
Sbjct: 63 LRHPNIVELKEVVVG--------KHLDSIFLVMEYCEQDLASLLDNMPTPFS-------E 107
Query: 483 TRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
+++K + L RGL YLHE+ +IHRD K SN+LL + K+ADFGLA+ G
Sbjct: 108 SQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162
Query: 542 YLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGR 584
T + T Y APE T + D+++ G +L ELL +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G FG VFKG+ + VAIK + + + E + E+ +LS+ + K G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 446 SSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
++ + E + GS L+ GP T +K L +GL YLH + +
Sbjct: 72 LK--GTKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEIL---KGLDYLHSEKK- 122
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
IHRD KA+N+LL K+ADFG+A Q + T +GT ++APE
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 624
K+D++S G+ +EL G P P +R + + P L G++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHP-------------MRVLFLIPKNNPPTLTGEF 225
Query: 625 PK--EDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
K ++FI AC+ + + RPT E+++
Sbjct: 226 SKPFKEFID------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 388 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
LG G FG V KG+ AV I + E L E ++ +L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
G ++ +L EL G L +L N H+ + ++ + G+ YL E +
Sbjct: 63 GIC---EAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 560
+HRD A N+LL +AK++DFGL+K A NY + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 561 TGHLLVKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+GV++ E + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
LG G FG V G VAIK + G + +F+ E +++ +L H LV+L G +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ + E + NG L ++L G L + + + D G+ YL +S I
Sbjct: 71 QKPL--YIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------YVAPEYAMT 561
HRD A N L+ + KV+DFG+ + L + G + PE
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620
KSDV+S+GV++ E+ T G+ P + N ++ R L P+L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NY-----EVVEMISRGFRLYRPKL 225
Query: 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
V + +C + RPT E+++++
Sbjct: 226 ASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 51/300 (17%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLH 434
NF+ +G+G F V+K + L DG VA+K++ + ++ L E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 435 HRNLVKLVGYYSSR-DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H N++K Y +S ++++ + EL G L + + T K +
Sbjct: 61 HPNVIK---YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
L ++H ++HRD K +N+ + K+ D GL GR + S++
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGL------GR--FFSSKTTAAHSL 166
Query: 554 VAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607
V Y M+ + KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------------------ 208
Query: 608 DKDRLEELADPRLGGKY---PKEDF---IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661
DK L L Y P + + +R + + C+ P+ +RP + V+Q K +
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 77/301 (25%), Positives = 115/301 (38%), Gaps = 84/301 (27%)
Query: 380 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE----------FLV 425
++FE ++G G FG V+ L G A+K L K
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRA 50
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 484
E ++L+ +VKL YYS +D +HL L E +P G L + L + + + R
Sbjct: 51 ERDILADADSPWIVKL--YYSFQDE-EHLYLVMEYMPGGDLMNLL---IRKDVFPEETAR 104
Query: 485 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539
+ +ALD+ L + IHRD K NIL++ + H K+ADFGL K+ + +
Sbjct: 105 FYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 540 TNYL----------------------STRVM-----GTFGYVAPEYAMTGHLLVKSDVYS 572
RV GT Y+APE ++ D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 573 YGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFI 630
GV+L E+L G P T+ + I+ K+ L DP E D I
Sbjct: 216 LGVILYEMLYGFPPF-----YSDTLQETYNK-IINWKESLRFPPDP----PVSPEAIDLI 265
Query: 631 R 631
Sbjct: 266 C 266
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 387 ILGEGGFGRVFKG-VLSDGTAVAIK----RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
ILG G G V+K L +A+K +T Q K+ + E+E+L + ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYIIGF 64
Query: 442 VG--YYSSRDSSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLA 496
G + +R S +C E + GSL+ + P LG +IA+ +GL
Sbjct: 65 YGAFFVENRIS----ICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLT 109
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
YL ++HRD K SN+L+ K+ DFG++ Q N ++ +GT Y+AP
Sbjct: 110 YLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAP 162
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
E + SDV+S G+ +EL GR P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 443
+G G FG V+ S VA+K+++ G+Q + ++ + EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 502
Y ++ ++ Y L L PL E + I A +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLHSH- 140
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT- 561
+IHRD KA NILL K+ADFG A ++ + +GT ++APE +
Sbjct: 141 --NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAM 192
Query: 562 --GHLLVKSDVYSYGVVLLELLTGRKP 586
G K DV+S G+ +E L RKP
Sbjct: 193 DEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 388 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 443
+G G FG V F + + VAIK+++ G+Q + ++ + EV L +L H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHE 500
Y ++ ++ Y L L PL ++IA A +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHS 133
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ +IHRD KA NILL K+ DFG A AP + +GT ++APE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183
Query: 560 MT---GHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILR 607
+ G K DV+S G+ +EL + P+ +M+ S ++ P L+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG+G FG+V+K + G A K + ++ ++++VE+E+L+ +H +VKL+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ + E P G++++ + L ++ L I L YLH +
Sbjct: 80 W--DGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHSMK---I 131
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL- 565
IHRD KA N+LL + K+ADFG++ A +T +GT ++APE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 566 ----VKSDVYSYGVVLLEL 580
K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 51/250 (20%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEM 429
+ + +E + +G+G FG VFK VA+K++ + KE F L E+++
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKI 64
Query: 430 LSRLHHRNLVKLV------GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW-- 481
L L H N+V L+ +R L +E E L G L N ++ +
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLS-NKNVKFTL 118
Query: 482 ---ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QA 535
+ MK+ L+ GL Y+H + ++HRD KA+NIL+ + K+ADFGLA+ +
Sbjct: 119 SEIKKVMKMLLN---GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 588
+ N + RV+ T Y PE LL+ D++ G ++ E+ T R P+
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPE------LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI- 223
Query: 589 MSQPSGQENL 598
M + Q L
Sbjct: 224 MQGNTEQHQL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 388 LGEGGFGRVFKGVLSDGTA--VAIKRLTC-------GGQQGDKEF---LVEVEML-SRLH 434
LG G FG V+K + +A+K + ++ DK + EV ++ +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 435 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H N+V+ YY + + L + +L+ L + E I +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
L YLH++ + ++HRD +NI+L + + DFGLAKQ + + L T V+GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSVVGTILY 179
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613
PE K+DV+++G +L ++ T + P N+++ A I +E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI------VE 227
Query: 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
+ +P G Y + V + +C+ P+A RP + +V
Sbjct: 228 AVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 380 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH-R 436
N+ E +G G G+V+K G +A+K++ G ++ +K L++++++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPN--GSLESWLHGP-----LGVNCHLDWETRMKIAL 489
+VK GY+ + S +C EL+ L + GP LG K+ +
Sbjct: 75 YIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----------KMTV 121
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ L YL E VIHRD K SNILL+ + + K+ DFG++ + + + TR G
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 550 TFGYVAPEY----AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y+APE +++DV+S G+ L+EL TG+ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG+G FG+V+K + G A K + ++ ++++VE+++L+ H N+VKL+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 447 SRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKI----ALDAARGLAYLH 499
++ L+ E G++++ L PL E ++++ L+A L YLH
Sbjct: 73 YENNLWILI--EFCAGGAVDAVMLELERPLT-------EPQIRVVCKQTLEA---LNYLH 120
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
E+ +IHRD KA NIL + K+ADFG++ A RT +GT ++APE
Sbjct: 121 ENK---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 560 MTGH-----LLVKSDVYSYGVVLLEL 580
M K+DV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 28/262 (10%)
Query: 358 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGG 416
GSL P E+ ++ F +G G FG V F + VAIK+++ G
Sbjct: 6 AGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62
Query: 417 QQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 473
+Q + ++ + EV+ L R+ H N ++ G Y ++ ++ Y L L PL
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 122
Query: 474 GVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
E + I A +GLAYLH + +IHRD KA NILL K+ADFG A
Sbjct: 123 Q-------EVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPV-D 588
A + +GT ++APE + G K DV+S G+ +EL + P+ +
Sbjct: 173 SIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
Query: 589 MSQPSGQENLVTWARPILRDKD 610
M+ S ++ P L+ +
Sbjct: 227 MNAMSALYHIAQNESPTLQSNE 248
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 381 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHR 436
+E +GEG FG+++ K SD IK LT + + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 492
N+V + S +++ + + E G L ++ GV + L W ++I+L
Sbjct: 60 NIVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL--- 112
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
GL ++H+ ++HRD K+ NI L +N AK+ DFG+A+Q + + L+ +GT
Sbjct: 113 -GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTP 166
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
Y++PE K+D++S G VL EL T + P +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRL 433
E TN + +G G FG V G VAIK++ K E+++L L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MK 486
H N++ L + S + + EL LG + H +R
Sbjct: 67 RHENIISLSDIFISPLEDIYFVT-EL-------------LGTDLHRLLTSRPLEKQFIQY 112
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
RGL Y+H V+HRD K SNIL+ N K+ DFGLA+ T Y+STR
Sbjct: 113 FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169
Query: 547 VMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 587
Y APE +T V+ D++S G + E+L G KP+
Sbjct: 170 Y-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGDKEFLV-EVEMLSRL---HH 435
+E + +GEG +G V+K L+ G VA+K++ ++G + E+ +L +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 436 RNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 489
N+V+L G + R+ L+ +E V + L ++L G L ET +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLV-FEHV-DQDLATYLSKCPKPG----LPPETIKDLMR 114
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
RG+ +LH ++HRD K NIL+ ++ K+ADFGLA+ T V+
Sbjct: 115 QLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVV 168
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
T Y APE + D++S G + EL R+P
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 388 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
LG+G FG V++G D T VA+K + ++ EFL E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 492
L+G S + L+ EL+ +G L+S+L + P L + +++A + A
Sbjct: 74 LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIA 129
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF- 551
G+AYL+ +HRD A N ++ ++F K+ DFG+ + E T+Y G
Sbjct: 130 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 552 -GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++APE G SD++S+GVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 57/274 (20%), Positives = 116/274 (42%), Gaps = 39/274 (14%)
Query: 395 RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKLVGYYSSRDS 450
++KG+ + V I+ +G K + E++ L R+ N++K+ G+ D
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKF-HKGHKVLIDITENEIKNLRRIDSNNILKIYGFII--DI 90
Query: 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHR 509
L L+ +L L L ++T++ +A+D +GL L++ ++P ++
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 510 DFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 566
+ + + L+ N+ K+ GL K P N++ + EY +
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY------TI 201
Query: 567 KSDVYSYGVVLLELLTGRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 625
K D+YS GVVL E+ TG+ P + ++ + ++ +L P
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII---------NKNNSL----KLPLDCP 248
Query: 626 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659
E + I AC + ++ +RP + E++ +L +
Sbjct: 249 LE----IKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 381 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRLHHR 436
+E ++G G FG V + +D V IK++ D+ E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 437 NLVKLVGYYSS-RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
N++ YY + + ++ E P G+L ++ N LD +T + + L
Sbjct: 60 NII---EYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLAL 114
Query: 496 AYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
++H ++HRD K NILL+ + K+ DFG++K Y V+GT Y+
Sbjct: 115 HHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCYI 168
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
+PE KSD+++ G VL EL + ++ +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKE---FLVEVEMLSRLH 434
N+ +LG G FG V+ +D G +A+K++ Q+ KE E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 492
H +V+ G + + + E +P GS++ L +G L N TR +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV-----TR-RYTRQIL 116
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVM 548
+G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ +T +S V
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVT 170
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT +++PE K+DV+S ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 388 LGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
LG+GGFG V + + G A K+L ++G + +VE +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
Y+ + + L ++ G L ++ N GL +LH Q
Sbjct: 60 -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
+I+RD K N+LL+N+ + +++D GLA + +G++ + GT G++APE
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 564 LLVKSDVYSYGVVLLELLTGRKP 586
D ++ GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 388 LGEGGFGRVFK----GVLSDGTA----VAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 437
LGEG FG+V G+ D VA+K L D LV E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-----CHLDWETR-----M 485
++ L+G ++D ++L E G+L +L P G++ C L E +
Sbjct: 80 IINLLGA-CTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
A ARG+ YL SQ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 138 SCAYQVARGMEYLA--SQKC-IHRDLAARNVLVTEDNVMKIADFGLARDVHN--IDYYKK 192
Query: 546 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
G ++APE +SDV+S+GV+L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 388 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 437
LGEG FG+V K + VA+K L + D LV E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 485
++ L+G ++D +++ E G+L +L P G+ D ++ +
Sbjct: 83 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
ARG+ YL SQ C IHRD A N+L+ N K+ADFGLA+ +Y
Sbjct: 141 SCTYQVARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDV--NNIDYYKK 195
Query: 546 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
G ++APE +SDV+S+GV++ E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 388 LGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
+G G FG+V G ++ G V +K L Q +FL E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+ + + +LL E P G L+ +L D T ++A + A GL +LH+++
Sbjct: 63 QCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPEYA- 559
IH D N LL + K+ D+GL+ + + +Y T ++ ++APE
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 560 -MTGHLLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612
+ G+LLV +S+V+S GV + EL G +P S ++ L R ++
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP--YRHLSDEQVLTYTVR------EQQ 227
Query: 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
+L PRL K P D R + C QRP+ EV
Sbjct: 228 LKLPKPRL--KLPLSD--RWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 70/245 (28%), Positives = 115/245 (46%), Gaps = 27/245 (11%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL---VG 443
LG G G VF V SD VA+K++ Q K L E++++ RL H N+VK+ +G
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 444 YYSSRDSSQHLLCYEL----VPNGSLESWL-----HGPLGVNCHLDWETRMKIALDAARG 494
S + EL + +E+ L GPL R+ RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEE-----HARL-FMYQLLRG 126
Query: 495 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAK-QAPE-GRTNYLSTRVMGTF 551
L Y+H + V+HRD K +N+ + + K+ DFGLA+ P YLS ++ +
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 552 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
Y +P ++ + K+ D+++ G + E+LTG+ + Q L+ + P++R++D
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 611 RLEEL 615
R E L
Sbjct: 243 RNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G G V+ + ++ G VAIK++ QQ KE ++ E+ ++ H N+V + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
D + + E + GSL + +D + + + L +LH +
Sbjct: 86 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 612
K D++S G++ +E++ G P P L+ T P L++ ++L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 434
N+ +LG+G FGRV+ +D G +A+K++ + + V E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 435 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 490
H +V+ G RD + L E +P GS++ L +G L N TR K
Sbjct: 63 HERIVQYYGCL--RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV-----TR-KYTRQ 114
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TR 546
G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ +T LS
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
V GT +++PE K+D++S G ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 381 NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLS 431
+E LG+G +G V S+ VAIK++T K+ L E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKIT---NVFSKKILAKRALRELKLLR 56
Query: 432 RLH-HRNLVKLVGYYSSRDSS-QHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKI 487
H+N+ L + L YE + L + PL + H +
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQSFIYQIL 115
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------KQAPEGRT 540
GL Y+H + V+HRD K N+L+ + K+ DFGLA + T
Sbjct: 116 -----CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 587
Y++TR Y APE ++ K+ DV+S G +L ELL GRKPV
Sbjct: 168 EYVATR-----WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 42/297 (14%)
Query: 388 LGEGGFGRV-----------------FKGVLSDGTAVAIKRLTCGGQQGDK-EFLVEVEM 429
LGEG FG V + VA+K L + + +FL E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLD----- 480
+SRL N+++L+ + D LC E + NG L +L H P D
Sbjct: 73 MSRLKDPNIIRLLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
+ T + +A A G+ YL S +HRD N L+ N+ K+ADFG+++ G
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
+ R + +++ E + G SDV+++GV L E+LT K SQ S E ++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIE 244
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
RD+ R L P P + + +C A +RP+ E+ +L
Sbjct: 245 NTGEFFRDQGRQVYLPKP---ALCPDS----LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-13
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 43/218 (19%)
Query: 388 LGEGGFGRVFKGVLSD---GTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL-HHRNLVKL 441
LG+G +G V+K + D VA+K++ + E+ L L H N+VKL
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+ + + L +E +E+ LH + N D R I + L Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQLLKALKYIHSG 126
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--------TNYLSTRVMGTFGY 553
+ VIHRD K SNILL ++ K+ADFGLA+ E T+Y++TR Y
Sbjct: 127 N---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-----WY 178
Query: 554 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
APE +L+ S Y+ GV +L E+L G+
Sbjct: 179 RAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 364 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 420
PT R + + E ++ S +G G +G V G VA+K+L+ Q
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 421 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 477
K E+ +L + H N++ L+ ++ S + LV + L + + +
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
H+ + + RGL Y+H +IHRD K SN+ + + K+ DFGLA+ +
Sbjct: 121 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 584
T Y++TR Y APE + H D++S G ++ ELLTGR
Sbjct: 173 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 387 ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF---LVEVEMLS-RLHHRNLVKL 441
+LG+G FG+VF L AIK L D + +VE +LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 442 VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 499
Y + + ++L E + G L + +CH D A + GL +LH
Sbjct: 62 ---YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLH 113
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPE 557
+++RD K NILL+ + H K+ADFG+ K+ + +T GT Y+APE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPE 166
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ D +S+GV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTA------VAIKRLTCGGQQGDKEFLVEVEMLSRLH 434
+ E +G G FGRV +AI + Q+ + E +L +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEVS 59
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAA 492
H +++L +++ D + E VP G L S+L G + L + + + AL+
Sbjct: 60 HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE-- 115
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
YLH +++RD K NILL+ H K+ DFG AK+ + RT L GT
Sbjct: 116 ----YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWTLC----GTPE 163
Query: 553 YVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 594
Y+APE GH D ++ G+++ E+L G P P G
Sbjct: 164 YLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
A + GL +LHE +I+RD K N+LL++ H K+ADFG+ K EG ++T
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 548 M-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 588
GT Y+APE ++ + D ++ GV+L E+L G+ P +
Sbjct: 156 FCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 66/238 (27%), Positives = 97/238 (40%), Gaps = 65/238 (27%)
Query: 382 FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLV--------EVEML 430
+E +G G +GRV+K DG AIK+ +GDKE E+ +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56
Query: 431 SRLHHRNLVKLVG-YYSSRDSSQHLLC----YEL--------------VPNGSLESWLHG 471
L H N+V LV + D S +LL ++L +P ++S L
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 472 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHA--KVA 527
L G+ YLH + V+HRD K +NIL+ E K+
Sbjct: 117 IL-------------------NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154
Query: 528 DFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 582
D GLA+ AP + V+ T Y APE + K+ D+++ G + ELLT
Sbjct: 155 DLGLARLFNAPL-KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 377 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 433
E + ++ S +G G +G+V + G VAIK+L+ Q K E+ +L +
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES----WLHGPL-GVNCH-------LDW 481
H N++ L+ ++ P SLE +L L G + + L
Sbjct: 72 DHENVIGLLDVFT--------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
+ + RGL Y+H +IHRD K SNI + + K+ DFGLA+ + T
Sbjct: 118 DHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174
Query: 542 YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR 584
Y++TR Y APE + H D++S G ++ ELLTG+
Sbjct: 175 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 77/252 (30%), Positives = 106/252 (42%), Gaps = 49/252 (19%)
Query: 404 GTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL--CYE 458
G VAIK L + + + F E + +RL+H N+V L+ S ++ LL +E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFE 59
Query: 459 LVPNGSLESWL--HGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 514
VP +L L G L G L M LDA LA H ++HRD K
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRL-----MLQVLDA---LACAHNQG---IVHRDLKPQ 108
Query: 515 NILL---ENNFHAKVADFGLAKQAPEGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLV 566
NI++ HAKV DFG+ P R T +T V+GT Y APE +
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 567 KSDVYSYGVVLLELLTGRK----------------PVDMSQPSGQEN--LVTWARPILRD 608
SD+Y++G++ LE LTG++ PVD+S P L R L
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 609 KDRLEELADPRL 620
R + P L
Sbjct: 229 DPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 388 LGEGGFGRV----------FKGVLSDG-----TAVAIKRLTCGGQQGDK-EFLVEVEMLS 431
LGEG FG V F G + VA+K L + + +FL E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSL---------ESWLHGPLGVNCHLD 480
RL + N+++L+G S D LC E + NG L ES + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VS 127
Query: 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
+ +A+ A G+ YL + +HRD N L+ N++ K+ADFG+++ G
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
+ R + ++A E + G SDV+++GV L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNL 438
NF+ LGEG + V+KG + G VA+K + ++G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
V+L + ++ +L +E + + L+ ++ GV LD T +G+A+
Sbjct: 61 VRL--HDVIHTENKLMLVFEYM-DKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
HE+ V+HRD K N+L+ K+ADFGLA+ A N S V+ T Y AP+
Sbjct: 117 HENR---VLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 559 AMTGHLLVKS-DVYSYGVVLLELLTGR 584
+ S D++S G ++ E++TGR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 36/273 (13%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+GEG G V G VA+K++ QQ + EV ++ HH N+V + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
D + + E + G+L + + ++ E + L R L+YLH V
Sbjct: 90 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 507 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
IHRD K+ +ILL ++ K++DFG ++K+ P+ ++ ++GT ++APE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRL 193
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622
+ D++S G++++E++ G P + P L+ R+ + PR+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKD 240
Query: 623 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ +R + E +QR T E++Q
Sbjct: 241 SHKVSSVLR--GFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 388 LGEGGFGRVFKGVLSDG-----------TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-H 434
LGEG FG+V V+++ T VA+K L + D + + E+EM+ +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CH---------LDWE 482
H+N++ L+G ++D +++ E G+L +L P G+ C+ L ++
Sbjct: 83 HKNIINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
+ A ARG+ YL S+ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 141 DLVSCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDY 195
Query: 543 LSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
G ++APE +SDV+S+GV+L E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-----KEFLVEVEMLSRLH 434
++P +G G +G V + G VAIK++ D K L E+++L
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---PHAFDVPTLAKRTLRELKILRHFK 62
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSL-----------ESWLHGPLGVNCHLDWET 483
H N++ + RD L P G+ ES LH + + L E
Sbjct: 63 HDNIIAI------RDI--------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRT 540
RGL Y+H VIHRD K SN+L+ + ++ DFG+A+ +P
Sbjct: 109 IRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 541 NYLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587
++ T + T Y APE ++ + D++S G + E+L GR+ +
Sbjct: 166 YFM-TEYVATRWYRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 434
N+ +LG+G FGRV+ D G +A K++ + + V E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 492
H +V+ G R + E +P GS++ L +G L + TR K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV-----TR-KYTRQIL 116
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR-VMGTF 551
G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ + R V GT
Sbjct: 117 EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+++PE K+DV+S G ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH---H 435
+EP + +G G +G V+K G VA+K + + G V EV +L RL H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 436 RNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALD 490
N+V+L+ ++ + + L +E V + L ++L P G L ET +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG----LPAETIKDLMRQ 116
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
RGL +LH + C++HRD K NIL+ + K+ADFGLA+ T V+ T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVT 170
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587
Y APE + D++S G + E+ RKP+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 387 ILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFL---------VEVEMLSRL 433
+LG+G FG+VF K D G A+K L K L +E ++L+ +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEV 55
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 492
+H +VKL +Y+ + + L + + G L + L + + E +K L + A
Sbjct: 56 NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELA 108
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
L +LH +I+RD K NILL+ H K+ DFGL+K++ + S GT
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163
Query: 553 YVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y+APE GH +D +S+GV++ E+LTG P
Sbjct: 164 YMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 387 ILGEGGFGRVFKGVLS----DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
ILG G FG + +G L VAI R C +Q + FL E L + H N+V+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVR 70
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
L G + + ++ E + NG+L+S+L G L M + A G+ YL E
Sbjct: 71 LEGVITR--GNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE 125
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG--TFGYVAPEY 558
+H+ A +L+ ++ K++ F + E ++ + T + G + APE
Sbjct: 126 MG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 590
H SDV+S+G+V+ E+++ G +P DMS
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 388 LGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 444
LG+G +G V+K VL T V A+K + + + ++E+++L + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ + +C E + GSL+ L+ + + +I +GL +L E+
Sbjct: 68 FFIEGAV--YMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTFGYVAPEYAMTG 562
+IHRD K +N+L+ N K+ DFG++ A +TN +G Y+APE +G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSG 176
Query: 563 HLL------VKSDVYSYGVVLLELLTGRKP 586
V+SDV+S G+ +LE+ GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 377 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL 433
E + P +G G +G V S+ VAIK++ + K L E+++L L
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL 61
Query: 434 HHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
H N++ + + R++ + + YEL +++ LH + + L +
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQYFLYQ 116
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR---TNYLSTRV 547
RGL Y+H + V+HRD K SN+LL N K+ DFGLA+ E T Y+ TR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172
Query: 548 MGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV 587
Y APE LL+ DV+S G + ELL GRKP+
Sbjct: 173 ----WYRAPE------LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLV 442
++G+G +G V + G VAIK++ + L E+++L L H ++V++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 443 GYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
S R+ + +EL +ES LH + N L E R L Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEY 558
+ V HRD K NIL + K+ DFGLA+ A + T T + T Y APE
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 176
Query: 559 AMTGHLLVKS----DVYSYGVVLLELLTGR 584
+ G K D++S G + E+LTG+
Sbjct: 177 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 434
+E +GEG +G VFK VA+KR+ D E L E+ +L L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELK 57
Query: 435 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H+N+V+L Y S + L L +E + L+ + N +D E +
Sbjct: 58 HKNIVRL---YDVLHSDKKLTLVFEYC-DQDLKKYFDS---CNGDIDPEIVKSFMFQLLK 110
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GLA+ H + V+HRD K N+L+ N K+ADFGLA+ Y S V+ T Y
Sbjct: 111 GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWY 165
Query: 554 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 587
P+ L S D++S G + EL +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G +G V + G VAIK+L+ Q K E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 445 YSSRDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
++S S + LV P +++ L +G L + + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMP--YMQTDLQKIMGH--PLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG- 562
+IHRD K N+ + + K+ DFGLA+ A T Y+ TR Y APE +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWM 190
Query: 563 HLLVKSDVYSYGVVLLELLTGR 584
H D++S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNL 438
EP +G G FG V+ DG VA+K++ Q K E++ML H N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 439 VKLVGYYSSRDSSQ--HLLCYE--LVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR 493
+ + D Q H+ +E V ++S LH + L + +K+ L R
Sbjct: 62 LSAL------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILR 114
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GL YLH ++HRD K N+L+ +N K+ DFGLA+ + +++ V+ + Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 554 VAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
APE M + H D++S G + ELL R P Q +L+T
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 388 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+GEG G V V S G VA+K++ QQ + EV ++ H N+V++ Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
D + + E + G+L + + ++ E + L + L+ LH V
Sbjct: 88 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 566
IHRD K+ +ILL ++ K++DFG Q + S ++GT ++APE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195
Query: 567 KSDVYSYGVVLLELLTGRKP 586
+ D++S G++++E++ G P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 382 FEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKEF--LVEVEMLSRLH--- 434
+E + +GEG +G+VFK + + G VA+KR+ + + EV +L L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 435 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
H N+V+L V S D L L +E V + L ++L + ET +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDK--VPEPGVPTETIKDMMFQL 119
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ T V+ T
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 173
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587
Y APE + D++S G + E+ RKP+
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
A + + GL +LH +I+RD K N++L++ H K+ADFG+ K E + ++TR
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 548 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT Y+APE D ++YGV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 66/259 (25%), Positives = 100/259 (38%), Gaps = 73/259 (28%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVE---------- 428
++FE ++G G FG V D G A+K+L K ++E E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI- 487
+L+ + +VKL YYS +D + L E +P G + + L + + + ETR I
Sbjct: 54 ILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIA 108
Query: 488 ----ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 533
A+D+ L Y IHRD K N+LL+ H K++DFGL
Sbjct: 109 ETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
Query: 534 -----------QAPEGRTNYLSTR---------------VMGTFGYVAPEYAMTGHLLVK 567
S R +GT Y+APE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 568 SDVYSYGVVLLELLTGRKP 586
D +S GV++ E+L G P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 25/285 (8%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 436
NF+ +G G F V++ L D VA+K++ + ++ + E+++L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
N++K + + + +L EL G L + + T K + +
Sbjct: 63 NVIKYLDSFIEDNELNIVL--ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
++H V+HRD K +N+ + K+ D GL + T S ++GT Y++P
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
E KSD++S G +L E+ + P + NL + + ++E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLCQ-------KIEQCD 224
Query: 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661
P L ++ E + ++ C+ P+ +QRP +G V Q K +
Sbjct: 225 YPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 387 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKE-FLVEVEMLSRLH-HRNLVKL 441
+LG+G FG+V L G A+K L Q D E + E +LS H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 500
Y + + E V G L + E R + A + L +LH+
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD 114
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGYVAPEYA 559
+I+RD K N+LL++ H K+ADFG+ K EG N +T GT Y+APE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
D ++ GV+L E+L G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 41/106 (38%), Positives = 58/106 (54%), Gaps = 15/106 (14%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
A + A GL +LH +I+RD K N++L+ H K+ADFG+ K E +TR
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 548 M-GTFGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 588
GT Y+APE Y G KS D +++GV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 388 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKL 441
+GEG FG K +L DG IK + + E EV +LS + H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 442 VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLA 496
Y S + + +L + + G L ++ GV + LDW ++ +AL
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------ 115
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
++H+ ++HRD K+ NI L + K+ DFG+A+ T L+ +GT Y++P
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSP 170
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT 582
E KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEML 430
E+ + + + +G G +G V + G VAIK+L Q K E+ +L
Sbjct: 12 EVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 431 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETR 484
+ H N++ L+ ++ S + LV G L H L E R
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLS-------EDR 119
Query: 485 MK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
++ + +GL Y+H +IHRD K N+ + + K+ DFGLA+Q T Y+
Sbjct: 120 IQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV 176
Query: 544 STRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 584
TR Y APE + H D++S G ++ E+LTG+
Sbjct: 177 VTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 72/239 (30%), Positives = 98/239 (41%), Gaps = 43/239 (17%)
Query: 381 NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL---TCGGQQGDKEF-LVEVEMLSR 432
NFE +LG G +G+VF G G A+K L T + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
+ + + Y D+ HL+ + V G L + L+ R
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLI-LDYVNGGELFTHLY------------QREHFTESEV 107
Query: 493 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 542
R L +LH Q +I+RD K NILL++ H + DFGL+K+ A E Y
Sbjct: 108 RVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 543 LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKP--VDMSQPSGQE 596
GT Y+APE GH D +S GV+ ELLTG P VD Q S E
Sbjct: 165 ---SFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTA-VAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 436
N FE ++GEG +G V K + VAIK+ + ++ + L E++ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
N+V+L + R + L +E V LE P GV + R I + +
Sbjct: 61 NIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYI-YQLIKAIH 114
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVA 555
+ H++ ++HRD K N+L+ +N K+ DFG A+ EG NY T + T Y +
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRS 169
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 47/138 (34%), Positives = 71/138 (51%), Gaps = 15/138 (10%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GL +LH +I+RD K N++L+ + H K+ADFG+ K+ G ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-----DMSQPSGQENLVTWARPILRD 608
+APE D +S+GV+L E+L G+ P D S + + + R I ++
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222
Query: 609 -KDRLEEL--ADP--RLG 621
KD LE+L DP RLG
Sbjct: 223 SKDILEKLFERDPTRRLG 240
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
GL +LH+ +I+RD K N+LL+ + H K+ADFG+ K+ G ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 554 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+APE + G +S D +S+GV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 16/231 (6%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+G+G G VF + ++ G VAIK++ Q + + E+ ++ L + N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
D + + E + GSL + +D + + + L +LH + V
Sbjct: 87 VGD--ELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHANQ---V 136
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
IHRD K+ N+LL + K+ DFG Q PE + ++GT ++APE
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYG 193
Query: 566 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 615
K D++S G++ +E++ G P P L+ T P L++ ++L +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEML 430
E+ E N P +G G +G V VA+K+L+ Q + E+ +L
Sbjct: 12 EVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 431 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG--VNCH-LDWETRMKI 487
+ H N++ L+ ++ S ++ LV N + L V C L E +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTN-----LMGADLNNIVKCQKLSDEHVQFL 123
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
RGL Y+H +IHRD K SN+ + + ++ DFGLA+QA + T Y++TR
Sbjct: 124 IYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR- 179
Query: 548 MGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 584
Y APE + H D++S G ++ ELL G+
Sbjct: 180 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 388 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+GEG G V S G VA+K++ QQ + EV ++ H N+V++ Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
D ++ E + G+L + + ++ E + L + L++LH V
Sbjct: 87 VGDELWVVM--EFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQG---V 136
Query: 507 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
IHRD K+ +ILL ++ K++DFG ++K+ P ++ ++GT ++APE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRL 190
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
+ D++S G++++E++ G P P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G G V+ + ++ G VAIK++ QQ KE ++ E+ ++ + N+V + Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
D + + E + GSL + +D + + + L +LH +
Sbjct: 86 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSNQ--- 135
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 612
K D++S G++ +E++ G P P L+ T P L++ +RL
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 24/163 (14%)
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
LA H S+ +IHRD K++NILL +N K+ DFG +K ++ + GT YV
Sbjct: 154 LAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
APE K+D++S GV+L ELLT ++P D + +EE
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF--------------------DGENMEE 252
Query: 615 LADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVV 654
+ L G+Y P + I A ++ + +RP+ +++
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 35/193 (18%)
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
LD + ++ + A+G+ +L S+ C IHRD A N+LL + AK+ DFGLA+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL--ASKNC-IHRDVAARNVLLTDGRVAKICDFGLARDI-MN 264
Query: 539 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPS 593
+NY+ V G ++APE V+SDV+SYG++L E+ + G+ P P
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----PG 317
Query: 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMG 651
IL + + + G + + DF + +I C E +RPT
Sbjct: 318 -----------ILVNSKFYKMVKR---GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363
Query: 652 EVVQSLKMVQRVI 664
++ Q ++QR +
Sbjct: 364 QISQ---LIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 387 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 439
I+G GGFG V+ +D G A+K L +QG+ L E MLS + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 440 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 494
+ + + D LC+ +L+ G L L HG E M+ A + G
Sbjct: 61 CMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFS-------EKEMRFYATEIILG 109
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 550
L ++H V++RD K +NILL+ + H +++D GLA K+ P +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158
Query: 551 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
GY+APE G S D +S G +L +LL G P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 388 LGEGGFGRV---FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
+G G G V F VL G VA+K+L+ Q K E+ +L ++H+N++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 443 GYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
++ + S + L EL+ + +L +H LD E + G+ +L
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHL 139
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H +IHRD K SNI+++++ K+ DFGLA+ A TN++ T + T Y APE
Sbjct: 140 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEV 193
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTG 583
+ D++S G ++ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 21/230 (9%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
+ L G GRVF G V +K GQ+G L+E +L ++H ++
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSV 119
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
+++ S + +L + + L ++L L + + I GL YL
Sbjct: 120 IRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYL 173
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H +IHRD K NI + + + D G A Q P +L + GT APE
Sbjct: 174 H---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLG--LAGTVETNAPEV 227
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
K+D++S G+VL E+L + PS E V L
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 388 LGEGGFGRVFK----GVLSD----GTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 437
LGEG FG+V + G+ VA+K L D L+ E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 485
++ L+G +++ +++ E G+L +L P G + D ++ +
Sbjct: 80 IINLLGV-CTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
A ARG+ YL +S+ C IHRD A N+L+ + K+ADFGLA+ + +Y
Sbjct: 138 SCAYQVARGMEYL--ESRRC-IHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKK 192
Query: 546 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
G ++APE +SDV+S+G+++ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 55/219 (25%)
Query: 388 LGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 437
+GEG F V K G AIK + K F L E++ L RL H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 438 LVKLVGY-YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
+++L+ + + L+ YEL+ PL E R+K +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG------RKRPLP-------EKRVKSYM 106
Query: 490 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLS 544
+ L ++H + + HRD K NIL++++ K+ADFG + + P T Y+S
Sbjct: 107 YQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYIS 160
Query: 545 TRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLT 582
TR Y APE +T G+ K D+++ G V E+L+
Sbjct: 161 TR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 18/232 (7%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 445
+G+G G V+ + ++ G VAI+++ QQ KE ++ E+ ++ + N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
D + + E + GSL + +D + + + L +LH +
Sbjct: 87 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 615
K D++S G++ +E++ G P P L+ T P L++ ++L +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 59/232 (25%)
Query: 382 FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLV---EVEML---- 430
F ++LG G FG+V +L++ G AIK L K ++ EVE L
Sbjct: 1 FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEK 50
Query: 431 ------SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+ H LV L + + D E G L +H H D +
Sbjct: 51 RIFETANSERHPFLVNLFACFQTEDHV--CFVMEYAAGGDL--MMH------IHTDVFSE 100
Query: 485 MKIALDAAR---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGR 539
+ AA GL YLHE+ +++RD K N+LL+ K+ADFGL K+ R
Sbjct: 101 PRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157
Query: 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 586
T ST GT ++APE L S D + GV++ E+L G P
Sbjct: 158 T---ST-FCGTPEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 387 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 439
I+G GGFG V+ +D G A+K L +QG+ L E MLS + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 440 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 494
+ + + D L + +L+ G L L HG E M+ A + G
Sbjct: 61 CMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFS-------EAEMRFYAAEIILG 109
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 550
L ++H V++RD K +NILL+ + H +++D GLA K+ P +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158
Query: 551 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
GY+APE G S D +S G +L +LL G P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 40/226 (17%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTC----GGQQGDKEF----------LVEVEMLSR 432
LGEG +G+V K G VAIK++ D++ L E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
+ H N++ LV Y D ++ + S L + L I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDI-------MASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------------KQAPEGR 539
GL LH+ +HRD +NI + + K+ADFGLA K R
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
++++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 436
NF +G G F V++ L DG VA+K++ + + + E+++L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM-------KIA 488
N++K YY+S L + EL G L + H + R+ K
Sbjct: 63 NVIK---YYASFIEDNELNIVLELADAGDLSRMIK-------HFKKQKRLIPEKTVWKYF 112
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
+ L ++H V+HRD K +N+ + K+ D GL + T S ++
Sbjct: 113 VQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LV 167
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
GT Y++PE KSD++S G +L E+ + P + NL + +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK----- 218
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 648
++E+ P L + E+ ++ + C+ P+ +RP
Sbjct: 219 --KIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLH 434
+ +++ +I+G G FG V++ + D + VAIK++ Q ++E L+ + L+
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 435 HRNLVKLVGYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-- 489
H N++ L YY + + +++ N +E P V+ ++ R AL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFL-----NVVME---FIPQTVHKYMKHYARNNHALPL 169
Query: 490 --------DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGR- 539
R LAY+H + HRD K N+L++ N H K+ DFG AK G+
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 540 -TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG 583
+Y+ +R Y APE + T H+ D++S G ++ E++ G
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 71/224 (31%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 381 NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRL----TCGGQQGDKEFLVEVEMLSR 432
+FE LG G FGRV KG G AIK L +Q E +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQ-HVAQEKSILME 74
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
L H +V ++ + + LL E V G L + HL + D A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLL--EFVVGGELFT----------HL--RKAGRFPNDVA 120
Query: 493 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ YLH +I+RD K N+LL+N H KV DFG AK+ P+ RT L
Sbjct: 121 KFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFTLC 176
Query: 545 TRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 586
GT Y+APE + GH K+ D ++ GV+L E + G P
Sbjct: 177 ----GTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 546
A + L +LH VI+RD K NILL+ H K+ADFG+ K EG N +T
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT Y+APE D ++ GV++ E++ G+ P
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 56/291 (19%)
Query: 388 LGEGGFGRVFKGVL---SDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR 436
LG+G F ++KGVL SD +V +K L + F ++S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGL 495
+LVKL G RD ++++ E V G L+ +LH V+ H W ++ +A A L
Sbjct: 62 HLVKLYG-VCVRD--ENIMVEEYVKFGPLDVFLHREKNNVSLH--W--KLDVAKQLASAL 114
Query: 496 AYLHEDSQPCVIHRDFKASNILL-------ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
YL ED + ++H + NIL+ K++D G+ R+
Sbjct: 115 HYL-EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI- 168
Query: 549 GTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
++APE G L + +D +S+G LLE+ + +S S E +
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICS-NGEEPLSTLSSSEKERFY----- 219
Query: 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+D+ RL L + I C + +RP+ +++ L
Sbjct: 220 QDQHRLPMPDCAELA------NLIN------QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 437
NF+ +GEG +G V+K G VA+K RL + + E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIAL-DAARG 494
+VKL+ + + L +E + + L+ ++ G+ L +K L +G
Sbjct: 61 IVKLLDVIHTENKL--YLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQG 112
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
LA+ H V+HRD K N+L+ K+ADFGLA+ Y T + T Y
Sbjct: 113 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 167
Query: 555 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 584
APE + + D++S G + E++T R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 381 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 437
+ ++GEG FGR + V SD A+K + E E +L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 492
+V + S ++ HL + E G L + G + L W +M +
Sbjct: 60 IV---AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGT 550
G+ ++HE V+HRD K+ NI L N K+ DFG A+ +P Y T V GT
Sbjct: 112 -GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GT 163
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599
YV PE KSD++S G +L EL T + P Q + +NL+
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 387 ILGEGGFGRVFKGVL-SDGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 441
++G+G FG+V SDG+ A+K L T ++ + E +L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+YS + + + + V G L L C L+ R A + A + YLH
Sbjct: 62 --HYSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPEYA 559
+ +I+RD K NILL++ H + DFGL K+ PE T+ GT Y+APE
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC----GTPEYLAPEVL 168
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPV---DMSQ 591
D + G VL E+L G P D+SQ
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
L YLHE +I+RD K N+LL++ H K+ D+G+ K+ R ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNY 162
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 589
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 373 EELKEATNNFEPASILGEGGFGRVFKGVLSDGT--AVAIKRL----TCGGQQGDKEFLVE 426
+ K +F LG G FGRV + VAIKR +Q D F E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SE 81
Query: 427 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWE 482
++L+ ++H V L G S +D S L E V G ++L P V C +
Sbjct: 82 RKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--YA 137
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
++ + + + L +++RD K N+LL+ + K+ DFG AK + RT
Sbjct: 138 AQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT 187
Query: 543 LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
L GT Y+APE + GH +D ++ G+ + E+L G P ++P
Sbjct: 188 LC----GTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFGY 553
L +LHE +I+RD K N+LL+ H K+ D+G+ K EG R ++ GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM--SQPSGQEN 597
+APE D ++ GV++ E++ GR P D+ + +N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 34/173 (19%)
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E+E+L ++H N+VK + Q LL E + GSLE H+ E +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL--EFMDGGSLE---------GTHIADEQFL 170
Query: 486 KIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
D AR G+AYLH ++HRD K SN+L+ + + K+ADFG+++ +
Sbjct: 171 A---DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 542 YLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKP 586
S+ +GT Y++PE T G+ D++S GV +LE GR P
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL--V 442
+GEG +G V+KG G VA+K RL + + E+ +L L H N+V L V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
SR L +E + + L+ +L L ++D E +G+ + H
Sbjct: 68 LMQESR----LYLIFEFL-SMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
V+HRD K N+L++N K+ADFGLA+ G + T + T Y APE +
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 563 HLL-VKSDVYSYGVVLLELLTGRKPV 587
D++S G + E+ T +KP+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
A + A GL +LH +I+RD K N++L++ H K+ADFG+ K E + ++T+
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 548 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT Y+APE D +++GV+L E+L G+ P +
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 22/231 (9%)
Query: 388 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+GEG G V G VA+K + QQ + EV ++ H+N+V++ Y S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--YKS 86
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ + E + G+L + L+ E + + L YLH V
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 507 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 562
IHRD K+ +ILL + K++DFG ++K P+ ++ ++GT ++APE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRT 192
Query: 563 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPILRDKDRL 612
+ D++S G++++E++ G P P + L P L++ ++
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 25/162 (15%)
Query: 441 LVGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAY 497
+V + S ++ +HL + E V G + L G L V+ RM A + L Y
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-----ARMYFA-ETVLALEY 116
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-------------YLS 544
LH ++HRD K N+L+ + H K+ DFGL+K T +L
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+V GT Y+APE + D ++ G++L E L G P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGY 553
L YLH V++RD K N++L+ + H K+ DFGL K EG ++ + + GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 38/235 (16%)
Query: 381 NFEPASILGEGGFGRVF---------------KGVLSDGTAVAIKRLTCGGQQGDKEFLV 425
NFE +LG G +G+VF VL T V + T +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTT-------EHTRT 53
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E ++L + + + Y D+ HL+ + + G L + L E ++
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLI-LDYINGGELFTHLSQRERFKEQ---EVQI 109
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
+ L +LH+ +I+RD K NILL++N H + DFGL+K+ E +
Sbjct: 110 YSG-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AY 164
Query: 546 RVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
GT Y+AP+ GH D +S GV++ ELLTG P + G++N
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTV---DGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 445
LGEG + V+KG+ +G VA+K ++ ++G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
++++ + E + + + P G++ + RGLAY+H
Sbjct: 73 HTKETLTFVF--EYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRGLAYIHGQH--- 123
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
++HRD K N+L+ K+ADFGLA+ Y S V T Y P+ + G
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGATD 180
Query: 566 VKS--DVYSYGVVLLELLTGR 584
S D++ G + +E+L G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
L +LHE +I+RD K N+LL+ + H K+ D+G+ K+ ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNY 162
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 589
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 445
LGEG + VFKG VA+K + ++G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIAL-DAARGLAYLHEDSQ 503
+ L +E + + L+ +L NC +L +KI + RGL+Y H+
Sbjct: 73 HTERCLT--LVFEYLDS-DLKQYLD-----NCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 562
++HRD K N+L+ K+ADFGLA+ A T S V+ T Y P+ + +
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 563 HLLVKSDVYSYGVVLLELLTGR 584
D++ G +L E+ TGR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 58/255 (22%)
Query: 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---------TCGGQQGDKEFLVEVEML 430
+FE ++G G FG V D G A+K L G + +++ LVE + L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 431 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
+VK+ +YS +D L E +P G + + L + + + ET+ IA +
Sbjct: 62 W------VVKM--FYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIA-E 109
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY------- 542
+ +H Q IHRD K N+LL++ H K++DFGL + RT +
Sbjct: 110 TVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 543 -------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 577
L+ +GT Y+APE M D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 578 LELLTGRKPVDMSQP 592
E+L G P P
Sbjct: 227 YEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 53/173 (30%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
+ ARG+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 180 SFQVARGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 606
++APE +SDV+S+GV+L E+ + G P P Q N R L
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQR--L 290
Query: 607 RDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
+D R+ E A P + I AC + +RPT +V+ L
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
+ ARG+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 179 SFQVARGMEFL--ASRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWAR 603
++APE +SDV+S+GV+L E+ + G P V + + +
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR------- 288
Query: 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
L++ R+ + P+ + +I C RPT E+V+ L
Sbjct: 289 --LKEGTRM----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTC-----GGQQGDKEFL---VEVEMLSRLHHRNLV 439
LG+G FG V+ ++ D AVA +RL G+ E + E ++LS+L H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 440 KLVGYYSSRDSSQHL--LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGL 495
K + RD+ + C + LE H L N +W ++ + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
Y+H+ ++HRD KA NI L+NN K+ DFG+++ G + L+T GT Y++
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCD-LATTFTGTPYYMS 173
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLEL 580
PE KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
L E ++HRD K++NI L K+ DFG +KQ + + +++ GT Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596
K+D++S GV+L ELLT +P PS +E
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 387 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSR 432
+LG+G FG+V +L + G A+K L KE ++ E +L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILK-------KEVIIAKDEVAHTLTESRVLQN 51
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKI-AL 489
H L L YS + + LC+ E G L L + E R +
Sbjct: 52 TRHPFLTAL--KYSFQ--THDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGA 102
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM- 548
+ L YLH V++RD K N++L+ + H K+ DFGL K EG ++ + +
Sbjct: 103 EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 156
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 386 SILGEGGFGRVFKGVLSDGTAV-------AIKRLTCGGQQGDKEFL-VEVEMLSRLHHRN 437
+LG+GG+G+VF+ G +K+ T Q D E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR--- 493
+V L+ Y+ + + L E + G L HL+ R I + D A
Sbjct: 62 IVDLI--YAFQTGGKLYLILEYLSGGELFM----------HLE---REGIFMEDTACFYL 106
Query: 494 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
L +LH Q +I+RD K NILL+ H K+ DFGL K++ ++
Sbjct: 107 SEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFC 161
Query: 549 GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKP 586
GT Y+APE M +GH K+ D +S G ++ ++LTG P
Sbjct: 162 GTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRN 437
+++E LGEG + V+KG +G VA+K + ++G + E +L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLA 496
+V L ++++ L +E V + P G+ H + +K+ L RGL+
Sbjct: 65 IVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGL--HPE---NVKLFLFQLLRGLS 117
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
Y+H Q ++HRD K N+L+ + K+ADFGLA+ Y + V T Y P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172
Query: 557 EYAM-TGHLLVKSDVYSYGVVLLELLTG 583
+ + + D++ G + +E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 12/113 (10%)
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
LD E + + A+G+++L S+ C IHRD A NILL + K+ DFGLA+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNC-IHRDLAARNILLTHGRITKICDFGLARDI-RN 266
Query: 539 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+NY+ V G ++APE +SDV+SYG++L E+ + G P
Sbjct: 267 DSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
+ +E +GEG +G+V+K + G VA+K RL + L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 437 N-LVKLVGYYSSRDSSQHLLCYELV---PNGSLESWLHGPLGVNCH-LDWETRMKIALDA 491
+V+L+ + + Y LV + L+ ++ L +T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGT 550
+G+A+ H+ V+HRD K N+L++ K+AD GL + +Y T + T
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174
Query: 551 FGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG 583
Y APE + H D++S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 388 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 444
LGEG + V+KG L+D VA+K + ++G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL-DAARGLAYLHED 501
+ S L +E + + L+ +L G +N H +K+ L RGL Y H
Sbjct: 73 IHTEKSLT--LVFEYL-DKDLKQYLDDCGNS-INMH-----NVKLFLFQLLRGLNYCHRR 123
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 560
V+HRD K N+L+ K+ADFGLA+ A T S V+ T Y P+ +
Sbjct: 124 K---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 561 TGHLLVKSDVYSYGVVLLELLTGR 584
+ + D++ G + E+ TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 382 FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
+ S L G G VF V +K +T G G E+++L + HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAI 148
Query: 439 VKLVGYYSSRDSSQHLLCYEL-VPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGL 495
+ L+ Y + +C + L +++ GPL + + + R+ L+A L
Sbjct: 149 INLIHAYRWKS----TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL---LEA---L 198
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
AYLH +IHRD K NI L+ +A + DFG A + GT +
Sbjct: 199 AYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE K+D++S G+VL E+
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
+ALDA + + IHRD K N+LL+ + H K+ADFG + T
Sbjct: 153 LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 547 VMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 586
V GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 47/160 (29%), Positives = 65/160 (40%), Gaps = 19/160 (11%)
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV--NCHLDWETRMKIALDAARG 494
N+V L Y S DS L + G L S + L + C W M +ALDA
Sbjct: 46 NMVCLHKYIVSEDSV--FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
LH + C RD +NILL++ H ++ F + + + Y
Sbjct: 101 ---LHREGIVC---RDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 594
APE D +S G +L ELLTG+ V+ PSG
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 70/257 (27%), Positives = 101/257 (39%), Gaps = 80/257 (31%)
Query: 382 FEPASILGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGDKE----------FLVEVEM 429
F+ +LG+G GRVF V GT A+K L DK+ L E E+
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVL-------DKKEMIKRNKVKRVLTEQEI 54
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 487
L+ L H L L Y+S + +L L + P G L L K +
Sbjct: 55 LATLDHPFLPTL---YASFQTETYLCLVMDYCPGGELFRLLQ-----------RQPGKCL 100
Query: 488 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEG 538
+ + AR L YLH +++RD K NILL + H ++DF L+KQ E
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
Query: 539 R--------------------------TNYLSTRVMGTFGYVAPEY-AMTGHLLVKSDV- 570
++ S +GT Y+APE + GH S V
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVD 214
Query: 571 -YSYGVVLLELLTGRKP 586
++ G++L E+L G P
Sbjct: 215 WWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 62/218 (28%), Positives = 87/218 (39%), Gaps = 50/218 (22%)
Query: 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL---- 441
LGEG + V+KG G VA+K + ++G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 442 --------VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
V Y D Q++ + G L V L R
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYM---DDCGGG-----LS-MHNVRLFL---------FQLLR 114
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--AKQAPEGRTNYLSTRVMGTF 551
GLAY H Q V+HRD K N+L+ K+ADFGL AK P + S V+ T
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVV-TL 167
Query: 552 GYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 584
Y P+ + + L D++ G + E+ TGR
Sbjct: 168 WYRPPDVLLGSTEYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKL 441
++G+G FG+V ++ A+K L ++ +K + E +L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
++S + + + + + G L L C L+ R A + A L YLH
Sbjct: 62 --HFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARF-YAAEIASALGYLHSL 115
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
+ +++RD K NILL++ H + DFGL K+ E N ++ GT Y+APE
Sbjct: 116 N---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHK 170
Query: 562 GHLLVKSDVYSYGVVLLELLTGRKP 586
D + G VL E+L G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLV--EVE 428
+FE ++G G FG V L + V +KR + +++ LV + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 429 MLSRLHH-----RNLVKLVGYYSSRDSSQHLLCYE-LVPNGSLESWLHGPLGVNCHLDWE 482
++ LH+ NL ++ YY D L +E +P +L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL------------- 108
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
M IA+D+ L Y +HRD K NIL++ N H ++ADFG + E T
Sbjct: 109 AEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 158
Query: 543 LSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
S+ +GT Y++PE AM G + D +S GV + E+L G P E+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF------YAES 212
Query: 598 LVTWARPILRDKDRLE 613
LV I+ K+R +
Sbjct: 213 LVETYGKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK------ 440
+G+G FG+V++ D A+K L+ KE + + E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 441 ---LVGY-YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-------IAL 489
+VG +S + S L + + G L W HL E R IA
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FW---------HLQKEGRFSEDRAKFYIA- 103
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ L +LH+ +++RD K NILL+ H + DFGL+K N + G
Sbjct: 104 ELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCG 158
Query: 550 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
T Y+APE + K D +S GV++ E+ G P
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 380 NNFEPASILGEGGFGRV---FKGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVEMLSRLHH 435
+F+ S++G G FG V + D A+ +K+ Q+ F E ++LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
+ +L Y+ +D L E P G L S L N + D A +
Sbjct: 61 PWIPQLQ--YAFQDKDNLYLVMEYQPGGDLLSLL------NRYEDQFDEDMAQFYLAELV 112
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
+H Q +HRD K N+L++ H K+ADFG A + + S +GT Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171
Query: 556 PEY--AMTGHLL----VKSDVYSYGVVLLELLTGRKP 586
PE M G V+ D +S GV+ E++ GR P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 387 ILGEGGFGRV-FKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
++G+G +G V +DG IK+L ++ K E ++LS+L H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLH 499
+ D +++ G L L G N ++W ++ +AL YLH
Sbjct: 67 SWEGEDGLLYIV-MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YLH 119
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
E ++HRD K N+ L KV D G+A+ E + + ST ++GT Y++PE
Sbjct: 120 EKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMAST-LIGTPYYMSPELF 174
Query: 560 MTGHLLVKSDVYSYGVVLLELLT 582
KSDV++ G + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 42/214 (19%)
Query: 388 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL--- 441
LGEG + VFKG L++ VA+K + ++G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 442 ---------VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
V Y +D Q++ C ++ +++ +L+ L
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL------------------ 114
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
RGLAY H V+HRD K N+L+ K+ADFGLA+ A T S V+ T
Sbjct: 115 -RGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TL 168
Query: 552 GYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 584
Y P+ + + + D++ G + E+ +GR
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 552
L YLH +++RD K N++L+ + H K+ DFGL K EG T+ + + GT
Sbjct: 107 ALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPE 160
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y+APE D + GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 552
L YLH + V++RD K N++L+ + H K+ DFGL K EG + + + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPE 161
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y+APE D + GVV+ E++ GR P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 438
N +P +G + +L VAIK+L+ Q K E+ ++ ++H+N+
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 439 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
+ L+ ++ + S + + EL+ + + LD E + G
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 138
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T+++ T + T Y
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-08
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 37/245 (15%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT-------AVAIKRLTCGGQQGDKEFL 424
Y++ + N +E +G G FG VF V T A++ + L ++ + +
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLK---EREKSQLV 60
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+EV ++ L H+N+V+ + + ++ + + + E G L + + ++
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 485 MKIALDAARGLAYLHE----DSQPCVIHRDFKASNILLE-------------NNFH---- 523
+ I LAY H + V+HRD K NI L NN +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELL 581
AK+ DFGL+K ++ +GT Y +PE + T KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 582 TGRKP 586
+G+ P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 438
N +P +G + VL VAIK+L+ Q K E+ ++ ++H+N+
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 439 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
+ L+ ++ + S + L EL+ + + LD E + G
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 131
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T+++ T + T Y
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 185
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 588
APE + D++S G ++ E L GR +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 42/247 (17%)
Query: 381 NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL-TCGGQQGDK---EFLVEVEMLSR 432
NFE +LG G +G+VF G A+K L Q K E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
+ + + Y ++ HL+ + V G + + L+ R + D
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLI-LDYVSGGEMFTHLY------------QRDNFSEDEV 107
Query: 493 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 542
R L +LH+ +++RD K NILL++ H + DFGL+K+ + E Y
Sbjct: 108 RFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 543 LSTRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
GT Y+APE GH D +S G+++ ELLTG P + ++ V+
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 601 WARPILR 607
R IL+
Sbjct: 221 --RRILK 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKE-----FLVEVEMLSRLHHRNLV 439
+GEG +G V+K G VA+K RL + + E + E+ +L L+H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 440 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM----KIALDAA-- 492
+L S L L +E + LD + M LD
Sbjct: 62 RL---LDVVHSENKLYLVFEFL-----------------DLDLKKYMDSSPLTGLDPPLI 101
Query: 493 --------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+G+AY H V+HRD K N+L++ K+ADFGLA+ Y
Sbjct: 102 KSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-- 156
Query: 545 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKP 586
T + T Y APE + D++S G + E++ R+P
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
YYS + ++ L E + G ++S LH + + D E +K + A L YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHG- 124
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAK 533
+IHRD K N+L+ N H K+ DFGL+K
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFG 552
L LH+ + VI+RD K NILL+ H + DFGL K + +TN GT
Sbjct: 106 LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPE 158
Query: 553 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
Y+APE + GH K+ D ++ GV+L E+LTG P
Sbjct: 159 YLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 17/110 (15%)
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTN 541
M +A+D+ L Y +HRD K N+LL+ N H ++ADFG + +G
Sbjct: 109 AEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 542 YLSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 586
S +GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 160 --SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 66/260 (25%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLS--RLHHR 436
++FE ++G G FG V D G A+K L K ++E E ++ R
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 437 NLVKLVG------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI--- 487
LV+ G +YS +D L E +P G + + L + + + T+ I
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAET 110
Query: 488 --ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY-- 542
A+DA L + IHRD K N+LL+ H K++DFGL + RT +
Sbjct: 111 VLAIDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 543 ------------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYS 572
L+ +GT Y+APE M D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 573 YGVVLLELLTGRKPVDMSQP 592
GV++ E+L G P P
Sbjct: 222 LGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 43/233 (18%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGG--QQGDKEFL-VEVE 428
+L+ ++E ++G G FG V + V T A+K L+ ++ D F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-- 486
+++ + +V+L +Y+ +D + E +P G L VN +++ K
Sbjct: 96 IMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---------VNLMSNYDVPEKWA 144
Query: 487 --------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPE 537
+ALDA + + IHRD K N+LL+ + H K+ADFG K E
Sbjct: 145 RFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 586
G +GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 196 GMVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 54/290 (18%)
Query: 388 LGEGGFGRVFKGVLSDGTAVA---IKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
+G G FG+V + T VA +K L + EFL + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARGLA 496
++ +LL +E G L+S+L W R ++A + A G+
Sbjct: 63 --QCVEAIPYLLVFEYCELGDLKSYL-------SQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYV 554
++H+ + +H D N L ++ KV D+G+ + +Y+ T ++
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS--RYKEDYIETEDDKCVPLRWL 168
Query: 555 APEY--AMTGHLLVK-----SDVYSYGVVLLELLTGRKPVDMSQP----SGQENLVTWAR 603
APE G L+ S+V++ GV L EL + +QP S +E L
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVL----N 219
Query: 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
+++D+ +L P+L Y + R + C +R T EV
Sbjct: 220 HVIKDQQ--VKLFKPQLELPYSE----RWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 37/106 (34%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 482 ETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
E R + A + A L YLH + +I+RD K NILL++ H + DFGL K+ E
Sbjct: 95 EPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
++ GT Y+APE D + G VL E+L G P
Sbjct: 152 T--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 387 ILGEGGFGRVFKGVLS-DGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 441
++G+G FG+V DG A+K L ++ K + E +L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 500
+YS + + + + V G L L E R + A + A L YLH
Sbjct: 62 --HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLHS 114
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+ +++RD K NILL++ H + DFGL K+ +T GT Y+APE
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKP 586
D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
+ A+G+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 185 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++APE ++SDV+S+GV+L E+ + G P
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---- 561
+IHRD K N+LL+ + H K+ADFG + E T V GT Y++PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 562 GHLLVKSDVYSYGVVLLELLTGRKP 586
G+ + D +S GV L E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 45/223 (20%)
Query: 382 FEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
+E +GEG +G V+K V ++ A+ RL + + E+ +L + H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 439 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA----- 492
V+L S + L L +E + LD + M + D A
Sbjct: 64 VRL---QDVVHSEKRLYLVFEYL-----------------DLDLKKHMDSSPDFAKNPRL 103
Query: 493 ---------RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNY 542
RG+AY H V+HRD K N+L++ +A K+ADFGLA+ G
Sbjct: 104 IKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVR 158
Query: 543 LSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 584
T + T Y APE + + H D++S G + E++ +
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 60/282 (21%), Positives = 117/282 (41%), Gaps = 39/282 (13%)
Query: 388 LGEGGFGRVFKGV---LSDG-----TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
LG+G F ++FKG+ + D T V +K L + + F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
G D + ++ E V GSL+++L ++ W ++++A A L +L
Sbjct: 63 LNYGVCVCGD--ESIMVQEYVKFGSLDTYLKKN-KNLINISW--KLEVAKQLAWALHFLE 117
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT--FGYVAPE 557
+ + H + A N+LL K + K + G + + + + +V PE
Sbjct: 118 DKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 558 -YAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
+L + +D +S+G L E+ +G KP+ + + +DR +
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---------QKKLQFYEDRHQ-- 223
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
P + + + C+ E + RP+ +++ L
Sbjct: 224 --------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG--RTNYLSTRVMGTF 551
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTNYLSTRVMGTFGYVAP 556
+H Q +HRD K N+LL+ N H ++ADFG K +G S+ +GT Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISP 172
Query: 557 EY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 586
E AM G + D +S GV + E+L G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 84/269 (31%)
Query: 380 NNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLVEV----EMLSRL 433
+F ++G+G FG V + V G A+K L + K+ L V ++L+
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAES 58
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE------TRMKI 487
+V L YYS +D+ L E +P G L + L + ++ TR +
Sbjct: 59 DSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYM 107
Query: 488 A-----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------- 532
A ++A L + IHRD K NIL++ H K++DFGL+
Sbjct: 108 AECVLAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 533 --KQAPEGRTNYL----------------------------STRVM-----GTFGYVAPE 557
++ +G++N + R+M GT Y+APE
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ + D +S G ++ E L G P
Sbjct: 219 IFLQQGYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
ARG+ +L S+ CV HRD A N+LL K+ DFGLA+ +NY+S TF
Sbjct: 247 ARGMEFLA--SKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKG--STF 300
Query: 552 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++APE SDV+SYG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 44/233 (18%)
Query: 387 ILGEGGFGRVFKGVLSD---GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVK 440
++G+GG G V+ D VA+K++ K FL E ++ + L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 441 LVGYYSSRDSSQHLLCY-------ELVPN----GSLESWLHGPLGVNCHLDWETRMKIAL 489
+ S D + + Y L+ + SL L V + I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV------GAFLSIFH 120
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE--------GR 539
+ Y+H V+HRD K NILL + D+G A K+ E
Sbjct: 121 KICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 540 TNYLST------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
N + +++GT Y+APE + +D+Y+ GV+L ++LT P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)
Query: 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+L G RV+ L + ++ ++ + EV +L L + L
Sbjct: 4 KLLKGGLTNRVYL--LGTKDEDYVLKIN-PSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
S L L W+ G L + E IA A LA LH+
Sbjct: 61 SGESDGWSYL---------LMEWIEGETLDEVSEEEKE---DIAEQLAELLAKLHQLPLL 108
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+ H D NIL+++ + D+ A P
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
A G+ +L S+ CV HRD A N+L+ K+ DFGLA+ +NY+S TF
Sbjct: 249 ANGMEFLA--SKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKG--STF 302
Query: 552 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
++APE SDV+S+G++L E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 65/282 (23%), Positives = 101/282 (35%), Gaps = 87/282 (30%)
Query: 382 FEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLVEVEMLS 431
F +G G FG V D A+ + R + +++ L E +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--- 59
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALD 490
+ +VKL YYS +D + +P G + S L R+ I D
Sbjct: 60 ---NEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEED 101
Query: 491 AAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL----------- 531
AR + +H+ IHRD K NIL++ + H K+ DFGL
Sbjct: 102 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 532 ------------------------AKQAPEGRTNY------LSTRVMGTFGYVAPE-YAM 560
+ P R L+ ++GT Y+APE
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG-QENLVTW 601
TG+ + D +S GV+L E+L G+ P P+ Q ++ W
Sbjct: 219 TGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 75/278 (26%)
Query: 382 FEPASILGEGGFGRVFKGVLSDGTAV-AIKRLTCGGQQGDKEFLV---------EVEMLS 431
F LG G FG V D A+ A+K L K+ L+ E ++L+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR------KKDVLLRNQVAHVKAERDILA 56
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 489
+ +V+L YYS +D + +P G + S L G + + + A+
Sbjct: 57 EADNEWVVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------------- 532
++ + + IHRD K NIL++ + H K+ DFGL
Sbjct: 115 ESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165
Query: 533 ----------------------------KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
++A L+ ++GT Y+APE +
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
Query: 565 LVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTW 601
D +S GV+L E+L G+ P P Q ++ W
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 50/170 (29%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHL 479
E +V M + N +KL YYS H+L + + +G L L G L
Sbjct: 58 EPMVHQLMK---DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA--- 109
Query: 480 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEG 538
E + KI L LH+ + +IH D K N+L + D+GL K G
Sbjct: 110 --EVK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG 161
Query: 539 RTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+ GT Y +PE + GH S D ++ GV+ ELLTG+ P
Sbjct: 162 -----TPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 43/273 (15%)
Query: 388 LGEGGFGRVFKGVLSDGT---AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G +G V+K DG A+K++ G E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 445 YSSRDSSQHLLCYELVPNGSLESW----LHGPLGVN---CHLDWETRMKIALDAARGLAY 497
+ S + L ++ + + W H N L + G+ Y
Sbjct: 67 FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 498 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTF 551
LH + V+HRD K +NIL+ K+AD G A+ +P L V+ TF
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 552 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK- 609
Y APE + K+ D+++ G + ELLT +P+ + QE++ T + P D+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR---QEDIKT-SNPFHHDQL 234
Query: 610 DRL---------EELADPRLGGKYP--KEDFIR 631
DR+ ++ D R +YP ++DF R
Sbjct: 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRR 267
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 59/224 (26%)
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD--WET 483
E ++L+ + +VKL YYS +D + +P G + S L L +
Sbjct: 51 ERDILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------- 532
+ +A+++ + + IHRD K NIL++ + H K+ DFGL
Sbjct: 109 ELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 533 ----------------------------------KQAPEGRTNYLSTRVMGTFGYVAPEY 558
++A + L+ ++GT Y+APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTW 601
+ D +S GV+L E+L G+ P P+ Q ++ W
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 58/228 (25%)
Query: 388 LGEGGFGRVFKGVLSDGTA---VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G +G V+K DG A+K++ G E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66
Query: 445 YSSR---------DSSQHLLCYEL--------------VPNGSLESWLHGPLGVNCHLDW 481
+ S D ++H L + + +P G ++S L+ L
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD------- 119
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QA 535
G+ YLH + V+HRD K +NIL+ K+AD G A+ +
Sbjct: 120 ------------GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 582
P L V+ TF Y APE + K+ D+++ G + ELLT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 53/276 (19%)
Query: 341 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAY----EELKEATNNFEPASILGEGGFGRV 396
+ E A P VT +LP+ + Y E++ +T F+ S+LGEG FG+V
Sbjct: 88 TTNVEVAPPPKKKKVTY--ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145
Query: 397 FKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSS 447
+ + AV I R + K +E++ + ++ + L+K+ Y+
Sbjct: 146 VEAWDRKRKEYCAVKIVRNVPKYTRDAK---IEIQFMEKVRQADPADRFPLMKIQRYF-- 200
Query: 448 RDSSQHLLCYELVPNGS-LESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
++ + H +C + G L W+ HGP + HL +I L Y H ++
Sbjct: 201 QNETGH-MCIVMPKYGPCLLDWIMKHGPFS-HRHL-----AQIIFQTGVALDYFH--TEL 251
Query: 505 CVIHRDFKASNILLEN---------NFH-------AKVADFGLAKQAPEGRTNYLSTRVM 548
++H D K NIL+E N ++ D G RT +STR
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTR-- 309
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
Y +PE + + +D++S G ++ EL TG+
Sbjct: 310 ---HYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 4/92 (4%)
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
R + YLHE+ +IHRD KA NI + + + DFG A P GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 34/171 (19%)
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL------CYELVPNGSLESWLHGPLGVNCHL 479
E+ L RL+H N++K+ S ++ + Y + + + + W PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-WKDRPL------ 265
Query: 480 DWETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+TR MK L A + Y+H+ +IHRD K NI L + + DFG A
Sbjct: 266 LKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA----- 314
Query: 538 GRTNYLSTRVMGTFGYV------APEYAMTGHLLVKSDVYSYGVVLLELLT 582
+ R +G+V +PE +D++S G++LL++L+
Sbjct: 315 --MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 13/112 (11%)
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD----FGLAKQAPEGRTNY 542
I A RGL YLH++ IHR+ KAS+IL+ + ++ + L + + + Y
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 543 ----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDM 589
ST V+ + G+ VKSD+YS G+ EL TGR P DM
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 35/219 (15%)
Query: 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKL 441
+ + K T VA+K++ KE L E+ +L H N++
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILP- 63
Query: 442 VGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL---DAARGL 495
Y +S L + L+ GS E L H P G+ E IA D L
Sbjct: 64 --YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----EL--AIAFILKDVLNAL 114
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADF----GLAKQAPEGRTNYLSTR-VMGT 550
Y+H S+ IHR KAS+ILL + ++ + K R + + +
Sbjct: 115 DYIH--SKGF-IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 551 FGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+++PE + G+ KSD+YS G+ EL G P
Sbjct: 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 726 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.54 | |
| PLN02236 | 344 | choline kinase | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.16 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.97 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.77 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.59 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.52 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.34 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.34 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.1 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.93 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.3 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.98 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.97 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.53 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.34 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.41 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-57 Score=492.77 Aligned_cols=291 Identities=58% Similarity=0.996 Sum_probs=257.8
Q ss_pred CccccCHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEe
Q 004869 366 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445 (726)
Q Consensus 366 ~~~~~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~ 445 (726)
..+.|+++|+..+|++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 55679999999999999999999999999999999999999999988765443156699999999999999999999999
Q ss_pred ecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 446 ~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
.+.+. +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...|+|+|||||++|||||+++++|
T Consensus 141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 84332 599999999999999999975433 799999999999999999999999998999999999999999999999
Q ss_pred EEecCccccCCC-CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPE-GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~-~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+|+.... ... ..+...||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.+..+++.|++.
T Consensus 218 lsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999977654 221 11111799999999999999999999999999999999999999987766777789999988
Q ss_pred hccchhhhhhhcCCccC-CCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLG-GKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~-~~~~~-e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.+.+. .+.+++|+++. +.++. +++.++..++.+|++.+|++||+|.||++.|+.+..
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88876 89999999987 66665 688899999999999999999999999999866544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=411.50 Aligned_cols=261 Identities=34% Similarity=0.527 Sum_probs=214.9
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
...+.||+|+||+||+|.+++...||||++....... .++|.+|+.+|.+++|||||+|+|+|.... ..+++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEEEeC
Confidence 3446699999999999999755559999998654333 458999999999999999999999997432 2689999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCCCCC
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEGR 539 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~~~~ 539 (726)
++|+|.++|+.. ....+++..+++++.|||+||+|||++++ |||||||++||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999863 34579999999999999999999999875 99999999999999997 99999999998765432
Q ss_pred cccccccccccccccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+ . .. ...+..
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-----~~----------~~~v~~ 260 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-----QV----------ASAVVV 260 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-----HH----------HHHHHh
Confidence 2234478999999999999 66999999999999999999999999975442 1 11 111222
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
...+...+.+....+..++.+||+.||++||++.|++..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2223344444666789999999999999999999999999998875544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=415.05 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=225.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.+.+....+.||+|.||+||+|... +...||||.++..... ..++|++|+++|..++|||||+|+|+|. ++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR--EG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc--cC
Confidence 3556677899999999999999853 3468999999977665 6789999999999999999999999998 45
Q ss_pred CceEEEEeecCCCChhhhccCCCC------C----cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG------V----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~------~----~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~ 520 (726)
..++||+|||..|||.+||..... . ..+|+..+.+.||.|||.|++||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 589999999999999999953211 1 224888999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 004869 521 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 599 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 599 (726)
+..|||+||||+|.....+......+..-..+||+||.++.++|+++||||||||+|||+++ |+.||....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------- 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------- 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------
Confidence 99999999999998887766555545667889999999999999999999999999999998 999987433
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
+.+-++.+.+.++ -.+|..+..++++|+..||+.+|.+||+++||-..|+...+..
T Consensus 711 --------n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 711 --------NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2233444444444 4678888888999999999999999999999999998876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=396.96 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=214.1
Q ss_pred cccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 382 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+...+.||+|.||.||.|.+++...||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++ ..+||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecc
Confidence 4456889999999999999988889999999865 344678999999999999999999999998433 7999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 541 (726)
+|+|.+||+. .....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||||+...++..
T Consensus 285 ~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y- 358 (468)
T KOG0197|consen 285 KGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY- 358 (468)
T ss_pred cCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-
Confidence 9999999986 23456888999999999999999999999 99999999999999999999999999995544332
Q ss_pred cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 542 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
.......-+..|.|||.+..+.++.|||||||||+||||+| |+.||...... .+-+.++...
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----------------ev~~~le~Gy 421 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----------------EVLELLERGY 421 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----------------HHHHHHhccC
Confidence 23344556789999999999999999999999999999999 89888643211 1112222333
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+-..|..+...+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 335566677789999999999999999999999888887754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=381.72 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=209.0
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++..+.||+|..|+|||++++ +++.+|+|.+..... ...+++.+|++++++.+|||||.++|.|..... +..++|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 344688999999999999976 688999999954432 335789999999999999999999999985443 69999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|++|+|++++.. .+.+++...-+|+.+|++||.|||+ .+ |+||||||+|||++..|.+||||||.++...+.
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999975 2568999999999999999999996 66 999999999999999999999999999987654
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ ....|+ ..+..+.+.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~-------~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIF-------ELLCAIVDE 297 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHH-------HHHHHHhcC
Confidence 34568899999999999999999999999999999999999999965411 111221 123334442
Q ss_pred ccCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 619 RLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 619 ~l~~~~~~-e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ...|. ....+++.++..||+.||.+||++.|+++|=.
T Consensus 298 pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 298 PP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 21 12233 25566999999999999999999999998843
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=377.64 Aligned_cols=272 Identities=28% Similarity=0.439 Sum_probs=207.4
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHh--cccCceeEEEEEeecCC--CCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSRD--SSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~~~~~~--~~~~~L 455 (726)
....+.++||+|+||.||||++. ++.||||++. .++.+.|.+|-++++. ++|+||++|+++-...+ ..+++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556789999999999999996 4899999997 4567789999999874 68999999999854322 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC------CCCceeecCCCccceeecCCCcEEEEec
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~------~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
|++|.++|+|.+||+. ..++|....+|+..+++||+|||+. .+|+|+|||||++||||.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999985 3599999999999999999999975 3588999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCC------CcchhHHHHHHHHHHHHhCCCCCC-CCCCCccchhh---
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL------LVKSDVYSYGVVLLELLTGRKPVD-MSQPSGQENLV--- 599 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~------s~ksDVwSfGvvL~ELltG~~Pf~-~~~~~~~~~l~--- 599 (726)
|||..+..+.........+||.+|||||++.+.-. ..+.||||+|.|||||++...-++ ...+..+.-+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99998876655545556899999999999976422 247999999999999999765443 11111111111
Q ss_pred ------hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 600 ------TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 600 ------~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
+-++..+-.+.....+.|.... -..+..+++.+..||..|++.|-|+.=|-+.+..+....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111111111111121111 134567899999999999999999999988887776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=388.23 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=212.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.+|...+.||+|||..||+++. ..|+.||+|++.+. .....+...+||++.++|+|||||+++++|+ |..+.||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE--Ds~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE--DSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee--cCCceEE
Confidence 5689999999999999999996 78999999999753 2334567889999999999999999999998 5669999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|.|+|++|+|..+++. ++.+++.+++.++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||...
T Consensus 96 vLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999974 567999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ...+.+||+.|+|||++....++..+||||+|||||-|+.|++||+... +.+-...+...
T Consensus 169 e~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~------- 233 (592)
T KOG0575|consen 169 EYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLN------- 233 (592)
T ss_pred cCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhc-------
Confidence 75432 3356799999999999999999999999999999999999999997432 11111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+ ...|.....+..+||.++|+.||.+|||+++|+.+-..
T Consensus 234 -~----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 234 -E----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -C----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1 12333445567899999999999999999999987443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=370.18 Aligned_cols=201 Identities=32% Similarity=0.516 Sum_probs=178.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..+|...+.||+|+|++||+|+++ ++..||||.+.... ....+....|+++|+.++|||||.|++++.. ....||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEE
Confidence 357888899999999999999965 57999999997663 3344567899999999999999999999874 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC------CcEEEEec
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN------FHAKVADF 529 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~------~~vKL~DF 529 (726)
|||||.||+|.+||+. .+.+++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+||
T Consensus 87 VMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999986 336899999999999999999999999 9999999999999764 56899999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
|+|+....+. .....+|++-|||||+++..+|+.|+|+||.|+||||+++|+.||+...
T Consensus 160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999887543 4467899999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.11 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=203.6
Q ss_pred HhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCc-------hhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~-------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
..+.|.+.+.||+|+||.|-+|. .++|+.||||+++...... .....+|+++|++|+|||||++.+++...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 34667888999999999999998 4579999999997543221 22357999999999999999999999844
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC---CcEEE
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKV 526 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~---~~vKL 526 (726)
...||||||++||+|.+++-. ++.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred -CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 477999999999999999965 345777888899999999999999999 9999999999999765 88999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
+|||+|+...+.. .+...+||+.|.|||++.++.. ..|.|+||+|||||-+++|..||...... ..+.
T Consensus 321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~---- 391 (475)
T KOG0615|consen 321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK---- 391 (475)
T ss_pred cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH----
Confidence 9999999876433 4667899999999999987643 34889999999999999999999643211 1111
Q ss_pred hhccchhhhhhhcCCccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~--~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+++...+.. ...-.+..++..++|.+||..||++|||+.|++++=|.
T Consensus 392 ---------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 392 ---------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred ---------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 111111111 01112345578899999999999999999999998554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=360.54 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=210.1
Q ss_pred cCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.+|+++++||+|.||+|||++ +.+|..||.|.++.+.. ...++...|+.+|++|+|||||+++++-...+...++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999998 67899999999985533 334678999999999999999999985444444458999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC-CCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-QPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~-~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||..|+|...++.-....+.+++..+++++.|+++||.++|..- +..|.||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999766666678999999999999999999999831 123999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... .....+||+.||+||.+.+..|+.|+||||+||++|||+.-+.||... ++...-+.+-+.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg------- 243 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG------- 243 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-------
Confidence 65433 346689999999999999999999999999999999999999999743 333332222211
Q ss_pred cCCccCCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~-~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ..+| .-....+.+||..|+..|++.||+.-.+++.
T Consensus 244 ---d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 244 ---DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred ---CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 00 1123 3345678899999999999999986444443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.62 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=206.1
Q ss_pred hcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||++++++|.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence 46799999999999999999974 2356899999975432 2345789999999999 89999999998864 33
Q ss_pred CceEEEEeecCCCChhhhccCCCCC-------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGV------------------------------------------------------- 475 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~------------------------------------------------------- 475 (726)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998642210
Q ss_pred ---cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccccccccccccc
Q 004869 476 ---NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552 (726)
Q Consensus 476 ---~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~ 552 (726)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 99999999999999999999999999986543322222233456789
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHH
Q 004869 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR 631 (726)
Q Consensus 553 Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~ 631 (726)
|+|||++.+..++.++|||||||+||||++ |..||....... .+. . .+.+.. . ...+......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~---~-~~~~~~------~----~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC---Q-RLKDGT------R----MRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH---H-HHhcCC------C----CCCCCCCCHH
Confidence 999999999999999999999999999997 999997533211 110 0 111110 0 0112233446
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 632 VCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 632 l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=387.78 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=215.4
Q ss_pred CcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
...+.++||.|.||.||+|+++- ...||||.++.+... ...+|+.|..||.+++||||++|.|+.. .....++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEE
Confidence 34678999999999999999752 357999999977543 3568999999999999999999999987 4558899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|.|||+||+|+.||+.+. +++++.++..++.+||.|++||-+.+ +|||||.++|||++.+..+||+||||+|..
T Consensus 708 iTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999998654 45999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCcccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 536 PEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 536 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.++..... +....-..+|.|||.+...+++.++||||||+||||.++ |.+||...... +-+.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIk 845 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIK 845 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHH
Confidence 66553322 223344679999999999999999999999999999877 99998643321 1111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
. ++...+-..|.++...|.+|+..||++|-++||.+.||+..|.++.+
T Consensus 846 a-Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 846 A-IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred H-HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1 12223335567778889999999999999999999999999988765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.39 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=202.8
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeec--CCCCceEEEEee
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYEL 459 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~--~~~~~~~LV~Ey 459 (726)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|.+++||||++++|++.. .+....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999998 57899999997654333 3668899999999999999999999875 344578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
+++|+|.++++. ...++|...++++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999975 24589999999999999999999984 6 789999999999999999999999999865432
Q ss_pred CcccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... . +.......
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~---~~~~i~~~-------- 237 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---E---IYDLIINK-------- 237 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhc--------
Confidence 2 23468899999999876 68899999999999999999999999743211 1 11111111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
......+......+.+++.+||+.||++|||++||++.|++++..
T Consensus 238 --~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~ 282 (283)
T PHA02988 238 --NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY 282 (283)
T ss_pred --CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence 111112223445688999999999999999999999999988753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=397.66 Aligned_cols=266 Identities=29% Similarity=0.450 Sum_probs=218.2
Q ss_pred hcCcccceeeeecCcEEEEEEEECC--Cc----EEEEEEcccC-CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD--GT----AVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~--g~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
..+.+..+.||+|.||.||+|.+.+ |. .||||.+... +.++..+|++|..+|++++|||||+++|+|.. ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence 4566778999999999999999753 33 4999999865 34556789999999999999999999999984 56
Q ss_pred ceEEEEeecCCCChhhhccCCCC---CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 452 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~---~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
..++++|||++|+|..||++.+. ....|+....+.++.|||+|+.||++++ +|||||..+|+||++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 88999999999999999986421 2346899999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhcc
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
||+|+.+.............-..+|||||.++.+.++.|+|||||||+|||++| |..||......+. .. .+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~~----~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---LL----DVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---HH----HHH
Confidence 999997665544333333355679999999999999999999999999999999 8999975432211 11 011
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
++. +| ..|..+...+++|+.+||+.+|++||++..|++.+..+.+....
T Consensus 919 ~gg--------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 919 EGG--------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred hCC--------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 111 22 45666777899999999999999999999999988888766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=352.07 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=205.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|+++++||+|+||+||+++.+ +++.+|+|.+++... .+.+...+|..+|.+++||+||++.-.|+ +...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ--t~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ--TEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc--cCCeEE
Confidence 468999999999999999999954 689999999986532 33466889999999999999999976655 667999
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
||+||+.||.|..+|++ .+.+++..+.-++..|+.||.|||+.+ |+||||||+|||||++|+++|+||||++.
T Consensus 102 lVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999975 456888989999999999999999999 99999999999999999999999999996
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.-.... .+...+||+.|||||++.+..|+..+|.||+|+++|||++|..||.... ...+...+.+.+
T Consensus 175 ~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 175 DLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK----- 241 (357)
T ss_pred cccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-----
Confidence 544332 2445799999999999999999999999999999999999999997532 233333333322
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP----Tm~EVl~~ 656 (726)
+ ...+.-...+..+++...|+.||++|- .+.+|-+|
T Consensus 242 -----~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 -----L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -----C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1 112222344578999999999999995 45555433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=367.16 Aligned_cols=269 Identities=26% Similarity=0.422 Sum_probs=212.1
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
.++.....+.+.+...||+|.||+||+|+|.+ .||||.++...... .+.|.+|+.+|++-+|.||+=|.|||...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p- 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP- 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence 35555556677888999999999999999853 49999998765443 46899999999999999999999999732
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
.+.+|+.||+|.+|+.+||.. +..++..+.+.||.|||+|+.|||.++ |||||||..||+|+++++|||+||
T Consensus 461 --~~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 461 --PLAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred --ceeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 349999999999999999963 346899999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
||+.....-..........|...|||||+++. ..|+..+||||||+|+|||+||..||. .+..++ +.|+ +
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq---Iifm---V 605 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ---IIFM---V 605 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh---eEEE---e
Confidence 99975443222222334568889999999974 468999999999999999999999997 222221 1111 1
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
..+..+.+.. .....+...+.+|+..||..++++||.+.+|+..|+.+...+
T Consensus 606 GrG~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 606 GRGYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111111111 112233446889999999999999999999999888887653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.06 Aligned_cols=261 Identities=30% Similarity=0.418 Sum_probs=206.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+++|++++|||||+++|.....+...+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677899999999999999965 48999999997653333567899999999999999999999754333236889999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecCccccCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPE 537 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~~~~ 537 (726)
|+++|+|.+++.+..+ .|++..+..++.||++||+|||+++ |+|||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999986332 5999999999999999999999999 999999999999999 79999999999987664
Q ss_pred CC-cccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 538 GR-TNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 538 ~~-~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.. .........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+.-.+....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 11 112234578999999999999643 345999999999999999999999642 11111111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.....+........+++..|++.||++|||++|++++....+
T Consensus 240 ----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 240 ----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111344445556889999999999999999999998865443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=348.29 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred cCcccceeeeecCcEEEEEEEECC-----------------CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKL 441 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-----------------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~l 441 (726)
++|++.+.||+|+||.||++.+++ +..||+|.+...... ...+|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998532 346999998754322 24579999999999999999999
Q ss_pred EEEeecCCCCceEEEEeecCCCChhhhccCCC---------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCce
Q 004869 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL---------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~---------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~I 506 (726)
++++.. ....++||||+++|+|.+++.... .....++|..+++++.|++.||+|||+.+ |
T Consensus 85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 999874 447899999999999999985421 11134788999999999999999999998 9
Q ss_pred eecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CC
Q 004869 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GR 584 (726)
Q Consensus 507 vHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~ 584 (726)
+||||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986654332222334456889999999998899999999999999999987 45
Q ss_pred CCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 585 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 585 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.||..... ................. .....+......+.+++.+||+.||++|||+.||++.|+
T Consensus 240 ~p~~~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTD---EQVIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCH---HHHHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66653221 11222221111111000 000112223346889999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.02 Aligned_cols=274 Identities=25% Similarity=0.396 Sum_probs=212.4
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHh--cccCceeEEEEEeec
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSS 447 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~~~~ 447 (726)
+.+--.+....+..+.+.||+|.||.||+|.|+ |+.||||++. ..+++.|.+|.++++. |+|+||+.|++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 344444556678899999999999999999996 6889999997 4557789999999986 599999999986322
Q ss_pred --CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-----CCCCceeecCCCccceeecC
Q 004869 448 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-----DSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 448 --~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-----~~~p~IvHrDIKp~NILLd~ 520 (726)
....+++||++|.++|||+|||.. ..++.+..++++..+|.||++||. +|+|.|.|||||++|||+.+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 123478999999999999999984 458899999999999999999995 48899999999999999999
Q ss_pred CCcEEEEecCccccCCCCCc--ccccccccccccccCccccccC----CC--CcchhHHHHHHHHHHHHhC---------
Q 004869 521 NFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMTG----HL--LVKSDVYSYGVVLLELLTG--------- 583 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~----~~--s~ksDVwSfGvvL~ELltG--------- 583 (726)
++.+.|+|+|||........ .......+||.+|||||++... .+ -..+||||||+|+||+...
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999987655421 2223457899999999998753 22 2469999999999999763
Q ss_pred -CCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 584 -RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 584 -~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~-----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
+.||....+.+.. ..+ ++. -+-..+++. ....+.+..+.+|++.||..+|.-|-|+-.|-+.|
T Consensus 432 y~~Pyyd~Vp~DPs-~ee-Mrk---------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPS-FEE-MRK---------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred hcCCcccCCCCCCC-HHH-Hhc---------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 3566544333211 111 111 111112222 23456778899999999999999999999999998
Q ss_pred HHHHHh
Q 004869 658 KMVQRV 663 (726)
Q Consensus 658 ~~i~~~ 663 (726)
.++.+.
T Consensus 501 ~~l~~~ 506 (513)
T KOG2052|consen 501 AKLSNS 506 (513)
T ss_pred HHHhcC
Confidence 887754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=390.89 Aligned_cols=262 Identities=27% Similarity=0.496 Sum_probs=213.3
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
...|...+.||+|+||.||+|+. .+|..||||++..... ....|++++++++|||||+++|+|.. ....++||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 34677889999999999999996 5789999999864322 22356889999999999999999974 45789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++++. ++|.++.+++.|+++||+|||..+.+.|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999963 8999999999999999999997655669999999999999999988876 665543321
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
. ....||..|||||++.+..++.|+|||||||++|||+||+.||+... .....+..|++....+ .....+.|
T Consensus 835 ~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 906 (968)
T PLN00113 835 D------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD-CHLDMWID 906 (968)
T ss_pred C------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCc-cchhheeC
Confidence 1 22368899999999999999999999999999999999999996432 2334567777655433 33556667
Q ss_pred CccCC--CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~--~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+.+.. ..+.++..++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 66643 2345667788999999999999999999999999988755
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.11 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=218.2
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCch-hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+....+.++||+|-||.|.++...++..||||+++....... ++|.+|+++|.+++|||||.|+|+|..++ .+++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHH
Confidence 445667899999999999999998889999999997765544 89999999999999999999999998544 789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|||++|+|..||..+.... +.-....+|+.||+.|++||.+.+ +|||||.++|+|+|.++++||+|||+++....
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999997643221 455677889999999999999999 99999999999999999999999999998888
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
+.......+.+-..+|||+|.+.-++++.++|||+||++|||+++ ...||.... .+..++-...+++......-+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcceec
Confidence 777666677788999999999999999999999999999999865 778886432 223333333333333221111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..|.-+..++++++.+||..|-++||+++++...|+.
T Consensus 767 -------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 767 -------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred -------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 2244455678999999999999999999999988765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.60 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++++|. +.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--VG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cC
Confidence 45788999999999999999973 235689999997443 23345789999999999 8999999999987 44
Q ss_pred CceEEEEeecCCCChhhhccCCCC--------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 474 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~-------------------------------------------------------- 474 (726)
...++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 578999999999999999864221
Q ss_pred ---------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 475 ---------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 475 ---------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
....++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0124788999999999999999999998 9999999999999999999999999998665433
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..+. ...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~--------- 333 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEG--------- 333 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhC---------
Confidence 2222223445678999999999999999999999999999998 88888643211 1111111 111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.....+.....++.+|+.+||+.||++||++.||++.|++
T Consensus 334 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 -YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0001111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.67 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+++++.+ +|+|||+++++|. +.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--HG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--CC
Confidence 457889999999999999998842 3457999999754332 245688999999999 8999999999987 44
Q ss_pred CceEEEEeecCCCChhhhccCCCC--------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 474 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~-------------------------------------------------------- 474 (726)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 588999999999999999853210
Q ss_pred ----------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccccc
Q 004869 475 ----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544 (726)
Q Consensus 475 ----------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 544 (726)
....+++.++++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1124788899999999999999999998 999999999999999999999999999866443322222
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 545 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
....++..|||||++.+..++.++|||||||++|||++ |+.||....... .+.. .. .......
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~----------~~~~~~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MV----------KRGYQMS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HH----------HcccCcc
Confidence 23346678999999999999999999999999999997 999996432111 1000 01 1111111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11222346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=361.73 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=212.0
Q ss_pred cCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
..|....+||+|..|.||.++ ..+++.||||++........+-.++|+.+|+..+|+|||++++-|... .++|.|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEe
Confidence 456777899999999999998 457889999999988777777889999999999999999999987643 58999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
||++|+|.|.+.. ..+++.++..|+.++++||+|||..+ |+|||||.+||||+.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999974 34899999999999999999999999 999999999999999999999999999887765
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. .....+||+.|||||++....|..|.||||||++++||+-|.+||-...+.....+ +..+ + -+
T Consensus 423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~n-g------~P 487 (550)
T KOG0578|consen 423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN-G------TP 487 (550)
T ss_pred cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------Hhhc-C------CC
Confidence 54 34668999999999999999999999999999999999999999965332211111 1111 1 11
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. -..+......+.+++.+||+.|+++|+++.|+|+|
T Consensus 488 ~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 K--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred C--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1 12344455568999999999999999999999987
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.21 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=205.2
Q ss_pred cCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
++|++.+.||+|+||.||+|...+ ...||+|.+...... ...+|.+|++++.+++|+||+++++++. +...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCc
Confidence 468889999999999999998643 257999998744322 2456899999999999999999999987 4457
Q ss_pred eEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC
Q 004869 453 HLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~ 520 (726)
.+++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence 8999999999999999964311 1145888999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 004869 521 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 599 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 599 (726)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~ 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence 99999999999986644332222334557889999999998899999999999999999998 99998643311 111
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.. +.. ......+.....++.+|+.+||+.||++||++.||+++|+.
T Consensus 237 ~~-------------i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EM-------------IRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-------------HHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111 11112233444568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=344.36 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=203.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|++.+.||+|+||.||+|++. ++. .||+|.++.... ...++|.+|+.+++.++|+||++++|+|.. ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 46899999999999999999863 333 489999875432 335678999999999999999999999863 357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 8999999999999999753 235889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||+..... .+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~--- 227 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKG--- 227 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCC---
Confidence 7654433222223345778999999999999999999999999999998 99998643211 1111 11111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.....+......+.+++.+||+.+|++||++.+++..|..+.+
T Consensus 228 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111122233468899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.97 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=208.3
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 376 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 376 ~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
+...++|..++.||+|+|++|++|+. ..+++||||++.+.- +...+....|-+.|.+| .||.|++|+--|. |.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cc
Confidence 33457899999999999999999994 568999999986542 23345567899999999 8999999976665 66
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
..+|+|+||++||+|.++|++ .+.+++...+.++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence 799999999999999999986 356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcc-----------cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 531 LAKQAPEGRTN-----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 531 la~~~~~~~~~-----------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
.|+.+...... .....++||..|.+||++..+..+..+|+|+||||||+|+.|.+||.... +.+
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyl- 294 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYL- 294 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHH-
Confidence 99977543211 11144899999999999999999999999999999999999999997432 111
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. .+++++ +.-.++....+.+.+|+.+.|..||++|+|..||-+|.
T Consensus 295 -i----------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 -I----------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -H----------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 111111 11233444445688999999999999999999998773
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=354.49 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=208.3
Q ss_pred hcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.+.|+..++||+|.||.||+|+ ..+|+.||+|++...... ......+||.+|++|+||||++|.+.........+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888999999999999999 568999999999866533 3356688999999999999999999988766778999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|+|||+. ||..++..+ .-.++..++..++.|++.||+|||..+ |+|||||.+|||||++|.+||+|||||+..
T Consensus 196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999977 898888743 346899999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh----------hhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----------TWARP 604 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~----------~~~~~ 604 (726)
....... .+..+-|..|.|||++.+ ..|+.+.|+||.||||.||+.|+..|......++...+ .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6554332 455678999999999886 47999999999999999999999999766544432211 12211
Q ss_pred hccchhhhhhhcCCccCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYP-------KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~-------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.. ...+.+. ..+. .......++|+..+|..||.+|.|+.++++.
T Consensus 348 kLP~----~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPH----ATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCc----ccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1110 0000000 0111 1112346789999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=338.99 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=200.5
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++++++|+||+++.+++. +....++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEE
Confidence 477889999999999999985 578999999986432 222346789999999999999999999887 44579999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 79 LTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999999998885321 235889999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ..... .+.
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~----------~~~ 218 (285)
T cd05631 154 EGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDR----------RVK 218 (285)
T ss_pred CCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHH----------Hhh
Confidence 3321 23456899999999999999999999999999999999999999754321110 00000 000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
.. ...++......+.+|+.+||+.||++||+ ++|++++
T Consensus 219 ~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 01222333446889999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.62 Aligned_cols=247 Identities=30% Similarity=0.436 Sum_probs=211.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.... +.+...+|++++++++|||||.++++|+ ...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEE
Confidence 57888999999999999999954 6789999999765433 3467899999999999999999999987 45699999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
.||+.| +|..+|.. ++.+.++.+..++.+++.||.|||+.+ |+|||+||.||||+.++++|+||||+|+.+.
T Consensus 80 te~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred ehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999977 99999975 567999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.. ....+.+.||+.|||||+..+..|+..+|+||+||||||+.+|++||.. ..+...++.+..+.
T Consensus 152 ~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~------- 216 (808)
T KOG0597|consen 152 TN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP------- 216 (808)
T ss_pred cC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC-------
Confidence 53 3355678999999999999999999999999999999999999999963 23333333333321
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+......+..++...|..||.+|.|-.+++.|
T Consensus 217 -----v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 -----VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12344556678899999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=361.95 Aligned_cols=262 Identities=30% Similarity=0.469 Sum_probs=208.8
Q ss_pred hcCcccceeeeecCcEEEEEEEECC--C--cE-EEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD--G--TA-VAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~--g--~~-VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++..+.++||+|+||.||+|++.- + .. ||||..+... ....++|++|.++|++++|+|||+++|++. +.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~--~~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV--LE 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--CC
Confidence 3455667999999999999999642 2 23 8999998532 344578999999999999999999999987 44
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
..+++|||+|.||+|.++|++..+ .++..++++++.++|+||+|||+++ ++||||.++|+|++.++.+||+|||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 588999999999999999986332 5999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+++....... ......-..+|+|||.+..+.|+.++|||||||++||+++ |..||...... +....+..+
T Consensus 308 Ls~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~- 378 (474)
T KOG0194|consen 308 LSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKN- 378 (474)
T ss_pred cccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhc-
Confidence 9876541111 1112235679999999999999999999999999999999 88898754311 111111111
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
...-..+......+..++.+||..+|++||+|.++.+.|+.+....+.
T Consensus 379 ---------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 ---------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111233344555678899999999999999999999999998775543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.34 Aligned_cols=251 Identities=31% Similarity=0.568 Sum_probs=193.6
Q ss_pred ccceeeeecCcEEEEEEEEC-----CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 383 EPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++.+.||+|.||.||+|.+. .+..|+||.++..... ..+.|.+|++.+++++|+||++++|+|. +....++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccc
Confidence 35689999999999999986 2578999999653322 3578999999999999999999999998 44468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||+++|+|.++|+.. ....+++.++++|+.|+++||.|||+.+ ++|+||+++|||+++++.+||+|||+++...
T Consensus 80 ~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999999863 1346899999999999999999999998 9999999999999999999999999998774
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
............+...|+|||.+....++.++||||||+++|||++ |+.||.... ...+. ..+ .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~---~~~-~~~~~---- 223 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEII---EKL-KQGQR---- 223 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHH---HHH-HTTEE----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc---ccc-ccccc----
Confidence 3322222334567889999999999999999999999999999999 678875331 11111 111 11111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
...+......+.+++.+||+.||++||++.+|++.|
T Consensus 224 ------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223344688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.36 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|++++.+++||||++++|++. .....
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCc
Confidence 357889999999999999999853 356899999986532 22357899999999999999999999987 44589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999742 235899999999999999999999998 9999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... ..... ..+.
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~--- 224 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDG--- 224 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCC---
Confidence 5432211 11122345678999999999999999999999999999775 99999643211 11111 0110
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.....+......+.+++.+||+.+|++||+++||++.|..+
T Consensus 225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112233345688999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=335.18 Aligned_cols=265 Identities=26% Similarity=0.351 Sum_probs=205.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
+.|+.+.++|+|+||.||+++.+ +|+.||||++.....+ -.+-.++|+++|++++|+|+|.|+.+|. ....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEE
Confidence 46888899999999999999965 5999999999754332 2355789999999999999999999987 45589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||++..=|.++-+.+ ..++...+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||||||+|+...
T Consensus 80 FE~~dhTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eeecchHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999885555554432 23778899999999999999999999 9999999999999999999999999999887
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh--------hhhhcc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW--------ARPILR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~--------~~~~~~ 607 (726)
.... ..+..+.|..|.|||.+.+ .+|....||||.||++.||++|..-|......++..++.- ...++.
T Consensus 153 ~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 153 APGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred CCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 4332 2356678999999999987 7899999999999999999999998876654444332211 111111
Q ss_pred chhhhhhhcCCcc------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRL------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l------~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+.-|.. ...++. ...-+.+++..||+.||.+|++-+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111111 112222 12357899999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.78 Aligned_cols=240 Identities=27% Similarity=0.412 Sum_probs=201.8
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
.++-||.|+.|.||+|++. ++.||||+++.- -..+|+.|++|+|+||+.|.|+|. ....+|||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec--CCceeEEeeeccccc
Confidence 3578999999999999996 578999998632 235789999999999999999998 456899999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
-|...|+. ...++-.....+..+||.|+.|||.+. |||||||+-||||..+..+||+|||-++...+.. .
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---T 267 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---T 267 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---h
Confidence 99999985 456788889999999999999999998 9999999999999999999999999998776542 2
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
...+.||..|||||+++....++|.||||||||||||+||..||....... +.| .-+ ...+.-.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----GVG-------sNsL~Lp 331 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----GVG-------SNSLHLP 331 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----ecc-------CCccccc
Confidence 345789999999999999999999999999999999999999996433211 111 111 1122334
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.|..+.+.+.-|+++||+-.|.+||++++|+.||..
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 566667778889999999999999999999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=350.87 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=207.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC----CC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG----GQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~ 450 (726)
...+|.+.+.||+|+||+|++|+. .+|+.||+|.+... .. ...+...+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 456899999999999999999985 46899999977653 12 23455678999999999 999999999988544
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEec
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADF 529 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DF 529 (726)
..++||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|||+.+ |+|||||++|||++.+ +++||+||
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 69999999999999999975 346888999999999999999999999 9999999999999999 99999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s-~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|++..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .....+.+.+
T Consensus 166 G~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~ 237 (370)
T KOG0583|consen 166 GLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRK 237 (370)
T ss_pred ccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhc
Confidence 99997741 122345678999999999999877 75 78999999999999999999998522 2222222222
Q ss_pred chhhhhhhcCCccCCCCChhh-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKED-FIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~-~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
... .++... ..++..++.+||..||.+|+|+.||+++=|..
T Consensus 238 ~~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 238 GEF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred CCc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 111 122222 45688999999999999999999999664443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.97 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CC
Confidence 3468888999999999999998633 478999999765444 34689999999999999999999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCC----------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 452 QHLLCYELVPNGSLESWLHGPL----------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~----------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
..+++|||+++|+|.++++... .....+++.++..++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 8999999999999999996432 12345889999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIE 235 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Confidence 9999999999986543322112233456788999999999999999999999999999998 9999864321 11111
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... .... ...+......+.+++.+||+.||++||++.||++.|+
T Consensus 236 ~~~-------------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT-------------QGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH-------------cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 0000 1112223346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=344.67 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=195.5
Q ss_pred eeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||+++. .+|+.||+|.+.... ......+.+|++++++++||||+++++++. +....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999986 468999999987432 223356788999999999999999999887 4458999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 541 (726)
+|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 9999999864 345889999999999999999999999 99999999999999999999999999975432211
Q ss_pred cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccC
Q 004869 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 621 (726)
Q Consensus 542 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 621 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .+.. ..
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~~~~----------~~-- 211 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILM----------EE-- 211 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHH---HHHc----------CC--
Confidence 22345799999999999999999999999999999999999999964321 11111 0111 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 622 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 622 ~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
..++......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 112333345688999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.58 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=204.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. +....+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEe
Confidence 35789999999999999999998888899999986433 23578999999999999999999999876 4457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999997532 345888999999999999999999988 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++....++.++|||||||++|||++ |+.||..... .....+... .. .
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~----~~------~ 222 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQR----GY------R 222 (261)
T ss_pred cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHc----CC------C
Confidence 221 1223346778999999998889999999999999999998 9999864321 111111110 00 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
. .........+.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 M----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 1111223458899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.18 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=204.6
Q ss_pred cCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|++.. ...||||.+...... ...+|.+|+.++++++|+||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceE
Confidence 578999999999999999999742 457999998754332 3457899999999999999999999886 445789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++|||+++|+|.+++.... ..+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 82 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 82 IITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999997532 36899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~---------- 222 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVE---------- 222 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHH----------
Confidence 753222222223445678999999998899999999999999999998 9999853221 11111110
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
+. .....+......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 223 ---~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 ---DG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00011223345688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.68 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=208.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCce
Confidence 46888899999999999999842 346799999876555555789999999999999999999999874 4578
Q ss_pred EEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 454 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 999999999999999964221 1235899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence 9999999999986654332222334557889999999999999999999999999999999 99998643211 1111
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
. +..... ...+......+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 237 ~-------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 C-------------ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H-------------HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 001000 011122234588999999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.10 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=208.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++. +...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence 467889999999999999999842 34568999987655555668999999999999999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCC---------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc
Q 004869 453 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 523 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~---------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~ 523 (726)
.+++|||+++|+|.+++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 899999999999999986422 11235899999999999999999999998 999999999999999999
Q ss_pred EEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 004869 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 524 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~ 602 (726)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~-- 233 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE-- 233 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999986644332222233456788999999998999999999999999999998 89998643211 1111
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+.. .... ..+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 234 -~i~~----------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQ----------GRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHc----------CCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111 0000 01112234589999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.55 Aligned_cols=271 Identities=28% Similarity=0.388 Sum_probs=206.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-----CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||++.++ ++..||+|++........+.|.+|++++++++|+||+++++++...+....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999853 5789999998766555567899999999999999999999988655556789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++... ...++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999642 235899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc---chh
Q 004869 535 APEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKD 610 (726)
Q Consensus 535 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~ 610 (726)
......... .....++..|+|||++.+..++.++|||||||++|||++|..++...... .......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 654332211 11223455699999999889999999999999999999988765422110 0000000000 000
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.+..........+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111112223345688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.43 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=201.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||++.++++..+|+|.+.... ...++|.+|++++++++|+||+++++++. +....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEEEEc
Confidence 4588889999999999999999888899999986432 33567999999999999999999999987 44578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.++++... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999999997422 35899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... .+. .. .
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i---~~~-~~---~--- 220 (256)
T cd05114 155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI---SRG-FR---L--- 220 (256)
T ss_pred ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---HCC-CC---C---
Confidence 11 1122345678999999998889999999999999999999 8999864321 1111111 110 00 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..+......+.+++.+||+.+|++||+++|+++.|
T Consensus 221 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 ----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11122234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.05 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=204.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++|+||+++++++.. ....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeeeee
Confidence 46788999999999999999998888899999987543 335779999999999999999999999873 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997532 346899999999999999999999998 999999999999999999999999999876532
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... .......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+... + +
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~---~-----------~ 218 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQ---V-----------D 218 (261)
T ss_pred ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH---H-----------H
Confidence 211 1112233468999999998899999999999999999999 9999864321 111110 0 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.......+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000111222334568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.48 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=205.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-PG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CC
Confidence 357899999999999999999742 2478999998754322 235678899999999 89999999998864 34
Q ss_pred CceEEEEeecCCCChhhhccCCCCC-------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGV------------------------------------------------------- 475 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~------------------------------------------------------- 475 (726)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999998532110
Q ss_pred --cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccc
Q 004869 476 --NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553 (726)
Q Consensus 476 --~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y 553 (726)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999998 999999999999999999999999999876443322222334567889
Q ss_pred cCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHH
Q 004869 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV 632 (726)
Q Consensus 554 ~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l 632 (726)
+|||++.+..++.++|||||||+||||++ |..||....... .+.. .+... .....+......+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~----------~~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEG----------TRMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhcc----------CCCCCCccCCHHH
Confidence 99999999999999999999999999998 999986432211 1110 11110 0111122334568
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 633 CTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 633 ~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.+++.+||+.+|++||++.||+++|+.+.+
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.95 Aligned_cols=270 Identities=32% Similarity=0.431 Sum_probs=208.2
Q ss_pred cccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 382 FEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
|...+.||+|+||+||++.+ .++..||+|.+..... .....|.+|++++++++|+||+++++++...+....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988763 3578899999875432 23567899999999999999999999987655567899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+++|+|.+++.. ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999964 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.|+....... .....+.... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ-MTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc-cchhhhhh
Confidence 5433211 1122345677999999988889999999999999999999999986432211 1111111100 00111222
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
..+.......+......+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222233344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=331.37 Aligned_cols=256 Identities=32% Similarity=0.476 Sum_probs=209.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
...+|++.+.||+|+||.||+|...++..+|+|.+..........+.+|++++++++|+||+++++++. +....++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEEE
Confidence 456788999999999999999998889999999998766555678999999999999999999999987 445789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999997532 346899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... ......++..|++||.+.+..++.++||||||+++|||++ |+.||..... ........
T Consensus 157 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~------------- 218 (261)
T cd05148 157 DVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT------------- 218 (261)
T ss_pred ccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH-------------
Confidence 321 1223456788999999988899999999999999999998 8999864321 11111110
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.......+......+.+++.+||+.||++|||++++++.|+.
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011111223344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.76 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=202.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.+++|++.+.||+|+||.||+|... ++..||||++..... ....+|.+|+.+++.++|+||+++++++. +.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4678999999999999999999853 246799999864322 23457899999999999999999999986 44
Q ss_pred CceEEEEeecCCCChhhhccCCCCC------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
...++||||+++|+|.++++..... ...++|..++.++.|+++||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence 5889999999999999998642211 234678899999999999999999988 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 603 (726)
||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... .....+
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~-- 233 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF-- 233 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--
Confidence 9999999986544332212222346788999999998899999999999999999999 6888864321 111110
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. .+... ...+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 -~----------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 -V----------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -H----------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 01000 0112233446889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.13 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=201.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|+||.||+|.+. +|+ .+++|.+..... ....++..|+.++++++|+||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCcc
Confidence 46778899999999999999963 344 478888754322 22356788888999999999999999874 2357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++|+|.++++.. ...++|..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 84 ~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 8999999999999999742 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...............++..|+|||++.++.++.++|||||||++|||++ |+.||....... +.++ +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~- 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGER- 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCc-
Confidence 7654333223344567889999999998899999999999999999998 999986432111 1111 111110
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
. ..+......+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 230 --~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 --L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 1111223357889999999999999999999998888664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.37 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence 468999999999999999999965 578899999875432 224579999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999974 235888999999999999999999853 29999999999999999999999999997654
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh-hccc-------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-ILRD------- 608 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~-~~~~------- 608 (726)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||....... +...... ....
T Consensus 156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccc
Confidence 322 234568999999999999999999999999999999999999996432211 1100000 0000
Q ss_pred -------------------------hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 609 -------------------------KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 609 -------------------------~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.+....+................+.+++.+||+.||++|||++|++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000111000000011223468899999999999999999999988654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.20 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++. +....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence 47899999999999999999975 578999999875432 23457889999999999999999999887 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++++.|..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 79 FEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999877665432 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh---------hhhhcc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW---------ARPILR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~---------~~~~~~ 607 (726)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||.............. ......
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 33221 22345689999999999988899999999999999999999999975432111100000 000000
Q ss_pred chhhhhhhcCCccCC------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGG------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~------~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+ ........+.... .+.......+.+++.+||+.||++|||++|++++
T Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 231 N-PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred c-chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0000000000000 0011123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.98 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=206.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
..++|++.+.||+|+||.||++... +...+|+|.+..... ....++.+|++++.++ +|+||+++++++. +
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--Q 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--C
Confidence 4567889999999999999999864 236799999875422 2335688999999999 7999999999987 4
Q ss_pred CCceEEEEeecCCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
....+++|||+++|+|.++++... .....+++..+++++.|++.||+|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 457899999999999999996421 22456899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 596 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~ 596 (726)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 241 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence 99999999999999987654332222233345678999999998899999999999999999998 88888633211
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.... ..........+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 242 ~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFK--------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0100 00111111223334456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=360.70 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=204.1
Q ss_pred CcccceeeeecCcEEEEEEEEC-C-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-D-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|++++++++|||||++++++.. ....+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence 4889999999999999999853 3 67889998765554445678889999999999999999999874 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.++|+........+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988653333456889999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
..........||++|+|||++.+..++.++|||||||++|||++|+.||..... ......... .
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~----------~ 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY----------G 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh----------C
Confidence 322233456799999999999999999999999999999999999999964321 111111111 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ...+......+.+++.+||+.||++||++.+++++
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 01122233458899999999999999999999764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.87 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~ 450 (726)
.++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.|.+|+++++++. ||||++++++|. +.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--KS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--cC
Confidence 568889999999999999999852 134799999975433 23457999999999996 999999999987 45
Q ss_pred CceEEEEeecCCCChhhhccCCCC--------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 474 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~-------------------------------------------------------- 474 (726)
...+|||||+++|+|.++|+....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 589999999999999999864210
Q ss_pred ------------------------------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee
Q 004869 475 ------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 518 (726)
Q Consensus 475 ------------------------------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL 518 (726)
....+++..+++++.|+++||+|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0124788889999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccch
Q 004869 519 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 597 (726)
Q Consensus 519 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~ 597 (726)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence 9999999999999986644332222233457788999999999899999999999999999997 99998643211 00
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
+.. ..... .....+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 349 ~~~----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYN----KIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHH----HHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 100 01110 001112233446889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.01 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|+||.||+|++ .++..||+|.+..... .....|.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCce
Confidence 4688889999999999999984 2467899999974332 223578899999999999999999999873 4578
Q ss_pred EEEEeecCCCChhhhccCCCC-------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC
Q 004869 454 LLCYELVPNGSLESWLHGPLG-------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~-------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~ 520 (726)
+++|||+++|+|.+++..... ....+++.+.+.++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence 999999999999999853210 1234788999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 004869 521 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 599 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 599 (726)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~ 236 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI 236 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Confidence 99999999999987644332222233456778999999988889999999999999999998 9889864321 1111
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.. .... .....+......+.+++.+||+.||++||++.+|.++|+.
T Consensus 237 ~~----~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EM----VRKR----------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 1110 0011222333468899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.27 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=200.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 47889999999999999999965 68999999986432 123456889999999999999999998876 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 79 LMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999964 235889999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 152 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~-------- 212 (291)
T cd05612 152 RDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILA-------- 212 (291)
T ss_pred cCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--------
Confidence 4321 2346899999999999988999999999999999999999999643211 11111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK 658 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~L~ 658 (726)
... .++......+.+++.+||+.||.+||+ ++|++++-+
T Consensus 213 --~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 213 --GKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred --CCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 111 122222345789999999999999995 899887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.93 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=202.2
Q ss_pred cccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCC----C
Q 004869 382 FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 451 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~----~ 451 (726)
|.+.+.||+|+||.||+|.+.. +..||+|+++.... .....+.+|++.++.++|+||+++++++...+. .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 36799999875432 223578999999999999999999998764332 3
Q ss_pred ceEEEEeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 452 QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
..++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 4789999999999999985432 12246899999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+..+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~------ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL------ 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH------
Confidence 99987654432222222345678999999988899999999999999999999 8888864321 1111111
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.. ....+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 229 -------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 -------RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------HcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0112233445689999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.87 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=205.5
Q ss_pred hcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCch-hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.+.|++.+.||.|..++||+|+ ...++.||||++..+..+.. +++.+|+..|+.++||||++++..|. ....+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv--v~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV--VDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE--ecceeEEe
Confidence 4679999999999999999999 45679999999986654444 78999999999999999999988877 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|.||.+|++.+.++... ...+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999997533 234889999999999999999999999 9999999999999999999999999876554
Q ss_pred CCCcc-ccc-ccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 537 EGRTN-YLS-TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 537 ~~~~~-~~~-~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
..... ... ...+||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+... +. ..+......+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll---~tLqn~pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LL---LTLQNDPPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HH---HHhcCCCCCc
Confidence 43321 112 55789999999999664 4789999999999999999999999975433221 00 0011111000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. -..+..+........+.+++..||+.||.+|||+++++++
T Consensus 253 ~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 L---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 0000111111122358899999999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.39 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=208.5
Q ss_pred HhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchh-HHHHHHHHHHhcc-cCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~-~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~ 454 (726)
..++|...++||.|.||.||+|+ ..+|..||||+++..-....+ --++|++.|++|+ |||||+|..++.+.+. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 35688999999999999999999 457899999999865433222 2478999999998 9999999999875544 899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+|||||+. +|++++++. ++.+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.
T Consensus 87 fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999955 999999863 567999999999999999999999999 99999999999999888999999999998
Q ss_pred CCCCCcccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh-----hhhccc
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-----RPILRD 608 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~-----~~~~~~ 608 (726)
...... .+..+.|..|.|||++. .+.|+.+.|||++|||++|+.+-+.-|.+....++..-+-.+ +..+.+
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 765442 35667899999999876 567899999999999999999999988765443332111000 000111
Q ss_pred hhhhhhhcCCccC--------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDRLEELADPRLG--------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~--------~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+..+...++-++. .-.+ ....++.+++.+|++.||++|||+.|++++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1112222221111 1112 245678999999999999999999999987
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=329.71 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=209.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC-----CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
..++|++.+.||+|+||.||+|...+ +..|++|++..... ...+.+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 35689999999999999999999765 68899999874422 2345688999999999999999999987643 45
Q ss_pred ceEEEEeecCCCChhhhccCCCCC----cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~----~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
..++++||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999653221 146899999999999999999999998 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
|||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+ ..+..+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---
Confidence 9999986644332222233456778999999998889999999999999999999 9999964321 11222111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.... . ..+......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 234 -~~~~--------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 -DGYR--------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -cCCC--------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1100 0 0111223458899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.75 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=203.8
Q ss_pred CcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 381 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
+|++.+.||+|+||.||+|+.. +...+++|.+..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCc
Confidence 4778899999999999999853 235789998875432 224578999999999999999999999874 4578
Q ss_pred EEEEeecCCCChhhhccCCCC--------------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCc
Q 004869 454 LLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 513 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~--------------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp 513 (726)
++++||+.+|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 999999999999999864211 1235889999999999999999999998 99999999
Q ss_pred cceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 004869 514 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 592 (726)
Q Consensus 514 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~ 592 (726)
+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986544332222233456778999999988889999999999999999998 9999864321
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
..+..+.. .......+......+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 236 ---~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ---ERLFNLLK--------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHHHHh--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111111 111111222334568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.90 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=206.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +++.||||.+..... .....|.+|++++++++|+||+++++++.. ....++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 57899999999999999999954 689999998764322 223568899999999999999999999874 458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
++||+++|+|.+++.........+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999988543233345788999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... +...+...+ ...
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-------~~~ 223 (267)
T cd08228 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-------EQC 223 (267)
T ss_pred cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-------hcC
Confidence 54321 12234688899999999988899999999999999999999999854321 111111111 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+ ..........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 224 ~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011 111123335689999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.98 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=202.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence 46899999999999999999975 58899999987432 223457889999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 79 AMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999964 235889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~l~~ 614 (726)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+..|. ..+.
T Consensus 152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------~~~~- 218 (333)
T cd05600 152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------ETLQ- 218 (333)
T ss_pred cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-------cccc-
Confidence 43 223457999999999999999999999999999999999999999754321110 111110 0000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+.. ..........+.+++.+||+.+|.+||++.|++++-
T Consensus 219 --~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 219 --RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred --CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0000 000012234578999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.49 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEEE
Confidence 57899999999999999999975 58899999986432 223457889999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 96 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999974 235788899999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+
T Consensus 169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~----------~i 227 (329)
T PTZ00263 169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYE----------KI 227 (329)
T ss_pred CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHH----------HH
Confidence 4322 2356999999999999999999999999999999999999999643211 1111 11
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
....+ .++.....++.+++.+||+.||++||+ +++++++
T Consensus 228 ~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 228 LAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred hcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 112222345789999999999999997 7888876
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.26 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=194.9
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||+++.. +|+.||+|.+.... ......+.+|++++++++||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 46999999999999964 68999999987432 2234567889999999999999999998874 458999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 541 (726)
+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 79 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 9999998864 235889999999999999999999998 99999999999999999999999999875432221
Q ss_pred cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccC
Q 004869 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 621 (726)
Q Consensus 542 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 621 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... . .+.....
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~----------~~~~~~~- 212 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---E----------LILMEEI- 212 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---H----------HHhcCCC-
Confidence 123456999999999999999999999999999999999999999643211 100 0 1111100
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 622 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 622 ~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
..+......+.+++.+||+.||++|+ ++.+++++-
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 12223344678999999999999998 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.59 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=197.6
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~~ 454 (726)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...+ ....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999964 68999999987432 223456889999999999999999999875432 23579
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+. ++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998864 335899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCc-ccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh---------hhh
Q 004869 535 APEGRT-NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TWA 602 (726)
Q Consensus 535 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~~ 602 (726)
...... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||............ .+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 112234579999999999875 67899999999999999999999999653321111000 000
Q ss_pred hhhccc--hhhhhhhcCCcc---CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 603 RPILRD--KDRLEELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 603 ~~~~~~--~~~l~~i~d~~l---~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+... ...+..+..... ...++ .....+.+++.+||+.||++|||++|++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000000000000 00000 122357899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=360.52 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=207.5
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCC--
Q 004869 376 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS-- 450 (726)
Q Consensus 376 ~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~-- 450 (726)
....++|.+.+.||+|+||+||+|+. .+|+.||||.+..... .....+.+|+.++..++|+|++++.+.+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33457999999999999999999985 4789999999875432 234568899999999999999999877653221
Q ss_pred ----CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEE
Q 004869 451 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 451 ----~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
...++||||+++|+|.++|+........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 1367999999999999999754444557899999999999999999999998 999999999999999999999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh
Confidence 99999987654322223345679999999999999999999999999999999999999996432 111111111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. .. ...+......+.+++.+||+.||++||++.+++++
T Consensus 259 ~~----------~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AG----------RY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cC----------CC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 00 11223334568899999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=325.61 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=203.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+|++.+.||+|+||.||+|... +++.||+|.+... ....+++.+|++++++++|+||+++++++.. ....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEE
Confidence 45788899999999999999965 5789999998743 3335679999999999999999999999873 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999996422 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.....
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~----------- 219 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLE----------- 219 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-----------
Confidence 211 1112234678999999998999999999999999999998 8999864321 11111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.......+......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111122223345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=331.62 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC--CCcEEEEEEcccCCCC--chhHHHHHHHHHHhc---ccCceeEEEEEeec---CC
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---RD 449 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~--~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~---~~ 449 (726)
++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+|+++++.+ +||||++++++|.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47889999999999999999863 4688999998754322 234677788887766 69999999998853 23
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 69999986422 335889999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~ 608 (726)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .+...... ...
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~ 230 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGE 230 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CCh
Confidence 9998654331 233456899999999999889999999999999999999999999754321110 00000000 000
Q ss_pred hhh------hhhhcCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDR------LEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~------l~~i~d~~l~~---~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ........... ....+....+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000000 0001122456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.73 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=192.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++|+||+++++++. +....++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEE
Confidence 34566789999999999999964 6899999998644322 2457899999999999999999999986 455889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+.. ...+..+..++.||++||+|||+.+ |+|||||++|||+++++.+||+|||+++....
T Consensus 152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999997643 2456778899999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||....... |......
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~----- 287 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCA----- 287 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH-----
Confidence 321 1234579999999998743 234568999999999999999999997332111 1110000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.. ......+.....++.+++.+||+.||++|||+.|++++-+
T Consensus 288 --~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 288 --ICM-SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred --Hhc-cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 000 0001112233446889999999999999999999998743
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=333.02 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=205.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.++ +|+||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-- 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-- 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence 57899999999999999999852 23579999997542 22345688899999999 79999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
....++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 4578999999999999999975321 1235899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 596 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~ 596 (726)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999986643222111222335578999999998889999999999999999998 8888853221
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
...... ... ......+......+.+++.+||+.+|++||++.||++.|+.+.+..
T Consensus 249 --~~~~~~-~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 --EELFKL-LKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --HHHHHH-HHc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111 110 0011122233456889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.48 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=198.7
Q ss_pred cccceeeeecCcEEEEEEEECCC-c--EEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CCc
Q 004869 382 FEPASILGEGGFGRVFKGVLSDG-T--AVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQ 452 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g-~--~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~~ 452 (726)
|.+.+.||+|+||.||+|++.++ . .||+|.++... ....+.|.+|++++++++|+||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678999999999999997543 2 68999887542 233467899999999999999999999875321 235
Q ss_pred eEEEEeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 453 HLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874221 12345899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+++...............++..|++||++.+..++.++||||||+++|||++ |+.||..... ..+.. .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcC
Confidence 9987654332111222346778999999999999999999999999999999 7888864221 11111 11111
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
... ..+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 11222334588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.56 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=201.3
Q ss_pred hcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
+++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ....|.+|+.++++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 4678999999999999999999753 568999988644322 24579999999999999999999998764 44
Q ss_pred ceEEEEeecCCCChhhhccCCCC---CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC---cEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK 525 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~---~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~---~vK 525 (726)
..++||||+++|+|.++++.... ....++|..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 77999999999999999965321 1235899999999999999999999998 99999999999998654 699
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~---~ 233 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME---F 233 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H
Confidence 999999987643322111222334578999999999999999999999999999997 99998743221 1111 0
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. ........+......+.+++.+||+.+|++||++.+|+++|+
T Consensus 234 ~-----------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 V-----------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-----------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 111111222333456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=324.14 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=201.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...++|.+|++++.+++||||+++++++.. ....+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence 4578889999999999999998777789999987443 335679999999999999999999999864 4468999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999997422 25899999999999999999999998 9999999999999999999999999988654432
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|++||++.+..++.++|||||||++|||++ |+.||...... .... ..... .
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~-~-------- 218 (256)
T cd05113 155 YT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQG-L-------- 218 (256)
T ss_pred ee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhcC-C--------
Confidence 11 1122346678999999998889999999999999999998 99998643211 1111 11110 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
....+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 --RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111222356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.56 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred CcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
+|++.+.||+|+||.||+|...+ +..||+|+++...... .+.|.+|+.++++++|+||+++++++.. ....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCce
Confidence 47778999999999999998632 4789999997543322 3568899999999999999999999874 4478
Q ss_pred EEEEeecCCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 454 LLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
++++||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999985211 11235788899999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||..... . +
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---D 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---H
Confidence 9999999999987654332222234456789999999988889999999999999999998 8888764321 1 1
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.. .+.+... ...+......+.+++.+||+.+|++||+++||++.|+
T Consensus 235 ~~~----------~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 235 VIE----------MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHH----------HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111 1111111 1223344456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.41 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=206.5
Q ss_pred cCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|...++||+|.||.||+|+ ..+|+.||||+++.+...+ .....+||+.|+.++|+||+.++++|. ....+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence 467888999999999999999 4579999999998764432 356789999999999999999999987 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+|||+. +|+..++.. ...++-..+..++.++++||+|||.+. |+||||||.|+|++++|.+||+|||+|+.+.
T Consensus 80 fEfm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEeccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 999965 999999753 456888999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh----------hhhhh-h
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL----------VTWAR-P 604 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l----------~~~~~-~ 604 (726)
..... .+..+-|..|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+...-++... ..|-. .
T Consensus 153 ~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 153 SPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 65443 233478999999999986 4789999999999999999999877765433322211 11110 0
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.+-..+.....+.+..-++ .+.....+++..++..||.+|.|+.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011111122122222222222 233456899999999999999999999876
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.97 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=207.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+++++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 467888999999999999999741 24579999987432 23346789999999999 89999999999874
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
....+++|||+++|+|.+++..... ....++|.+++.++.|+++||+|||+.+ ++||||||+||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 4578999999999999999975321 1235788999999999999999999998 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 999999999999999987654332222333456788999999998889999999999999999998 778875322
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
...+...+ .... ....+......+.+++.+||+.+|++||++.||++.|+.+....
T Consensus 245 --~~~~~~~~-~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 --VEELFKLL-KEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHHHHH-HcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111 1110 01112233456889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.35 Aligned_cols=254 Identities=25% Similarity=0.304 Sum_probs=202.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 47899999999999999999965 68999999987432 233467889999999999999999999887 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 99999999999999752 45889999999999999999999988 999999999999999999999999999866
Q ss_pred CCCC---------------------------cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 004869 536 PEGR---------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 536 ~~~~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
.... .........||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 5432 0012234569999999999999999999999999999999999999997
Q ss_pred CCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 004869 589 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSL 657 (726)
Q Consensus 589 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-m~EVl~~L 657 (726)
...... ....+.... ..+.-.........+.+++.+|++ ||.+||+ ++|++++.
T Consensus 232 ~~~~~~------~~~~i~~~~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 232 SDTLQE------TYNKIINWK--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCHHH------HHHHHhccC--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 543111 111111100 000000001123457889999998 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.96 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=204.1
Q ss_pred hcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+++++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CC
Confidence 4578899999999999999998642 36899999875432 234578999999999999999999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCCCC------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
..++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 789999999999999999643221 234789999999999999999999998 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... .....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~- 235 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI- 235 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh-
Confidence 999999986654332222233457889999999998899999999999999999998 8999864321 11111110
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.. ....+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 236 ------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ------------DGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------------cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 01122233456899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.55 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=203.3
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.|.+|++++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEEe
Confidence 46888999999999999999988888899999875433 3567999999999999999999999874 2357999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++++|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999997522 335899999999999999999999998 9999999999999999999999999998664432
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||++.+..++.++||||||+++|||++ |..||..... .....+. . .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~---~-----------~ 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQV---E-----------R 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH---H-----------c
Confidence 11 1122345678999999988889999999999999999999 8889864321 1111111 0 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
......+......+.+++.+|++.+|++|||++++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112233344568999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.98 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|+..+.||+|+||+||+|++. +|+ .||+|.++.... ...+++.+|+.++..++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 357888999999999999999853 444 489999875433 234678899999999999999999999863 35
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++++||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 78999999999999999752 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+...............++..|+|||...+..++.++|||||||++|||++ |..||+.... ..+..+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~~- 228 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEK----GE- 228 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CC-
Confidence 87654332222222345678999999998899999999999999999998 8999864321 112221111 00
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
....+......+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 ---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001112233458899999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.08 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|++++++++|+||+++++++. +....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEec
Confidence 3577889999999999999998777889999986433 23467899999999999999999999986 44578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++++|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...+..
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 81 MANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999999997432 25899999999999999999999998 9999999999999999999999999998664322
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... . ..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---~-------~~---- 216 (256)
T cd05059 155 YT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES---V-------SA---- 216 (256)
T ss_pred cc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH---H-------Hc----
Confidence 11 1112234568999999999999999999999999999999 89998643211 11110 0 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
......+......+.+++.+||+.+|++|||+.|+++.|
T Consensus 217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001111222344688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.49 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=194.6
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
+.||+|+||.||+|+.. +++.||+|.+..... .....|.+|++++++++|+||+++++++.. ....++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 46999999999999964 688999998864322 234578999999999999999999999874 45789999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 79 DFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999999642 235889999999999999999999998 99999999999999999999999999876543221111
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~ 622 (726)
.....++..|+|||.+.++.++.++||||||+++|||++ |..||...... .... ........
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~--------------~~~~~~~~ 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE--------------AIEQGVRL 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH--------------HHHcCCCC
Confidence 111223567999999998899999999999999999998 88888632211 1000 00111111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 623 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 623 ~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..+......+.+++.+||+.+|++|||+.||++.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222333456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.47 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=212.5
Q ss_pred HHhcCcccceeeeecCcEEEEEEEECCC-cEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEE-Eeec---CC-
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVG-YYSS---RD- 449 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg-~~~~---~~- 449 (726)
....++++.+.|.+|||+.||+|+...+ ..||+|++-..+....+...+||++|++|+ |+|||.+++ .... ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788999999999999999997765 999999998887777788999999999997 999999999 3221 12
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
..+++|+||||+||.|-|++..... ..|++.++++|+.|+++|+++||... |+|||||||-+||||..++..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 3578999999999999999975333 34999999999999999999999986 55999999999999999999999999
Q ss_pred CccccCCCCCc-c----ccc--ccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 530 GLAKQAPEGRT-N----YLS--TRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 530 Gla~~~~~~~~-~----~~~--~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
|.|.-.-.... . ... -...-|+.|.|||.+. +...++|+|||+|||+||-|+....||+.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 99864322111 0 000 1234689999999774 678899999999999999999999999854321
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.|++....-........++.+||..||+.||++||++-+|+..+..++..
T Consensus 265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 12222221112235567899999999999999999999999998887654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.19 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=208.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 57999999999999999999976 78999999886422 2235678999999999999999999999874 457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+++|+|.+++.........+++.+++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999998653333456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||.... .++..+......
T Consensus 157 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-------- 222 (267)
T cd08224 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK-------- 222 (267)
T ss_pred cCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc--------
Confidence 43321 1223468889999999998899999999999999999999999986432 111111111100
Q ss_pred cCCccCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 616 ~d~~l~~~~~~-e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
......+. .....+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 223 ---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 ---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00111111 23346889999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.75 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=198.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++|+||+++++++. +....++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEE
Confidence 57899999999999999999965 688999999875432 23456789999999999999999999986 345789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 83 e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 83 EYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred eCCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 99974 999988642 234788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-hhh-------hhhccc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWA-------RPILRD 608 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~-------~~~~~~ 608 (726)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||............ ... ++....
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 221 1234568999999998875 56899999999999999999999999754322111100 000 000000
Q ss_pred hhhhhhhcCCccCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.........+..... ........+.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 001111111111000 001122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=339.24 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... ....+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 35789999999999999999973 34678999999754322 345688999999999 689999999988643 3
Q ss_pred CceEEEEeecCCCChhhhccCCCCC-------------------------------------------------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGV------------------------------------------------------- 475 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~------------------------------------------------------- 475 (726)
...+++|||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998642110
Q ss_pred --------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccc
Q 004869 476 --------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547 (726)
Q Consensus 476 --------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~ 547 (726)
...++|..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788899999999999999999998 999999999999999999999999999865433222222234
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCCh
Q 004869 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 626 (726)
Q Consensus 548 ~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~ 626 (726)
.++..|+|||++.+..++.++||||||+++|||++ |..||...... ..+.. .+.... ....+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~----------~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGT----------RMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccC----------CCCCCC
Confidence 46778999999998899999999999999999997 89998643211 11100 111110 001111
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 627 EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 627 e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.....+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122357899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.52 Aligned_cols=267 Identities=26% Similarity=0.368 Sum_probs=201.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++|+||++++++|.. ....++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 468999999999999999999975 578899998875422 224578999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999964 23578899999999999999999974 5 999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh------hhhh----h
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT------WARP----I 605 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~------~~~~----~ 605 (726)
.... .....||..|+|||++.+..++.++|||||||++|||++|+.||............. +... .
T Consensus 155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 3321 233468999999999998899999999999999999999999996433211100000 0000 0
Q ss_pred ccc--------------hhhhhhhcCCccC---CCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 606 LRD--------------KDRLEELADPRLG---GKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 606 ~~~--------------~~~l~~i~d~~l~---~~~~-~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+. ......+.+.... ...+ .....++.+++.+||+.||++|||+.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000 0000000000000 0000 012245789999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.34 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=204.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
.+|.+.+.||+|+||.||+++.. .+..||+|.++.... ...+++.+|+++++++ +|+||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 46888999999999999999742 123689998874432 2346789999999999 79999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
....++++||+++|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 4578999999999999999964221 1235889999999999999999999998 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 596 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~ 596 (726)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 99999999999999987654332222223345678999999999999999999999999999998 888885432
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
...+...+.. . .....+......+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 242 -~~~~~~~~~~-~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 242 -VEELFKLLKE-G----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -HHHHHHHHHc-C----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111111 0 01111223344688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.94 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=193.2
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||.||+|+.. +++.||+|.+... .......+.+|++++.+++||||+++++++. +....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence 799999999999965 5789999998643 2233457889999999999999999999887 445899999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 79 ELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 99999974 335889999999999999999999998 99999999999999999999999999986433221 2
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ . .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~----------~--~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP----------L--R 211 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC----------C--C
Confidence 334579999999999999999999999999999999999999996432 111112111111 0 1
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPT---m~EVl~~ 656 (726)
++......+.+++.+||+.||++||+ +.|++++
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 22233345789999999999999975 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.76 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=195.4
Q ss_pred eeeecCcEEEEEEEE---CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 387 ILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l---~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
.||+|+||.||+|.+ .++..+|+|+++..... ..+++.+|+.++++++|+||+++++++. ....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 589999999999975 35788999998754322 3467899999999999999999999874 336789999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 541 (726)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999964 235889999999999999999999998 999999999999999999999999999876543321
Q ss_pred cc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 542 YL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 542 ~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
.. .....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... ++ ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~----------~~ 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IE----------SG 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----------CC
Confidence 11 122334678999999988889999999999999999998 99999643211 11111 11 11
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.....+......+.+++.+||+.||++||++++|++.|+.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1112233344568899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.25 Aligned_cols=264 Identities=26% Similarity=0.348 Sum_probs=211.8
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--------------CchhHHHHHHHHHHhcccCcee
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--------------QGDKEFLVEVEMLSRLHHRNLV 439 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~iL~~L~HpNIV 439 (726)
-....+.|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|+|||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 344568899999999999999999995 4689999999864321 1125788999999999999999
Q ss_pred EEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCccc-CChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee
Q 004869 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 518 (726)
Q Consensus 440 ~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~-Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL 518 (726)
+|+.+..+.....+|||+|||..|.+...=- .+. +++.++++++.++..||+|||.++ |+||||||+|+||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence 9999998888889999999999988865322 334 899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCccccCCCCC---cccccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 519 ENNFHAKVADFGLAKQAPEGR---TNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 519 d~~~~vKL~DFGla~~~~~~~---~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
+++|++||+|||.+..+..+. ....-...+||+.|||||...++. .+.+.||||+||+||.|+.|+.||...
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~- 322 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD- 322 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-
Confidence 999999999999998764321 111223478999999999887632 357899999999999999999999632
Q ss_pred CCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 592 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
...+ ...++++..+.-....+..+.+.+||.++|+.||++|.+..+|..|.+.-..
T Consensus 323 -----~~~~----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 -----FELE----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -----hHHH----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1222 2233444444322233456678999999999999999999999998876543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.05 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=195.8
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||+++.. +|+.||||++.... ......+.+|++++++++||||+++.+++. +....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 46999999999999964 68999999997532 233457889999999999999999999887 4458999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 541 (726)
+|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 79 GGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 9999999864 235899999999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccC
Q 004869 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 621 (726)
Q Consensus 542 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 621 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~--------~---- 211 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME--------D---- 211 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccC--------C----
Confidence 123457999999999999999999999999999999999999999643211 111111111 0
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 622 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 622 ~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
..++......+.+++.+||+.||++|+ ++.|++++-
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 112233344588999999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.11 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=194.7
Q ss_pred eeeeecCcEEEEEEEE----CCCcEEEEEEcccCC----CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+.||+|+||.||+++. .+++.||||.++... ......+.+|++++++++||||+++++++.. ....++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 6899999999999985 357899999987432 2233567889999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 80 EYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred eCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999864 335778889999999999999999998 99999999999999999999999999875433
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+..
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~----------~~~~~ 214 (323)
T cd05584 153 EGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTI----------DKILK 214 (323)
T ss_pred CCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHH----------HHHHc
Confidence 221 223457999999999999888999999999999999999999999743211 111 11111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
... ..+......+.+++.+||+.||++|| ++.+++++-
T Consensus 215 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 215 GKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 111 12233344688999999999999999 899988763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.68 Aligned_cols=255 Identities=30% Similarity=0.460 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.++||+|+||.||+|+..++..||+|++.... ...+.|.+|++++++++|+||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEE
Confidence 35689999999999999999998777789999997533 33567999999999999999999999864 235799999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997422 235789999999999999999999998 999999999999999999999999999866543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ... . .+..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~---~----------~~~~ 218 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---D----------QVER 218 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH---H----------HHhc
Confidence 221 1223346778999999988899999999999999999999 88888643211 000 0 0000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
......+.+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000112233445688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.42 Aligned_cols=262 Identities=20% Similarity=0.243 Sum_probs=194.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+|.+.+.||+|+||.||+++.. .++.||||... ...+.+|+++|++++|+|||++++++.. ....++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence 46999999999999999999975 47889999643 2346789999999999999999999874 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
++ .++|.+++... ...++|.+++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 47899888642 235899999999999999999999998 999999999999999999999999999866443
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-cc----chhhhhhhhhccchh---
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQ----ENLVTWARPILRDKD--- 610 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~-~~----~~l~~~~~~~~~~~~--- 610 (726)
..........||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+...+........
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2222233457999999999999999999999999999999999988765322111 10 111111110000000
Q ss_pred -----hh-hhhcC---CccCCCCCh-------hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 -----RL-EELAD---PRLGGKYPK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 -----~l-~~i~d---~~l~~~~~~-------e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ..... ......... .....+.+|+.+||+.||++|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 000000000 111257789999999999999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.74 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=204.5
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.++||+|+||.||+|...+++.||+|.+.... .....|.+|++++++++|+|++++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEE
Confidence 46788999999999999999998889999999987543 33568999999999999999999999864 346899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999986532 346899999999999999999999998 999999999999999999999999999766532
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++....++.++||||||+++|||++ |+.||..... ....... .
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~---------- 217 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----E---------- 217 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----H----------
Confidence 211 1223346778999999998889999999999999999999 9999964321 1111110 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.......+.....++.+++.+||+.+|++||+++++++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000011122223468999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.79 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=203.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCc-hhHHHHHHHHHHhcc-cCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~ 449 (726)
..++|.+.+.||+|+||.||+|++. .+..||||+++...... .+.+.+|+++|.++. |+|||+++++|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3456788899999999999999864 24689999997543322 357899999999997 9999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCC-------------------------------------------------------
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLG------------------------------------------------------- 474 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~------------------------------------------------------- 474 (726)
....++||||+++|+|.++|+....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4578999999999999999964321
Q ss_pred ---------------------------------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccc
Q 004869 475 ---------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 515 (726)
Q Consensus 475 ---------------------------------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~N 515 (726)
....++|..+++++.|++.||+|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1124678888999999999999999988 9999999999
Q ss_pred eeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 004869 516 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG 594 (726)
Q Consensus 516 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~ 594 (726)
||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111223457789999999998889999999999999999998 888986432111
Q ss_pred cchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 595 ~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+. ..+........+......+.+++.+||+.+|++||+++||++.|+.+.
T Consensus 350 --~~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QFY--------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 000 001111111122233456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.37 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=199.1
Q ss_pred cCcccceeeeecCcEEEEEEEECC--CcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~--g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+++++.++||||+++++++. +....+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEE
Confidence 578999999999999999998543 3689999986432 233457889999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999975 235889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. .. ...+.
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~-~~~i~-------- 241 (340)
T PTZ00426 181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LI-YQKIL-------- 241 (340)
T ss_pred cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HH-HHHHh--------
Confidence 5432 12457999999999999888999999999999999999999999743211 00 01111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.... .++......+.+++.+||+.||++|+ +++|++++
T Consensus 242 --~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 --EGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --cCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1110 12222334578999999999999995 89999876
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.59 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=197.8
Q ss_pred CcccceeeeecCcEEEEEEEE----CCCcEEEEEEcccCC----CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCC
Q 004869 381 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~ 451 (726)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|++++.++ +|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 588899999999999999885 357899999986421 22235678899999999 5999999998876 445
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 78999999999999999964 335889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
++........ ......||..|+|||++.+. .++.++|||||||++|||++|+.||......... ......+..
T Consensus 152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~--- 225 (332)
T cd05614 152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK--- 225 (332)
T ss_pred CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc---
Confidence 9865433221 22345799999999998865 4788999999999999999999999643322111 111111111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
.++ ..+......+.+++.+||+.||++|| ++++++++-
T Consensus 226 -----~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 -----CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 111 12222334578999999999999999 788888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.69 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|... .+..||||.++.... ...+.+.+|+++++++ +|+||+++++++.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 457999999999999999999741 345799999875432 2245789999999999 79999999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+++|||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 57899999999999999997522 234899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~--------- 255 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYK--------- 255 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHH---------
Confidence 9986654332212223456788999999999999999999999999999998 99998643211 11111
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+.......+.....++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 256 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 -----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111122234688999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.77 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=199.8
Q ss_pred cCcccceeeeecCcEEEEEEEECC---------------CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD---------------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG 443 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~---------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg 443 (726)
++|++.+.||+|+||.||+++..+ ...||+|.+..... .....|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 23589999875422 22457999999999999999999999
Q ss_pred EeecCCCCceEEEEeecCCCChhhhccCCCC--------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccc
Q 004869 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG--------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 515 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~--------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~N 515 (726)
++. .....++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 85 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 85 VCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 987 44578999999999999999864211 1124788999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 004869 516 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPS 593 (726)
Q Consensus 516 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~Pf~~~~~~ 593 (726)
|++++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999986544332222233456789999999998899999999999999999998 5567653321
Q ss_pred ccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 594 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
................ ......+......+.+++.+||+.||++||++++|++.|+
T Consensus 239 --~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --EQVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111000 0000111122346899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.20 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEECC-C--cEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-G--TAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-g--~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|...+ + ..+++|.++... ....+.|.+|++++.++ +||||+++++++. +....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcce
Confidence 578899999999999999998753 3 347888887432 22346789999999999 7999999999986 345789
Q ss_pred EEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 455 LCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+++||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCC
Confidence 99999999999999964321 1235889999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 601 (726)
.+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...... . .
T Consensus 157 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~---~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---E---L 227 (297)
T ss_pred eEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H---H
Confidence 999999999864322111 111233567999999998889999999999999999997 99999643211 1 1
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
..... .......+......+.+++.+||+.+|.+||+++++++.|+.+.+..
T Consensus 228 ~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 YEKLP-----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHh-----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 11111122223346889999999999999999999999998877644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.55 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=203.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-----------------CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVK 440 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~ 440 (726)
..+|++.+.||+|+||.||+|...+ +..||+|.+..... ...+.|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988542 24589999875433 23467899999999999999999
Q ss_pred EEEEeecCCCCceEEEEeecCCCChhhhccCCCC-------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCc
Q 004869 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG-------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 513 (726)
Q Consensus 441 llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~-------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp 513 (726)
+++++.. ....++++||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 9999874 3588999999999999999975331 1225899999999999999999999998 99999999
Q ss_pred cceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 004869 514 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQ 591 (726)
Q Consensus 514 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~Pf~~~~ 591 (726)
+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999986644332222334557789999999998899999999999999999998 667775322
Q ss_pred CCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 592 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
............+... .......+.....++.+++.+||+.||++|||+.||++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ---DQQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---hHHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111121111111110 00001112222346899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.40 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=206.5
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+. .+++.+|||.+..... ....++.+|+++++.++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 4688889999999999999995 5789999998864322 223578899999999999999999999874 458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999998643333456899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......|+..|+|||++.+..++.++||||||+++|||++|..||..... ....+... +...
T Consensus 157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-------~~~~ 223 (267)
T cd08229 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-------IEQC 223 (267)
T ss_pred ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhh-------hhcC
Confidence 44322 12335688999999999988899999999999999999999999863221 11111111 1111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+.. ........+.+++.+||+.||++||||.+|++.++++
T Consensus 224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111 1122344688999999999999999999999988775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.16 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|...++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCce
Confidence 56788899999999999999742 356899999876655556789999999999999999999999874 4578
Q ss_pred EEEEeecCCCChhhhccCCCC-----------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 454 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~-----------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 999999999999999964321 1135889999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 601 (726)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~-- 234 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI-- 234 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH--
Confidence 999999999976543322112223345788999999999999999999999999999998 899986432111 11
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..+.... ....+......+.+++.+||+.||++||+++||++.|+
T Consensus 235 -----------~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 -----------ECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----------HHHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0010100 00111223345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.92 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CC---cEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++|+|++++++++. +....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCc
Confidence 357888999999999999999974 23 379999987543 223467899999999999999999999987 44578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++++|.++++.. ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 82 MIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999642 245899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
.......... ......+..|+|||++....++.++|||||||++|||++ |+.||..... . .+...+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~~i~-~~-- 226 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMKAIN-DG-- 226 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHHHHh-cC--
Confidence 6654322111 112234567999999998899999999999999999997 9999864321 1 1111111 00
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.....+.+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111222345688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.37 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=197.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+.. +++.||||.+...... ....+.+|++++++++|+||+++++++.. ....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 468999999999999999999975 6889999998754322 23467889999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 82 FEYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99995 6888887642 235888999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------ 609 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 609 (726)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.. ........
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLER-IFLVLGTPNEDTWP 230 (303)
T ss_pred CCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHH-HHHHhCCCChhhcc
Confidence 3221 1233568999999998865 457899999999999999999999997532210 11100 00000000
Q ss_pred --hhhhhhcCCccCCCCCh---------hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 --DRLEELADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 --~~l~~i~d~~l~~~~~~---------e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...............+. .....+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000000000 012357789999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.24 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=195.7
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||+||++... +|+.||+|.+...... ..+.+..|++++++++|+||+++.+++. .....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence 699999999999864 6889999998643222 2356788999999999999999999876 345789999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~ 153 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--K 153 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--c
Confidence 999888543333456899999999999999999999998 99999999999999999999999999986654332 1
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+..... .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~----------~~~~~~~~--~ 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK----------QRILNDSV--T 219 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHH----------HhhcccCC--C
Confidence 2345789999999999999999999999999999999999999964322110 00000 01111111 1
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
++......+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2223345688999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.28 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=202.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++|+||+++++++. +.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4578999999999999999999753 245899998864432 22346889999999999999999999986 34
Q ss_pred CceEEEEeecCCCChhhhccCCCC------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
...++||||+++|+|.++++.... ....+++..+.+++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 578999999999999999964221 1234567788999999999999999998 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 603 (726)
||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... .....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~--- 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK--- 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---
Confidence 9999999986544332222223345778999999999999999999999999999998 7888854221 11111
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.+... ...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 233 ----------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ----------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111110 011222335689999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.12 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=194.3
Q ss_pred eeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++..++|+||+++.+++. +....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999985 468999999987432 223456788999999999999999999887 4458999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999998864 2358999999999999999999997 67 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+.. ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~---~~~i~~----------~~- 212 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL---FELILM----------EE- 212 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HH---HHHHhc----------CC-
Confidence 123456999999999999999999999999999999999999999643211 11 111110 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
..++......+.+++.+||+.||++|+ ++.+++++-
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 012223334588999999999999996 899998773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.27 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=202.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.|.+|++++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEc
Confidence 4688899999999999999998777789999886433 33567899999999999999999999874 2467899999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.++++... ...++|..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 335889999999999999999999998 9999999999999999999999999998664332
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ....+.. .
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~----------- 218 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE---R----------- 218 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---c-----------
Confidence 11 1122346778999999998899999999999999999999 89998643211 1111110 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
......+......+.+++.+||+.||++||++++|++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011222334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.55 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=195.9
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
++||+|+||.||+++.. +++.||||.++... ....+.+.+|..++.++ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence 46999999999999965 68899999997532 22335688899999998 7999999999987 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 79 SGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999998864 245899999999999999999999998 99999999999999999999999999875322111
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc--cchhhhhhhhhccchhhhhhhcCC
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......+..... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~ 220 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LEK 220 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------HcC
Confidence 2234579999999999999999999999999999999999999997432211 111122221111 111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT------m~EVl~~ 656 (726)
.. ..+......+.+++.+||+.||.+|++ +++++++
T Consensus 221 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 122333446889999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.37 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|.+.+.||+|+||.||+++.. ++..||+|.++.... ....++.+|+++++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 357888999999999999999742 245799999874432 2345788999999999 6999999999986
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+....+++|||+++|+|.+++..... ....++|.++++++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 34578999999999999999964321 1245899999999999999999999998 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654322111222334568999999998899999999999999999999 88888643211
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.+... .... .....+......+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 244 -~~~~~----~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 -ELFKL----LREG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -HHHHH----HHcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11111 1110 001122233446889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.74 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=195.5
Q ss_pred eeeecCcEEEEEEEEC---CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCC
Q 004869 387 ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
.||+|+||.||+|++. ++..||+|.+...... ..+.|.+|++++++++|+||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence 3899999999999864 3567999998754322 2356899999999999999999999874 3468999999999
Q ss_pred CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccc
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 542 (726)
|+|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 79 GPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999999642 235899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred c-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 543 L-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 543 ~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
. .....++..|+|||++.+..++.++|||||||++||+++ |..||...... ..... +.. ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~----------~~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSF----IEQ----------GK 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHC----------CC
Confidence 1 122234678999999988889999999999999999996 99999643211 11111 111 11
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
....+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122333445688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=316.78 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEE
Confidence 357888999999999999999875 78899999975543 46789999999999999999999999874 558899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999999997522 235899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+.... ..
T Consensus 156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~--------- 214 (256)
T cd05039 156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EK--------- 214 (256)
T ss_pred cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hc---------
Confidence 21 2335678999999998899999999999999999997 9999864321 1111111 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
......+......+.+++.+||+.+|++||++.|+++.|+.
T Consensus 215 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 215 -GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00111122234568899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.89 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-----------------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-----------------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKL 441 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~l 441 (726)
++|++.+.||+|+||.||++... ++..||+|.+..... ...++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 234689999875432 234679999999999999999999
Q ss_pred EEEeecCCCCceEEEEeecCCCChhhhccCCCC-------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcc
Q 004869 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG-------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 514 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~-------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~ 514 (726)
++++.. ....+++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 85 LAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred EEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 999874 4478999999999999999965321 1234788899999999999999999998 999999999
Q ss_pred ceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 004869 515 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQP 592 (726)
Q Consensus 515 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~Pf~~~~~ 592 (726)
|||+++++.+||+|||+++...............++..|++||....+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986644332222233445678999999888889999999999999999998 6677753221
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. ............... .... ..+......+.+++.+||+.||++||++.||++.|+
T Consensus 240 ~---~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 E---QVIENTGEFFRDQGR--QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHHHhhccc--cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111001100000 0000 111223356889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=341.12 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=198.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEE
Confidence 47899999999999999999964 68999999997432 223356788999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 79 IMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999974 235899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcc------------------------------------cccccccccccccCccccccCCCCcchhHHHHHHHHHH
Q 004869 536 PEGRTN------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLE 579 (726)
Q Consensus 536 ~~~~~~------------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~E 579 (726)
...... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 321100 00112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004869 580 LLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 656 (726)
Q Consensus 580 LltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT---m~EVl~~ 656 (726)
|++|+.||....... ....+......+ ..+ . .......+.+++.+|+. +|.+|++ +.|++++
T Consensus 232 l~~G~~Pf~~~~~~~------~~~~i~~~~~~~---~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 232 MLVGYPPFCSDNPQE------TYRKIINWKETL---QFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hhcCCCCCCCCCHHH------HHHHHHcCCCcc---CCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999997543211 011111100000 000 0 00122357789999997 8999998 9999886
Q ss_pred H
Q 004869 657 L 657 (726)
Q Consensus 657 L 657 (726)
-
T Consensus 297 ~ 297 (364)
T cd05599 297 P 297 (364)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.12 Aligned_cols=271 Identities=28% Similarity=0.399 Sum_probs=208.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-----CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
+.|+..+.||+|+||.||+|++. ++..||||.+...... ..+.|.+|++++++++|+||+++++++...+....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 3678999999755443 45689999999999999999999999876556688
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+++|||+++++|.+++.... ..++|..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997532 25899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh--ccchh
Q 004869 534 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI--LRDKD 610 (726)
Q Consensus 534 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--~~~~~ 610 (726)
.......... .....++..|++||.+.+..++.++||||||+++|||++|+.|+......... ++... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHH
Confidence 7763322211 11234566799999999889999999999999999999999988543211100 00000 00001
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.+..........+.....++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111111112223335688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=324.46 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...++|.+|++++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CC
Confidence 467999999999999999999863 467899999875432 234679999999999999999999999873 45
Q ss_pred ceEEEEeecCCCChhhhccCCC------------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPL------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 513 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~------------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp 513 (726)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 7899999999999999996321 11234788899999999999999999998 99999999
Q ss_pred cceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 004869 514 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 592 (726)
Q Consensus 514 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~ 592 (726)
+||++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543322111222345678999999998999999999999999999998 8888853221
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.++... +.+.... ..+.....++.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 ------~~~~~~----------~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 ------EEVIYY----------VRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHHH----------HhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 1111110 112233456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.97 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=200.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
+|+..++||+|+||.||++... +++.||||.+..... .....+.+|++++++++|+||+++++++.. ....++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 4788999999999999999964 688999999864322 223457889999999999999999998874 4489999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 79 LTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999988642 1345899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..... . ..+
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~-~----------~~~ 217 (285)
T cd05605 154 EGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEV-E----------RRV 217 (285)
T ss_pred CCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHH-H----------HHh
Confidence 3321 123468999999999998899999999999999999999999997432111 00000 0 000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.. ....++......+.+++.+||+.||++|| ++++++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 KE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 01122333345688999999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.02 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=193.9
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHH---HhcccCceeEEEEEeecCCCCceE
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEML---SRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
|++.+.||+|+||.||+|... +|+.||||.++... ....+.+.+|++++ ++++||||+++++++. +....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence 677899999999999999964 68999999997432 22335567776665 5668999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|..+++. ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 99999999999998863 35899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.
T Consensus 151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-------- 214 (324)
T cd05589 151 GMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-------- 214 (324)
T ss_pred CCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH--------
Confidence 432221 223467999999999999999999999999999999999999999743211 1111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.... .++......+.+++.+||+.||++|| ++.+++++
T Consensus 215 --~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 215 --NDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --hCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1110 12223344578999999999999999 57777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.44 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=202.2
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||+|+.. +++.|++|.+.... ....+++.+|++++++++|+|++++++++. +....++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEE
Confidence 4778899999999999999965 68999999986432 334567899999999999999999999987 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 79 EYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999999997532 346889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......|+..|+|||+..+..++.++||||||+++|||++|+.||..... ..... ...+
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~~---------- 215 (256)
T cd08529 154 NTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---KIIR---------- 215 (256)
T ss_pred ccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHc----------
Confidence 322 12334688999999999999999999999999999999999999964331 11111 1110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ....+......+.+++.+||+.+|++||++.+++++
T Consensus 216 ~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 GV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 011122233468999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.80 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=199.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+++++.++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEE
Confidence 47899999999999999999964 68899999997532 223456889999999999999999999887 4457999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999753 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+....
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~ 225 (330)
T cd05601 153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQ 225 (330)
T ss_pred CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCC
Confidence 543321 223457999999999986 456789999999999999999999999643211 1111111110
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .+.-.........+.+++..||+ +|.+||++++++++
T Consensus 226 ~--------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 R--------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C--------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 00000011123457889999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.88 Aligned_cols=251 Identities=30% Similarity=0.490 Sum_probs=202.5
Q ss_pred eeeeecCcEEEEEEEECC----CcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++++.+++|+|++++++++.. ....+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 469999999999999753 7889999998654433 5789999999999999999999999874 56899999999
Q ss_pred CCCChhhhccCCCCC-----cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 461 PNGSLESWLHGPLGV-----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~-----~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
++++|.+++...... ...+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999763211 356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.............++..|+|||.+....++.++||||||+++|||++ |..||..... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~------------- 219 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEY------------- 219 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-------------
Confidence 65432222344567889999999998899999999999999999999 6999875421 111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.+ ......+......+.+++.+||+.+|++||++.|++++|+
T Consensus 220 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 LRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 110 0011122233456889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.51 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=201.1
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC-----chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|++|.||++.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 5789999999999999999985 46899999988643221 23568889999999999999999999874 4489
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 80 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999999999864 235788999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
......... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~----------- 216 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AI----------- 216 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HH-----------
Confidence 654322111 1123457889999999999889999999999999999999999986432110 00
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
............+......+.+++.+||+.+|++|||+.|++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 000011111122333444688999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=316.14 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=205.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++. +....+++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEEE
Confidence 356899999999999999999998888899999987543 34578999999999999999999999986 345789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997532 345899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..
T Consensus 156 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~--------- 219 (261)
T cd05034 156 DEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV---ER--------- 219 (261)
T ss_pred hhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hc---------
Confidence 221 11122335678999999998899999999999999999998 99998543211 111110 00
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
......+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 --GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011122223468899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.03 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=200.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCC----C
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----S 450 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~----~ 450 (726)
.++..|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888999999999999999964 57899999987543 3456788999999998 6999999999986432 2
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+++|||+++|+|.+++.... ...++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999997522 345889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 605 (726)
+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .+.. .
T Consensus 157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~-~ 228 (272)
T cd06637 157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL-I 228 (272)
T ss_pred Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH-H
Confidence 9986543221 223456899999999986 3457889999999999999999999996432111 0000 0
Q ss_pred ccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 606 ~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ...... ........+.+++.+||+.+|++|||+.|++++
T Consensus 229 ~~-------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PR-------NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hc-------CCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 000111 111222457899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.63 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=194.8
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++.+++|+||+++++++. +....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEE
Confidence 688899999999999999985 467899999997532 223456889999999999999999999987 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 80 MDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999964 235788899999999999999999998 9999999999999999999999999986432
Q ss_pred CCCc---------------------------------------------ccccccccccccccCccccccCCCCcchhHH
Q 004869 537 EGRT---------------------------------------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY 571 (726)
Q Consensus 537 ~~~~---------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVw 571 (726)
.... ........||..|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 0011235799999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHH--ccccCCCCCCC
Q 004869 572 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--CVAPEANQRPT 649 (726)
Q Consensus 572 SfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~--CL~~dP~~RPT 649 (726)
||||++|||++|+.||......... ..+..... .+..........++.+++.+ |+..++..||+
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~------~~i~~~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQ------LKVINWEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHH------HHHHcccc--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999999754321100 00000000 00000001122346677776 55666777999
Q ss_pred HHHHHHHH
Q 004869 650 MGEVVQSL 657 (726)
Q Consensus 650 m~EVl~~L 657 (726)
+.|++++-
T Consensus 299 ~~~~l~hp 306 (381)
T cd05626 299 ADDIKAHP 306 (381)
T ss_pred HHHHhcCc
Confidence 99999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=337.42 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=172.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|++++.+++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence 47899999999999999999864 58899999986432 222356788999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 79 IMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999974 345899999999999999999999998 999999999999999999999999999754
Q ss_pred CCCCcc---------------------------------cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh
Q 004869 536 PEGRTN---------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 536 ~~~~~~---------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt 582 (726)
...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 321100 00123579999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 004869 583 GRKPVDMS 590 (726)
Q Consensus 583 G~~Pf~~~ 590 (726)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=314.02 Aligned_cols=247 Identities=32% Similarity=0.473 Sum_probs=196.1
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 464 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~Gs 464 (726)
++||+|+||.||+|...++..||+|.+...... ....|.+|++++++++|+||+++++++.. ....++||||+++|+
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCc
Confidence 369999999999999888899999998754332 23468899999999999999999999874 457899999999999
Q ss_pred hhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccccc
Q 004869 465 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544 (726)
Q Consensus 465 L~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 544 (726)
|.+++... ...+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++......... ..
T Consensus 79 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 151 (250)
T cd05085 79 FLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS 151 (250)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence 99998642 235789999999999999999999998 999999999999999999999999998754332211 11
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 545 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
....++..|+|||++.+..++.++||||||+++||+++ |..||...... ..... ... .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~----~~~----------~~~~~ 214 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQ----VEK----------GYRMS 214 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHc----------CCCCC
Confidence 12234678999999998899999999999999999998 99998643211 11100 000 01111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22233456899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=316.05 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||++... |..||+|.++.. ...+.|.+|+.++++++|+|++++++++.. +....++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEEC
Confidence 47888999999999999999875 678999998643 235679999999999999999999998653 34568999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999997532 234889999999999999999999998 9999999999999999999999999988654322
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..+ +...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~---~~~~---------- 215 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR---VEKG---------- 215 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HhcC----------
Confidence 12334668999999998899999999999999999998 9999863221 111111 1000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.....+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01111223344688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.18 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=200.2
Q ss_pred cCcccceeeeecCcEEEEEEEECC-C---cEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.+|++.+.||+|+||.||+|.+.. + ..||||.+.... ....++|..|++++++++||||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceE
Confidence 357889999999999999999643 3 369999987542 223468999999999999999999999986 445789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 82 IITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999999753 235899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCccccccc-c--cccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 535 APEGRTNYLSTR-V--MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 535 ~~~~~~~~~~~~-~--~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
............ . ..+..|+|||++.+..++.++|||||||++|||++ |..||..... .....+... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~----~- 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ----D- 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc----C-
Confidence 544322111111 1 12457999999999999999999999999999886 9999864321 111111110 0
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.....+.+....+.+++.+||+.+|++||++++|+..|+.+
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011223334578999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.08 Aligned_cols=248 Identities=32% Similarity=0.497 Sum_probs=197.3
Q ss_pred eeeeecCcEEEEEEEECC----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
++||+|+||.||+|++.. +..||+|.+...... ..+++.+|++++++++|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence 469999999999998532 268999999755442 3567999999999999999999999875 33679999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999999752 25899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 541 NYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+..+... ...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~------- 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GER------- 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCc-------
Confidence 211 112234568999999998899999999999999999998 9999864321 112222111 000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
...+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 217 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 ---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 012222334688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.66 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=200.6
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++.. ....++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence 35789999999999999999996 4688999999975544455678899999999999999999999874 45889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999864 235889999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+... ...+. .. .
T Consensus 159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~------~~---~ 225 (267)
T cd06646 159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMS------KS---N 225 (267)
T ss_pred ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeee------cC---C
Confidence 221 123346889999999874 34578899999999999999999999853322111 00000 00 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
...+.... .......+.+++.+||+.+|++||++++++++|
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111110 112234688999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.83 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
..|++.+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|++++++++|+|++++.+++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999984 357889999987443 2234678999999999999999999999876545678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++++|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999999642 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------ccchhhhhhh
Q 004869 534 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS---------GQENLVTWAR 603 (726)
Q Consensus 534 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~---------~~~~l~~~~~ 603 (726)
......... ......++..|+|||++.+..++.++|||||||++|||++++.|....... ++.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-- 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH--
Confidence 765432211 122345777899999998888999999999999999999987765321100 00000000
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
...+.+ ......+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 --------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 --------VRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred --------HHHHHc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000111 111111223445789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.80 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=195.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++. +....|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence 4789999999999999999985 468999999986432 223456888999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999964 245788899999999999999999999 999999999999999999999999999643
Q ss_pred CCCCcc---------------------------------------------cccccccccccccCccccccCCCCcchhH
Q 004869 536 PEGRTN---------------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDV 570 (726)
Q Consensus 536 ~~~~~~---------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDV 570 (726)
...... .......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 211000 00012469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCC---
Q 004869 571 YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR--- 647 (726)
Q Consensus 571 wSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~R--- 647 (726)
|||||++|||++|+.||........ ...+......+ .-+ . .......+.+++.+|++ +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~---~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHET------YRKIINWRETL---YFP---D--DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCcc---CCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999999964332110 01111100000 000 0 00122357889999998 66665
Q ss_pred CCHHHHHHHH
Q 004869 648 PTMGEVVQSL 657 (726)
Q Consensus 648 PTm~EVl~~L 657 (726)
+++.|++++-
T Consensus 297 ~~~~~~l~hp 306 (377)
T cd05629 297 GGAHEIKSHP 306 (377)
T ss_pred CCHHHHhcCC
Confidence 6999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.25 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=195.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhccc-CceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H-pNIV~llg~~~~~~~~~~~L 455 (726)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++| ++|+++.+++. +....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence 5888999999999999999965 57889999987432 2334568889999999976 45888888876 3458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999864 235889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~-------------~i 213 (324)
T cd05587 152 IFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQ-------------SI 213 (324)
T ss_pred CCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH-------------HH
Confidence 22211 12345699999999999999999999999999999999999999974321 11111 11
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm-----~EVl~~ 656 (726)
.... ..++......+.+++.+||+.||.+|++. +++.++
T Consensus 214 ~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 214 MEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 12223334467899999999999999986 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.54 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=207.6
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
-|++++.||.|+-|.|-+|+. .+|+.+|||++..... .......+||-+|+-+.|||+++++++++ +..++|||
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEEEE
Confidence 467789999999999999995 5799999999976522 22346789999999999999999999987 55699999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
.||+++|-|.++|-. .+++.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999975 456999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.+. .-.+.+|.+.|.|||++++..| ..++||||.|||||.|+||+.||++ +|+.....++.+...
T Consensus 164 ~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~f----- 229 (786)
T KOG0588|consen 164 PGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGVF----- 229 (786)
T ss_pred CCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCcc-----
Confidence 543 3355689999999999999988 5799999999999999999999983 343333322222211
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..|.....++.+|+.+|+..||++|.|++||++|-+.
T Consensus 230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 1233334457889999999999999999999988543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.90 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=195.9
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~L 455 (726)
+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +|++|+++.+++.. ....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5888999999999999999965 57899999987532 22234567788888877 58999999998873 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999864 235889999999999999999999998 999999999999999999999999999754
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..+
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~-------------~~i 213 (323)
T cd05616 152 MWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF-------------QSI 213 (323)
T ss_pred CCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHH-------------HHH
Confidence 32221 22345799999999999999999999999999999999999999974321 1111 111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm-----~EVl~~ 656 (726)
.... ..++.....++.+++.+||+.||++|++. .++.++
T Consensus 214 ~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 214 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111 12233344568899999999999999984 666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=315.13 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=213.1
Q ss_pred HhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC---CCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~---~~~~~ 453 (726)
..++|++.+.||+|||+.||+++ +.++..+|+|++.....++.+..++|++..++++|||++++++++... ...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999998 678899999999988877788899999999999999999999886432 23568
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
||++.|...|+|.+.+.........+++.+.++|+.++++||++||+... +++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999997655555579999999999999999999999864 59999999999999999999999999987
Q ss_pred cCCCCCcc-------cccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 534 QAPEGRTN-------YLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 534 ~~~~~~~~-------~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
...-.-.. .......-|..|.|||.+. +...++|+|||||||+||+|+.|..||+..-..+.. +..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS--laL-- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS--LAL-- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--EEE--
Confidence 65421110 0112345688999999885 456789999999999999999999999753322211 000
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.++.+.-.......+.+.+++.+|++.||.+||++.+++..+..+
T Consensus 254 ----------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 ----------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111111111345689999999999999999999999988765
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=314.81 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=204.7
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||.|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 4678999999875432 2345688999999999999999999987655566789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHH-----hCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-----EDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH-----~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
||+++++|.+++.........+++..++.++.|++.||+||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754333457899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...+... .
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~---~------- 222 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASK---I------- 222 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHH---H-------
Confidence 87654332 1233468999999999998889999999999999999999999997533 1111111 1
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ......+......+.+++.+||+.+|++||++.+|+++
T Consensus 223 ---~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 ---KE-GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---hc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01 11112233344568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=325.75 Aligned_cols=260 Identities=29% Similarity=0.438 Sum_probs=200.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCc--EEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|++++.++ +|+||+++++++. +....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCc
Confidence 357888999999999999999964 443 46888776432 23345788999999999 8999999999986 44578
Q ss_pred EEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 454 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
++||||+++|+|.++++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence 999999999999999964321 1235789999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE 234 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence 999999999986432111 1112234678999999988889999999999999999998 99998643211 1111
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
. . .. ......+......+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 235 ~---~----------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 K---L----------PQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred H---H----------hc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 00 000111122234578999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=340.19 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=196.3
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..+|++.+.||+|+||.||++.. .+++.||+|... .+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEE
Confidence 46799999999999999999996 468899999754 3457899999999999999999999874 44789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|++. ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 789888864 235889999999999999999999998 99999999999999999999999999975432
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-----chhhhhhhhh-------
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPI------- 605 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~-----~~l~~~~~~~------- 605 (726)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.......
T Consensus 235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 235 INA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 221 122345799999999999999999999999999999999999988753321110 0000000000
Q ss_pred -ccchhhhhhhc----CC-cc-CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 606 -LRDKDRLEELA----DP-RL-GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 606 -~~~~~~l~~i~----d~-~l-~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
......+.... .. .. ....+ .+....+.+|+.+||+.||++|||++|++++-
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00000000000 00 00 00000 11234678899999999999999999999763
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.95 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=199.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
..++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++. +....
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence 3568999999999999999999965 6889999998642 2223455788999999999999999999887 45589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.++++. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999999864 24778888999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~ 263 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHK 263 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC
Confidence 6643321 122345799999999998653 4789999999999999999999999743211 1111111110
Q ss_pred hhhhhhcCCccCCCCCh--hhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPK--EDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL 657 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~--e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~L 657 (726)
.. + .++. .....+.+++.+||+.+|.+ |+++.|++++-
T Consensus 264 ~~--------~--~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 NS--------L--TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred Cc--------C--CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00 0 1111 22346788999999999988 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.87 Aligned_cols=249 Identities=21% Similarity=0.360 Sum_probs=194.7
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++.++ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 47999999999999965 57899999997542 22335678899998877 79999999999874 45899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 79 NGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99999998864 245889999999999999999999998 99999999999999999999999999975432211
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc--cchhhhhhhhhccchhhhhhhcCC
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+..... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~ 220 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LEK 220 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hcC
Confidence 2234579999999999999999999999999999999999999996422111 111111211111 111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT------m~EVl~~ 656 (726)
. ...+......+.+++.+||+.||++||+ +.+++++
T Consensus 221 ~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 1233334456889999999999999998 5777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.75 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=210.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchh---HHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDK---EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~---~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
...+|++.+.||+|.||+|-+|.. ..|+.||||.+++....+.+ .+.+||+||+.|+||||+.++.+|++ ....
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceE
Confidence 356899999999999999999984 67999999999877655544 46789999999999999999999984 4488
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.|||||..+|.|+||+.. .+.|++.+...++.||..|+.|+|.++ ++|||||.+|||||.++++||+||||+.
T Consensus 129 vivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999999975 457999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
.+.+.. .-+.++|++-|.+||++.+..| .+..|-|||||+||-|+.|..||+..+ ...++ +++-+.
T Consensus 202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lv---rQIs~G---- 268 (668)
T KOG0611|consen 202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLV---RQISRG---- 268 (668)
T ss_pred hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHH---HHhhcc----
Confidence 776543 3466899999999999999988 588999999999999999999998643 12222 111111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
... ..+.....+-||+|||-.||++|-|+.+|..+.|.
T Consensus 269 ------aYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 269 ------AYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ------ccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 111 11112235779999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.11 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=207.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..|...++||+|.||.||||... .++.||+|.+.... ..+.++.+.|+.+|..++++||.+++|.|. .+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl--~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL--KGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee--ecccHHHHH
Confidence 35667789999999999999954 68899999998654 344578999999999999999999999887 456899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|||.+|++.+.|+. ...+++....-++.++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+.....
T Consensus 91 ey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999974 234477888889999999999999999 99999999999999999999999999987765
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ....++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..... .+.+-.-
T Consensus 164 ~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~P 228 (467)
T KOG0201|consen 164 TVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAP 228 (467)
T ss_pred hhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCC
Confidence 433 3366899999999999998899999999999999999999999997665532111 1111223
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
|.+.+.+. ..+.+++..||+.||+.||++.+++++
T Consensus 229 P~L~~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 34444333 348899999999999999999999876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.12 Aligned_cols=249 Identities=31% Similarity=0.466 Sum_probs=198.4
Q ss_pred eeeeecCcEEEEEEEECC--C--cEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD--G--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|++++++++|+||+++++++.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 468999999999999643 3 3699999986655 456789999999999999999999999864 6889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++..... ..++|..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999999975322 46899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 541 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.+ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ... ....... .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~--------~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QIL---KKIDKEG--------E 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHhcC--------C
Confidence 21 1223457889999999999899999999999999999998 99998643211 111 1111000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
....+......+.+++.+||+.+|++||++.||++.|.
T Consensus 219 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 --RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112223346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.83 Aligned_cols=267 Identities=28% Similarity=0.437 Sum_probs=206.6
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeec
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 447 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~ 447 (726)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999864 5789999987642 22346788999999999 69999999998743
Q ss_pred ---CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 448 ---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 448 ---~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
.+....++||||+++|+|.++++........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 2345689999999999999988643333456889999999999999999999998 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF 239 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence 9999999986643321 1233468999999998753 457889999999999999999999986432211 110
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+ ... ..+.+ ..+......+.+++.+||+.||++|||+.||++++
T Consensus 240 ~~----~~~-------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KI----PRN-------PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hc----ccc-------CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 000 00000 01111223588999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.63 Aligned_cols=251 Identities=29% Similarity=0.453 Sum_probs=193.5
Q ss_pred eeeeecCcEEEEEEEECC-Cc--EEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD-GT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|++.+ +. .+++|.++... ....+.+.+|++++.++ +|+||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 468999999999999753 43 56888887432 23346788999999999 79999999999874 44789999999
Q ss_pred CCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 461 PNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 461 ~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
++|+|.++++... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECC
Confidence 9999999996432 11235889999999999999999999988 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhcc
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
||+++...... .......+..|+|||++....++.++|||||||++|||++ |..||...... ... ..+.
T Consensus 156 fgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~---~~~~- 225 (270)
T cd05047 156 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---EKLP- 225 (270)
T ss_pred CCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH---HHHh-
Confidence 99986332111 1111234667999999988889999999999999999997 99998643211 111 1110
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.......+......+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 226 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00001112223345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.12 Aligned_cols=236 Identities=29% Similarity=0.396 Sum_probs=199.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- ..+...+|..+|+.+.||+++++.+-|. +...++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~--d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK--DNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec--cCCeEEE
Confidence 57888999999999999999965 6889999999754322 2345788999999999999999998876 6679999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||++||.|..+|++ .+++++..++-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 122 vmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999986 456899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... +-..+||+.|+|||++..+.+...+|-|||||++|||+.|..||...++. . ..+.+
T Consensus 195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~----------iY~KI 253 (355)
T KOG0616|consen 195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------Q----------IYEKI 253 (355)
T ss_pred cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------H----------HHHHH
Confidence 543 34578999999999999999999999999999999999999999865531 1 12222
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCC
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 647 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~R 647 (726)
....+ .+|.-....+.+|+...|+.|-.+|
T Consensus 254 ~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22222 3444444567889999999999999
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.66 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=193.7
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
++||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +|+||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence 46999999999999965 57899999987532 23345678899999876 7999999999987 445799999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 79 NGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999999864 235889999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~----------~~ 213 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHD----------DV 213 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcC----------CC
Confidence 223457999999999999989999999999999999999999999743311 111111111 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRP-------TMGEVVQSL 657 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RP-------Tm~EVl~~L 657 (726)
..+......+.+++.+||+.||++|| ++.+++++-
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11222234578999999999999999 888888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.49 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=192.8
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +++.||||.+... .....+.+..|.+++..+ +|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 5789999998743 223345678899998877 6999999999987 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 79 NGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999999864 235889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~----------~~ 213 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILND----------EV 213 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC----------CC
Confidence 23345799999999999999999999999999999999999999974321 1111111111 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm------~EVl~~ 656 (726)
..+......+.+++.+||+.||++||++ ++++++
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1122233457899999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.66 Aligned_cols=237 Identities=26% Similarity=0.369 Sum_probs=186.2
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHH-HHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
++||+|+||.||+|+.. +|+.||+|.+.... ......+.+|.. +++.++|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999974 68899999986432 122345556654 578899999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 79 NGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99999988864 235788889999999999999999998 9999999999999999999999999987542221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+. ...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~----------~~~~ 213 (321)
T cd05603 151 -ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNIL----------HKPL 213 (321)
T ss_pred -CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHh----------cCCC
Confidence 12334579999999999999899999999999999999999999996432 111111111 1111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG 651 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~ 651 (726)
..+......+.+++.+||+.||.+||+..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12233345688999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.29 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=203.4
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++|+|++++++++.. ....++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeec
Confidence 5788899999999999999985 4688999999987666666789999999999999999999999874 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.++++. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999863 24788999999999999999999998 999999999999999999999999998765432
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. .+..+ ... .
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~~---------~ 232 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----ATN---------G 232 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hcC---------C
Confidence 21 1223468899999999998889999999999999999999999996543211 11111 000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
......+......+.+++.+||..+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00001122233457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.61 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=190.7
Q ss_pred eeeeecCcEEEEEEEE----CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 386 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++|+||+++++++. +....++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence 6799999999999874 3578999999874322 23346778999999999999999999987 44589999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999964 335899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ..
T Consensus 153 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~----------~~ 214 (318)
T cd05582 153 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILK----------AK 214 (318)
T ss_pred C--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHc----------CC
Confidence 1 223457999999999999888999999999999999999999999743211 11111111 11
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~E 652 (726)
. ..+......+.+++.+||+.||++||++.+
T Consensus 215 ~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 L--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 122233345789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.27 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=190.8
Q ss_pred eeeeecCcEEEEEEEECC---CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....|.+|+.++++++|+||+++++++. +....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCC
Confidence 368999999999998643 45799999875443 23357899999999999999999999986 4457899999999
Q ss_pred CCChhhhccCCCC-CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 462 NGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 462 ~GsL~d~L~~~~~-~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
+|+|.++++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999974322 1234677888899999999999999998 99999999999999999999999999976543332
Q ss_pred ccccccccccccccCccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~-------~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........++..|+|||++... .++.++||||||+++|||++ |+.||....... ...+. .. ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~--~~~ 227 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---VR--EQQ 227 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---hh--ccc
Confidence 2222335578899999988642 35789999999999999996 999996433211 11110 00 000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..+.++.+.. .....+.+++..|+ .+|++|||++||++.|.
T Consensus 228 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111222211 12334778999999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.57 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|+|++++++++. +....+++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEc
Confidence 4678889999999999999998778899999987443 23567999999999999999999999986 44578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999999742 235789999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++.+|+|||++.++.++.++||||||+++|||++ |+.||..... ..+... . ... .....
T Consensus 155 ~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~---~-~~~---~~~~~- 222 (256)
T cd05112 155 YT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVET---I-NAG---FRLYK- 222 (256)
T ss_pred cc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH---H-hCC---CCCCC-
Confidence 11 1122335678999999998899999999999999999998 9999864321 111111 1 000 00011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
+......+.+++.+||+.+|++||++.|+++.|
T Consensus 223 ------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.07 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=202.0
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++.. ....
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 80 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFF 80 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEE
Confidence 4456777777889999999999999954 578899999876655566789999999999999999999999874 4588
Q ss_pred EEEEeecCCCChhhhccCCCCCcccC--ChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~L--s~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFG 530 (726)
++++||+++++|.+++.... ..+ ++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999997422 224 77888999999999999999998 999999999999976 6799999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
++........ ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||....... ...|......
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~- 228 (268)
T cd06624 155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK- 228 (268)
T ss_pred hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-
Confidence 9876543221 122345889999999987643 7899999999999999999999986432111 1111110000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+......+.+++.+||+.+|++|||+.|++++
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0112233344568899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.79 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=196.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC------CC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~------~~ 450 (726)
...+|++.+.||+|+||.||+|+.. +++.||||++... .....+|+.+|++++|+|||++++++... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 6889999988632 23446799999999999999999876421 12
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEec
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADF 529 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DF 529 (726)
..+++||||+++ +|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 777776532233456899999999999999999999999 99999999999998654 7999999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.......-..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 99987654322 223568999999998875 468999999999999999999999997543221 111111100000
Q ss_pred h-hhh-------hhhc-----CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 K-DRL-------EELA-----DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 ~-~~l-------~~i~-----d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. +.+ ..+. ...+...++.....++.+|+.+||+.||.+|||+.|++++-+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 000 0000 000111122223356889999999999999999999998743
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.85 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=197.6
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||+|+||.||+|+. .+++.||+|.+..... ...+++.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 4678889999999999999985 4688999999865422 234578999999999999999999999874 44789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999999997653 3677888999999999999999998 99999999999999999999999999986543
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~l~~i~ 616 (726)
.. .....||..|+|||++.+..++.++||||||+++|||++|+.||......... ....+. ..+.
T Consensus 148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~ 213 (279)
T cd06619 148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIV 213 (279)
T ss_pred cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHh
Confidence 22 23457899999999999889999999999999999999999999643221110 000111 1111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.............++.+++.+||+.+|++||+++|++++-+
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 111000011112345789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.57 Aligned_cols=257 Identities=30% Similarity=0.471 Sum_probs=203.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|++.+.||+|+||.||+|.+. +|. .||+|.+..... ....++.+|++++++++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 46788899999999999999864 233 589998875543 234678999999999999999999999874 578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999999753 234899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...............++..|+|||.+....++.++|+||||+++||+++ |+.||+..... .+... +. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~~-~---- 226 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL---LE-K---- 226 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH---Hh-C----
Confidence 7654332222222334678999999988899999999999999999998 99998643211 11111 10 0
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 ------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00011122233457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.96 Aligned_cols=269 Identities=23% Similarity=0.273 Sum_probs=207.8
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+.++.|++|.||.||+|+. ++++.||+|+++...... .-.-++||.+|.+++|||||.+..+....+-...|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4688899999999999999995 478999999998554222 2346899999999999999999999877777789999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||||+. +|..++..- ..++...++.-+..|+++||+|||++. |+|||||++|+|+.+.|.+||+|||+|+...
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 899988742 356888999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh--------hhhhhcc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT--------WARPILR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~--------~~~~~~~ 607 (726)
.... ..+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++-|......++.+.+- -.|+-+.
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 6532 3467789999999999886 468999999999999999999999887654433322110 0000000
Q ss_pred chh-----hhhhhcCCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 DKD-----RLEELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 ~~~-----~l~~i~d~~l~~~~~~e-~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.-. ......-..++..+... ..+.-.+|+..+|..||.+|-|++|.+++=
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 000 00000001112222222 234567899999999999999999999873
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=337.98 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=197.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
..++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++. +....
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEE
Confidence 4578999999999999999999965 5789999998642 1223456889999999999999999999987 45589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999964 24788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ...
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~------- 256 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTY------- 256 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHH-------
Confidence 7643221 122345799999999998754 3789999999999999999999999643211 111
Q ss_pred hhhhhhcCCccCCCCCh--hhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPK--EDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL 657 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~--e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~L 657 (726)
..+.+.......+. .....+.+++.+|++.++.+ |+++.|++++-
T Consensus 257 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 257 ---SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ---HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11111110011111 22345778899999865544 89999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.47 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=201.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|+.. .+..+|+|.++.... ...+.|.+|+.++.+++||||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccE
Confidence 57888999999999999999863 234799999875432 23467899999999999999999999986 345789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999743 235899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 535 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 535 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....+.. +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~- 227 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYR- 227 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCc-
Confidence 65432211 1122234568999999998899999999999999999886 99998643211 1111111 0000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
...+......+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122234578999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.15 Aligned_cols=248 Identities=30% Similarity=0.468 Sum_probs=197.3
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 464 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~Gs 464 (726)
++||+|+||.||++...+++.||+|.+...... ..+.|.+|++++++++|+||+++++++. +....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence 469999999999999877999999998765443 4567999999999999999999999987 4458899999999999
Q ss_pred hhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccccc
Q 004869 465 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544 (726)
Q Consensus 465 L~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 544 (726)
|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...........
T Consensus 79 l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 79 LLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99999642 235788999999999999999999998 999999999999999999999999999865432211111
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 545 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
....++..|+|||++.++.++.++|||||||++|||++ |..||....... .... ........
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~--------------~~~~~~~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER--------------IESGYRMP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH--------------HhcCCCCC
Confidence 12234667999999998899999999999999999999 888886432111 1110 00001111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+......+.+++.+||+.+|++|||+.||++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 22333456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.67 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=203.6
Q ss_pred HHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
...++|+++..||+|+||.||+++. .+|..+|+|++++... ...+..+.|-.+|...+++.||+|+-.|+ +...
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ--D~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ--DKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec--CCCe
Confidence 3568999999999999999999995 4699999999986543 33456788999999999999999976655 6779
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
+||||||++||++..+|.. ...|++..+..++.+++-|++.+|+.| +|||||||+|+|||..|++||+||||+
T Consensus 216 LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred eEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999975 456999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCC----------------------CCcc----ccc-------------------ccccccccccCccccccCCCCcc
Q 004869 533 KQAPE----------------------GRTN----YLS-------------------TRVMGTFGYVAPEYAMTGHLLVK 567 (726)
Q Consensus 533 ~~~~~----------------------~~~~----~~~-------------------~~~~GT~~Y~APE~l~~~~~s~k 567 (726)
.-... .... ... ...+||+.|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 42211 0000 000 12579999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC
Q 004869 568 SDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 646 (726)
Q Consensus 568 sDVwSfGvvL~ELltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~ 646 (726)
+|.||+|||+||||.|.+||....+... .+++.|...+..-. ......+..+||.+|+. ||++
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999999999987655432 23444432221110 01112467899999999 9999
Q ss_pred CCC---HHHHHHH
Q 004869 647 RPT---MGEVVQS 656 (726)
Q Consensus 647 RPT---m~EVl~~ 656 (726)
|-- +.||-+|
T Consensus 433 RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 433 RLGSKGAEEIKKH 445 (550)
T ss_pred hcCcccHHHHhcC
Confidence 965 6666554
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=340.66 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=195.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.+|++.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEE
Confidence 36899999999999999999954 58899999986432 223456889999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 79 v~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 79 VMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999975 235788888999999999999999998 999999999999999999999999998532
Q ss_pred CCCC-----------------------------------------cccccccccccccccCccccccCCCCcchhHHHHH
Q 004869 536 PEGR-----------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 574 (726)
Q Consensus 536 ~~~~-----------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfG 574 (726)
.... .........||+.|||||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 00011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC---CHH
Q 004869 575 VVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP---TMG 651 (726)
Q Consensus 575 vvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP---Tm~ 651 (726)
|++|||++|+.||....+... ...+...... +...........+.+++.+|+ .+|.+|+ ++.
T Consensus 232 vilyell~G~~Pf~~~~~~~~------~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAET------QLKVINWETT--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHH------HHHHhccCcc--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999999999975432211 0001000000 000001112234667787766 4999999 899
Q ss_pred HHHHH
Q 004869 652 EVVQS 656 (726)
Q Consensus 652 EVl~~ 656 (726)
|++++
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.15 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=189.8
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++..+ +|+||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 57889999987432 22334566777777654 8999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 79 NGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999999864 235888999999999999999999998 9999999999999999999999999997643322
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~---~~~~i~~~------------ 211 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DE---LFDSILND------------ 211 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHcC------------
Confidence 123345799999999999998999999999999999999999999974321 11 11111100
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~-EVl~~ 656 (726)
...++......+.+++.+||+.||++||++. +++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0112222334578999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.90 Aligned_cols=251 Identities=30% Similarity=0.488 Sum_probs=195.7
Q ss_pred eeeeecCcEEEEEEEECC-------CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+.||+|+||.||+|+..+ +..+|+|.+..... .....|.+|++++++++|+||+++++++. +....+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEE
Confidence 469999999999998642 25799998865432 34567999999999999999999999987 445789999
Q ss_pred eecCCCChhhhccCCCC---CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-----cEEEEec
Q 004869 458 ELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-----HAKVADF 529 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~---~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-----~vKL~DF 529 (726)
||+++|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999964321 1234789999999999999999999988 99999999999999877 8999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..... .....+. ..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~ 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TA 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hc
Confidence 99986543322212223346788999999999999999999999999999998 9999863321 1111111 00
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ....+......+.+++.+||+.+|++||++++|++.|+
T Consensus 229 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 00112223456889999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.28 Aligned_cols=256 Identities=22% Similarity=0.291 Sum_probs=195.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.|.+|+.++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence 47899999999999999999964 5889999998642 1223456889999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999999999642 235888999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~ 225 (331)
T cd05597 153 LADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE 225 (331)
T ss_pred CCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 44322 12233469999999999863 4578899999999999999999999964321 111111111111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCC--CCCCCHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA--NQRPTMGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP--~~RPTm~EVl~~L 657 (726)
.. .+ +. ........+.+++.+|+..++ ..|+++.+++++-
T Consensus 226 ~~-~~--~~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 226 HF-QF--PP----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred cc-cC--CC----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00 00 00 011123356778888775543 3488999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.83 Aligned_cols=258 Identities=29% Similarity=0.489 Sum_probs=201.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|+..+.||+|+||.||+|++. +|. .||+|.+...... ...++.+|+.++++++|+||++++|+|.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 46778899999999999999863 444 5788988644322 23478899999999999999999999863 246
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 7999999999999998742 235788999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ......+. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLL----EKGERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HCCCCC
Confidence 7654332222223446778999999998999999999999999999997 889986432 11111111 111000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..+......+.+++..||..+|++||+++++++.|+.+.+.
T Consensus 231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122234688999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.16 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=213.9
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
++.+-.+.++...++||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|.. ..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~--Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CC
Confidence 3444445667788999999999999999863 567999999854 3457899999999999999999999999984 44
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..|||+|||.+|+|.|||+... +..++-...+.++.||+.|++||..++ +|||||..+|+|+.++..+||+||||
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 7899999999999999998633 234666778899999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
++++..+... ........+.|.|||-+....++.|+|||+|||+||||.| |-.||...+ + ..+..+++.+.
T Consensus 412 sRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqVY~LLEkgy 483 (1157)
T KOG4278|consen 412 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYGLLEKGY 483 (1157)
T ss_pred hhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHHHHHHhccc
Confidence 9988654321 2223446789999999999999999999999999999988 888886432 1 11122232222
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
+-+.|+.+...+++|+++||+.+|.+||+++|+-+.++.+.
T Consensus 484 ----------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 ----------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ----------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22345566677999999999999999999999999987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.69 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC---ceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---QHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~---~~~L 455 (726)
-.|+..+++|.|+||.||+|.+. +++.||||+.-.+ .+.-.+|+++|++++|||||+|+-+|...... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677899999999999999965 5789999998633 33345799999999999999999888765444 4568
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFGla~~ 534 (726)
|||||+. +|.+.++.....+..++...+.-+..|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 999999754344566888889999999999999999988 9999999999999975 9999999999998
Q ss_pred CCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-hhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRL 612 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l 612 (726)
...+..+ ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+.... .+++..++-+-... +.+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 8665443 22345778999999886 47999999999999999999999999764433 33333222111100 000
Q ss_pred h-------hhcCCccCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 E-------ELADPRLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~-------~i~d~~l~~-----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. +...+.+.. -.......+.++++.++|+.+|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 111111111 1222334568899999999999999999999876
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.20 Aligned_cols=266 Identities=30% Similarity=0.434 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeec
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 447 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~ 447 (726)
++++++..++++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566777789999999999999999999996 468899999986432 2346788899999999 79999999999864
Q ss_pred CC---CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 448 RD---SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 448 ~~---~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
.+ ....++||||+++|+|.++++........+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 33 24689999999999999998643333456899999999999999999999998 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 9999999986543321 12234688999999987643 3689999999999999999999998643211 1111
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.+ . .. +.+ ..+.+....+.+++.+||+.+|++||++.|++++
T Consensus 244 ~~~~----~--~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPR----N--PP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhc----C--CC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100 0 00 000 1122233458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.26 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||++... ++..+|+|.+...... ....+.+|++++.+++|+||+++++++. +....++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEe
Confidence 47899999999999999999964 5788999988754222 2356889999999999999999999987 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+++++|.++++. ...+++..+..++.|+++||.|||+ .+ ++||||||+|||+++++.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 79 EHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999975 2458899999999999999999997 46 9999999999999999999999999987654
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------- 609 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 609 (726)
... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...+........
T Consensus 152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcc
Confidence 322 233568899999999988889999999999999999999999986433111 111110000000
Q ss_pred ----------------hhhhhhcCCccCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 ----------------DRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ----------------~~l~~i~d~~l~~~~~~-e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.....+.... ....+. .....+.+++.+||+.+|++|||+.||+++.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000000000 000111 1233588999999999999999999999886553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.66 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=189.2
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHH-HHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|.. +++.++||||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence 46999999999999965 68999999986432 222345556655 457899999999999887 445889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999999864 345888999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~----------~~~ 213 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN----------KPL 213 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc----------CCC
Confidence 23345799999999999999999999999999999999999999964321 111111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG----EVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~----EVl~~ 656 (726)
..+......+.+++.+||+.||++||++. |++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 214 --RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11112234588999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.04 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence 46789999999999999999998778889999887432 235678999999999999999999998763 46899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997532 345889999999999999999999988 999999999999999999999999999866443
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++....++.++|+|||||++||+++ |+.||..... .....+.. ..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~----~~-------- 219 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE----RG-------- 219 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----CC--------
Confidence 221 1222346678999999998889999999999999999999 8999864321 11111110 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.....+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001122233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.99 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=196.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-----CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++|+||+++++++........
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 588999998864322 123468889999999999999999998875445678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999964 234889999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCc-ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~-~--------- 219 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAI-F--------- 219 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHH-H---------
Confidence 6543211 11112345889999999999888999999999999999999999999643211 000 0
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...........+......+.+++ +||..+|++||+++||+++
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 220 -KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00000001122222233455666 7888899999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=338.03 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=192.4
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
+|+..++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++. +....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEE
Confidence 588999999999999999996 468899999986432 122456889999999999999999999987 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 80 MDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999964 235788889999999999999999998 9999999999999999999999999975331
Q ss_pred CCC---------------------------------------------cccccccccccccccCccccccCCCCcchhHH
Q 004869 537 EGR---------------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY 571 (726)
Q Consensus 537 ~~~---------------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVw 571 (726)
... .........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 100 00011234699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC--
Q 004869 572 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-- 649 (726)
Q Consensus 572 SfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-- 649 (726)
||||+||||++|+.||....+... . ..+.... ..+...........+.+++.+|+ .+|++|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~--~----~~i~~~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLET--Q----MKVINWQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHH--H----HHHHccC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 999999999999999975432110 0 0000000 00000000111234566776765 48999987
Q ss_pred -HHHHHHH
Q 004869 650 -MGEVVQS 656 (726)
Q Consensus 650 -m~EVl~~ 656 (726)
+.|++++
T Consensus 298 ~~~ei~~h 305 (382)
T cd05625 298 GADEIKAH 305 (382)
T ss_pred CHHHHhcC
Confidence 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=329.58 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=194.5
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence 47999999999999964 57899999997542 22335678899999888 6999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 79 NGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999998864 235899999999999999999999998 99999999999999999999999999975332211
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||+.|+|||++.+..++.++|||||||+||||++|+.||+........+...+...... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~- 219 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---------EKP- 219 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH---------hCC-
Confidence 12345799999999999999999999999999999999999999964332222222222111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm------~EVl~~ 656 (726)
...+......+.+++.+||+.||++|+++ .+++++
T Consensus 220 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 -IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11222333457899999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.80 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=192.6
Q ss_pred eeeeecCcEEEEEEEEC----CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS----DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.+++.++|+||+++++++... ....++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 46899999999999853 24579999986432 23346788999999999999999999987543 34678999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999997432 23678888999999999999999988 99999999999999999999999999986543221
Q ss_pred c--cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 541 N--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 541 ~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
. .......++..|+|||++.+..++.++|||||||++|||++| ..||.... ...+... .... . .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~---~~~~-~------~ 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY---LLQG-R------R 220 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---HhcC-C------C
Confidence 1 011234567789999999988999999999999999999995 45554321 1111111 1110 0 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
. ..+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 221 ~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 L----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 111122345889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.50 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=164.1
Q ss_pred ceeeeecCcEEEEEEEEC---CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 385 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++........+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 2456789999999999999999999987655667899999985
Q ss_pred CCChhhhccCCC-----CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee----cCCCcEEEEecCcc
Q 004869 462 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 532 (726)
Q Consensus 462 ~GsL~d~L~~~~-----~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL----d~~~~vKL~DFGla 532 (726)
++|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 11235888999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCcc-cccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 533 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 533 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876433211 12234578999999999876 458999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.43 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=202.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|.+.+.||+|+||.||+|.+.+ ...||||...... ....+.|.+|++++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 3568888999999999999998643 2468999887544 2334679999999999999999999998863 357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceee
Confidence 8999999999999999742 224899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... +..+...++..|+|||.+....++.++||||||+++||+++ |+.||...... ....+. ......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~ 227 (270)
T cd05056 156 YLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERL 227 (270)
T ss_pred ecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcC
Confidence 6654321 12223345578999999988889999999999999999986 99999643311 111111 000000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
..+......+.+++.+|+..+|++|||+.+++..|+.+..
T Consensus 228 ----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122333468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.40 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=191.3
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||.||+++.. +|+.||+|.+..... ...+.+..|++++++++||||+++.+++. +....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 799999999999864 589999999864321 22345667999999999999999999886 445899999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 79 DLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred CHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 999988642 2335889999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.... .....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----------~~~~~- 217 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----------DEVKF- 217 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----------ccccc-
Confidence 233568999999999998889999999999999999999999996432111 11111111111 01100
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......++.+++.+||+.||++||+++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 001123357899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.12 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=193.6
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||+||+|+.. +++.||||.+.... ......+.+|.+++..+ +|+||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999975 57899999987532 23345678899999888 6999999999987 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 79 NGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999998864 235899999999999999999999998 99999999999999999999999999875322221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+.. ...
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~---~~~~i~~----------~~~ 213 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DE---LFQSILE----------DEV 213 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HH---HHHHHHc----------CCC
Confidence 12345689999999999999999999999999999999999999964321 11 1111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm-----~EVl~~ 656 (726)
.++......+.+++.+||+.||++||++ .+++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1222233468899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.74 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=199.0
Q ss_pred CcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+|...+.||+|+||.||+|...+|+.+|||.+...... ..+.+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence 47788999999999999999888999999988643221 12458889999999999999999999874 46899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 79 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 79 IFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999999999999964 235789999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCc----ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 535 APEGRT----NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 535 ~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~~- 224 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGAHR- 224 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhhcc-
Confidence 532111 111223568999999999998889999999999999999999999996432111 0000 00000
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+. .+......+.+++.+||+.+|++||++.|++++
T Consensus 225 ----~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 ----GLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----CCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111 222233458899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.76 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=201.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ..+.|.+|++++++++|+||+++++++. +...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCc
Confidence 57889999999999999999964 2467999988654333 3467999999999999999999999986 4457
Q ss_pred eEEEEeecCCCChhhhccCCCCCc-----ccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVN-----CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~-----~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
.++||||+++|+|.++++...... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 899999999999999997533211 25899999999999999999999998 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
|||+++....... .......++..|+|||.+.+...+.++||||||+++|||++ |..||..... ..+...
T Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----- 230 (275)
T cd05046 160 LLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----- 230 (275)
T ss_pred ccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH-----
Confidence 9999875433221 12233456788999999988888999999999999999999 7888853221 111111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..........+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 --------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00011111112223346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.92 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCC----C
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~ 450 (726)
..++|++.+.||+|+||.||++... .++.||||++..... ...+.+.+|+.+++.++|+||+++++++...+ .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 588999999975422 23457888999999999999999999876432 2
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 67776642 4788899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh-h--------h-
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-V--------T- 600 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l-~--------~- 600 (726)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........... . .
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998654322 22345789999999999999999999999999999999999999975432111000 0 0
Q ss_pred ------hhhhhccchhhhhhhcCCc-----c---CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 601 ------WARPILRDKDRLEELADPR-----L---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 601 ------~~~~~~~~~~~l~~i~d~~-----l---~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..............+..+. + ...........+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000000000000000000 0 0011112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.59 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=190.9
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +|+.||+|.++... ....+.+..|.+++... +|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence 46999999999999975 58899999987532 22345667788888765 8999999999987 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 79 NGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999999864 235888999999999999999999998 99999999999999999999999999875332211
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..+.. ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~---~~~~~--------~~~-- 213 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELF---ESIRV--------DTP-- 213 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHh--------CCC--
Confidence 23446799999999999999999999999999999999999999964321 1111 10000 011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~-EVl~~ 656 (726)
.++......+.+++.+||+.||++||++. ++.++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11222334578999999999999999984 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.71 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=198.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-----CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|++++++++|+||+++++++........
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999964 589999998864321 123468889999999999999999998865445578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+++|||+++|+|.+++.. ...+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999864 234788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-----------~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-----------I 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-----------H
Confidence 65422111 1122345889999999998888999999999999999999999998632111 00 0
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
............+......+.+++.+|+. +|++||+++||+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00111111122344444567889999995 89999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.87 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
++|+..+.||+|+||.||+|+..+ ++.|++|.+..... .+++.+|++++++++|+||+++++++.. ....++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEe
Confidence 578899999999999999999764 78999999874432 6789999999999999999999999874 468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998642 246899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||....+.... ... .. ...+
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~~----~~-------~~~~ 217 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMI----PN-------KPPP 217 (256)
T ss_pred cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hhh----cc-------CCCC
Confidence 21 123345888999999999889999999999999999999999999743321110 000 00 0000
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ..+......+.+++.+||+.||++|||+.||+++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 1112223458899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=342.92 Aligned_cols=270 Identities=19% Similarity=0.324 Sum_probs=197.7
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhccc------CceeEEEEEe
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH------RNLVKLVGYY 445 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H------pNIV~llg~~ 445 (726)
+++...+++|++.++||+|+||+||+|... +++.||||+++... ...+++..|++++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999864 57889999986432 223456778888887765 4588999988
Q ss_pred ecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCC--
Q 004869 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNF-- 522 (726)
Q Consensus 446 ~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~-- 522 (726)
.. +....++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 201 ~~-~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 201 QN-ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred Ec-CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 64 345789999988 7789998864 24589999999999999999999974 7 99999999999998765
Q ss_pred --------------cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 004869 523 --------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 523 --------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999988643221 234679999999999999999999999999999999999999997
Q ss_pred CCCCCccchhhh---------hhhhhccchhhhhhhcCCc--cCCCC---------------ChhhHHHHHHHHHHcccc
Q 004869 589 MSQPSGQENLVT---------WARPILRDKDRLEELADPR--LGGKY---------------PKEDFIRVCTIAAACVAP 642 (726)
Q Consensus 589 ~~~~~~~~~l~~---------~~~~~~~~~~~l~~i~d~~--l~~~~---------------~~e~~~~l~~Li~~CL~~ 642 (726)
..........+. |...... .....+.+.. +.... .......+++|+.+||+.
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGT--EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccc--hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 544322111110 1100000 0000000000 00000 001123578999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 004869 643 EANQRPTMGEVVQSLKM 659 (726)
Q Consensus 643 dP~~RPTm~EVl~~L~~ 659 (726)
||++|||++|+++|=+.
T Consensus 425 dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYV 441 (467)
T ss_pred ChhhCCCHHHHhcCccc
Confidence 99999999999987444
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.63 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=198.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---------hhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
+|.+.+.||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 4677899999999999999864 57899999886543221 1468889999999999999999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred CccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 588999999999999999964 235788999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc----ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 531 LAKQAPEGRT----NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 531 la~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
+++....... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~------- 222 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIF------- 222 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHH-------
Confidence 9987653211 11112345888999999999888999999999999999999999999743210 0000
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+ ..+......+.+++.+||+.||++||++.||+++
T Consensus 223 ----~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 ----KIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00011111 2222334568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.87 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=199.1
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~~ 454 (726)
+|++.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 478999999986432 223467889999999999999999999986432 12679
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 578887754 345899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch----
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK---- 609 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---- 609 (726)
....... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||....+..+...+.. .+...
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~g~~~~~~ 228 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD---LLGTPSLEA 228 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---HcCCCCHHH
Confidence 5433221 22334688999999998764 578999999999999999999999975443221111000 00000
Q ss_pred ------hhhhhhcCCccC-------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 610 ------DRLEELADPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 610 ------~~l~~i~d~~l~-------~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.....+...... .....+...++.+++.+||+.||++|||+.|++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000000000 0111222446789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.31 Aligned_cols=242 Identities=28% Similarity=0.417 Sum_probs=190.9
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 46999999999999965 57899999987532 23345577788888764 89999999999874 45899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 79 NGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999999964 235889999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+... +. ...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~---i~--------~~~~-- 213 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS---IR--------MDNP-- 213 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH---HH--------hCCC--
Confidence 22345799999999999999999999999999999999999999964321 111111 00 0011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~-EVl~~ 656 (726)
.++......+.+++.+||+.||++||++. ++.++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11222234578999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.70 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=163.4
Q ss_pred ceeeeecCcEEEEEEEEC---CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 385 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
.++||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++|+||+++++++...+....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999965 35789999986432 2356889999999999999999999987656668899999986
Q ss_pred CCChhhhccCCC-----CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee----cCCCcEEEEecCcc
Q 004869 462 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 532 (726)
Q Consensus 462 ~GsL~d~L~~~~-----~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL----d~~~~vKL~DFGla 532 (726)
+ +|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7877764211 11235888999999999999999999998 9999999999999 56789999999999
Q ss_pred ccCCCCCcc-cccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 533 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 533 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
+........ .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 11234578999999999876 45799999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.36 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=200.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|++|.||++... +++.||+|++..... ...+.+.+|++++++++|+|++++++.+.. +....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 5888999999999999999964 578899999865432 334578899999999999999999987653 234678999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999997422 335899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++.+..++.++||||||++++||++|+.||+.... ..+.......
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~--------- 217 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG--------- 217 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc---------
Confidence 221 22345688999999999999999999999999999999999999864321 1111111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ...+......+.+++.+||+.+|++||++.|++++
T Consensus 218 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 -KL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 11222334568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.27 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=203.6
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++|+|++++++++. +....++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEE
Confidence 4689999999999999999985 568999999997665556678899999999999999999999987 4458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999863 35899999999999999999999998 999999999999999999999999998865433
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.... .. ..... .+
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~----~~~~~-------~~ 233 (296)
T cd06655 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----IATNG-------TP 233 (296)
T ss_pred cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH----HHhcC-------Cc
Confidence 22 123346889999999999888999999999999999999999999754321110 00 00000 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ..+......+.+++.+||+.||++||++.+|+++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 1122223457889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.28 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=199.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC----C
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~ 450 (726)
..++|++.+.||+|+||.||++... +|..||||++.... ......+.+|+.+++.++|+||+++++++...+ .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 58899999986432 233467889999999999999999999886432 1
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999965 66666642 3788889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh-------
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR------- 603 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~------- 603 (726)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ +.....
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSA 243 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcH
Confidence 997643321 22345789999999999999999999999999999999999999975432110 000000
Q ss_pred -----------hhccchh-----hhhhhcCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 604 -----------PILRDKD-----RLEELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 604 -----------~~~~~~~-----~l~~i~d~~l~---~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
....... ...+....... ..........+.+++.+||+.||++|||+.|++++-+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000000 00000000000 00011123457899999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.91 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=195.1
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhc---ccCceeEEEEEeecC---CCC
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSR---DSS 451 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~~---~~~ 451 (726)
+|++.+.||+|+||.||+|+.. +|+.||+|.+...... ....+.+|+++++++ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999965 6889999998754322 234567788877766 699999999987642 234
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..+++|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 48988886422 234899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccch-
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDK- 609 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~- 609 (726)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... .+..+........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98664322 123456899999999999889999999999999999999999998643221110 0010000000000
Q ss_pred -hhh---hhhcCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 -DRL---EELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 -~~l---~~i~d~~l~---~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .....+... .....+....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000000 00111223457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.00 Aligned_cols=253 Identities=32% Similarity=0.516 Sum_probs=198.4
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchh--HHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~--~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|++.+.||+|+||+||+++.. +++.||+|.+......... ...+|+.++++++|+||+++++++.. ....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 678899999999999999975 4668999999865433222 34569999999999999999999874 558899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.. ...+++..++.++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 79 YCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999972 456899999999999999999999998 999999999999999999999999999864221
Q ss_pred CcccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
........++..|+|||++. +..++.++||||+|+++|+|++|..||........ ........... .. .
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~--~~---~ 221 (260)
T PF00069_consen 152 --NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRP--LP---S 221 (260)
T ss_dssp --TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTH--HH---H
T ss_pred --ccccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccc--cc---c
Confidence 12334567899999999998 88899999999999999999999999975411111 11111111000 00 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. .........+.+++.+||+.||++||++.+++++
T Consensus 222 -~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 -SS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -HT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0001112578999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.34 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=202.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~ 452 (726)
..++|.+.++||+|.||+|+++.++ +++.+|||.++++. .++.+..+.|.+++.... ||.+++|+.+|+ ...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cCCe
Confidence 3578999999999999999999976 57899999998764 344567888999988775 999999998887 4559
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
+|+||||+.||++..+.+ ...+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999665555 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+....... .+++.+||+.|||||++.+..|+...|-|||||+||||+.|..||...+.. . ..
T Consensus 516 Ke~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e-------------~F 577 (694)
T KOG0694|consen 516 KEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---E-------------VF 577 (694)
T ss_pred cccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---H-------------HH
Confidence 96542222 456789999999999999999999999999999999999999999754311 1 11
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm 650 (726)
+.++.. ...||.....+...|+.++|..+|++|--+
T Consensus 578 dsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111 124566666778999999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.99 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=195.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++. +....++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 47899999999999999999965 5788999998642 1223345888999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999742 235888999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
..... .......||+.|+|||++.+ +.++.++|||||||+||||++|+.||..... ......+.....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~ 225 (331)
T cd05624 153 NQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEE 225 (331)
T ss_pred cCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCC
Confidence 44322 12233569999999999875 5678999999999999999999999964321 111111111110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~ 656 (726)
.. .+. ....+....+.+++.+|+..++.+ |+++++++++
T Consensus 226 ~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 000 001122346788999998865544 4689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.82 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=200.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+|++.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++. +....+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEe
Confidence 5788999999999999999964 68899999986432 233467889999999999999999999987 4458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 79 YCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999886422 335788999999999999999999998 999999999999999999999999999766433
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... ........ .
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~----------~ 215 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQ----------G 215 (255)
T ss_pred cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhc----------C
Confidence 21 223456889999999999888999999999999999999999999643211 11111100 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ...+......+.+++.+||+.||++||++.||+..
T Consensus 216 ~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 01122233457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.37 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=215.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC-----CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++.....++||+|.||.||+|.+.+ .-.||||..+.+.. ...+.|+.|.-+|+.++|||||+|+|+|.. .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---c
Confidence 34555677899999999999999643 23689999887543 446789999999999999999999999963 3
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++|||.++-|.|..||+.+. ..|+......++.||+.+|+|||+.. +|||||..+|||+....-+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 7899999999999999998643 35888999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
++.+.+... +..+...-...|||||.+.-.+++.++|||.|||.+||+++ |..||..-...+.- ..+++++
T Consensus 538 SR~~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe 609 (974)
T KOG4257|consen 538 SRYLEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE 609 (974)
T ss_pred hhhccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC
Confidence 998876553 34556677889999999999999999999999999999987 99999754322211 1122222
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+-.+|+.+...++.|+.+||..||.+||++.|+...|..+.+
T Consensus 610 ----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 ----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 225667777789999999999999999999999999988765
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.95 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=199.5
Q ss_pred cccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCC----C
Q 004869 382 FEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 451 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~----~ 451 (726)
|.+.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|++++++++|+||+++++++...+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 368899999875432 234578899999999999999999998764322 1
Q ss_pred ceEEEEeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 452 QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
..++++||+++|+|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478899999999998875321 11234788999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ..+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence 99987654332222233446678999999998889999999999999999999 8888863321 11111111 0
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
... + ..+......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 231 ~~~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0 11122335689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.29 Aligned_cols=241 Identities=25% Similarity=0.368 Sum_probs=191.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~L 455 (726)
+|+..+.||+|+||.||+|... +|+.||+|.+.... ....+.+..|.+++..+. |++|+++.+++.. ....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 4778899999999999999864 68899999987432 233456788999998885 5778888888763 457999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999999864 235899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+. . .+
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~----------~i 213 (323)
T cd05615 152 MVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF---Q----------SI 213 (323)
T ss_pred CCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---H----------HH
Confidence 32221 12345699999999999998999999999999999999999999974321 1111 1 11
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm 650 (726)
.... ..++......+.+++.+||+.+|.+|++.
T Consensus 214 ~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 MEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111 11223334467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=319.60 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=203.9
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++. .....++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEee
Confidence 36789999999999999999995 478999999998665556677899999999999999999999987 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999863 34788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+..... . ..... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----~~~~~-------~ 232 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IATNG-------T 232 (297)
T ss_pred Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----eccCC-------C
Confidence 321 1233468899999999999889999999999999999999999996543211100 0 00000 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+. ...+......+.+++.+||+.+|++||++.+|+++
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01122233457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.35 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=194.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.++||+|+||.||+++.. +++.||+|.+... .......|.+|+.++..++|+||+++.+++. +....++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence 47899999999999999999975 4788999998632 1222345888999999999999999999887 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999999742 235888999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~ 225 (332)
T cd05623 153 MEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE 225 (332)
T ss_pred ccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCc
Confidence 43322 1223457999999999986 3467899999999999999999999996432 1111111111110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~ 656 (726)
... -+ .........+.+++.+|+..++++ |+++.|++++
T Consensus 226 ~~~---~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQ---FP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc---CC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00 001122345778888888654444 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.08 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=197.7
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++.. ....++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEec
Confidence 567789999999999999975 477889999876554556778999999999999999999999874 45889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999999988642 246899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 541 NYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
......++..|+|||++. +..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~----~~~------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKI----AKS------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHH----hhc-------
Confidence 123356899999999874 345788999999999999999999998643211 111110 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..+.. ..+......+.+++.+||+.||++||++.+++++-
T Consensus 224 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 224 EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000 11122234588999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.01 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=187.4
Q ss_pred eeeeecCcEEEEEEEECC---CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++|+||+++++++. +....++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCC
Confidence 358999999999997543 35788888764432 22457889999999999999999999987 4457999999999
Q ss_pred CCChhhhccCCCCC-cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 462 NGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 462 ~GsL~d~L~~~~~~-~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
+|+|.+++...... ....++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999999754322 233567888999999999999999998 99999999999999999999999999875433221
Q ss_pred ccccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 541 NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..+. ...... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~----~~~~~~--~ 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLK----QVVREQ--D 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH----HHhhcc--C
Confidence 111223346778999998743 356889999999999999999 78888643211 1000 011110 0
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..+.++.+ +......+.+++..|+ .||++|||++||++.|
T Consensus 228 ~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11112222 2223344677888888 4999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.60 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=199.4
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++++++|+|++++++.+.. ....++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 3777899999999999999964 6889999998654322 23457889999999999999999998874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 79 ~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 79 LTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999999986421 235889999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .. ...... ..
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~-~~~~~~------~~- 220 (285)
T cd05630 154 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE-VERLVK------EV- 220 (285)
T ss_pred CCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH-HHhhhh------hh-
Confidence 3321 12346899999999999999999999999999999999999999753221100 00 000000 00
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK 658 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~L~ 658 (726)
...++......+.+++.+||+.||++||| +.|++++-+
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 221 ----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 00112222345789999999999999999 889988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.39 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=198.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC---CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..+|++.+.||+|+||.||++... .+..||+|.+... +.+.+|+++|++++|+||+++++++.. ....++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW--KSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee--CCEEEE
Confidence 457999999999999999999753 3578999988632 345689999999999999999998873 457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+||++. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 688888843 346899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccch-----
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDK----- 609 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~----- 609 (726)
.............||..|+|||++.+..++.++|||||||++|||++|+.||......... .+....+.+-...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 5443322233567999999999999999999999999999999999999999654432211 1111000000000
Q ss_pred ---h----hhhhhcCCccCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 610 ---D----RLEELADPRLGGKYP-------KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 610 ---~----~l~~i~d~~l~~~~~-------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. ..... .......+. ......+.+++.+||+.||++|||+.|++++=
T Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 316 NGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred ccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0 00000 000000000 01123577899999999999999999999873
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=314.38 Aligned_cols=264 Identities=28% Similarity=0.342 Sum_probs=206.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++|+||++++++|...+....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 578999999875433 3346789999999999999999999998766666789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++|+||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987543233445888999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--ccchhhhhhhhhccchhhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS--GQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..+.... . ...+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~---~~~~ 228 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--P---NPEL 228 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC--C---chhh
Confidence 221 2345788999999999999999999999999999999999999754321 111122221110 0 0000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+. . .........+.+++.+||+.+|++|||+.||+++-+
T Consensus 229 ~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 229 KDE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred ccC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 000 0 000122356889999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.24 Aligned_cols=192 Identities=24% Similarity=0.338 Sum_probs=163.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
...+|++.+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++|+||+++++++.. ....++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 4468999999999999999999975 467899997542 234579999999999999999999874 4578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||+ .|+|.+++... ...++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEcc-CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9999 56898888642 346899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf 587 (726)
... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 123456999999999999999999999999999999999866555
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=320.14 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=198.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|.+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.. ....++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence 57899999999999999999965 578899999875432 233567899999999999999999999874 45789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 84 EYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99975 888887642 234788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh--------hhhccc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--------RPILRD 608 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~--------~~~~~~ 608 (726)
... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ++.+..
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 221 1223467899999998865 46889999999999999999999999754322111111000 000000
Q ss_pred hhhhhhhcCCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 KDRLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 ~~~l~~i~d~~l~~----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.........+.... .........+.+++.+||+.||++|||+.|++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00000000000000 000112335789999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.16 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=197.8
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+|++.+.+++.. ....+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 3677899999999999999964 688999999864422 223457889999999999999999988874 4578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 79 LTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999999886421 235899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ ...+.... .
T Consensus 154 ~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~----------~ 218 (285)
T cd05632 154 EGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRV----------L 218 (285)
T ss_pred CCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhh----------h
Confidence 3221 1234689999999999988999999999999999999999999974321110 11111100 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
.. ...++......+.+++..||+.||++||+ +.+++++
T Consensus 219 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 219 ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00 01122223345789999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.15 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|++++.+++|+||+++++++. +....++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 47889999999999999999965 68899999986432 223456888999999999999999999887 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 79 IMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999964 345889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCc---------------------------------ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh
Q 004869 536 PEGRT---------------------------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 536 ~~~~~---------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt 582 (726)
..... ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 32110 001123579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004869 583 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 656 (726)
Q Consensus 583 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT---m~EVl~~ 656 (726)
|+.||....+.. ....+......+ ..+ ... ....++.+++.+|+. ||++|++ +.|++++
T Consensus 232 G~~Pf~~~~~~~------~~~~i~~~~~~~---~~p---~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 232 GYPPFCSETPQE------TYRKVMNWKETL---VFP---PEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCce---ecC---CCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 999997543211 111111100000 000 000 122356778888764 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.35 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=201.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++++++++.. ....++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEE
Confidence 46888899999999999999965 68899999987543 3334678999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.++++.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999999999742 6899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||....+.. ....... ...
T Consensus 151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~-------~~~ 215 (274)
T cd06609 151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK-------NNP 215 (274)
T ss_pred ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh-------cCC
Confidence 321 2234568889999999998889999999999999999999999996543211 0000000 001
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.+... .....+.+++.+||+.+|++|||+++++++
T Consensus 216 ~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111 023357899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.24 Aligned_cols=239 Identities=21% Similarity=0.376 Sum_probs=186.7
Q ss_pred eeeeecCcEEEEEEEECC-------------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 386 SILGEGGFGRVFKGVLSD-------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
+.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR--DVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCC
Confidence 468999999999998532 23588998875544445678999999999999999999999873 457
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-------EE
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-------AK 525 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~-------vK 525 (726)
.+++|||+++|+|..+++.. ...+++..+++++.|+++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence 89999999999999988642 235899999999999999999999998 999999999999987664 89
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccchhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL-TGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELl-tG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+.........
T Consensus 153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------- 219 (262)
T cd05077 153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------- 219 (262)
T ss_pred eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------
Confidence 9999998754322 2235788999999886 567899999999999999998 588887532211100
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+...... ........+.+|+.+||+.||++||++.+|++.+
T Consensus 220 ----------~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 ----------RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 0111234578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.98 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=199.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++|+||+++++++. +....++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEE
Confidence 357888899999999999999864 68899999987655444567889999999999999999999987 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999864 235889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.... .. .... .
T Consensus 159 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~----~~~~-----~ 225 (267)
T cd06645 159 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----MTKS-----N 225 (267)
T ss_pred ccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh----hhcc-----C
Confidence 221 123456899999999874 456889999999999999999999998643321110 00 0000 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+.... .......+.+++.+||+.+|++||++++|+++
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00011100 00112357899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=308.46 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++|+||+++++++. +....+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEE
Confidence 367899999999999999999964 57889999998665556678999999999999999999999886 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999998752 245889999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcccccccccccccccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+... ..... ...
T Consensus 154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~---------~~~ 220 (262)
T cd06613 154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLIS---------KSN 220 (262)
T ss_pred hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---------hcc
Confidence 221 12335688899999998776 889999999999999999999999964332111 11000 000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+....+ .........+.+++.+||+.+|.+|||+.+|+.+
T Consensus 221 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 221 FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111 1122234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.53 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
++|++.+.||+|+||.||+|+.. +++.|++|.+........+.+.+|++++++++|+||+++++++.. ....++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEEe
Confidence 56889999999999999999975 588999999976655556789999999999999999999998873 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887532 235899999999999999999999998 999999999999999999999999998754332
Q ss_pred CcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.. ......++..|+|||++. ...++.++|||||||++|||++|+.||...... .........
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~----- 230 (292)
T cd06644 164 LQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS----- 230 (292)
T ss_pred cc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcC-----
Confidence 21 123456888999999885 345688999999999999999999998643211 000001000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.. ..+......+.+++.+||+.+|++||+++|++++
T Consensus 231 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 --EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 1122233457899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.20 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=210.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+..+++|+|+||.+++.+.+ ++..+++|++...... ..+...+|+.++++++|||||.+.+.+... +...+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEE
Confidence 57888999999999999998854 5789999999765433 344678899999999999999999988732 2348999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|+|++||+|.+.|.+.. ...+.++.+++++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998644 346889999999999999999999888 9999999999999999999999999999887
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....+||+.||.||.+.+..|..|+|||||||++|||++-+++|...+ ....+..+.+ .
T Consensus 158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~------~-- 221 (426)
T KOG0589|consen 158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINR------G-- 221 (426)
T ss_pred Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhh------c--
Confidence 6542 3456889999999999999999999999999999999999999997543 1111111111 1
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.....+.....++..++..|++.+|+.||++.+++.+-
T Consensus 222 ---~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 222 ---LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ---cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 11233445556789999999999999999999999873
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.29 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=199.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-----CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+|+..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++. +....+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence 4677899999999999999976 789999999865432 23467899999999999999999999986 445889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+++||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 79 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 79 IFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 99999999999999964 235889999999999999999999998 99999999999999999999999999886
Q ss_pred CCCCCcccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..... ......|+..|++||.+.... ++.++|+||||+++|||++|+.||...... .....+ ...
T Consensus 152 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~~----- 217 (258)
T cd06632 152 VVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI----GRS----- 217 (258)
T ss_pred ccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH----Hhc-----
Confidence 54432 123456889999999988776 899999999999999999999999643211 111100 000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
......+......+.+++.+||+.+|++||++.+++++
T Consensus 218 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 -----KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00011222233457889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.66 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=198.2
Q ss_pred CcccceeeeecCcEEEEEEEECC--CcEEEEEEcccCCC----------CchhHHHHHHHHHHh-cccCceeEEEEEeec
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQ----------QGDKEFLVEVEMLSR-LHHRNLVKLVGYYSS 447 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~--g~~VAVK~l~~~~~----------~~~~~f~~Ei~iL~~-L~HpNIV~llg~~~~ 447 (726)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... ....++.+|+.++.+ ++|+||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999764 68899998863321 122457788888875 79999999999987
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEE
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
+....+++|||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++|+||+|+||++++++.+||
T Consensus 80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEE
Confidence 4458999999999999999885322223468899999999999999999996 55 999999999999999999999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
+|||++....... ......|+..|++||++.+..++.++||||||+++|||++|+.||..... .......
T Consensus 156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~- 225 (269)
T cd08528 156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKI- 225 (269)
T ss_pred ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHH-
Confidence 9999998755432 22345689999999999988899999999999999999999999864321 1111111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+..............+.+++.+||+.||++||++.||..+++
T Consensus 226 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 ---------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100001112345889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.06 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||+||++... +|+.||+|.+..... ...+.+.+|+++++.++|+||+++++++.. ....++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence 57888899999999999999964 688999998875432 335678999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+++|+|.+++.. ...+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999864 2358999999999999999999997 46 9999999999999999999999999987543
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-----chhhhhhhhhccchhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDKDR 611 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~-----~~l~~~~~~~~~~~~~ 611 (726)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..+........
T Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd06620 156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-- 229 (284)
T ss_pred hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence 221 1235689999999999888999999999999999999999999975432211 11112221111110
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+.+. ..+....+.+++.+||+.||++|||+.||+++...++
T Consensus 230 -----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 -----PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -----CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01110 1113345889999999999999999999998765544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.34 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=197.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC----------chhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ----------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~----------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
+|...+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|++++++++|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4677899999999999999854 6889999988642111 12357889999999999999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 45889999999999999999752 46889999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|+++...............|+..|+|||.+.... ++.++||||||+++||+++|..||..... ...+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~ 226 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFK-LGN 226 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHH-hhc
Confidence 9998654332222233456889999999987654 78999999999999999999999863221 111100 000
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ........ ....+....+.+++.+||+.+|++||++++|+++
T Consensus 227 ~--~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 K--RSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c--ccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 00000111 1111223468899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.01 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=200.7
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
.++....++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-- 113 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 113 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 344455689999999999999999999965 57899999986321 223456788999999999999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
+....++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 45589999999999999999864 24788888999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
||+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... ......
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~ 258 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSK 258 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 999987643321 122345799999999998753 378999999999999999999999974321 111111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 658 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~L~ 658 (726)
+......+ .-.........+.+++.+||+.++.+ |+++.|++++.+
T Consensus 259 i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 259 IMNHKNSL--------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHcCCCcc--------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11111100 00011123345788999999844433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.26 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=202.3
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||.++. .+++.+++|++.... ....+++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 588899999999999999884 468899999986542 3345678999999999999999999999874 45889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999999999997532 345899999999999999999999998 99999999999999999999999999986644
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .....+..
T Consensus 154 ~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~---------- 215 (256)
T cd08221 154 EYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ---------- 215 (256)
T ss_pred ccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc----------
Confidence 332 223456899999999998888999999999999999999999998643211 11111111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.... ..+......+.+++.+||+.+|++||++.|+++++
T Consensus 216 ~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1110 11122334588999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.33 Aligned_cols=246 Identities=30% Similarity=0.507 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEEC
Confidence 4688899999999999999976 57789999986432 34678999999999999999999999753 247999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999997532 235789999999999999999999988 9999999999999999999999999997653321
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.... ..
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~---------- 212 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKECV-EK---------- 212 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHHH-hC----------
Confidence 12234568999999998899999999999999999998 99998643211 111111 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
......+......+.+++.+||+.+|++||+++++++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0111112223356889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=312.29 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|+|++++++++. +....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEE
Confidence 47888999999999999999975 589999999864432 23456889999999999999999999987 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++++|..++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 79 FEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999999888753 235899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhhhhhhhcc-------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARPILR------- 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~~~------- 607 (726)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... +.........
T Consensus 152 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 152 GPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred CCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 43321 223457889999999876 567899999999999999999999997543221110 0000000000
Q ss_pred chhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..........+......+ ......+.+++.+||+.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000111100001 0113457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=309.46 Aligned_cols=237 Identities=25% Similarity=0.472 Sum_probs=188.1
Q ss_pred eeeeecCcEEEEEEEECCCc-----------EEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 386 SILGEGGFGRVFKGVLSDGT-----------AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence 46999999999999975432 5788877644333 6789999999999999999999999874 4679
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-------cEEEE
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-------HAKVA 527 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-------~vKL~ 527 (726)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999999997532 25889999999999999999999998 99999999999999887 79999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|||+++..... ....++..|+|||++... .++.++||||||+++|||++ |..||........ ..+..
T Consensus 151 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~- 220 (259)
T cd05037 151 DPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ- 220 (259)
T ss_pred CCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh-
Confidence 99999865431 223467789999998876 78999999999999999999 5777754321111 11100
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... ..+......+.+++.+||..+|.+|||+.||++.|
T Consensus 221 ------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ------------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 01111125688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.50 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=186.7
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHH-HHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence 46999999999999864 68999999986431 223345666665 467789999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999998864 345889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... ........ ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~----------~~~ 213 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH----------KPL 213 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc----------CCc
Confidence 223457999999999999999999999999999999999999999643211 11111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~E 652 (726)
.........+.+++.+|++.+|++||++.+
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 111123345788999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=320.14 Aligned_cols=269 Identities=24% Similarity=0.356 Sum_probs=209.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcc--cCCCCchhHHHHHHHHHHhcccCceeEEEEEeec---CCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---RDSS 451 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~--~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~---~~~~ 451 (726)
....|...+.||+|+||.|+.+.. .+|+.||||++. .......+.-.+|+++|+.++|+||+.+.+++.. .+-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678999999999999995 468999999997 4445556788999999999999999999998764 3456
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..|+|+|+| +-+|...++. +..|+......++.|+++||+|+|+.+ |+||||||+|+|++.+...||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 789999999 5699999975 344888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
|+...........+..+-|..|.|||++. ...|+...||||.|||+.||++|+.-|.+.+...+..++...-..- ..+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 99876543334457778899999999876 5689999999999999999999999997765444443332211111 011
Q ss_pred hhhhhcCC----------ccC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 RLEELADP----------RLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~----------~l~-----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+..+... ... ..++ .......+|+.+||..||.+|+|++|.+++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111100 000 0111 222357889999999999999999999987
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.94 Aligned_cols=238 Identities=24% Similarity=0.400 Sum_probs=185.4
Q ss_pred eeeecCcEEEEEEEECC-------------------------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEE
Q 004869 387 ILGEGGFGRVFKGVLSD-------------------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~l 441 (726)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998865444445678999999999999999999
Q ss_pred EEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
+++|.. ....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++++
T Consensus 82 ~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVR--GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEe--CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence 999874 45789999999999999998642 235889999999999999999999988 9999999999999764
Q ss_pred C-------cEEEEecCccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCC
Q 004869 522 F-------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELL-TGRKPVDMSQP 592 (726)
Q Consensus 522 ~-------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELl-tG~~Pf~~~~~ 592 (726)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3 4899999998644321 12357788999998875 56899999999999999995 69999864332
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... ..+ .... . ..+......+.+++.+||+.+|++|||+.+|++.|
T Consensus 228 ~~~---~~~----~~~~--------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEK---ERF----YEKK--------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---HHH----HHhc--------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 111 0000 0 01111123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.21 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=187.3
Q ss_pred eeeecCcEEEEEEEECCC---cEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCC
Q 004869 387 ILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
.||+|+||.||+|...++ ..+++|.+..... ...+.|.+|+++++.++||||++++++|. +....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCC
Confidence 599999999999985433 3466777664432 34568999999999999999999999987 44578999999999
Q ss_pred CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccc
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 542 (726)
|+|.++++........+.+..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999754332345677788899999999999999998 9999999999999999999999999986432221111
Q ss_pred ccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 543 LSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 543 ~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
......++..|+|||++.. ..++.++|||||||++|||++ |..||..... .......+.+ ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~--~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD--QQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh--cccc
Confidence 1234567889999998753 245789999999999999997 5667753221 1111111111 1112
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
+.++.+... ....+.+++..|| .+|++||+++||++.|
T Consensus 229 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 233333222 2345778999999 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.41 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=196.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|++|.||+|+.. ++..||+|++..... ...+.+.+|++++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEE
Confidence 5788899999999999999964 689999999865432 23467889999999999999999999987 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||++ ++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 9997 689888864222 346899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh-------ccch
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------LRDK 609 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~-------~~~~ 609 (726)
... ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+....... +...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 154 PVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred Ccc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcc
Confidence 221 12234578899999988654 57899999999999999999999997433211 000000000 0000
Q ss_pred ---hhhhhhcCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 ---DRLEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ---~~l~~i~d~~l~~---~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
............. ........++.+++.+||+.||++|||+.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000 0011123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=313.41 Aligned_cols=267 Identities=27% Similarity=0.390 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++|+||+++++++.. ....+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36889999999999999999975 57899999987432 2234678999999999999999999999874 4579999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++++.|..++.. ...+++.+++.++.|++.||.|||+.+ ++|+||+++||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 79 FEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999998877766643 234889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-hhhhhh-------cc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPI-------LR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~~~-------~~ 607 (726)
..... ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+..... .+.... +.
T Consensus 152 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 152 ARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 44321 22345688899999999888 8899999999999999999999998643221110000 000000 00
Q ss_pred chhhhh-----hhcCCc-cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLE-----ELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~-----~i~d~~-l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...... ...++. ....++.....++.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000000 0001222234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.70 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=199.6
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEE
Confidence 4667788999999999999864 57889999887443 233457899999999999999999999987 4457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999999999863 35889999999999999999999988 999999999999999999999999999766433
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.|+....+... ..+ ... ...+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~~------~~~~ 219 (277)
T cd06642 155 QI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IPK------NSPP 219 (277)
T ss_pred ch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hhc------CCCC
Confidence 21 12234688899999999988999999999999999999999999864322110 000 000 0011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. ........+.+++.+||+.+|++||++.||+++-.
T Consensus 220 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 220 T----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred C----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 1 12223345889999999999999999999998744
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.15 Aligned_cols=258 Identities=32% Similarity=0.481 Sum_probs=202.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCC----CC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~----~~ 451 (726)
.+++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999975 578899999875433 346799999999999 6999999999986433 34
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999998753323456899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
+........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.. ..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~ 231 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP 231 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh
Confidence 876543221 1233568899999998753 35678999999999999999999999643211 11111 00
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ..+.+ ..+......+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~-------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN-------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc-------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00011 1122234468899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.48 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++|+||+++++++. +....++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 47889999999999999999975 5899999998654322 2457889999999999999999999986 45589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++++|.++... ...++|.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 79 FEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999988754 234899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhhhhccchh----
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKD---- 610 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~---- 610 (726)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ..+..+.........
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 4332 2233568899999998875 4578899999999999999999999864332110 001111111000000
Q ss_pred ---hhhhhcCCccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 ---RLEELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ---~l~~i~d~~l~~~-----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+..... ........+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 011223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.91 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=198.9
Q ss_pred cccceeeeecCcEEEEEEEECC-----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 382 FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++++.+++|+||+++++++.. ....++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEE
Confidence 3567899999999999999753 388999999755443 46789999999999999999999999874 358999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++..
T Consensus 79 i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999997522 112899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ..+.... ... .
T Consensus 154 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~~-~---- 221 (258)
T smart00219 154 YDDDYY-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL---KKG-Y---- 221 (258)
T ss_pred cccccc-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hcC-C----
Confidence 654221 1112347889999999988889999999999999999998 7888764211 1111111 000 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
....+.....++.+++.+|++.+|++|||+.|+++.|
T Consensus 222 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011122344688999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.67 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=194.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHH-HHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~i-L~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+..|+.. ++.++|+||+++++++. +....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEE
Confidence 47899999999999999999965 689999999875432 234456667775 55668999999999987 44579999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|||++ |+|.+++.........+++..++.++.|++.||+|||++ + ++||||||+|||+++++.+||+|||+++..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99996 688888864333345689999999999999999999987 6 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
.... ..+...|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ...+.. ...
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~---- 222 (283)
T cd06617 155 VDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE---- 222 (283)
T ss_pred cccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh----
Confidence 4322 1233468889999998864 45688999999999999999999998632211 011100 000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
-..+.+. .......+.+++.+||+.+|++||++.+++++-
T Consensus 223 ---~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 223 ---EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred ---cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0001110 011234588999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.76 Aligned_cols=267 Identities=23% Similarity=0.302 Sum_probs=198.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC----C
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~ 450 (726)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+ .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999854 57899999997532 233467889999999999999999999875422 2
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 77777642 3788899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh---------hh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TW 601 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~ 601 (726)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ .+
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998654322 223457899999999999999999999999999999999999999754321110000 00
Q ss_pred hhh-------hccchh-----hhhhhcCCcc---CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 602 ARP-------ILRDKD-----RLEELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 602 ~~~-------~~~~~~-----~l~~i~d~~l---~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... ...+.. ..+.+..... ...........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000 000000 0000000000 0001111234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.18 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=203.1
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
++.++......|++.+.||+|+||.||+|.. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 5556666778999999999999999999996 467899999886433 2345788899999998 699999999997532
Q ss_pred ----CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 449 ----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 449 ----~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
.....+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 2457899999999999999996432 234788889999999999999999998 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.....
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 9999999876543221 123356899999999875 3467889999999999999999999996432111000
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ......+.. ........+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~-----------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 L-----------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h-----------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000000111 111223458899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.61 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=202.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.|.+|++++++++|+||+++++++. +....++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEe
Confidence 357889999999999999999974 68899999997655555678999999999999999999999987 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999999998642 235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
... ......++..|+|||++. ...++.++||||||+++|||++|+.||...... ..+.. ....
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~---- 223 (280)
T cd06611 156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK----ILKS---- 223 (280)
T ss_pred ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH----HhcC----
Confidence 221 123456899999999875 345678999999999999999999999643211 11111 1000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..+.+ ..+......+.+++.+||+.+|.+||++.+|+++-+
T Consensus 224 ---~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 224 ---EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred ---CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 00011 111222345789999999999999999999998733
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.38 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=201.0
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+++.+|++++++++|+||+++++++. +....++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence 588899999999999999985 468899999986432 233457899999999999999999999986 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 79 DYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999999986422 235788999999999999999999998 99999999999999999999999999986644
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......|+..|+|||++.+..++.++|||||||+++||++|+.||..... ..........
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~--------- 216 (256)
T cd08218 154 TVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG--------- 216 (256)
T ss_pred chh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC---------
Confidence 321 12234588899999999988899999999999999999999999864321 1111111110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ...+......+.+++.+||+.+|++||++.||+++
T Consensus 217 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 -SY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 11222334468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.96 Aligned_cols=239 Identities=23% Similarity=0.313 Sum_probs=185.8
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHH-HHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|.. +++.++|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence 46999999999999965 57889999986432 122334555544 567889999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+.+..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 79 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999974 234778888899999999999999999 99999999999999999999999999975432221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~----------~~ 213 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK----------PL 213 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhC----------Cc
Confidence 233457999999999999999999999999999999999999999643211 111111111 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EV 653 (726)
.........+.+++.+||+.||.+||++.+.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1112233457899999999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.56 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=209.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|.||.||+|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++||. +....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee--ccceeE
Confidence 468999999999999999999954 67889999986542 234568999999999999999999999997 556899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|++||..+|+|...|... ...++++.....+..|+|.||.|+|..+ |+||||||+|+|++.++..||+|||-+..
T Consensus 99 LilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999852 2456888999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.+.. .....+||..|++||...+..++...|+|++|++.||++.|..||+... ..... .+
T Consensus 174 ~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etY-------------kr 233 (281)
T KOG0580|consen 174 APSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETY-------------KR 233 (281)
T ss_pred cCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHH-------------HH
Confidence 5532 2356789999999999999999999999999999999999999997543 11111 11
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
+..-.+ .+|......+.++|.+|+..+|.+|.+..|++.+-+..
T Consensus 234 I~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 234 IRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 111111 22333344578999999999999999999999886543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.78 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=197.8
Q ss_pred HHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCC----
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---- 449 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---- 449 (726)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3567899999999999999999985 4678999999874322 23456788999999999999999998875322
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 24578999988 7899988753 35899999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+....-..
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTP 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 999865432 233468999999999876 578999999999999999999999996432111 111110000000
Q ss_pred -hhh--------hhhhcCCccCCCCCh--------hhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 -KDR--------LEELADPRLGGKYPK--------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 -~~~--------l~~i~d~~l~~~~~~--------e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... ...... .+. ..+. .....+.+++.+||+.||++|||+.|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000 000000 000 0010 11224678999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.19 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=202.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..|+..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence 35777889999999999999965 58899999987543 2334678999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 82 EYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999999863 34788999999999999999999998 99999999999999999999999999976644
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......++..|+|||++.+..++.++|||||||++|||++|..||....+.... . ...
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-----------~~~ 214 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F-----------LIP 214 (277)
T ss_pred Ccc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h-----------hhh
Confidence 321 123346888999999999888999999999999999999999998643221100 0 000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..............+.+++.+||+.+|++||++.+++++-..
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 011112233445568899999999999999999999988543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.13 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=198.9
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+. +....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence 588899999999999999986 468899999987543 233567899999999999999999999876 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFGla~~~~ 536 (726)
||+++++|.+++.... ...+++..+++++.|+++||+|||+.+ ++|+||||+||+++++ +.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 79 EYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred ecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 9999999999997522 335889999999999999999999998 9999999999999854 568999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-------- 216 (256)
T cd08220 154 SKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-------- 216 (256)
T ss_pred CCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc--------
Confidence 4321 22356889999999999888999999999999999999999998643211 111111100
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ....+......+.+++.+||+.+|++|||+.|++++
T Consensus 217 --~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 --T-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --C-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 011122233458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.95 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=211.3
Q ss_pred cceeeeecCcEEEEEEEE-CCC----cEEEEEEcccC-CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 384 PASILGEGGFGRVFKGVL-SDG----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l-~~g----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..++||+|+||+||+|.| ..| -+||+|.+... ..+..++++.|+-+|.+++|||+++|+|+|... .+.||+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvt 776 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVT 776 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHH
Confidence 458899999999999996 333 46899988654 334467899999999999999999999999743 488999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
+||+.|+|.||++.++ ..+.-...+.|..|||+||.|||++. ++||||..+|||+.+-..+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998643 35777899999999999999999998 99999999999999999999999999999887
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
....+......-.+.|||=|.+....|+.++|||||||.+||++| |..|++.....+ +..+++.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR----- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER----- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc-----
Confidence 766665566667789999999999999999999999999999999 999997543222 2223333322
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
-..|+-+...++.++.+||..|++.||+++++...+....+
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 24566667779999999999999999999999988776543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.63 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=197.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++. +....++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEE
Confidence 57899999999999999999865 578999999875432 23456788999999999999999999987 445799999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 84 EYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred eccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9997 5899888642 235788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc---------
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR--------- 607 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~--------- 607 (726)
... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......+.
T Consensus 157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchh
Confidence 221 1223457889999998865 4578899999999999999999999975432111 110000000
Q ss_pred --chhhhhhhcCCccCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 --DKDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 --~~~~l~~i~d~~l~~~----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..........+..... ........+.+++.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000000000100000 0112233578999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.42 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=205.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|++|.||+|+.. +++.|+||++..... ...+.+.+|++++.+++|+|++++++++.. ....+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence 47889999999999999999976 489999999876544 345789999999999999999999999874 46899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999742 468999999999999999999999 88 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..........+..+..
T Consensus 152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 43321 234568899999999999999999999999999999999999997544211111111111
Q ss_pred CCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e-~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... ...+.. ....+.+++.+||+.+|++||++.|++++
T Consensus 217 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 111122 33568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.06 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=200.1
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++. +....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 478889999999999999985 57899999998643211 2357899999999999999999999987 45588
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCcc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLA 532 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla 532 (726)
++|+||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++
T Consensus 79 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 999999999999999964 235889999999999999999999998 99999999999998765 6999999998
Q ss_pred ccCCCCCc--ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 533 KQAPEGRT--NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 533 ~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
........ ........|+..|+|||.+.+..++.++||||+|+++|||++|+.||.......... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~------- 221 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIF------- 221 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHH-------
Confidence 76654311 111223568899999999988889999999999999999999999996433211111 100
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...........+......+.+++.+||+.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 ---KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000011122333344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.60 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=199.7
Q ss_pred CcccceeeeecCcEEEEEEEEC---CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999998633 33346788899999999999999999999866557899
Q ss_pred EEEeecCCCChhhhccCCCCC-cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC----CCcEEEEec
Q 004869 455 LCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADF 529 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~-~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~----~~~vKL~DF 529 (726)
+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766432222 236888999999999999999999998 999999999999999 999999999
Q ss_pred CccccCCCCCc-ccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-------hhhh
Q 004869 530 GLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-------NLVT 600 (726)
Q Consensus 530 Gla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-------~l~~ 600 (726)
|+++....... ........++..|+|||++.+. .++.++|||||||+++||++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 1122345678999999988764 5789999999999999999999999754432200 0110
Q ss_pred hhhhhcc----------chhhhhhhcCCccCCCCC---------h--hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILR----------DKDRLEELADPRLGGKYP---------K--EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~----------~~~~l~~i~d~~l~~~~~---------~--e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+-. .........+......++ . ....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 000000000000001111 0 223458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.88 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEE
Confidence 47889999999999999999975 4899999999754332 3456889999999999999999999986 4458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+.+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 79 VMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999999987422 346899999999999999999999998 999999999999999999999999998755
Q ss_pred CCCCcc---------------------------cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 004869 536 PEGRTN---------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 536 ~~~~~~---------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
...... .......||..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 322110 01123468899999999998889999999999999999999999996
Q ss_pred CCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 004869 589 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT----MGEVVQS 656 (726)
Q Consensus 589 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT----m~EVl~~ 656 (726)
..... .. +..+.+..............+.+++.+||+.||++||+ ++|++++
T Consensus 234 ~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 234 GSNRD--ET--------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCchH--HH--------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 43311 11 11111111111111113456899999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.16 Aligned_cols=239 Identities=23% Similarity=0.429 Sum_probs=187.6
Q ss_pred eeeeecCcEEEEEEEECC--------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+.||+|+||.||+|.... ...||+|.+........+.|.+|+.+++.++|+|++++++++.. ....++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEE
Confidence 469999999999998642 23488888865544455688999999999999999999999874 34789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc--------EEEEec
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--------AKVADF 529 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~--------vKL~DF 529 (726)
||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +|++||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999997532 25889999999999999999999998 999999999999987765 699999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCccchhhhhhhhhcc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~-~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+........ .. ...
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~ 219 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYE 219 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHH
Confidence 998654322 23457889999999986 45799999999999999999985 55543221110 00 000
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. ....+.....++.+++.+||+.||++|||++++++.|
T Consensus 220 ----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 ----------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0112223335688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=323.04 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=185.5
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhc---ccCceeEEEEEeecCCCCceEEEEeec
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
||+|+||+||+|+.. +|+.||||++..... .....+..|..++.+. +||||+++++++. +....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 799999999999964 589999999864321 1223456677777665 6999999999887 445899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 79 SGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999999864 345889999999999999999999998 99999999999999999999999999875433221
Q ss_pred ccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
......||..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~--------~~ 215 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGK--------VR 215 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCC--------CC
Confidence 22345799999999998754 479999999999999999999999964321 11111111100 01
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQS 656 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RP----Tm~EVl~~ 656 (726)
+.. ......+.+++.+||+.||++|| ++.|++++
T Consensus 216 ~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 100 11233578899999999999998 57777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=303.51 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=199.4
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|...+.||+|+||.||+|... +++.|++|.+...... ..+.+.+|++++++++|+||+++++++. +....++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 4788899999999999999964 6889999998765443 4567899999999999999999999876 455889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+++||++++++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 79 EYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred ecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999975 234788999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccc--cccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 538 GRTNYL--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 538 ~~~~~~--~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...... .....++..|+|||++.+.. .+.++||||||+++||+++|+.||....... . .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~---~~~~~~~----- 221 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--Q---IMFHVGA----- 221 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--H---HHHHHhc-----
Confidence 332111 11346788999999998766 8899999999999999999999996432110 0 0000000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+.+.. .......+.+++.+||+.+|++||++.|++.+
T Consensus 222 --~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 222 --GHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00111100 11113457899999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.69 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||++... +|..||+|.+.... ......+.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEE
Confidence 46888999999999999999975 68999999887542 2224578999999999999999999998874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+++++|..+++... ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred eecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999987531 123689999999999999999999974 6 9999999999999999999999999997654
Q ss_pred CCCcccccccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ....
T Consensus 155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~---------- 217 (286)
T cd06622 155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFA---------- 217 (286)
T ss_pred CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHH----------
Confidence 322 2234588899999988544 3588999999999999999999999643211 1110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+..+.+.. ....+.+....+.+++.+||+.+|++||++++++++-+
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 218 QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111111111 11223334456889999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=349.22 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.++||+|+||.||+|+.. +|+.||+|++...... ..+.|.+|++++++++||||+++++++. +....++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEE
Confidence 57999999999999999999964 5899999999754222 2357999999999999999999999987 4458899
Q ss_pred EEeecCCCChhhhccCCC-------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 456 CYELVPNGSLESWLHGPL-------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~-------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
+|||+++|+|.+++.... .....+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEe
Confidence 999999999999986311 11234677888999999999999999998 99999999999999999999999
Q ss_pred cCccccCCCCCc----------------ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 004869 529 FGLAKQAPEGRT----------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592 (726)
Q Consensus 529 FGla~~~~~~~~----------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~ 592 (726)
||+++....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999986621110 0011235699999999999999999999999999999999999999964321
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 662 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-Tm~EVl~~L~~i~~ 662 (726)
.. . .+. . .+.++.... ...+....+.+++.+|++.||++|| +++++++.|+...+
T Consensus 237 ~k---i-~~~-~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RK---I-SYR-D---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh---h-hhh-h---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 0 000 0 000100000 0012233578899999999999995 67777777777654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=298.70 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=205.4
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999875543 3456789999999999999999999998754336889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999752 26899999999999999999999988 99999999999999999999999999987765
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
...........++..|++||.+.+...+.++||||||+++++|++|+.||..... ...... .+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~----------~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY----------KIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH----------hccc
Confidence 4321112345688999999999888899999999999999999999999975431 111111 1111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+......+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112233334568999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.39 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=203.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+|++++++.+. +....++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEE
Confidence 47899999999999999999954 678999999865432 24567999999999999999999999886 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.++++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999974221 235899999999999999999999998 99999999999999999999999999976654
Q ss_pred CCccc--ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 538 GRTNY--LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 538 ~~~~~--~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... ......|+..|+|||++... .++.++|+|||||++|||++|+.||...... ..+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~----~~------ 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTL----QN------ 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHh----cC------
Confidence 33221 22334689999999998877 7899999999999999999999999644321 1111111 10
Q ss_pred hcCCccCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKY-PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~-~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.+.... .......+.+++.+||+.||++||++.||+++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001111110 01223457899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.35 Aligned_cols=266 Identities=17% Similarity=0.218 Sum_probs=192.9
Q ss_pred cceeeeec--CcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 384 PASILGEG--GFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 384 ~~~~LG~G--~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+.++||+| +||+||+++. .+|+.||+|++...... ..+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 46789999 7899999986 46899999999754322 23467789999999999999999999874 458899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+......
T Consensus 80 ~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 80 FMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred ccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 999999999996422 234889999999999999999999998 999999999999999999999999875443221
Q ss_pred Ccc-----cccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc---c
Q 004869 539 RTN-----YLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---D 608 (726)
Q Consensus 539 ~~~-----~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~---~ 608 (726)
... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 232 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccc
Confidence 110 01122356788999999876 468999999999999999999999996432111 00000000000 0
Q ss_pred -hh-hhhhh--------cCCc-----------------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 -KD-RLEEL--------ADPR-----------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 -~~-~l~~i--------~d~~-----------------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ..+++ .+.. ............+.+++.+||+.||++|||++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00 00000 0000 000111122346889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.43 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=209.3
Q ss_pred cccceeeeecCcEEEEEEEEC--CC--cEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~--~g--~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..+.++||+|.||.|++|.|. +| ..||||.++.+... ...+|++|+.+|-+|+|+|+++|+|+... ....||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHH
Confidence 445688999999999999985 34 46899999876554 56789999999999999999999999863 468899
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+|.++.|+|.+.|++ .....|-......++.|||.|+.||..++ +|||||..+|+||-..-.+||+||||.+.+.
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999986 33456888899999999999999999999 9999999999999999999999999999988
Q ss_pred CCCcccccc-cccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 537 EGRTNYLST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 537 ~~~~~~~~~-~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.....|.+. ...-.+.|+|||.+....++.++|||+|||+||||+| |..||-.... ..+-+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~ 326 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILK 326 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHH
Confidence 776655443 3345778999999999999999999999999999998 7788754321 11222
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+|..-.-.-++.+.+.+++++..||..+|++|||+..|++.+
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2233323345677788899999999999999999999998654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.34 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=199.6
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5788999999999999999964 689999999875542 234679999999999999999999999874 55889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+ +++|.+++... ...+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 79 EYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred ccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999 99999998642 245899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-------
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------- 609 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 609 (726)
... .......|+..|+|||++.+. .++.++||||+|+++|||++|+.+|....... ...+....+...
T Consensus 152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 152 EEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhh
Confidence 321 112345689999999988754 46899999999999999999987775432211 111110000000
Q ss_pred ----hhhhhhcCCccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 ----DRLEELADPRLG----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ----~~l~~i~d~~l~----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+..+... .....+....+.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 00001223578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.83 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=195.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++. +....++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEE
Confidence 67899999999999999999965 6889999998754322 2345788999999999999999999987 445899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++ +|.+++.... ..+++...+.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 83 EYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred ecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 99974 9999886432 35889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc--hhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KDRLEE 614 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~l~~ 614 (726)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .+ ......+.. ......
T Consensus 156 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QL-HKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HH-HHHHHhcCCCChhhhhh
Confidence 2111 122346889999998875 4578999999999999999999999964431110 00 000000000 000000
Q ss_pred h------c--------CCccCCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 L------A--------DPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i------~--------d~~l~~~~~-~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. . ...+....+ ......+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0 000000000 0112457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.95 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=201.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+||+++++++.. ....++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 46788899999999999999975 588999999876532 334678999999999999999999999874 46899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999999997522 468889999999999999999999 77 9999999999999999999999999987653
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------- 217 (265)
T cd06605 153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV---------- 217 (265)
T ss_pred HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh----------
Confidence 3221 12568889999999999899999999999999999999999996432111 11111111111
Q ss_pred CCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e-~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... ...+.. ....+.+++.+||..||++|||+.|++.+
T Consensus 218 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1110 011111 33458899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.86 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=194.9
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++|+||+++++++. +....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence 4788899999999999999965 688999999875422 22356788999999999999999999986 455899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 79 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 79 EYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 9997 5888887632 235899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc--hh---h
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KD---R 611 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~---~ 611 (726)
.... .....++..|+|||++.+. .++.++|||||||++|||++|..|+...... ...+. ........ .. .
T Consensus 152 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 152 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLK-RIFRLLGTPTEESWPG 227 (284)
T ss_pred CCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHH-HHHHHhCCCChHHhHH
Confidence 3221 1234578899999988765 4689999999999999999999986432211 11110 00000000 00 0
Q ss_pred hhhhcCCccCC---------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPRLGG---------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~---------~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+....+..... .........+.+++.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000100000 0111223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=296.17 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=202.4
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++.. ....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEec
Confidence 4778899999999999999975 688999999986655456789999999999999999999999874 3578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999999987521 46899999999999999999999988 9999999999999999999999999998765543
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. .....++..|++||++....++.++||||||+++++|++|+.||....... .+.. ... ... +.
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~--~~~-----~~ 216 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFK----IAT--NGP-----PG 216 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHH----HHh--cCC-----CC
Confidence 2 234568899999999988889999999999999999999999986432111 0000 000 000 00
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ........+.+++.+||+.||++|||+.|++++
T Consensus 217 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011113458899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=352.20 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=201.6
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
...++|++.+.||+|+||+||++... ++..||+|.+..... .....|..|+.++++++|||||+++++|.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999964 577899998875432 234578999999999999999999998876556678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCC----CceeecCCCccceeecC---------
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ----PCVIHRDFKASNILLEN--------- 520 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~----p~IvHrDIKp~NILLd~--------- 520 (726)
+|||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+. ..|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997533333568999999999999999999998542 23999999999999964
Q ss_pred --------CCcEEEEecCccccCCCCCcccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 521 --------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 521 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999998664322 2234579999999999864 45889999999999999999999999643
Q ss_pred CCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 591 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 591 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ....... +... +.+. .......+.+||..||+.+|.+||++.|++++
T Consensus 247 ~~-----~~qli~~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN-----FSQLISE-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc-----HHHHHHH-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 1111111 1100 0110 01123458899999999999999999999865
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.55 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=198.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++++. .....++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeC
Confidence 3444567999999999999864 58899999987655555667899999999999999999999887 44588999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 101 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 101 LEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999998853 34889999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ... .+.....+.
T Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~----------~~~~~~~~~ 237 (292)
T cd06658 173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR----------RIRDNLPPR 237 (292)
T ss_pred c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------HHHhcCCCc
Confidence 1 1233568999999999988889999999999999999999999986432111 000 011111111
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .......+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111 11122357789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.44 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=198.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
-|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEE
Confidence 3667889999999999999864 678999998864332 23457889999999999999999999987 4458899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 83 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999999863 35889999999999999999999998 999999999999999999999999998766433
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......++..|+|||++.+..++.++|+|||||++|||++|..||...... .+..... .. ..+
T Consensus 155 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~------~~~ 219 (277)
T cd06641 155 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIP-KN------NPP 219 (277)
T ss_pred hh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHh-cC------CCC
Confidence 21 122346888999999999888999999999999999999999998642211 0110000 00 001
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. .+......+.+++.+||+.+|++||++.+++++-
T Consensus 220 ~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 220 T----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred C----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1 1222334578999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.58 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=195.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+. +....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEE
Confidence 47889999999999999999965 578999999875432 23456889999999999999999999887 4458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 79 VMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999964 235889999999999999999999998 999999999999999999999999998742
Q ss_pred CCCC-------------cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 536 PEGR-------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 536 ~~~~-------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
.... .........++..|+|||++.+..++.++|+|||||++|||++|..||...... .+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~ 225 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF 225 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 1110 001112345788999999998888999999999999999999999999643211 111
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... .....+.... .....+.+++.+||+.||++||++.++.+.
T Consensus 226 ~~~~~-----~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 226 GQVIS-----DDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred HHHHh-----cccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 11110 0011111111 123357899999999999999995444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.52 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=202.6
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
++|++.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+|++++++++.. ....++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEEe
Confidence 5788899999999999999985 4678999999875555556788999999999999999999999874 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999864 24788999999999999999999998 999999999999999999999999998765433
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......|+..|++||++.+..++.++||||||+++||+++|+.||......... .. .... .
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~----~~~~---------~ 231 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----IATN---------G 231 (293)
T ss_pred cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--ee----hhcC---------C
Confidence 22 123346889999999998888999999999999999999999999754322110 00 0000 0
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
......+......+.+++.+||+.+|++||++++++.+-
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000011122234578899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.36 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=200.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++.+++|+||+++++++...+....++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999975 5889999999754322 23457889999999999999999999876555789999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 59999886422 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhh---------hhh--
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVT---------WAR-- 603 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~---------~~~-- 603 (726)
..... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......... .+.. |..
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 43221 2234578899999988754 4689999999999999999999999754321110 0000 000
Q ss_pred hhccch-hhhhhhcCCccCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDK-DRLEELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~-~~l~~i~d~~l~~~~~~e-~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.... ..........+...++.. ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 000000111111122222 24457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.27 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-----CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999996 468999999875321 1223578899999999999999999999876555678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+++++|.+++.. ...+++...++++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999864 234788999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc-ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... ........++..|+|||++.+..++.++|+|||||++|||++|+.||...... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~--------------~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA--------------I 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH--------------H
Confidence 6533111 11122356899999999999888999999999999999999999999643211 00 1
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
............+......+.+++.+||+ ++.+||+..+++.+
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111111122344444568899999999 47999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=304.36 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=198.5
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcc---cCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~~~~~L 455 (726)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++ |+|++++++++. +....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEE
Confidence 577889999999999999996 468999999987543 233467889999999997 999999999986 4457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999999864 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||........ ..+ . . .
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~---~-~------~ 216 (277)
T cd06917 152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MML---I-P------K 216 (277)
T ss_pred CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhc---c-c------c
Confidence 54332 12334688999999988754 568999999999999999999999964322110 000 0 0 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
...+.+... .....+.+++.+||+.||++||++.|++++-
T Consensus 217 ~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 217 SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 001111111 1234588999999999999999999998763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.64 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEE
Confidence 47889999999999999999965 58999999986432 223456889999999999999999999987 4458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999975 246889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... .....|+..|+|||.+.+...+.++||||||+++|||++|+.||..... ... ...+
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~-------------~~~~ 210 (290)
T cd05580 152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQI-------------YEKI 210 (290)
T ss_pred CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHH-------------HHHH
Confidence 543 2234688999999999888889999999999999999999999964331 000 0011
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.... ...+......+.+++.+||+.||.+|+ +++|++++
T Consensus 211 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 211 LEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred hcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 112222345688999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.52 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=199.4
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|+||+++++++.. ....++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecC
Confidence 334457999999999999864 688999999976555556778999999999999999999998874 45889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999998753 34889999999999999999999998 99999999999999999999999999876543321
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ......
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~----~~------~~~~~~ 237 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRL----RD------SPPPKL 237 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hc------cCCCCc
Confidence 1233568999999999998889999999999999999999999996433211 11100 00 000000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.........+.+++.+||+.+|++||+++|++++-..
T Consensus 238 --~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 238 --KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred --cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 0111123357889999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.79 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=197.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-----chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+|+..+.||+|+||.||+|... +|+.||||++...... ....+..|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 4778899999999999999964 6899999999755432 23457789999999999999999999874 45889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+ +|+|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 999999 999999997522 36899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc------
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR------ 607 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~------ 607 (726)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|..+|....... .+.......-.
T Consensus 152 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 152 FGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENW 227 (298)
T ss_pred ccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhh
Confidence 6543221 223456888999998864 467899999999999999999987776433211 11110000000
Q ss_pred -chhhhhhhcCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 -DKDRLEELADPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 -~~~~l~~i~d~~l~~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+............ .......+.+++.+||+.||++|||+.||+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000011 11223568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.33 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=200.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCc-eeEEEEEeecCC----C
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRD----S 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpN-IV~llg~~~~~~----~ 450 (726)
...|+..++||+|+||+||+|+. .+|+.||+|++.....+ -.....+|+-+|++++|+| ||.|.+++...+ .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999994 57899999999865442 2356789999999999999 999999987533 2
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
..++||+||++. +|.+++.........++-..+..++.|+++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 378899999954 999999754322234666889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+|+...-.... .+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.......+ +...++ .+...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~-~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFR-LLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHH-HcCCC
Confidence 99966533322 3556799999999999877 789999999999999999999988865433211 111000 00000
Q ss_pred -----hhhhhhcCCc--cCCCC-Ch-------hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 -----DRLEELADPR--LGGKY-PK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 -----~~l~~i~d~~--l~~~~-~~-------e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+.+-. ..... +. .......+++.+||+.+|.+|.|++.++.|
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000000000 00000 00 111356789999999999999999999876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.23 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=201.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC--CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~ 453 (726)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +|+||+++++++...+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999965 5889999988643 223345678899999999 99999999999876556678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||++ ++|.+++.. ..++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599998864 15789999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc---cccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-
Q 004869 534 QAPEGRTN---YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD- 608 (726)
Q Consensus 534 ~~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~- 608 (726)
........ .......||..|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66443221 12234568999999998765 56789999999999999999999999644322111000000000000
Q ss_pred ------hhhhhhhcC----CccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 ------KDRLEELAD----PRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ------~~~l~~i~d----~~l~--~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
......+.+ .... ..........+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000110 0000 00001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.15 Aligned_cols=245 Identities=30% Similarity=0.422 Sum_probs=199.7
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCch---hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|..++.||.|+||.||.|+. .+.+.||||++.....+.. ++++.|++.|.+++|||++.+.|+|.. ....|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 366778899999999999995 4678999999986655543 578899999999999999999999873 4478999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||| -|+-.|+|.-. .+++.+-++..|+.+.+.||+|||+++ .||||||+.||||.+.|.|||+|||.|....
T Consensus 105 MEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9999 55777777422 346888899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.. ..++||+.|||||++. .++|+-|+||||||++..||.-.++|+.... -..-...+.++.
T Consensus 178 PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNe---- 241 (948)
T KOG0577|consen 178 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE---- 241 (948)
T ss_pred ch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcC----
Confidence 43 3578999999999874 6899999999999999999999999975322 111122222221
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.|.+. ..+....++.++..||+.-|.+|||.++++.+
T Consensus 242 ---sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 ---SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22222 34556678999999999999999999988765
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.60 Aligned_cols=268 Identities=20% Similarity=0.281 Sum_probs=195.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++++|.+.+.||+|+||.||+|... +|+.||+|++...... ....+.+|++++++++|+||+++.+++. +....++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEE
Confidence 3578999999999999999999864 6889999998754332 2346789999999999999999999987 4457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|+||+. ++|.+++... ...+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 81 v~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 999995 6777776532 234778889999999999999999998 999999999999999999999999999765
Q ss_pred CCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh----------h
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR----------P 604 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----------~ 604 (726)
...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||+............|.. .
T Consensus 154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 432211 2234578999999998754 57889999999999999999999997543211110000000 0
Q ss_pred hccchhhhhhhcCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.................... .......+.+++.+|++.||++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000000 00112457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=306.19 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=195.6
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 5888999999999999999864 688999999875432 22357889999999999999999999986 455889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 79 EFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred eccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9995 68999886422 345899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-------
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------- 609 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 609 (726)
.... .....++..|+|||++.+.. ++.++||||||+++|||+||+.||...... ..+.......-...
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 153 PVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred Cccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhh
Confidence 3221 22345788999999887644 588999999999999999999999643211 11111110000000
Q ss_pred hhh---hhhcCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRL---EELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l---~~i~d~~l~~---~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+ .......... .........+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000000 0001112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=299.79 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=199.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 5788999999999999999965 57889999986542 233457889999999999999999999886 445889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 536 (726)
||+++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 79 EYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999997532 235799999999999999999999998 99999999999998875 56999999998665
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ...+......
T Consensus 154 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~--------- 216 (257)
T cd08225 154 DSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ--------- 216 (257)
T ss_pred CCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc---------
Confidence 4321 1223458899999999988889999999999999999999999986432 1111111111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... .........+.+++.+||+.+|++|||+.||+++
T Consensus 217 -~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 -GYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -ccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1110 1111223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.54 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=204.4
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|++++++++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5788899999999999999965 588999999976543 345678999999999999999999998874 46889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.........+++..++.++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999999754323457899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .......|+..|+|||...+..++.++||||+|+++|+|++|+.||+..... ........
T Consensus 156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------- 217 (258)
T cd08215 156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK---------- 217 (258)
T ss_pred Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc----------
Confidence 32 1223456889999999999888999999999999999999999998643211 11111111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ....+......+.+++.+||..+|++|||+.|++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 111222334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=319.75 Aligned_cols=254 Identities=27% Similarity=0.309 Sum_probs=208.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~ 452 (726)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+..... .+...+|+++|+++. |||||.+.+.|+. ...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 3567888899999999999999966 49999999997654433 358899999999998 9999999999984 448
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC----CCcEEEEe
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVAD 528 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~----~~~vKL~D 528 (726)
+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+.. ++.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999753 3899999999999999999999999 999999999999954 35799999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
||++...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+...
T Consensus 183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred CCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 9999987662 24567899999999999999999999999999999999999999997654222111 11111
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ......-......+.+++..|+..||.+|+|+.++++|-|
T Consensus 254 ~~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DF--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CC--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 10 1111111222456788999999999999999999999744
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.09 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=194.5
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+|++++++++...+....++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999954 688999999875422 22334567999999985 999999999988654468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|++ |+|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 5888888642 235899999999999999999999998 999999999999999 99999999999876433
Q ss_pred CcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-hhhhhhc
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRLEELA 616 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l~~i~ 616 (726)
.. .....++..|+|||++.. +.++.++|||||||++|||++|..||......+ .+.+........ .......
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 22 123457889999997654 567899999999999999999999996543211 111111111000 0000000
Q ss_pred ---------CCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 ---------DPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 ---------d~~l~~----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.... .........+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0011234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.37 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=202.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 5788999999999999999854 67899999987543 2334578899999999999999999998763 46899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999998653333356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .....++..|++||.+.+..++.++|+||||+++|||++|+.||...... .+... . .
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~---~-----------~ 214 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYK---V-----------Q 214 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---H-----------h
Confidence 41 12345888999999999989999999999999999999999999643311 11100 0 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+......+.+++.+||+.+|++||++.|++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011111222344568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.55 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=207.2
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhc-ccCceeEEEEE
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRL-HHRNLVKLVGY 444 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L-~HpNIV~llg~ 444 (726)
-+..-++|+..+.||+|..+.|-++..+ +|.++|+|++....... .++-..|+.+|+++ .||||+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445567888999999999999988754 68899999986543211 13456799999998 59999999999
Q ss_pred eecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 445 ~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
|+ .+..+++|+|.|+.|.|.|+|.. .-.++++...+|+.|+..|++|||..+ |+||||||+|||+|++.++
T Consensus 92 ye--s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 92 YE--SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI 162 (411)
T ss_pred cc--CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence 87 44588999999999999999975 446899999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 598 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l 598 (726)
||+|||++.....+.. -...+||++|+|||.+.. ..|+...|+|++|||+|-|+.|..||.... ++
T Consensus 163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qm 234 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QM 234 (411)
T ss_pred EEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HH
Confidence 9999999998877653 356789999999998853 357889999999999999999999996421 11
Q ss_pred hhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 599 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 599 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
. ..+.+.+.+. ++-.+.. .+....+.+||.+||+.||.+|.|++|+++|-..++-.
T Consensus 235 l-MLR~ImeGky---qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 235 L-MLRMIMEGKY---QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred H-HHHHHHhccc---ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 1 1111111110 0001100 12234578999999999999999999999997665443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.44 Aligned_cols=249 Identities=29% Similarity=0.386 Sum_probs=195.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+.|+..+.||+|+||.||+|... +|+.||+|.+...... ..+++.+|++++++++|+||+++.++|.. ....++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 56888899999999999999964 6899999998644322 23568899999999999999999999874 457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|+||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999996 5777776532 235899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||....... .........
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~~--- 230 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND--- 230 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcCC---
Confidence 432 2345788999999874 4568899999999999999999999986432111 000000000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.+.+ ........+.+++.+||+.+|++||++.+|+.+.+.
T Consensus 231 ----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 231 ----SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ----CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0011 112234468999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.27 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=197.9
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|++.+.||+|+||.||+|+.. +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++...+....++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999965 58899999998653 233457889999999999999999999987543468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 899888642 246899999999999999999999998 999999999999999999999999999876544
Q ss_pred CcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhh----ccchhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPI----LRDKDRL 612 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~----~~~~~~l 612 (726)
... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||+........ .+....... +.....+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1233457888999997764 46789999999999999999999999754321110 000000000 0000000
Q ss_pred ---h-----hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 ---E-----ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ---~-----~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ......+...+.......+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0000000000011124468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.98 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=203.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.+++|+..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+|++++++++.. ....+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEE
Confidence 4567888899999999999999976 688999999975544 46678999999999999999999999874 3589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999997532 36899999999999999999999988 9999999999999999999999999987554
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ......++..|++||++.+..++.++|||||||++|||++|+.||....+.. .... .... ..
T Consensus 168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~----~~~~--~~---- 233 (286)
T cd06614 168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL----ITTK--GI---- 233 (286)
T ss_pred cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhc--CC----
Confidence 3221 1223457889999999988889999999999999999999999986432110 0000 0000 00
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.. .........+.+++.+||+.+|.+||++.+|+++..
T Consensus 234 -~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 234 -PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred -CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 000 011112345889999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.52 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=195.1
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence 699999999999975 488999999865332 23467899999999999999999999886 455889999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++...... .
T Consensus 79 ~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~ 148 (262)
T cd05572 79 ELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K 148 (262)
T ss_pred cHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence 999999752 34889999999999999999999988 9999999999999999999999999998765432 1
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....++..|++||.+....++.++|+||||+++|||++|..||...... ...... .+.+......
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----------~~~~~~~~~~ 214 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYN----------DILKGNGKLE 214 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHH----------HHhccCCCCC
Confidence 22346888999999998888999999999999999999999999754321 111111 1111111122
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
++......+.+++.+||+.+|++||+ ++|++++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 33333456899999999999999999 7777664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.61 Aligned_cols=272 Identities=25% Similarity=0.314 Sum_probs=200.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|... +|+.||+|.+....... ...+.+|++++++++|+||+++++++...+....++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 58999999987543222 335678999999999999999999987555567899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+. ++|.+++... ...+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 4888888642 246899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhhhh-------hhhc
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWA-------RPIL 606 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~-------~~~~ 606 (726)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +..+. +...
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543211 223346788999998875 457899999999999999999999997543221110 00000 0000
Q ss_pred cchhhhhhhcCC--ccCC--CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 607 RDKDRLEELADP--RLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 607 ~~~~~l~~i~d~--~l~~--~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...........+ .... .........+.+++.+||+.||++|||++|++++-+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000000000000 0000 0000113456789999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.96 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=197.5
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+|+..+.||+|++|.||+|+.. +|+.||||.+...... ..+.+.+|++++++++|+||+++++++.. ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence 5888999999999999999975 6889999999765433 34567889999999999999999999874 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++ +|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9985 8988886432 2346899999999999999999999998 999999999999999999999999999765432
Q ss_pred CcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhhhhhhhccchhhhhhhc
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARPILRDKDRLEELA 616 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~l~~i~ 616 (726)
.. ......++..|++||++.+. .++.++|||||||++|||++|+.||.......... +....... .....+.+.
T Consensus 154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (284)
T cd07836 154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP--TESTWPGIS 229 (284)
T ss_pred cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC--ChhhHHHHh
Confidence 21 11234578899999988654 56899999999999999999999997543221100 00000000 000000000
Q ss_pred C-CccCCCC-----------ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 D-PRLGGKY-----------PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d-~~l~~~~-----------~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+ +...... .......+.+++.+|++.||.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000000 01123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.46 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=198.8
Q ss_pred cccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 382 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.++++++|+||+++++++. .....++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEecc
Confidence 44457999999999999985 468899999987555555667899999999999999999999887 345889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999874 34889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....+. ......... ..+..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-------~~~~~ 235 (285)
T cd06648 171 --RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-------LPPKL 235 (285)
T ss_pred --ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-------CCCCC
Confidence 122346889999999998888999999999999999999999998643221 111111100 01111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1 111123468999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.43 Aligned_cols=269 Identities=20% Similarity=0.268 Sum_probs=195.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCC---Cc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS---SQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~---~~ 452 (726)
++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++ |+||+++++++...+. ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999965 689999998865432 23457889999999995 6999999998864332 23
Q ss_pred eEEEEeecCCCChhhhccCCCCC-cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecC
Q 004869 453 HLLCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFG 530 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~-~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFG 530 (726)
.+++|||+++ +|.+++...... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888643222 346899999999999999999999998 999999999999998 8999999999
Q ss_pred ccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .+...........
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 99865332211 122356889999998865 457899999999999999999999996432111 1110000000000
Q ss_pred h-h---hhhhcC----CccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 D-R---LEELAD----PRLG----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~-~---l~~i~d----~~l~----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. . .....+ +... .........++.+++.+||+.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0 000000 0000 00001223458899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.45 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=201.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
+|++.+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. +....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 5888999999999999999975 589999999975432 23568899999999999999999998876 45589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 9999999999999752 46889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......... +.......
T Consensus 152 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~-------- 216 (258)
T cd05578 152 PDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET-------- 216 (258)
T ss_pred CCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc--------
Confidence 432 123356888999999999888999999999999999999999999754322111 11111110
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM--GEVVQ 655 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm--~EVl~ 655 (726)
.....+......+.+++.+||+.||.+||++ +|+++
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1112233334568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.06 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=202.4
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCC
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 464 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~Gs 464 (726)
-+||+|.||+||-|+.. +...+|||.+...+....+-+..||.+-++++|.|||+++|.|. +++..-+.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCc
Confidence 46999999999999954 56789999998777777778899999999999999999999976 5557889999999999
Q ss_pred hhhhccCCCCCcccC--ChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEEEEecCccccCCCCCcc
Q 004869 465 LESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTN 541 (726)
Q Consensus 465 L~d~L~~~~~~~~~L--s~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~~~~~~~~~ 541 (726)
|.++|+..= +++ .+.+.--+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++....- +
T Consensus 659 LSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--n 730 (1226)
T KOG4279|consen 659 LSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--N 730 (1226)
T ss_pred HHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--C
Confidence 999997421 234 56777889999999999999999 99999999999995 5899999999999876433 3
Q ss_pred cccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 542 YLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 542 ~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
..+..+.||..|||||++..+ .|..++|||||||++.||.||++||..-+... -.+.++---.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFkVGmyK 795 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFKVGMYK 795 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------Hhhhhhccee
Confidence 345678899999999999865 58899999999999999999999995332110 0011111112
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....|.+...+...+|.+|+.+||.+||++.++++.
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2345677888889999999999999999999999864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.62 Aligned_cols=271 Identities=23% Similarity=0.332 Sum_probs=196.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCC------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 449 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~------ 449 (726)
-++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999964 6899999998644322 2345678999999999999999999886432
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 235699999996 4888887642 235899999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcc--cccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh-
Q 004869 530 GLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI- 605 (726)
Q Consensus 530 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~- 605 (726)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||..................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866432211 112334578899999988664 4788999999999999999999998754322111111110000
Q ss_pred ----ccchhhhh---hhcCCc-----cCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 606 ----LRDKDRLE---ELADPR-----LGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 606 ----~~~~~~l~---~i~d~~-----l~~~-~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
........ .+..+. .... .+......+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 000000 0000 000112356789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.57 Aligned_cols=250 Identities=29% Similarity=0.387 Sum_probs=195.9
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|++++++++|+|++++++++.. ....++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEE
Confidence 4777899999999999999964 6889999998754322 23468899999999999999999999874 4478999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++ |+|.+++... ...++|.++..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++....
T Consensus 104 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 104 MEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 99996 5888777532 235899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.. ....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+..+ .
T Consensus 177 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~----~------- 237 (317)
T cd06635 177 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI----A------- 237 (317)
T ss_pred Cc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH----H-------
Confidence 32 2346888999999874 457889999999999999999999998643211 001111 0
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
...............+.+++.+||+.+|.+||++.+|++++..+.
T Consensus 238 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 238 ---QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000000111223345889999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.32 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=195.7
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|+..+.||+|++|.||+|... +|..||+|++..... ...+.+.+|++++++++|+|++++++++. +....+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence 567899999999999999964 789999999875432 22357889999999999999999999987 4468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|++ ++|.+++.... ...+++..+++++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 79 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 79 FLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred ccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 995 69999986532 235899999999999999999999988 999999999999999999999999999765432
Q ss_pred CcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh-------
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD------- 610 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------- 610 (726)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+....+.......
T Consensus 153 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 153 VRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred ccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhh
Confidence 211 1223568899999987654 5789999999999999999999999644321 111111110000000
Q ss_pred hhhhhc-------CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 RLEELA-------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~-------d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.+.. .... ..........+.+++.+||+.+|++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000 00111222457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.42 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=207.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~ 454 (726)
....|+++++||+||.+.||++...+.+.||+|++... +.+....|.+|++.|.+|+ |.+||+|++|-. ..+.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--TDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--cCceEE
Confidence 45678899999999999999999888889999988643 3344578999999999995 999999999965 356899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||||- .-+|..+|++.. .....| .++.+..|++.++.+.|.++ |||.||||.|+|+-. |.+||+|||+|..
T Consensus 437 mvmE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 999987 559999998633 223445 78889999999999999999 999999999999975 5899999999999
Q ss_pred CCCCCcccccccccccccccCccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
+....+.......+||+.||+||.+... ..+.++||||+|||||+|+.|+.||.... ..|
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~-- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI-- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH--
Confidence 9887777777788999999999988532 25678999999999999999999996211 112
Q ss_pred hhccchhhhhhhcCCccCCCCChhhH-HHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDF-IRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~-~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+..+.|+.-.-+++.--. .++.+++..||+.||++||+..|++++
T Consensus 580 ------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 34566677755444443211 228899999999999999999999976
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.60 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=197.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~ 453 (726)
+++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++...+ ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468999999986432 223456888999999999999999999875432 2357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+. ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 488887753 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc-ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc--h
Q 004869 534 QAPEGRTNY-LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--K 609 (726)
Q Consensus 534 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~ 609 (726)
......... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...+....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 654322111 1233568999999998754 568899999999999999999999996432111 11111111110 0
Q ss_pred hhhhhhcCCcc---------CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELADPRL---------GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l---------~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+....+.+... ....+ ......+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111111000 00000 1123458899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.36 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=200.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCC----C
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~ 450 (726)
..++|+..+.||+|+||.||+|+.. +|+.||+|.+... .....+.+.+|++++++++|+||+++++++.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 6899999998643 2233456788999999999999999999876432 2
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588888753 2788899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hh--------hh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LV--------TW 601 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~--------~~ 601 (726)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... +. .+
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998654322 1233468899999999999999999999999999999999999996443211000 00 00
Q ss_pred hhh-------hccc-----hhhhhhhcCCcc----CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 602 ARP-------ILRD-----KDRLEELADPRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 602 ~~~-------~~~~-----~~~l~~i~d~~l----~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... .... .....++..... ...........+.+++.+||+.||++|||+.|++++=+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000 0000 000001111000 00011123456789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.17 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=193.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++. +....+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEE
Confidence 35666789999999999999964 589999999875432 23457899999999996 999999999876 34578999
Q ss_pred EeecCCCChhhhccCC-CCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 457 YELVPNGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~-~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||+.. +|.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 999864 555433210 01134689999999999999999999975 6 99999999999999999999999999976
Q ss_pred CCCCCcccccccccccccccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
...... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~--- 226 (288)
T cd06616 158 LVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG--- 226 (288)
T ss_pred hccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC---
Confidence 543221 1334688999999998766 68999999999999999999999996432 111111111110
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.+...........+.+++.+||+.+|++|||++||+++
T Consensus 227 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 ----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111222234568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.00 Aligned_cols=264 Identities=24% Similarity=0.297 Sum_probs=200.5
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-c-----CceeEEEEEeecCCCCce
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-H-----RNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~llg~~~~~~~~~~ 453 (726)
+|++.+.||+|.||.|-+|.. .+++.||||+++... .-..+-..|+.+|..|+ | -|+|++++||.. .++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccce
Confidence 789999999999999999994 569999999998432 22345567999999997 4 489999999884 4599
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC--CCcEEEEecCc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGL 531 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--~~~vKL~DFGl 531 (726)
|||+|.+ .-+|+++|+.+. ...++...++.|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 459999998643 345899999999999999999999999 999999999999965 34799999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh------------
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV------------ 599 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~------------ 599 (726)
+......-. ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+....++...+
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987665433 334567899999999999999999999999999999998877654433332111
Q ss_pred -------------hhhhhhccchh------------hhhhhcCCcc--------CCCCChhhHHHHHHHHHHccccCCCC
Q 004869 600 -------------TWARPILRDKD------------RLEELADPRL--------GGKYPKEDFIRVCTIAAACVAPEANQ 646 (726)
Q Consensus 600 -------------~~~~~~~~~~~------------~l~~i~d~~l--------~~~~~~e~~~~l~~Li~~CL~~dP~~ 646 (726)
.|......... ......+... ........-..+.+++.+||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 01111000000 0000001100 01112233456899999999999999
Q ss_pred CCCHHHHHHHHH
Q 004869 647 RPTMGEVVQSLK 658 (726)
Q Consensus 647 RPTm~EVl~~L~ 658 (726)
|+|..|+++|-+
T Consensus 493 R~tp~qal~Hpf 504 (586)
T KOG0667|consen 493 RITPAQALNHPF 504 (586)
T ss_pred cCCHHHHhcCcc
Confidence 999999998844
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.36 Aligned_cols=254 Identities=24% Similarity=0.290 Sum_probs=203.9
Q ss_pred cCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+.|++.+.||+|.-|+||++.+++ +..+|+|++.+.... .....+.|-+||+.++||.+..|++.++. ....||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEE
Confidence 456778999999999999999864 589999999765433 23456779999999999999999999874 448899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|||||+||+|..++++. ..+.+++..++-++..|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+...
T Consensus 155 ~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999863 3557999999999999999999999999 999999999999999999999999987432
Q ss_pred CC---------------------------------CCc---------------------ccccccccccccccCcccccc
Q 004869 536 PE---------------------------------GRT---------------------NYLSTRVMGTFGYVAPEYAMT 561 (726)
Q Consensus 536 ~~---------------------------------~~~---------------------~~~~~~~~GT~~Y~APE~l~~ 561 (726)
.. ... ...+...+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 11 000 011234689999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccc
Q 004869 562 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVA 641 (726)
Q Consensus 562 ~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~ 641 (726)
...+.+.|-|+|||+||||+.|..||...... ..+..++-..+.-.-..+....+.+||++.|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999754321 12222222222111112445568899999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 004869 642 PEANQRPT----MGEVVQS 656 (726)
Q Consensus 642 ~dP~~RPT----m~EVl~~ 656 (726)
.||++|-. +.||-+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 8888776
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.70 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=186.8
Q ss_pred eeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHh---cccCceeEEEEEeecCCCCceEEEEee
Q 004869 387 ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSR---LHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~---L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.||+|+||.||++... +++.||+|.+..... .....+.+|..++.. .+|+|++.+.+++.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999964 588999998865422 122344555554443 479999999998874 4478999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 79 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 79 MNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999864 345899999999999999999999999 9999999999999999999999999987554322
Q ss_pred cccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+... ..
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~------------ 212 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL------------ 212 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh------------
Confidence 123468999999998864 5678999999999999999999999964432211111000 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
......+.....++.+++.+||+.||++|| +++|++++.
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 001122233345688999999999999999 699998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.75 Aligned_cols=248 Identities=31% Similarity=0.468 Sum_probs=201.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4788899999999999999865 578999999976543 344678999999999999999999999873 45889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999999999998642 46899999999999999999999998 99999999999999999999999999987755
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.... .....++..|+|||...+...+.++|||++|+++|||++|+.||...... . ..|. ....
T Consensus 152 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~--~~~~--~~~~--------- 214 (254)
T cd06627 152 VSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--A--ALFR--IVQD--------- 214 (254)
T ss_pred Cccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--H--HHHH--Hhcc---------
Confidence 4321 23346889999999998888899999999999999999999998643211 0 0010 0000
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+......+.+++.+||+.+|++||++.|++.+
T Consensus 215 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 215 --DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0011222234468899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=300.80 Aligned_cols=267 Identities=19% Similarity=0.285 Sum_probs=194.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+||+++++++. +....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence 57899999999999999999965 688999999865432 22357889999999999999999999987 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~~ 535 (726)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++ ++.+||+|||+++..
T Consensus 80 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred Eeccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99995 58888875422 223577888899999999999999998 999999999999985 567999999999765
Q ss_pred CCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhhhhhh----hccch
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARP----ILRDK 609 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~----~~~~~ 609 (726)
...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+... ...+... .+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 154 GIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred CCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 432211 123457889999998876 457899999999999999999999997543211100 0000000 00000
Q ss_pred hhhhhhcC--CccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELAD--PRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d--~~l~~----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+..... +.... ........++.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000 0011223457899999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.72 Aligned_cols=242 Identities=28% Similarity=0.432 Sum_probs=191.2
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||.||+++.. +|+.|++|.+..... ...+.+.+|++++++++|+||+++++.+. +....+++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 689999999999976 489999999875433 33467889999999999999999998876 455889999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc---
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT--- 540 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~--- 540 (726)
+|.++++.. ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 79 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 79 DLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999999742 25899999999999999999999998 99999999999999999999999999876543321
Q ss_pred ---ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 541 ---NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 541 ---~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
........++..|++||.......+.++||||||+++|||++|+.||...... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------- 215 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN---------- 215 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc----------
Confidence 11223356788999999998888999999999999999999999999644311 11111110
Q ss_pred CccCCCCChh--hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e--~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ..+.. ....+.+++.+||+.+|++|||+.++.+.
T Consensus 216 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 216 GKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred CCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 000 01111 13467899999999999999999444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.13 Aligned_cols=271 Identities=23% Similarity=0.362 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecC--CCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--~~~~~ 453 (726)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++... +....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999954 68999999987542 23346788899999999999999999887532 33468
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 689999864 234899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCc--ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh---------h
Q 004869 534 QAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------W 601 (726)
Q Consensus 534 ~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~---------~ 601 (726)
....... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 6543221 112234578999999998865 468899999999999999999999996543221110000 0
Q ss_pred hhhhccchhhhhhhcCC-ccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 602 ARPILRDKDRLEELADP-RLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~-~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.... . ...+....+. ......+ ......+.+++.+||+.+|++||++.+++++-+.
T Consensus 236 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 236 LNRI-G-SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhh-c-hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0000 0 0011111100 0000111 1234568999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=300.07 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=198.1
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCC----
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---- 449 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---- 449 (726)
...++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 588999999975432 23356788999999999999999999886432
Q ss_pred ----CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 450 ----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 450 ----~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
....++++||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 3378999999976 777777542 235899999999999999999999998 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~- 232 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISR- 232 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-
Confidence 9999999866543321 1123356788999998764 457899999999999999999999997433211 1111000
Q ss_pred hccch--hhhhhh--------cC------CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILRDK--DRLEEL--------AD------PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~~~--~~l~~i--------~d------~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... .....+ .+ ....... ......+.+++.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000000 00 0000000 0123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.91 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=191.5
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||+||++... +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++.. ....++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 689999999999854 68899999986432 2234567889999999999999999998874 45789999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 150 (277)
T cd05577 79 DLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---K 150 (277)
T ss_pred cHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---c
Confidence 9999997532 235899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.......... . +...... ....
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-----------~~~~~~~-~~~~ 216 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-----------LKRRTLE-MAVE 216 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-----------HHhcccc-cccc
Confidence 223457889999999988889999999999999999999999996443211100 0 0000000 0111
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.+......+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 2222344688999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.66 Aligned_cols=266 Identities=23% Similarity=0.350 Sum_probs=198.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~ 452 (726)
.++|.+.+.||+|+||+||+|+. .+++.||||.+... .......+.+|+.++++++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999995 46899999998743 2223456788999999999999999999876432 135
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.+++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 689988864 245899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh-hhhhh-------
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-VTWAR------- 603 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~------- 603 (726)
+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........... .....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86644321 2233467889999998865 5688999999999999999999999965321110000 00000
Q ss_pred hhccchhhhhhhc-------CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDKDRLEELA-------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~~~l~~i~-------d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...... ...... +.... .........+.+++.+||+.+|++|||++|++++
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNE-KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCch-hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 000000 00000 0011234567899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.91 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=194.8
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhc---ccCceeEEEEEeecCCC---Cc
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDS---SQ 452 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~~~~---~~ 452 (726)
|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++.++ +|+|++++++++...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999976 4899999999743322 234577788887766 59999999999875432 23
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+++||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 48998886422 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh-h
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-R 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~-~ 611 (726)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+......... .
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHh
Confidence 87644321 12335788999999999989999999999999999999999998743321 111111110000000 0
Q ss_pred -------hhhhcCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 -------LEELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 -------l~~i~d~~l~---~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......... .....+....+.+++.+||+.||.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 00111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=307.65 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=193.4
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~ 451 (726)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 468999999987432 222356889999999999999999999876432 23
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 56899999964 7776653 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh-------
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR------- 603 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~------- 603 (726)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9765332 123467889999999876 468899999999999999999999997533211100000000
Q ss_pred -hhccchhhhhhhcC--Ccc-CCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 -PILRDKDRLEELAD--PRL-GGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 -~~~~~~~~l~~i~d--~~l-~~~~---~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+.. ...... +.. .... .......+.+++.+||+.||++||+++|++.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKA-AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccc-hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000 000 0000 00123357899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=298.76 Aligned_cols=271 Identities=26% Similarity=0.368 Sum_probs=224.8
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEE
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY 444 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~ 444 (726)
..++....++++...++-+|.||.||+|.|. +.+.|-||.++....+ ....++.|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456667788999999999999999999654 3456788888754333 34568889999999999999999999
Q ss_pred eecCCCCceEEEEeecCCCChhhhccCCC----CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC
Q 004869 445 YSSRDSSQHLLCYELVPNGSLESWLHGPL----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 445 ~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~----~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~ 520 (726)
+.. +....+.+|.++.-|+|..||...+ ...+.++-.+...++.|++.|++|||+++ ++|.||..+|++||+
T Consensus 356 ~ie-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIE-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred Eee-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 875 5567889999999999999997222 22345788899999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 004869 521 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 599 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 599 (726)
...+||+|=.++|.....+.++..........||++|.+....|+..+|||||||+||||+| |+.||...++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999999888888877777778899999999999999999999999999999998 999997655443222
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
++.++.++. .|..+..++..++..||..+|++||+++|++.-|.++...
T Consensus 510 -----ylkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 -----YLKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----HHhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 233443332 3445566799999999999999999999999999886543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.15 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=201.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~ 454 (726)
++|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++ |+||+++++++. +....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 47889999999999999999965 68999999986532 223467889999999998 999999999876 445889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 79 FVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 99999999999999975 236999999999999999999999998 99999999999999999999999999886
Q ss_pred CCCCCcc------------------cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 004869 535 APEGRTN------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596 (726)
Q Consensus 535 ~~~~~~~------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~ 596 (726)
....... .......++..|+|||...+..++.++||||||++++|+++|+.||..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~ 228 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---Y 228 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---H
Confidence 5433210 112234678999999999888899999999999999999999999974431 0
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM----GEVVQS 656 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm----~EVl~~ 656 (726)
.. ...+.+ .....+......+.+++.+||+.+|++||++ ++++++
T Consensus 229 ~~-------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 LT-------------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH-------------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 011111 1112233334568899999999999999999 787754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.71 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|...+ ++.||||.++.... ....++..|++++.+.. |+||+++++++. +....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEE
Confidence 3678889999999999999999864 89999999975432 23456777888777775 999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+|||+. ++|.+++... ...+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++..
T Consensus 92 v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 92 CMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999985 4777766532 2368999999999999999999997 46 99999999999999999999999999976
Q ss_pred CCCCCcccccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
....... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+.........
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~- 235 (296)
T cd06618 165 LVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE- 235 (296)
T ss_pred ccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-
Confidence 6443221 2335788999999987553 789999999999999999999999642211 01111111110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.+.. ........++.+++.+||+.||++||++.+++++.+.
T Consensus 236 ------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 236 ------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred ------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 0000 0011223468899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=323.10 Aligned_cols=272 Identities=20% Similarity=0.250 Sum_probs=187.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC--CcEEEEE------------------EcccCCCCchhHHHHHHHHHHhcccCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD--GTAVAIK------------------RLTCGGQQGDKEFLVEVEMLSRLHHRN 437 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~--g~~VAVK------------------~l~~~~~~~~~~f~~Ei~iL~~L~HpN 437 (726)
..++|++.+.||+|+||+||++.++. +..+++| ++. ........+.+|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11122356889999999999999
Q ss_pred eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCC-CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 438 IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~-~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
||++++++... ...++++|++. ++|.+++.... .........+...++.|++.||+|||+.+ |+||||||+||
T Consensus 225 Iv~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99999998743 47899999984 57777765321 11222345667789999999999999998 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~P-f~~~~~~~~ 595 (726)
|++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999999876543221 22345799999999999999999999999999999999998754 432221111
Q ss_pred chhhhhhhhhc-------cchhhhhhhcCCc-c---CCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 596 ENLVTWARPIL-------RDKDRLEELADPR-L---GGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 596 ~~l~~~~~~~~-------~~~~~l~~i~d~~-l---~~~~~~-----e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..+......+. .....+...++.. . ....+. .....+.+++.+||+.||++|||+.|++++-
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 12111111000 0000000110000 0 000000 0112356789999999999999999999863
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.41 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=195.4
Q ss_pred ceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 385 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
..+||+|+||.||++... +|+.||||++..........+.+|+.++++++|+|++++++++.. ....+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence 367999999999999864 689999999875555556679999999999999999999999874 45899999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 99998853 24789999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....|+..|++||++.+..++.++|+||||+++|||++|..||...... ....... ....+.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~----------~~~~~~~~~- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR----------DNLPPKLKN- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----------hhCCcccCC-
Confidence 23356889999999998888899999999999999999999998643211 1111000 000111100
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11123357889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.72 Aligned_cols=273 Identities=22% Similarity=0.304 Sum_probs=202.9
Q ss_pred ccCHHHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEe
Q 004869 369 FLAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445 (726)
Q Consensus 369 ~~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~ 445 (726)
.....++...+++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|+||+++.+++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344567778889999999999999999999985 468999999987532 22245688899999999999999999987
Q ss_pred ecCC----CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 446 SSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 446 ~~~~----~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
.... ....+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 5322 23467888877 7899988863 34899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +..
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~ 229 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL 229 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 99999999998865332 223467889999998866 5688999999999999999999999964332111 100
Q ss_pred hhhhhccc-hhhhhhh-----------cCCccCCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 601 WARPILRD-KDRLEEL-----------ADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 601 ~~~~~~~~-~~~l~~i-----------~d~~l~~~---~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
........ ......+ ........ ........+.+++.+|++.||.+||++.+++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00000000 0000000 00000000 0001233578999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.14 Aligned_cols=261 Identities=16% Similarity=0.210 Sum_probs=182.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCCch-----------hHHHHHHHHHHhcccCceeEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGD-----------KEFLVEVEMLSRLHHRNLVKLVG 443 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~L~HpNIV~llg 443 (726)
.++|++.++||+|+||.||+|...+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999754 34566665433222111 11222334455678999999998
Q ss_pred EeecCCCC--ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 444 YYSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 444 ~~~~~~~~--~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
++...... ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 76543321 3467777764 356666543 123567888999999999999999998 9999999999999999
Q ss_pred CcEEEEecCccccCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 004869 522 FHAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~ 596 (726)
+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999866432211 11123469999999999999999999999999999999999999997542211
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
....... .+.+..+...... .......+.+++..|++.+|++||+++++++.|
T Consensus 241 ~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAK-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhH-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000 0011111111111 111234588999999999999999999998765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.62 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=191.5
Q ss_pred HHHHHHhcCcccceee--eecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 373 EELKEATNNFEPASIL--GEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 373 ~el~~~t~~f~~~~~L--G~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.+.....++|++.+.+ |+|+||.||+++. .++..+|+|.+....... .|+.....+ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 3444556677777776 9999999999985 467889999986432211 123222222 69999999999874
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEE
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVA 527 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~ 527 (726)
....++||||+++|+|.+++... ..++|.+++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 34899999999999999999752 36899999999999999999999998 99999999999999988 99999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 153 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-- 223 (267)
T PHA03390 153 DYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-- 223 (267)
T ss_pred cCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--
Confidence 999987654321 2358899999999999899999999999999999999999997432211 1122222111
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-m~EVl~~ 656 (726)
.... .........+.+++.+||+.+|.+||+ ++|++++
T Consensus 224 ---------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ---------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0000 111223345889999999999999996 6998864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.90 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=196.3
Q ss_pred ceeeeecCcEEEEEEEEC-CCcEEEEEEcccC----CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 385 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
..+||+|+|-+||||... +|.+||--.++.. +....+.|..|+++|+.|+|+|||+++.++.+.+.....+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999864 5788885544321 22334789999999999999999999999987777778899999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEEEEecCccccCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~~~~~~ 538 (726)
+..|+|..|+++. +.++.+.+.+|+.||++||.|||++. |+|+|||||.+||+|+ ..|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999863 45778899999999999999999986 5699999999999996 4689999999999987654
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc--hhhhhhhc
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KDRLEELA 616 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~l~~i~ 616 (726)
.. ..+.||+.|||||.+. ..|++..||||||+.++||+|+..||..-... ....+++... ...+..+-
T Consensus 200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHHcCCCHHHhhccC
Confidence 32 3378999999999877 88999999999999999999999999643321 1122222221 11222222
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
| .++.++|.+||.. .++|||+.|++++
T Consensus 270 d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 D------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2 3578999999999 9999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=301.14 Aligned_cols=271 Identities=25% Similarity=0.332 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCC------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 449 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~------ 449 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6889999998654322 2346789999999999999999998865322
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++|+||+.+ +|.+.+... ...+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 2357999999965 677777542 335899999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCccc---------ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 530 GLAKQAPEGRTNY---------LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 530 Gla~~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
|+++......... ..+...++..|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9997654322111 1123467889999998765 45789999999999999999999999643322111100
Q ss_pred -hhhhhh----ccchhhhhhhcCCccCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 600 -TWARPI----LRDKDRLEELADPRLGGKYP-------KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 600 -~~~~~~----~~~~~~l~~i~d~~l~~~~~-------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...... +.....+....+.......+ ......+.+++.+||+.||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000 00000000000000000000 1112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.64 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=208.8
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
-|.+.+.||+|.|..|-+|++ -+|..||||++.+...+. ...++.|++.|+-++|||||+|+.+.. ....+|||+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD--TQTKlyLiL 96 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID--TQTKLYLIL 96 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc--ccceEEEEE
Confidence 467778999999999999984 379999999997654333 356889999999999999999999876 455899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee-cCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL-d~~~~vKL~DFGla~~~~ 536 (726)
|.-++|+|+|||-++ ...+.+....+++.||+.|+.|+|... +|||||||+||.+ ..-|-+||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999643 345889999999999999999999999 9999999999876 667899999999998887
Q ss_pred CCCcccccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.+.. -+..+|...|-|||++.+..|+ ++.||||||||||-|++|+.||+... +.+.+-.+
T Consensus 171 PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmI 231 (864)
T KOG4717|consen 171 PGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMI 231 (864)
T ss_pred Ccch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhh
Confidence 6653 3567899999999999998886 78999999999999999999997443 23345555
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+|-. ...|.....++.+||..||..||.+|-+.+||+..
T Consensus 232 mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 5533 24566777789999999999999999999999754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.34 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=197.5
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|+..+.||+|++|.||+|... +|+.+++|++...... ....+.+|++++++++|+||+++++++. +....++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence 566789999999999999864 6889999998754332 3467889999999999999999999887 4468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++ +|.+++... ...+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 79 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 79 FMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred ccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9975 888888642 246899999999999999999999998 999999999999999999999999999876544
Q ss_pred CcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-h-------hhhhhccc-
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-T-------WARPILRD- 608 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~-------~~~~~~~~- 608 (726)
.. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... . ..+....+
T Consensus 152 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 152 VR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred cc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 31 12234578899999998876 7899999999999999999999998654321110000 0 00000000
Q ss_pred -hhhhhhhcCCccC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 -KDRLEELADPRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 -~~~l~~i~d~~l~--~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
........+.... .....+...++.+++.+||+.||.+||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000000 00112234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=328.68 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=209.2
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC----C----CcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEee
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS----D----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYS 446 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~----~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~ 446 (726)
...++..+.+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34455566679999999999999843 1 45799999986543 3457899999999998 5999999999998
Q ss_pred cCCCCceEEEEeecCCCChhhhccCCC---CCc---------ccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcc
Q 004869 447 SRDSSQHLLCYELVPNGSLESWLHGPL---GVN---------CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 514 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~~GsL~d~L~~~~---~~~---------~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~ 514 (726)
. ....++|+||+..|+|.++|+..+ ... ..++....+.++.|||.|++||++.. ++||||..+
T Consensus 373 ~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 373 Q--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred c--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 5 568999999999999999998654 111 13888999999999999999999998 999999999
Q ss_pred ceeecCCCcEEEEecCccccCCCCCccccccccc--ccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 004869 515 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 591 (726)
Q Consensus 515 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~--GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~ 591 (726)
|||+.++..+||+|||+|+........ ...... -...|||||.+....|+.|+|||||||+||||+| |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999976654432 212222 3567999999999999999999999999999999 888986411
Q ss_pred CCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 592 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
....+.+ .++++.++ ..|..+..++++++..||+.+|++||++.|+++.++...
T Consensus 527 --~~~~l~~----~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 --PTEELLE----FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --cHHHHHH----HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 0112221 22222222 335555667899999999999999999999999998853
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.20 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=195.3
Q ss_pred CcccceeeeecCcEEEEEEEE----CCCcEEEEEEcccCCC----CchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCC
Q 004869 381 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~ 451 (726)
+|++.+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++.+++. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence 478889999999999999985 3688999999874321 2245688899999999 5999999998876 345
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 78999999999999999964 235788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
++........ ......|+..|+|||++.+. .++.++||||||+++|||++|+.||...... .....+.......
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~- 227 (290)
T cd05613 152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS- 227 (290)
T ss_pred ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-
Confidence 9865433211 12235688999999998753 4678999999999999999999998643211 1111111111110
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
...++......+.+++.+||+.||++|| ++.+++.+
T Consensus 228 -----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0112233344678999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.82 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=208.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
-|.++.+||+|+||.||++.++ .|+.||||++... .+.++...|+.+|++.+.+++|+++|.|. ....+++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhh
Confidence 4678899999999999999965 6999999999754 35678999999999999999999999776 45689999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
|..|++.|.++. .+++|++.++..++...++||+|||... -+|||||..||||+.+|.+||+|||.|-.+.+..
T Consensus 110 CGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 110 CGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred cCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999974 3567999999999999999999999988 7999999999999999999999999998765543
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. ....+.||+.|||||++..-.|+.++||||+|+...||..|++||....+.... +.-. -.|-
T Consensus 184 A--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FMIP------T~PP 246 (502)
T KOG0574|consen 184 A--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FMIP------TKPP 246 (502)
T ss_pred H--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------Eecc------CCCC
Confidence 2 345678999999999999999999999999999999999999999765543211 1000 0011
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..-.-|.+...++-+++++||-.+|++|-|+.+++++
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1112345556678999999999999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.25 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=193.4
Q ss_pred CcccceeeeecCcEEEEEEEECC-CcEEEEEEcccC-----CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|++++++++||||+++++++. +....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence 47888999999999999998643 444555555422 1223345778999999999999999999876 445789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++.........+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++.
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceee
Confidence 999999999999998643333456999999999999999999999998 999999999999976 4699999999976
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ...........
T Consensus 155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~------ 220 (260)
T cd08222 155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG------ 220 (260)
T ss_pred cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC------
Confidence 643322 2233568889999999988888999999999999999999999986322 11111111100
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 221 -~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 -PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011 1223334468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.07 Aligned_cols=265 Identities=20% Similarity=0.248 Sum_probs=192.6
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++. +....+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccC
Confidence 445556666666666655 6899999998754 2334467999999999999999999999887 4457899999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc-
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT- 540 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~- 540 (726)
+|+|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 83 YGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999997532 235788999999999999999999998 99999999999999999999999999875532211
Q ss_pred ----ccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh----hhccch-
Q 004869 541 ----NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR----PILRDK- 609 (726)
Q Consensus 541 ----~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~~~- 609 (726)
........++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence 111233457889999999875 357899999999999999999999997533211 1111000 000000
Q ss_pred -----hhhhh----hcCCcc----CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 610 -----DRLEE----LADPRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 610 -----~~l~~----i~d~~l----~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..+.. ..++.. ...........+.+++.+||+.||++|||++|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00000 000000 01112223356889999999999999999999998744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=293.63 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=186.1
Q ss_pred eeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC---chhHHHHHHHHH---HhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 387 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEML---SRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL---~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.||+|+||.||++.. .+++.||+|.+...... ....+..|..++ +..+|+||+.+++++.. ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 489999999999986 45889999998754322 122345554443 44579999999998874 4588999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 79 ~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 79 MNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999998864 346899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||............ . .....+.
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~--------~~~~~~~ 216 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---R--------MTLTMAV 216 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---H--------HhhccCC
Confidence 1234689999999998754 6899999999999999999999999754322111100 0 0000111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
..+......+.+++.+|+..+|.+|| ++.|++++
T Consensus 217 ----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12222345688999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.98 Aligned_cols=265 Identities=20% Similarity=0.261 Sum_probs=192.6
Q ss_pred eeeeec--CcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEG--GFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G--~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
..||+| +||+||++... +|+.||+|.+...... ..+.+.+|+.+++.++|+||+++++++.. ....++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 456666 99999999964 7899999998754322 23578899999999999999999999874 45789999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
.+|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+........
T Consensus 82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999999987532 234888999999999999999999998 99999999999999999999999986543322111
Q ss_pred cc-----ccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh---------
Q 004869 541 NY-----LSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP--------- 604 (726)
Q Consensus 541 ~~-----~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~--------- 604 (726)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccc
Confidence 00 01112356679999998763 57899999999999999999999996432111 00000000
Q ss_pred hccch----------------------hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 605 ILRDK----------------------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 605 ~~~~~----------------------~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..... .....+.+..+...........+.+++.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00000 00000111111122233445678999999999999999999999988554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.25 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=195.3
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|++.+.||+|+||.||+|+.. +++.|+||++...... ......+|+..+.+++ |+|++++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 567899999999999999975 4788999998754322 2334567999999999 9999999999874 568999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+ +|+|.+++.... ...+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 99 889999987532 246899999999999999999999998 999999999999999999999999999866443
Q ss_pred CcccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhhhhhhh----ccchhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARPI----LRDKDRL 612 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~----~~~~~~l 612 (726)
.. .....++..|+|||++. ...++.++|+||||+++|||++|+.||.......... ...+.... +.+...+
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 21 12346788999999875 4567899999999999999999999986443211100 00000000 0000000
Q ss_pred hhhcCCccCC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGG-------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~-------~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+..... .........+.+++.+||+.+|++|||++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 0001113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.11 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+++|++.+.||+|.|+.||+... .+|+.+|+|.+... ...+.+++.+|+++-+.|+|||||+|..-+. +....||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEE
Confidence 46788889999999999999875 46899999988643 2345678899999999999999999998765 4558899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec---CCCcEEEEecCcc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLA 532 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd---~~~~vKL~DFGla 532 (726)
|+|+|.||+|..-+-. +..+++..+-..+.||+++|.|+|.++ |+|||+||.|+||- ..--+||+|||+|
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999866643 234677788899999999999999999 99999999999994 3446999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
.....+. .....+||++|||||++....|+..+|||+.|||||-|+.|+.||.... +..+. .++......
T Consensus 161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rly---e~I~~g~yd- 230 (355)
T KOG0033|consen 161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---EQIKAGAYD- 230 (355)
T ss_pred EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHH---HHHhccccC-
Confidence 9887433 3456789999999999999999999999999999999999999997532 11111 111111111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+++.-.. ...++..+|+.+||..||.+|.|+.|.+++-|.
T Consensus 231 ---~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 231 ---YPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred ---CCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 1111111 223356789999999999999999999877543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.30 Aligned_cols=268 Identities=23% Similarity=0.248 Sum_probs=193.6
Q ss_pred CcccceeeeecCcEEEEEEEEC-C--CcEEEEEEcccCC--CCchhHHHHHHHHHHhc-ccCceeEEEEEeecC--CCCc
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-D--GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR--DSSQ 452 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~--g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~--~~~~ 452 (726)
+|++.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|++++.++ +|+||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 6789999986432 22245788999999999 599999999875422 2345
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++++||+. ++|.+++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788888885 689998864 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCc--ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh-h--------h
Q 004869 533 KQAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-V--------T 600 (726)
Q Consensus 533 ~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l-~--------~ 600 (726)
+....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||........... . .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 111234578999999998765 4689999999999999999999999875432110000 0 0
Q ss_pred hhhhhccchh-hhhhhcCCccCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILRDKD-RLEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~~~~-~l~~i~d~~l~~---~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+...+..... ............ .........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 000000000000 0001123458899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.68 Aligned_cols=269 Identities=25% Similarity=0.314 Sum_probs=200.9
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~~ 454 (726)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999965 48999999987543 334567999999999999999999999876432 23689
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++|||++ ++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 589998864 236899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcc-cccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh-hhhhhhh----c-
Q 004869 535 APEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-VTWARPI----L- 606 (726)
Q Consensus 535 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~~----~- 606 (726)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ....... +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6543210 112345678899999999887 889999999999999999999999965432111000 0000000 0
Q ss_pred -cchhhhhhhcCC-ccCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 607 -RDKDRLEELADP-RLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 607 -~~~~~l~~i~d~-~l~~-----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
............ .... .........+.+++.+||+.+|++||++.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000000000000 0000 00111234588999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.97 Aligned_cols=250 Identities=28% Similarity=0.389 Sum_probs=193.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+.|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+++.+|+++++.++|+|++++++++.. ....++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence 34677789999999999999964 578899999864322 223568899999999999999999999874 457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999996 6888877532 235889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... ....+. +.
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~----~~---- 229 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA----QN---- 229 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHh----hc----
Confidence 432 2345788999999874 3567889999999999999999999985422110 001000 00
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+.. ........+.+++.+||+.+|++||++.+++++.+..
T Consensus 230 ---~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 230 ---ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00111 1112334578999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.20 Aligned_cols=239 Identities=22% Similarity=0.280 Sum_probs=182.9
Q ss_pred eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHH-HhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEML-SRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL-~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|... +|+.||||.+...... ....+..|..++ ...+|+|++++++++. +....++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence 56999999999999864 5889999998644321 123345555554 4458999999999987 345899999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 80 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 80 NGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999964 235888999999999999999999998 99999999999999999999999999876433
Q ss_pred ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCcc
Q 004869 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620 (726)
Q Consensus 541 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 620 (726)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||...... . ......... ...
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~~~~--------~~~ 212 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---A---VFDNILSRR--------INW 212 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhcc--------cCC
Confidence 12345888999999998888899999999999999999999999643211 1 111010000 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 004869 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653 (726)
Q Consensus 621 ~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EV 653 (726)
...........+.+++.+||+.+|++||++.++
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 001111223458899999999999999976544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.49 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=196.4
Q ss_pred CcccceeeeecCcEEEEEEEE----CCCcEEEEEEcccCC----CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCC
Q 004869 381 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~ 451 (726)
+|++.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 477889999999999999984 356889999986432 22345688999999999 5999999998876 345
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 78999999999999999864 235888999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
++........ ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ....+.......
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~- 227 (288)
T cd05583 152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS- 227 (288)
T ss_pred cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-
Confidence 8865443221 122346889999999987654 7889999999999999999999986322111 111111111110
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
. ...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 -------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 11222233457899999999999999998887665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=299.98 Aligned_cols=266 Identities=25% Similarity=0.312 Sum_probs=199.6
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
+...+++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCC
Confidence 3446789999999999999999999854 78999999886432 2234678899999999999999999998863 234
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++++||+ +++|.++++. ..+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 5689988863 24778888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hh--------hhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NL--------VTW 601 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l--------~~~ 601 (726)
++...... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .+ .+|
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 87543221 23457889999998766 56899999999999999999999999644321100 00 011
Q ss_pred hhhhccchhhhhhhcCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~-----e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...... ......+..-......+. .....+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111110 011111111111111111 123568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=296.31 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=190.7
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
|...+.||+|+||.||+|+.. +|+.|++|++...... ..+.+.+|++++++++|+|++++++++.. ....++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence 566688999999999999964 6889999998754332 23568889999999999999999999874 45789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+. |+|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 9995 5787777532 235899999999999999999999998 99999999999999999999999999864332
Q ss_pred CCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....... .........
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~----- 236 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND----- 236 (313)
T ss_pred ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-----
Confidence 12346889999999874 4668899999999999999999999986432111 111111000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.. ........+.+++.+||+.+|++||++.+++++
T Consensus 237 --~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 --SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 011112347889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.83 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=195.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCC--------
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS-------- 450 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~-------- 450 (726)
.+|+..+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999964 688999999976665566788999999999999999999987653221
Q ss_pred ----CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEE
Q 004869 451 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAK 525 (726)
Q Consensus 451 ----~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vK 525 (726)
...++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999997 589888853 34889999999999999999999998 99999999999997 466789
Q ss_pred EEecCccccCCCCCcc-cccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 526 VADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 526 L~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
|+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765332111 11123457889999998654 567889999999999999999999996543211110000000
Q ss_pred hhccc--hhh----hh-hhcCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRD--KDR----LE-ELADPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~--~~~----l~-~i~d~~l~~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.... ... .. ........... ......++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 000 00 00000000000 01123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=299.39 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=194.0
Q ss_pred cCcc-cceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--------------hhHHHHHHHHHHhcccCceeEEEE
Q 004869 380 NNFE-PASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------------DKEFLVEVEMLSRLHHRNLVKLVG 443 (726)
Q Consensus 380 ~~f~-~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~llg 443 (726)
++|. +.+.||+|+||.||+|... +++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 3577999999999999964 68999999986443221 125788999999999999999999
Q ss_pred EeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc
Q 004869 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 523 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~ 523 (726)
++. .....+++|||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ ++|+|||++||+++.++.
T Consensus 88 ~~~--~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYV--EGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEe--cCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 987 3458899999996 699999864 335889999999999999999999998 999999999999999999
Q ss_pred EEEEecCccccCCCCC------------cccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 524 AKVADFGLAKQAPEGR------------TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 524 vKL~DFGla~~~~~~~------------~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
+||+|||+++...... .........++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999997654111 00111223468899999998764 4689999999999999999999999754
Q ss_pred CCCccchhhhhhhhhccchhh--------h------hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 591 QPSGQENLVTWARPILRDKDR--------L------EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 591 ~~~~~~~l~~~~~~~~~~~~~--------l------~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+. .......+..... + ......... .........+.+++.+||+.+|++||+++|++.+
T Consensus 238 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 32211 1110000000000 0 000000000 0011123457899999999999999999999976
Q ss_pred HH
Q 004869 657 LK 658 (726)
Q Consensus 657 L~ 658 (726)
-+
T Consensus 314 ~~ 315 (335)
T PTZ00024 314 EY 315 (335)
T ss_pred cc
Confidence 43
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.20 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=196.3
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 566788999999999999965 58999999998653 2234678899999999999999999999873 468999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 997 59999997522 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhh-------hhccc-
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWAR-------PILRD- 608 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~-------~~~~~- 608 (726)
... .....++..|+|||++.+. .++.++|||||||++|||++|+.||......... .+..... ....+
T Consensus 152 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 152 LRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 221 2234467789999998776 7899999999999999999999998653321110 0000000 00000
Q ss_pred ---hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 ---KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ---~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
................+ .....+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000000 113468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=300.53 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=196.7
Q ss_pred HHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCC---
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--- 450 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~--- 450 (726)
...++|++.+.||+|+||.||+|.. .+|..||||++..... ...+.+.+|++++++++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 4689999999864322 223568899999999999999999998864322
Q ss_pred -CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 451 -SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 451 -~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
...++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 2468999999 7799988863 35889999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hh--------h
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NL--------V 599 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l--------~ 599 (726)
|+++...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... .+ .
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998654321 23457889999998876 46889999999999999999999999743321100 00 0
Q ss_pred hhhhhhccchhhhhhhcC--CccC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 600 TWARPILRDKDRLEELAD--PRLG----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d--~~l~----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.|...+... . ...... +... ..........+.+++.+|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSE-D-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcch-h-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0 000000 0000 00011223357899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.01 Aligned_cols=273 Identities=25% Similarity=0.374 Sum_probs=205.7
Q ss_pred cccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CCceEE
Q 004869 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHLL 455 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~~~~L 455 (726)
+...+.||+|+||.||+|+ ...|+.||||.++... ....+.+.+|+++|++++|+|||+++++-.... .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456889999999999999 4579999999998643 334577899999999999999999999854433 456789
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec--CCC--cEEEEecCc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNF--HAKVADFGL 531 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd--~~~--~vKL~DFGl 531 (726)
+||||.+|||+..|..+.+ ...|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998655 356999999999999999999999999 99999999999983 333 479999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
|+...++. .....+||..|++||.+.. +.|+..+|.|||||++||.+||..||..........-+.|.. ..+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCCC
Confidence 99887654 4567899999999999984 889999999999999999999999996443221111122211 111111
Q ss_pred hhhhhcCCccCC------------CCChhhHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHH
Q 004869 611 RLEELADPRLGG------------KYPKEDFIRVCTIAAACVAPEANQRP--TMGEVVQSLKMVQR 662 (726)
Q Consensus 611 ~l~~i~d~~l~~------------~~~~e~~~~l~~Li~~CL~~dP~~RP--Tm~EVl~~L~~i~~ 662 (726)
......++...+ ........++-..+..+|..+|++|- ...+....+..|.+
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111111111 11223345566777778888899998 66666666555543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.65 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred CcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
-|++...||.|+||.||+|+.++ +...|.|.+...+..+.++|+-||+||...+||+||+|++.|... +.++++.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEee
Confidence 35667789999999999999764 445577888766667778999999999999999999999977643 479999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
|.||-.+..+-. -...|+..++.-++.|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred cCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 999999887753 2456999999999999999999999999 999999999999999999999999998654322
Q ss_pred cccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 540 TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
......+.||+.|||||+.+ ...|+.++||||||+.|.||..+.+|-....+ ......+..
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaK------- 249 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK------- 249 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhh-------
Confidence 22334578999999999875 35789999999999999999999998643221 111111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
---|.+ ..|......+.+++.+||..||..||++.++++|
T Consensus 250 SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111122 1233445568899999999999999999999876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=281.46 Aligned_cols=239 Identities=29% Similarity=0.379 Sum_probs=192.1
Q ss_pred eeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 388 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 388 LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++|+||+++++.+. +....+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence 699999999999975 5889999998754332 3457899999999999999999998876 455889999999999
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 543 (726)
+|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 79 ~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 79 ELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 999999752 35899999999999999999999988 99999999999999999999999999987654321 2
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 544 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 544 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
.....++..|++||...+...+.++|+||||+++|||++|+.||..... ... ...... .. ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~---~~~~~~----------~~--~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI---YEKILK----------DP--LR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHhc----------CC--CC
Confidence 2345688899999999888889999999999999999999999964331 111 111111 11 11
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCH---HHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTM---GEVVQ 655 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm---~EVl~ 655 (726)
.+......+.+++.+||..||++||++ .++++
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 222224467899999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=300.68 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=196.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCC----
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---- 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~---- 450 (726)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 57899999986432 2234567889999999999999999987653221
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 3489999998 6799998863 35899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch-hhh--------
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVT-------- 600 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~-l~~-------- 600 (726)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99866432 123457889999998865 467899999999999999999999996433211100 000
Q ss_pred hhhhhccchhhhhhhcCC---ccCCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILRDKDRLEELADP---RLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~---~l~~~~---~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+...... ......... .....+ .......+.+++.+||+.+|++|||+.||+++
T Consensus 239 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISS--ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccc--hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 000000000 000000 01123468899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=335.23 Aligned_cols=254 Identities=28% Similarity=0.370 Sum_probs=199.3
Q ss_pred HhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.+-++.....||.|.||.||-|. .++|+..|||.++.... ...+.+.+|..++..|+|||+|+++|+-. +...++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee--cHHHHH
Confidence 34566777899999999999998 56799999998874432 23456889999999999999999999865 445889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|.||||++|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||.||||+.+|.+|++|||.|..
T Consensus 1311 IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999974 223556666778899999999999999 99999999999999999999999999988
Q ss_pred CCCCCcc--cccccccccccccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 535 APEGRTN--YLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 535 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+.....+ ..-...+||+.|||||++.+. ....++||||+|||++||+||++||...+. .|+-.+.-.
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~- 1455 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVA- 1455 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHh-
Confidence 7654211 112356899999999999753 456789999999999999999999964321 122111100
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .-....|.....+-.+++.+||+.||++|.++.|++++
T Consensus 1456 ----~----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 ----A----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----c----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0 01123344445556889999999999999999888765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=306.92 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
...|.+...||+|.|+.|.+|+.. ++..||||.+.+..... .+.+.+|+++|..++|||||+++.+... ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 457889999999999999999954 68999999997654332 3458899999999999999999999874 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+.+|.+++||..+ ..+....+..++.|+.++++|||+++ |+|||||++||||+.+.++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999763 34566888999999999999999999 999999999999999999999999999877
Q ss_pred CCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..+. .....+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+... +...-.+.++.+.+
T Consensus 206 ~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------lk~Lr~rvl~gk~r--- 273 (596)
T KOG0586|consen 206 DYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------LKELRPRVLRGKYR--- 273 (596)
T ss_pred cccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------cccccchheeeeec---
Confidence 6433 3456789999999999998776 589999999999999999999998432 21111122222211
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.+.-...++.++++++|-.+|.+|++++++.++-|.
T Consensus 274 ---------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 274 ---------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ---------ccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 122223357789999999999999999999877543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=325.13 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=190.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecC------
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------ 448 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~------ 448 (726)
+-..+|+..+.||+||||.||+++.+ ||+.||||++.... ........+|++.|++|+|||||+++..+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678999999999999999999965 89999999997653 22335678899999999999999987321000
Q ss_pred ----------------------------------------------------------------------CC--------
Q 004869 449 ----------------------------------------------------------------------DS-------- 450 (726)
Q Consensus 449 ----------------------------------------------------------------------~~-------- 450 (726)
++
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 00
Q ss_pred ---------------------------------CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHH
Q 004869 451 ---------------------------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497 (726)
Q Consensus 451 ---------------------------------~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~y 497 (726)
..+||=||||+..+|.++++.+.-.. .-...++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 13577889999988888887532111 346788999999999999
Q ss_pred HHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC----------------CCCcccccccccccccccCcccccc
Q 004869 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP----------------EGRTNYLSTRVMGTFGYVAPEYAMT 561 (726)
Q Consensus 498 LH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~----------------~~~~~~~~~~~~GT~~Y~APE~l~~ 561 (726)
+|+.+ ||||||||.||+||++..|||+|||+|.... .+......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998621 0111123456789999999999875
Q ss_pred C---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC--CChhhHHHHHHHH
Q 004869 562 G---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK--YPKEDFIRVCTIA 636 (726)
Q Consensus 562 ~---~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~--~~~e~~~~l~~Li 636 (726)
. .|+.|+|+||+||||+||+. ||.... +. ...+..+.+..+... +.......=..+|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER-------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER-------------ASILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HH-------------HHHHHhcccCCCCCCcccccccchHHHHHH
Confidence 4 59999999999999999986 454211 11 111222222222211 2222333447899
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 004869 637 AACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 637 ~~CL~~dP~~RPTm~EVl~~ 656 (726)
.++++.||++|||+.|+++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=316.99 Aligned_cols=145 Identities=28% Similarity=0.396 Sum_probs=128.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|.+.++||+|+||.||+|... +++.||||++...... ....+.+|++++..++|+||+++++++. +....+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEE
Confidence 67999999999999999999975 6889999999754322 2357888999999999999999998876 3458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
||||+++++|.++++. ...+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999964 235788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=294.77 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=202.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
..+.|+.-++||+||||.||-++.+ +|+.+|.|++.+.. .++..-.++|-+||.+++.+.||.+--.|. ....+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe--Tkd~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE--TKDAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec--CCCce
Confidence 3467888899999999999999854 69999999886432 334455788999999999999999866565 44589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
|||+..|.||+|.-+|.... +..+++..++-++.+|+.||++||... ||.||+||+|||||+.|+++|+|+|||.
T Consensus 261 ClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 99999999999999997533 246899999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.+..+... ...+||.+|||||++.+..|+...|-||+||+||||+.|+.||......... .+.-+..+.+
T Consensus 336 ei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~----- 405 (591)
T KOG0986|consen 336 EIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLED----- 405 (591)
T ss_pred ecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcc-----
Confidence 88876542 3348999999999999999999999999999999999999999633211000 0000111111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
...++..-.++..+|....|+.||++|-- +++|.+|
T Consensus 406 -------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 406 -------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred -------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 12345445556788888999999999964 4566554
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=278.48 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=192.6
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+.+..||.|..|.||+.+.. .|..+|||.+...+. .+.+.++..+.++.+-+ .|+||+.+|||.. +...+++||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHH
Confidence 344578999999999999965 589999999976543 34567888888877665 8999999999984 447889999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
.| ...++.+|+. ..+++.+..+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||||||++-.+-+.
T Consensus 172 lM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 98 3456666653 2345777888899999999999999865 3999999999999999999999999999877665
Q ss_pred CcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.. .++..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||......- +....++.+.
T Consensus 246 kA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~e------ 311 (391)
T KOG0983|consen 246 KA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEE------ 311 (391)
T ss_pred cc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcC------
Confidence 43 355679999999999864 478999999999999999999999997532111 1111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
-|.+.+. ......+++++..||+.|+.+||...+++++
T Consensus 312 -PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1222211 1123458899999999999999999999876
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=282.31 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=199.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
..++|+.+++||+|.||+|-+++- .+|+.+|+|++++.-. .+...-+.|-++|+..+||.+..|.-.|+ ....+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceE
Confidence 347899999999999999999984 4789999999986532 23345677999999999999988865554 45589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
|+||||..||.|.-+|.. ...+++....-+...|+.||.|||+.+ ||.||||.+|.|||.+|++||+||||++
T Consensus 244 CFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999999975 345788888889999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.--... ..+...+||+.|+|||++....|....|-|.+|||+|||++|+.||...+. ..+.+. ++ ++
T Consensus 317 E~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeL---Il-----~e 383 (516)
T KOG0690|consen 317 EEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFEL---IL-----ME 383 (516)
T ss_pred hccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHH---HH-----hh
Confidence 543222 235678999999999999999999999999999999999999999975432 111111 01 11
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
++ .+|.....+...|+...|..||.+|- .+.||.++
T Consensus 384 d~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 DL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11 23444445577899999999999995 35566544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.32 Aligned_cols=220 Identities=20% Similarity=0.208 Sum_probs=174.5
Q ss_pred cCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhc
Q 004869 391 GGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 469 (726)
Q Consensus 391 G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L 469 (726)
|.||.||+++. .+++.||+|++.... .+.+|...+....||||+++++++. +....+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHH
Confidence 89999999996 468899999997432 3445566666667999999999887 445899999999999999998
Q ss_pred cCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccc
Q 004869 470 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549 (726)
Q Consensus 470 ~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~G 549 (726)
.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||++....... ....+
T Consensus 77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~ 144 (237)
T cd05576 77 SK----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV 144 (237)
T ss_pred HH----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence 64 234899999999999999999999998 9999999999999999999999999886654321 22345
Q ss_pred cccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhH
Q 004869 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF 629 (726)
Q Consensus 550 T~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~ 629 (726)
+..|+|||++.+..++.++||||+|+++|||++|+.|+....... ..... ...+....
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~----------~~~~~~~~ 202 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTT----------LNIPEWVS 202 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccccc----------cCCcccCC
Confidence 778999999988889999999999999999999998875321100 00000 01122223
Q ss_pred HHHHHHHHHccccCCCCCCCHH
Q 004869 630 IRVCTIAAACVAPEANQRPTMG 651 (726)
Q Consensus 630 ~~l~~Li~~CL~~dP~~RPTm~ 651 (726)
..+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 4578999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=266.98 Aligned_cols=238 Identities=31% Similarity=0.410 Sum_probs=191.4
Q ss_pred CcEEEEEEEEC-CCcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhc
Q 004869 392 GFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 469 (726)
Q Consensus 392 ~fG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L 469 (726)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence 58999999976 48999999998665544 6789999999999999999999999874 45889999999999999998
Q ss_pred cCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccc
Q 004869 470 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549 (726)
Q Consensus 470 ~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~G 549 (726)
.... .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......+
T Consensus 79 ~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 79 KKRG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred Hhcc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 7422 2889999999999999999999998 9999999999999999999999999998765532 2234568
Q ss_pred cccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChh-h
Q 004869 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE-D 628 (726)
Q Consensus 550 T~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e-~ 628 (726)
+..|++||.+....++.++|||+||++++||++|..||.... .......+.. ........... .
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~-------------~~~~~~~~~~~~~ 213 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG-------------KPKPPFPPPEWKI 213 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh-------------ccCCCCccccccC
Confidence 889999999998889999999999999999999999986421 1111111111 00000000000 3
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 629 FIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 629 ~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+.+++.+|+..+|++||++.+++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 3468899999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=278.22 Aligned_cols=268 Identities=23% Similarity=0.401 Sum_probs=205.1
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecC
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSR 448 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~ 448 (726)
+++++.+.|. +.||+|+|+.|--++ +.+|.++|||++.+..........+|++++.+.+ |+||++|+.+|+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-- 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE-- 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--
Confidence 4566666553 789999999999887 6789999999998776666788999999999985 999999999997
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC---cEE
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK 525 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~---~vK 525 (726)
+....|||||-|.||+|..+|++ .+.+++.++.++..+|+.||.|||.++ |.|||+||+|||..+.. -+|
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred ccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCcee
Confidence 55689999999999999999986 457899999999999999999999999 99999999999996543 489
Q ss_pred EEecCccccCCCCCcc-----cccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 004869 526 VADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 595 (726)
Q Consensus 526 L~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~ 595 (726)
|+||.|..-....... ..-...+|+..|||||+.. ...|+.++|.||||||||-|++|..||...-..+-
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 9999987644322111 1112467899999999763 34678999999999999999999999965432221
Q ss_pred chhhhhhhhhcc---chhhhhhhcCCccCCCCChhhH----HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 596 ENLVTWARPILR---DKDRLEELADPRLGGKYPKEDF----IRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 596 ~~l~~~~~~~~~---~~~~l~~i~d~~l~~~~~~e~~----~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.|-+...- +....+.+.+.. -++|.++. .+..+++...+..|+.+|-++.+++++-+
T Consensus 300 ----GWdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 300 ----GWDRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred ----CccCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 12111100 011222222222 24555443 34567888899999999999999998643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=303.37 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=216.7
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeec
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 447 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~ 447 (726)
+.++.+..-++.|++.+.||.|.+|.||+++ .++++.+|+|++... ....++...|.++|+.+ +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444555567789999999999999999999 557889999988644 34467788899999987 69999999999864
Q ss_pred C---CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 448 R---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 448 ~---~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
. .+.++|||||||.+|+..|++++.. ...+.|+.+..|+..+++||.+||.+. ++|||||-.||||+.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 2 3568999999999999999998765 567999999999999999999999998 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
||.|||++........ .....+||+.|||||++.. ..|+.++|+||||++-.||.-|.+|+.+..+...
T Consensus 163 KLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---- 236 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 236 (953)
T ss_pred EEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----
Confidence 9999999987765433 3455789999999999864 3577899999999999999999999875443211
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+ +....+|...-.-+..-..++.++|..||..|-++||++.+++++
T Consensus 237 -----L------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -----L------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----h------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 111123333334466777889999999999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=298.42 Aligned_cols=265 Identities=22% Similarity=0.332 Sum_probs=184.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-----------------CCCcEEEEEEcccCCCCchhH--------------HHHH
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-----------------SDGTAVAIKRLTCGGQQGDKE--------------FLVE 426 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~E 426 (726)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 235689999987543322233 3457
Q ss_pred HHHHHhcccCce-----eEEEEEeecC------CCCceEEEEeecCCCChhhhccCCCCC--------------------
Q 004869 427 VEMLSRLHHRNL-----VKLVGYYSSR------DSSQHLLCYELVPNGSLESWLHGPLGV-------------------- 475 (726)
Q Consensus 427 i~iL~~L~HpNI-----V~llg~~~~~------~~~~~~LV~Ey~~~GsL~d~L~~~~~~-------------------- 475 (726)
+.++.+++|.++ +++++||... +....+|||||+++|+|.++|+...+.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 6788887532 234689999999999999999743210
Q ss_pred cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccC
Q 004869 476 NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555 (726)
Q Consensus 476 ~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 555 (726)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567889999999999999999998 99999999999999999999999999976543221 11122345889999
Q ss_pred ccccccCC----------------------CCcchhHHHHHHHHHHHHhCCC-CCCCCCCCc------cchhhhhhhhhc
Q 004869 556 PEYAMTGH----------------------LLVKSDVYSYGVVLLELLTGRK-PVDMSQPSG------QENLVTWARPIL 606 (726)
Q Consensus 556 PE~l~~~~----------------------~s~ksDVwSfGvvL~ELltG~~-Pf~~~~~~~------~~~l~~~~~~~~ 606 (726)
||.+.... ...+.||||+||+++||++|.. |+....... ...+..|.. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence 99875432 1235799999999999999875 664221100 011111111 00
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCC---CCCCCHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA---NQRPTMGEVVQSL 657 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP---~~RPTm~EVl~~L 657 (726)
.. ...-...........+++.++|..+| .+|+|++|+++|-
T Consensus 458 ~~----------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 458 GQ----------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred cc----------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 00 00000111223457789999999766 6899999999873
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=313.80 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=209.8
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeec
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~ 447 (726)
..+++-..++|+++++||+|+||.|..++.+ +++.||+|++.+. ...+..-|..|-.+|..-+.+=|+++.-.|.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ- 145 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ- 145 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-
Confidence 4556667799999999999999999999965 6889999999752 2344567888999999888888888864444
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
|..++|||||||+||+|-.++.+. . .+++..+.-++..|+-||.-||+.| +|||||||+|||||..|++||+
T Consensus 146 -D~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 -DERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred -CccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 777999999999999999999752 2 6888999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM----T-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
|||.+-.+...+ ...+...+|||-|++||++. + +.|+..+|-||+||++|||+.|..||.. ++++.-.
T Consensus 218 DFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY 290 (1317)
T KOG0612|consen 218 DFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETY 290 (1317)
T ss_pred cchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHH
Confidence 999998776543 33556678999999999985 2 5789999999999999999999999973 4555544
Q ss_pred hhhccchhhhhhhcCCccCCCCC--hhhHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPT---MGEVVQSL 657 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~--~e~~~~l~~Li~~CL~~dP~~RPT---m~EVl~~L 657 (726)
..++..++.+ .+| .+...+..+||++.+. +|+.|-. ++++-.|-
T Consensus 291 ~KIm~hk~~l----------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 291 GKIMNHKESL----------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHHhchhhhc----------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 4444433222 222 2234567788888777 5888988 88888774
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=304.99 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=171.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-C----CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEe----ecC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-D----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY----SSR 448 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~----~~~ 448 (726)
..++|++.+.||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.++..++..+ ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 68999999863221 1222221 11222222222222111 113
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCC----------------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGV----------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 512 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~----------------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIK 512 (726)
+....+|||||+++++|.++++..... ........+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456889999999999999998642100 001123345679999999999999998 9999999
Q ss_pred ccceeecC-CCcEEEEecCccccCCCCCcccccccccccccccCccccccC----------------------CCCcchh
Q 004869 513 ASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----------------------HLLVKSD 569 (726)
Q Consensus 513 p~NILLd~-~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~~s~ksD 569 (726)
|+|||+++ ++.+||+|||+++...... .+......+|+.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 6899999999998664432 2234456789999999965321 2445779
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh---hhhcCCccC----CCC--ChhhHHHHHHHHHHcc
Q 004869 570 VYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL---EELADPRLG----GKY--PKEDFIRVCTIAAACV 640 (726)
Q Consensus 570 VwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l---~~i~d~~l~----~~~--~~e~~~~l~~Li~~CL 640 (726)
||||||+||||+++..+++.. +..+.+.+....... .....+... ..+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987665421 111111110000000 001111100 000 0011123458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004869 641 APEANQRPTMGEVVQS 656 (726)
Q Consensus 641 ~~dP~~RPTm~EVl~~ 656 (726)
+.||++|||+.|+++|
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999987
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.43 Aligned_cols=207 Identities=27% Similarity=0.343 Sum_probs=170.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC---C--CcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS---D--GTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~---~--g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
....|+....||+|.||.||+|.-. + ...+|+|+++.... .-.....+|+.+++.++|+|++.|..++... .
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 3456888999999999999999632 2 23799999985532 2235678999999999999999999998754 5
Q ss_pred CceEEEEeecCCCChhhhccCCC-CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC----CcEE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAK 525 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~-~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~----~~vK 525 (726)
...+|++||.+. +|...|+-++ ...+.+.-..+..|+.||+.|+.|||++- |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 689999999977 8888875332 22346888899999999999999999998 9999999999999876 9999
Q ss_pred EEecCccccCCCCCc-ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 004869 526 VADFGLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDM 589 (726)
Q Consensus 526 L~DFGla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~ 589 (726)
|+|||+++.+.+.-. .+....++-|..|.|||.+.+ .+|+.+.|||+.|||+.||+|-.+-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999998765332 223446788999999999886 4789999999999999999998777753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.16 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=198.8
Q ss_pred hcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCC-Cc------hhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QG------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~-~~------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++|-++.+||+|||+.||+|. +...+.||||+-..+.. .+ .+...+|.+|-+.|.||.||++++|+.- +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-cc
Confidence 3567788999999999999998 55678999998654321 11 2346789999999999999999999864 45
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVA 527 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~ 527 (726)
...|-|+|||+|.+|+-||+. .+.+++.++..|+.||+.||.||.+.. |+|||.||||.||||.+ -|.+||.
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 678999999999999999976 446899999999999999999999886 55999999999999954 5789999
Q ss_pred ecCccccCCCCCcc-----cccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 004869 528 DFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 598 (726)
Q Consensus 528 DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l 598 (726)
||||++.+...... ..++...||..|++||.+.-+ ..+.|.||||.|||+|..+.|+.||..... +..+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 99999988765433 235567899999999987643 568899999999999999999999975432 1222
Q ss_pred hhhhhhhccchhhhhhhcCCccCCCCC--hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004869 599 VTWARPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655 (726)
Q Consensus 599 ~~~~~~~~~~~~~l~~i~d~~l~~~~~--~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~ 655 (726)
..+.. ++ ...- -.+| +....+...+|++||+..-++|....++..
T Consensus 694 LqeNT-Il----------kAtE-VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENT-IL----------KATE-VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhhc-hh----------ccee-ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 21110 01 1000 0111 122334678999999999999987777654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=270.28 Aligned_cols=256 Identities=23% Similarity=0.280 Sum_probs=198.9
Q ss_pred HhcCcccc-eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecC--CCCc
Q 004869 378 ATNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR--DSSQ 452 (726)
Q Consensus 378 ~t~~f~~~-~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~--~~~~ 452 (726)
.+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|.+. +.....+|+++-=.. .|+|||.++++|.+. ....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 67999999999988854 68999999986 234557788865444 599999999998742 3446
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEec
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADF 529 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DF 529 (726)
+++|||.|+||.|...+... ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 77999999999999999763 2456999999999999999999999999 999999999999964 567999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
|+|+...... .....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........ . .
T Consensus 209 GFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---s---------p 273 (400)
T KOG0604|consen 209 GFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---S---------P 273 (400)
T ss_pred ccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---C---------h
Confidence 9999765432 23456789999999999999999999999999999999999999975432110 0 0
Q ss_pred hhhhhhcCCccCCCCChhh----HHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKED----FIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~----~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
+.-..+.... -.+|.++ .+...++|+.+|..+|.+|-|+.|++.+-+.-
T Consensus 274 gMk~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 274 GMKRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred hHHhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 0011111111 1233332 34567899999999999999999999875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=292.50 Aligned_cols=244 Identities=24% Similarity=0.286 Sum_probs=195.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++.|+....+|.|+|+.|-++.. .+++..+||++... ..+-.+|+.++... +|+||+++.+.+. +..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceec--CCceeee
Confidence 367788888999999999999885 46789999999754 23345678777666 6999999999987 5668999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee-cCCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL-d~~~~vKL~DFGla~~ 534 (726)
|||++.+|-|.+.+... .... ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999988877642 1223 677889999999999999999 9999999999999 6999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... ....+-|..|.|||++....|++++|+||||++||+|++|+.||...... .++ +..
T Consensus 466 ~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-------------~~~ 525 (612)
T KOG0603|consen 466 LERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-------------HTR 525 (612)
T ss_pred Cchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-------------HHh
Confidence 7654 12335688999999999999999999999999999999999999754322 111 111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+.. +.+.........+|+.+||+.||.+||+|.++..+-+.
T Consensus 526 i~~----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 526 IQM----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hcC----CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 12223344567899999999999999999999987554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=274.96 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=189.2
Q ss_pred cceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHh-cccCceeEEEEEeecCCCCceEEEEeec
Q 004869 384 PASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSR-LHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~-L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
.+..||.|.||+|+|-.++ .|+..|||++..... .+.++++.|.+...+ -+.||||+++|.+. ..+..|++||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cCCceeeeHHHH
Confidence 3577999999999998864 689999999986654 455788899887555 46899999999876 345899999999
Q ss_pred CCCChhhhccCC-CCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 461 PNGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 461 ~~GsL~d~L~~~-~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+ -||+.+.+.- .-....+.+.-+-+|+...++||.||.+.-+ |+|||+||+|||||..|.+||||||++-.+.++-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 4 4766554310 0113357778888888889999999987653 9999999999999999999999999997665432
Q ss_pred cccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
..+...|-..|||||.+.. ..|+.++||||||++|+|+.||+.||.... +..+....+.... -
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd-------p 287 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD-------P 287 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC-------C
Confidence 3355678899999999863 458999999999999999999999996432 1111111111110 0
Q ss_pred CccCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~-~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
|.+... -..+....++.++..|+..|-++||...++.++
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111110 011234468899999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=273.50 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=198.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhccc--C----ceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--R----NLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--p----NIV~llg~~~~~~~ 450 (726)
.+++|.+...+|+|.||.|-.+... .+..||||+++.-.. -.+..+-|+++|.++.+ | -+|.+.+||.. .
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--r 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--R 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--c
Confidence 3788999999999999999998854 478999999974322 23456779999999942 2 37778788763 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC----------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---------- 520 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---------- 520 (726)
++.|+|+|.+ |-|+.|+|.. +...++....+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 5899999998 6699999986 33456888999999999999999999999 999999999999942
Q ss_pred ----------CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 521 ----------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 521 ----------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
+..+||+|||.|....+.. +..+.|..|.|||++.+..++..+||||+||||.|+.+|..-|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998755433 4567899999999999999999999999999999999999988765
Q ss_pred CCCccchhhhh--------------hhhhccchhhhh-----------hhcCCc----cCCCCChhhHHHHHHHHHHccc
Q 004869 591 QPSGQENLVTW--------------ARPILRDKDRLE-----------ELADPR----LGGKYPKEDFIRVCTIAAACVA 641 (726)
Q Consensus 591 ~~~~~~~l~~~--------------~~~~~~~~~~l~-----------~i~d~~----l~~~~~~e~~~~l~~Li~~CL~ 641 (726)
+..+..-+.+- ....+..+ +++ .+.++- ..-.....+..++.+|+..||.
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 53322111100 00000000 000 000000 0001234556679999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004869 642 PEANQRPTMGEVVQS 656 (726)
Q Consensus 642 ~dP~~RPTm~EVl~~ 656 (726)
.||.+|+|+.|++++
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=271.60 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=194.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
.+|..+.+||+|+||+|.+|..+ +.+.+|||+++++-. ++.+--+.|-++|.-. +-|.++++..+++.. ..+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLy 426 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLY 426 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--hhee
Confidence 47888999999999999999865 467899999986522 2223346677887766 468888988887644 4899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+.||+|--++++ -+.+.+..+.-+|..||-||-+||+.+ |+.||||..||+||.+|++||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999988875 345777889999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
---... .+...+||+.|+|||++....|....|-|||||+||||+.|+.||+..+.. +....
T Consensus 500 ni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~a 561 (683)
T KOG0696|consen 500 NIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQA 561 (683)
T ss_pred cccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHH
Confidence 433322 345689999999999999999999999999999999999999999864321 11222
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 648 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP 648 (726)
+.+.. -.+|.....+...+....|...|.+|-
T Consensus 562 I~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 IMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 22222 256777777788899999999999994
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=279.11 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=192.5
Q ss_pred ceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 385 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
.++||+|.||+||-|.. ++|+.||||.+.+.. ......+.+|+.||++++||.||.|...|+. ....+.|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhc
Confidence 48899999999999995 479999999997543 2334678999999999999999999988874 448899999995
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC---CcEEEEecCccccCCCC
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGLAKQAPEG 538 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~---~~vKL~DFGla~~~~~~ 538 (726)
|.-|+-.|.. ..++|++....-+..||+.||.|||.++ |+|+||||+||||.+. -.+||||||+|+.+++.
T Consensus 647 GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 647 GDMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred chHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 5444444442 2446888888889999999999999999 9999999999999643 47999999999998765
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
. ....++||+.|+|||+++.+.|...-|+||.|||+|--++|..||...... .+. +++ ..-+.-+
T Consensus 721 s---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----ndQ----IQN---AaFMyPp 785 (888)
T KOG4236|consen 721 S---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----NDQ----IQN---AAFMYPP 785 (888)
T ss_pred h---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hHH----hhc---cccccCC
Confidence 3 345678999999999999999999999999999999999999999743211 110 000 0011111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.... +......++|...|+..-.+|-+.+.-+.+-
T Consensus 786 ~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 786 NPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred Cchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1111 2233467899999999999999998877653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=243.86 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=193.7
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+|...++||+|.||+||+|+. ++++.||+|+++.++.. .....++|+-+|+.++|.|||+++++... ...+-||+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 466678999999999999994 46889999999765433 24578999999999999999999998753 34788999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|||. .+|.+|... .++.++.+....++.|+++||.++|+++ +.|||+||.|.|++.+|+.|++|||+++.++-
T Consensus 81 e~cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HHhh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9995 488888753 2446888999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhh--ccch--hh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPI--LRDK--DR 611 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~--~~~~--~~ 611 (726)
.-.. .+..+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++-|...+-.++ +...++.+ ..+. ..
T Consensus 154 pvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred ceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCc
Confidence 4322 2345678999999999875 57899999999999999987 5555554332222 22211111 1110 11
Q ss_pred hhhhcCCccCCCCChh---------hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPRLGGKYPKE---------DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e---------~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+..+.|-..-..++.. ....=.+++...+.-+|.+|.++++.+++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2223332222222211 11123466777777799999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=293.72 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=188.1
Q ss_pred CcccceeeeecCcEE-EEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEe
Q 004869 381 NFEPASILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~-Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
-|...+++|.|+.|+ ||+|.+ +|+.||||++-.+ ......+|+..|+.- +|+|||++++. +.+....|++.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEEeh
Confidence 345567899998876 899999 4789999999632 234557899999887 59999999654 557778999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-----CCcEEEEecCccc
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAK 533 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-----~~~vKL~DFGla~ 533 (726)
.| ..+|.|++...........-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 45999999864111111222556788999999999999998 999999999999965 3679999999999
Q ss_pred cCCCCCcccc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
....+..... .....||.||+|||++....-+..+||||+|||+|..++| .+||...-.. +.| ++.....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~~~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILTGNYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhcCccc
Confidence 8876554322 3456799999999999988888899999999999999985 8999643211 111 1222211
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+..+.. ..++ +..+||.+|++.+|..||++.+|+.|
T Consensus 732 L~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111110 1111 57889999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=263.75 Aligned_cols=270 Identities=22% Similarity=0.341 Sum_probs=197.8
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecC------CCC
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DSS 451 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~------~~~ 451 (726)
.|+...+||+|.||.||+|+.+ +|+.||+|++...++. -...-++|+++|..++|+|++.++..|... +..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4566789999999999999954 5788999887543322 235678999999999999999999988642 234
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..||||++|+. +|..+|... ...++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999976 888888642 345888999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCc--ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh--------
Q 004869 532 AKQAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT-------- 600 (726)
Q Consensus 532 a~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~-------- 600 (726)
++.+..... ....+..+-|..|.+||.+.+ ..|+.+.|||.-|||+.||+||.+-+.......+..++.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 986643321 112345667999999998875 578999999999999999999998776543222221111
Q ss_pred hhhhhccchhhhhhhcCCccC-CCCC--hhh------HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLG-GKYP--KED------FIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~-~~~~--~e~------~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
-+|+...+-...+.+-.+-+. +.+. .+. ..+.++|+..++..||.+|+++++++++-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111111111111111010 1000 000 12468899999999999999999998774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=236.87 Aligned_cols=210 Identities=36% Similarity=0.572 Sum_probs=181.1
Q ss_pred eeecCcEEEEEEEECC-CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCCh
Q 004869 388 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 465 (726)
Q Consensus 388 LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL 465 (726)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++.. ....++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence 6899999999999764 899999999755432 34679999999999999999999999874 3588999999999999
Q ss_pred hhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecCccccCCCCCccccc
Q 004869 466 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLS 544 (726)
Q Consensus 466 ~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~~~~~~~~~~~ 544 (726)
.+++.... ..+++..+..++.+++++|++||+.+ ++|+||++.||+++. ++.++|+|||.+........ ..
T Consensus 79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 99987421 35889999999999999999999998 999999999999999 89999999999987654321 12
Q ss_pred ccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC
Q 004869 545 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623 (726)
Q Consensus 545 ~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 623 (726)
....+...|++||..... ..+.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 334578899999998877 888999999999999999
Q ss_pred CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 624 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 624 ~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.+++..|++.+|++||++.+++++
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=276.45 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCc-EEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~-~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.+++....||-||||.|-++..++.. .+|+|.+++.. ....+....|-++|...+.+.||+++.-|. +....|+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYm 497 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYM 497 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhh
Confidence 45666788999999999999876533 38888887543 333456788999999999999999988776 6668999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+||-|-||.|...|++ ++.++..+..-++..+.+|++|||+++ ||.|||||+|.+||.+|-+||.|||+|+.+
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999976 456888889999999999999999999 999999999999999999999999999998
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..+.. +-.++||+.|.|||++.++..+..+|.||||+++|||++|++||...++....+++ +.. ++.+
T Consensus 571 ~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkG---id~i 638 (732)
T KOG0614|consen 571 GSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKG---IDKI 638 (732)
T ss_pred ccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhh---hhhh
Confidence 77653 34578999999999999999999999999999999999999999876654333321 211 2222
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK 658 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~L~ 658 (726)
.+|........+|+++.+..+|.+|-- +.+|-+|-|
T Consensus 639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 639 -------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 223333344678888989999999976 677777654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=272.72 Aligned_cols=207 Identities=25% Similarity=0.368 Sum_probs=170.4
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
-|..++.||-|+||.|.+++. ++...+|+|.+.+.+- +.......|-.||...+.+-||+|+-.|. |...+|+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ--DkdnLYFV 707 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV 707 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec--cCCceEEE
Confidence 366778899999999999984 4567899999976542 22345678999999999999999965544 67799999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++||++-.+|-+ .+.+.+..++-++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998864 234677778888899999999999999 9999999999999999999999999985331
Q ss_pred ---------CCCc-------------------------------ccccccccccccccCccccccCCCCcchhHHHHHHH
Q 004869 537 ---------EGRT-------------------------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 576 (726)
Q Consensus 537 ---------~~~~-------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvv 576 (726)
+++. .+.....+||+.|+|||++....++.-+|-||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 011123679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCccc
Q 004869 577 LLELLTGRKPVDMSQPSGQE 596 (726)
Q Consensus 577 L~ELltG~~Pf~~~~~~~~~ 596 (726)
||||+.|+.||-...+.+..
T Consensus 861 l~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHHHhhCCCCccCCCCCcce
Confidence 99999999999877766543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=244.41 Aligned_cols=205 Identities=29% Similarity=0.419 Sum_probs=168.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC-CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
..++......||+|++|.|-+-++ .+|+..|||++... ..+..+..++|+.+..+- ..|.+|.++|.+. +....+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEE
Confidence 344555568899999999988874 47999999999754 334456788899886654 6999999999765 456899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++||.|. -||+.+-++-...+..+.+.-+-+|+..+.+||.|||++-+ ++|||+||+|||++.+|++|+||||++-.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccccccee
Confidence 9999994 48888776544456678889999999999999999998754 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAM----TGHLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
+.++-. .+...|-..|||||.+. ...|+.|+||||||+.+.||.+++.||+..
T Consensus 199 L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 655432 23356788999999885 347899999999999999999999999743
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=252.12 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=197.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---hhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|.++++||+|+|.+|.++++. +.+.+|+|++++.-..+ ..-.+.|-.+..+. +||.+|.|..+|. ....+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceE
Confidence 468999999999999999999964 67899999998653322 23356687787766 6999999998876 44589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++|.||++||+|--++++ ...|.++.+.-+...|+-||.|||+.| |+.||||..|+|||..|++||.|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 999999999999887764 446889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-ccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~l 612 (726)
.--... ..++..+||+.|+|||++++..|....|-|++||+++||+.|+.||+...-. ...+..++.-+++-
T Consensus 400 e~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil----- 472 (593)
T KOG0695|consen 400 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL----- 472 (593)
T ss_pred cCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-----
Confidence 643322 2356789999999999999999999999999999999999999999854311 12333333322221
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 648 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP 648 (726)
...+ ..|.....+...+++.-|+.||.+|-
T Consensus 473 ----ekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 ----EKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----hhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 1112 23444445667888999999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=256.12 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=196.6
Q ss_pred ccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCC---CCceEEE
Q 004869 383 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHLLC 456 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~~LV 456 (726)
+..+-||.|+||.||..+. ++|+.||.|++..- +....+.+.+|+++|..++|.|++..++...-.. -.+.|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999885 47999999998632 2223578899999999999999999888654221 1256788
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+|.|. .+|.+.+-. ...++-..+.-+..||++||+|||+.+ |.||||||.|.|++.+...||||||+++...
T Consensus 136 TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 89884 488888864 346888888889999999999999999 9999999999999999999999999999766
Q ss_pred CCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh--------hcc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP--------ILR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~--------~~~ 607 (726)
..... .++..+-|..|.|||++++. +|+.+.||||.|||+.||+..+.-|....+..+..++.-... ..-
T Consensus 208 ~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 54433 34556788999999999974 789999999999999999999988876665554443321100 000
Q ss_pred chhhhhhhcC----CccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 608 DKDRLEELAD----PRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 608 ~~~~l~~i~d----~~l~~----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
++.+...+.. +.+.. ..+...-.+...+...++..||++|.+.++.+.++-
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0001011100 00000 001122234566788899999999999999887753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=233.09 Aligned_cols=199 Identities=35% Similarity=0.481 Sum_probs=170.7
Q ss_pred cccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 382 FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++.. ....++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence 5667899999999999999765 889999999865544 56789999999999999999999999863 4578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++++|.+++..... .+++..+..++.+++++|.+||+.+ ++|+||+++||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999975221 1789999999999999999999998 9999999999999999999999999998765442
Q ss_pred cccccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPVDM 589 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~ 589 (726)
.. ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11 12334678899999998 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=231.08 Aligned_cols=261 Identities=19% Similarity=0.316 Sum_probs=199.2
Q ss_pred hcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+++|+|.|+.||.|. ..+++.++||.++ .-..+...+|+++|..|+ |+||++|+++..+.......|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5789999999999999999998 5578899999997 344678899999999997 9999999999988888889999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFGla~~~ 535 (726)
+||+.+.+...+.. .|+.-.+...+.+++.||.|+|+.| |.|||+||.|+++|.. -..+|+|+|+|...
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999988766543 3777888999999999999999999 9999999999999864 56999999999877
Q ss_pred CCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc------
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD------ 608 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~------ 608 (726)
..+... ...+.+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||...... .++++..++-+-.+
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence 654432 22345667888998864 56788899999999999999999999644322 23344333211100
Q ss_pred -------hhhhhhhcCCccCCC---C-C---h-hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 -------KDRLEELADPRLGGK---Y-P---K-EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 -------~~~l~~i~d~~l~~~---~-~---~-e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+.++....+.. + . . -...+..+++...|..|-.+|+|+.|...+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011122111111100 0 0 0 112457889999999999999999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=246.13 Aligned_cols=266 Identities=21% Similarity=0.308 Sum_probs=193.9
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-----c---CceeEEEEEeec--C
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----H---RNLVKLVGYYSS--R 448 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~llg~~~~--~ 448 (726)
.+|.+.++||-|.|++||++.. .+.+.||+|+.+.. ..-.+..+.||++|++++ | ..||+|+++|.. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5789999999999999999984 46789999998743 333566788999999984 2 469999999864 4
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-------
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN------- 521 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~------- 521 (726)
++.++|||+|++ |-+|..+|... ..+.+....+.+|+.||+.||.|||.++ +|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 467899999999 77899998742 2345888999999999999999999987 49999999999999310
Q ss_pred ----C---------------------------------------------------------------------------
Q 004869 522 ----F--------------------------------------------------------------------------- 522 (726)
Q Consensus 522 ----~--------------------------------------------------------------------------- 522 (726)
+
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 004869 523 -------------------------------------------------------------------------------- 522 (726)
Q Consensus 523 -------------------------------------------------------------------------------- 522 (726)
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc----cchh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG----QENL 598 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~----~~~l 598 (726)
++||+|||-|.-... ..+....|..|.|||++.+..|+..+||||++|++|||+||..-|+-....+ +..+
T Consensus 392 ~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 012222222221111 0122345778999999999999999999999999999999999986433211 1111
Q ss_pred ---h----hhhhhhccchhhhhhhcCCc--------c-----------CCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 004869 599 ---V----TWARPILRDKDRLEELADPR--------L-----------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652 (726)
Q Consensus 599 ---~----~~~~~~~~~~~~l~~i~d~~--------l-----------~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~E 652 (726)
+ ..-+.+...+..-.++++.+ | ...++.++..++.+++.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 11122222222222222221 0 12457788889999999999999999999999
Q ss_pred HHHH
Q 004869 653 VVQS 656 (726)
Q Consensus 653 Vl~~ 656 (726)
.+++
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=262.52 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=202.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
-.++|+....+|.|.||.|||++. ..++..|||.++.....+..-.+.|+-+++..+|+|||.++|-|... ...+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh--cCcEEE
Confidence 356899999999999999999995 46899999999987777777788999999999999999999988744 478999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||||.+|+|.+.-+. ..++++.++..++....+||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+.
T Consensus 91 MEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 999999999998875 457999999999999999999999999 7899999999999999999999999987665
Q ss_pred CCCcccccccccccccccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l---~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..-. ....+.||+.|||||+. +.+.|..++|||+.|+...|+---+.|.....+.. .+. +..+.
T Consensus 164 ati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~------LmTkS--- 230 (829)
T KOG0576|consen 164 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALF------LMTKS--- 230 (829)
T ss_pred hhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHH------Hhhcc---
Confidence 4322 23457899999999976 46789999999999999999987777754332221 110 00000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...-+.++.+ ..-..-+-++++.|+..+|++||+++.++++
T Consensus 231 ~~qpp~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 231 GFQPPTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCCcccCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0011112111 1123347789999999999999999887653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=236.22 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=192.8
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~~ 452 (726)
.+|.-+..+|.|.- .|..+.. -.++.||+|++... .....+...+|..++..++|+||++++.++.-.. ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 5555442 24789999998644 3344567889999999999999999999886322 346
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.|+||||| .++|...++. .++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 79999999 5689888862 3566788899999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh---------
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR--------- 603 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~--------- 603 (726)
+..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+. ..+..|.+
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcCCC
Confidence 865433 3456678899999999999888999999999999999999999888632 22222221
Q ss_pred ------------hhccchhh-----h-hhhcCCccCC--CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 ------------PILRDKDR-----L-EELADPRLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ------------~~~~~~~~-----l-~~i~d~~l~~--~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+...+ . +.+.|..... ..+........+++.+||-.||++|-+++++++|
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111000 0 0111111110 1111223356789999999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=249.62 Aligned_cols=197 Identities=24% Similarity=0.387 Sum_probs=167.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhcc---cCceeEEEEEee
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLH---HRNLVKLVGYYS 446 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~---HpNIV~llg~~~ 446 (726)
..+|...+.+|+|+||.|+++.++ +...|+||.+.+...-. .-..-.||.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999976 46789999887543211 112445999999997 999999999998
Q ss_pred cCCCCceEEEEeec-CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 447 SRDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~-~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
+...+||+||-. ++-+|.++|.. ...+++.++..|+.||+.|+++||+.+ |+|||||-+|+.++.+|-+|
T Consensus 640 --ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 640 --DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred --cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 455899999965 56789999964 456899999999999999999999999 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
|+|||.+.....+.- ..++||.+|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus 711 lidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999987766542 457899999999999988874 56899999999999999988885
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=246.89 Aligned_cols=274 Identities=23% Similarity=0.252 Sum_probs=202.0
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc------cCceeEEEE
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH------HRNLVKLVG 443 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~------HpNIV~llg 443 (726)
.+.--+....+|.+....|+|-|++|.+|... -|..||||++..+.. -.+.=+.|+++|++|+ .-|+++|+-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33333445678999999999999999999854 477999999985432 2355678999999995 347788877
Q ss_pred EeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-C
Q 004869 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-F 522 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~ 522 (726)
.|. ...++|||+|-+ ..+|.+.|++ .+.+..|....+..++.|+.-||..|...+ |+|.||||.|||+++. .
T Consensus 502 ~F~--hknHLClVFE~L-slNLRevLKK-yG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 502 HFK--HKNHLCLVFEPL-SLNLREVLKK-YGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN 574 (752)
T ss_pred Hhh--hcceeEEEehhh-hchHHHHHHH-hCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence 665 455899999988 5699999985 344566888999999999999999999998 9999999999999874 5
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
.+||||||.|....+... +...-+..|.|||++.+..|+...|+||.||.||||.||+..|.+........+..-.
T Consensus 575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 789999999987765432 1122345699999999999999999999999999999999988765433222111110
Q ss_pred -----hhhccchhhhhhhcCCcc--------------------------------C--CCCChhh---HHHHHHHHHHcc
Q 004869 603 -----RPILRDKDRLEELADPRL--------------------------------G--GKYPKED---FIRVCTIAAACV 640 (726)
Q Consensus 603 -----~~~~~~~~~l~~i~d~~l--------------------------------~--~~~~~e~---~~~l~~Li~~CL 640 (726)
..+++.+.-..+-+|..+ . ..++.++ ...+.+|+..|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 111111111111111110 0 1133333 356788999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004869 641 APEANQRPTMGEVVQS 656 (726)
Q Consensus 641 ~~dP~~RPTm~EVl~~ 656 (726)
..||++|-|..+.++|
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=223.33 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=187.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.+.|.+.+.||+|.||.+-++.++ ..+.+++|-+... ....++|.+|...--.| .|.||+.-+++... ....++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEEEe
Confidence 467888999999999999999976 4678999988643 23467899998876666 59999988765332 34477899
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee-c-CCCcEEEEecCcccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-E-NNFHAKVADFGLAKQ 534 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL-d-~~~~vKL~DFGla~~ 534 (726)
+||++.|+|..-+.. ..+.+....+++.|++.|+.|+|+++ +||||||.+|||+ + +..++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999988753 23677888999999999999999999 9999999999999 3 345899999999986
Q ss_pred CCCCCcccccccccccccccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
.+..- ....-+..|.+||..... ...+.+|||.||++++.++||+.||... ......+..|..-.-+..
T Consensus 173 ~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccC
Confidence 54322 223345679999976543 3457799999999999999999999732 233344455543222221
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..+ |+.-..+. .++.++-++-+..++++|--..++.++.
T Consensus 247 ~~~-----P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PAL-----PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccC-----chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 11112222 3466778888999999996666655543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.10 Aligned_cols=169 Identities=21% Similarity=0.198 Sum_probs=127.1
Q ss_pred CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccc
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 542 (726)
|+|.++++.. ...++|.+++.++.|+++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999742 345999999999999999999999876 999999999999999 99998654322
Q ss_pred ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCC
Q 004869 543 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 622 (726)
Q Consensus 543 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~ 622 (726)
..||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+....... ++.. .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~--------~~~~-~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD--------DPRD-R 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC--------Cccc-c
Confidence 258899999999999999999999999999999999999996432111 1111111110000 0000 0
Q ss_pred CCChhhHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 623 KYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 623 ~~~~e~~~--~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
..+..... .+.+++.+||+.+|++||++.|+++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 01111222 58999999999999999999999999887643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=270.42 Aligned_cols=200 Identities=19% Similarity=0.269 Sum_probs=140.2
Q ss_pred hccc-CceeEEEEEeecC-----CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCc
Q 004869 432 RLHH-RNLVKLVGYYSSR-----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505 (726)
Q Consensus 432 ~L~H-pNIV~llg~~~~~-----~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~ 505 (726)
.++| .||++++++|... +....++++||+ +++|.++|... ...+++.+++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 6888888877321 223567788987 66999999742 345899999999999999999999999
Q ss_pred eeecCCCccceeecCC-------------------CcEEEEecCccccCCCCCc--------------cccccccccccc
Q 004869 506 VIHRDFKASNILLENN-------------------FHAKVADFGLAKQAPEGRT--------------NYLSTRVMGTFG 552 (726)
Q Consensus 506 IvHrDIKp~NILLd~~-------------------~~vKL~DFGla~~~~~~~~--------------~~~~~~~~GT~~ 552 (726)
|+||||||+||||+.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666653211000 000112458889
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHH
Q 004869 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV 632 (726)
Q Consensus 553 Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l 632 (726)
|||||++.+..++.++|||||||+||||++|..|+.... .....+. .....+.. .....+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLR----------HRVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHH----------HhhcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988764211 0000000 00111110 1112345
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 004869 633 CTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 633 ~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..++.+||+.+|.+||+|.||+++-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 6788999999999999999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=234.81 Aligned_cols=201 Identities=28% Similarity=0.422 Sum_probs=165.3
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCC
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD 449 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~ 449 (726)
+....+.|...++||+|.|++||++.+. .++.||+|.+...+ ......+|+++|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 3445678899999999999999999853 36789999997543 3456899999999995 9999999998874
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEe
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD 528 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~D 528 (726)
....++|+||++.-...+++.. ++...+..++..+..||+++|.+| |+||||||+|+|.+. .+.-.|.|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 4489999999999999988864 778899999999999999999999 999999999999974 56789999
Q ss_pred cCccccCC-----------------C--C--------------Cccc---------ccccccccccccCcccccc-CCCC
Q 004869 529 FGLAKQAP-----------------E--G--------------RTNY---------LSTRVMGTFGYVAPEYAMT-GHLL 565 (726)
Q Consensus 529 FGla~~~~-----------------~--~--------------~~~~---------~~~~~~GT~~Y~APE~l~~-~~~s 565 (726)
||||.... . + ...+ ......||+||.|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99996110 0 0 0000 0012569999999999875 4568
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCC
Q 004869 566 VKSDVYSYGVVLLELLTGRKPVDM 589 (726)
Q Consensus 566 ~ksDVwSfGvvL~ELltG~~Pf~~ 589 (726)
.++||||.|||++-+++++.||..
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred Cccceeeccceeehhhcccccccc
Confidence 999999999999999999999964
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-23 Score=224.14 Aligned_cols=167 Identities=20% Similarity=0.168 Sum_probs=130.6
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC--CCcEEEEEEcccCC-----CCchhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~--~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
...++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|+|++..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999864 57788999875321 11245689999999999999998533221
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC-CccceeecCCCcEEEEe
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVAD 528 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI-Kp~NILLd~~~~vKL~D 528 (726)
...+|||||+++++|... .. . ....++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~-~---------~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP-H---------GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc-c---------chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 257999999999999732 11 0 11467889999999999998 999999 99999999999999999
Q ss_pred cCccccCCCCCcccc------cccccccccccCccccccC
Q 004869 529 FGLAKQAPEGRTNYL------STRVMGTFGYVAPEYAMTG 562 (726)
Q Consensus 529 FGla~~~~~~~~~~~------~~~~~GT~~Y~APE~l~~~ 562 (726)
||+|+.......... -+...+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999997765432221 1356789999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-21 Score=200.92 Aligned_cols=261 Identities=30% Similarity=0.405 Sum_probs=195.9
Q ss_pred cccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC---chhHHHHHHHHHHhcccC-ceeEEEEEeecCCCCceEEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHR-NLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~Hp-NIV~llg~~~~~~~~~~~LV~ 457 (726)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++. .....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEE
Confidence 667889999999999999986 78999999765443 357899999999999988 7999999984 333479999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 536 (726)
+|+.+++|.+++...... ..+.......+..|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++...
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999777642211 25788899999999999999999999 99999999999999988 79999999998655
Q ss_pred CCCccc----ccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-ccchhhhhhhhhccc
Q 004869 537 EGRTNY----LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTWARPILRD 608 (726)
Q Consensus 537 ~~~~~~----~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~-~~~~l~~~~~~~~~~ 608 (726)
...... ......||..|++||.+.. .......|+|++|++++++++|..||...... ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT- 232 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC-
Confidence 433221 2356789999999999987 57889999999999999999999997644321 00111111110000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .................+.+++..|+..+|..|.++.+....
T Consensus 233 --~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 --P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001112457789999999999999999987765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=213.38 Aligned_cols=248 Identities=20% Similarity=0.317 Sum_probs=194.0
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
.+..+|.+...|..|+|++.++ .+++|++.... ....++|..|.-.|+-+.||||+.++|.|. ...++.++..||
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceEeeeec
Confidence 3456788999999999999754 46677776443 233468999999999999999999999997 446889999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE--ecCccccCCCC
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA--DFGLAKQAPEG 538 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~--DFGla~~~~~~ 538 (726)
+.|+|+..||+.. .-.++-.++.++++++|+|++|||+.. |-|.---|.+..+++|++.+++|+ |--++..
T Consensus 270 p~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred cchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999743 345778899999999999999999986 335556789999999999998885 3222211
Q ss_pred CcccccccccccccccCccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s---~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.....-.+.||+||.+..++-+ ..+|+|||.++||||.|...||....+.+-. .++
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mki 401 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKI 401 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhh
Confidence 1122346789999999876543 5799999999999999999999765443221 122
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.-+.++...|......+++|+.-|+..||.+||.++.|+-.|++++
T Consensus 402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 3344555667777778999999999999999999999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=210.91 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=193.6
Q ss_pred CcccceeeeecCcEEEEEEEECCC--cEEEEEEcccCCCCchhHHHHHHHHHHhccc----CceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSDG--TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH----RNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~g--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H----pNIV~llg~~~~~~~~~~~ 454 (726)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.+ .++..+++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 799999999999999999996543 4788888775433333378889999998873 57888887763 2445789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-----CcEEEEec
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-----FHAKVADF 529 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-----~~vKL~DF 529 (726)
+||+.+ |-+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 889999875432 467999999999999999999999999 9999999999999754 46999999
Q ss_pred Cccc--cCCCCCc----ccc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 004869 530 GLAK--QAPEGRT----NYL--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 530 Gla~--~~~~~~~----~~~--~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 601 (726)
|+++ ....... ... ....+||..|.++....+...+.+.|+||++.++.|++.|..||.............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~- 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE- 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH-
Confidence 9998 3222211 111 124569999999999999999999999999999999999999996443221111000
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
. ......... ....... .+.++...+-..+..++|....+...|+.....
T Consensus 251 -----~--~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 251 -----K--DPRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -----H--Hhhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 000001110 1122223 345555555568899999999999988776554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=227.35 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=183.7
Q ss_pred ccceeeeecCcEEEEEEEE-CCCcEEEEEEccc---CCCCch---hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 383 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTC---GGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~---~~~~~~---~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
...+++|.|.+|.|+.... ......+.|.... ...... ..+..|+.+-..++|+|++..+..+.... ...-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchh
Confidence 3568899999997777663 2334444443321 111111 12455777778889999988777655332 3344
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
.|||+++ +|..++... ..++-.++..++.|+..|++|+|+.| |.|||+|++|++++.++.+||+|||.+...
T Consensus 399 ~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 4999999 999999752 35788899999999999999999999 999999999999999999999999999766
Q ss_pred CCCCcc--cccccccccccccCccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCccch----hhhhhhhhccc
Q 004869 536 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLV-KSDVYSYGVVLLELLTGRKPVDMSQPSGQEN----LVTWARPILRD 608 (726)
Q Consensus 536 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~-ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~----l~~~~~~~~~~ 608 (726)
...... ......+|+-.|+|||++.+..|.. ..||||.|+++..|++|+.||......+... ...|.. ....
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-~~~~ 549 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-IFEG 549 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc-cccC
Confidence 544433 4566788999999999999999975 5899999999999999999997554443321 111110 0000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... .-.+...+...++.++|+.||.+|-|+++|++.=
T Consensus 550 ~~~------------~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 550 PNR------------LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred hHH------------HHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 000 1112234567899999999999999999999763
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=184.40 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=196.4
Q ss_pred hcCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhccc-CceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~llg~~~~~~~~~~~LV 456 (726)
..+|.+.++||.|+||.+|.|. ..+|..||||.-+... ...++..|.+++..|+| ..|..+..|.. +...-.||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc--ccccceee
Confidence 4579999999999999999998 5689999999876432 23467889999999975 44555555544 45577899
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFGla~ 533 (726)
||.+ |-+|+++..- ....++..+++-++.|++.-++|+|.++ ++||||||+|+|..- ...+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 9998 8899998862 2346888999999999999999999999 999999999999864 3468999999999
Q ss_pred cCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 534 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 534 ~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
...+..+. .......||.+|.+=-...+...+.+.|+-|+|.+|..+..|..||..-......+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----------- 231 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----------- 231 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----------
Confidence 77654321 11235679999999887777888899999999999999999999997644332211
Q ss_pred hhhhhhhcCC-------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 609 KDRLEELADP-------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 609 ~~~l~~i~d~-------~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
..+.+... .+...+|. ++.-.+.-|-..-=++-|...-+-+.+..+.+.+..
T Consensus 232 --KyEkI~EkK~s~~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 232 --KYEKISEKKMSTPIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred --HHHHHHHhhcCCCHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 11111111 12233443 366677788777778889998888887777665543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=189.38 Aligned_cols=173 Identities=12% Similarity=0.159 Sum_probs=135.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhH---------HHHHHHHHHhcccCceeEEEEEeecC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
...+|+..++||.|+||.||+... ++..+|||.+........+. |.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 56789999997543332222 68899999999999999999886533
Q ss_pred C------CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 449 D------SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 449 ~------~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+ ....+|+|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 2 235789999999999988742 221 34569999999999999 99999999999999988
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHH
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 581 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELl 581 (726)
++|+|||..+........ -.+.....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755332211 01445556778999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=219.85 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=182.1
Q ss_pred CcccceeeeecCcEEEEEEEECCCcEEEEEEcccCC-CCchhHHHHHHHH--HHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-QQGDKEFLVEVEM--LSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~-~~~~~~f~~Ei~i--L~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++...+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-. .....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHHH
Confidence 6777899999999999999998887 8999886544 3334455544443 44568999999876633 233567888
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC--
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-- 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~-- 535 (726)
+|..+ +|+|.|.. +..|...+.+.|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||..-+..
T Consensus 101 qyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 88854 89998864 456788889999999999999999999 999999999999999999999999876533
Q ss_pred CCCC---cccccccccccccccCccccccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 004869 536 PEGR---TNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 536 ~~~~---~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 600 (726)
++++ ..+.......-..|+|||.+... ..+++.||||+||+++||++ |+++|+.. ++..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 2221 11122222334479999976431 26788999999999999988 78888643 2333
Q ss_pred hhhhh-ccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 601 WARPI-LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 601 ~~~~~-~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
|...- .....-++++-|. .+..++..|++.||++|-++++.++.-.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 32221 1111223444343 3578999999999999999999998743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.7e-20 Score=183.11 Aligned_cols=140 Identities=16% Similarity=0.176 Sum_probs=108.6
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--c-------hhHH-----------------HHHHHHHHhcccCce
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--G-------DKEF-----------------LVEVEMLSRLHHRNL 438 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ei~iL~~L~HpNI 438 (726)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 1122 349999999988776
Q ss_pred eEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHH-HhCCCCceeecCCCcccee
Q 004869 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 439 V~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yL-H~~~~p~IvHrDIKp~NIL 517 (726)
.....+.. . ..+|||||+++++|...+.. ...+++....+++.|++.+|.|| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL--K--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe--c--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 43332221 1 34899999999877654322 23588899999999999999999 6888 999999999999
Q ss_pred ecCCCcEEEEecCccccCC
Q 004869 518 LENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~ 536 (726)
++ ++.++|+|||+|....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=181.47 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=189.4
Q ss_pred cCcccceeeeecCcEEEEEEE-ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
-.|++.++||+|.||..+.|+ +-+++.||||.-... .+.-++..|.+.++.|. .++|-..+ |...++.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vY--YFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVY--YFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCcee--eeccccchhhhhh
Confidence 368899999999999999998 557899999976532 23456778899888885 57776664 3345667788999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-----CCcEEEEecCcc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA 532 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-----~~~vKL~DFGla 532 (726)
|.+ |-+|+|+..- ....++.++++.+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|.|||+|
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 7799988752 2346899999999999999999999999 999999999999963 346899999999
Q ss_pred ccCCCCCccc-----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 533 KQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 533 ~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
+...+..+.. ......||.+||+=....+...+.+.|+-|+|=++...+.|..||..-.....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn------------ 244 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN------------ 244 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch------------
Confidence 9776543321 12346799999999999999999999999999999999999999975432211
Q ss_pred chhhhhhhcCCcc-------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 608 DKDRLEELADPRL-------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 608 ~~~~l~~i~d~~l-------~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
+.+.+++-+... ...+|. ++..-+.-.-..+=.+-|..+-+...+..+...+
T Consensus 245 -K~kYeKIGe~Kr~T~i~~Lc~g~P~----efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 245 -KEKYEKIGETKRSTPIEVLCEGFPE----EFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -HHHHHHhccccccCCHHHHHhcCHH----HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 112222222211 112232 2333333333446667899888777666655433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=175.47 Aligned_cols=140 Identities=16% Similarity=0.153 Sum_probs=111.2
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--------------------------hhHHHHHHHHHHhcccCce
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------------------------DKEFLVEVEMLSRLHHRNL 438 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~iL~~L~HpNI 438 (726)
...||+|+||.||+|+..+|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 1123578999999999987
Q ss_pred eEEEEEeecCCCCceEEEEeecCCCChhhh-ccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccce
Q 004869 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI 516 (726)
Q Consensus 439 V~llg~~~~~~~~~~~LV~Ey~~~GsL~d~-L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NI 516 (726)
.....+.. . ..+|||||++++++... +. ...++.....+++.|++.+|.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILL--K--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEe--c--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 54444432 1 34899999998865433 32 2346778899999999999999999 88 99999999999
Q ss_pred eecCCCcEEEEecCccccCCC
Q 004869 517 LLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~ 537 (726)
|++ ++.++|+|||+++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=171.50 Aligned_cols=185 Identities=17% Similarity=0.091 Sum_probs=140.1
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCch----hHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEE
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~----~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.+...|++|+||+||.+.- ++..++.+.+.....-.. ..|.+|+++|++++ |+++.+++++ ...+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 4568899999999997666 678888887764433111 24789999999995 5889999886 2469999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC-CccceeecCCCcEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI-Kp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||++|.+|...+.. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++....
T Consensus 78 eyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999998764421 11357789999999999999 999999 7999999999999999999998655
Q ss_pred CCCcc----c-------ccccccccccccCccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 004869 537 EGRTN----Y-------LSTRVMGTFGYVAPEYAMTG-HLL-VKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 537 ~~~~~----~-------~~~~~~GT~~Y~APE~l~~~-~~s-~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
..... . .......++.|++|+...-. ..+ .+.+-++-|.-+|.++|++.+..
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 43210 0 01123467888888854322 223 56788899999999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.3e-19 Score=195.60 Aligned_cols=218 Identities=24% Similarity=0.389 Sum_probs=160.6
Q ss_pred HHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeec
Q 004869 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR 509 (726)
Q Consensus 430 L~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHr 509 (726)
|+.+.|.|+.+++|.+.. +...+.|.+|+..|+|.|.+.. ....++|.-...+..+++.||+|||... -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 456889999999999884 4789999999999999999975 2456999999999999999999999764 23999
Q ss_pred CCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccC-------CCCcchhHHHHHHHHHHHHh
Q 004869 510 DFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 510 DIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-------~~s~ksDVwSfGvvL~ELlt 582 (726)
.++++|+++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998766431111112223345679999988763 24678999999999999999
Q ss_pred CCCCCCCCCCCcc-chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 583 GRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 583 G~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+.||+....... ..++.+++. . -....-|.+... .+....+..++.+||..+|++||++++|-..++.+.
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~---~---~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK---G---GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccCccccccccCChHHHHHHHHh---c---CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999976433222 222222211 0 001111111100 022335889999999999999999999987776654
Q ss_pred H
Q 004869 662 R 662 (726)
Q Consensus 662 ~ 662 (726)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=181.74 Aligned_cols=236 Identities=19% Similarity=0.293 Sum_probs=151.3
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhcc----------cCceeEEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLH----------HRNLVKLVGYYS 446 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~----------HpNIV~llg~~~ 446 (726)
.+...+.||.|+++.||.++.. +|+.+|||........ ..+++.+|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999975 5899999988654422 2355666654444422 212222222111
Q ss_pred c----------CCCC-----ceEEEEeecCCCChhhhcc---CCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceee
Q 004869 447 S----------RDSS-----QHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 508 (726)
Q Consensus 447 ~----------~~~~-----~~~LV~Ey~~~GsL~d~L~---~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvH 508 (726)
. .+.. +.+++|+-+ .+||.+++. ........+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 0 0111 346778777 568888763 11111334566778888899999999999999 999
Q ss_pred cCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccC--------CCCcchhHHHHHHHHHHH
Q 004869 509 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--------HLLVKSDVYSYGVVLLEL 580 (726)
Q Consensus 509 rDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~s~ksDVwSfGvvL~EL 580 (726)
+|||++|++++.+|.++|+||+.....+... .. ...+..|.+||..... .++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887654321 11 3455789999976432 468899999999999999
Q ss_pred HhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCC
Q 004869 581 LTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 647 (726)
Q Consensus 581 ltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~R 647 (726)
++|+.||+...+..... | .-..|. +..+.+.+||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~---~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998653322111 1 011333 555678899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=169.40 Aligned_cols=138 Identities=19% Similarity=0.240 Sum_probs=106.6
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-----ccCceeEEEEEeecCCC-Cc-eEE
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-----HHRNLVKLVGYYSSRDS-SQ-HLL 455 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~llg~~~~~~~-~~-~~L 455 (726)
...+.||+|+||.||. .-.++. .+||++........+.+.+|+++++.+ .||||++++|++....+ +. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 223344 479988765555567899999999999 57999999999876432 23 337
Q ss_pred EEee--cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHH-HHHHhCCCCceeecCCCccceeecC----CCcEEEEe
Q 004869 456 CYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL-AYLHEDSQPCVIHRDFKASNILLEN----NFHAKVAD 528 (726)
Q Consensus 456 V~Ey--~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL-~yLH~~~~p~IvHrDIKp~NILLd~----~~~vKL~D 528 (726)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 6689999999641 24444 35678888777 8999999 999999999999974 34899999
Q ss_pred cCcc
Q 004869 529 FGLA 532 (726)
Q Consensus 529 FGla 532 (726)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-17 Score=196.89 Aligned_cols=200 Identities=22% Similarity=0.241 Sum_probs=157.5
Q ss_pred HHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc---cCceeEEEEEeecCCC
Q 004869 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDS 450 (726)
Q Consensus 374 el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~ 450 (726)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|.-+... .-+|.--.+++.||+ -+-|..+...+...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~-- 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQ-- 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccC--
Confidence 4445567899999999999999999998889999999876433 234444455666665 12222222222222
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-------CCc
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------NFH 523 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-------~~~ 523 (726)
...+||+||.+.|+|.|++.. .+.++|...+.++.|+++-+++||..+ |||+||||+|.||.. ...
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 356899999999999999973 556999999999999999999999999 999999999999942 446
Q ss_pred EEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 004869 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 585 (726)
Q Consensus 524 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~ 585 (726)
++|+|||.+..+.--.........++|-++-.+|...++.++..+|.|.+..+++-|+.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 89999999865533222223455678899999999999999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-18 Score=194.64 Aligned_cols=225 Identities=28% Similarity=0.343 Sum_probs=175.7
Q ss_pred eeeecCcEEEEEEE----ECCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEee
Q 004869 387 ILGEGGFGRVFKGV----LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 387 ~LG~G~fG~Vykg~----l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.+|+|.||.|++++ .+.|..+|+|.+++..... ......|-.++...+ |+.+|++.-.+. .....+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhh
Confidence 37999999999876 2347788998886543221 224566888888887 999999976655 45688999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
..+|.|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-+..
T Consensus 79 ~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 79 LRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999999988865 334666777777888899999999999 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. .+||..|||||++. ......|-||||++++||+||..||.. +..+.++.
T Consensus 152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~------------ 201 (612)
T KOG0603|consen 152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK------------ 201 (612)
T ss_pred h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh------------
Confidence 2 17999999999988 567789999999999999999999963 11111111
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm 650 (726)
..-..|.+......+++..++..+|.+|--.
T Consensus 202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1123456666667788888999999999655
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=160.53 Aligned_cols=148 Identities=17% Similarity=0.170 Sum_probs=115.8
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC----------------------chhHHHHHHHH
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ----------------------GDKEFLVEVEM 429 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~i 429 (726)
..++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 34455555558888999999999999999888999999987643210 01236778999
Q ss_pred HHhcccCc--eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCcee
Q 004869 430 LSRLHHRN--LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507 (726)
Q Consensus 430 L~~L~HpN--IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~Iv 507 (726)
+..+.|.+ +...++. ...+++|||+++++|.+.... .....++.+++.++.++|+.+ ++
T Consensus 87 l~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~ 147 (198)
T cd05144 87 LKALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---II 147 (198)
T ss_pred HHHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CC
Confidence 99998874 4444432 245899999999999875431 345678899999999999988 99
Q ss_pred ecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 508 HRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 508 HrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
||||||+||++++++.++|+|||++......
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccCCCc
Confidence 9999999999999999999999999765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=161.17 Aligned_cols=134 Identities=19% Similarity=0.316 Sum_probs=111.1
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
+.||+|++|.||+|.+ +|..|++|+........ ...+.+|++++..++|+|+.....++.. ....+++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEE
Confidence 5799999999999988 56789999865432211 2357889999999999998776666553 34678999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
||++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++.
T Consensus 79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998631 12 78899999999999999998 99999999999999 78999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.2e-18 Score=186.22 Aligned_cols=171 Identities=27% Similarity=0.425 Sum_probs=131.9
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
.+++.|++|...+|.+||.+... ....+|...+.++.|++.|++| ++ .+|||+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975332 3457888999999999999999 66 89999999999999999999999999
Q ss_pred cccCCCCC----cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhc
Q 004869 532 AKQAPEGR----TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 532 a~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
........ .....+...||..||+||.+.+.+|+.|+||||||++|+|+++ -...++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence 87665543 1223466789999999999999999999999999999999997 3322220
Q ss_pred cchhhhhhhcCCc----cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 004869 607 RDKDRLEELADPR----LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653 (726)
Q Consensus 607 ~~~~~l~~i~d~~----l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EV 653 (726)
...+.++.|.. ...++|.+ ..++.+++.+.|.+||++.++
T Consensus 466 --~~t~~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 --IATLTDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HHhhhhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 11122222222 22233433 578999999999999944443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=164.26 Aligned_cols=144 Identities=16% Similarity=0.177 Sum_probs=111.9
Q ss_pred cCcccceeeeecCcEEEEEEE--ECCCcEEEEEEcccCCCC------------------------chhHHHHHHHHHHhc
Q 004869 380 NNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQ------------------------GDKEFLVEVEMLSRL 433 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~--l~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~L 433 (726)
..|++.+.||+|+||.||+|. ..+|+.||||.+...... ....+..|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 568999999998754211 012356899999999
Q ss_pred ccCc--eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC
Q 004869 434 HHRN--LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 511 (726)
Q Consensus 434 ~HpN--IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI 511 (726)
.+.+ +.+.+++ . ..++||||+++++|..++.. ...+...+...++.|++.+|.+||+.+. ++||||
T Consensus 108 ~~~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEe----c--CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCC
Confidence 7633 3344432 1 35899999999888776532 1234556678999999999999998863 999999
Q ss_pred CccceeecCCCcEEEEecCccccCC
Q 004869 512 KASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 512 Kp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=182.02 Aligned_cols=139 Identities=20% Similarity=0.283 Sum_probs=110.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEc-ccCCC-------CchhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQ-------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l-~~~~~-------~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
....|...+.||+|+||.||+|.+.+.. +++|+. ..... ...+.+.+|++++.+++|+|++....++..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 3455667899999999999999986544 444432 21111 112468899999999999999887777653
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 346789999999999999874 35678999999999999998 9999999999999 5779999999
Q ss_pred CccccC
Q 004869 530 GLAKQA 535 (726)
Q Consensus 530 Gla~~~ 535 (726)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=156.22 Aligned_cols=130 Identities=21% Similarity=0.299 Sum_probs=103.7
Q ss_pred eeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.||+|+||.||+|.+ +|..|++|......... ...+.+|++++..++|+++.....++. +....+++||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV--DPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE--ECCCCEEEEE
Confidence 489999999999996 56789999865432111 245778999999999886554443433 2335689999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|++|++|.+++.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999875310 078999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=165.04 Aligned_cols=200 Identities=22% Similarity=0.288 Sum_probs=139.6
Q ss_pred ccCceeEEEEEeec-------------------------CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHH
Q 004869 434 HHRNLVKLVGYYSS-------------------------RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488 (726)
Q Consensus 434 ~HpNIV~llg~~~~-------------------------~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia 488 (726)
+|||||++.++|.+ .++..+|+||.-.+ -+|.++|.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987642 12345788888774 489998863 235667778899
Q ss_pred HHHHHHHHHHHhCCCCceeecCCCccceee--cCCC--cEEEEecCccccCCCCC--ccccc--ccccccccccCccccc
Q 004869 489 LDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNF--HAKVADFGLAKQAPEGR--TNYLS--TRVMGTFGYVAPEYAM 560 (726)
Q Consensus 489 ~qIa~gL~yLH~~~~p~IvHrDIKp~NILL--d~~~--~vKL~DFGla~~~~~~~--~~~~~--~~~~GT~~Y~APE~l~ 560 (726)
.|+++|+.|||.++ |.|||+|++|||+ |+|+ ...|+|||.+-...... -.+.+ -...|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999998 3443 57899999875433211 11111 1235778899999875
Q ss_pred cCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHH
Q 004869 561 TGH------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCT 634 (726)
Q Consensus 561 ~~~------~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~ 634 (726)
... .-.|+|.|+.|.+-||+++...||...... .+. .....+-.-|.+...++. .+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~---------~r~Yqe~qLPalp~~vpp----~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLD---------TRTYQESQLPALPSRVPP----VARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eec---------hhhhhhhhCCCCcccCCh----HHHH
Confidence 432 246999999999999999999999753211 111 011122222333334444 4788
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 004869 635 IAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 635 Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
++...|+.||++|++..-..+.|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999998766555543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-14 Score=136.54 Aligned_cols=135 Identities=22% Similarity=0.194 Sum_probs=113.2
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhccc--CceeEEEEEeecCCCCceEEEEeecC
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++... ....++++||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecC
Confidence 45789999999999999855 7899999864433 4679999999999987 588999887653 357899999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++.+..+ ++.....++.+++++|++||.....+++|+|++++||++++++.+++.|||.++.
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 4466778899999999999987545699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=178.85 Aligned_cols=209 Identities=22% Similarity=0.343 Sum_probs=140.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..+|+.+++|..|+||.||..+++ ..+.+|+|+-+ .. ...+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 367889999999999999999876 35678884322 11 11110 12222222222
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|+-...++.. +++.. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+.+....
T Consensus 136 -----gDc~tllk~~----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNI----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccC----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 4444444421 12221 2278899999998 99999999999999999999999999875432
Q ss_pred CCc-------------ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 538 GRT-------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 538 ~~~-------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
... ......++||+.|+|||++....|..-.|.|++|+|+||.+-|+.||....+.+- +..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~ 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhh
Confidence 111 1112356899999999999999999999999999999999999999986543321 111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 648 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP 648 (726)
++.+.... .+ . ...++ .+..+++.+.|+.+|..|-
T Consensus 270 visd~i~w---pE-~-dea~p----~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VISDDIEW---PE-E-DEALP----PEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhccc---cc-c-CcCCC----HHHHHHHHHHHHhChHhhc
Confidence 22211000 00 0 11222 3477899999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=144.06 Aligned_cols=137 Identities=21% Similarity=0.246 Sum_probs=99.8
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--hhH----------------------HHHHHHHHHhcccCc--e
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKE----------------------FLVEVEMLSRLHHRN--L 438 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~----------------------f~~Ei~iL~~L~HpN--I 438 (726)
.+.||+|+||.||+|...+|+.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999998889999999886432111 111 135666666665443 4
Q ss_pred eEEEEEeecCCCCceEEEEeecCCCChhhh-ccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccce
Q 004869 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI 516 (726)
Q Consensus 439 V~llg~~~~~~~~~~~LV~Ey~~~GsL~d~-L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NI 516 (726)
.+.+++ ...+++|||++++++... +... ... .+...++.+++.++.++|. .+ |+||||||+||
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 444433 145899999999654322 2110 011 6678899999999999999 77 99999999999
Q ss_pred eecCCCcEEEEecCccccCCC
Q 004869 517 LLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~ 537 (726)
+++ ++.++|+|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 89999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.4e-14 Score=146.25 Aligned_cols=138 Identities=20% Similarity=0.249 Sum_probs=105.8
Q ss_pred ceeee-ecCcEEEEEEEECCCcEEEEEEcccCCC-------------CchhHHHHHHHHHHhcccCce--eEEEEEeecC
Q 004869 385 ASILG-EGGFGRVFKGVLSDGTAVAIKRLTCGGQ-------------QGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSR 448 (726)
Q Consensus 385 ~~~LG-~G~fG~Vykg~l~~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNI--V~llg~~~~~ 448 (726)
...|| .||.|+||++... +..++||++..... .....+.+|++++.+++|+++ ...+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999998875 67799998853210 122457889999999998875 6777765432
Q ss_pred CCC--ceEEEEeecCC-CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 449 DSS--QHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 449 ~~~--~~~LV~Ey~~~-GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
... ..++|+||+++ .+|.+++... .++. ..+.+++.+|.+||+.+ |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 221 23599999997 6999888631 2333 23678999999999999 99999999999999988999
Q ss_pred EEecCccccC
Q 004869 526 VADFGLAKQA 535 (726)
Q Consensus 526 L~DFGla~~~ 535 (726)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-15 Score=172.88 Aligned_cols=256 Identities=24% Similarity=0.288 Sum_probs=187.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC--CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~ 454 (726)
..|.+.+.||+|.|+.|-..... ....+|+|.+.... ....+....|..+-..+. |.|++.+++... +....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCcccc
Confidence 35666777999999999887753 34567777776443 111223344777777776 999999999865 555889
Q ss_pred EEEeecCCCChhhhc-cCCCCCcccCChhhhHHHHHHHHHHHHHHH-hCCCCceeecCCCccceeecCCC-cEEEEecCc
Q 004869 455 LCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGL 531 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L-~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH-~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGl 531 (726)
+..+|..+|++.+-+ +.. ....+....-.+..|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 999999999999988 431 113566777889999999999999 777 99999999999999999 999999999
Q ss_pred cccCCC-CCcccccccccc-cccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 532 AKQAPE-GRTNYLSTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 532 a~~~~~-~~~~~~~~~~~G-T~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
|..... ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|.....
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~-- 248 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG-- 248 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc--
Confidence 988776 444444455678 9999999988874 55788999999999999999999997554333 12222221110
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .....-........++...++..+|+.|.+.+++...
T Consensus 249 --~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 --R--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --c--------cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 0001111122346678889999999999999988643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-12 Score=146.63 Aligned_cols=143 Identities=24% Similarity=0.264 Sum_probs=104.3
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc----------------------------------------hhHHH
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----------------------------------------DKEFL 424 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~ 424 (726)
.+.||.|++|.||+|++.+|+.||||+.+.+.... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999975431100 01355
Q ss_pred HHHHHHHhcc----cCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHH-HHHHHH
Q 004869 425 VEVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR-GLAYLH 499 (726)
Q Consensus 425 ~Ei~iL~~L~----HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~-gL~yLH 499 (726)
+|.+.+.+++ |.+-+.+-.++.. .....+|||||++|++|.++...... .. .+.+++..+++ .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~-~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD-RTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh-hcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH
Confidence 6777666663 3344444444432 23467999999999999987642110 11 34567777766 478899
Q ss_pred hCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 500 ~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
..+ ++|+|++|.||+++++++++++|||++.....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 888 99999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-13 Score=142.81 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=144.6
Q ss_pred HHHHhcccCceeEEEEEeecC---CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCC
Q 004869 428 EMLSRLHHRNLVKLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504 (726)
Q Consensus 428 ~iL~~L~HpNIV~llg~~~~~---~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p 504 (726)
.-|-++.|-|||++..|+.+. +.....++.|||..|+|..+|++.......+......+|+.||..||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445667899999999987642 345678999999999999999876555566777888899999999999999886 5
Q ss_pred ceeecCCCccceeecCCCcEEEEecCccccCCC--CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh
Q 004869 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 505 ~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~--~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt 582 (726)
+|+|+++..+.|++..++-+|++----...... ...........+-++|.+||+-...+.+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 599999999999999999888853111110000 000111223457789999999888888899999999999999988
Q ss_pred CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 583 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 583 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
|..--...... ...-..... .+..+-++. =..++..|++.+|+.||+|++++.|
T Consensus 278 lEiq~tnseS~-~~~ee~ia~-------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESK-VEVEENIAN-------VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcce-eehhhhhhh-------heeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 75421111000 000000000 000011111 1357889999999999999998765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=119.01 Aligned_cols=131 Identities=16% Similarity=0.070 Sum_probs=98.5
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeE-EEEEeecCCCCceEEEEeecCCC
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~-llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
.+.|+.|.++.||+++.. +..|++|....... ....+.+|++++..+.+.+++. ++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~----~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD----PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe----CCCCeEEEEecCCC
Confidence 357889999999999875 67899998764322 2345788999999997666543 44432 12458999999998
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC--CCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~--~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++.+.. .....++.+++++|+.||..+ ..+++|+|+++.||+++ ++.+++.|||.+..
T Consensus 77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876531 112346788999999999887 33469999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-11 Score=139.30 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=174.6
Q ss_pred cCcccceeeee--cCcEEEEEEEE---CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCC
Q 004869 380 NNFEPASILGE--GGFGRVFKGVL---SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 380 ~~f~~~~~LG~--G~fG~Vykg~l---~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~ 451 (726)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.++....+. +.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cCC
Confidence 34566788999 99999999986 3578899998543222 33334456777777774 999999666554 455
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHH----HHHHHHhCCCCceeecCCCccceeecCC-CcEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENN-FHAKV 526 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~----gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL 526 (726)
..++-+|++ +.+|..+.+... ..+.....+.+..+..+ ||.++|..+ ++|-|+|+.||++..+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 778888888 578888887532 23566677777777777 999999998 9999999999999998 88999
Q ss_pred EecCccccCCCCCcc---cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 527 ADFGLAKQAPEGRTN---YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 527 ~DFGla~~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
+|||+...+....-. ....+..|...|++||.. .+.++...|+|++|.+.+|..+|.......- ...|..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~ 337 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ 337 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc
Confidence 999999888765421 112233678899999955 4567889999999999999998876543210 011211
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~ 655 (726)
++....-.++.+ .-..++...+.++++.++..|++.+.+..
T Consensus 338 --~r~~~ip~e~~~---------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --LRQGYIPLEFCE---------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccccCchhhhc---------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111110011111 11123445888999999999999887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.7e-11 Score=136.92 Aligned_cols=148 Identities=17% Similarity=0.197 Sum_probs=98.5
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCC--------------------------c------------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--------------------------G------------ 419 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~--------------------------~------------ 419 (726)
...|+. +.||+|++|.||+|++.+ |+.||||+++.+-.. .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999987 999999998643100 0
Q ss_pred --hhHHHHHHHHHHhcc----cCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHH
Q 004869 420 --DKEFLVEVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493 (726)
Q Consensus 420 --~~~f~~Ei~iL~~L~----HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~ 493 (726)
+-+|.+|...+.+++ +.+.+.+-.++.+ -....+|||||++|+.|.++-.-.. ...+ +..++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHH
Confidence 013555666666653 4455555555432 2346899999999999987422100 0111 1122222221
Q ss_pred -HHHHHHhCCCCceeecCCCccceeecCCC----cEEEEecCccccCCC
Q 004869 494 -GLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVADFGLAKQAPE 537 (726)
Q Consensus 494 -gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~DFGla~~~~~ 537 (726)
-+..++..| ++|+|+||.||+++.++ ++++.|||++.....
T Consensus 271 ~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 223344567 99999999999999888 999999999987654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.2e-10 Score=112.44 Aligned_cols=144 Identities=22% Similarity=0.245 Sum_probs=110.8
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCC-CchhHHHHHHHHHHhccc--CceeEEEEEeecCC-CCceEEEEeecC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRD-SSQHLLCYELVP 461 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~H--pNIV~llg~~~~~~-~~~~~LV~Ey~~ 461 (726)
+.|+.|..+.||++...+|+.+++|....... .....+..|.++++.+++ .++.+++.+..... .+..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778899999764432 134678999999999976 34566777654321 125689999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC---------------------------------------
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--------------------------------------- 502 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~--------------------------------------- 502 (726)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9998876631 23667778888888888888888521
Q ss_pred --------------CCceeecCCCccceeecC--CCcEEEEecCcccc
Q 004869 503 --------------QPCVIHRDFKASNILLEN--NFHAKVADFGLAKQ 534 (726)
Q Consensus 503 --------------~p~IvHrDIKp~NILLd~--~~~vKL~DFGla~~ 534 (726)
..+++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 356899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.5e-09 Score=106.74 Aligned_cols=136 Identities=17% Similarity=0.169 Sum_probs=98.1
Q ss_pred eeeeecCcEEEEEEEECC-------CcEEEEEEcccCCC----------------------CchhHHH----HHHHHHHh
Q 004869 386 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQ----------------------QGDKEFL----VEVEMLSR 432 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-------g~~VAVK~l~~~~~----------------------~~~~~f~----~Ei~iL~~ 432 (726)
..||.|--+.||.|.-.+ +..+|||..+.... ...+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 47899997653210 0011223 79999999
Q ss_pred ccc--CceeEEEEEeecCCCCceEEEEeecCCCChhh-hccCCCCCcccCChhhhHHHHHHHHHHHHHH-HhCCCCceee
Q 004869 433 LHH--RNLVKLVGYYSSRDSSQHLLCYELVPNGSLES-WLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVIH 508 (726)
Q Consensus 433 L~H--pNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d-~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yL-H~~~~p~IvH 508 (726)
+.. -++-+.+++ ...+|||||+.++.+.. .|+. ..++..+...+..+++.+|..| |+.+ ++|
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 863 456666654 25689999997654422 2221 1234455677889999999999 8888 999
Q ss_pred cCCCccceeecCCCcEEEEecCccccCC
Q 004869 509 RDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 509 rDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+||++.|||+++ +.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999999974 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.8e-09 Score=122.86 Aligned_cols=166 Identities=18% Similarity=0.221 Sum_probs=123.1
Q ss_pred ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCC
Q 004869 401 LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 480 (726)
Q Consensus 401 l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls 480 (726)
..++..|.|...+...........+-++.|+.++||||++++..+. .....|||+|-+. -|..+++. ++
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~--Pl~~~lk~-------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVR--PLETVLKE-------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeeccc--cHHHHHHH-------hH
Confidence 4467888888877554433345677888999999999999998876 4458999999874 56666653 33
Q ss_pred hhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccc
Q 004869 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560 (726)
Q Consensus 481 ~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 560 (726)
-......+.||+.||.|||+.+. ++|++|.-..|++++.|+.||++|.++........ .......-..|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence 46677788999999999997664 99999999999999999999999999865543221 011111222466666544
Q ss_pred cCCCCcchhHHHHHHHHHHHHhC
Q 004869 561 TGHLLVKSDVYSYGVVLLELLTG 583 (726)
Q Consensus 561 ~~~~s~ksDVwSfGvvL~ELltG 583 (726)
... -..|.|-||+++||++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 322 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=127.69 Aligned_cols=247 Identities=23% Similarity=0.252 Sum_probs=171.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC--CCcEEEEEEcccCCCCchhH--HHHHHHHHHhc-ccCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQQGDKE--FLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~--~g~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~ 452 (726)
.+.+|..+..||.|.|+.|++...+ ++..|++|.+.........+ -+.|+.+...+ .|.+++.....+... ..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--cc
Confidence 4567889999999999999997744 67899999987654433322 24566666665 477777765544422 35
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecCc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGL 531 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFGl 531 (726)
.++=-||++++++...+. ....++...++++..|++.++.++|+.. ++|+|+||+||++.++ +..+++|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence 568889999999887662 2345778889999999999999999888 9999999999999886 8899999999
Q ss_pred cccCCCCCccccccccccccccc--CccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYV--APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+..+..... .....-+++ +++......+..+.|+||||.-+.|.++|..--. +.+.|.... .
T Consensus 414 ~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~i~--~- 477 (524)
T KOG0601|consen 414 WTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLTIR--S- 477 (524)
T ss_pred ccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccceeee--c-
Confidence 864322111 112223344 5555566778899999999999999999875321 112222111 0
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+.. +++ +.. ...+..+...+...++..||.+.++..+...
T Consensus 478 ~~~-----p~~----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 GDT-----PNL----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccc-----cCC----Cch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000 111 111 1345667888899999999999888765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.4e-08 Score=107.47 Aligned_cols=171 Identities=20% Similarity=0.254 Sum_probs=129.9
Q ss_pred cEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeec--CCCCceEEEEeecCC-CChhhh
Q 004869 393 FGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYELVPN-GSLESW 468 (726)
Q Consensus 393 fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~--~~~~~~~LV~Ey~~~-GsL~d~ 468 (726)
-.+.||+.. .||..|+.|+++....+.......-+++.+++.|.|+|+|..++.. .+...++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457888884 4799999999954433333334556889999999999999988652 234578999999997 677776
Q ss_pred ccCCCC-----------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 469 LHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 469 L~~~~~-----------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
-..... .+....+..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543211 1234677889999999999999999999 88899999999999999999999998776654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 585 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~ 585 (726)
+... -+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPTE----------------PLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCc----------------chhH---HhhhhHHHHHHHHHHHhhccc
Confidence 4311 1111 125699999999999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.7e-08 Score=96.54 Aligned_cols=129 Identities=18% Similarity=0.268 Sum_probs=95.5
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEc-ccCCCCc-------hhHHHHHHHHHHhcccCc--eeEEEEEeecCCCCceEE
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQQG-------DKEFLVEVEMLSRLHHRN--LVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l-~~~~~~~-------~~~f~~Ei~iL~~L~HpN--IV~llg~~~~~~~~~~~L 455 (726)
..+++|+-..+|.+.+.+ ..+++|.- .+.-... .....+|.+++.+++--. ...++.+ +.....|
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----D~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----DPDNGLI 76 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCEE
Confidence 357899999999997754 44566643 2221111 134677999999886433 3334433 4557889
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+|||++|-.|.+.|... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999888642 3567777888888999999 99999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-08 Score=96.75 Aligned_cols=143 Identities=21% Similarity=0.306 Sum_probs=100.8
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEE-cccCCCC-------chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKR-LTCGGQQ-------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~-l~~~~~~-------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
....|-+|+-+.|+++.+. |+...||. +.+.-.. ..+...+|++.|.+++--.|.--.-++. |...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~--D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI--DTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE--ecCCCeE
Confidence 5688999999999999985 56666664 3322111 2356788999999986444433322333 3345689
Q ss_pred EEeecCC-CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC---cEEEEecCc
Q 004869 456 CYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGL 531 (726)
Q Consensus 456 V~Ey~~~-GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~---~vKL~DFGl 531 (726)
+|||+++ -++.+++..... ...+......++..|-+.+.-||.++ |+|+||..+||+|..++ .+.+.|||+
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 9999977 478888864221 12222333788899999999999999 99999999999996543 468999999
Q ss_pred ccc
Q 004869 532 AKQ 534 (726)
Q Consensus 532 a~~ 534 (726)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3e-09 Score=125.72 Aligned_cols=250 Identities=22% Similarity=0.226 Sum_probs=167.0
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
...+.|.+.+-+-+|.++.++.+.-. .|...+.|...... .+..+....+-.++-..+||-++...-- ......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s--~~~rsP 878 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS--FPCRSP 878 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC--CCCCCC
Confidence 34567788888889999999987632 34334444333221 1112222233333333445666654322 123457
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.+|+++|..+++|...|+... ..+.+........+.+.++|||... +.|||++|.|+|...++..+++|||..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence 899999999999999998532 3555566667777889999999887 899999999999999999999999844
Q ss_pred ccCCCC-----------------------------CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC
Q 004869 533 KQAPEG-----------------------------RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 583 (726)
Q Consensus 533 ~~~~~~-----------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG 583 (726)
...... +.........||+.|.+||...+......+|.|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 322100 000112346799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccC-CCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 004869 584 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMG 651 (726)
Q Consensus 584 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~ 651 (726)
..||....+.... +.+...... ...+.+...+..+++...+..++.+|-.|.
T Consensus 1032 ~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999755432210 111111110 112233344566788888899999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=100.69 Aligned_cols=143 Identities=18% Similarity=0.122 Sum_probs=101.6
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCC-----------chhHHHHHHHHHHhcccC--ceeEEEEEeecCC---
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRD--- 449 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~Hp--NIV~llg~~~~~~--- 449 (726)
+.+-+.....|++..+ +|+.|.||+....... ....+.+|.+.+.++... .....+++.....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556778777 5678999977433211 112478999999888533 3334455543211
Q ss_pred CCceEEEEeecCCC-ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-------C
Q 004869 450 SSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------N 521 (726)
Q Consensus 450 ~~~~~LV~Ey~~~G-sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-------~ 521 (726)
....+||+|++++- +|.+++.... ....+...+..++.+++..+.-||..| |+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8998875311 123445677789999999999999999 999999999999975 5
Q ss_pred CcEEEEecCcccc
Q 004869 522 FHAKVADFGLAKQ 534 (726)
Q Consensus 522 ~~vKL~DFGla~~ 534 (726)
..+.|+||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=93.70 Aligned_cols=126 Identities=22% Similarity=0.316 Sum_probs=84.4
Q ss_pred EEEEEEECCCcEEEEEEcccCCCC---------------------c-----hhHHHHHHHHHHhcccC--ceeEEEEEee
Q 004869 395 RVFKGVLSDGTAVAIKRLTCGGQQ---------------------G-----DKEFLVEVEMLSRLHHR--NLVKLVGYYS 446 (726)
Q Consensus 395 ~Vykg~l~~g~~VAVK~l~~~~~~---------------------~-----~~~f~~Ei~iL~~L~Hp--NIV~llg~~~ 446 (726)
.||.|...+|..+|||..+..... . .....+|.+.|.++..- ++-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999888999999987542100 0 12356799999999765 455666542
Q ss_pred cCCCCceEEEEeecC--CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHH-HHhCCCCceeecCCCccceeecCCCc
Q 004869 447 SRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY-LHEDSQPCVIHRDFKASNILLENNFH 523 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~--~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~y-LH~~~~p~IvHrDIKp~NILLd~~~~ 523 (726)
..+|||||++ |..+..+... .++......++.+++..+.. +|..+ |+|+||...|||++++ .
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred -----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 4589999998 5455443321 12245667788888886665 57888 9999999999999988 9
Q ss_pred EEEEecCccccCC
Q 004869 524 AKVADFGLAKQAP 536 (726)
Q Consensus 524 vKL~DFGla~~~~ 536 (726)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.7e-06 Score=89.76 Aligned_cols=270 Identities=17% Similarity=0.192 Sum_probs=153.7
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEE----eecCCCCc-eEEEE
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY----YSSRDSSQ-HLLCY 457 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~----~~~~~~~~-~~LV~ 457 (726)
..+-||+|+-+.+|-.- .-..-+.|+..........+ .+..|... .||-+-.=+.| ....+... .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999999532 11123446665332222221 22333333 45533221111 01112222 34556
Q ss_pred eecCCC-ChhhhccC--CCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 458 ELVPNG-SLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 458 Ey~~~G-sL~d~L~~--~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
..+.+. -..+++.- .+.......|...++++..+|.+.+-||..| .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 655543 23333321 1122345789999999999999999999999 88899999999999999999998544333
Q ss_pred CCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCccc-h-hh-hhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQE-N-LV-TWARPI 605 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG-~~Pf~~~~~~~~~-~-l~-~~~~~~ 605 (726)
..++ . ..-..+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||......... + +. +.+...
T Consensus 167 ~~ng-~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG-T--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC-c--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2222 1 123357889999999654 23446789999999999999886 9999753321111 0 00 011001
Q ss_pred ccchhhhhhhcCCccCCCCChhh-HHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHHhhh
Q 004869 606 LRDKDRLEELADPRLGGKYPKED-FIRVCTIAAACVAPE--ANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 606 ~~~~~~l~~i~d~~l~~~~~~e~-~~~l~~Li~~CL~~d--P~~RPTm~EVl~~L~~i~~~~~ 665 (726)
+........-..+. ....|.+. ...+-.+-.+|+... +.-|||++-.+..|..+.+.+.
T Consensus 244 f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 10000000000000 01112111 123455667777653 5689999999999988877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=89.24 Aligned_cols=109 Identities=25% Similarity=0.252 Sum_probs=83.9
Q ss_pred hhHHHHHHHHHHhcc--cCceeEEEEEeecCCC--CceEEEEeecCCC-ChhhhccCCCCCcccCChhhhHHHHHHHHHH
Q 004869 420 DKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS--SQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARG 494 (726)
Q Consensus 420 ~~~f~~Ei~iL~~L~--HpNIV~llg~~~~~~~--~~~~LV~Ey~~~G-sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~g 494 (726)
.....+|.+.+.++. .-...+.+++...... ...+||+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 346788999888885 3344555665543222 2458999999984 7999886411 14556778999999999
Q ss_pred HHHHHhCCCCceeecCCCccceeecCCC---cEEEEecCccccC
Q 004869 495 LAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQA 535 (726)
Q Consensus 495 L~yLH~~~~p~IvHrDIKp~NILLd~~~---~vKL~DFGla~~~ 535 (726)
++-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 99999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.9e-06 Score=86.26 Aligned_cols=140 Identities=18% Similarity=0.184 Sum_probs=102.7
Q ss_pred eeecCcEEEEEEEECCCcEEEEEEcccC---C---CCchhHHHHHHHHHHhccc--CceeEEEEEee---cCCCCceEEE
Q 004869 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCG---G---QQGDKEFLVEVEMLSRLHH--RNLVKLVGYYS---SRDSSQHLLC 456 (726)
Q Consensus 388 LG~G~fG~Vykg~l~~g~~VAVK~l~~~---~---~~~~~~f~~Ei~iL~~L~H--pNIV~llg~~~---~~~~~~~~LV 456 (726)
-|+||.+-|++-.+. |..+-+|+-... + ......|.+|+..|.++.. -.+.+.+ ++. ......-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 357899999998775 457889987521 1 2356789999999999963 2344444 322 1122346799
Q ss_pred EeecCC-CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc--EEEEecCccc
Q 004869 457 YELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~-GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~--vKL~DFGla~ 533 (726)
+|-+++ -+|.+++... ...+.+...+..+..++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5888888532 1224566777899999999999999999 999999999999986666 9999998776
Q ss_pred c
Q 004869 534 Q 534 (726)
Q Consensus 534 ~ 534 (726)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.8e-06 Score=90.10 Aligned_cols=148 Identities=21% Similarity=0.198 Sum_probs=105.4
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC----------------------chhHHHHHHH
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ----------------------GDKEFLVEVE 428 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~ 428 (726)
.+..+.....-..+.+.||.|--+.||.|....|.++|||.=+.+... ......+|.+
T Consensus 82 AL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 82 ALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 333343333345667999999999999999999999999964322100 1124577999
Q ss_pred HHHhcccC--ceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCce
Q 004869 429 MLSRLHHR--NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506 (726)
Q Consensus 429 iL~~L~Hp--NIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~I 506 (726)
.|.+|.-. .+-+-+++ +...+||||+++--|...- ++....-.++..|++-+.-+-..| +
T Consensus 162 ~L~~L~~~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---i 223 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---I 223 (304)
T ss_pred HHHHhhhcCCCCCCcccc------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---c
Confidence 99998654 56666543 3678999999986665432 223444556666666666555677 9
Q ss_pred eecCCCccceeecCCCcEEEEecCccccCC
Q 004869 507 IHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 507 vHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+|+|+..=||++++||.+.++||--+....
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccccCC
Confidence 999999999999999999999998776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-07 Score=108.54 Aligned_cols=151 Identities=21% Similarity=0.279 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc-------cccccccccccccCcccccc
Q 004869 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-------YLSTRVMGTFGYVAPEYAMT 561 (726)
Q Consensus 489 ~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~-------~~~~~~~GT~~Y~APE~l~~ 561 (726)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++......... ....-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999764 4999999999999999999999999998755442110 01111234568999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHcc
Q 004869 562 GHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 640 (726)
Q Consensus 562 ~~~s~ksDVwSfGvvL~ELltG~~P-f~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL 640 (726)
...+.++|+||+||++|-+..|..+ +...... ..+.. +...+..-.-.++.+...++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSF---------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhh---------hhcccccccccccccCcHHHHHHHHHHh
Confidence 8899999999999999999855444 3322111 11100 0001111111223344455777888899
Q ss_pred ccCCCCCCCHHHHHH
Q 004869 641 APEANQRPTMGEVVQ 655 (726)
Q Consensus 641 ~~dP~~RPTm~EVl~ 655 (726)
..+..-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=82.08 Aligned_cols=138 Identities=17% Similarity=0.233 Sum_probs=82.0
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce--eEEEEEeecCCCCceEEEEeecCCC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-++ .+.+++.. +.....+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeecCCc
Confidence 67899999999983 24457788876422 34557889999998864433 45555554 334567899999886
Q ss_pred C-hhhhc---------------------cCCCCCcccCChhhhHH-HHH----------HHHH-HHHHHHh-CCCCceee
Q 004869 464 S-LESWL---------------------HGPLGVNCHLDWETRMK-IAL----------DAAR-GLAYLHE-DSQPCVIH 508 (726)
Q Consensus 464 s-L~d~L---------------------~~~~~~~~~Ls~~~~~~-ia~----------qIa~-gL~yLH~-~~~p~IvH 508 (726)
+ +.+.+ |...... ........ +-. .+.+ ...+|.. ...+.++|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 3 22111 1100000 00000000 000 0111 1122221 12356899
Q ss_pred cCCCccceeecCCCcEEEEecCccc
Q 004869 509 RDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 509 rDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+|+.+.||++++++ +.|.||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=81.23 Aligned_cols=146 Identities=19% Similarity=0.205 Sum_probs=85.7
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc--eeEEEEEeecCC-CCceEEEEeecC
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVGYYSSRD-SSQHLLCYELVP 461 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~~~~~~-~~~~~LV~Ey~~ 461 (726)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++.++.... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 58999987533 33567888999998886433 456666443222 234689999999
Q ss_pred CCChhh----------------hc---cCCCCCcccCChhh---------hHHH------------HHHHHH-HHHHHHh
Q 004869 462 NGSLES----------------WL---HGPLGVNCHLDWET---------RMKI------------ALDAAR-GLAYLHE 500 (726)
Q Consensus 462 ~GsL~d----------------~L---~~~~~~~~~Ls~~~---------~~~i------------a~qIa~-gL~yLH~ 500 (726)
+..+.. .+ |..........+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 11100000111100 0000 111222 2333332
Q ss_pred ----CCCCceeecCCCccceeec-CCCcEEEEecCccc
Q 004869 501 ----DSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK 533 (726)
Q Consensus 501 ----~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~ 533 (726)
....+++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2456799999999999999 66667899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=8.4e-06 Score=93.52 Aligned_cols=142 Identities=21% Similarity=0.276 Sum_probs=96.3
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCC---------------------c-------------------hhHHHH
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---------------------G-------------------DKEFLV 425 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~---------------------~-------------------~~~f~~ 425 (726)
+-|+.++-|.||+|++.+|+.||||+.+.+-.. . +-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678999999999999999999999986532100 0 013455
Q ss_pred HHHHHHhcc----cCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHH-HHHHHh
Q 004869 426 EVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG-LAYLHE 500 (726)
Q Consensus 426 Ei~iL~~L~----HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~g-L~yLH~ 500 (726)
|...+.+++ +..-+.+-.+|.+ -.+...|+|||++|-.+.+...... ..++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehh-ccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 666666653 2333344444432 2347799999999999988853211 1122 33444444442 333444
Q ss_pred CCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 501 ~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
.| +.|.|..|.||+++.++++.+.|||+......
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 66 99999999999999999999999999876654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.6e-05 Score=78.38 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=84.4
Q ss_pred eeeecCc-EEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEeecCCCC
Q 004869 387 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGS 464 (726)
Q Consensus 387 ~LG~G~f-G~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~Ey~~~Gs 464 (726)
.|-.|.. ..||+.... +..+.||+..... .....+|++++..+. +--+.+++++... ....++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCcc
Confidence 3445555 789998764 4678888876432 345778999998884 4345566666542 245789999999987
Q ss_pred hhhhc-------------------cCCCCCcccCC--hhhhHHHHH--------------------HHHHHHHHHHh---
Q 004869 465 LESWL-------------------HGPLGVNCHLD--WETRMKIAL--------------------DAARGLAYLHE--- 500 (726)
Q Consensus 465 L~d~L-------------------~~~~~~~~~Ls--~~~~~~ia~--------------------qIa~gL~yLH~--- 500 (726)
|.... |........+. +........ .+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 11100000110 000000000 01111222211
Q ss_pred -CCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 501 -DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 501 -~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
...++++|+|+.+.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 234679999999999999998888999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.3e-05 Score=78.26 Aligned_cols=140 Identities=16% Similarity=0.163 Sum_probs=93.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhH---------HHHHHHHHHhcccCc---eeEEEEEe
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHHRN---LVKLVGYY 445 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~HpN---IV~llg~~ 445 (726)
...+|...+++-......|.+-.. +|..+++|..........+. ..+++..+.+++... ...++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457788888888888888888777 46789999887543322222 233445455553222 22222221
Q ss_pred ec---CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 446 SS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 446 ~~---~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
.- .-....+|+|||++|..|.++.. ++. .++..+.+++.-||+.| ++|+|..|+|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 11 11235579999999988877643 221 35566778899999999 99999999999998664
Q ss_pred cEEEEecCcccc
Q 004869 523 HAKVADFGLAKQ 534 (726)
Q Consensus 523 ~vKL~DFGla~~ 534 (726)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00016 Score=75.01 Aligned_cols=153 Identities=18% Similarity=0.222 Sum_probs=104.5
Q ss_pred cCHHHHHHHhcCcccceeee---ecCcEEEEEEEECCCcEEEEEEcccCCCC-------------------chh----H-
Q 004869 370 LAYEELKEATNNFEPASILG---EGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-------------------GDK----E- 422 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG---~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-------------------~~~----~- 422 (726)
.+++.+....++..+..+.| .|--..||+|...++..+|||+.+..... ..+ .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666777767766666655 56667899999888999999988643211 011 1
Q ss_pred HHHHHHHHHhcc--cCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh
Q 004869 423 FLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500 (726)
Q Consensus 423 f~~Ei~iL~~L~--HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~ 500 (726)
..+|...|.++. +-.+-+-+++. ...|||||+.... ...+.-....+...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 245888888874 45555555543 3589999996541 11111112223334567778888888887776
Q ss_pred -CCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 501 -DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 501 -~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
.+ +||+||..=|||+. ++.+.|+|||-|....
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 55 99999999999999 7899999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.94 E-value=4e-05 Score=77.07 Aligned_cols=105 Identities=25% Similarity=0.230 Sum_probs=82.1
Q ss_pred HHHHHHHHhccc-CceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC
Q 004869 424 LVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502 (726)
Q Consensus 424 ~~Ei~iL~~L~H-pNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~ 502 (726)
..|.-+++.+++ +++.+++|+|- .+++.||...+++...- .....-..-+|..|.+||.++++.+.+|++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 357888888876 69999999983 37789999887664320 00001123689999999999999999999865
Q ss_pred CCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
...+...|++++|+-+++++++|+.|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 445888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=87.97 Aligned_cols=81 Identities=16% Similarity=0.213 Sum_probs=58.4
Q ss_pred ceeeeecCcEEEEEEEECCC---cEEEEEEcccCCC-CchhHHHHHHHHHHhcc-cCce--eEEEEEeecCC-CCceEEE
Q 004869 385 ASILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNL--VKLVGYYSSRD-SSQHLLC 456 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNI--V~llg~~~~~~-~~~~~LV 456 (726)
.+.|+.|.++.+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++++|...+ .+..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 4677887654322 23457889999999995 6654 77777775321 2457899
Q ss_pred EeecCCCCh
Q 004869 457 YELVPNGSL 465 (726)
Q Consensus 457 ~Ey~~~GsL 465 (726)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00017 Score=74.55 Aligned_cols=143 Identities=18% Similarity=0.201 Sum_probs=77.9
Q ss_pred eeeeecCcE-EEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC---ceeEEEEEeecCCC-CceEEEEeec
Q 004869 386 SILGEGGFG-RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDS-SQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG-~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~llg~~~~~~~-~~~~LV~Ey~ 460 (726)
+.|+.||.. .||+. +..+++|.... ......+.+|.+++..+... .+-+.++.....+. ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 48875 23577776543 12345788999999887532 23334433322111 2348899999
Q ss_pred CCCChhhhc------------------cCCCCCcccC-------------ChhhhH--HHH-------HHHHHHH-HH-H
Q 004869 461 PNGSLESWL------------------HGPLGVNCHL-------------DWETRM--KIA-------LDAARGL-AY-L 498 (726)
Q Consensus 461 ~~GsL~d~L------------------~~~~~~~~~L-------------s~~~~~--~ia-------~qIa~gL-~y-L 498 (726)
+|.++.+.. |.-....... .|.... .+. .+....+ +. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 997775331 2110000000 111110 000 0111111 11 1
Q ss_pred Hh--CCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 499 HE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 499 H~--~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+. ...++++|+|+.+.||+++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1345699999999999999776667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.4e-06 Score=96.12 Aligned_cols=185 Identities=19% Similarity=0.165 Sum_probs=129.0
Q ss_pred cccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc-eeEEEEEeecCCCCceEEEEeec
Q 004869 382 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+...+-+++|+++++||.+-.-.+...++.+... ....-++++|.+++||| .+..++-+. .....+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC--cccccchhhhhh
Confidence 3444567899999999987433334446655422 44566899999999999 555444433 334677899999
Q ss_pred CCC-ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 461 PNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 461 ~~G-sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
.+| +-..... .....+..-+...+...-+++|+|||+.. =+|+| ||+..+ +..|.+||+.........
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 877 2222111 11122333344556666778999999875 58999 887766 578999999987765543
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf 587 (726)
......+|+.|+|||+.....+..+-|+|+.|+--.++--|-.|-
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234567999999999999999999999999998766776666654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.7e-05 Score=84.80 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=93.2
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC-------------------------------------chhHHHHHH
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-------------------------------------GDKEFLVEV 427 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-------------------------------------~~~~f~~Ei 427 (726)
.+-||.-+.|.||+|++++|+.||||+-+.+-.. .+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3679999999999999999999999975432110 011466676
Q ss_pred HHHHhc----ccCc---eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHH-HHH
Q 004869 428 EMLSRL----HHRN---LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA-YLH 499 (726)
Q Consensus 428 ~iL~~L----~HpN---IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~-yLH 499 (726)
+-..++ .|-+ -|.+-.++.+ -.....|+||||+|..+.|.-.-. ...++-. .++..+.++.. -+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~-~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~---~i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD-LSTKRVLTMEYVDGIKINDLDAID---KRGISPH---DILNKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh-cCcceEEEEEecCCccCCCHHHHH---HcCCCHH---HHHHHHHHHHHHHHH
Confidence 655544 4555 2223334432 234789999999998887764211 1123333 34443333322 222
Q ss_pred hCCCCceeecCCCccceeec----CCCcEEEEecCccccCCC
Q 004869 500 EDSQPCVIHRDFKASNILLE----NNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 500 ~~~~p~IvHrDIKp~NILLd----~~~~vKL~DFGla~~~~~ 537 (726)
..| ++|+|=.|.||++. .++.+.+.|||+......
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 345 99999999999998 377899999999886654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00063 Score=73.26 Aligned_cols=81 Identities=14% Similarity=0.065 Sum_probs=58.6
Q ss_pred cccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhccc---CceeEEEEEeecC-CCCceEEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSR-DSSQHLLCY 457 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~llg~~~~~-~~~~~~LV~ 457 (726)
....+.||.|..+.||+....+++ +.+|..+. ......|.+|.+.|+.+.- -.+.+++++|... ..+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344578999999999998766664 66676432 1134588999999998853 3677888877532 234579999
Q ss_pred eecCCCCh
Q 004869 458 ELVPNGSL 465 (726)
Q Consensus 458 Ey~~~GsL 465 (726)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00024 Score=74.41 Aligned_cols=139 Identities=18% Similarity=0.138 Sum_probs=80.0
Q ss_pred eeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEEeecCCCChh
Q 004869 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPNGSLE 466 (726)
Q Consensus 388 LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~Ey~~~GsL~ 466 (726)
+..|-.+.+|+... ++..+++|........-.-+..+|.++++.+...+++ ++++.. + -.+||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~---~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E---HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C---CEEEEEeccCcccc
Confidence 45677888998874 5667888876543222112467899999988654343 333332 1 36899999987764
Q ss_pred hh-----------------ccCCCCCcccCChhhhH-HHHHH---------HHHHHHHHHhC-----CCCceeecCCCcc
Q 004869 467 SW-----------------LHGPLGVNCHLDWETRM-KIALD---------AARGLAYLHED-----SQPCVIHRDFKAS 514 (726)
Q Consensus 467 d~-----------------L~~~~~~~~~Ls~~~~~-~ia~q---------Ia~gL~yLH~~-----~~p~IvHrDIKp~ 514 (726)
.. ||........++..... ....+ +.+-+..+-.. ..+.++|+|+.+.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 31 12211111112211111 11111 11112222211 1356999999999
Q ss_pred ceeecCCCcEEEEecCcccc
Q 004869 515 NILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 515 NILLd~~~~vKL~DFGla~~ 534 (726)
||++++++ ++|.||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00052 Score=69.53 Aligned_cols=127 Identities=26% Similarity=0.389 Sum_probs=91.5
Q ss_pred cCcccceeeeecCc-EEEEEEEECCCcEEEEEEccc---CCC------------------CchhHHHHHHHHHHhcc---
Q 004869 380 NNFEPASILGEGGF-GRVFKGVLSDGTAVAIKRLTC---GGQ------------------QGDKEFLVEVEMLSRLH--- 434 (726)
Q Consensus 380 ~~f~~~~~LG~G~f-G~Vykg~l~~g~~VAVK~l~~---~~~------------------~~~~~f~~Ei~iL~~L~--- 434 (726)
.+++..+.||.|.- |.||++++. |+.+|+|.+.. ... ....-|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999994 67999999322 000 01135888999988885
Q ss_pred cCce--eEEEEEeecCC----------------CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHH
Q 004869 435 HRNL--VKLVGYYSSRD----------------SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496 (726)
Q Consensus 435 HpNI--V~llg~~~~~~----------------~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~ 496 (726)
+.++ |+.+||..-.. .....||.||++... ....+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4566 89999863221 112356777775532 112334567777888
Q ss_pred HHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 497 yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 999999 999999999986 4589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00035 Score=69.03 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=88.8
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeE-EEEEeecCCCCceEEEEeecC
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~-llg~~~~~~~~~~~LV~Ey~~ 461 (726)
...+.|++|++|.||+|.+.+ ..+|+|.-..++ ....+..|.++|..+.-.++-+ ++.|- .-.+.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhhc
Confidence 345789999999999999965 578988776433 3567899999999998666554 33331 2345599999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCC-ccceeecCCCcEEEEecCccccC
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK-ASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIK-p~NILLd~~~~vKL~DFGla~~~ 535 (726)
|-.|.++-... -.+-...+++.---|...| |-|+.|. |..++|.++..+.|+||.-|...
T Consensus 96 G~~L~~~~~~~-----------~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIGG-----------DRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhcc-----------cHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88887765421 1223344455544455556 8898887 44444445559999999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00087 Score=68.91 Aligned_cols=141 Identities=21% Similarity=0.188 Sum_probs=81.6
Q ss_pred eeeeecCcEEEEEEEECC--CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEEeecCC
Q 004869 386 SILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~--g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
+.|..|-...+|+....+ +..|++|....... ...+..+|+.+++.+...+++ ++++.+ + -.++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~---~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF---Q---NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe---C---CcEEEEeeCC
Confidence 567788888999988764 67888997653321 122345789999988644443 343332 1 1379999999
Q ss_pred CChhhh-----------------ccCCCCCc-------ccC-ChhhhHHHHH----------------------HHH---
Q 004869 463 GSLESW-----------------LHGPLGVN-------CHL-DWETRMKIAL----------------------DAA--- 492 (726)
Q Consensus 463 GsL~d~-----------------L~~~~~~~-------~~L-s~~~~~~ia~----------------------qIa--- 492 (726)
.++... +|...... ... -|..+..+.. .+.
T Consensus 77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 156 (235)
T cd05157 77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI 156 (235)
T ss_pred CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence 776321 11110000 011 1222111111 111
Q ss_pred HHHH-HHHhC-CCCceeecCCCccceeecC-CCcEEEEecCccc
Q 004869 493 RGLA-YLHED-SQPCVIHRDFKASNILLEN-NFHAKVADFGLAK 533 (726)
Q Consensus 493 ~gL~-yLH~~-~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~ 533 (726)
..|. .+... ....++|+|+.+.|||+++ ++.+.|.||..|.
T Consensus 157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1111 11111 2356999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0014 Score=66.49 Aligned_cols=134 Identities=17% Similarity=0.277 Sum_probs=91.2
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccCC----------------CCchhHHHHHHHHHHhcc------cCceeEE
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----------------QQGDKEFLVEVEMLSRLH------HRNLVKL 441 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV~l 441 (726)
....||+|+.-.||. +.++....||++.... ....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999995 4455667888876544 223467788888877776 7889999
Q ss_pred EEEeecCCCCceEEEEeecCC------CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccc
Q 004869 442 VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 515 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~------GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~N 515 (726)
+|+...+ ...-+|+|.+.+ -+|.+++.. ..++. ...+ .+-+-.+||-+++ |+.+|++|.|
T Consensus 83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHN 148 (199)
T ss_pred eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHcC---CeecCCCccc
Confidence 9998743 356778887654 246777743 22433 3333 3334455777777 9999999999
Q ss_pred eeecCC---C-cEEEEe-cCccc
Q 004869 516 ILLENN---F-HAKVAD-FGLAK 533 (726)
Q Consensus 516 ILLd~~---~-~vKL~D-FGla~ 533 (726)
|++... . .+.|.| ||-..
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEEEecCCCceEEEEEeCCCCcc
Confidence 999532 2 577777 56543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0024 Score=71.44 Aligned_cols=75 Identities=19% Similarity=0.194 Sum_probs=53.8
Q ss_pred eeeeecCcEEEEEEEECCC-cEEEEEEcccC-----C--CCchhHHHHHHHHHHhcc---cCceeEEEEEeecCCCCceE
Q 004869 386 SILGEGGFGRVFKGVLSDG-TAVAIKRLTCG-----G--QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~~~~~ 454 (726)
+.||.|.+..||++...+| +.|+||.-... . ....+.+..|.+.|..+. -.++.+++.+ +....+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----D~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----DEELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE----CCCCCE
Confidence 5789999999999998777 48999985311 1 123456777888888763 2456677766 334678
Q ss_pred EEEeecCCCC
Q 004869 455 LCYELVPNGS 464 (726)
Q Consensus 455 LV~Ey~~~Gs 464 (726)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00092 Score=71.31 Aligned_cols=145 Identities=19% Similarity=0.165 Sum_probs=86.6
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc--eeEEEEEee----cCCCCceEEEEe
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVGYYS----SRDSSQHLLCYE 458 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg~~~----~~~~~~~~LV~E 458 (726)
.+.|..|....+|+....++ .+++|+... ........|++++..+++.+ +.+.+.... ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999876554 688888763 23456777888888885433 444443211 011235689999
Q ss_pred ecCCCChhh----h----------ccCCC-CC------cccCChhhhH----------HHHHHHHHHHHHHHh----CCC
Q 004869 459 LVPNGSLES----W----------LHGPL-GV------NCHLDWETRM----------KIALDAARGLAYLHE----DSQ 503 (726)
Q Consensus 459 y~~~GsL~d----~----------L~~~~-~~------~~~Ls~~~~~----------~ia~qIa~gL~yLH~----~~~ 503 (726)
|++|..+.. . ||... +. .....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877643 0 11100 00 0112232211 011123334455543 123
Q ss_pred CceeecCCCccceeecCCCcEEEEecCccc
Q 004869 504 PCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 504 p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
..++|+|+.+.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998778899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0023 Score=69.19 Aligned_cols=160 Identities=16% Similarity=0.146 Sum_probs=86.1
Q ss_pred cCHHHHHHHhcCccc-----ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc--eeEEE
Q 004869 370 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV 442 (726)
Q Consensus 370 ~~~~el~~~t~~f~~-----~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~ll 442 (726)
++.+++....+.|.+ .+.|+.|....+|+....+| .+++|+.. . ...+....|++++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 455566555555644 34566777789999887665 58888875 1 22344445666666664222 22333
Q ss_pred EEe----ecCCCCceEEEEeecCCCChhh-----------h---ccCCC-CC------cccCCh-hhhHH----------
Q 004869 443 GYY----SSRDSSQHLLCYELVPNGSLES-----------W---LHGPL-GV------NCHLDW-ETRMK---------- 486 (726)
Q Consensus 443 g~~----~~~~~~~~~LV~Ey~~~GsL~d-----------~---L~~~~-~~------~~~Ls~-~~~~~---------- 486 (726)
... .....+..+++++|++|..+.. . +|... +. ...+.| .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 210 0011335689999999875421 0 11110 00 011112 11111
Q ss_pred --HHHH-HHHHHHHHHhC----CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 487 --IALD-AARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 487 --ia~q-Ia~gL~yLH~~----~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
...+ +...++.+... -+.++||+|+.+.|||++++...-|.||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 23469999999999999977666899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0012 Score=80.41 Aligned_cols=198 Identities=22% Similarity=0.203 Sum_probs=135.1
Q ss_pred HHHHHHHHHhcccCceeEEEEEeecCCCC--ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh
Q 004869 423 FLVEVEMLSRLHHRNLVKLVGYYSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500 (726)
Q Consensus 423 f~~Ei~iL~~L~HpNIV~llg~~~~~~~~--~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~ 500 (726)
...|++.+.++.|+|++.+++|-...... ...+..+++..-++...+.. -..+.....+.+..++..||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44577788899999999999885432211 22344578877788777753 3357778888999999999999999
Q ss_pred CCCCceeecCCCcc---ceeecCCCcEEEE--ecCccccCCCCCcccccccccccccccCccccccCCCC--cchhHHHH
Q 004869 501 DSQPCVIHRDFKAS---NILLENNFHAKVA--DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL--VKSDVYSY 573 (726)
Q Consensus 501 ~~~p~IvHrDIKp~---NILLd~~~~vKL~--DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s--~ksDVwSf 573 (726)
.. ..|.-+..+ +--.+.++.+.++ ||+..+...+... .....-+..|.++|......+. .+.|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence 86 666666555 5555667777777 9988876654332 1223345568888877765554 45799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 004869 574 GVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653 (726)
Q Consensus 574 GvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EV 653 (726)
|..+..+..|..+-.... ....+.+. .... ...+....|+..+.++|+...++
T Consensus 379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDV----LSTS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-------------------chhhhhcc----ccch----hhhhhhhhhcchhhhhccchhhh
Confidence 999999998865422100 01111111 1111 35667889999999999999999
Q ss_pred HHHH
Q 004869 654 VQSL 657 (726)
Q Consensus 654 l~~L 657 (726)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.003 Score=67.70 Aligned_cols=141 Identities=27% Similarity=0.288 Sum_probs=84.1
Q ss_pred eeeeecCcEEEEEEEECC-------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~ 457 (726)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+...++. ++++++. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence 456667777999988755 4788899865432 2234567888888888643333 4444432 2 3589
Q ss_pred eecCCCChhhh-----------------ccCCCCC--c-----ccCChhhhHH--------------------------H
Q 004869 458 ELVPNGSLESW-----------------LHGPLGV--N-----CHLDWETRMK--------------------------I 487 (726)
Q Consensus 458 Ey~~~GsL~d~-----------------L~~~~~~--~-----~~Ls~~~~~~--------------------------i 487 (726)
||++|..+... ||..... . ...-|....+ +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99998776531 1211100 0 0001111111 1
Q ss_pred HHHHHHHHHHHHh------CCCCceeecCCCccceeecCC----CcEEEEecCccc
Q 004869 488 ALDAARGLAYLHE------DSQPCVIHRDFKASNILLENN----FHAKVADFGLAK 533 (726)
Q Consensus 488 a~qIa~gL~yLH~------~~~p~IvHrDIKp~NILLd~~----~~vKL~DFGla~ 533 (726)
...+..-+.+|-. ....+++|+|+.+.|||++++ +.++++||..|.
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 1122223334432 245679999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0039 Score=67.19 Aligned_cols=160 Identities=18% Similarity=0.163 Sum_probs=91.0
Q ss_pred CHHHHHHHhcCccc-----ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc--eeEEEE
Q 004869 371 AYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVG 443 (726)
Q Consensus 371 ~~~el~~~t~~f~~-----~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~llg 443 (726)
+.++|....+.|.+ .+.++.|....+|+....+| .+++|+..... ...+...|++++..|...+ +.+.+.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 44566555555544 35567777789999876555 57788765321 2345566778887775322 344443
Q ss_pred Eee----cCCCCceEEEEeecCCCChhhh--------------ccCCC-CCc-------ccCChhhhH------------
Q 004869 444 YYS----SRDSSQHLLCYELVPNGSLESW--------------LHGPL-GVN-------CHLDWETRM------------ 485 (726)
Q Consensus 444 ~~~----~~~~~~~~LV~Ey~~~GsL~d~--------------L~~~~-~~~-------~~Ls~~~~~------------ 485 (726)
... ....+..+++++|++|..+... +|... +.. ..-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 211 1123456899999998654311 12100 000 001121110
Q ss_pred HHHHHHHHHHHHHHh----CCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 486 KIALDAARGLAYLHE----DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 486 ~ia~qIa~gL~yLH~----~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.....+.+.++++.. ..+.+++|+|+.+.||++++++...|.||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123344555542 224569999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0078 Score=64.62 Aligned_cols=141 Identities=22% Similarity=0.330 Sum_probs=72.4
Q ss_pred cccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc---cCceeEEEEEeecCCCCceEEEEe
Q 004869 382 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.+..+.|+-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+ ..+|++|
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEEEE
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEEEE
Confidence 3445778999999999977 567889999876 333457889999999884 345667777765433 4599999
Q ss_pred ecCCCCh--h------h---hccC-CC-CC----------------cccCChh-----hhHHHHHHHH------------
Q 004869 459 LVPNGSL--E------S---WLHG-PL-GV----------------NCHLDWE-----TRMKIALDAA------------ 492 (726)
Q Consensus 459 y~~~GsL--~------d---~L~~-~~-~~----------------~~~Ls~~-----~~~~ia~qIa------------ 492 (726)
|++.+.. . . .||. .. +. ...-+|. +|+.-..+.+
T Consensus 93 ~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~ 172 (288)
T PF03881_consen 93 FLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELER 172 (288)
T ss_dssp --------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHH
T ss_pred eecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHH
Confidence 9988711 1 0 1222 10 00 0011332 1222222111
Q ss_pred --HHHH-HHHh-CCCCceeecCCCccceeecCCCcEEEEe
Q 004869 493 --RGLA-YLHE-DSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 493 --~gL~-yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
+.+. .|+. .-+|+++|+||.+.|++.+.++.+.|.|
T Consensus 173 l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~D 212 (288)
T PF03881_consen 173 LVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFD 212 (288)
T ss_dssp HHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S
T ss_pred HHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeec
Confidence 1111 1221 2268999999999999999999899987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.023 Score=60.66 Aligned_cols=32 Identities=22% Similarity=0.462 Sum_probs=26.6
Q ss_pred CCceeecCCCccceeecCCCc-EEEEecCcccc
Q 004869 503 QPCVIHRDFKASNILLENNFH-AKVADFGLAKQ 534 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~~~-vKL~DFGla~~ 534 (726)
.+.++|+|+.+.|||++++++ .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 456999999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0032 Score=67.64 Aligned_cols=138 Identities=20% Similarity=0.206 Sum_probs=96.1
Q ss_pred CcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC-----------------C-----chhHHHHHHHHHHhcc-cCc
Q 004869 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-----------------Q-----GDKEFLVEVEMLSRLH-HRN 437 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~-----------------~-----~~~~f~~Ei~iL~~L~-HpN 437 (726)
-+...+.||-|--+.||.+...+|+..++|.-..+.. . ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4677899999999999999999999999884322110 0 0113456888888885 322
Q ss_pred -eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 438 -LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 438 -IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+.+.+ +....++|||++.+-.|...-+- ...-.+...+..-+.-|..+| +||+|+.-=||
T Consensus 173 pVPkpi------D~~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPI------DHNRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNI 233 (465)
T ss_pred CCCCcc------cccceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcC---ceecccchhee
Confidence 22333 33467899999998888764431 122233444444456677788 99999999999
Q ss_pred eecCCCcEEEEecCccccCCC
Q 004869 517 LLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~ 537 (726)
++++++.++++||--......
T Consensus 234 mv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred EEecCCCEEEeechHhhccCC
Confidence 999999999999987654443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.024 Score=62.34 Aligned_cols=141 Identities=17% Similarity=0.204 Sum_probs=80.9
Q ss_pred eeeeecCcEEEEEEEECC-----CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEEee
Q 004869 386 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~Ey 459 (726)
..|-.|-...+|+..+.+ ++.|++|....... ..-+..+|.+++..+..-++. ++++.+. + + .|++|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~--~-g---~v~ef 114 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFP--N-G---RVEEF 114 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEEC--C-c---eEEEe
Confidence 345457777889887532 36788888764432 222346799999888654444 4455442 2 1 58999
Q ss_pred cCCCChhhh-----------------ccCCC--CCcccCChhhhHHHHHHH-----------------HHHHHHH----H
Q 004869 460 VPNGSLESW-----------------LHGPL--GVNCHLDWETRMKIALDA-----------------ARGLAYL----H 499 (726)
Q Consensus 460 ~~~GsL~d~-----------------L~~~~--~~~~~Ls~~~~~~ia~qI-----------------a~gL~yL----H 499 (726)
+++.+|... +|... +.....-|.+..++..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 987776421 12211 000011233332322111 1112222 2
Q ss_pred h-CCCCceeecCCCccceeecC-CCcEEEEecCccc
Q 004869 500 E-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAK 533 (726)
Q Consensus 500 ~-~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~ 533 (726)
. .....++|+|+++.|||+++ ++.++++||..+.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 22346999999999999986 4689999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.042 Score=59.74 Aligned_cols=141 Identities=16% Similarity=0.190 Sum_probs=79.7
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcc-cCCCCchhHHHHHHHHHHhccc--CceeEEEEEeecCCCCceEEEEeecCC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~-~~~~~~~~~f~~Ei~iL~~L~H--pNIV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
+.+..|..-.+|+.... ++.+++.+-. ...........+|.++|+.+.- --+-..+++|....-+..+.||+|++|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 33333333344444333 6777777221 1112233455678888887643 233345566653322467999999998
Q ss_pred CChhhhccCCCCCcccCChhhhHHHH-HHHHHHH----------------------------------------------
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIA-LDAARGL---------------------------------------------- 495 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia-~qIa~gL---------------------------------------------- 495 (726)
..+.+.+.... . . .+++ ..+++.|
T Consensus 110 e~~~~~~~~~~-----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 110 EVVWSALPPES-----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eeccCcCCccc-----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 54443332100 0 0 0111 1333333
Q ss_pred ----HHHHhC-----CCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 496 ----AYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 496 ----~yLH~~-----~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
.+|+.+ +.++++|+|+.+.||+++.+.-+=|.||+++..-.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 333332 24679999999999999998889999999987543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0011 Score=82.36 Aligned_cols=161 Identities=14% Similarity=0.001 Sum_probs=113.8
Q ss_pred HHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC--C
Q 004869 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--S 502 (726)
Q Consensus 425 ~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~--~ 502 (726)
.|..-++...|++++....-....+..+.+.+++|+.+|.+.+.|-+.......++..-+...-.+......-.|.. +
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555679888776554444455678899999999999999865444344444333333333324444444432 2
Q ss_pred CCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh
Q 004869 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt 582 (726)
....+|+++|+-|.+|..+..+|++++|+.+...... .......+++.|+.++....-.++.|+|+|..|+-+|+..-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 3447899999999999999999999999998332211 12234567889999999888899999999999999999988
Q ss_pred CCCCC
Q 004869 583 GRKPV 587 (726)
Q Consensus 583 G~~Pf 587 (726)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87665
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.059 Score=58.16 Aligned_cols=32 Identities=16% Similarity=0.259 Sum_probs=28.4
Q ss_pred CCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
..+++|+|+.+.|+|++.++.+.+.||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.043 Score=55.68 Aligned_cols=29 Identities=31% Similarity=0.503 Sum_probs=21.1
Q ss_pred ceeecCCCccceee-cCCCcEEEEecCccc
Q 004869 505 CVIHRDFKASNILL-ENNFHAKVADFGLAK 533 (726)
Q Consensus 505 ~IvHrDIKp~NILL-d~~~~vKL~DFGla~ 533 (726)
.++|+|+.+.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 889999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.082 Score=56.59 Aligned_cols=29 Identities=31% Similarity=0.462 Sum_probs=25.4
Q ss_pred CceeecCCCccceeecCCCcEEEEecCccc
Q 004869 504 PCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 504 p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999988 578899999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.1 Score=57.01 Aligned_cols=142 Identities=15% Similarity=0.203 Sum_probs=80.2
Q ss_pred eeeeecCcEEEEEEEECC----CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.|..|-...+|+....+ +..|++|....... ..-+..+|..+++.+..-++- ++++++. + + +|.+|+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~-G---~i~~fi 92 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--N-G---MIQSFI 92 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--C-c---Eeehhh
Confidence 445557777889887543 23788887764332 223446799999988755553 4555542 2 1 589999
Q ss_pred CCCChhh-----------------hccCCC--CCcccCChhhhHHHHHHH----------------------HHHHHHHH
Q 004869 461 PNGSLES-----------------WLHGPL--GVNCHLDWETRMKIALDA----------------------ARGLAYLH 499 (726)
Q Consensus 461 ~~GsL~d-----------------~L~~~~--~~~~~Ls~~~~~~ia~qI----------------------a~gL~yLH 499 (726)
++-.|.. .||... .....--|....++..++ .+-+..+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 8766532 012211 000011233222222111 11122111
Q ss_pred ----h-CCCCceeecCCCccceeecC-CCcEEEEecCcccc
Q 004869 500 ----E-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ 534 (726)
Q Consensus 500 ----~-~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~ 534 (726)
. ..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 22346899999999999974 57899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.19 Score=56.44 Aligned_cols=80 Identities=16% Similarity=0.163 Sum_probs=52.2
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccC----CC---CchhHHHHHHHHHHhcc---cCceeEEEEEeecCCCCceE
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCG----GQ---QGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~----~~---~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~~~~~ 454 (726)
.+.||-|....||+.... +..|+||+-... +. .....-..|.+.|..+. ..++.+++.++. ...+
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TMAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CCCE
Confidence 467899999999998764 456899976511 11 12233344567776653 247778888864 3568
Q ss_pred EEEeecCCC--Chhhhc
Q 004869 455 LCYELVPNG--SLESWL 469 (726)
Q Consensus 455 LV~Ey~~~G--sL~d~L 469 (726)
++|||++++ .+.+.|
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 899999773 454443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.15 Score=56.48 Aligned_cols=73 Identities=18% Similarity=0.230 Sum_probs=48.2
Q ss_pred eeeecCcEEEEEEEECCC-cEEEEEEcc----c-C-C-CCchhHHHHHHHHHHhcc--cC-ceeEEEEEeecCCCCceEE
Q 004869 387 ILGEGGFGRVFKGVLSDG-TAVAIKRLT----C-G-G-QQGDKEFLVEVEMLSRLH--HR-NLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 387 ~LG~G~fG~Vykg~l~~g-~~VAVK~l~----~-~-~-~~~~~~f~~Ei~iL~~L~--Hp-NIV~llg~~~~~~~~~~~L 455 (726)
.||-|....||++...+| +.|+||.-. . + + .-......-|.+.|.... -| .+.+++.| +.....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----cccccee
Confidence 479999999999997654 579999753 1 1 1 222344556778887653 34 34455554 4456789
Q ss_pred EEeecCCC
Q 004869 456 CYELVPNG 463 (726)
Q Consensus 456 V~Ey~~~G 463 (726)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.19 Score=55.10 Aligned_cols=142 Identities=23% Similarity=0.268 Sum_probs=83.1
Q ss_pred eeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc------eeEEEEEeecCCC--CceEEEEee
Q 004869 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS--SQHLLCYEL 459 (726)
Q Consensus 388 LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~llg~~~~~~~--~~~~LV~Ey 459 (726)
|.+ .-..+|+....+|+. ++|..... ....+...|+..|..+.-.+ +..+=|-....-. ...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556789988877776 78877654 34566777888888774222 1222121111112 367789999
Q ss_pred cCCCChhh-hc--------------cC--------CCCCcccCChhh-------------hHHHHHHHHHHHHHHHhC--
Q 004869 460 VPNGSLES-WL--------------HG--------PLGVNCHLDWET-------------RMKIALDAARGLAYLHED-- 501 (726)
Q Consensus 460 ~~~GsL~d-~L--------------~~--------~~~~~~~Ls~~~-------------~~~ia~qIa~gL~yLH~~-- 501 (726)
++|..+.. .- |. .........|.. ......++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988873 11 10 011111234431 111233334444444432
Q ss_pred --CCCc---eeecCCCccceeecCCCc-EEEEecCccc
Q 004869 502 --SQPC---VIHRDFKASNILLENNFH-AKVADFGLAK 533 (726)
Q Consensus 502 --~~p~---IvHrDIKp~NILLd~~~~-vKL~DFGla~ 533 (726)
-... +||+|+.+.|||++.+.. +.+.|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1222 899999999999998874 8899999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.021 Score=64.76 Aligned_cols=50 Identities=22% Similarity=0.316 Sum_probs=39.0
Q ss_pred hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccC
Q 004869 420 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 471 (726)
Q Consensus 420 ~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~ 471 (726)
..+.+....+++.+.|+|+...+.+... ......+|+|++ +.||++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhh-ccchHHHHHh
Confidence 4566777888999999999999987653 334578899998 6699998864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.26 Score=61.94 Aligned_cols=145 Identities=22% Similarity=0.231 Sum_probs=80.0
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-------cCceeEEE-E----EeecCCCC-c
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-------HRNLVKLV-G----YYSSRDSS-Q 452 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-------HpNIV~ll-g----~~~~~~~~-~ 452 (726)
+.|+ |..-.+|+....+|..+++|+..... .......|.+.|..|. -|.+++-. | .....++. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4453 45678899888888889999987542 2334444556665552 22333221 1 11111111 4
Q ss_pred eEEEEeecCCCChhhhcc-----------------------CCCCCcccCChhhh-----------------HHHHHHHH
Q 004869 453 HLLCYELVPNGSLESWLH-----------------------GPLGVNCHLDWETR-----------------MKIALDAA 492 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~-----------------------~~~~~~~~Ls~~~~-----------------~~ia~qIa 492 (726)
.+-+++|++|..|.+... ........+.|... ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 567899999987765210 00111123444321 12222333
Q ss_pred HHHH-----HHHhCCCCceeecCCCccceeecCCC--cEE-EEecCcccc
Q 004869 493 RGLA-----YLHEDSQPCVIHRDFKASNILLENNF--HAK-VADFGLAKQ 534 (726)
Q Consensus 493 ~gL~-----yLH~~~~p~IvHrDIKp~NILLd~~~--~vK-L~DFGla~~ 534 (726)
+.++ .|.. -+..+||+|+.+.|||++.+. ++. |.|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 1211 233499999999999999875 455 999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.28 Score=54.92 Aligned_cols=74 Identities=18% Similarity=0.252 Sum_probs=45.1
Q ss_pred eeeeecCcEEEEEEEECCC--cE-----EEEEEcccCCCCchhHHHHHHHHHHhcccCceeE-EEEEeecCCCCceEEEE
Q 004869 386 SILGEGGFGRVFKGVLSDG--TA-----VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g--~~-----VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~-llg~~~~~~~~~~~LV~ 457 (726)
+.|..|-...+|++...++ .. |.++... ......-+-.+|+++++.+...++-+ +++.+. -.+++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~ 128 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQ 128 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEE
Confidence 4555688889999876443 12 3433321 11122223467999999997665554 444432 26999
Q ss_pred eecCCCChh
Q 004869 458 ELVPNGSLE 466 (726)
Q Consensus 458 Ey~~~GsL~ 466 (726)
||++|-+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999997764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.93 Score=49.46 Aligned_cols=93 Identities=15% Similarity=0.085 Sum_probs=54.5
Q ss_pred cCHHHHHHHhcCcccc---e-eeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC--ceeEEE-
Q 004869 370 LAYEELKEATNNFEPA---S-ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLV- 442 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~---~-~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~ll- 442 (726)
++.+.+..+...+-+. + ..-.+.-..||+....+|..+++|....+ .....+...|++.+..|... .++..+
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~ 89 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLA 89 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5556665555444321 1 22234567899988878888999987532 23456677888888777421 122211
Q ss_pred --E--EeecCCCCceEEEEeecCCCCh
Q 004869 443 --G--YYSSRDSSQHLLCYELVPNGSL 465 (726)
Q Consensus 443 --g--~~~~~~~~~~~LV~Ey~~~GsL 465 (726)
| +.. -++..+.++++++|...
T Consensus 90 ~~G~~~~~--~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 90 FNGQTLHE--HQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCCEEEE--ECCEEEEEEeeeCCCCC
Confidence 1 111 12356789999987654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.2 Score=55.24 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=93.7
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcccCC-----C----Cc------------h----hH-HHHHHHHHHhcccCc
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-----Q----QG------------D----KE-FLVEVEMLSRLHHRN 437 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~-----~----~~------------~----~~-f~~Ei~iL~~L~HpN 437 (726)
+-..|..|--..||.+.-.+|..+|||+.+..- . .+ . +- ...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346688899999999999899999999875320 0 00 0 11 245888888887544
Q ss_pred eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 438 IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
|.----+. -....|||+|+.+... - .+.-....++...+..+-.|+++-+.-|-..+. +||.||.==|+|
T Consensus 228 IP~PePIl----Lk~hVLVM~FlGrdgw---~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 228 IPCPEPIL----LKNHVLVMEFLGRDGW---A-APKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCCCCcee----eecceEeeeeccCCCC---c-CcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 32111011 1145799999953211 1 111113346667777888888888888877664 999999999999
Q ss_pred ecCCCcEEEEecCccccC
Q 004869 518 LENNFHAKVADFGLAKQA 535 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~ 535 (726)
+.+ |.+.|+|-+-+...
T Consensus 298 yhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred EEC-CEEEEEEccccccC
Confidence 865 58999998877544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.41 Score=49.67 Aligned_cols=75 Identities=17% Similarity=0.252 Sum_probs=49.3
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc---eeEEEEEeecCCCCceEEEEeecCC
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN---LVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN---IV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
+.+.-|.--..|+... +...+.||.-. ......|..|+.-|..|.--| +-+.+.+ ..+....|||+||++-
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylVle~L~~ 95 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLVLEYLPT 95 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEEEeeccC
Confidence 4455555556666544 35678888753 233457888988888775444 4455444 3356688999999998
Q ss_pred CChh
Q 004869 463 GSLE 466 (726)
Q Consensus 463 GsL~ 466 (726)
|.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 7776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.31 Score=50.33 Aligned_cols=151 Identities=16% Similarity=0.182 Sum_probs=90.4
Q ss_pred CcEEEEEEEECCCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhcc
Q 004869 392 GFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH 470 (726)
Q Consensus 392 ~fG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~ 470 (726)
+..+.-.|..+-| ...+|++..-... ...-|.++.+++++++ .|+++.. .+...+-++.|+|..-.
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~------ 140 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK------ 140 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc------
Confidence 3344444433223 2456666544333 4567888999999886 4677752 24445568888883311
Q ss_pred CCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccccccccccc
Q 004869 471 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550 (726)
Q Consensus 471 ~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT 550 (726)
... ..++.--...|.-.|+..+ ..+|+|-.|+||+-|..|.+||.|=+..-. .+
T Consensus 141 ----------i~~-~N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~ 194 (308)
T PF07387_consen 141 ----------INF-SNFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQ 194 (308)
T ss_pred ----------cch-hHHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhh--------------he
Confidence 011 1222222467778886643 399999999999999999999999654321 01
Q ss_pred ccccCccccccCCCCcchhHHHHHHHHHHHHhCC
Q 004869 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584 (726)
Q Consensus 551 ~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~ 584 (726)
.-|.--| ....+.++.+=+|=.-++++....
T Consensus 195 V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 195 VNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 1122211 223566788888877777877644
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.33 Score=54.40 Aligned_cols=74 Identities=16% Similarity=0.209 Sum_probs=49.9
Q ss_pred ceeeeecCcEEEEEEEECC-CcEEEEEEcc----cC-C-CCchhHHHHHHHHHHhcc--cC-ceeEEEEEeecCCCCceE
Q 004869 385 ASILGEGGFGRVFKGVLSD-GTAVAIKRLT----CG-G-QQGDKEFLVEVEMLSRLH--HR-NLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~----~~-~-~~~~~~f~~Ei~iL~~L~--Hp-NIV~llg~~~~~~~~~~~ 454 (726)
.+.||-|.-..||++...+ ++.|+||.-. .+ + .-..+...-|.+.|+... -| .+.+++.| +.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----CcHHhh
Confidence 4678999999999999743 5679999643 11 1 122355666888888763 34 45556554 445678
Q ss_pred EEEeecCC
Q 004869 455 LCYELVPN 462 (726)
Q Consensus 455 LV~Ey~~~ 462 (726)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 99999965
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.77 Score=48.89 Aligned_cols=32 Identities=31% Similarity=0.422 Sum_probs=26.0
Q ss_pred CCceeecCCCccceeecCC--C---cEEEEecCcccc
Q 004869 503 QPCVIHRDFKASNILLENN--F---HAKVADFGLAKQ 534 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~--~---~vKL~DFGla~~ 534 (726)
...++|||++..|||+..+ + .+++.||-+++.
T Consensus 214 ~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 214 FNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred ceEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 3469999999999999654 3 689999988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.41 E-value=1.2 Score=50.72 Aligned_cols=75 Identities=13% Similarity=0.108 Sum_probs=46.1
Q ss_pred ceeeeecCcEEEEEEEECC---------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceE
Q 004869 385 ASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHL 454 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~ 454 (726)
.+.|..|-.-.+|+....+ ++.|.+++...+... .-.-.+|..++..+...+|- ++++.+. -.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~-lIdR~~E~~v~~~ls~~gi~P~l~~~f~------gg 182 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE-LYNPISEFEVYKTMSKYRIAPQLLNTFS------GG 182 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc-eeCHHHHHHHHHHHHHCCCCCceEEEeC------CC
Confidence 3455566667788776542 357888877543322 22446688888888655544 3455432 24
Q ss_pred EEEeecCCCChh
Q 004869 455 LCYELVPNGSLE 466 (726)
Q Consensus 455 LV~Ey~~~GsL~ 466 (726)
.|.||++|-+|.
T Consensus 183 ~I~efi~g~~l~ 194 (442)
T PTZ00296 183 RIEEWLYGDPLR 194 (442)
T ss_pred EEEEeeCCccCC
Confidence 689999987553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 726 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-54 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1339), Expect = 0.0
Identities = 126/316 (39%), Positives = 178/316 (56%), Gaps = 6/316 (1%)
Query: 348 KPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAV 407
K + L S P + + +L+EATNNF+ ++G G FG+V+KGVL DG V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 408 AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES 467
A+KR T QG +EF E+E LS H +LV L+G+ R+ + +L Y+ + NG+L+
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKR 124
Query: 468 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527
L+G + WE R++I + AARGL YLH +IHRD K+ NILL+ NF K+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181
Query: 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587
DFG++K+ E +LST V GT GY+ PEY + G L KSDVYS+GVVL E+L R +
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 588 DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 647
S P NL WA +LE++ DP L K E + A C+A + R
Sbjct: 242 VQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 648 PTMGEVVQSLKMVQRV 663
P+MG+V+ L+ R+
Sbjct: 301 PSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 509 bits (1312), Expect = e-177
Identities = 128/299 (42%), Positives = 183/299 (61%), Gaps = 7/299 (2%)
Query: 363 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-DK 421
H + + EL+ A++NF +ILG GGFG+V+KG L+DGT VA+KRL QG +
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 481
+F EVEM+S HRNL++L G+ ++ LL Y + NGS+ S L LDW
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 541
R +IAL +ARGLAYLH+ P +IHRD KA+NILL+ F A V DFGLAK T
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT- 189
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLV 599
+++T V GT G++APEY TG K+DV+ YGV+LLEL+TG++ D+++ + + L+
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
W + +L++K +LE L D L G Y E+ ++ +A C +RP M EVV+ L+
Sbjct: 250 DWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 493 bits (1273), Expect = e-172
Identities = 105/309 (33%), Positives = 172/309 (55%), Gaps = 21/309 (6%)
Query: 363 HPTSTRFLAYEELKEATNNFEP------ASILGEGGFGRVFKGVLSDGTAVAIKRLTCG- 415
T ++ ELK TNNF+ + +GEGGFG V+KG + + T VA+K+L
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 416 ---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 472
++ ++F E++++++ H NLV+L+G+ S D L Y +PNGSL L
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
G L W R KIA AA G+ +LHE+ IHRD K++NILL+ F AK++DFGLA
Sbjct: 125 DG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
+ + + +++R++GT Y+APE + G + KSD+YS+GVVLLE++TG VD +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
+ L+ I ++ +E+ D ++ + ++A+ C+ + N+RP + +
Sbjct: 240 --PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 653 VVQSLKMVQ 661
V Q L+ +
Sbjct: 297 VQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 1e-99
Identities = 86/325 (26%), Positives = 132/325 (40%), Gaps = 26/325 (8%)
Query: 357 LGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG 416
+G H +S L E L + + + G FG V+K L VA+K
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 417 QQGDKEFLVEVEMLSRLHHRNLVKLVGY--YSSRDSSQHLLCYELVPNGSLESWLHGPLG 474
+Q + EV L + H N+++ +G + L GSL +L +
Sbjct: 60 KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 475 VNCHLDWETRMKIALDAARGLAYLHED-------SQPCVIHRDFKASNILLENNFHAKVA 527
+ W IA ARGLAYLHED +P + HRD K+ N+LL+NN A +A
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLT 582
DFGLA + G++ + +GT Y+APE ++ D+Y+ G+VL EL +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 583 GRKPVDMSQPSGQENL--VTWARPILRDKDRL--EELADPRLGGKYPKEDFIR-VCTIAA 637
D P L D + + P L + K + +C
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 638 ACVAPEANQRPTMGEVVQSLKMVQR 662
C +A R + G V + + +QR
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-69
Identities = 70/338 (20%), Positives = 131/338 (38%), Gaps = 41/338 (12%)
Query: 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 429
A E +N + ++G G +G V+KG L D VA+K + + F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 430 --LSRLHHRNLVKLVGY---YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+ + H N+ + + ++ ++LL E PNGSL +L DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113
Query: 485 MKIALDAARGLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADFGLAK----- 533
++A RGLAYLH + +P + HRD + N+L++N+ ++DFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 534 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRK 585
G + + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 586 PVDMSQPSGQENL----VTWARPILRDKDRL--EELADPRLGGKYPKEDFI--RVCTIAA 637
+ + + + P D L E P+ + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 638 ACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 675
C +A R T + + + + E +++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-65
Identities = 89/317 (28%), Positives = 136/317 (42%), Gaps = 51/317 (16%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
++G G FG V K VAIK++ + K F+VE+ LSR++H N+VKL G
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA-- 69
Query: 447 SRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ +C E GSL + LHG + M L ++G+AYLH
Sbjct: 70 ----CLNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 505 CVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 563
+IHRD K N+LL K+ DFG A T G+ ++APE +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 564 LLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWA-----RPILRDKDRLEELAD 617
K DV+S+G++L E++T RKP ++ P+ + + WA RP L
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPL----------- 225
Query: 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 677
+ PK + ++ C + + +QRP+M E+V+ + + R D L
Sbjct: 226 IK---NLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC-- 276
Query: 678 ANLRQSSTTFDSDGTSS 694
Q S DG
Sbjct: 277 ----QHSLPPGEDGRVE 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-65
Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 38/298 (12%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 445
+G G FG V + G+ VA+K L + EFL EV ++ RL H N+V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA- 102
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
+ E + GSL LH G LD R+ +A D A+G+ YLH P
Sbjct: 103 -VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
++HR+ K+ N+L++ + KV DFGL++ + T S GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 566 VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--ELADPRLGG 622
KSDVYS+GV+L EL T ++P +++ V A + RLE +P++
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAA--VGFKCKRLEIPRNLNPQVA- 269
Query: 623 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANL 680
I C E +RP+ ++ L+ + + + NR++L
Sbjct: 270 -----------AIIEGCWTNEPWKRPSFATIMDLLRPLIK-------SAVPPPNRSDL 309
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-65
Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNL 438
+G+GGFG V KG + D + VAIK L G +G+ +EF EV ++S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
VKL G + + E VP G L L + W ++++ LD A G+ Y+
Sbjct: 86 VKLYGLMHN----PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 499 HEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
+ P ++HRD ++ NI L++ AKVADFGL++Q + + + ++G F +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 554 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKD 610
+APE K+D YS+ ++L +LTG P + S + + I +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 611 RLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
R E PRL + C + + +RP +V+ L
Sbjct: 248 RPTIPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-61
Identities = 59/287 (20%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 444
L E G ++KG G + +K L ++F E L H N++ ++G
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
S + L +P GSL + LH +D +K ALD ARG+A+LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------Y 558
+ + +++++ + A+++ + ++ S M +VAPE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 615
+D++S+ V+L EL+T P D+S + + + R
Sbjct: 186 DTNRR---SADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRPTIPPG 235
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
P + + C+ + +RP +V L+ +Q
Sbjct: 236 ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-61
Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 46/287 (16%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHRNLVKLV 442
I+G GGFG+V++ G VA+K + + E ++ + L H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
G L E G L L G + + + A+ ARG+ YLH+++
Sbjct: 73 G--VCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 503 QPCVIHRDFKASNILL--------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
+IHRD K+SNIL+ +N K+ DFGLA++ G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWM 181
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 613
APE SDV+SYGV+L ELLTG P + + V + + +K L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYG--VAMNKLALP 234
Query: 614 --ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ C P+ + RP+ ++ L
Sbjct: 235 IPSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-61
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 445
+G G FG V+KG G VA+K L + F EV +L + H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 446 SSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
S+ L + SL LH + + + IA ARG+ YLH
Sbjct: 89 ----STAPQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAM 560
+IHRD K++NI L + K+ DFGLA + ++ ++ G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620
+ +SDVY++G+VL EL+TG+ P Q + + R +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRGSLSPDLSKVRS- 252
Query: 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
PK + + A C+ + ++RP+ ++ ++ + R
Sbjct: 253 --NCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 68/357 (19%), Positives = 134/357 (37%), Gaps = 51/357 (14%)
Query: 339 SKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK 398
+ P E+ + + + G P + ++++ +G+G +G V+
Sbjct: 3 TYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMV-------KQIGKGRYGEVWM 55
Query: 399 GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY--YSSRDSSQHL 454
G G VA+K + + E E+ + H N++ + + +Q
Sbjct: 56 GKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111
Query: 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHR 509
L + NGSL +L LD ++ +K+A + GL +LH + +P + HR
Sbjct: 112 LITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 510 DFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV- 566
D K+ NIL++ N +AD GLA + + +GT Y+ PE + L
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRN 225
Query: 567 ------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVTWARPILRDKDR 611
+D+YS+G++L E+ + + + + K R
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 612 LEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 667
P ++ ++ +R + + C A R T V ++L + + +
Sbjct: 286 ------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 42/298 (14%)
Query: 388 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG+G FG+ K G + +K L ++ + FL EV+++ L H N++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG--V 75
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ E + G+L + + W R+ A D A G+AYLH + +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---I 129
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY------------LSTRVMGTFGYV 554
IHRD + N L+ N + VADFGLA+ + +T V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP---VDMSQPSGQENLVTWARPILRDKDR 611
APE K DV+S+G+VL E++ N+ + +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-YCPPNC 248
Query: 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 669
I C + +RP+ ++ L+ ++ + P
Sbjct: 249 PPSFFP-----------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-58
Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 444
+G+G +G V++G G VA+K + + +K + E E+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 445 --YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 501
S S+Q L GSL +L LD + ++I L A GLA+LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 502 ----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVA 555
+P + HRD K+ NIL++ N +AD GLA + + + +GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 556 PE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVT 600
PE + D++++G+VL E+ + + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLK 658
+ + D+ R P + ++ + + + + C + R T + ++L
Sbjct: 246 MRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 51/295 (17%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 444
++G+G FG+V+ G G VAI+ + D K F EV + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ L +L S + LD +IA + +G+ YLH ++
Sbjct: 98 --CMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH--AKG 150
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
++H+D K+ N+ +N + DFGL GR G ++APE
Sbjct: 151 -ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 562 GHLLV---------KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-----RPILR 607
SDV++ G + EL P +QP+ + W +P L
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNLS 264
Query: 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
+E++D I C A E +RPT +++ L+ + +
Sbjct: 265 QIGMGKEISD-----------------ILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-55
Identities = 63/303 (20%), Positives = 123/303 (40%), Gaps = 42/303 (13%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 444
+G+G FG V++G G VA+K + + ++ + E E+ L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 445 YSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
+ + + Q L + +GSL +L+ + E +K+AL A GLA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEI 159
Query: 503 Q-----PCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 555
P + HRD K+ NIL++ N +AD GLA + + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 556 PEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLV 599
PE + + + ++D+Y+ G+V E+ + + ++
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659
+ + K R + + + + + I C R T + ++L
Sbjct: 279 EMRKVVCEQKLRP-NIPNRWQSCEALRV----MAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 660 VQR 662
+ +
Sbjct: 334 LSQ 336
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 91/299 (30%), Positives = 127/299 (42%), Gaps = 31/299 (10%)
Query: 386 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 439
LGEG FG+V G VA+K L G Q + E+++L L+H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
K G ++ L E VP GSL +L + + A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH 151
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV----- 554
+Q IHRD A N+LL+N+ K+ DFGLAK PEG Y + G
Sbjct: 152 --AQHY-IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 613
APE SDV+S+GV L ELLT S P+ L+ A+ + E
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 614 ELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 670
L G + P+ D V + C EA+ RPT ++ LK V + Q P+
Sbjct: 263 LLER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-43
Identities = 85/302 (28%), Positives = 124/302 (41%), Gaps = 28/302 (9%)
Query: 386 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
S LG+G FG V + G VA+K+L G ++F E+++L LH +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
G L E +P+G L +L LD + + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG- 144
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 558
S+ C +HRD A NIL+E+ H K+ADFGLAK P +Y R G + APE
Sbjct: 145 -SRRC-VHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAPES 201
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617
+SDV+S+GVVL EL T K S + ++ R + LE L +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 618 PRLGGKYPKEDFIRVCTIA-----AACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLT 672
G + P C C AP RP+ + L M+ +
Sbjct: 260 ---GQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313
Query: 673 SS 674
++
Sbjct: 314 TA 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 388 LGEGGFGRVFKGVL-SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+G G FG VF G L +D T VA+K +FL E +L + H N+V+L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 446 SSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
+ + + ELV G ++L G L +T +++ DAA G+ YL S+
Sbjct: 182 TQKQP--IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLE--SK 232
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMT 561
C IHRD A N L+ K++DFG++++ +G Y ++ + APE
Sbjct: 233 CC-IHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEALNY 289
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
G +SDV+S+G++L E + G P ++ S Q+ R + RL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNL---SNQQ-----TREFVEKGGRLPC----- 336
Query: 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
P+ V + C A E QRP+ + Q L+ +++
Sbjct: 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVG 443
+G G F V+KG+ VA L + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 444 YYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+ S + + EL+ +G+L+++L + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 502 SQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+ P +IHRD K NI + K+ D GLA + + V+GT ++APE
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYE 203
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEELADP 618
+ DVY++G+ +LE+ T P S +N R + +++A P
Sbjct: 204 EKYDE-SVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT 649
+ ++ I C+ ++R +
Sbjct: 258 EV------KEIIE------GCIRQNKDERYS 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 19/286 (6%)
Query: 386 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
LG+G FG V + G VA+K+L ++ ++F E+E+L L H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
G S L E +P GSL +L +D ++ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG- 131
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 558
++ IHRD NIL+EN K+ DFGL K P+ + + + G + APE
Sbjct: 132 -TKRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPES 188
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
V SDV+S+GVVL EL T + + + + +E L +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN- 247
Query: 619 RLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
G+ P+ D + I C NQRP+ ++ + ++
Sbjct: 248 --NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 81/330 (24%), Positives = 128/330 (38%), Gaps = 28/330 (8%)
Query: 350 RTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVL--- 401
D T + + FE + LG+G FG V
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQ----FEERHLKFLQQLGKGNFGSVEMCRYDPL 65
Query: 402 --SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459
+ G VA+K+L ++ ++F E+E+L L H N+VK G S L E
Sbjct: 66 QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 519
+P GSL +L +D ++ +G+ YL ++ IHRD NIL+E
Sbjct: 126 LPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG--TKRY-IHRDLATRNILVE 179
Query: 520 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVL 577
N K+ DFGL K P+ + Y + G + APE V SDV+S+GVVL
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 578 LELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTI 635
EL T + + + + +E L + G+ P+ D + I
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMI 295
Query: 636 AAACVAPEANQRPTMGEVVQSLKMVQRVIE 665
C NQRP+ ++ + ++ +
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 24/288 (8%)
Query: 386 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 439
LGEG FG+V + G VA+K L G + E+E+L L+H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
K G + + L E +P+GSL+ +L ++ + ++K A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLG 143
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPE 557
S+ +HRD A N+L+E+ K+ DFGL K + Y + + + APE
Sbjct: 144 --SRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPE 199
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
M + SDV+S+GV L ELLT S + ++ + + L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 617 DPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 661
+ G + P V + C + + R + +++ +++
Sbjct: 258 E---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 41/308 (13%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
++ LGEGGF V L DG A+KR+ C QQ +E E +M +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 440 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+LV Y ++H G+L + + L + + + L RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-------GT 550
+H HRD K +NILL + + D G QA + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 551 FGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604
Y APE + + ++DV+S G VL ++ G P DM G +
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258
Query: 605 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
++++ ++ + + + + +QRP + ++ L+ +Q
Sbjct: 259 AVQNQLS------IPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEALQP 306
Query: 663 VIECQDPT 670
Q T
Sbjct: 307 PAPGQHTT 314
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-39
Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 42/307 (13%)
Query: 359 GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLT 413
G P+ R L E K+ +LG G FG V+KG+ VAIK L
Sbjct: 1 GEAPNQALLRILKETEFKKIK-------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 414 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 472
+ +KE L E +++ + + ++ +L+G + S L +L+P G L ++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH 110
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
++ + + + A+G+ YL ++HRD A N+L++ H K+ DFGLA
Sbjct: 111 KD---NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMS 590
K Y + ++A E + +SDV+SYGV + EL+T G KP +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI- 223
Query: 591 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650
E IL +RL + P I V I C +A+ RP
Sbjct: 224 --PASE-----ISSILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKF 266
Query: 651 GEVVQSL 657
E++
Sbjct: 267 RELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 388 LGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 443
LG G FG V +GV VAIK L G ++ D E + E +++ +L + +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 503
+ +L E+ G L +L G + ++ + G+ YL +
Sbjct: 78 VCQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EE 128
Query: 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 561
+HRD A N+LL N +AK++DFGL+K + Y + R G + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINF 187
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP 586
+SDV+SYGV + E L+ G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 370 LAYEELKEATNNFEPASI------LGEGGFGRVFKGVL---SDGTAVAIKRLTCG--GQQ 418
+A EE++ + + LG G FG V KG VA+K L
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 419 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 478
E L E ++ +L + +V+++G + +L E+ G L +L N H
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQ----NRH 113
Query: 479 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
+ + +++ + G+ YL + +HRD A N+LL +AK++DFGL+K
Sbjct: 114 VKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
Query: 539 RTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
Y + G + + APE KSDV+S+GV++ E + G+KP
Sbjct: 171 ENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 74/326 (22%)
Query: 363 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 421
H RF +F+ ++G GGFG+VFK DG IKR+ + ++
Sbjct: 3 HTVDKRFG---------MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNE 49
Query: 422 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY--------------ELVPNGSLES 467
+ EV+ L++L H N+V G + D E G+LE
Sbjct: 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 468 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527
W+ G LD +++ +G+ Y+H +I+RD K SNI L + K+
Sbjct: 110 WIEKRRGE--KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164
Query: 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELL 581
DFGL + GT Y++PE Y G + D+Y+ G++L ELL
Sbjct: 165 DFGLVTSL--KNDGKRTRSK-GTLRYMSPEQISSQDY---GK---EVDLYALGLILAELL 215
Query: 582 TGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAAC 639
T +L D + + K+ ++
Sbjct: 216 HVCDT-----AFETSKFFT-------------DLRDGIISDIFDKKEKTLLQ------KL 251
Query: 640 VAPEANQRPTMGEVVQSLKMVQRVIE 665
++ + RP E++++L + ++ E
Sbjct: 252 LSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 54/306 (17%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 437
++FE ++LG+G FG+V K D AIK++ ++ L EV +L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 438 LVKLVGYYSSRDSSQHLLCY-----------ELVPNGSLESWLHGPLGVNCHLDWETRMK 486
+V+ + R + + E NG+L +H N + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ------------ 534
+ L+Y+H +IHRD K NI ++ + + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 535 -APEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
G ++ L++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------F 228
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 650
S V + + P K IR + + N+RP
Sbjct: 229 STGMERVNILKKLRSVSIEF----PPDFDDNKMKVEKKIIR------LLIDHDPNKRPGA 278
Query: 651 GEVVQS 656
++ S
Sbjct: 279 RTLLNS 284
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 387 ILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLV 439
LG+G FG V +G +VA+K L + +F+ EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L G + + EL P GSL L G H T + A+ A G+ YL
Sbjct: 85 RLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYL- 137
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAP 556
IHRD A N+LL K+ DFGL + P+ +Y+ F + AP
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEE 614
E T SD + +GV L E+ T G++P + + +G + L I ++ +RL
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQIL----HKIDKEGERLPR 246
Query: 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
P++ + + C A + RPT + L
Sbjct: 247 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+G G FG V G + VAIK + G + +F+ E E++ +L H LV+L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ + L E + +G L +L G ET + + LD G+AYL E++ V
Sbjct: 74 --EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL-EEAC--V 125
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 564
IHRD A N L+ N KV+DFG+ + + + ++ F +PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 565 LVKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+GV++ E+ + G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+++ E + GSL +L L + +K +LD + YL
Sbjct: 85 EEKGGLYIVT-EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 564
+HRD A N+L+ + AKV+DFGL + ST+ G APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT------KEAS-STQDTGKLPVKWTAPEALREKKF 191
Query: 565 LVKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+G++L E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 86/315 (27%), Positives = 133/315 (42%), Gaps = 37/315 (11%)
Query: 351 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGT 405
+ A L L T + L + S+ LG+G FG V+ G + T
Sbjct: 150 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT 209
Query: 406 AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 465
VAIK L G + FL E +++ +L H LV+L S + E + GSL
Sbjct: 210 RVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSL 265
Query: 466 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525
+L G G +L + +A A G+AY+ + +HRD +A+NIL+ N K
Sbjct: 266 LDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCK 320
Query: 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GR 584
VADFGLA+ + + APE A+ G +KSDV+S+G++L EL T GR
Sbjct: 321 VADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 585 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAP 642
P P + +++ L+++ G + P + + C
Sbjct: 380 VPY----------------PGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRK 420
Query: 643 EANQRPTMGEVVQSL 657
E +RPT + L
Sbjct: 421 EPEERPTFEYLQAFL 435
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 46/327 (14%)
Query: 358 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 416
G +P + L + NF +G G F V++ L DG VA+K++
Sbjct: 10 GPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69
Query: 417 QQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGP 472
K + E+++L +L+H N++K YY+S L EL G L +
Sbjct: 70 LMDAKARADCIKEIDLLKQLNHPNVIK---YYASFIEDNELNIVLELADAGDLSRMIKHF 126
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
+ T K + L ++H V+HRD K +N+ + K+ D GL
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ +T + V GT Y++PE Y KSD++S G +L E+ + P
Sbjct: 184 RFF-SSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAALQSP 235
Query: 587 VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEA 644
+ NL + + I + P Y +E + C+ P+
Sbjct: 236 FYGD----KMNLYSLCKKIEQCD------YPPLPSDHYSEELRQLVN------MCINPDP 279
Query: 645 NQRPTMGEVVQSLKMVQRVIECQDPTL 671
+RP + V + +R+ C +L
Sbjct: 280 EKRPDVTYV---YDVAKRMHACTASSL 303
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G FG V G VA+K + G D EF E + + +L H LVK G S
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 447 SRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ E + NG L ++L HG L+ +++ D G+A+L
Sbjct: 74 --KEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFL---ESH 123
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMT 561
IHRD A N L++ + KV+DFG+ + + Y +GT + APE
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQY--VSSVGTKFPVKWSAPEVFHY 179
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP 586
KSDV+++G+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 387 ILGEGGFGRVFKGVLSDG-----TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
+LG G FG V KGV V IK + G+Q + + + L H ++V+
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
L+G S L + +P GSL + G L + + + A+G+ YL
Sbjct: 80 LLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYL-- 131
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+ ++HR+ A N+LL++ +VADFG+A P L + ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 561 TGHLLVKSDVYSYGVVLLELLT-GRKP 586
G +SDV+SYGV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 55/304 (18%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 437
+FEP LG GGFG VF+ D AIKR+ ++ +E + EV+ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 438 LVKLVGYYSS-----------RDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETR 484
+V+ Y+++ S + L +L +L+ W++G + +
Sbjct: 65 IVR---YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVC 120
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---------- 534
+ I L A + +LH ++HRD K SNI + KV DFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 594
T +GT Y++PE K D++S G++L ELL P
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFS 228
Query: 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 652
+ +R+ P L + ++ ++P +RP
Sbjct: 229 TQMERVRTLTDVRNLKF------PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAIN 276
Query: 653 VVQS 656
++++
Sbjct: 277 IIEN 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 46/297 (15%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+G R L+ + +G L +++ + + + L A+G+ YL
Sbjct: 92 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLA 145
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------Y 553
S+ V HRD A N +L+ F KVADFGLA+ + Y V G +
Sbjct: 146 --SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEY--YSVHNKTGAKLPVKW 198
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDR 611
+A E T KSDV+S+GV+L EL+T G P D+ + + L R
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFD-----ITVYLLQGRR 250
Query: 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668
L + P+ + + C P+A RP+ E+V + + +
Sbjct: 251 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVK 440
ILGEG FG V +G L VA+K + Q+ +EFL E + H N+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 441 LVGYYSSRDSSQHLLCY---ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGL 495
L+G S + G L ++L H+ +T +K +D A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLSTR 546
YL S +HRD A N +L ++ VADFGL+ +Q + + +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK---MPVK 214
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ A E KSDV+++GV + E+ T G P
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G FG V+ G + T VA+K L G D FL E ++ +L H+ LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ E + NGSL +L P G+ L + +A A G+A++ +
Sbjct: 79 QE---PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGH 563
IHRD +A+NIL+ + K+ADFGLA+ + Y T G + APE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED--NEY--TAREGAKFPIKWTAPEAINYGT 186
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV-I 255
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ + E + GSL +L L + +K +LD + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLL 565
+HRD A N+L+ + AKV+DFGL K+A + L + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFS 364
Query: 566 VKSDVYSYGVVLLELLT-GRKP 586
KSDV+S+G++L E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G FG V G VAIK + G D EF+ E +++ L H LV+L G +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ E + NG L ++L + +++ D + YL
Sbjct: 90 --KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYL---ESKQF 141
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 564
+HRD A N L+ + KV+DFGL++ + + ++ V F PE M
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 565 LVKSDVYSYGVVLLELLT-GRKP 586
KSD++++GV++ E+ + G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
++G+G FG V+ G D AIK L+ + FL E ++ L+H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G + + +G L ++ P + + + L ARG+ YL
Sbjct: 88 IGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL--A 141
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 556
Q +HRD A N +L+ +F KVADFGLA+ + Y S + + A
Sbjct: 142 EQKF-VHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQ-QHRHARLPVKWTAL 197
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
E T KSDV+S+GV+L ELLT G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 79/327 (24%), Positives = 133/327 (40%), Gaps = 39/327 (11%)
Query: 387 ILGEGGFGRVFKGVLSDG-----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVK 440
+LG G FG V+KG+ VAIK L + +KE L E +++ + + ++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
L+G + S L +L+P G L ++ ++ + + + A+G+ YL
Sbjct: 82 LLGICLT---STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYL-- 133
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
++HRD A N+L++ H K+ DFGLAK Y + ++A E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 561 TGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADP 618
+SDV+SYGV + EL+T G KP + E IL +RL +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASE-----ISSILEKGERLPQ---- 240
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ---RVIECQDPTLTSS 674
P I V I C +A+ RP E++ KM + R + Q
Sbjct: 241 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 294
Query: 675 NNRANLRQSSTTFDSDGTSSMFSSGPY 701
+ + D + + + Y
Sbjct: 295 PSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 19/265 (7%)
Query: 329 ICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASIL 388
+ S + ++ + + +P D P + ++ + L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD--IEL 344
Query: 389 GEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 444
G G FG V +GV VAIK L G ++ D E + E +++ +L + +V+L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ +L E+ G L +L G + ++ + G+ YL +
Sbjct: 405 CQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTG 562
+HR+ A N+LL N +AK++DFGL+K + Y + R G + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514
Query: 563 HLLVKSDVYSYGVVLLELLT-GRKP 586
+SDV+SYGV + E L+ G+KP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+LG+G +G V+ G LS+ +AIK + + + E+ + L H+N+V+ Y
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---YL 85
Query: 446 SSRDSSQHLLCY-ELVPNGSLESWL---HGPLGVNCHLDWETRMK-IALDAARGLAYLHE 500
S + + + E VP GSL + L GPL N E + GL YLH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIGFYTKQILEGLKYLHD 140
Query: 501 DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-- 557
+ ++HRD K N+L+ + K++DFG +K+ + GT Y+APE
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 558 -YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 592
G+ +D++S G ++E+ TG+ P ++ +P
Sbjct: 196 DKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVK 440
+LG+G FG V + L VA+K L +EFL E + H ++ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 441 LVGYYSSRDSSQHLLCY----ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 494
LVG + L + +G L ++L +L +T ++ +D A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--G 552
+ YL S+ IHRD A N +L + VADFGL+++ +Y
Sbjct: 150 MEYL--SSRNF-IHRDLAARNCMLAEDMTVCVADFGLSRKIYS--GDYYRQGCASKLPVK 204
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++A E V SDV+++GV + E++T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 436
++E +G G +GR K SDG + K L G + +K+ LV EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
N+V+ R ++ + E G L S + +LD E +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 497 YLHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
H D V+HRD K +N+ L+ + K+ DFGLA+ T++ T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
+PE Y KSD++S G +L EL P + A I
Sbjct: 184 SPEQMNRMSYNE------KSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREG 231
Query: 609 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
K R+ +Y E + I + + RP++ E+++
Sbjct: 232 K-------FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G R L+ + +G L +++ + + + L A+G+ +L
Sbjct: 156 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFL--A 209
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 556
S+ V HRD A N +L+ F KVADFGLA+ + + S T + A
Sbjct: 210 SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVH-NKTGAKLPVKWMAL 265
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
E T KSDV+S+GV+L EL+T G P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 71/326 (21%), Positives = 110/326 (33%), Gaps = 50/326 (15%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 396
+K +AK + T T E +E + +G G FG V
Sbjct: 15 SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEV 74
Query: 397 FKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453
+ G A+K RL + E+ + L +V Y +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVP---LYGAVREGPW 124
Query: 454 LLCY-ELVPNGSLESWL--HGPLGVNCHLDWETR-MKIALDAARGLAYLHEDSQPCVIHR 509
+ + EL+ GSL + G L E R + A GL YLH ++H
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLP-------EDRALYYLGQALEGLEYLHTR---RILHG 174
Query: 510 DFKASNILLENN-FHAKVADFGLAKQ-APEGRTNYLSTR--VMGTFGYVAPEYAM-TGHL 564
D KA N+LL ++ A + DFG A P+G L T + GT ++APE M
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 565 LVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 623
K D++S ++L +L G P + + + PI L
Sbjct: 235 A-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT------- 286
Query: 624 YPKEDFIRVCTIAAACVAPEANQRPT 649
I+ + E R +
Sbjct: 287 ---AQAIQ------EGLRKEPVHRAS 303
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 387 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G FG V+ + T VA+K + G + FL E ++ L H LVKL +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506
+ E + GSL +L G + + A G+A++ Q
Sbjct: 254 K---EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV---APEYAMTGH 563
IHRD +A+NIL+ + K+ADFGLA+ + Y T G + APE G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIED--NEY--TAREGAKFPIKWTAPEAINFGS 361
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP 586
+KSDV+S+G++L+E++T GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 387 ILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
+ + E + G+L +L + + +A + + YL +
Sbjct: 79 TREPPF--YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYL---EKKN 131
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 563
IHRD A N L+ N KVADFGL++ + + F APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP 586
+KSDV+++GV+L E+ T G P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 387 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
+GEG FG V +G+ AVAIK + +FL E + + H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G + + + EL G L S+L LD + + A + LAYL
Sbjct: 82 IGVITE---NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYL--- 132
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
+HRD A N+L+ +N K+ DFGL++ E T Y +++ ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 191
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKP 586
SDV+ +GV + E+L G KP
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 387 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 505
+ + E + G+L +L + + +A + + YL + +
Sbjct: 286 T--REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 506 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 563
IHR+ A N L+ N KVADFGL++ + + F APE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 564 LLVKSDVYSYGVVLLELLT-GRKP 586
+KSDV+++GV+L E+ T G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 75/236 (31%), Positives = 109/236 (46%), Gaps = 16/236 (6%)
Query: 357 LGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGTAVAIKR 411
L L T + L + S+ LG+G FG V+ G + T VAIK
Sbjct: 239 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 298
Query: 412 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 471
L G + FL E +++ +L H LV+L S + E + GSL +L G
Sbjct: 299 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKG 354
Query: 472 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531
G +L + +A A G+AY+ + +HRD +A+NIL+ N KVADFGL
Sbjct: 355 ETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 409
Query: 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
A+ + + APE A+ G +KSDV+S+G++L EL T GR P
Sbjct: 410 ARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 64/350 (18%), Positives = 123/350 (35%), Gaps = 55/350 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 436
+ +GEG FG+ DG IK + ++E EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 437 NLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
N+V+ + S L + G L ++ GV + + +
Sbjct: 84 NIVQYRESFEENGS----LYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLA 137
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L ++H+ ++HRD K+ NI L + ++ DFG+A+ + GT Y+
Sbjct: 138 LKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYL 192
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
+PE Y KSD+++ G VL EL T + + ++ I+
Sbjct: 193 SPEICENKPYNN------KSDIWALGCVLYELCTLKHAFE------AGSMKNLVLKIISG 240
Query: 609 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666
P + Y + + RP++ +++ + +R+ +
Sbjct: 241 S-------FPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKF 287
Query: 667 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 716
P L + TF G+ + + P SG ++ +
Sbjct: 288 LSPQLIAEE------FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKIT 331
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 63/305 (20%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRL-H 434
T F +G G FG VFK V DG AIKR G ++ L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 435 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H ++V+ Y+S+ H+L E GSL + + + + L R
Sbjct: 70 HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENN-------------------FHAKVADFGLAKQ 534
GL Y+H S ++H D K SNI + K+ D G +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 535 APEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
+ G ++A E HL K+D+++ + ++ P
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL-----P 231
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 650
+ W +R PR+ +E + ++ + P+ +RP+
Sbjct: 232 RNGD---QWHE--IRQGRL------PRIPQVLSQEFTELLK------VMIHPDPERRPSA 274
Query: 651 GEVVQ 655
+V+
Sbjct: 275 MALVK 279
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 387 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
I+G G G V G L VAIK L G + + +FL E ++ + H N+++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G + ++ E + NGSL+++L G + + G+ YL
Sbjct: 116 EGVVT--RGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYL--- 167
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 559
S +HRD A N+L+++N KV+DFGL++ E + T G APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKP 586
SDV+S+GVV+ E+L G +P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 387 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
ILGEG FG V++GV + VA+K +K +F+ E ++ L H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G + EL P G L +L L T + +L + +AYL
Sbjct: 79 IGIIEE---EPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--- 129
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEY 558
+HRD NIL+ + K+ DFGL++ + +Y + T +++PE
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDY--YKASVTRLPIKWMSPES 185
Query: 559 AMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
SDV+ + V + E+L+ G++P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 65/356 (18%), Positives = 125/356 (35%), Gaps = 57/356 (16%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL--HHRNLVKLVG 443
+G GG +VF+ + AIK + + E+ L++L H +++L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
Y + E N L SWL + D R + + +H+
Sbjct: 77 YE--ITDQYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQH 127
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---- 557
++H D K +N L+ + K+ DFG+A Q T+ + +GT Y+ PE
Sbjct: 128 G---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 558 --YAMTGHLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
+ KSDV+S G +L + G+ P N +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI----------S 228
Query: 611 RLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664
+L + DP ++P +D ++ C+ + QR ++ E++ + +
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 665 ECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 720
++ + +S + + Y S ++ N S + F +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 338
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 387 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 441
++G G FG V G L +VAIK L G + + +FL E ++ + H N+++L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
G + S ++ E + NGSL+S+L + + A G+ YL
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYL--- 163
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 559
S +HRD A NIL+ +N KV+DFGL + + +TR G +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKIPIRWTSPEAI 222
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKP 586
SDV+SYG+VL E+++ G +P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 65/282 (23%), Positives = 96/282 (34%), Gaps = 42/282 (14%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHR 436
+F+ S LG G +G VFK DG A+KR G + L EV ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
V+ + + L L EL SL+ L D L
Sbjct: 118 CCVR---LEQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLAL 170
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
A+LH ++H D K +NI L K+ DFGL + G + G Y+A
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMA 224
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
PE + +DV+S G+ +LE+ + P G E LR
Sbjct: 225 PELLQGSYGT-AADVFSLGLTILEVACNMEL-----PHGGEGW-----QQLRQGY----- 268
Query: 616 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
P E + + P+ R T ++
Sbjct: 269 LPPEFTAGLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 95/450 (21%), Positives = 156/450 (34%), Gaps = 62/450 (13%)
Query: 225 ITPHTGISFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPM 284
I P GIS+ + ++V + K + Q +A +P
Sbjct: 244 IGPEEGISYLTDKGANPTHLADFNQVQTIQYSNSEDK-------DRKGMLQLKIAGAP-- 294
Query: 285 KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIIC----SCAFRGRKSK 340
P + ++ S + LI G L+ II K
Sbjct: 295 -------EPLTVTAPSLTIAENMADLIDGYC--RLVNGATQSFIIRPQKEGERALPSIPK 345
Query: 341 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGR 395
+ E R+ Y + I +GEG FG
Sbjct: 346 LANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGD 405
Query: 396 VFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450
V +G+ AVAIK + +FL E + + H ++VKL+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462
Query: 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 510
+ + EL G L S+L LD + + A + LAYL S+ V HRD
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLE--SKRFV-HRD 516
Query: 511 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDV 570
A N+L+ +N K+ DFGL++ E T Y +++ ++APE SDV
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 571 YSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKED 628
+ +GV + E+L G KP + + + + +RL P
Sbjct: 576 WMFGVCMWEILMHGVKPFQGV---KNND-----VIGRIENGERLPM----------PPNC 617
Query: 629 FIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ ++ C A + ++RP E+ L
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 387 ILGEGGFGRVFKGVLSDGTA-----VAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
++G G FG V+KG+L + VAIK L G + + +FL E ++ + H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
L G S ++ E + NG+L+ +L G + + A G+ YL
Sbjct: 111 LEGVIS--KYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYL-- 163
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-------MGTFGY 553
+ +HRD A NIL+ +N KV+DFGL++ + +T
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
APE SDV+S+G+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 22/227 (9%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGY 444
ILG+G VF+G G AIK + + E E+L +L+H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 504
+ +L E P GSL + L P L + + D G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 505 CVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
++HR+ K NI+ + K+ DFG A++ + + GT Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEYLHPDMYE 188
Query: 561 TGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 598
L D++S GV TG P P + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 44/289 (15%)
Query: 381 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HH 435
+F P +LG G G + + D VA+KR+ E EV++L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEH 77
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
N+++ D + EL +L+ ++ + L+ + + GL
Sbjct: 78 PNVIRYFCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGL 131
Query: 496 AYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTR-VMG 549
A+LH + ++HRD K NIL+ A ++DFGL K+ GR ++ V G
Sbjct: 132 AHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 550 TFGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
T G++APE + D++S G V +++ P G+ IL
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQAN--IL 241
Query: 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
L+ L + + + I +A + +RP+ V++
Sbjct: 242 LGACSLDCLHPEKHEDVIAR-ELIE------KMIAMDPQKRPSAKHVLK 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 387 ILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
LG+G F ++FKGV T V +K L + + F M+S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
V G +++L E V GSL+++L ++ ++++A A + +L
Sbjct: 75 VLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL 129
Query: 499 HEDSQPCVIHRDFKASNILLE--------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
+ +IH + A NILL N K++D G++ + L R+
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--KDILQERIPWV 184
Query: 551 FGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLT-GRKP 586
PE L + +D +S+G L E+ + G KP
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 387 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 439
LG+G FG V++GV T VAIK + ++ EFL E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IALDAAR 493
+L+G S L+ EL+ G L+S+L P N + + +A + A
Sbjct: 92 RLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLS 544
G+AYL+ + V HRD A N ++ +F K+ DFG+ ++ +G L
Sbjct: 150 GMAYLN--ANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL---LP 203
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
R M +PE G SDV+S+GVVL E+ T +P
Sbjct: 204 VRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 388 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+VF + VA+K L + ++F E E+L+ L H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR---------MKIALD 490
G + L+ +E + +G L +L HGP + + +A
Sbjct: 109 FG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
A G+ YL + +HRD N L+ K+ DFG+++ T+Y R +G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDY--YR-VGG 218
Query: 551 FGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ PE + +SDV+S+GVVL E+ T G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 50/240 (20%), Positives = 88/240 (36%), Gaps = 30/240 (12%)
Query: 364 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--K 421
T L ++ + + +G GG +VF+ + AIK +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71
Query: 422 EFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC 477
+ E+ L++L + ++L Y + E N L SWL +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYE--ITDQYIYMVMECG-NIDLNSWLKKKKSI---- 124
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
D R + + +H+ ++H D K +N L+ + K+ DFG+A Q
Sbjct: 125 --DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 538 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLV-----KSDVYSYGVVLLELLTGRKP 586
T+ + +GT Y+ PE + KSDV+S G +L + G+ P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 38/225 (16%)
Query: 388 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 441
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 489
G D ++ +E + +G L +L P L + IA
Sbjct: 83 YG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRV 547
A G+ YL + +HRD N L+ N K+ DFG++ R Y + RV
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRV 191
Query: 548 MGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
G + PE M +SDV+S+GV+L E+ T G++P
Sbjct: 192 GGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 60/326 (18%)
Query: 387 ILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNLVKL 441
++GEG FG+V K + AIKR+ + D +F E+E+L +L HH N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 489
+G R L E P+G+L +L L + + A
Sbjct: 92 LGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---- 545
D ARG+ YL SQ IHRD A NIL+ N+ AK+ADFGL++ Y+
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGR 202
Query: 546 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVT 600
R M A E SDV+SYGV+L E+++ G P M + E
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE---- 249
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 659
L RLE+ P E V + C + +RP+ +++ SL +M
Sbjct: 250 -LYEKLPQGYRLEK---PL---NCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 298
Query: 660 VQRVIECQDPTLTSSNNRANLRQSST 685
++ + TL A + S+
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 73/405 (18%), Positives = 141/405 (34%), Gaps = 51/405 (12%)
Query: 335 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 394
RG K + + + D+ LG S+ A E + + +G GG
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGRIYSILKQIGSGGSS 70
Query: 395 RVFKGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDS 450
+VF+ + AIK L Q + E+ L++L + ++L Y
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITD 128
Query: 451 SQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 508
+ E N L SWL + D R + + +H+ ++H
Sbjct: 129 QYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQHG---IVH 178
Query: 509 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTG 562
D K +N L+ + K+ DFG+A Q T+ + +G Y+ PE +
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 563 HLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE--EL 615
KSDV+S G +L + G+ P N ++ I+ +E ++
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDI 292
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 675
+ L +D ++ C+ + QR ++ E++ + + ++
Sbjct: 293 PEKDL------QDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
Query: 676 NRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 720
+ +S + + Y S ++ N S + F +
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 385
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 387 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 439
LG G FG V++G +S VA+K L + D+ +FL+E ++S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 496
+ +G S S + EL+ G L+S+L P L + +A D A G
Sbjct: 97 RCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 497 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
YL + IHRD A N LL AK+ DFG+A+ S G
Sbjct: 155 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAM 206
Query: 554 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ PE M G K+D +S+GV+L E+ + G P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 22/234 (9%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 437
+ + + ILG+G VF+G G AIK + + E E+L +L+H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+VKL + +L E P GSL + L P L + + D G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 498 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
L E+ ++HR+ K NI+ + K+ DFG A++ + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEY 181
Query: 554 VAPEYAMTGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 598
+ P+ L D++S GV TG P P + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-33
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 23/211 (10%)
Query: 382 FEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNL 438
+E + GG G ++ + +G V +K L G + + E + L+ + H ++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 439 VKLVGYYSSRDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
V++ + D + Y E V SL+ L + L+ L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL------PVAEAIAYLLEILPAL 195
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
+YLH +++ D K NI+L K+ D G + Y + GT G+ A
Sbjct: 196 SYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY----LYGTPGFQA 245
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE V +D+Y+ G L L
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 440
LG GG V+ VAIK + + +E L EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 498
+ + + L E + +L ++ HGPL +T + G+ +
Sbjct: 76 M--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL------SVDTAINFTNQILDGIKHA 127
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H+ ++HRD K NIL+++N K+ DFG+AK A + + V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
A +D+YS G+VL E+L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 387 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 438
LG G FG+V + + VA+K L G + + E+++L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMK 486
V L+G ++ ++ E G+L ++L L E +
Sbjct: 94 VNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST- 545
+ A+G+ +L + IHRD A NILL K+ DFGLA+ + +Y+
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKG 208
Query: 546 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ M APE ++SDV+S+GV+L E+ + G P
Sbjct: 209 DARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 22/258 (8%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 433
+ +E LG GGFG V + + G VAIK+ ++E E++++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 434 HHRNLVKLVGYYSSR----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
+H N+V + LL E G L +L+ C L +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLS 128
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTR 546
D + L YLHE+ +IHRD K NI+L K+ D G AK+ +G +
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEF 183
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
V GT Y+APE V D +S+G + E +TG +P V W +
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHG-KV 236
Query: 607 RDKDRLEELADPRLGGKY 624
R+K + L G
Sbjct: 237 REKSNEHIVVYDDLTGAV 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 388 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
LGE FG+V+KG L AVAIK L + + EF E + +RL H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIA 488
L+G + + + +G L +L V L+ + +
Sbjct: 77 LLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
A G+ YL S V H+D N+L+ + + K++D GL ++ +Y
Sbjct: 135 AQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYA--ADYYKLLGN 189
Query: 549 GTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
++APE M G + SD++SYGVVL E+ + G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 387 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 439
LG G FG V++G +S VA+K L + D+ +FL+E ++S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 496
+ +G S S + EL+ G L+S+L P L + +A D A G
Sbjct: 138 RCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 497 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
YL + IHRD A N LL AK+ DFG+A+ G
Sbjct: 196 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAM 247
Query: 554 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ PE M G K+D +S+GV+L E+ + G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 428
+FE LG+G FG V+ +A+K L K L EVE
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-------FKAQLEKAGVEHQLRREVE 61
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 486
+ S L H N+++L GY+ D+++ L E P G++ L + T
Sbjct: 62 IQSHLRHPNILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTA-T 113
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
+ A L+Y H VIHRD K N+LL + K+ADFG + AP R L
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168
Query: 547 VMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKP 586
GT Y+ PE H K D++S GV+ E L G+ P
Sbjct: 169 --GTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 440
ILG GG V L D VA+K L D F + E + + L+H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 441 L--VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLA 496
+ G + + E V +L + GP+ + +++ DA + L
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIADACQALN 130
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST-RVMGTFGYVA 555
+ H++ +IHRD K +NI++ KV DFG+A+ + + T V+GT Y++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
PE A + +SDVYS G VL E+LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 388 LGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 437
LGEG FG+V VA+K L + D + + E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 485
++ L+G + + E G+L +L P G+ D +
Sbjct: 103 IINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
ARG+ YL + IHRD A N+L+ N K+ADFGLA+ Y T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKT 216
Query: 546 RV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
M APE +SDV+S+GV++ E+ T G P
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 20/208 (9%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 440
++G GG G V++ VA+K ++ D F E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 498
+ + Q + L+ L + L GPL + I L
Sbjct: 99 I--HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP------PRAVAIVRQIGSALDAA 150
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
H HRD K NIL+ + A + DFG+A + + L +GT Y+APE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPER 206
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
H ++D+Y+ VL E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 43/238 (18%), Positives = 90/238 (37%), Gaps = 48/238 (20%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV-------------- 425
N++ L +G F ++ D A+K+ +K L
Sbjct: 31 NDYRIIRTLNQGKFNKI-ILCEKDNKFYALKKY-------EKSLLEKKRDFTKSNNDKIS 82
Query: 426 ----------EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL 473
E+++++ + + + G + + + + YE + N S+ + L
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 474 --GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531
C + + I +Y+H ++ + HRD K SNIL++ N K++DFG
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKP 586
++ + + + GT+ ++ PE + K D++S G+ L + P
Sbjct: 199 SEYMVDKK---IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 41/348 (11%), Positives = 77/348 (22%), Gaps = 51/348 (14%)
Query: 340 KASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG 399
+ +P P T + L + + L G VF
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 400 V-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRN------------------ 437
+ A+K T G + E +RL +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 438 ------LVKLVGYYSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIAL 489
+L + +LL L S L +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
R A L ++H F N+ + + + D +
Sbjct: 202 QLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSV 253
Query: 550 TFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607
Y E+ + + G+ + + P + P + +W RP LR
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLR 310
Query: 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ I + + +R E ++
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEAME 352
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 387 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 438
LG G FG+V + VA+K L +K + E++++S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL----------HGPLGVNCHLDWETRMKIA 488
V L+G + L+ E G L ++L N + +
Sbjct: 113 VNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--- 545
A+G+A+L + IHRD A N+LL N AK+ DFGLA+ +NY+
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNA 226
Query: 546 ----RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ M APE V+SDV+SYG++L E+ + G P
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 47/235 (20%)
Query: 387 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 439
LGEG FG+V K T VA+K L + + L E +L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC------------------HL 479
KL G S+D L+ E GSL +L +G L
Sbjct: 90 KLYGA-CSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 480 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539
+ A ++G+ YL ++ ++HRD A NIL+ K++DFGL++ E
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE- 203
Query: 540 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+Y+ + M A E +SDV+S+GV+L E++T G P
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 387 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 438
LG G FG+V + VA+K L ++ + E+++LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 484
V L+G + L+ E G L ++L +
Sbjct: 90 VNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ + A+G+A+L + IHRD A NILL + K+ DFGLA+ +NY+
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-SNYVV 203
Query: 545 T-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+ M APE +SDV+SYG+ L EL + G P
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 71/308 (23%), Positives = 117/308 (37%), Gaps = 59/308 (19%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL----VEVEMLSRL-H 434
N ILG G G V G VA+KR+ +F +E+++L+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDD 67
Query: 435 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-D 490
H N+++ ++ L + EL N +L+ + N L E L
Sbjct: 68 HPNVIRYYCSETTDR---FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILL-------------ENNFHAKVADFGLAKQAPE 537
A G+A+LH +IHRD K NIL+ N ++DFGL K+
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 538 GRTNYLSTR--VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 588
G++++ + GT G+ APE + L D++S G V +L+ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238
Query: 589 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQR 647
P G + I+R L+E+ + D I + + +R
Sbjct: 239 ---PFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKR 287
Query: 648 PTMGEVVQ 655
PT +V++
Sbjct: 288 PTAMKVLR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 42/230 (18%)
Query: 387 ILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHR 436
LGEG FG+V VA+K L + D + + E+EM+ + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETR 484
N++ L+G + + E G+L +L + ++
Sbjct: 148 NIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ ARG+ YL + IHRD A N+L+ N K+ADFGLA+ Y
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKK 261
Query: 545 TRV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
T M APE +SDV+S+GV++ E+ T G P
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 38/362 (10%), Positives = 97/362 (26%), Gaps = 73/362 (20%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 396
R +A+ + T++ + A +L + T F EL E ++LG+
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89
Query: 397 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 427
+ G + + + F+
Sbjct: 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 485
+++ + ++++ Y + + L + L R+
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
++ L R LA LH ++H + +I+L+ + F +
Sbjct: 210 QLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV----- 261
Query: 546 RVMGTFGYVAPEYAMTGHLLV-----------KSDVYSYGVVLLELLTGRKPVDMSQPSG 594
+ G+ PE + D ++ G+V+ + P+
Sbjct: 262 -SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT------ 314
Query: 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 654
++ + + I R + + + + R + +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM 358
Query: 655 QS 656
++
Sbjct: 359 ET 360
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 77/341 (22%), Positives = 129/341 (37%), Gaps = 72/341 (21%)
Query: 388 LGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 437
LGEG FG+V + T VA+K L + D + + E+EM+ + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 485
++ L+G + + E G+L +L P G+ + +
Sbjct: 137 IINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
A ARG+ YL + IHRD A N+L+ + K+ADFGLA+ Y T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKT 250
Query: 546 -------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP----S 593
+ M APE +SDV+S+GV+L E+ T G P
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVP 298
Query: 594 GQENLVTWARPILRDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 651
+E +L++ R++ L Y + C +QRPT
Sbjct: 299 VEELF-----KLLKEGHRMDKPSNCTNEL---Y---------MMMRDCWHAVPSQRPTFK 341
Query: 652 EVVQSL-KMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDG 691
++V+ L ++V + ++ ++ +G
Sbjct: 342 QLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFNG 382
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 428
++F+ LG+G FG V+ + +A+K L K L E+E
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVL-------FKSQLEKEGVEHQLRREIE 66
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 486
+ S L H N++++ Y+ D + L E P G L L HG + +
Sbjct: 67 IQSHLRHPNILRMYNYFH--DRKRIYLMLEFAPRGELYKELQKHGRFD-----EQRSATF 119
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
+ + A L Y HE VIHRD K N+L+ K+ADFG + AP R +
Sbjct: 120 ME-ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-- 173
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT Y+ PE K D++ GV+ E L G P
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 43/232 (18%)
Query: 388 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 440
+GEG FGRVF+ T VA+K L + +F E +++ + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR-------------- 484
L+G L +E + G L +L P V +
Sbjct: 115 LLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 485 ----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
+ IA A G+AYL + V HRD N L+ N K+ADFGL++
Sbjct: 173 CAEQLCIARQVAAGMAYLS--ERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 541 NYLSTRVMGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
Y + PE +SDV++YGVVL E+ + G +P
Sbjct: 230 -Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 47/235 (20%)
Query: 387 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 438
+LG G FG+V VA+K L ++ + E++M+++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 484
V L+G + L +E G L ++L +++E +
Sbjct: 112 VNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 485 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539
+ A A+G+ +L +HRD A N+L+ + K+ DFGLA+
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 540 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 586
+NY+ + M APE G +KSDV+SYG++L E+ + G P
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 62/260 (23%), Positives = 94/260 (36%), Gaps = 35/260 (13%)
Query: 341 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV 400
+P + K G P + + + LG+GGF + F+
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 401 -LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHRNLVKLVGYYSSRD 449
A K + K L+ E+ + L H+++V G++ D
Sbjct: 62 DADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--D 112
Query: 450 SSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 507
+ + EL SL L + E R G YLH + VI
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALT-----EPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 508 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLV 566
HRD K N+ L + K+ DFGLA + E + GT Y+APE GH
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGTPNYIAPEVLSKKGHSF- 220
Query: 567 KSDVYSYGVVLLELLTGRKP 586
+ DV+S G ++ LL G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 69/326 (21%), Positives = 116/326 (35%), Gaps = 56/326 (17%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYY 445
L EGGF V++ + G A+KRL ++ ++ + EV + +L H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 446 SSRDSSQHLLCYELV-----PNGSL-----ESWLHGPLGVNCHLDWETR-MKIALDAARG 494
S E + G L + GPL +KI R
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-------SCDTVLKIFYQTCRA 148
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA---PEGRTNYLSTRVM--- 548
+ ++H +P +IHRD K N+LL N K+ DFG A P+ + ++
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 549 ----GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601
T Y PE + + + K D+++ G +L L + P +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------- 258
Query: 602 ARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
I+ K + P +Y IR A + +R ++ EVV L+ +
Sbjct: 259 -LRIVNGKYSI-----PPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEI 306
Query: 661 QRVIECQDPTLTSSNNRANLRQSSTT 686
+ + N S T
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSAT 332
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 58/310 (18%)
Query: 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRN 437
++FE S LG G G VFK G +A K + + + + E+++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 494
+V +Y + S + +C E + GSL+ L G + K+++ +G
Sbjct: 93 IVG---FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKG 143
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L YL E + ++HRD K SNIL+ + K+ DFG++ Q + ++ +GT Y+
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYM 197
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP------------VDMSQPSGQENLVTWA 602
+PE H V+SD++S G+ L+E+ GR P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 603 RPILRDKDRLEELADPRLG------------------GKYPKE--DFIRVCTIAAACVAP 642
R R ++ + P + G + E DF+ C I
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK------ 311
Query: 643 EANQRPTMGE 652
+R + +
Sbjct: 312 NPAERADLKQ 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 40/230 (17%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------- 425
+ E +F+ ++LG+G F V++ + G VAIK + DK+ +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQR 57
Query: 426 ---EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHL 479
EV++ +L H ++++L Y+ DS+ L E+ NG + +L P
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYFE--DSNYVYLVLEMCHNGEMNRYLKNRVKPFS----- 110
Query: 480 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE 537
+ E R + G+ YLH ++HRD SN+LL N + K+ADFGLA + P
Sbjct: 111 ENEARHFMH-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 538 GRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKP 586
+ T + GT Y++PE A + H L +SDV+S G + LL GR P
Sbjct: 167 EK---HYT-LCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 42/416 (10%), Positives = 99/416 (23%), Gaps = 78/416 (18%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 396
++ AD++ R + EL E ++LG+
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAY 94
Query: 397 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 427
+ G + + + F+
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 485
+++ + ++++ Y + + L + L R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
++ L R LA LH ++H + +I+L+ + F + +
Sbjct: 215 QLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIG 270
Query: 546 RVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
R A + D ++ G+ + + P + +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD------DAALG 324
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
+ I R + + + + R + +
Sbjct: 325 GSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM------ 362
Query: 661 QRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 716
+ P R L + + +DG + P SG S D +
Sbjct: 363 ------ETPEYE--QLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAV 410
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 29/235 (12%)
Query: 373 EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKEFLVE 426
E + + +LGEG F +V++ D +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIG 114
Query: 427 VEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWE 482
+++ RL +K + ++ S +L EL G+L + ++ +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----------ENNFHAKVADFGL 531
+ A+ + +H+ +IH D K N +L + + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ + T T G+ E + D + + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 38/281 (13%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEM-LSRLHHR 436
++ EP LG G +G V K + G +A+KR+ + K L+++++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
V G +C EL+ + SL+ + + + + KIA+ + L
Sbjct: 67 FTVTFYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYVA 555
+LH VIHRD K SN+L+ K+ DFG++ + ++ G Y+A
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMA 177
Query: 556 PE----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611
PE VKSD++S G+ ++EL R P +W P + +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP-----------YDSWGTPF-QQLKQ 225
Query: 612 LEELADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPT 649
+ E P+L K+ E DF C + +RPT
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKK------NSKERPT 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 35/222 (15%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEM 429
+ LG+GGF + F+ A K + K L+ E+ +
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISI 68
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKI 487
L H+++V G++ D +L EL SL L + E R
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVL--ELCRRRSLLELHKRRKALT-----EPEAR-YY 120
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
G YLH + VIHRD K N+ L + K+ DFGLA + E +
Sbjct: 121 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-L 175
Query: 548 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT Y+APE GH + DV+S G ++ LL G+ P +
Sbjct: 176 CGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 82/279 (29%), Positives = 118/279 (42%), Gaps = 49/279 (17%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLV 439
F +G+G FG VFKG+ VAIK + + + E + E+ +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 440 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARG 494
K YY S L + E + GS L GPL +IA + +G
Sbjct: 84 K---YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL---------DETQIATILREILKG 131
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 552
L YLH + IHRD KA+N+LL + K+ADFG+A Q T+ R +GT
Sbjct: 132 LDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTFVGTPF 184
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612
++APE K+D++S G+ +EL G P P L+ P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236
Query: 613 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 649
P L G Y K +F+ AC+ E + RPT
Sbjct: 237 -----PTLEGNYSKPLKEFV------EACLNKEPSFRPT 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 67/296 (22%), Positives = 124/296 (41%), Gaps = 44/296 (14%)
Query: 372 YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 424
E+L+ + +P +G+G G V+ + ++ G VAI+++ Q + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
E+ ++ + N+V Y S L + E + GSL + +D
Sbjct: 66 NEILVMRENKNPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 117
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
+ + + L +LH + VIHRD K+ NILL + K+ DFG Q T
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQ 170
Query: 544 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVT 600
S R ++GT ++APE K D++S G++ +E++ G P ++ + + T
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 601 WARPILRDKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
P L++ ++L DF+ C + E +R + E++Q
Sbjct: 231 NGTPELQNPEKLSAIF-----------RDFLNRCL----EMDVE--KRGSAKELLQ 269
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 442
+LG+G FG V G A+K + + + L EV++L +L H N++KL
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----MKIALDAARGLA 496
++ D L E+ G L + E ++ L +
Sbjct: 93 EFFE--DKGYFYLVGEVYTGGELFDEIISRKRFS-------EVDAARIIRQVLSG---IT 140
Query: 497 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
Y+H++ ++HRD K N+LLE+ + + ++ DFGL+ + + ++ GT Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKI-GTAYY 194
Query: 554 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+APE + G K DV+S GV+L LL+G P
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 42/253 (16%)
Query: 360 SLPHPTSTRFLAYEELKEATNNFEPASI---------LGEGGFGRVFKGV-LSDGTAVAI 409
+L + F+ + +L + P ++ LG G G V VAI
Sbjct: 107 ALSLSRNKVFV-FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 410 KRL------TCGGQQGDKEFLV--EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461
+ + ++ D V E+E+L +L+H ++K+ ++ D+ + + EL+
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAEDYYIVLELME 222
Query: 462 NGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL- 518
G L + + L + + YLHE+ +IHRD K N+LL
Sbjct: 223 GGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 273
Query: 519 --ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAMTGHLLVKSDVYSY 573
E + K+ DFG +K E + + T GT Y+APE T D +S
Sbjct: 274 SQEEDCLIKITDFGHSKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 574 GVVLLELLTGRKP 586
GV+L L+G P
Sbjct: 331 GVILFICLSGYPP 343
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 40/250 (16%)
Query: 360 SLPHPTSTRFLAYEEL---KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 415
S+ + R L +L ++ FE ++G G +G+V+KG + G AIK +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 416 GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGS----LE 466
G + ++E E+ ML + HHRN+ G + ++ L E GS ++
Sbjct: 61 GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 467 SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 523
+ L IA + RGL++LH+ VIHRD K N+LL N
Sbjct: 120 NTKGNTL---------KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167
Query: 524 AKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVV 576
K+ DFG++ Q + R +GT ++APE KSD++S G+
Sbjct: 168 VKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 577 LLELLTGRKP 586
+E+ G P
Sbjct: 224 AIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 372 YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 424
L+ + +P + +GEG G V G VA+K + QQ +
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
EV ++ H N+V+ Y S + L + E + G+L + L+ E
Sbjct: 91 NEVVIMRDYQHFNVVE---MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQ 142
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
+ + LAYLH VIHRD K+ +ILL + K++DFG Q + +
Sbjct: 143 IATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDV 195
Query: 544 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
R ++GT ++APE + D++S G++++E++ G P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 47/220 (21%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 443
LG G +G V AIK + T + + L EV +L L H N++KL
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR--- 493
++ D + L E G L D +I +DAA
Sbjct: 104 FFE--DKRNYYLVMECYKGGEL-------------FD-----EIIHRMKFNEVDAAVIIK 143
Query: 494 ----GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTR 546
G+ YLH+ + ++HRD K N+LLE+ + K+ DFGL+ + R
Sbjct: 144 QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKER 198
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ GT Y+APE + K DV+S GV+L LL G P
Sbjct: 199 L-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 70/304 (23%), Positives = 129/304 (42%), Gaps = 40/304 (13%)
Query: 360 SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 418
S+ + + + + +G G +G V K V G +A+KR+ +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 419 GD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV 475
+ K+ L++++++ R +V+ +Y + +C EL+ + S + + V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 476 NCHLDWETRM-KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534
+ E + KI L + L +L E+ + +IHRD K SNILL+ + + K+ DFG++ Q
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 535 APEGRTNYLS-TRVMGTFGYVAPEYAMTGHLL----VKSDVYSYGVVLLELLTGRKPVDM 589
+ ++ TR G Y+APE V+SDV+S G+ L EL TGR P
Sbjct: 176 L----VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 590 SQPSGQ--ENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEAN 645
+V P L + + ++ +F+ +C + +
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSE----------EREFSPSFINFVNLCLTK------DES 275
Query: 646 QRPT 649
+RP
Sbjct: 276 KRPK 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 62/231 (26%), Positives = 90/231 (38%), Gaps = 58/231 (25%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRL------------TCGGQQGDKEFLV-EVEMLSR 432
LG G +G V + + AIK + + E + E+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---- 488
L H N++KL + D L E G L + +I
Sbjct: 103 LDHPNIIKLFDVFE--DKKYFYLVTEFYEGGEL-------------FE-----QIINRHK 142
Query: 489 ---LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQA 535
DAA G+ YLH+ + ++HRD K NILLEN + K+ DFGL+
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ L R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 200 SKDYK--LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 42/268 (15%)
Query: 340 KASPKETAKPRTADAVTLGGSLPHPTSTRF--LAYEELKEATNNFEPASI------LGEG 391
+ P T + G P P R L ++ E +P + +G G
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65
Query: 392 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSS 447
FG V+ + + VAIK+++ G+Q + ++ + EV L +L H N ++ Y
Sbjct: 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---YRGC 122
Query: 448 RDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHED 501
L E + + PL ++IA A +GLAYLH
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHSH 173
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
+ +IHRD KA NILL K+ DFG A + +GT ++APE +
Sbjct: 174 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILA 224
Query: 562 GHLL---VKSDVYSYGVVLLELLTGRKP 586
K DV+S G+ +EL + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 66/345 (19%), Positives = 112/345 (32%), Gaps = 92/345 (26%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEML------- 430
+FEP +G GGFG VF+ D AIKR+ ++ +E + EV+ L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 431 ----------------------------------------------SRLHHRNLVKLVGY 444
R K
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 445 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
S + L +L +L+ W++ + + + I + A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ----------APEGRTNYLSTRVMGTFG 552
++HRD K SNI + KV DFGL T +GT
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612
Y++PE + K D++S G++L ELL E + +R+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-------QMERVRIITD--VRNLKF- 291
Query: 613 EELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 656
KYP+E ++ ++P +RP +++++
Sbjct: 292 ----PLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIEN 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
+E LG+G FG+V+K G A K + ++ ++++VE+E+L+ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 441 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
L+G Y L + E P G++++ + L + L +LH
Sbjct: 81 LLGAYYHDG---KLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH 134
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPE 557
+IHRD KA N+L+ ++ADFG++ + L R +GT ++APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN----LKTLQKRDSFIGTPYWMAPE 187
Query: 558 YAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 586
M + K+D++S G+ L+E+ P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 73/244 (29%), Positives = 105/244 (43%), Gaps = 48/244 (19%)
Query: 363 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGD 420
H +S R Y + + +LG+G FG V K A+K + + D
Sbjct: 6 HHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 421 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 479
L EVE+L +L H N++KL DSS + EL G L
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL-------------F 109
Query: 480 DWETRMKIA-------LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NF 522
D +I DAAR G+ Y+H+ + ++HRD K NILLE+ +
Sbjct: 110 D-----EIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161
Query: 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582
K+ DFGL+ + + R+ GT Y+APE + G K DV+S GV+L LL+
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
Query: 583 GRKP 586
G P
Sbjct: 218 GTPP 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 55/278 (19%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 396
++A A+P+ + + P + A +E + ++P ++G G V
Sbjct: 54 LLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---KYDPKDVIGRGVSSVV 110
Query: 397 FKGV-LSDGTAVAIK-------RLTCGGQQGDKEFLV-EVEMLSRLH-HRNLVKLVGYYS 446
+ V + G A+K RL+ + +E E +L ++ H +++ L+ Y
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170
Query: 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAARG 494
SS L ++L+ G L D+ ETR M+ L+A
Sbjct: 171 --SSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEA--- 212
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
+++LH ++ ++HRD K NILL++N +++DFG + G L GT GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELC-GTPGYL 266
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
APE + D+++ GV+L LL G P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 66/233 (28%), Positives = 94/233 (40%), Gaps = 21/233 (9%)
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 420
H +S R Y + + F LG G FG V S G IK + Q
Sbjct: 5 HHHSSGRENLYFQ-GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 421 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 479
E E+E+L L H N++K+ + D + E G L + L
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 480 ---DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 533
MK ++A LAY H V+H+D K NIL ++ + K+ DFGLA+
Sbjct: 122 SEGYVAELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ + GT Y+APE + K D++S GVV+ LLTG P
Sbjct: 176 LFKSD--EHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 61/216 (28%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+LG G F VF G A+K + D E+ +L ++ H N+V L Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAAR 493
S + L +LV G L D + ++ L A
Sbjct: 76 ESTTH--YYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSA-- 118
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
+ YLHE+ ++HRD K N+L N + DFGL+K G +ST GT
Sbjct: 119 -VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-GT 170
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GYVAPE D +S GV+ LL G P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 61/260 (23%)
Query: 356 TLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK---- 410
T +LP ST N+EP ILG G V + + A+K
Sbjct: 1 TRDAALPGSHST--------HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDV 52
Query: 411 ----RLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 464
+ Q +E + EV++L ++ H N+++L Y ++ L ++L+ G
Sbjct: 53 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGE 110
Query: 465 LESWLHGPLGVNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFK 512
L D+ ETR M+ L+ + LH+ + ++HRD K
Sbjct: 111 L-------------FDYLTEKVTLSEKETRKIMRALLEV---ICALHKLN---IVHRDLK 151
Query: 513 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLV 566
NILL+++ + K+ DFG + Q G L GT Y+APE
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPG--EKLREVC-GTPSYLAPEIIECSMNDNHPGYGK 208
Query: 567 KSDVYSYGVVLLELLTGRKP 586
+ D++S GV++ LL G P
Sbjct: 209 EVDMWSTGVIMYTLLAGSPP 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 42/238 (17%), Positives = 81/238 (34%), Gaps = 23/238 (9%)
Query: 363 HPTSTRFLAYEELKEATNNFEPASILGEG--GFGRVFKGV-LSDGTAVAIKR--LTCGGQ 417
H + F +E +++G+G V G V ++R L
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 418 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 476
+ E+ + +H N+V Y ++ + L + + GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVP---YRATFIADNELWVVTSFMAYGSAKDLIC--THFM 122
Query: 477 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
++ I + L Y+H +HR KAS+IL+ + ++
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 537 EGRT-----NYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKP 586
+ + +++PE + +L KSD+YS G+ EL G P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 37/230 (16%)
Query: 373 EELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV 425
++L E + +P + LGEG +G V+K + G VAIK++ + +E +
Sbjct: 16 KKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIK 73
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLE---SWLHGPLGVNCHLDW 481
E+ ++ + ++VK YY S + L + E GS+ + L
Sbjct: 74 EISIMQQCDSPHVVK---YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-------- 122
Query: 482 ETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
T +IA +GL YLH IHRD KA NILL HAK+ADFG+A Q
Sbjct: 123 -TEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL--- 175
Query: 539 RTNYLSTR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
T+ ++ R V+GT ++APE +D++S G+ +E+ G+ P
Sbjct: 176 -TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 54/239 (22%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLV--E 426
K + + + LG G G V VAIK + ++ D V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 427 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----- 481
+E+L +L+H ++K+ ++ D+ + + EL+ G L D
Sbjct: 66 IEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGEL-------------FDKVVGNK 109
Query: 482 -----ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGL 531
+ L A + YLHE+ +IHRD K N+LL + + K+ DFG
Sbjct: 110 RLKEATCKLYFYQMLLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 532 AKQAPEGRTNYLSTRVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+K E + + T GT Y+APE G+ D +S GV+L L+G P
Sbjct: 164 SKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 51/290 (17%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH-HR 436
N+ E +G G G+V+K G +A+K++ G + + K L++++++ + H
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIALDAAR 493
+V+ + + ++ + + EL+ + + + GP+ K+ + +
Sbjct: 85 YIVQ---CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL------GKMTVAIVK 135
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTF 551
L YL E VIHRD K SNILL+ K+ DFG++ + + + G
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-----AGCA 188
Query: 552 GYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARP 604
Y+APE +++DV+S G+ L+EL TG+ P + + ++ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248
Query: 605 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 652
+L + + F++ C + +RP +
Sbjct: 249 LLPGHM------------GFSGDFQSFVKDCLTK------DHRKRPKYNK 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 17/218 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 437
+++E ++G G V VAIKR+ Q + L+ E++ +S+ HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWE-TRMKIAL---DAA 492
+V YY+S L L +L+ GS+ + + H IA +
Sbjct: 75 IVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTR--VMG 549
GL YLH++ Q IHRD KA NILL + ++ADFG++ A G R +G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 550 TFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 586
T ++APE K+D++S+G+ +EL TG P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 58/257 (22%)
Query: 358 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG 416
G + A E ++ + F+ + G+G FG V G G +VAIK++
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--- 57
Query: 417 QQGDKEF----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-----LLCYELVPNGSLES 467
D F L ++ L+ LHH N+V+L Y+ + + E VP
Sbjct: 58 --QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----D 110
Query: 468 WLHGPLGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNIL 517
LH R ++A R + LH S V HRD K N+L
Sbjct: 111 TLHR------CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVL 163
Query: 518 L-ENNFHAKVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS------ 568
+ E + K+ DFG AK+ N Y+ +R Y APE L+ +
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTA 212
Query: 569 -DVYSYGVVLLELLTGR 584
D++S G + E++ G
Sbjct: 213 VDIWSVGCIFAEMMLGE 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 59/277 (21%), Positives = 89/277 (32%), Gaps = 67/277 (24%)
Query: 365 TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQ 418
+ L E + +G+G +G V + AIK ++ +
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 419 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL------------- 465
+ EV ++ +LHH N+ +L Y D L EL G L
Sbjct: 71 DVERIKTEVRLMKKLHHPNIARLYEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 466 -------------ESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDS 502
+ + + + L YLH
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 503 QPCVIHRDFKASNILLEN--NFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPE 557
+ HRD K N L +F K+ DFGL+K + G ++T+ GT +VAPE
Sbjct: 189 ---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
Query: 558 --------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y K D +S GV+L LL G P
Sbjct: 245 VLNTTNESYGP------KCDAWSAGVLLHLLLMGAVP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-----------EVEMLSRLHH 435
LGEG +G+V + + A+K L K+ L E+++L RL H
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 436 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 493
+N+++LV + + Q + + E G E + LD + + A
Sbjct: 66 KNVIQLVDVLYN-EEKQKMYMVMEYCVCGMQE------M-----LDSVPEKRFPVCQAHG 113
Query: 494 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
GL YLH ++H+D K N+LL K++ G+A+ +
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 547 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 588
G+ + PE A K D++S GV L + TG P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/249 (26%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQ 417
H +S R Y + + +LG+G FG V K A+K + +
Sbjct: 5 HHHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 418 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 477
L EVE+L +L H N++KL DSS + EL G L
Sbjct: 64 DTST-ILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL------------ 108
Query: 478 HLDWETR------------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NF 522
D + +K + Y+H+ + ++HRD K NILLE+ +
Sbjct: 109 -FDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDC 161
Query: 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVL 577
K+ DFGL+ + + R+ GT Y+APE Y K DV+S GV+L
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPEVLRGTYDE------KCDVWSAGVIL 212
Query: 578 LELLTGRKP 586
LL+G P
Sbjct: 213 YILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 42/268 (15%)
Query: 338 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFE------PASILGEG 391
S A E ++ L +P P + + + ILG G
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPF--DHRIVTAKQGAVNSFYTVSKTEILGGG 100
Query: 392 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450
FG+V K + G +A K + G + +E E+ ++++L H NL++L +
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SK 158
Query: 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHE 500
+ +L E V G L D L D G+ ++H+
Sbjct: 159 NDIVLVMEYVDGGEL-------------FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 501 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 558
++H D K NIL N K+ DFGLA++ L GT ++APE
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNF-GTPEFLAPEV 259
Query: 559 AMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ +D++S GV+ LL+G P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 55/234 (23%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLH 434
++ + ++G G FG VF+ L + VAIK++ DK F E++++ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVK 90
Query: 435 HRNLVKLVGYYSSRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
H N+V L ++ S + + E VP ++ ++K +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR------ASRHYAKLKQTMP 139
Query: 491 AA----------RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR 539
R LAY+H + HRD K N+LL + K+ DFG AK G
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 540 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 584
N Y+ +R Y APE L+ + D++S G V+ EL+ G+
Sbjct: 197 PNVSYICSRY-----YRAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 51/262 (19%), Positives = 93/262 (35%), Gaps = 35/262 (13%)
Query: 338 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 397
+ P+ D + + + ++ + ++ LG G FG V
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVH 68
Query: 398 KGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456
+ V + G K + E+ ++++LHH L+ L + D + +L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLI 126
Query: 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDSQPCV 506
E + G L D + + GL ++HE S +
Sbjct: 127 LEFLSGGEL-------------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 507 IHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 564
+H D K NI+ E + K+ DFGLA + + T + APE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTT-ATAEFAAPEIVDREPV 227
Query: 565 LVKSDVYSYGVVLLELLTGRKP 586
+D+++ GV+ LL+G P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 45/218 (20%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 445
+G G +G V V A K++ + F E+E++ L H N+++L +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 446 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR----- 493
D++ L EL G L + ++ DAAR
Sbjct: 76 E--DNTDIYLVMELCTGGEL-------------FE-----RVVHKRVFRESDAARIMKDV 115
Query: 494 --GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVM 548
+AY H+ + V HRD K N L + K+ DFGLA + G + T+V
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV- 169
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT YV+P+ + G + D +S GV++ LL G P
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 53/231 (22%)
Query: 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 428
+F+ ILGEG F V + AIK L +K ++ E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERD 82
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
++SRL H VKL Y++ +D + NG L ++
Sbjct: 83 VMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLK----------YIRKIGS--FD 128
Query: 489 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
R L YLH +IHRD K NILL + H ++ DFG AK
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVK-----SDVYSYGVVLLELLTGRKP 586
+ +GT YV+PE L K SD+++ G ++ +L+ G P
Sbjct: 186 QARANSFVGTAQYVSPEL-----LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 72/282 (25%), Positives = 111/282 (39%), Gaps = 63/282 (22%)
Query: 336 GRKSKASPKETAKPRTADAVTLGGSLPHP-------TSTRFLAYEELKEATNNFEPASIL 388
GR S E+ KP + + T + ++ ++
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 389 GEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHRNLVKLVGYYS 446
G G FG V++ L D G VAIK++ DK F E++++ +L H N+V+L ++
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 447 SRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA---------- 492
S + + + VP ++ +R K L
Sbjct: 118 SSGEKKDEVYLNLVLDYVP-----ETVYR------VARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMG 549
R LAY+H + HRD K N+LL+ + K+ DFG AKQ G N Y+ +R
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 550 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 584
Y APE L+ + DV+S G VL ELL G+
Sbjct: 222 ---YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 70/269 (26%), Positives = 101/269 (37%), Gaps = 60/269 (22%)
Query: 338 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 397
+S +S +A P TA V +E E LG G V+
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----------LGRGATSIVY 70
Query: 398 KGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455
+ A+K L + DK+ + E+ +L RL H N++KL + + L
Sbjct: 71 RCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISL 125
Query: 456 CYELVPNGSLESWLHGPLGVNCHLDW--------ETRMKIALDAAR-------GLAYLHE 500
ELV G L D E DAA +AYLHE
Sbjct: 126 VLELVTGGEL-------------FDRIVEKGYYSER------DAADAVKQILEAVAYLHE 166
Query: 501 DSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
+ ++HRD K N+L + K+ADFGL+K + T GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTPGYCAPE 220
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ D++S G++ LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 380 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLV---EVEM------ 429
N+F I+G GGFG V+ G A+K L DK+ + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERI 241
Query: 430 ----LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
+S +V + Y+ + +L+ G L L + E M
Sbjct: 242 MLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADM 294
Query: 486 KI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ A + GL ++H V++RD K +NILL+ + H +++D GLA + + +
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 348
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
V GT GY+APE G S D +S G +L +LL G P
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLH 434
++N++ LG+G F V + V + G A K + + K E + +L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA------ 488
H N+V+L + S H L ++LV G L + I
Sbjct: 64 HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL-------------FE-----DIVAREFYS 103
Query: 489 -LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPE 537
DA+ +AY H + ++HR+ K N+LL K+ADFGLA + +
Sbjct: 104 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 538 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT GY++PE Y+ D+++ GV+L LL G P
Sbjct: 161 SEA--WHGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 431
+ ++ LG G F V K S G A K + + +E + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 488
++ H N++ L Y + + +L ELV G L D +A
Sbjct: 71 QVLHHNVITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110
Query: 489 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 533
+A G+ YLH + H D K NI+L H K+ DFGLA
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ +G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 56/239 (23%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK----------------------RLTCGGQQGDKEFL 424
+G+G +G V +D T A+K R GG + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 425 V----EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 480
E+ +L +L H N+VKLV + + +ELV G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127
Query: 481 WETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
T ++ D AR G+ YLH +IHRD K SN+L+ + H K+ADFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVD 588
+ +G LS V GT ++APE + DV++ GV L + G+ P
Sbjct: 185 NE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 438
LGEG +G V V AVA+K + D + V E+ + L+H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67
Query: 439 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 493
VK Y R L E G L + M A+
Sbjct: 68 VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110
Query: 494 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 546
G+ YLH + HRD K N+LL+ + K++DFGLA L+
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 547 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT YVAPE + DV+S G+VL +L G P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 431
+++E LG G F V K G A K RL+ + +E + EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 488
+ H N++ L + + + +L ELV G L D +A
Sbjct: 64 EIRHPNIITLHDIFE--NKTDVVLILELVSGGEL-------------FD-----FLAEKE 103
Query: 489 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAK 533
+A + G+ YLH + H D K NI+L + N K+ DFG+A
Sbjct: 104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 161 KIEAGNE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 46/220 (20%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---------EVEMLSRLHHRN 437
+G+G F +V + G VAIK + DK L EV ++ L+H N
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 438 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 494
+VKL + ++ + L L E G + +L HG + E R
Sbjct: 76 IVKL---FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSA 126
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
+ Y H Q ++HRD KA N+LL+ + + K+ADFG + + G L G Y
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFC-GAPPYA 180
Query: 555 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
APE Y G + DV+S GV+L L++G P D
Sbjct: 181 APELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 431
+ ++ LG G F V K S G A K + + +E + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 488
++ H N++ L Y + + +L ELV G L D +A
Sbjct: 71 QVLHPNIITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110
Query: 489 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 533
+A G+ YLH + H D K NI+L H K+ DFGLA
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ +G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 61/253 (24%), Positives = 93/253 (36%), Gaps = 68/253 (26%)
Query: 361 LPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTC 414
+ T TRF +L E LG+G F V + V + G A +L+
Sbjct: 1 MATITCTRFTEEYQLFE---------ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA 51
Query: 415 GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG 474
Q + E + L H N+V+L S H L ++LV G L
Sbjct: 52 RDHQKLER---EARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGEL--------- 97
Query: 475 VNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---E 519
+ + ++ L+A + + H+ V+HR+ K N+LL
Sbjct: 98 ----FEDIVAREYYSEADASHCIQQILEA---VLHCHQMG---VVHRNLKPENLLLASKL 147
Query: 520 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 573
K+ADFGLA + GT GY++PE Y D+++
Sbjct: 148 KGAAVKLADFGLAIEVEGE-QQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWAC 199
Query: 574 GVVLLELLTGRKP 586
GV+L LL G P
Sbjct: 200 GVILYILLVGYPP 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 80/404 (19%), Positives = 129/404 (31%), Gaps = 110/404 (27%)
Query: 347 AKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGT 405
P + GG L + +E ++G+G F V + + G
Sbjct: 1 GSPGISGGG--GGILDMADDDVLF--------EDVYELCEVIGKGPFSVVRRCINRETGQ 50
Query: 406 AVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460
A+K + T ++ E + L H ++V+L+ YS + +E +
Sbjct: 51 QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS--SDGMLYMVFEFM 108
Query: 461 PNGSL--ESWLHGPLGVN------CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 512
L E G H M+ L+A L Y H+++ +IHRD K
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHY-----MRQILEA---LRYCHDNN---IIHRDVK 157
Query: 513 ASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAMTGHLLV 566
+LL EN+ K+ FG+A Q E RV GT ++APE G
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRV-GTPHFMAPEVVKREPYGK--- 212
Query: 567 KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY-- 624
DV+ GV+L LL+G P + E L + + GKY
Sbjct: 213 PVDVWGCGVILFILLSGCLP-------------FYGTK--------ERLFEGIIKGKYKM 251
Query: 625 PKE----------DFIRVC---------TIAAA------CVAPEANQRPTMGEVVQSLK- 658
D +R T+ A + + E V+ L+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311
Query: 659 ---------MVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTS 693
V + ++ + + F D TS
Sbjct: 312 FNARRKLKGAVLAAVSSH----KFNSFYGDPPEELPDFSEDPTS 351
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 60/224 (26%), Positives = 86/224 (38%), Gaps = 51/224 (22%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLSRLHHRNLVK 440
LG G F V K S G A K R + +E + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 493
L Y + + +L ELV G L D +A +A
Sbjct: 79 LHEVYE--NKTDVILILELVAGGEL-------------FD-----FLAEKESLTEEEATE 118
Query: 494 -------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNY 542
G+ YLH + H D K NI+L + K+ DFGLA + G
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 543 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 174 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 364 PTSTRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG 419
RFL ++ L+ + F +LG GGFG VF + G A K+L
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL------- 218
Query: 420 DKEFLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESW 468
+K+ L + L+++H R +V L + ++ L L ++ G +
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL---AYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 469 LHGPLGVNCHLDWETRMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 523
++ N E R I GL +LH+ + +I+RD K N+LL+++ +
Sbjct: 276 IYNVDEDNPGFQ-EPRAIFYTAQIVS----GLEHLHQRN---IIYRDLKPENVLLDDDGN 327
Query: 524 AKVADFGLAKQAPEG--RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLEL 580
+++D GLA + G +T GT G++APE + G S D ++ GV L E+
Sbjct: 328 VRISDLGLAVELKAGQTKTK---GYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEM 382
Query: 581 LTGRKP 586
+ R P
Sbjct: 383 IAARGP 388
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 65/267 (24%), Positives = 99/267 (37%), Gaps = 69/267 (25%)
Query: 347 AKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGT 405
A + G ST+F ++KE LG+G F V + V + G
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKE---------ELGKGAFSVVRRCVHKTTGL 55
Query: 406 AVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 462
A K + + K E + +L H N+V+L + S H L ++LV
Sbjct: 56 EFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ--EESFHYLVFDLVTG 112
Query: 463 GSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR-------GLAYLHEDSQPCVIH 508
G L + I DA+ +AY H + ++H
Sbjct: 113 GEL-------------FE-----DIVAREFYSEADASHCIQQILESIAYCHSNG---IVH 151
Query: 509 RDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
R+ K N+LL K+ADFGLA + + GT GY++PE +L
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GTPGYLSPE------VL 202
Query: 566 VKS------DVYSYGVVLLELLTGRKP 586
K D+++ GV+L LL G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 438
LGEG +G V V AVA+K + D + V E+ + L+H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67
Query: 439 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 493
VK Y R L E G L + M A+
Sbjct: 68 VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110
Query: 494 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 546
G+ YLH + HRD K N+LL+ + K++DFGLA L+
Sbjct: 111 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 547 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT YVAPE + DV+S G+VL +L G P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 71/311 (22%), Positives = 107/311 (34%), Gaps = 77/311 (24%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 444
+LGEG RV + L A+K + EVEML + HRN+++L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR---- 493
+ + + L +E + GS+ L I L+A+
Sbjct: 80 FE--EEDRFYLVFEKMRGGSI-------------LS-----HIHKRRHFNELEASVVVQD 119
Query: 494 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGR------TN 541
L +LH + HRD K NIL E+ K+ DF L T
Sbjct: 120 VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKPVDMSQPSGQE 596
L T G+ Y+APE D++S GV+L LL+G P G+
Sbjct: 177 ELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-----GRC 230
Query: 597 NLVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEA 644
L + GKY P + D I + +A
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS------KLLVRDA 284
Query: 645 NQRPTMGEVVQ 655
QR + +V+Q
Sbjct: 285 KQRLSAAQVLQ 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 37/225 (16%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 433
KE + A LG G FG V + V S K + G D+ + E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIA 58
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---D 490
HRN++ L + S + ++ +E + + + L +
Sbjct: 59 RHRNILHLHESFESMEE--LVMIFEFISGLDI-------------FERINTSAFELNERE 103
Query: 491 AAR-------GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTN 541
L +LH + + H D + NI+ + + K+ +FG A+Q G
Sbjct: 104 IVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
Y APE + +D++S G ++ LL+G P
Sbjct: 160 -FRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 55/246 (22%)
Query: 367 TRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE 422
RFL ++ L+ N F +LG+GGFG V + G A K+L +K+
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKK 220
Query: 423 FLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH 470
+ M L +++ R +V L Y ++D+ LC L+ G L+
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA----LCLVLTLMNGGDLKF--- 273
Query: 471 GPLGVNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNF 522
H+ + A GL LH + +++RD K NILL+++
Sbjct: 274 -------HIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHG 323
Query: 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLEL 580
H +++D GLA PEG+T RV GT GY+APE + S D ++ G +L E+
Sbjct: 324 HIRISDLGLAVHVPEGQTI--KGRV-GTVGYMAPEVVKNERY--TFSPDWWALGCLLYEM 378
Query: 581 LTGRKP 586
+ G+ P
Sbjct: 379 IAGQSP 384
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 52/267 (19%), Positives = 95/267 (35%), Gaps = 38/267 (14%)
Query: 337 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP----ASILGEGG 392
R+ ++ R V+ + + ++ ++ LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 393 FGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451
FG V + + G A K + + + E++ +S L H LV L + +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 228
Query: 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHED 501
++ YE + G L + + +A GL ++HE+
Sbjct: 229 -MVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 502 SQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ +H D K NI+ K+ DFGL ++ + GT + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT-GTAEFAAPEVA 328
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ +D++S GV+ LL+G P
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 55/264 (20%), Positives = 88/264 (33%), Gaps = 79/264 (29%)
Query: 355 VTLGGSLPHPTSTRFLA-YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL 412
+ + P P Y+ K+ +LG G G+V + G A+K L
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLSKQ---------VLGLGVNGKVLECFHRRTGQKCALKLL 62
Query: 413 TCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSRDSSQHLLCYELVPNGSLES 467
EV+ + ++V ++ Y L+ E + G L
Sbjct: 63 -------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-- 113
Query: 468 WLHGPLGVNCHLDWETRMKIA---------LDAAR-------GLAYLHEDSQPCVIHRDF 511
+I +AA + +LH + + HRD
Sbjct: 114 -----------FS-----RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDV 154
Query: 512 KASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 568
K N+L + + K+ DFG AK+ + L T T YVAPE +L
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPE------VLGPE 204
Query: 569 ------DVYSYGVVLLELLTGRKP 586
D++S GV++ LL G P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 66/310 (21%), Positives = 102/310 (32%), Gaps = 98/310 (31%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HHRNLVK 440
LGEG F K V A A+K + K E+ L H N+VK
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEANTQKEITALKLCEGHPNIVK 70
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 493
L + D L EL+ G L + +I +A+
Sbjct: 71 LHEVFH--DQLHTFLVMELLNGGEL-------------FE-----RIKKKKHFSETEASY 110
Query: 494 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 543
++++H+ V+HRD K N+L + N K+ DFG A+ P L
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL 166
Query: 544 STRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
T T Y APE LL ++ D++S GV+L +L+G+ P
Sbjct: 167 KTPC-FTLHYAAPE------LLNQNGYDESCDLWSLGVILYTMLSGQVPF---------- 209
Query: 598 LVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEAN 645
+ E+ G + E D I+ + + N
Sbjct: 210 ---QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQ------GLLTVDPN 260
Query: 646 QRPTMGEVVQ 655
+R M +
Sbjct: 261 KRLKMSGLRY 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 63/229 (27%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 436
LG G FG+V G G VA+K L +++ + E++ L H
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 493
+++KL Y + + E V G L ++ HG R++ AR
Sbjct: 72 HIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEE--MEAR 114
Query: 494 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
+ Y H + V+HRD K N+LL+ + +AK+ADFGL+ +G +L T
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 169
Query: 546 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
G+ Y APE YA G + D++S GV+L LL G P D
Sbjct: 170 SC-GSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV----------EVE 428
++FE +G+G FG+V +D A+K + +K+ V E++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQ 67
Query: 429 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 488
++ L H LV L +YS +D + +L+ G L HL K
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRY----------HLQQNVHFKE- 114
Query: 489 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
+ + L YL +IHRD K NILL+ + H + DF +A P
Sbjct: 115 -ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 541 NYLSTRVMGTFGYVAPE----YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
T + GT Y+APE G+ + D +S GV ELL GR+P
Sbjct: 171 ---ITTMAGTKPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 61/242 (25%)
Query: 373 EELKEATNNF----EPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFL 424
++L + F E +G G + + + + A+K + +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------ 64
Query: 425 VEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 483
E+E+L R H N++ L Y D + EL+ G L LD
Sbjct: 65 -EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL-------------LDKIL 108
Query: 484 RMK---------IALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFG 530
R K + + + YLH V+HRD K SNIL N ++ DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 584
AKQ L T T +VAPE +L + D++S GV+L +LTG
Sbjct: 166 FAKQLRAE-NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 585 KP 586
P
Sbjct: 218 TP 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 38/269 (14%)
Query: 335 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 394
+S A L + P + + + ++ +LG GGFG
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK-------EPLESQYQVGPLLGSGGFG 57
Query: 395 RVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLHHR--NLVKLVGYY 445
V+ G+ +SD VAIK R++ G+ + + +EV +L ++ +++L+ ++
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 446 SSRDSSQHLLCYELV-PNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
DS +L E P L ++ G L R + + H
Sbjct: 118 ERPDS--FVLILERPEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH--- 166
Query: 503 QPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
V+HRD K NIL+ N K+ DFG + + GT Y PE+ +
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVYSPPEW-IR 221
Query: 562 GHLLV--KSDVYSYGVVLLELLTGRKPVD 588
H + V+S G++L +++ G P +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 62/251 (24%), Positives = 97/251 (38%), Gaps = 50/251 (19%)
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCG 415
P LA E E + + S LG G FG V+ V V +K ++
Sbjct: 7 PKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65
Query: 416 GQQGDKEFL---VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 472
D + +E+ +LSR+ H N++K++ + ++ ++LV +E HG
Sbjct: 66 CWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF------FQLV----ME--KHGS 113
Query: 473 LG-VNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFH 523
+ +D R+ A + YL +IHRD K NI++ +F
Sbjct: 114 GLDLFAFIDRHPRLDE--PLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFT 168
Query: 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVL 577
K+ DFG A G T GT Y APE Y G + +++S GV L
Sbjct: 169 IKLIDFGSAAYLERG--KLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTL 220
Query: 578 LELLTGRKPVD 588
L+ P
Sbjct: 221 YTLVFEENPFC 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 61/245 (24%), Positives = 93/245 (37%), Gaps = 49/245 (20%)
Query: 367 TRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD------ 420
EL + + + G +G V GV S+G VAIKR+ G
Sbjct: 9 AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS 68
Query: 421 -----KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGP 472
K L E+ +L+ HH N++ L + + + L L EL + + L
Sbjct: 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQV 123
Query: 473 LGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNF 522
+ +I + GL LHE V+HRD NILL +N
Sbjct: 124 IHDQ---------RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNN 171
Query: 523 HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLE 579
+ DF LA++ T+Y++ R Y APE M K D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 580 LLTGR 584
+ +
Sbjct: 227 MFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 66/253 (26%)
Query: 379 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHR 436
+ + LG G FG V + + G A+K++ D + E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHV 60
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------------ 478
N++KLV Y+ + + + L +G +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 479 -------LDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENN 521
L R ++ R + ++H + HRD K N+L+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177
Query: 522 FHA-KVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVY 571
+ K+ DFG AK+ + Y+ +R Y APE L++ + D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSIDLW 226
Query: 572 SYGVVLLELLTGR 584
S G V EL+ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/227 (24%), Positives = 82/227 (36%), Gaps = 61/227 (26%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 440
+G G FG VA+K + ++ + E+ L H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-------ERGAAIDENVQREIINHRSLRHPNIVR 80
Query: 441 LVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---- 493
+ HL + E G L + G R D AR
Sbjct: 81 F---KEVILTPTHLAIIMEYASGGELYERICNAG------------RFSE--DEARFFFQ 123
Query: 494 ----GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRV 547
G++Y H + HRD K N LL+ + K+ DFG +K + + + V
Sbjct: 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTV 178
Query: 548 MGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
GT Y+APE Y G +DV+S GV L +L G P +
Sbjct: 179 -GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 49/222 (22%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVG 443
LG G F V + + S G A K L + D + E+ +L ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR- 493
Y ++S+ +L E G + D R
Sbjct: 97 VYE--NTSEIILILEYAAGGEI-------------FS-----LCLPELAEMVSENDVIRL 136
Query: 494 ------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLS 544
G+ YLH+++ ++H D K NILL + K+ DFG++++ L
Sbjct: 137 IKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LR 191
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
+ GT Y+APE + +D+++ G++ LLT P
Sbjct: 192 EIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 63/229 (27%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR----------LHHR 436
LG G FG+V G G VA+K L +++ + ++++ + H
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 493
+++KL Y + + + E V G L ++ +G R+ +R
Sbjct: 77 HIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDE--KESR 119
Query: 494 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
G+ Y H + V+HRD K N+LL+ + +AK+ADFGL+ +G +L T
Sbjct: 120 RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174
Query: 546 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
G+ Y APE YA G + D++S GV+L LL G P D
Sbjct: 175 SC-GSPNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 77/283 (27%)
Query: 335 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 394
+ P+ + L + Y+ + +LG G G
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGING 76
Query: 395 RVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSR 448
+V + A+K L EVE+ R ++V++V Y
Sbjct: 77 KVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR------ 493
L+ E + G L +I +A+
Sbjct: 130 GRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREASEIMKSIG 171
Query: 494 -GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGRTNYLSTRVMG 549
+ YLH + + HRD K N+L + K+ DFG AK+ N L+T
Sbjct: 172 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPC-Y 225
Query: 550 TFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKP 586
T YVAPE +L D++S GV++ LL G P
Sbjct: 226 TPYYVAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 360 SLPHPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 415
S P P + F E K E + +G G +G V V G VAIK+L
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61
Query: 416 GQQGD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL 469
Q K E+ +L + H N++ L+ ++ ++ L + + L
Sbjct: 62 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDL 116
Query: 470 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529
+ L + + +GL Y+H +IHRD K N+ + + K+ DF
Sbjct: 117 GKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172
Query: 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
GLA+QA T Y+ TR Y APE + ++ D++S G ++ E++TG+
Sbjct: 173 GLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 58/231 (25%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---------- 425
+ F+ LG G FGRV K G A+K L DK+ +V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKIL-------DKQKVVKLKQIEHTLN 90
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E +L ++ LVKL +S +D+S + E V G + S HL R
Sbjct: 91 EKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFS----------HLRRIGR- 137
Query: 486 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+ AR YLH +I+RD K N+L++ + +V DFG AK+ +
Sbjct: 138 -FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-K 192
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 586
GRT L GT +APE ++ G+ K+ D ++ GV++ E+ G P
Sbjct: 193 GRTWTLC----GTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 56/225 (24%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 436
LGEG FG+V VA+K + ++ L E+ L L H
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 437 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IAL 489
+++KL Y + + + E G L ++ + + E R I
Sbjct: 70 HIIKL---YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC- 119
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ Y H + ++HRD K N+LL++N + K+ADFGL+ +G N+L T G
Sbjct: 120 ----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSC-G 169
Query: 550 TFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 588
+ Y APE YA G + DV+S G+VL +L GR P D
Sbjct: 170 SPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 433
E + + +G G +G V + G VAIK+L+ Q K E+ +L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 434 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
H N++ L+ ++ S ++ L +++ L +G+ E +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLK--FSEEKIQYLVY 133
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+GL Y+H V+HRD K N+ + + K+ DFGLA+ A T Y+ TR
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 550 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
Y APE ++ ++ D++S G ++ E+LTG+
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEV 427
++K +E LGEG F V+K + VAIK++ G + K+ L E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 486
++L L H N++ L+ + + + + L ++ + LE + + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSN---ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKA 116
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLST 545
L +GL YLH+ ++HRD K +N+LL+ N K+ADFGLAK R +
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTH 171
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
+V+ T Y APE LL + +Y GV +L ELL
Sbjct: 172 QVV-TRWYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLH----HR 436
LG+GGFG VF G L+D VAIK R+ D +EV +L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 494
+++L+ ++ +++ +L +P L ++ GPLG +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERP-LPAQDLFDYITEKGPLGEG-----PSR-CFFGQVVAA 151
Query: 495 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 553
+ + H V+HRD K NIL+ AK+ DFG + + GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTRVY 204
Query: 554 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 588
PE+ ++ H + V+S G++L +++ G P +
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 377 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 433
++ +G G G V + VAIK+L+ Q K E+ ++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 434 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
+H+N++ L+ ++ + S + + EL+ +L + L RM L
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMEL-------DHERMSYLL 133
Query: 490 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTR 546
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
Y APE + D++S G ++ E++ G
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 45/224 (20%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSRL 433
+E +GEG +G VFK G VAIK+ + D L E+ ML +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQL 59
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNCHLDWETRMKIALD 490
H NLV L+ + R HL+ +E + L+ + I
Sbjct: 60 KHPNLVNLLEVFR-RKRRLHLV-FEYCDHTVLHELDR-------YQRGVPEHLVKSITWQ 110
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGR--TNYLSTRV 547
+ + + H+ + IHRD K NIL+ + K+ DFG A+ + ++TR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
Y +PE LLV Y V V ELL+G
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-19
Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 41/233 (17%)
Query: 373 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 425
+L+ ++E ++G G FG V K A+K L+ + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E ++++ + +V+L +Y+ +D + E +P G L + +
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS-------------NY 163
Query: 486 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+ AR L +H IHRD K N+LL+ + H K+ADFG + +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVLLELLTGRKP 586
T V GT Y++PE + D +S GV L E+L G P
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)
Query: 362 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 420
+ + ++ + + S +GEG +G V + VAIK+++ Q
Sbjct: 9 AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68
Query: 421 -KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 476
+ L E+++L R H N++ + + + + + + + +L +E+ L+ L
Sbjct: 69 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQ 123
Query: 477 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
HL + RGL Y+H + V+HRD K SN+LL K+ DFGLA+ A
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 537 EGR------TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
T Y++TR Y APE + KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 58/231 (25%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F+ LG G FGRV + +G A+K L KE +V +VE
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVL-------KKEIVVRLKQVEHTND 55
Query: 429 ---MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
MLS + H ++++ + + +D+ Q + + + G L S L R
Sbjct: 56 ERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFS----------LLRKSQRF 103
Query: 486 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
A+ L YLH +I+RD K NILL+ N H K+ DFG AK P+
Sbjct: 104 PN--PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 538 GRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
T L GT Y+APE + + KS D +S+G+++ E+L G P
Sbjct: 159 -VTYTLC----GTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 40/234 (17%)
Query: 373 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 425
++++ +FE ++G G FG V K A+K L E F
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E ++L + + L +Y+ +D + L + G L + L +
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLS-----------KFED 170
Query: 486 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
++ + AR + +H+ +HRD K NIL++ N H ++ADFG + E
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 586
T S V GT Y++PE D +S GV + E+L G P
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 46/248 (18%)
Query: 357 LGGSLPHPTSTRFLAYEEL-KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC 414
+G H +S L E L ++ +E ++GEG +G V K G VAIK+
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL- 59
Query: 415 GGQQGDKEF-----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLE 466
+ D + + E+++L +L H NLV L+ + +L+ +E V + LE
Sbjct: 60 --ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRWYLV-FEFVDHTILDDLE 115
Query: 467 SWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 526
LD++ K G+ + H + +IHRD K NIL+ + K+
Sbjct: 116 L-------FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165
Query: 527 ADFGLAKQ-APEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------V 576
DFG A+ A G + ++TR Y APE LLV Y V +
Sbjct: 166 CDFGFARTLAAPGEVYDDEVATR-----WYRAPE------LLVGDVKYGKAVDVWAIGCL 214
Query: 577 LLELLTGR 584
+ E+ G
Sbjct: 215 VTEMFMGE 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 38/268 (14%), Positives = 74/268 (27%), Gaps = 61/268 (22%)
Query: 388 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKL 441
G + ++ + D VA+ + G D +E L LSR+ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+ L+ E + GSL+ ++ A H
Sbjct: 97 --LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP------VGAIRAMQSLAAAADAAHRA 148
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561
V S + + + +G V+ +
Sbjct: 149 G---VALSIDHPSRVRV----------------SIDGDV------VLAYPATMPDANP-- 181
Query: 562 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR-L 620
+ D+ G L LL R P+ + + + P RD + +P +
Sbjct: 182 -----QDDIRGIGASLYALLVNRWPLP------EAGVRSGLAPAERDTA--GQPIEPADI 228
Query: 621 GGKYPKEDFIRVCTIAAACVAPEANQRP 648
P + + +AA V + R
Sbjct: 229 DRDIPFQ----ISAVAARSVQGDGGIRS 252
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 43/232 (18%)
Query: 372 YEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 427
YE ++++ LG G + VF+ + +++ V +K L K+ E+
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREI 81
Query: 428 EMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-- 484
++L L N++ L S L +E V N + L D++ R
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLT-----DYDIRFY 135
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--TN 541
M L + L Y H ++HRD K N+++ + ++ D+GLA+ G+
Sbjct: 136 MYEIL---KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 586
+++R + PE LLV D++S G +L ++ ++P
Sbjct: 190 RVASRY-----FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 433
+E +GEG +G VFK VA+KR+ D E L E+ +L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H+N+V+L S L +E L+ + N LD E +
Sbjct: 59 KHKNIVRLHDVLHSDKKL--TLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLK 112
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFG 552
GL + H V+HRD K N+L+ N K+A+FGLA+ R S V+ T
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVV-TLW 166
Query: 553 YVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGRKP 586
Y P+ +L + +YS + + EL +P
Sbjct: 167 YRPPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 360 SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ 418
S PT R + + E ++ S +G G +G V + G VA+K+L+ Q
Sbjct: 9 SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 419 GD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGP 472
K E+ +L + H N++ L+ ++ S + L L + + L+
Sbjct: 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNI 123
Query: 473 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
+ L + + RGL Y+H +IHRD K SN+ + + K+ DFGLA
Sbjct: 124 VKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
+ + T Y++TR Y APE + ++ D++S G ++ ELLTGR
Sbjct: 180 RHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 433
++ +G G G V VAIK+L+ Q K E+ ++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 434 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
+H+N++ L+ ++ + + + L EL +++ L + + LD E +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQME--LDHERMSYLLY 171
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTRV 547
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
Y APE + D++S G ++ E++ +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 56/269 (20%), Positives = 95/269 (35%), Gaps = 48/269 (17%)
Query: 373 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 425
+E++ ++FE ++G G F V K G A+K + E F
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E ++L R + +L +++ +D + L E G L + L +
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS-----------KFGE 157
Query: 486 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+I + AR + +H +HRD K NILL+ H ++ADFG +
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY-------SYGVVLLELLTGRKPVDMS 590
T V GT Y++PE + Y + GV E+ G+ P
Sbjct: 215 DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-- 271
Query: 591 QPSGQENLVTWARPILRDKDRLEELADPR 619
++ I+ K+ L
Sbjct: 272 ----ADSTAETYGKIVHYKEHLSLPLVDE 296
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLSRL 433
+ +E + +G+G FG VFK G VA+K++ + +KE F L E+++L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLL 73
Query: 434 HHRNLVKLVGYYSSRDSSQHL------LCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
H N+V L+ ++ S + L ++ + L L ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRV 129
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTNYLS 544
GL Y+H + ++HRD KA+N+L+ + K+ADFGLA+ A + N +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
RV+ T Y PE LL+ Y + ++ E+ T
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 51/307 (16%), Positives = 98/307 (31%), Gaps = 62/307 (20%)
Query: 336 GRKSKASPKETAKPRTADAVTLGGSLPHPTST--------RFLAYEELKEATNNFEPASI 387
G +A+ + T V+ + + +E +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLSRLHHRN 437
+G G +G V + + VAIK++ + F L E+ +L+RL+H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 438 LVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
+VK+ + + L + E+ +S +L + + G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLST 545
+ Y+H ++HRD K +N L+ + KV DFGLA
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 546 RVMGTFGYVAPEYAMTGH----------LLVKSDVYSYGV-------VLLELLTGRKPVD 588
++ + +TGH L++ + Y+ + + ELL K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 589 MSQPSGQ 595
Sbjct: 286 AYHADRG 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSR 432
+++ F+ LG G + V+KG+ + G VA+K + ++G + E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 490
L H N+V+L + + L +E + N L+ ++ L+
Sbjct: 60 LKHENIVRLYDVIHTENKL--TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMG 549
+GLA+ HE+ ++HRD K N+L+ K+ DFGLA+ T S+ V+
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVV- 170
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
T Y AP+ +L+ S YS + +L E++TG+
Sbjct: 171 TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 434
++ +GEG +G V+K S G VA+KR+ + E + E+ +L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
H N+V L+ S L +E + L+ L L RG
Sbjct: 78 HPNIVSLIDVIHSERCL--TLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRG 131
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 553
+A+ H+ ++HRD K N+L+ ++ K+ADFGLA+ R+ + V+ T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVV-TLWY 185
Query: 554 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
AP+ +L+ S YS V + E++TG+
Sbjct: 186 RAPD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 35/229 (15%)
Query: 377 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 435
+ + + LG GG G VF V +D VAIK++ Q K L E++++ RL H
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67
Query: 436 RNLVKLV-----------GYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
N+VK+ S + + E +E+ L L L E
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG-PLLEEH 121
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--- 539
RGL Y+H + V+HRD K +N+ + + K+ DFGLA+
Sbjct: 122 ARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 540 ---TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
+ L T+ Y +P ++ + K+ D+++ G + E+LTG+
Sbjct: 179 GHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 434
+ +GEG +G V+K + G A+K++ + + E + E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
H N+VKL ++ +L +E + L+ L L+ T L G
Sbjct: 59 HSNIVKLYDVIHTKKRL--VLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNG 112
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 553
+AY H+ V+HRD K N+L+ K+ADFGLA+ R + ++ T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIV-TLWY 166
Query: 554 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
AP+ +L+ S YS + + E++ G
Sbjct: 167 RAPD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 434
+++F+ S+LGEG +G V G VAIK++ + L E+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 435 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLH-----GPLGVNCHLDWETRMK 486
H N++ + + S ++ + + EL +++ LH L + H+ +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLS-DDHIQY----- 116
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
R + LH + VIHRD K SN+L+ +N KV DFGLA+ E +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 547 VMGTF--GYV------APEYAMTGHLLVKS-DVYSYGVVLLELLTGR 584
+ +V APE +T ++ DV+S G +L EL R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
N FE +LG+G FG+V K G A+K L KE +V EV
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKIL-------KKEVIVAKDEVAHTLT 197
Query: 429 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+L H L L S + L E G L L + E R
Sbjct: 198 ENRVLQNSRHPFLTAL---KYSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDR 249
Query: 485 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
+ + L YLH S+ V++RD K N++L+ + H K+ DFGL K EG +
Sbjct: 250 ARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA 304
Query: 544 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+ + GT Y+APE + + ++ D + GVV+ E++ GR P
Sbjct: 305 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 27/226 (11%)
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGL 495
V L S SSQ V SL + + D+ T + + A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
+L S+ C IHRD A NILL K+ DFGLA+ + ++A
Sbjct: 207 EFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE- 613
PE ++SDV+S+GV+L E+ + G P P + + R L++ R+
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRR--LKEGTRMRA 317
Query: 614 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ P + Y C E +QRPT E+V+ L
Sbjct: 318 PDYTTPEM---Y---------QTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 30/155 (19%), Positives = 58/155 (37%), Gaps = 20/155 (12%)
Query: 387 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 438
LG G FG+V + + VA+K L G + + + E+++L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
V L+G ++ ++ E G+L ++L R + +G +
Sbjct: 89 VNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136
Query: 499 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533
I D K + ++ + + F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 53/235 (22%)
Query: 378 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ-GDKEF----LVEVEMLS 431
AT+ +EP + +G G +G V+K G VA+K + G + EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 432 RLH---HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
RL H N+V+L V S D + L +E V L ++L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL------------DKAP 113
Query: 486 KIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535
L A RGL +LH + C++HRD K NIL+ + K+ADFGLA+
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 584
L+ V+ T Y APE +L++S D++S G + E+ +
Sbjct: 171 --SYQMALTPVVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 380 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 437
+ LGEG + V+KG VA+K + ++G + EV +L L H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+V L + S L +E + L+ +L ++ RGLAY
Sbjct: 62 IVTLHDIIHTEKSL--TLVFEYLDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAY 115
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAP 556
H + V+HRD K N+L+ K+ADFGLA+ + +T V+ T Y P
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVV-TLWYRPP 169
Query: 557 EYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
+ +L+ S YS + + E+ TGR
Sbjct: 170 D------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 70/280 (25%), Positives = 105/280 (37%), Gaps = 55/280 (19%)
Query: 335 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 394
+ D ++ H T L K NFE +LG G +G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 395 RVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLVE----VE--------MLSRLHHRNL 438
+VF K D G A+K L K +V+ E + L
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----- 493
V L +Y+ + ++ L + + G L + HL R +
Sbjct: 122 VTL--HYAFQTETKLHLILDYINGGELFT----------HLSQRERFT--EHEVQIYVGE 167
Query: 494 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
L +LH+ +I+RD K NILL++N H + DFGL+K+ T GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223
Query: 551 FGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
Y+AP+ +GH K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 42/222 (18%)
Query: 388 LGEGGFGRVFKGV---LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 444
+G G +G V+K D A+K++ G E+ +L L H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA----------RG 494
+ S + L ++ + L + + + L G
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIK-----FHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 495 LAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQ-APEGRTNYLSTRVMG 549
+ YLH + V+HRD K +NIL+ K+AD G A+ + V+
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 550 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 584
TF Y APE LL+ + D+++ G + ELLT
Sbjct: 198 TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 49/229 (21%)
Query: 380 NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV---EVEM--- 429
+ FE +LG+G FG+VF K SD A+K L K L V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76
Query: 430 ---LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
L ++H +VKL + + + L L + + G L + L + E +
Sbjct: 77 RDILVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDV 128
Query: 486 K-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
K +AL L +LH +I+RD K NILL+ H K+ DFGL+K E
Sbjct: 129 KFYLAELAL----ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESID 178
Query: 541 NYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+ GT Y+APE GH +S D +S+GV++ E+LTG P
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 63/233 (27%), Positives = 94/233 (40%), Gaps = 59/233 (25%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
N+F+ +LG+G FG+V K G A+K L KE ++ EV
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKIL-------RKEVIIAKDEVAHTVT 54
Query: 429 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+L H L L + + L E G L HL E
Sbjct: 55 ESRVLQNTRHPFLTAL---KYAFQTHDRLCFVMEYANGGELFF----------HLSRERV 101
Query: 485 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
+ AR L YLH V++RD K N++L+ + H K+ DFGL K
Sbjct: 102 FT--EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--- 153
Query: 537 EGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
EG ++ + + GT Y+APE + ++ D + GVV+ E++ GR P
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 54/262 (20%)
Query: 363 HPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 418
H +S R Y + +N+ ++G G +G V+ + VAIK++
Sbjct: 6 HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN----- 60
Query: 419 GDKEF---------LVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLE 466
+ F L E+ +L+RL +++L + L + E+ +
Sbjct: 61 --RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----AD 113
Query: 467 SWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525
S L L E +K I + G ++HE +IHRD K +N LL + K
Sbjct: 114 SDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK 169
Query: 526 VADFGLA----KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS--- 568
V DFGLA + N L + +T H L++
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229
Query: 569 ----DVYSYGVVLLELLTGRKP 586
D++S G + ELL +
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQS 251
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 380 NNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSR 432
+E + +GEG +G+VFK + + G VA+KR+ Q +E + EV +L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRH 67
Query: 433 LH---HRNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
L H N+V+L + R++ L+ +E V L ++L + ET
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLV-FEHVDQ-DLTTYLDKVPEP--GVPTETIK 123
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
+ RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ L++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTS 178
Query: 546 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 584
V+ T Y APE +L++S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 59/235 (25%)
Query: 380 NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV----EVE--- 428
FE +LG+GG+G+VF K ++ G A+K L K +V +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTK 69
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
+L + H +V L + + L L E + G L L+ E
Sbjct: 70 AERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFM----------QLEREG 116
Query: 484 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535
D A L +LH+ +I+RD K NI+L + H K+ DFGL K++
Sbjct: 117 IFM--EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171
Query: 536 --PEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
T+ GT Y+APE +GH ++ D +S G ++ ++LTG P
Sbjct: 172 IHDGTVTHTFC----GTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 41/224 (18%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 433
+ + + LGEG +G V+K + VAIKR+ + ++E + EV +L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
HRN+++L L +E E+ L + N +
Sbjct: 91 QHRNIIELKSVIHHNHRL--HLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHA-----KVADFGLAKQ-APEGRTNYLSTRV 547
G+ + H +HRD K N+LL + + K+ DFGLA+ R + +
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 548 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 584
+ T Y PE +L+ S YS V + E+L
Sbjct: 199 I-TLWYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---------- 434
LG G F V+ + + T VA+K + + + E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 435 -HRNLVKLVGYYSSR-DSSQHL-LCYELV-PN--GSLESWLHGPLGVNCHLDWETRMKIA 488
+++KL+ +++ + + H+ + +E++ N ++ + H + + + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-----VK-QIS 137
Query: 489 LDAARGLAYLHEDSQPCVIHRDFKASNILL------ENNFHAKVADFGLAKQAPEGRTNY 542
GL Y+H +IH D K N+L+ EN K+AD G A E TN
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 543 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 584
+ TR Y +PE + +D++S ++ EL+TG
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 9e-15
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F +LG+G FG+V KG A+K L K+ ++ +VE
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 390
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+ L +L + + + E V G L + E
Sbjct: 391 EKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPH 443
Query: 485 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
A + A GL +L +I+RD K N++L++ H K+ADFG+ K E + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV 497
Query: 544 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+T+ GT Y+APE + KS D +++GV+L E+L G+ P
Sbjct: 498 TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 431
+ +E S++G+G FG+V K + VAIK Q +EV +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA----QIEVRLLE 105
Query: 432 RLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWE 482
++ +V L ++ R HL L +E++ + +L L GV+ +L
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFR---NHLCLVFEML-SYNLYDLLRNTNFRGVSLNL--- 158
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRT 540
TR K A L +L + +IH D K NILL N + K+ DFG + Q +
Sbjct: 159 TR-KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 541 NYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 584
Y+ +R F Y +PE Y + D++S G +L+E+ TG
Sbjct: 217 QYIQSR----F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 50/229 (21%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F +LG+G FG+VF K AIK L K+ ++ +VE
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKAL-------KKDVVLMDDDVECTMV 66
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+ H L + + + + E + G L + +CH +R
Sbjct: 67 EKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSR 119
Query: 485 MK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539
I L GL +LH +++RD K NILL+ + H K+ADFG+ K E
Sbjct: 120 ATFYAAEIIL----GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENM 169
Query: 540 TNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
T GT Y+APE + G S D +S+GV+L E+L G+ P
Sbjct: 170 LGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 46/227 (20%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F +LG+G FG+V KG A+K L K+ ++ +VE
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 69
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
+ L +L +S + L E V G L + E
Sbjct: 70 EKRVLALPGKPPFLTQL---HSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEP 121
Query: 484 RMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
A + A GL +L +I+RD K N++L++ H K+ADFG+ K E +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 175
Query: 543 LSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
++T+ GT Y+APE A + KS D +++GV+L E+L G+ P
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 54/231 (23%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
++F ++G+G FG+V K + A+K L K+ ++ E +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVL-------QKKAILKKKEEKHIMS 87
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
+L + H LV L + S ++ L + + G L L E
Sbjct: 88 ERNVLLKNVKHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEP 139
Query: 484 RMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538
R + IA L YLH + +++RD K NILL++ H + DFGL K E
Sbjct: 140 RARFYAAEIAS----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---EN 189
Query: 539 RTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+ +T GT Y+APE + ++ D + G VL E+L G P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 63/228 (27%)
Query: 386 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLHHR---- 436
++G+G FG+V K VA+K + + +K F E+ +L L +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 437 --NLVKLVGYYSSRDSSQHLLC----------YELVPNGSLESWLHGPLGVNCHLDWETR 484
N++ ++ ++ R H+ C YEL+ + G + L R
Sbjct: 158 TMNVIHMLENFTFR---NHI-CMTFELLSMNLYELIKKNKFQ-------GFSLPL---VR 203
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNY 542
K A + L LH++ +IH D K NILL+ + KV DFG + + Y
Sbjct: 204 -KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 543 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 584
+ +R F Y APE Y M D++S G +L ELLTG
Sbjct: 260 IQSR----F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 60/234 (25%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+NFE +LG+G FG+V K G A+K L K+ ++ +VE
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVL-------KKDVILQDDDVECTMT 72
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 483
+ +H L +L + + L E V G L H+
Sbjct: 73 EKRILSLARNHPFLTQL---FCCFQTPDRLFFVMEFVNGGDLMF----------HIQKSR 119
Query: 484 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535
R AR L +LH+ +I+RD K N+LL++ H K+ADFG+ K
Sbjct: 120 RFD--EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-- 172
Query: 536 PEGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
EG N ++T GT Y+APE + + D ++ GV+L E+L G P
Sbjct: 173 -EGICNGVTTATFCGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 3e-13
Identities = 43/254 (16%), Positives = 69/254 (27%), Gaps = 66/254 (25%)
Query: 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--------QQGDKEFLVEVEM 429
T + +GEG FG VF+ + D T VAIK + G Q+ +E L E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 430 LSRLH---------HRNLVKLVGYY----------------------------SSRDSSQ 452
L + L + Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 512
+ E G + L T I LA + HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 513 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP--EYAMTGHLLVKSDV 570
N+LL+ K+ K + + + G +Y ++ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 571 YSYGVVLLELLTGR 584
+ + +L TG
Sbjct: 239 FCDVSMDEDLFTGD 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 47/225 (20%), Positives = 72/225 (32%), Gaps = 77/225 (34%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLV 442
+LG G G+V + A+K L EVE+ R ++V++V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 443 GYY--SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDA 491
Y L+ E + G L +I +A
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREA 119
Query: 492 AR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTN 541
+ + YLH + + HRD K N+L + N K+ DFG AK+
Sbjct: 120 SEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------- 169
Query: 542 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586
G Y D++S GV++ LL G P
Sbjct: 170 -----TTGE-KYDK-----------SCDMWSLGVIMYILLCGYPP 197
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 56/232 (24%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F+ ++G G + +V K A+K + KE + +++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVV-------KKELVNDDEDIDWVQT 58
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+H LV L + + S+ E V G L + H+ + +
Sbjct: 59 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDL---MF-------HMQRQRK 106
Query: 485 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536
+ + AR L YLHE +I+RD K N+LL++ H K+ D+G+ K
Sbjct: 107 LP--EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--- 158
Query: 537 EGRTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
EG +T GT Y+APE + G S D ++ GV++ E++ GR P
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 65/248 (26%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVE 426
+E LG+G +G V+K + G VA+K++ F E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFRE 58
Query: 427 VEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
+ +L+ L H N+V L+ + + L ++ +E+ LH + R
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVI----------RA 103
Query: 486 KIALDA---------ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---K 533
I + + YLH ++HRD K SNILL H KVADFGL+
Sbjct: 104 NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS-------DVYSYGVV 576
N + T + + +T + +L+ S D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 577 LLELLTGR 584
L E+L G+
Sbjct: 221 LGEILCGK 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 380 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 428
+F+ ++G G + +V K A++ + KE + +++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVV-------KKELVNDDEDIDWVQT 101
Query: 429 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
+H LV L + + S+ E V G L + E
Sbjct: 102 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEH 154
Query: 485 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 543
+ + + + L YLHE +I+RD K N+LL++ H K+ D+G+ K EG
Sbjct: 155 ARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD 208
Query: 544 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 586
+T GT Y+APE + G S D ++ GV++ E++ GR P
Sbjct: 209 TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 75/251 (29%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 431
N F +G+G FGRV + + A+K + T + +E ++L
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA----KIEADILK 86
Query: 432 RL-----HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWET 483
++ ++ N+VK G + D H+ L +E + SL + + G +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYD---HMCLIFEPL-GPSLYEIITRNNYNGFHIED---I 139
Query: 484 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA------------------- 524
+ ++ + L YL + S + H D K NILL++ +
Sbjct: 140 K-LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 525 ------KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYS 572
K+ DFG A + + ++TR Y APE + + SD++S
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWS 244
Query: 573 YGVVLLELLTG 583
+G VL EL TG
Sbjct: 245 FGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 71/247 (28%)
Query: 379 TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK------RLTCGGQQGDKEFLVEVEML 430
+E LGEG FG+V + + + VA+K + + +E+ +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR---EAA----RLEINVL 70
Query: 431 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 481
++ + V + +++ H+ + +EL+ + +L +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFH---GHMCIAFELL-GKNTFEFLKENNFQPYPLPH-- 124
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 524
R +A L +LHE+ + H D K NIL N+
Sbjct: 125 -VR-HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 525 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 576
+VADFG A E T ++TR Y PE +A DV+S G +
Sbjct: 180 SIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCI 228
Query: 577 LLELLTG 583
L E G
Sbjct: 229 LFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 71/247 (28%)
Query: 379 TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK--RLTCGGQQGDKEF----LVEVEML 430
+ +E LGEG FG+V + + + G VA+K + + E+++L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 431 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 481
L+ V+++ ++ H+ + +EL+ S ++ +G L
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHH---GHICIVFELL-GLSTYDFIKENGFLPFRLDH-- 119
Query: 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 524
R K+A + + +LH + + H D K NIL + +
Sbjct: 120 -IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 525 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 576
KV DFG A E + +STR Y APE ++ DV+S G +
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCI 223
Query: 577 LLELLTG 583
L+E G
Sbjct: 224 LIEYYLG 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 54/232 (23%), Positives = 86/232 (37%), Gaps = 49/232 (21%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
+++ +GEG FG +F+G L + VAIK Q E+ ++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YK 60
Query: 437 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIAL 489
L G YY ++ ++L +L+ G SLE L C +T A
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLED-----LLDLCGRKFSVKTVAMAAK 113
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK-----VADFGLAKQAPEGRTN--- 541
+ +HE S +++RD K N L+ V DFG+ K + T
Sbjct: 114 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
Query: 542 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
Y + + GT Y + HL + D+ + G V + L G P
Sbjct: 171 PYREKKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 42/235 (17%), Positives = 80/235 (34%), Gaps = 53/235 (22%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLV------ 439
+G+GGFG ++ ++ +V + E++ R +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 440 ---KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNC--HLDWETRM 485
K +G + S ++ L+ + +T +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-----IYEANAKRFSRKTVL 155
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTN 541
+++L L Y+HE +H D KASN+LL + + + D+GLA + +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY--LVDYGLAYRYCPEGVH 210
Query: 542 ----YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
R GT E+ + H V + D+ G +++ LTG P
Sbjct: 211 KAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 66/416 (15%), Positives = 128/416 (30%), Gaps = 95/416 (22%)
Query: 203 VSQIELINFYVLSLSQLNISMDITPH----TGISFSASDA-------SAINFS---LTTH 248
VS+++ +L +L + ++ +G ++ A D ++F L
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 249 KVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKG-KHSN 307
+ T++ + L + +P S++ +S+ + H +K ++
Sbjct: 191 NCNSPETVLEMLQKLLYQ-IDPNWTSRSDHSSNIKL--RIHSIQAELRRLLKSKPYENCL 247
Query: 308 LIL----------IFGIG-TGLLITAIISVLIICSCAFRGRKSKA------SPKET---- 346
L+L F + LL T V S A S +P E
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 347 AK---------PRTADAV------TLGGSLPHPTST----RFLAYEELKEAT----NNFE 383
K PR + S+ +T + + ++L N E
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 384 PASILGEGGFGRVFK--GVLSDGTAVAIKRLTCGGQQGDKEFLVEVE-MLSRLHHRNLVK 440
PA + ++F V + L+ K +V ++++LH +LV+
Sbjct: 368 PAE------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNKLHKYSLVE 418
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-----HLDWETRMKIALDAARG- 494
S + EL E LH + V+ D + + LD
Sbjct: 419 --KQPKESTISIPSIYLELKVKLENEYALHRSI-VDHYNIPKTFDSDDLIPPYLD---QY 472
Query: 495 ----LAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEGRTNYLS 544
+ + H ++ + R + L+ F K+ A A N L
Sbjct: 473 FYSHIGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 65/402 (16%), Positives = 115/402 (28%), Gaps = 106/402 (26%)
Query: 373 EELKEATNNFEPASILGEG----GFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVE-- 426
+ K + E I+ G R+F +LS + +++ + + +FL+
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM-VQKFVEEVLRINYKFLMSPI 98
Query: 427 --------------VEMLSRLHHRNLVKLVGYYSSRDSS-----QHLLCYELVPNGSLES 467
+E RL++ N Y SR Q L EL P ++
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDN-QVFAKYNVSRLQPYLKLRQAL--LELRPAKNVL- 154
Query: 468 WLHGPLGVNCHLDWETRMK--IALDAARGLAYLHEDSQPCVIH-----RDFKASNIL--L 518
+ G LG K +ALD +Y + I +L L
Sbjct: 155 -IDGVLGSG---------KTWVALDVCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 519 ENNFHAKVADF---GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV 575
+ + ++ + R + + + + Y LLV +V +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL--KSKPYENC--LLVLLNVQNAKA 258
Query: 576 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDK---DRL------EELADPRLGGKYPK 626
++ + L+T R K D L D P
Sbjct: 259 W--------NAFNL----SCKILLT-----TRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 627 ED---FIRVCTIAAACVAPEANQR-PTMGEVVQSLKMVQRVIECQDPTLTSSN-NRANLR 681
E ++ + E P + L ++ I +D T N N
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNP------RRLSIIAESI--RDGLATWDNWKHVNCD 353
Query: 682 QSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLH 723
+ +T + SS+ P FD +VF H
Sbjct: 354 KLTTIIE----SSLNVLEPAEYRKMFDR-----LSVFPPSAH 386
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
N + +G G FG ++ G ++ G VAIK + Q +E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 493
+ + + + +++ EL+ G SLE L C +T + +A
Sbjct: 65 VGIPTI-RWCGAEGDYNVMVMELL--GPSLED-----LFNFCSRKFSLKTVLLLADQMIS 116
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 546
+ Y+H + IHRD K N L+ + DFGLAK+ + RT+ Y +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 547 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
+ GT YA + HL + + D+ S G VL+ G P
Sbjct: 174 NLTGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 55/232 (23%), Positives = 84/232 (36%), Gaps = 49/232 (21%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
NF +G G FG + G L VAIK + Q E+ ++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59
Query: 437 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNCH--LDWETRMKIAL 489
L G YY + + EL+ G SLE L C +T + IA+
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLED-----LFDLCDRTFSLKTVLMIAI 112
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKV--ADFGLAKQAPEGRTN--- 541
+ Y+H + +I+RD K N L+ N + DF LAK+ + T
Sbjct: 113 QLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
Query: 542 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
Y + + GT Y + HL + D+ + G + + L G P
Sbjct: 170 PYREHKSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 44/232 (18%), Positives = 81/232 (34%), Gaps = 50/232 (21%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV------- 439
+G GGFG ++ + A + Q + E++ R+ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 440 --KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNCH--LDWETRMK 486
+G Y S + +V L+ + T ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKIS------GQNGTFKKSTVLQ 155
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV--ADFGLAKQAPEGRTN--- 541
+ + L Y+HE+ +H D KA+N+LL +V AD+GL+ + +
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 542 -YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
+ GT E+ + H V +SDV G +L L G+ P
Sbjct: 213 QENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 50/277 (18%), Positives = 85/277 (30%), Gaps = 67/277 (24%)
Query: 358 GGSLPHPTSTRFLAY---EELKEAT-------NNFEPASILGEGGFGRVFKGV------- 400
G L E L T ++ S G +++
Sbjct: 10 GVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTC 69
Query: 401 --LSDGTAVAIK------RLTCGG---QQGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSR 448
++K RL Q+ K V L + +G+ +
Sbjct: 70 DSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ 129
Query: 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPC 505
D + L+ L SL+S L L + +++A L +LHE+
Sbjct: 130 DKYRFLVLPSLGR--SLQSALD-----VSPKHVLSERSVLQVACRLLDALEFLHENE--- 179
Query: 506 VIHRDFKASNILLENNFHAKV--ADFGLAKQ---------APEGRTNYLSTRVMGTFGYV 554
+H + A NI ++ ++V A +G A + EG + G
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE----GD---- 231
Query: 555 APEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
E+ M H +SD+ S G +L+ L G P
Sbjct: 232 -LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
N F +G G FG ++ G + VAIK + Q L E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGG 62
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 493
+ V + + ++L +L+ G SLE L C L +T + +A
Sbjct: 63 TGIPNV-RWFGVEGDYNVLVMDLL--GPSLED-----LFNFCSRKLSLKTVLMLADQMIN 114
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 546
+ ++H S +HRD K N L+ A + DFGLAK+ + T+ Y +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 547 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 586
+ GT YA + HL + + D+ S G VL+ L G P
Sbjct: 172 NLTGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 56/302 (18%), Positives = 91/302 (30%), Gaps = 87/302 (28%)
Query: 388 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446
LG G F V+ + VA+K + + L E+ +L + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102
Query: 447 SRDSSQHLL-CYELV-PNGSLESWLHGPLGVN----------CHLDWETRMKIALDAARG 494
LL +++ NG+ + LG + L KI +G
Sbjct: 103 VV----QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 495 LAYLHEDSQPCVIHRDFKASNILLE----------------------------------- 519
L YLH + +IH D K NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 520 --------------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 565
K+AD G A + T + TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 566 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 625
+D++S + EL TG + RD+D + + + L GK P
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEY----------TRDEDHIALIIE--LLGKVP 319
Query: 626 KE 627
++
Sbjct: 320 RK 321
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 726 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.67 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.36 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.87 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.21 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.96 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=464.29 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=207.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|. +....
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT--EGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEE
Confidence 57888899999999999999864 47889999998766556678999999999999999999999997 44589
Q ss_pred EEEEeecCCCChhhhccCCCC-----------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 454 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~-----------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+||||||++|+|.++|+.... ....++|.++++|+.|||+||+|||+.+ |+||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 999999999999999975321 1246999999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 601 (726)
++||+|||+++...........+...||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~ 272 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDC 272 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999997765544444456789999999999999999999999999999999999 8999974321 111111
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
+. ... ....|.....++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 273 ---i~-~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ---IT-QGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HH-HTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HH-cCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 110 1123334445689999999999999999999999999988763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=461.90 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=215.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|. +...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCE
Confidence 367889999999999999999864 47789999998766556678999999999999999999999997 4458
Q ss_pred eEEEEeecCCCChhhhccCCC---------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc
Q 004869 453 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 523 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~---------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~ 523 (726)
.+||||||++|+|.++|+... .....++|.++++|+.||++||+|||+++ |+||||||+||||++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 999999999999999997421 22346999999999999999999999998 999999999999999999
Q ss_pred EEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 004869 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 524 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~ 602 (726)
+||+|||+|+...............||+.|||||++.+..++.|+|||||||+||||+| |+.||..... ..+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~-- 241 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE-- 241 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH--
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--
Confidence 99999999987655443333445679999999999999999999999999999999999 8999975321 11111
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+.. .. ....|.....++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 242 -~i~~-~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 -CITQ-GR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -HHHH-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHc-CC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 10 1123344455689999999999999999999999999888664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=457.15 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=211.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++|||||+++|+|. +...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT--KDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE--ECCE
Confidence 45677899999999999999973 467899999975433 33578999999999999999999999997 4457
Q ss_pred eEEEEeecCCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC
Q 004869 453 HLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~ 520 (726)
.+||||||++|+|.++|+... .....++|.++++|+.|||+||+|||+.+ |+||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence 899999999999999996432 11346999999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 004869 521 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 599 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 599 (726)
++++||+|||+++...........+...||++|||||++.++.++.++|||||||+||||+| |+.||..... ..+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 99999999999987654443334456789999999999999999999999999999999998 8999974321 1111
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+ ..+ .....+.+....+.+|+.+||+.||++||||+||+++|+.+
T Consensus 258 ~~i----~~~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMI----RNR----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH----HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH----HcC----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 111 11123445556789999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=450.85 Aligned_cols=263 Identities=28% Similarity=0.469 Sum_probs=205.6
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.++||+|+||+||+|++++ .||||+++.... ...+.|.+|+++|++++|||||+++|+|.. ...+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEE
Confidence 4578889999999999999999753 599999875432 234679999999999999999999999852 368999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||||++|+|.++|+.. ...++|.++++|+.|||+||+|||+.+ |+||||||+||||++++++||+|||+|+...
T Consensus 110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999753 346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
............||+.|||||++.+ +.|+.|+|||||||+||||+||+.||...... ..+.. .+..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~----~~~~----- 252 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIF----MVGR----- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHH----HHHT-----
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHH----HHhc-----
Confidence 5443334456789999999999864 46899999999999999999999999743321 11111 1111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
....+.+ ...+.+....+.+|+.+||+.||++||||.||+++|+.++..+
T Consensus 253 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 253 GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111111 1223334456889999999999999999999999999887543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=451.13 Aligned_cols=272 Identities=25% Similarity=0.383 Sum_probs=219.2
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCC-chhHHHHHHHHHHhccc-CceeEEEEE
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHH-RNLVKLVGY 444 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~H-pNIV~llg~ 444 (726)
.+.+...++|++.+.||+|+||+||+|++.+ ++.||||++...... ..++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556889999999999999999998642 357999999765433 34679999999999965 999999999
Q ss_pred eecCCCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 004869 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 512 (726)
Q Consensus 445 ~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIK 512 (726)
|.. +...++||||||++|+|.++|+.... ....++|..++.++.|||+||+|||+++ |+|||||
T Consensus 137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 863 23468999999999999999974321 1245899999999999999999999999 9999999
Q ss_pred ccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 004869 513 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 591 (726)
Q Consensus 513 p~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~ 591 (726)
|+||||++++.+||+|||+|+...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999997765544444556789999999999999999999999999999999998 999997533
Q ss_pred CCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 592 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.. .. +...+.++ .....|.....++.+++.+||+.||++|||+.||+++|+.+.+..
T Consensus 293 ~~--~~----~~~~i~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 293 ID--EE----FCRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CS--HH----HHHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH--HH----HHHHHHcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11 11 11111111 111233344456899999999999999999999999999887643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=437.23 Aligned_cols=273 Identities=23% Similarity=0.364 Sum_probs=203.4
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHH--HHHHHHHhcccCceeEEEEEeecCCC--CceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL--VEVEMLSRLHHRNLVKLVGYYSSRDS--SQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~--~Ei~iL~~L~HpNIV~llg~~~~~~~--~~~~L 455 (726)
++|.+.+.||+|+||+||+|++ +|+.||||++... ..+++. +|+..+.+++|||||+++|+|...+. ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4678889999999999999998 5799999999643 233444 45566678999999999999975443 35799
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-----CCCceeecCCCccceeecCCCcEEEEecC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-----~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
|||||++|+|.++|+. ..++|..+++++.|+++||+|||++ ..++|+||||||+||||++++++||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999974 3589999999999999999999987 23349999999999999999999999999
Q ss_pred ccccCCCCCcc--cccccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 531 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 531 la~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
+|+........ ......+||+.|||||++.+. .++.|+|||||||+||||+||+.|+........ ....+.
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~ 232 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLV 232 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTS
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhcc
Confidence 99876543322 122346799999999998754 467899999999999999999988753322111 000000
Q ss_pred hhhccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
............+.+..+....+ .+....+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00000001111222223322222 2455678999999999999999999999999998865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=439.20 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=209.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.. ...+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEe
Confidence 56999999999999999999975 689999999987666667789999999999999999999999884 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
||++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999963 35899999999999999999999999 999999999999999999999999999977543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+.. -..+
T Consensus 224 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~-------~~~~ 288 (346)
T 4fih_A 224 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRD-------NLPP 288 (346)
T ss_dssp SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-------SSCC
T ss_pred CC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-------CCCC
Confidence 32 234578999999999999999999999999999999999999999743211 11111110 0111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ .........+.+|+.+||+.||++|||++|+++|
T Consensus 289 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1122334568899999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=440.50 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=202.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|+++|++++|||||++++++.. ....|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence 68999999999999999999964 6899999999755332 34679999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
||||++|+|.++|.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 102 mEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999996422 335788899999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... ...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ..+....+....
T Consensus 177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~------- 241 (350)
T 4b9d_A 177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS------- 241 (350)
T ss_dssp HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC-------
T ss_pred CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-------
Confidence 321 12345689999999999999999999999999999999999999997432 111111121110
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
-+ ..+......+.+|+.+||+.||++|||++|++++-+
T Consensus 242 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 242 FP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 01 112233345889999999999999999999998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=430.54 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=207.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.+.|++.++||+|+||+||+|+.. +|+.||||+++.... +.+|+++|++++|||||++++++.. ....||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE--GPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 457888999999999999999964 689999999975322 3579999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 536 (726)
|||++|+|.++|+. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+...
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999974 346999999999999999999999999 99999999999999987 69999999999775
Q ss_pred CCCcc---cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTN---YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~---~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........ ...+........
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCCGGG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCCCch
Confidence 43211 122346799999999999999999999999999999999999999975432221 111111111110
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
..+......+.+++.+||+.||++|||+.|++++|....+...
T Consensus 277 ---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 ---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 1223334458899999999999999999999999988766543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=424.94 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=198.0
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecC--CCCceEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLLC 456 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--~~~~~~LV 456 (726)
|++.++||+|+||+||+|+.. +++.||||++..... ...+.|.+|+++|++++|||||+++++|... +...++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356788999999999999965 688999999964432 2346799999999999999999999998642 23468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~~ 535 (726)
||||++|+|.++|+. ...+++..+..++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999974 3468999999999999999999998863 4999999999999984 899999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ......+....
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~~------ 246 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGV------ 246 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTC------
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcCC------
Confidence 432 2345689999999998865 6999999999999999999999999643211 11111111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ...+.....++.+|+.+||+.||++|||++|+++|
T Consensus 247 -~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 -KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01111222357899999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=431.83 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=209.2
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++. +....||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 5799999999999999999996 46899999999643 2334567999999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.++|.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 110 vmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999974 346999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
............+||+.|||||++.+..|+.++||||+||+||||++|+.||.... .......+...
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~------- 249 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKL------- 249 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHT-------
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcC-------
Confidence 65444444556789999999999999999999999999999999999999997432 11111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. .++.....++.+|+.+||+.||++|||++|++.+
T Consensus 250 ---~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 250 ---EY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---CC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---CC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11 2233334568899999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=441.52 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=209.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.+.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.. ...+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEE
Confidence 357999999999999999999965 689999999987766677889999999999999999999999984 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
|||++|+|.++++. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 228 Ey~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999999963 35899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+. ....
T Consensus 300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-------~~~~ 364 (423)
T 4fie_A 300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-------DNLP 364 (423)
T ss_dssp SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-------HSCC
T ss_pred CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-------cCCC
Confidence 432 234578999999999999999999999999999999999999999743211 1111111 0011
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.+ .........+.+|+.+||+.||++|||+.|+++|
T Consensus 365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 1112233458899999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=412.29 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=191.2
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++. +....|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK--SKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEE
Confidence 5899999999999999999995 468999999997543 223467999999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 91 vmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999 6899999964 346999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... .....+||+.|||||++.+..+ +.++||||+||+||||++|+.||.... .......+....
T Consensus 163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~----- 228 (275)
T 3hyh_A 163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV----- 228 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-----
T ss_pred CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-----
Confidence 5432 2345689999999999998776 589999999999999999999997432 111111111110
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. .++......+.+|+.+||+.||++|||++|++++=+
T Consensus 229 ---~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 229 ---Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1 122233445889999999999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=421.90 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=196.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++|++++|||||++++++.. ....
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 57999999999999999999852 46899999997532 2233468899999999999999999999874 4589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
||||||+++|+|.++|.. ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 102 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999974 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+....+.+.
T Consensus 175 ~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~----- 241 (304)
T 3ubd_A 175 ESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKA----- 241 (304)
T ss_dssp C-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-----
T ss_pred eccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcC-----
Confidence 6544322 23456899999999999999999999999999999999999999974321 1111111111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
.. .++.....++.+|+.+||+.||++||| ++|+++|
T Consensus 242 -----~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 -----KL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -----CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -----CC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11 223333456889999999999999998 5677765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=410.09 Aligned_cols=251 Identities=26% Similarity=0.471 Sum_probs=188.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCC-------
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS------- 450 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~------- 450 (726)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999964 6899999999755433 24678999999999999999999999865432
Q ss_pred ---CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 451 ---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 451 ---~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
...|+||||+++|+|.++++.... ....++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 236899999999999999975322 234566778899999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCCcc----------cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 004869 528 DFGLAKQAPEGRTN----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597 (726)
Q Consensus 528 DFGla~~~~~~~~~----------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~ 597 (726)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence 99999876543221 11234579999999999999999999999999999999996 66421 11
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCCh---hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPK---EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~---e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .+..+.+ ..++. +....+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~----------~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVR----------TLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH----------HHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH----------HHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0111111 11221 222346789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=403.13 Aligned_cols=288 Identities=42% Similarity=0.705 Sum_probs=245.8
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCC
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 449 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~ 449 (726)
+.+.++...+++|+..+.||+|+||.||+|++.+|+.||||++........+.+.+|++++++++||||+++++++. +
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--E 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--C
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--C
Confidence 44455666789999999999999999999998889999999998776666788999999999999999999999987 4
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+++|+|.+++.........++|..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 55889999999999999999765444456999999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
|+++...............||..|+|||++.+..++.++|||||||++|||++|+.||....+........|...... .
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-N 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-T
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-c
Confidence 999876543333333456799999999999999999999999999999999999999987666655566666544332 2
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..+..+.++.+....+.+....+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 345566677776677888888999999999999999999999999999988764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.58 Aligned_cols=290 Identities=43% Similarity=0.730 Sum_probs=243.5
Q ss_pred CccccCHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEE
Q 004869 366 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY 444 (726)
Q Consensus 366 ~~~~~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~ 444 (726)
..+.+++.++....++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++|+||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34568899999999999999999999999999999888999999999755332 33479999999999999999999999
Q ss_pred eecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 445 ~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
+. +....++||||+++|+|.++++........++|..++.++.|++.||+|||+...++|+||||||+|||+++++.+
T Consensus 96 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 96 CM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EC--CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred Ee--cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 87 4457899999999999999998755555679999999999999999999999922239999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCccchhhhhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ--PSGQENLVTWA 602 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~--~~~~~~l~~~~ 602 (726)
||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||+... ......+..|.
T Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999999876543322 2344569999999999999999999999999999999999999996321 12233455666
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...... ..+..+.+..+...++.+....+.+++.+||+.||++|||+.||+++|+.
T Consensus 253 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 555443 45566777777778888889999999999999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=405.36 Aligned_cols=269 Identities=22% Similarity=0.342 Sum_probs=202.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecC----CCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----~~~~ 452 (726)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++... +...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 7999999999754332 235688999999999999999999987532 3457
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 789999975 346999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC--cccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh-----
Q 004869 533 KQAPEGR--TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP----- 604 (726)
Q Consensus 533 ~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~----- 604 (726)
+...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+.-...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764432 12234457899999999998875 569999999999999999999999975432211111000000
Q ss_pred hccc--hhhhhhhcCCc-cCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILRD--KDRLEELADPR-LGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~~--~~~l~~i~d~~-l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.. ........... .....+ .....++.+|+.+||+.||++|||+.|+++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000000000 000011 0122457899999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=397.35 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=170.2
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~ 451 (726)
...++|++.+.||+|+||+||+|+.+ .++.||||++... .....+.+|+++|.++ +|||||++++++.. ..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 45678999999999999999999853 4678999998643 3356788999999998 69999999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecC
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFG 530 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFG 530 (726)
..||||||+++|+|.++++ .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 8999999999999999985 3889999999999999999999999 9999999999999876 799999999
Q ss_pred ccccCCCCCcc--------------------------cccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhC
Q 004869 531 LAKQAPEGRTN--------------------------YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG 583 (726)
Q Consensus 531 la~~~~~~~~~--------------------------~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG 583 (726)
+|+........ ...+..+||+.|||||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432211 112335799999999999875 589999999999999999999
Q ss_pred CCCCCCC
Q 004869 584 RKPVDMS 590 (726)
Q Consensus 584 ~~Pf~~~ 590 (726)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=383.48 Aligned_cols=275 Identities=27% Similarity=0.370 Sum_probs=212.8
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCC--CCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD--SSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~--~~~~~LV 456 (726)
.++|++.+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999985 7899999996432 22345667899999999999999999987543 2347999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC----------CCCceeecCCCccceeecCCCcEEE
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED----------SQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~----------~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
|||+++|+|.++++. ..++|..++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999974 3489999999999999999999998 7 999999999999999999999
Q ss_pred EecCccccCCCCCcccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 601 (726)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987665443333344679999999999886 3566789999999999999999999975443322222111
Q ss_pred hhhhccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 602 ARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.............+.........+ ......+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111101111111111222221111 23456689999999999999999999999999998874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=412.96 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=207.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. +...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEE
Confidence 368999999999999999999964 68999999998665555677899999999999999999999987 456899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC--CcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~--~~vKL~DFGla~~~ 535 (726)
|||++|+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 234 E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999999642 245899999999999999999999999 9999999999999854 89999999999987
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+.....
T Consensus 308 ~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~----- 373 (573)
T 3uto_A 308 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW----- 373 (573)
T ss_dssp CTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC-----
T ss_pred cCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCC-----
Confidence 65432 34567999999999999999999999999999999999999999743211 11111111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.............+.+|+.+||+.||++|||+.|+++|
T Consensus 374 ---~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111223457899999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=368.73 Aligned_cols=284 Identities=36% Similarity=0.608 Sum_probs=230.9
Q ss_pred cccCHHHHHHHhcCcccc------eeeeecCcEEEEEEEECCCcEEEEEEcccCC----CCchhHHHHHHHHHHhcccCc
Q 004869 368 RFLAYEELKEATNNFEPA------SILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRN 437 (726)
Q Consensus 368 ~~~~~~el~~~t~~f~~~------~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpN 437 (726)
..|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 458999999999999877 8999999999999987 57899999986432 223467999999999999999
Q ss_pred eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 438 IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
|+++++++. +....++||||+++|+|.+++.... ....++|..++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 92 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSS--DGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEEC--SSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred eEEEEEEEe--cCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999987 4457899999999999999997422 2346899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~ 597 (726)
+++++.+||+|||+++...............||..|+|||.+.+ .++.++||||||+++|||++|+.||...... ..
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QL 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HH
Confidence 99999999999999987655433333445679999999998764 5889999999999999999999999754322 12
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+..+..........+....+..+ ...+......+.+++.+||+.||++|||+.||+++|+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22232222223334455555544 34566677889999999999999999999999999988743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=384.72 Aligned_cols=265 Identities=25% Similarity=0.403 Sum_probs=213.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|++.+.||+|+||.||+|+.. ++..||||+++..... ..+.+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468999999999999999999852 3567999999755322 245789999999999 8999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+....++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 44579999999999999999974321 1235899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--- 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999999987655443333344568899999999999999999999999999999999 9999974321
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
..+... +.. ......+......+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 312 ~~~~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 312 EELFKL----LKE----------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GGHHHH----HHT----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHH----Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111 000 11112233344568999999999999999999999999999877544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=370.73 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=215.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|.+.+.||+|+||+||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++.. ....++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEE
Confidence 357899999999999999999975 689999999876555566789999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++++.. ...++|.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp ECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999999742 345899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccc------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh
Q 004869 538 GRTNY------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605 (726)
Q Consensus 538 ~~~~~------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 605 (726)
..... ......||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------ 234 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence 32211 111457999999999999999999999999999999999999998654322211100
Q ss_pred ccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhcCC
Q 004869 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668 (726)
Q Consensus 606 ~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~~~ 668 (726)
......+......++ ..+.+++.+||+.||++|||+.|+++.|+.+...+....
T Consensus 235 -----~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 235 -----NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp -----CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred -----hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 011111111112233 347899999999999999999999999999988766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=369.19 Aligned_cols=275 Identities=27% Similarity=0.380 Sum_probs=211.3
Q ss_pred hcCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++...+....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999985 2588999999986655556789999999999999999999999875555578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999742 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch---
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--- 609 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--- 609 (726)
........ .......+|..|+|||++.+..++.++||||||+++|||++|..|+..... ....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCTHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCccccchhH
Confidence 76543321 122334578889999999999999999999999999999999998853210 0000000000000
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..+............+......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 011111111112223344456689999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.37 Aligned_cols=274 Identities=24% Similarity=0.397 Sum_probs=217.5
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEE
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKL 441 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~l 441 (726)
+...+.....++|++.+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34555566678999999999999999999984 24578999999754332 235799999999999 79999999
Q ss_pred EEEeecCCCCceEEEEeecCCCChhhhccCCCCC----------------------------------------------
Q 004869 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV---------------------------------------------- 475 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~---------------------------------------------- 475 (726)
++++... ....++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 92 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9998743 34589999999999999999754321
Q ss_pred ----------------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 476 ----------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 476 ----------------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999999 9999999999999999999999999998765544
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .+.. .+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~---------- 311 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKE---------- 311 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHH----------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHc----------
Confidence 3334455678999999999999999999999999999999998 999996543211 1111 1110
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
......+......+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 011112223344688999999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=409.60 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHH---HHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.++||+|+||+||+|+.. +|+.||||++.+.. ........+| +++++.++|||||++++++. +..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~~~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPD 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSS
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--ECC
Confidence 367999999999999999999965 68999999986431 2223334444 55666778999999999987 455
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
.+||||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|++||+|||+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccce
Confidence 89999999999999999974 346999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
|+...... ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||..........+ .....
T Consensus 339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~---- 407 (689)
T 3v5w_A 339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL---- 407 (689)
T ss_dssp CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHH----
T ss_pred eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhc----
Confidence 98775443 234689999999999975 5799999999999999999999999964332211111 11111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~L 657 (726)
... ..++.....++.+|+.+||+.||++|++ ++||++|-
T Consensus 408 ------~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 408 ------TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ------HCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ------CCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 111 1223333456889999999999999998 78888763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.20 Aligned_cols=263 Identities=29% Similarity=0.449 Sum_probs=203.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..++|++.+.||+|+||+||+|+. +|+.||||++....... .+.|.+|++++++++||||+++++++. +....++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--STTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCceEE
Confidence 457899999999999999999987 57889999997554332 357899999999999999999999987 4457899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+.+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999997522 22358999999999999999999998864 3999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~-------------~ 251 (309)
T 3p86_A 190 ASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAA-------------V 251 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH-------------H
T ss_pred ccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-------------H
Confidence 43321 233467999999999999999999999999999999999999999743211 11110 0
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.........+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000111122333445688999999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.37 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=208.1
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEE
Confidence 46899999999999999999995 5789999999986666667789999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999974 35889999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... ..
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~-------~~ 233 (297)
T 3fxz_A 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATN-------GT 233 (297)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHH-------CS
T ss_pred ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC-------CC
Confidence 332 23446799999999999999999999999999999999999999964321110 0000000 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+ ....+......+.+++.+||+.||++|||++|++++
T Consensus 234 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 111223344568899999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.70 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=208.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++. .+..||||+++.... ...+.|.+|++++++++||||+++++++.. ....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCcc
Confidence 467899999999999999999974 345699999975432 234679999999999999999999999874 4578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999999743 245899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCc-ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~---------- 266 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISS---------- 266 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHH----------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----------
Confidence 7754332 122334457889999999999999999999999999999999 9999964321 111110
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
+. .......+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 267 ---~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 267 ---VE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 00 0111122333445688999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=383.23 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|.+.+.||+|+||.||+|++. +++.||||.++..... ..+.|.+|+++|++++||||+++++++. +....++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--cCCCcEEE
Confidence 468899999999999999999986 6899999998754322 2357899999999999999999999987 44578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++++. ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999973 1345899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ...... +.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~----~~-------- 329 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREF----VE-------- 329 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHH----HH--------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HH--------
Confidence 4322111122346788999999999999999999999999999998 9999964321 111111 11
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.......+......+.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus 330 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 --KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1111122333445688999999999999999999999999988753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.36 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=211.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++. +....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCceEEEEE
Confidence 35789999999999999999999888999999997543 34578999999999999999999999987 4457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999753 235899999999999999999999999 999999999999999999999999999866443
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .... .+..
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~-------------~~~~ 222 (269)
T 4hcu_A 160 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE-------------DIST 222 (269)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH-------------HHHT
T ss_pred cc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH-------------HHhc
Confidence 21 12233457889999999999999999999999999999999 99999743211 1111 0100
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 -GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 01111222234468899999999999999999999999998865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=376.66 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=215.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|.+.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 468999999999999999999852 2357999999754332 236789999999999 8999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+....++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 44578999999999999999974321 1245899999999999999999999998 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|+++++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987765443333445668899999999999999999999999999999999 9999964321
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhcC
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 667 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~~ 667 (726)
..+.... . .......+......+.+++.+||+.||++|||+.||+++|+.+.......
T Consensus 300 ~~~~~~~----~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 300 EELFKLL----K----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHH----H----------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHH----H----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 1111111 1 11111222333456889999999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=366.43 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=215.9
Q ss_pred ccCHHHHHHHhcC----------cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc
Q 004869 369 FLAYEELKEATNN----------FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 437 (726)
Q Consensus 369 ~~~~~el~~~t~~----------f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN 437 (726)
.++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4788888888765 777889999999999999976 78999999998776666788999999999999999
Q ss_pred eeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 438 IV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
|+++++++.. ....++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||
T Consensus 104 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 104 VVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp BCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred cceEEEEEEE--CCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 9999999874 4589999999999999999874 35899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~ 597 (726)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~ 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---Q 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H
T ss_pred ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 99999999999999987654322 223467999999999999999999999999999999999999999643211 1
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.... +.....+.+ .........+.+++.+||+.||++|||+.|++++-+
T Consensus 249 ~~~~----------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 249 AMKR----------LRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHHH----------HHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHH----------HhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1111 111111111 111223345889999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.35 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=211.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--QDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cCC
Confidence 56899999999999999999985 2457899999975432 23467899999999999999999999987 445
Q ss_pred ceEEEEeecCCCChhhhccCCCC--------------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC
Q 004869 452 QHLLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 511 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~--------------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI 511 (726)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 78999999999999999975322 1234899999999999999999999999 999999
Q ss_pred CccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 004869 512 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS 590 (726)
Q Consensus 512 Kp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~ 590 (726)
||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987755443333344567899999999999999999999999999999999 99999754
Q ss_pred CCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 591 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 591 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
... .+.... . .......+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 257 ~~~---~~~~~~----~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 PPE---RLFNLL----K----------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CGG---GHHHHH----H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHHh----h----------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 321 111111 0 001112223334568899999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.75 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=204.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|++.+.||+|+||+||+|++. +++ .||+|.+.... ....+.|.+|++++++++||||++++++|.. ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---SS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---CC
Confidence 357999999999999999999964 344 46888886433 3445789999999999999999999999874 25
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++|+||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 78999999999999999742 245899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+...............+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----------- 230 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----------- 230 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH-----------
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH-----------
Confidence 87765444334445667889999999999999999999999999999999 999997543211 111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+........+......+.+++.+||+.||++||++.||+++|+.+.+.
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 231 ---ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111111122334455688999999999999999999999999988654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=355.40 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=210.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|+..++..||||++..... ..+++.+|++++.+++||||+++++++. +....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceEEEEE
Confidence 468999999999999999999998888999999975443 3577999999999999999999999986 4457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999642 345899999999999999999999999 999999999999999999999999999876554
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ... ..
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~----------~~ 220 (268)
T 3sxs_A 158 QYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVV---LKV----------SQ 220 (268)
T ss_dssp CEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---HHH----------HT
T ss_pred hhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHH---HHH----------Hc
Confidence 322 2233457788999999999899999999999999999999 99999643211 100 000 00
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
. .....+......+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 221 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 221 G-HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp T-CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred C-CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0 0011122223458899999999999999999999999988754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=370.37 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=211.1
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 376 KEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 376 ~~~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
....++|++.+.||+|+||.||+|+.. +++.||||.++..... ..+.|.+|++++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--
Confidence 345688999999999999999999974 3478999999754332 2467999999999999999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCC--------------------cccCChhhhHHHHHHHHHHHHHHHhCCCCceee
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGV--------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 508 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~--------------------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvH 508 (726)
+....++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 445889999999999999999643211 146899999999999999999999999 999
Q ss_pred cCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 004869 509 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV 587 (726)
Q Consensus 509 rDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf 587 (726)
|||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986643322222334568999999999999999999999999999999999 99999
Q ss_pred CCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 588 DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 588 ~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..... ..+.. .+.+... ...+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 278 ~~~~~---~~~~~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAH---EEVIY-------------YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCH---HHHHH-------------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCh---HHHHH-------------HHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 64321 11111 1111111 112333345688999999999999999999999999887543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=366.54 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=204.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+||+++++++. +....++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEEEE
Confidence 368999999999999999999975 789999999865432 23467899999999999999999999987 45588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999975 345899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
............||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|...
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----------- 224 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----------- 224 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT-----------
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc-----------
Confidence 4333333345679999999999987775 789999999999999999999997543221 111111110
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.............+.+++.+||+.||++|||+.|++++-
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 225 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000001122234578999999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=378.68 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=198.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++. ++..||||+++.... ...+.|.+|++++++++||||+++++++. +....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCce
Confidence 357899999999999999999864 567899999975432 23467999999999999999999999987 44588
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.++++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999753 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
........ .......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~---------- 262 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA---------- 262 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----------
Confidence 76543221 11223346788999999999999999999999999999998 9999964321 111111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
++.......+......+.+++.+||+.||++||++.||++.|+.+.+.
T Consensus 263 ----i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 263 ----VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 111111122333445689999999999999999999999999988764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=357.31 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=208.2
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|.+.++..||||++.... ...+++.+|++++.+++|+||+++++++. +....++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeEEEEe
Confidence 56899999999999999999999888899999997543 33578999999999999999999999987 4557899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999742 345899999999999999999999999 999999999999999999999999999866443
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .... .+..
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~-------------~~~~ 236 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE-------------HIAQ 236 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH-------------HHHT
T ss_pred cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHH-------------HHhc
Confidence 21 11223457889999999999999999999999999999998 99999743311 1110 0110
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 237 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 237 -GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11111222233468899999999999999999999999998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=379.54 Aligned_cols=266 Identities=27% Similarity=0.417 Sum_probs=210.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++. +..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCC
Confidence 467999999999999999999953 46789999997442 233457899999999999999999999987 445
Q ss_pred ceEEEEeecCCCChhhhccCCC---CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC---cEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK 525 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~---~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~---~vK 525 (726)
..++||||+++|+|.+++.... .....+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 7899999999999999996422 12245899999999999999999999999 99999999999999554 599
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~--- 298 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF--- 298 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH---
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---
Confidence 999999985533222222344568999999999999999999999999999999998 9999964321 111111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
+.. ......+......+.+|+.+||+.||++|||+.||+++|+.+.+..+.
T Consensus 299 ----------i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 299 ----------VTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ----------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----------HHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 000 011112233344688999999999999999999999999998775544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=367.93 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=210.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
..++|++.+.||+|+||.||+|+. .++..||||.+.... ....+.+.+|++++.++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 457899999999999999999996 245689999997542 23456799999999999 89999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCCC-------------------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecC
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGV-------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 510 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~-------------------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrD 510 (726)
....++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 45789999999999999999753221 134899999999999999999999999 99999
Q ss_pred CCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 004869 511 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM 589 (726)
Q Consensus 511 IKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~ 589 (726)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433333445668899999999999999999999999999999998 9999975
Q ss_pred CCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 590 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 590 ~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.... ..+... + ........+......+.+++.+||+.||++|||+.||+++|+.+...
T Consensus 278 ~~~~--~~~~~~----~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVD--ANFYKL----I----------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCS--HHHHHH----H----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcH--HHHHHH----H----------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 4321 111111 1 11111122333345688999999999999999999999999887553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.61 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHh--cccCceeEEEEEeecC--CCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSR--DSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~~~~~--~~~~~~ 454 (726)
.++|++.+.||+|+||+||+|++ +|+.||||++.. ...+.+..|.+++.. ++||||+++++++... .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 688999999863 345667778888777 7999999999986532 234689
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHH--------hCCCCceeecCCCccceeecCCCcEEE
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH--------~~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
+||||+++|+|.++++. ..+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999963 35899999999999999999999 666 999999999999999999999
Q ss_pred EecCccccCCCCCccc--ccccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 004869 527 ADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG----------RKPVD 588 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELltG----------~~Pf~ 588 (726)
+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654433211 12334799999999999876 456799999999999999999 77775
Q ss_pred CCCCCccchhhhhhhhhccchhhhhhhcCCccC-CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 589 MSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 589 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
........ ...... ..... ...+.+. ...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-FEDMRK-VVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-HHHHHH-HHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-hhhhhH-HHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43322211 111000 00000 0001110 011234567799999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=366.53 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=206.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcE----EEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTA----VAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++|+||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCc
Confidence 357999999999999999999964 4443 8888875433 333467889999999999999999999985 346
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence 89999999999999999752 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+...............||..|+|||++.+..++.++|||||||++|||++ |+.||....... +..... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~-- 233 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLE----KG-- 233 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHH----TT--
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHH----cC--
Confidence 98765544444456678899999999999999999999999999999999 999997543221 111110 00
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.....+......+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 234 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 --------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111122223477899999999999999999999999887553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=361.43 Aligned_cols=265 Identities=26% Similarity=0.416 Sum_probs=212.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
..++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346899999999999999999985 2467899999975433 2346799999999999 99999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCC--------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccc
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 515 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~--------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~N 515 (726)
....++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 4578999999999999999974321 1225899999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 004869 516 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG 594 (726)
Q Consensus 516 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~ 594 (726)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987765543333345568889999999999999999999999999999999 999996543211
Q ss_pred cchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 595 ~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..... .. . ......+......+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 256 --~~~~~----~~------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 --KFYKM----IK------E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --HHHHH----HH------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHH----hc------c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111 10 0 111111223344688999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.23 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=196.7
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC----CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|++. |+.||||++..... ...+.+.+|++++++++||||+++++++. +....+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--CC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCceE
Confidence 368999999999999999999985 78999999875432 22467899999999999999999999987 445789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC--------CCcEEE
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--------NFHAKV 526 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--------~~~vKL 526 (726)
+||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++. ++.+||
T Consensus 83 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999999963 35899999999999999999999988555889999999999986 778999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
+|||+++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-------- 222 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V-------- 222 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H--------
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H--------
Confidence 99999986544322 24569999999999999999999999999999999999999996432110 0
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.............+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111111112223333445689999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=358.52 Aligned_cols=273 Identities=21% Similarity=0.297 Sum_probs=213.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999975 48999999997533 2335678899999999999999999999886666688999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee----cCCCcEEEEecCcc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 532 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL----d~~~~vKL~DFGla 532 (726)
|||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999975321 223899999999999999999999999 9999999999999 88889999999999
Q ss_pred ccCCCCCcccccccccccccccCccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAM--------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
+....... .....||..|+|||++. +..++.++|||||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYK 238 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Confidence 87655432 23456999999999886 57889999999999999999999999964332211 1111111
Q ss_pred hccchh--hhh---hh------c--CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 605 ILRDKD--RLE---EL------A--DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 605 ~~~~~~--~l~---~i------~--d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
+..... ... .. . +-.............+.+++.+||+.||++|||++|++++....
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111000 000 00 0 00111234556677889999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.63 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--------------------------chhHHHHHHHHHH
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--------------------------GDKEFLVEVEMLS 431 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--------------------------~~~~f~~Ei~iL~ 431 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999964 6889999998754311 1356899999999
Q ss_pred hcccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC
Q 004869 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 511 (726)
Q Consensus 432 ~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI 511 (726)
+++||||+++++++........++||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986556689999999999999987652 46899999999999999999999999 999999
Q ss_pred CccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCC
Q 004869 512 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 512 Kp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654322 233457999999999987655 4788999999999999999999996
Q ss_pred CCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 589 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 589 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... ...+...+.. ..............+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 242 DER------IMCLHSKIKS----------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CSS------HHHHHHHHHH----------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred Ccc------HHHHHHHHhc----------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 432 1111111110 0010011112234588999999999999999999998763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.74 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|++. ++.||||++...... ..+.|.+|++++++++||||+++++++...+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999985 788999999765322 34579999999999999999999999986655788999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++++... ...+++..++.++.|+++||+|||+.+. .|+||||||+|||+++++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999998532 2358999999999999999999998763 49999999999999999999999999876432
Q ss_pred CCCcccccccccccccccCccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~---ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||....... .. .
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~----------~ 221 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IG----------M 221 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HH----------H
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HH----------H
Confidence 2 2346899999999998765544 8999999999999999999996432110 00 1
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+.........+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111112223334456889999999999999999999999998874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.73 Aligned_cols=278 Identities=30% Similarity=0.412 Sum_probs=216.7
Q ss_pred CcccceeeeecCcEEEEEEEEC-----CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.|++.+.||+|+||+||++.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3489999999999999998753 578999999985532 2346789999999999999999999999876567889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999974 24899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 535 APEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 535 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... .......+|..|+|||++.+..++.++||||||+++|||++|+.||...... ......+..... ....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQM-TVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHH-HHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccch-hHHHHH
Confidence 7654322 1233456888999999999999999999999999999999999998632100 000000100000 011122
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhcCC
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~~~ 668 (726)
...+.......+......+.+++.+||+.||++|||+.|+++.|+.+.+....+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 2222333333344455678999999999999999999999999999988766543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=367.27 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=204.9
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..+|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++. +....++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE--TEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEE
Confidence 46899999999999999999997 5789999999975432 23457889999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999964 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... ......||+.|+|||++.+..+. .++|||||||++|||++|+.||.... .......+...
T Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~------ 229 (328)
T 3fe3_A 165 TVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRG------ 229 (328)
T ss_dssp SSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC------
T ss_pred CCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC------
Confidence 5433 23456799999999999988775 89999999999999999999997432 11111111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ..+......+.+++.+||+.||++|||++|++++
T Consensus 230 ----~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 ----KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1222334458899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=366.87 Aligned_cols=277 Identities=28% Similarity=0.379 Sum_probs=216.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++|+||+++++++...+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999984 3678999999986655556779999999999999999999999876666789
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999642 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh-hhccchhh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR-PILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~-~~~~~~~~ 611 (726)
........ .......||..|+|||++.+..++.++||||||+++|||++|+.||...... ....+.. ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGCERDVPALSR 252 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC----CCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhcccccccccHHH
Confidence 77544322 1233456888999999999999999999999999999999999998532110 0000000 00000011
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
+............+......+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22222222223334455567899999999999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=385.16 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=211.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
...++|++.+.||+|+||.||+|+++++..||||+++... ...+.|.+|+++|++++||||+++++++. ....++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEE
Confidence 3457899999999999999999999888999999998543 44678999999999999999999999985 3468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++|+.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999742 1235889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... .......+|..|+|||++....++.++|||||||+||||++ |+.||..... ..+... + ...
T Consensus 336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~---i-~~~------ 401 (454)
T 1qcf_A 336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA---L-ERG------ 401 (454)
T ss_dssp CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH---H-HHT------
T ss_pred CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHH---H-HcC------
Confidence 3221 11223457889999999999999999999999999999999 9999964321 111111 0 000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.....+......+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 402 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 ----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1111233344568999999999999999999999999887644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.98 Aligned_cols=274 Identities=24% Similarity=0.396 Sum_probs=217.0
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEE
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLV 442 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~ll 442 (726)
...+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444455678999999999999999999984 34688999999754332 345789999999999 799999999
Q ss_pred EEeecCCCCceEEEEeecCCCChhhhccCCCCC------------cccCChhhhHHHHHHHHHHHHHHHhCCCCceeecC
Q 004869 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 510 (726)
Q Consensus 443 g~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~------------~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrD 510 (726)
+++... ....++||||+++|+|.+++...... ...+++..++.++.|+++||.|||+.+ |+|||
T Consensus 98 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 98 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 998643 34689999999999999999764321 123889999999999999999999998 99999
Q ss_pred CCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 004869 511 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM 589 (726)
Q Consensus 511 IKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~ 589 (726)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655443333445678999999999999999999999999999999998 9999964
Q ss_pred CCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 590 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 590 ~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
..... .+.. .+... .. ...+......+.+++.+||+.||++|||+.||+++|+.+.+..
T Consensus 254 ~~~~~--~~~~----~~~~~------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDE--EFCR----RLKEG------TR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSH--HHHH----HHHHT------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhH--HHHH----HhccC------cc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 33211 1111 01000 00 1112223346889999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.99 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=196.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC-C---cEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~-g---~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
..++|++.+.||+|+||.||+|+... + ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999653 2 27999999754 233457899999999999999999999998743321
Q ss_pred ----ceEEEEeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 452 ----QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 452 ----~~~LV~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
..++||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 2389999999999999995321 11225899999999999999999999999 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN---- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----
Confidence 999999987655433323344567889999999999999999999999999999999 999997543211 111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.+.... ....+......+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 251 ---------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 ---------YLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ---------HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---------HHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 010000 11223334456899999999999999999999999999887643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.65 Aligned_cols=266 Identities=25% Similarity=0.397 Sum_probs=212.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|++.+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 478999999999999999999863 467899999975432 2345789999999999 8999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+....++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 44578999999999999999975332 1234899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999999987765433223344567889999999999999999999999999999999 9999964321
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
..+.... ... . ....+......+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 266 ~~~~~~~----~~~------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 EELFKLL----KEG------H----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHH----HHT------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHH----hcC------C----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111111 000 0 1112223344688999999999999999999999999998876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=356.37 Aligned_cols=269 Identities=24% Similarity=0.366 Sum_probs=205.8
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc--ccCceeEEEEEeecCCC
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL--HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~llg~~~~~~~ 450 (726)
.......++|++.+.||+|+||.||+|+.. |+.||||++.. .....+..|.+++..+ +|+||+++++++.....
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334445678999999999999999999985 89999999863 2345566677776655 89999999999875432
Q ss_pred --CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC--------CCCceeecCCCccceeecC
Q 004869 451 --SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--------SQPCVIHRDFKASNILLEN 520 (726)
Q Consensus 451 --~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~--------~~p~IvHrDIKp~NILLd~ 520 (726)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKK 177 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECT
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECC
Confidence 578999999999999999963 3589999999999999999999988 6 999999999999999
Q ss_pred CCcEEEEecCccccCCCCCccc--ccccccccccccCccccccCCCCcc------hhHHHHHHHHHHHHhC---------
Q 004869 521 NFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTGHLLVK------SDVYSYGVVLLELLTG--------- 583 (726)
Q Consensus 521 ~~~vKL~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~k------sDVwSfGvvL~ELltG--------- 583 (726)
++.+||+|||+++......... ......||+.|+|||++.+.....+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998665433211 1224579999999999987766654 9999999999999999
Q ss_pred -CCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 584 -RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 584 -~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
+.||......... ... ....+.........+ .+....+.+++.+||+.||++|||+.||+++|
T Consensus 258 ~~~p~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS-YED----------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCTTTTTSCSSCC-HHH----------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccHhhhcCCCCc-hhh----------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 5555432221111 000 001111112222222 25667799999999999999999999999999
Q ss_pred HHHHHhh
Q 004869 658 KMVQRVI 664 (726)
Q Consensus 658 ~~i~~~~ 664 (726)
+.+.+..
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 9987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.77 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=211.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..++|++.+.||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++|+||+++++++. ....++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEEEE
Confidence 346899999999999999999999888899999997543 34678999999999999999999999975 23689999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999742 1236899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+... +..
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~---~~~--------- 225 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQN---LER--------- 225 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH---HHT---------
T ss_pred cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHH---Hhc---------
Confidence 3321 2233457889999999998999999999999999999999 9999864321 111111 000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
......+......+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 226 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 226 --GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 00111222333468899999999999999999999999999876544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.32 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=209.4
Q ss_pred cCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999984 368899999997543 3345789999999999999999999999986655678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999532 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc--chh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR--DKD 610 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~~ 610 (726)
........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+.... ............ ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCcccccCHH
Confidence 77654322 22334568889999999999999999999999999999999998864211 000000000000 001
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+............+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111111222233444556899999999999999999999999998875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.82 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhccc--CceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~H--pNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||++...+++.||||++...... ..+.+.+|+++|.+++| +||+++++++. +....+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCEEE
Confidence 4679999999999999999999888999999998754332 23678999999999976 99999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||| +.+|+|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 86 lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999 568899999975 345899999999999999999999999 99999999999997 57899999999987
Q ss_pred CCCCCcccccccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~------ 226 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----Q------ 226 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----H------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----H------
Confidence 755443333445679999999999865 6789999999999999999999999964221 0
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...+..+.++.....++......+.+++.+||+.||++|||+.|++++.+.
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 227 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 112223333333334444444568899999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=377.26 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=207.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|.+. |+.||||.++... ..+.|.+|+++|++++||||+++++++... ....++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEE
Confidence 467899999999999999999985 6899999997543 457899999999999999999999998643 346899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.++++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999997421 234789999999999999999999999 999999999999999999999999999865332
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
. ....++..|+|||++.+..++.++|||||||+||||++ |+.||....... .... +..
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~--------- 401 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEK--------- 401 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHT---------
T ss_pred c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHc---------
Confidence 1 22367889999999999999999999999999999998 999997543211 1110 111
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11112233444568999999999999999999999999998865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.10 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEe
Confidence 357899999999999999999998889999999975543 35789999999999999999999999874 457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999742 235889999999999999999999999 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..... .+. .
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~---~i~----------~ 220 (267)
T 3t9t_A 158 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE---DIS----------T 220 (267)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---HHH----------T
T ss_pred cc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHH---HHh----------c
Confidence 11 11233457889999999999999999999999999999999 8999864321 11111 110 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
. .....+......+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 221 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 221 G-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp T-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0111122233468899999999999999999999999998865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=384.89 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=211.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|++.. +..||||.++... ...++|.+|+++|++++||||++++++|. +....++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCcEEEE
Confidence 35678999999999999999999864 7899999997543 34678999999999999999999999987 44578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++|+... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999997422 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... .......+|..|+|||++.+..++.++|||||||+||||++ |+.||...... .+...
T Consensus 370 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~-------------- 431 (495)
T 1opk_A 370 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL-------------- 431 (495)
T ss_dssp TCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH--------------
T ss_pred CCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------------
Confidence 4322 12233457789999999999999999999999999999999 99999753311 11111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
+........+......+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111111233344456889999999999999999999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=351.83 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=197.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|+... +..||+|++...... ..+.|.+|+.++++++||||+++++++. ....
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCcc
Confidence 4689999999999999999999643 457999998754322 3457899999999999999999999974 3468
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999999742 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----------- 229 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----------- 229 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH-----------
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH-----------
Confidence 7654322 12234567889999999999999999999999999999997 99999754321 11111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
+.... ....+......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 230 --i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 230 --IENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 10100 0112233345688999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=364.06 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=205.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|++++++++||||+++++++. +....+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE--eCCEEE
Confidence 368999999999999999999975 6899999999643 2334567899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999999964 345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+..
T Consensus 155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~------- 219 (337)
T 1o6l_A 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---RLFELILM------- 219 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHH-------
T ss_pred cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---H---HHHHHHHc-------
Confidence 433221 23456799999999999999999999999999999999999999964321 1 11111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
... .++......+.+++.+||+.||++|| +++||+++-
T Consensus 220 ---~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 220 ---EEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---CCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 111 12333345688999999999999999 899998873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.86 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=199.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCC------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS------ 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~------ 450 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999976 789999999975443 345679999999999999999999998864322
Q ss_pred -------------------------------------------------CceEEEEeecCCCChhhhccCCCCCcccCCh
Q 004869 451 -------------------------------------------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDW 481 (726)
Q Consensus 451 -------------------------------------------------~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~ 481 (726)
...++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 137999999999999999986432 344677
Q ss_pred hhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcc----------cccccccccc
Q 004869 482 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN----------YLSTRVMGTF 551 (726)
Q Consensus 482 ~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~----------~~~~~~~GT~ 551 (726)
..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999999 999999999999999999999999999877554211 1223457999
Q ss_pred cccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHH
Q 004869 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR 631 (726)
Q Consensus 552 ~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~ 631 (726)
.|+|||++.+..++.++|||||||++|||++|..|+.. .... ......... ..........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~----------~~~~~~~~~-~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRI----------ITDVRNLKF-PLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHH----------HHHHHTTCC-CHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHH----------HHHhhccCC-CcccccCChh
Confidence 99999999999999999999999999999998766421 0000 000111000 0001122345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 004869 632 VCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 632 l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.+++.+||+.||++|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7889999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=354.97 Aligned_cols=259 Identities=31% Similarity=0.463 Sum_probs=200.4
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||+|++. ++.||||++.. ....+.|.+|++++++++||||+++++++. + ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--N--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--CcEEEEEc
Confidence 57899999999999999999985 68899999963 234578999999999999999999999875 2 47999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-EEEEecCccccCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-AKVADFGLAKQAPEG 538 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~-vKL~DFGla~~~~~~ 538 (726)
+++|+|.++++... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997532 2234788999999999999999999932222999999999999988876 799999999765432
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.....||..|+|||++.+..++.++||||||+++|||++|+.||....... ....|. ... -..+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~--~~~-------~~~~ 223 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWA--VHN-------GTRP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHH--HHT-------TCCC
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHH--Hhc-------CCCC
Confidence 223469999999999999999999999999999999999999997433211 111111 000 0011
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
.........+.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11222334588999999999999999999999999998776543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=350.16 Aligned_cols=255 Identities=32% Similarity=0.555 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCch-------hHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~-------~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+. .+++.||||++........ +.+.+|++++++++|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 46899999999999999999997 4789999999975443222 678999999999999999999999853
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-----EE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AK 525 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~-----vK 525 (726)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+. +|+||||||+|||++.++. +|
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 -PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -TTEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -CCeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEE
Confidence 237999999999999988642 3468999999999999999999998863 3999999999999988776 99
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~---- 239 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-I---- 239 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-H----
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-H----
Confidence 9999999854332 23457999999999984 5567899999999999999999999997543221110 0
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
..+.........+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 240 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 ---------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111112223334445689999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.56 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +++.||+|.+....... .+.|.+|++++++++||||+++++++. +....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEE
Confidence 468999999999999999999964 68999999986543332 357899999999999999999999987 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999964 346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~---- 229 (294)
T 4eqm_A 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV---- 229 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC----
T ss_pred cccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC----
Confidence 654322 1233457999999999999999999999999999999999999999743211 11111111100
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ 661 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-Tm~EVl~~L~~i~ 661 (726)
+.............+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus 230 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 230 ---PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ---CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ---CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0000011122234588999999999999998 8999988877654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=379.16 Aligned_cols=258 Identities=30% Similarity=0.440 Sum_probs=205.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.. ...++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEe
Confidence 356789999999999999999999888889999998544 345789999999999999999999999863 4689999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999631 1235899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... .......+|..|+|||++.+..++.++|||||||+||||++ |+.||...... ..... + .
T Consensus 333 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~---i-~--------- 395 (452)
T 1fmk_A 333 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ---V-E--------- 395 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH---H-H---------
T ss_pred Cce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H-H---------
Confidence 321 12233457889999999999999999999999999999999 99999643211 11110 0 0
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.......+......+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 396 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 396 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011112233444568899999999999999999999999887654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.35 Aligned_cols=267 Identities=18% Similarity=0.210 Sum_probs=211.6
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++. +....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeEEE
Confidence 46799999999999999999995 578999999986432 345689999999999 7999999999987 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-----EEEEecCc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL 531 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~-----vKL~DFGl 531 (726)
|||+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 99999999742 235899999999999999999999998 999999999999987776 99999999
Q ss_pred cccCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 532 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 532 a~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--- 234 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 234 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH---
Confidence 9876543221 12345679999999999999999999999999999999999999997644332222111111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
.... ....+.+...++ ..+.+++.+||+.||++||++++|++.|+.+.+....
T Consensus 235 ~~~~---~~~~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 235 EKKQ---STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHH---HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhcc---CccHHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0000 000001111223 3588999999999999999999999999998775543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=358.21 Aligned_cols=276 Identities=24% Similarity=0.406 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHH--HHhcccCceeEEEEEeec---CCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGYYSS---RDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~i--L~~L~HpNIV~llg~~~~---~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++|+||+++++++.. .+....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 5799999999732 34455555555 445899999999986532 233457
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC---------CCCceeecCCCccceeecCCCcE
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------SQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~---------~~p~IvHrDIKp~NILLd~~~~v 524 (726)
++||||+++|+|.+++.. ...++..++.++.|+++||+|||+. + |+||||||+|||++.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 899999999999999964 2358899999999999999999998 7 9999999999999999999
Q ss_pred EEEecCccccCCCCCc------ccccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 525 KVADFGLAKQAPEGRT------NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 525 KL~DFGla~~~~~~~~------~~~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987653221 112234569999999999876 456789999999999999999987764332
Q ss_pred CCccc--hhhhhhhhhccchhhhhh-hcCCccCCCCC------hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 592 PSGQE--NLVTWARPILRDKDRLEE-LADPRLGGKYP------KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 592 ~~~~~--~l~~~~~~~~~~~~~l~~-i~d~~l~~~~~------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
..... .+....... .....+.. +.........+ ......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCC-chHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21111 000000000 00000111 11111111222 2345579999999999999999999999999999887
Q ss_pred hhhcC
Q 004869 663 VIECQ 667 (726)
Q Consensus 663 ~~~~~ 667 (726)
..+..
T Consensus 319 ~~~~~ 323 (336)
T 3g2f_A 319 IWERN 323 (336)
T ss_dssp CCCC-
T ss_pred HHHhc
Confidence 65543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=358.95 Aligned_cols=276 Identities=27% Similarity=0.392 Sum_probs=213.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE-----CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||++++ .+|+.||||++........+.+.+|++++++++|+||+++++++...+....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999984 3688999999987655556789999999999999999999999876555678
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999742 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc---h
Q 004869 534 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---K 609 (726)
Q Consensus 534 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~ 609 (726)
......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.... ............. .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~----~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP----AEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH----HHHHHHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH----HHHHHhhccccchhhhH
Confidence 775543221 1233457888999999999999999999999999999999999875211 0000000000000 0
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
..+.+..........+......+.+++.+||+.||++|||+.||++.|+.+.+.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111111111111223344456899999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.26 Aligned_cols=270 Identities=24% Similarity=0.399 Sum_probs=211.8
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHh--cccCceeEEEEEeecC
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSR 448 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~llg~~~~~ 448 (726)
.........++|++.+.||+|+||.||+|+. +|+.||||++.. ...+.+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 4444455667899999999999999999998 589999999963 345678899999988 7899999999998754
Q ss_pred CC--CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHH--------hCCCCceeecCCCccceee
Q 004869 449 DS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNILL 518 (726)
Q Consensus 449 ~~--~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH--------~~~~p~IvHrDIKp~NILL 518 (726)
+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 32 278999999999999999963 35899999999999999999999 667 9999999999999
Q ss_pred cCCCcEEEEecCccccCCCCCccc--ccccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhC-------
Q 004869 519 ENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG------- 583 (726)
Q Consensus 519 d~~~~vKL~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSfGvvL~ELltG------- 583 (726)
+.++.+||+|||+++......... ......||..|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998665433211 22345799999999998765 334789999999999999999
Q ss_pred ---CCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004869 584 ---RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655 (726)
Q Consensus 584 ---~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~ 655 (726)
+.||........ ....+.. .+....+....+ .+....+.+|+.+||+.||++|||+.||++
T Consensus 261 ~~~~~p~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SVEEMRK----------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCCCTTTTTSCSSC-CHHHHHH----------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCccccCcCcc-cHHHHHH----------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 677754332211 1111111 111112222222 355667999999999999999999999999
Q ss_pred HHHHHHHh
Q 004869 656 SLKMVQRV 663 (726)
Q Consensus 656 ~L~~i~~~ 663 (726)
+|+.+.+.
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99998763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.90 Aligned_cols=268 Identities=26% Similarity=0.387 Sum_probs=201.0
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
...++|.+.+.||+|+||.||+|++. ++..||||++...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999864 3458999999755332 23678999999999999999999999875433
Q ss_pred C---ceEEEEeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 451 S---QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 451 ~---~~~LV~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
. ..++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 2 4599999999999999984221 22356899999999999999999999998 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~-- 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYL-- 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH--
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHH--
Confidence 999999987654432222344567889999999999999999999999999999999 88898643321 111110
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
. .. .....+......+.+++.+||+.||++|||+.+++++|+.+.+.+
T Consensus 263 -~----------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 -L----------HG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -H----------TT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -H----------cC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 00 011122333456899999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.47 Aligned_cols=260 Identities=27% Similarity=0.477 Sum_probs=194.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+..+ .||||+++..... ..+.|.+|++++++++|+||+++++++. ....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence 4679999999999999999998743 5999999754332 2467999999999999999999999763 3468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999642 345899999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
............||..|+|||++. +..++.++||||||+++|||++|+.||...... ..+..... ..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~----~~---- 241 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVG----RG---- 241 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHH----HT----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhc----cc----
Confidence 433222334567999999999986 667889999999999999999999999643321 11111110 00
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
...+.+ ..........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 242 -~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 242 -SLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -ccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 001111 1112233456899999999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=357.81 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||+||+|+..+|+.||||++...... ..+.+.+|++++++++||||+++++++. +....++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCCEEEEE
Confidence 4789999999999999999999988999999999754322 2467899999999999999999999987 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99997 4888888642 235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD------- 608 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~------- 608 (726)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... ....
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~-~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFS-ILGTPNPREWP 245 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHH-HHCCCCTTTSG
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHH-HHCCCChHHhh
Confidence 3322 2234578999999999876 56899999999999999999999999754433211 11100 0000
Q ss_pred -hhhhhhhcCCccC--CCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 -KDRLEELADPRLG--GKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 -~~~l~~i~d~~l~--~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+....+.... ... ......++.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000 000 11122457899999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=359.87 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcE----EEEEEcccC-CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTA----VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~----VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|++.+.||+|+||.||+|+.. +++. ||+|.+... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---SS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---CC
Confidence 467999999999999999999964 4443 578877543 23446789999999999999999999999874 24
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 88999999999999999742 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+...............+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----------- 230 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----------- 230 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH-----------
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH-----------
Confidence 87755443333444567889999999999999999999999999999999 999997543211 111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+........+......+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 231 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ---ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111122333445688999999999999999999999999988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=361.10 Aligned_cols=267 Identities=27% Similarity=0.405 Sum_probs=211.2
Q ss_pred HHhcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
...++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-- 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 346789999999999999999999642 24799999975433 2346789999999999 8999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC----------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 518 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~----------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL 518 (726)
+....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 44578999999999999999963210 1235789999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccch
Q 004869 519 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 597 (726)
Q Consensus 519 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~ 597 (726)
+.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 9999999999999986654433223344567889999999999999999999999999999998 999997433211 1
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
... .... ......+......+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 276 ~~~----~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 FYK----LVKD----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHH----HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH----HHhc----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 111 1110 0111112223346889999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.27 Aligned_cols=265 Identities=18% Similarity=0.203 Sum_probs=210.3
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||.+.... ..+.+.+|+++++++ +|+||+++++++.. ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence 46899999999999999999995 578999999987543 245689999999999 99999999999874 4578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-----EEEEecCc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL 531 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~-----vKL~DFGl 531 (726)
|||+ +|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999 99999999742 346999999999999999999999999 999999999999999887 99999999
Q ss_pred cccCCCCCccc-----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 532 AKQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 532 a~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~ 233 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ---KIG 233 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH---HHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH---HHH
Confidence 98764432211 1235679999999999999999999999999999999999999997654322211111 111
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
.... ......+...+ . .+.+++.+||+.||.+||++++|++.|+.+.+...
T Consensus 234 ~~~~---~~~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 234 DTKR---ATPIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHH---HSCHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhhc---cCCHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 0000 00000011111 2 68899999999999999999999999998876553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=348.66 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++.+ +..||||.+..... ...+.|.+|++++++++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence 4689999999999999999998643 34699999975432 235679999999999999999999999752 357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 8999999999999999642 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~--- 230 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKG--- 230 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHT---
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcC---
Confidence 7654322 12234567889999999999999999999999999999998 999996433211 11110 000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.. ...+......+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 231 ---~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 231 ---DR----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CC----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 00 1112223345889999999999999999999999999887643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=349.66 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=213.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|+.. ++..||+|.+... ....+.+.+|++++++++|+||+++++++. +....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEEEE
Confidence 4678999999999999999999976 4789999999743 334578999999999999999999999987 44578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999997422 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... .......+|..|+|||++.+..++.++||||||+++|||++ |..||...... ......
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~------------- 225 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL------------- 225 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH-------------
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------
Confidence 4332 22334567889999999999999999999999999999999 99998654311 111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
........+......+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 226 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 226 -EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111223333456889999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.53 Aligned_cols=263 Identities=26% Similarity=0.411 Sum_probs=211.5
Q ss_pred hcCcccce-eeeecCcEEEEEEEEC---CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~-~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|.+.+ .||+|+||.||+|.+. ++..||||++..... ...+.+.+|++++++++||||+++++++. ....
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCc
Confidence 35666766 9999999999999853 578899999986432 23467999999999999999999999984 2368
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence 9999999999999999642 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
........ .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~----~--- 228 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE----Q--- 228 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHH----T---
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHh----c---
Confidence 77543321 11233457899999999998899999999999999999998 9999965332 11111110 0
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhcC
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 667 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~~ 667 (726)
......+......+.+++.+||+.||++||++.|++++|+.+.......
T Consensus 229 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 229 -------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -------CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 0111223334456899999999999999999999999999988765543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.19 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=204.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|+++|++++||||+++++++. +..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--NRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE--eCC
Confidence 467999999999999999999975 6899999999754322 2467999999999999999999999987 455
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC----cEEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 527 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~ 527 (726)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 89999999999999999964 346899999999999999999999999 99999999999998776 79999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... .+ ...+..
T Consensus 162 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~---~~~i~~ 232 (361)
T 2yab_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANITA 232 (361)
T ss_dssp CCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHT
T ss_pred ecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh
Confidence 9999987655322 23457999999999999999999999999999999999999999643211 11 111111
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..... ++.. .......+.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 233 VSYDF----DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp TCCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cCCCC----Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000 0000 011224578999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=350.90 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=198.7
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.. ....++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEE
Confidence 57999999999999999999998899999999975432 224678999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp ECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 99975 999998742 245889999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-----hh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----DR 611 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-----~~ 611 (726)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..... ..... ..
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~ 227 (288)
T 1ob3_A 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTPNSKNWPN 227 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTSTT
T ss_pred ccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HHCCCChhhchh
Confidence 221 1234568999999999876 458999999999999999999999997533111 1111100 00000 00
Q ss_pred hhh--hcCCccC-------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEE--LADPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~--i~d~~l~-------~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+ ..++... ..........+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0011100 00111233457899999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.37 Aligned_cols=268 Identities=26% Similarity=0.426 Sum_probs=211.3
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEe
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYY 445 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~ 445 (726)
+++....++|++.+.||+|+||.||+|+.. +++.||||.+..... .....|.+|++++++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344456788999999999999999999864 367899999975432 2345689999999999999999999998
Q ss_pred ecCCCCceEEEEeecCCCChhhhccCCC------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec
Q 004869 446 SSRDSSQHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 519 (726)
Q Consensus 446 ~~~~~~~~~LV~Ey~~~GsL~d~L~~~~------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd 519 (726)
. +....++||||+++|+|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 98 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 98 S--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred c--cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 7 4457899999999999999996311 01135689999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 004869 520 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL 598 (726)
Q Consensus 520 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l 598 (726)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH
Confidence 999999999999986544332222334567899999999999999999999999999999999 8899864321 111
Q ss_pred hhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 599 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 599 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
... +..... ...+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 250 ~~~-------------~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRF-------------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHH-------------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 111111 11222334468899999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.01 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++. +..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence 356999999999999999999975 6899999999754322 3467999999999999999999999987 455
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC----cEEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 527 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~ 527 (726)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 89999999999999999964 346899999999999999999999999 99999999999999887 89999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+..
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~~~~ 231 (326)
T 2y0a_A 161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL---ANVSA 231 (326)
T ss_dssp CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHH
T ss_pred ECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH---HHHHh
Confidence 9999987654322 23457999999999999999999999999999999999999999643211 111 00000
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.. ..............+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 232 VN--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp TC--------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred cC--------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00 0000000011224578999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=364.73 Aligned_cols=275 Identities=17% Similarity=0.217 Sum_probs=208.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEECC------CcEEEEEEcccCCCCc-----------hhHHHHHHHHHHhcccCceeE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLVK 440 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~------g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV~ 440 (726)
..++|++.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 4789999987543111 112344555666778999999
Q ss_pred EEEEeecCCC--CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee
Q 004869 441 LVGYYSSRDS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 518 (726)
Q Consensus 441 llg~~~~~~~--~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL 518 (726)
+++++..... ...+|||||+ +|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 9999875322 4579999999 99999999742 246999999999999999999999998 9999999999999
Q ss_pred c--CCCcEEEEecCccccCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 519 E--NNFHAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 519 d--~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
+ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876432211 11133459999999999999999999999999999999999999997432
Q ss_pred CCccchhhhhhhhhccchhhhhhhcCCccC-CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhcC
Q 004869 592 PSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 667 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~~ 667 (726)
.. .....+..... ...+..+.++.+. ..++ ..+.+++.+||+.||++||++.+|++.|+.+.+.....
T Consensus 266 ~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 266 KD--PKYVRDSKIRY--RENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp TC--HHHHHHHHHHH--HHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cC--HHHHHHHHHHh--hhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11 12222111111 1223333333322 2223 35889999999999999999999999999987765443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.43 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=199.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999975 6899999999755432 23678999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999976 555555421 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-h---hh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-K---DR 611 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~---~~ 611 (726)
.... ......||..|+|||++.+.. ++.++|||||||++|||++|..||...... ...+.......... . ..
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTT
T ss_pred Cccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhh
Confidence 3322 234457899999999998765 799999999999999999998886432211 11111111000000 0 00
Q ss_pred hhhhcCC---------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADP---------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~---------~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+. .............+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 00011112334567899999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.28 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcc--cCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~--HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+++|.+++ |+||+++++++.. ....++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEE
Confidence 469999999999999999999888999999999754332 3467899999999996 5999999999874 447999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||| +.+|+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 568899999975 235888999999999999999999998 99999999999996 579999999999877
Q ss_pred CCCCcccccccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
.............||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------- 273 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 273 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----------
Confidence 54433333345679999999999865 46889999999999999999999999642210
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...+..+.++.....++......+.+++.+||+.||++|||+.|++++-+.
T Consensus 274 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 274 ----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp ----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ----HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 011222333333323333334568899999999999999999999988554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=366.75 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=200.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~ 452 (726)
..++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|.+++..+ +||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TPDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eCCE
Confidence 3578999999999999999999965 5899999998743 223345688999999988 6999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999964 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 172 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~------ 237 (353)
T 3txo_A 172 KEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAIL------ 237 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH------
T ss_pred eecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHH------
Confidence 86433221 23456799999999999999999999999999999999999999974321 11111111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm------~EVl~~ 656 (726)
.... .++......+.+++.+||+.||++||++ .|+++|
T Consensus 238 ----~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 ----NDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----HCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----cCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111 2233334568899999999999999998 788776
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=363.36 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC-----CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 457999999999999999999964 6899999998532 12245779999999999999999999999874 458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc---EEEEec
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADF 529 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~---vKL~DF 529 (726)
.++||||+++|+|.+++.........+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999888642222335899999999999999999999999 999999999999986654 999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+. ..+....
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~---~~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---EGIIKGK 248 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH---HHHHHTC
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH---HHHHcCC
Confidence 99987754322 2344579999999999999999999999999999999999999997421 1111 1111100
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. .++..... ....+.+++.+||+.||++|||+.|++++-+
T Consensus 249 ~~----~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 249 YK----MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CC----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CC----CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 00 00000011 2245789999999999999999999998744
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.00 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=205.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|++++++++||||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEE
Confidence 468999999999999999999975 58899999987432 334678899999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC--CCcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--~~~vKL~DFGla~~~ 535 (726)
||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999999642 235899999999999999999999999 999999999999987 789999999999877
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+.......
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~---~~~~i~~~~~~~--- 222 (321)
T 1tki_A 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---Q---IIENIMNAEYTF--- 222 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---H---HHHHHHHTCCCC---
T ss_pred CCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---H---HHHHHHcCCCCC---
Confidence 54432 24467999999999999888999999999999999999999999743211 1 111111110000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+.... ......+.+++.+||+.||++|||+.|++++-+.
T Consensus 223 -~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 223 -DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -Chhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 00000 1123458899999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.07 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=206.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeec---------
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--------- 447 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~--------- 447 (726)
...+|++.+.||+|+||.||+|+.. +|+.||+|++... .+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999976 7899999999743 2467899999999999999999998753
Q ss_pred -----CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 448 -----RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 448 -----~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
.+....++||||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 1133579999999999999999642 1346899999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+... ..+
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~- 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF- 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH-
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH-
Confidence 999999999987654332 23456999999999999999999999999999999999999876310 011
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
...+.+..+...++ ..+.+++.+||+.||++|||+.|++++|+.+.+..+
T Consensus 228 ---------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 ---------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HHHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------HHHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111222222233 347899999999999999999999999998865443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=356.08 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=192.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.++||+|+||+||+|+.. +|+.||||++...... ....+..|+..+.++ +|+||++++++|. +....+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEEE
Confidence 357999999999999999999976 7899999998654332 233566677666666 8999999999987 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+ +|+|.+++... ...++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 77999988642 245999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... ......||++|+|||++.+ .++.++|||||||++|||++|..++... ......
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~------------- 264 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQL------------- 264 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHH-------------
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHH-------------
Confidence 65432 2234569999999998875 7899999999999999999997766421 111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.........+......+.+++.+||+.||++|||+.|++++
T Consensus 265 -~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 -RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00000000111223458899999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.57 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||+++++++. +....
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECCEE
Confidence 468999999999999999999975 57899999997542 22345688999999887 8999999999987 45589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999974 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc--hhhhhhhhhccchhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~ 611 (726)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+.
T Consensus 202 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~--------- 270 (396)
T 4dc2_A 202 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------- 270 (396)
T ss_dssp CCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH---------
T ss_pred ecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH---------
Confidence 6432221 234568999999999999999999999999999999999999999643321111 111111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm------~EVl~~ 656 (726)
...+....+ .++......+.+|+.+||+.||++||++ .||+++
T Consensus 271 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 271 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111111111 2333344568899999999999999985 677765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.30 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=204.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 467999999999999999999975 68999999986443 2335678999999999999999999999874 4588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999974 345899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
............||..|+|||++.+..+ +.++||||||+++|||++|+.||....... ..+..|... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~~----- 226 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KT----- 226 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT----CT-----
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc----cc-----
Confidence 3332223345679999999999987765 789999999999999999999997543221 111111110 00
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...........+.+++.+||+.||++|||+.|++++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000111223457899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=385.59 Aligned_cols=258 Identities=30% Similarity=0.440 Sum_probs=210.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..++|++.+.||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|+||+++++++.. ...+|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEee
Confidence 456789999999999999999999888889999998544 345789999999999999999999999863 4689999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++|+.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 341 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999631 1235899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
... .......++..|+|||++....++.++|||||||+||||++ |+.||..... ..+... +..
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~----i~~-------- 479 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQ----VER-------- 479 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHH----HHT--------
T ss_pred Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHc--------
Confidence 211 11223457889999999999999999999999999999999 9999964321 111111 000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 480 --~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 480 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11112233444568899999999999999999999999887643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.51 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
.++|++.+.||+|+||.||+|++.. +..||||.+...... ....+.+|++++++++||||+++++++. +...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cCCC
Confidence 3567888999999999999998643 235999999754322 3457899999999999999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 89999999999999999742 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 533 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 533 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+........ .......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~---------- 261 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK---------- 261 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHH----------
Confidence 876543221 12233456889999999999999999999999999999999 9999964321 11111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
.+.+. .....+......+.+++.+||+.||++||++.|+++.|+.+.+..+
T Consensus 262 ---~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 262 ---AINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ---HHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---HHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11110 1111223334568899999999999999999999999998876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.28 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=203.9
Q ss_pred cCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.+|++.+.||+|+||.||+|++.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++.. +....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCceE
Confidence 468889999999999999998643 23689999875433 234678999999999999999999998754 345789
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999742 345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc--ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 535 APEGRT--NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 535 ~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
...... ........||+.|+|||.+.+..++.++||||||+++|||++ |..||....... .... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~--- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQG--- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTT---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcC---
Confidence 654321 112234567889999999999999999999999999999999 455554332111 1110 0000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
.....+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 249 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 --------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0011122223458899999999999999999999999999877543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.74 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=205.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|++++++++||||+++++++...+....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 6899999999754332 3457899999999999999999999886555668999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC--CCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~--~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743222345899999999999999999999876 2349999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... ..+... +
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~---i-------- 228 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGK---I-------- 228 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---H--------
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHH---H--------
Confidence 7654321 22345789999999999999999999999999999999999999974321 111110 1
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
..... ...+......+.+++.+||+.||++||++.||+++++
T Consensus 229 --~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 229 --REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp --HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --hhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00000 1122233446889999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.18 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=206.7
Q ss_pred HhcCcccce-eeeecCcEEEEEEEEC---CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 378 ATNNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 378 ~t~~f~~~~-~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
..++|.+.+ .||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++. ..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 346788888 9999999999999642 4688999999754322 2467999999999999999999999984 34
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 68999999999999999974 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccch
Q 004869 532 AKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 532 a~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~- 235 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAML----EK- 235 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----HT-
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----Hc-
Confidence 98765443221 1223456789999999999899999999999999999999 9999975321 1111111 00
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
......+......+.+++.+||+.||++||++.||++.|+.+.....
T Consensus 236 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 236 ---------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 01112233344568999999999999999999999999998876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=351.74 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=201.2
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-C-------cEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-G-------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-g-------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+... + ..||+|.+........+.+.+|++++++++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--G 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--T
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--C
Confidence 4679999999999999999998643 3 4799999976655666789999999999999999999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc-------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH------- 523 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~------- 523 (726)
...++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence 5789999999999999999742 234899999999999999999999999 999999999999998887
Q ss_pred -EEEEecCccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 004869 524 -AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 524 -vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 601 (726)
+||+|||++...... ....||..|+|||++.+ ..++.++|||||||++|||++|..|+...... ......
T Consensus 159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH
T ss_pred eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHH
Confidence 999999998754321 23468899999999987 77899999999999999999965554322111 000000
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
... ...+.... ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 231 ----~~~--------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 ----YED--------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ----HHT--------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ----hhc--------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 01111112 2247889999999999999999999999988754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=356.66 Aligned_cols=266 Identities=27% Similarity=0.412 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE------CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CC
Confidence 46899999999999999999984 246789999997442 2334678999999999999999999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCCC---CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAK 525 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~---~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vK 525 (726)
..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 78999999999999999975321 1245899999999999999999999999 999999999999984 45699
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~- 259 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT- 259 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH-
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHh-
Confidence 999999976543332223344568999999999999999999999999999999998 9999864321 11111110
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
.. .....+......+.+++.+||+.||++||++.||+++|+.+.+..+.
T Consensus 260 ------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 260 ------------SG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp ------------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ------------cC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 00 01112223344688999999999999999999999999998765443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.78 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=194.9
Q ss_pred hcCcccceeeeecCcEEEEEEEE----CCCcEEEEEEcccCC----CCchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++. +.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--TG 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--CS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--cC
Confidence 46799999999999999999997 478999999997542 223456889999999999999999999987 44
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 589999999999999999964 345889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~---- 234 (327)
T 3a62_A 167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKIL---- 234 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH----
T ss_pred cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH----
Confidence 9976433221 23345799999999999999999999999999999999999999974321 11111111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
.... ..+......+.+++.+||+.||++|| ++.|++++-
T Consensus 235 ------~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 235 ------KCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp ------HTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred ------hCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 1111 12233345688999999999999999 788988763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.51 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=205.5
Q ss_pred CcccceeeeecCcEEEEEEEECC-C---cEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~~-g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.|...++||+|+||.||+|++.+ + ..||+|.+..... ...+.|.+|++++++++||||+++++++...+ ...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence 46667999999999999998532 2 3799999875433 23467899999999999999999999986433 34589
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
+|||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 101 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999999752 345899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCc--ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 536 PEGRT--NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 536 ~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~---------- 242 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA---------- 242 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----------
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----------
Confidence 44221 1122345688999999999999999999999999999999996666532211 111111110
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
.......+......+.+++.+||+.||++|||+.|+++.|+.+.+.+..
T Consensus 243 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 243 ----QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0001112223334688999999999999999999999999998876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=374.29 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=209.0
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeec
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~ 447 (726)
+.++....++|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|++++..++|+||++++++|.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~- 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ- 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 4455566789999999999999999999976 4789999998642 1222345899999999999999999999987
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
+....+|||||+++|+|.++|... ...+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 145 -~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 -DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp -CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred -eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 455899999999999999999752 245899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...
T Consensus 218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~ 290 (437)
T 4aw2_A 218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETY 290 (437)
T ss_dssp CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH
T ss_pred chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHH
Confidence 9999987654332 2234467999999999987 567899999999999999999999999743211 111
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL 657 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~L 657 (726)
..++.... .+.-+..... ....+.+|+.+||..+|++ ||+++|++++-
T Consensus 291 ~~i~~~~~---~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 291 GKIMNHKE---RFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHHTHHH---HCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred Hhhhhccc---cccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 11111111 1111111111 2345789999999888888 99999999873
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=358.98 Aligned_cols=252 Identities=26% Similarity=0.330 Sum_probs=188.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|+||+++++++. +....++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE--TPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe--cCCeEEEE
Confidence 3568999999999999999999976 57899999997542 3467889999999999999999999987 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFGla~ 533 (726)
|||+++|+|.+++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999975 345899999999999999999999998 999999999999975 8899999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+. ..+.....
T Consensus 200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~---~~i~~~~~--- 268 (349)
T 2w4o_A 200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMF---RRILNCEY--- 268 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHH---HHHHTTCC---
T ss_pred ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHH---HHHHhCCC---
Confidence 664322 223467999999999999999999999999999999999999999643211 1011 11111000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
........+....+.+++.+||+.||++|||+.|++++
T Consensus 269 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 -----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112233468899999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.35 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=199.1
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++|+||+++++++.. ....+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 45799999999999999999996 4789999999975332 234578999999999999999999999874 45899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.........+++..++.++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998642222345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... +...+..... .
T Consensus 186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-------~ 252 (310)
T 2wqm_A 186 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-------Q 252 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHH-------T
T ss_pred ecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhh-------c
Confidence 644321 22345689999999999999999999999999999999999999964321 1111111110 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
...+.. ........+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 253 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 253 CDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 000111 112223458899999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=382.95 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=206.2
Q ss_pred cCcccce-eeeecCcEEEEEEEEC---CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~-~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.. ...+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeE
Confidence 4455555 8999999999999864 466899999986533 346789999999999999999999999863 3689
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 412 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999999999999743 345899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 535 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 535 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........ ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+...+ ..
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i----~~---- 554 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQ---- 554 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH----HT----
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----Hc----
Confidence 65433211 1223346789999999999999999999999999999998 99999754321 111111 11
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
......+......+.+|+.+||+.||++||++.+|++.|+.+......
T Consensus 555 ------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 555 ------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 111123334445689999999999999999999999999998765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=359.19 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=204.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
..++|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++. +....+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEE
Confidence 4568999999999999999999975 6899999999754332 3357889999999999999999999987 455889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC---CcEEEEecCc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGL 531 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~---~~vKL~DFGl 531 (726)
+||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999974 345899999999999999999999999 9999999999999765 4599999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .+.....
T Consensus 178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~---~i~~~~~- 247 (362)
T 2bdw_A 178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYA---QIKAGAY- 247 (362)
T ss_dssp CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCC-
T ss_pred ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHhCCC-
Confidence 987654322 2346799999999999999999999999999999999999999964321 11111 1110000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+ ............+.+++.+||+.||++|||+.|++++-+
T Consensus 248 -----~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 248 -----D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp -----C--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred -----C--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0 000000122345889999999999999999999988743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.10 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. +....+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE--eCCEEE
Confidence 367999999999999999999975 68999999986431 234567889999999999999999999987 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence 99999999999999974 245889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~-------- 216 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL-------- 216 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH--------
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH--------
Confidence 5432 2345799999999999999999999999999999999999999964321 11111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
.... .++......+.+++.+||+.||++|| +++||+++
T Consensus 217 --~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 217 --NAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --HCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --hCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111 12233344688999999999999999 89999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.57 Aligned_cols=262 Identities=25% Similarity=0.294 Sum_probs=200.2
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC-----CCCchhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
+....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-- 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence 4556778999999999999999999964 6889999998643 2344578999999999999999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------------------------------CcccCChhhhHHHHHHHH
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------------------------------VNCHLDWETRMKIALDAA 492 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------------------------------~~~~Ls~~~~~~ia~qIa 492 (726)
+....++||||+++|+|.+++..... ....+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 45589999999999999999852100 012346677889999999
Q ss_pred HHHHHHHhCCCCceeecCCCccceeecCCC--cEEEEecCccccCCCCC--cccccccccccccccCcccccc--CCCCc
Q 004869 493 RGLAYLHEDSQPCVIHRDFKASNILLENNF--HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMT--GHLLV 566 (726)
Q Consensus 493 ~gL~yLH~~~~p~IvHrDIKp~NILLd~~~--~vKL~DFGla~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~--~~~s~ 566 (726)
+||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999999 99999999999998766 89999999998653321 1112345679999999999875 67899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCC--CChhhHHHHHHHHHHccccCC
Q 004869 567 KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK--YPKEDFIRVCTIAAACVAPEA 644 (726)
Q Consensus 567 ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~--~~~e~~~~l~~Li~~CL~~dP 644 (726)
++|||||||++|||++|+.||...... .. ...+. ....... ........+.+++.+||+.||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~--~~----~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDA--DT----ISQVL----------NKKLCFENPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHH----------HCCCCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChH--HH----HHHHH----------hcccccCCcccccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999999643211 11 11111 1111000 011123468899999999999
Q ss_pred CCCCCHHHHHHHH
Q 004869 645 NQRPTMGEVVQSL 657 (726)
Q Consensus 645 ~~RPTm~EVl~~L 657 (726)
++|||+.|++++-
T Consensus 320 ~~Rps~~~~l~hp 332 (345)
T 3hko_A 320 DERFDAMRALQHP 332 (345)
T ss_dssp TTSCCHHHHHHSH
T ss_pred hHCCCHHHHhcCh
Confidence 9999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.46 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=199.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|... |+.||||.+... ...+.+.+|++++++++|+||+++++++.. +....++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCceEEEEe
Confidence 468999999999999999999885 789999999743 245789999999999999999999998753 3347899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999641 1224889999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... + .
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~---~-~---------- 228 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR---V-E---------- 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH---H-T----------
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H-h----------
Confidence 2 23357889999999999999999999999999999998 99999643211 11110 0 0
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.......+......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 011112223334568899999999999999999999999998865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.86 Aligned_cols=265 Identities=25% Similarity=0.321 Sum_probs=205.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC--CCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--~~~~~~L 455 (726)
.++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++... .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999996 57899999999765555567899999999999999999999998632 2347889
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999743233456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcc-------cccccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh
Q 004869 536 PEGRTN-------YLSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605 (726)
Q Consensus 536 ~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 605 (726)
...... .......||..|+|||++.+.. ++.++||||||+++|||++|+.||........ .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence 421110 0012345799999999987554 68899999999999999999999852110000 00000
Q ss_pred ccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 606 ~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
. ...............+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 260 ~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 V----------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp H----------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred h----------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 001111111223346889999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=352.15 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcE--EEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTA--VAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~--VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|+.. +|.. ||||.+.... ....+.+.+|++++.++ +||||+++++++.. ....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceE
Confidence 57999999999999999999964 5554 4999987432 33456799999999999 89999999999874 45899
Q ss_pred EEEeecCCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 455 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997543 22346899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 601 (726)
.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~- 252 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE- 252 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH-
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHH-
Confidence 99999999997543211 1233457889999999999899999999999999999998 99999643211 1111
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+. . ......+......+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 253 --~~~-~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 --KLP-Q----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp --HGG-G----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --Hhh-c----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 110 0 011122233345688999999999999999999999999987663
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.83 Aligned_cols=256 Identities=20% Similarity=0.265 Sum_probs=195.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++. +....++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe--eCCEEEEEE
Confidence 468999999999999999999975 78999999997543 33467899999999999999999999987 455899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc--EEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~--vKL~DFGla~~~ 535 (726)
||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999964 345899999999999999999999999 999999999999987765 999999999754
Q ss_pred CCCCcccccccccccccccCccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~k-sDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
.... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ...... .
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~----------~ 233 (361)
T 3uc3_A 169 VLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ----------R 233 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH----------H
T ss_pred cccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH----------H
Confidence 3222 2234579999999999988887655 8999999999999999999975432211 111111 1
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+................+.+|+.+||+.||++|||+.|++++-+.
T Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 111111111111223458899999999999999999999998554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.26 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=194.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCC--c
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS--Q 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~--~ 452 (726)
.++|++.+.||+|+||.||+|+. .+++.||||++....... .+.|.+|++++++++||||+++++++...+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 578999999997653332 34688999999999999999999998754322 3
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.++++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999964 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 876543221 1223456999999999999999999999999999999999999999643211 111111111000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... .... ....+.+++.+||+.||++||+..+++++
T Consensus 238 ~~~~----~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 PPSA----RHEG----LSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CHHH----HSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred Cccc----ccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 0011 23458899999999999999987776654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=363.32 Aligned_cols=275 Identities=21% Similarity=0.302 Sum_probs=214.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|.+.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999975 48999999997533 2335678899999999999999999999886666678999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee----cCCCcEEEEecCcc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 532 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL----d~~~~vKL~DFGla 532 (726)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975321 223899999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCcccccccccccccccCcccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
+...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 8765432 2234579999999998865 56788999999999999999999999643321111 111111
Q ss_pred hccchh--hh---hhhc--------CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 605 ILRDKD--RL---EELA--------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 605 ~~~~~~--~l---~~i~--------d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+..... .. .... +.......+......+.+++.+||+.||++||+++|+++.++.+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111000 00 0000 0011123445667788999999999999999999999999988765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.20 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=204.0
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 376 KEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 376 ~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
....++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++. +.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TK 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eC
Confidence 345679999999999999999999975 68999999997532 23456788899999987 8999999999987 45
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 589999999999999999964 345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+...
T Consensus 164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~---~~~i~~~-- 233 (345)
T 1xjd_A 164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EEL---FHSIRMD-- 233 (345)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHC--
T ss_pred hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHH---HHHHHhC--
Confidence 9986533221 23456799999999999999999999999999999999999999974321 111 1111110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 656 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~-EVl~~ 656 (726)
.. .++......+.+++.+||+.||++||++. ||+++
T Consensus 234 ------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 ------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 12223344688999999999999999998 77655
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.42 Aligned_cols=267 Identities=20% Similarity=0.294 Sum_probs=210.6
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++++++|++++..++++.. +....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEE
Confidence 57899999999999999999996 578999999987543 33578999999999999888777777653 445789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCcccc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 534 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~~ 534 (726)
||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 99999999632 235899999999999999999999999 9999999999999 5889999999999987
Q ss_pred CCCCCccc-----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh-hhhhhccc
Q 004869 535 APEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT-WARPILRD 608 (726)
Q Consensus 535 ~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~-~~~~~~~~ 608 (726)
........ ......||..|+|||++.+..++.++|||||||++|||++|+.||............. ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 65433211 1234679999999999999999999999999999999999999997644322222111 11100000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
. . +.+...++ ..+.+++.+||+.||++|||+.||++.|+.+......
T Consensus 238 ~--~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 P--I-----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp C--H-----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred c--h-----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 0 01112233 3588999999999999999999999999998775543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.16 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=207.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++++++|+|++..++++.. +....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEEE
Confidence 457899999999999999999996 578999999876433 23468899999999999888887777653 44578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~ 533 (726)
|||+ +|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999999732 235899999999999999999999999 9999999999999 789999999999998
Q ss_pred cCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh-hhhhcc
Q 004869 534 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW-ARPILR 607 (726)
Q Consensus 534 ~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~-~~~~~~ 607 (726)
........ .......||..|+|||++.+..++.++|||||||++|||++|+.||.............. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 76543321 122346799999999999999999999999999999999999999976443322221111 110000
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
. .. +.....++ ..+.+++.+||+.||++|||++||++.|+.+.+...
T Consensus 237 ~--~~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 237 T--PI-----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp S--CH-----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred c--hh-----hhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 00 00111223 358899999999999999999999999999877654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.76 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=197.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 68999999999999999999975 58999999986543322 3568899999999999999999999874 4588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999998864 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh-hh-------hcc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-RP-------ILR 607 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~-~~-------~~~ 607 (726)
.... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||............... .. ...
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 4322 2234578999999999876 67899999999999999999999999754322211111000 00 000
Q ss_pred chhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..........+......+ ......+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 1223457899999999999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=363.64 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=204.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ--DEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEEE
Confidence 67999999999999999999965 5889999998643 2334567899999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999975 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.....
T Consensus 166 ~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--------- 233 (384)
T 4fr4_A 166 PRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------- 233 (384)
T ss_dssp CTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---------
T ss_pred cCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---------
Confidence 5432 2345679999999999874 458999999999999999999999997544332222111110
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-m~EVl~~ 656 (726)
.. ...++......+.+|+.+||+.||++||+ +++|.++
T Consensus 234 ----~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 234 ----TT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----hc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 00 01223334456889999999999999998 7777654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=371.25 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=207.6
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
.++....++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++|||||++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 344456789999999999999999999975 5889999998642 1233456889999999999999999999987
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
+....++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 45589999999999999999963 34889999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~ 284 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSK 284 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHH
Confidence 999987654332 1234567999999999998665 78999999999999999999999974321 111111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 658 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~--RPTm~EVl~~L~ 658 (726)
+...... +..+. .......+.+|+.+||+.+|.+ ||+++||++|-+
T Consensus 285 i~~~~~~---~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 285 IMNHKNS---LTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHTHHHH---CCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred HHhcccc---ccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 1111110 00010 1122345889999999999988 999999998743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.56 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=205.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+..........+.+|+++|++++||||+++++++. +....++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE--eCCEEEEEE
Confidence 468999999999999999999975 68899999997655445567899999999999999999999987 456899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC--CCcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--~~~vKL~DFGla~~~ 535 (726)
||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999999742 235899999999999999999999999 999999999999974 578999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+....
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~---~~i~~~~------ 266 (387)
T 1kob_A 202 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETL---QNVKRCD------ 266 (387)
T ss_dssp CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH---HHHHHCC------
T ss_pred CCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCC------
Confidence 54322 2345799999999999999999999999999999999999999974321 1111 1111000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..............+.+++.+||+.||++|||+.|++++
T Consensus 267 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 --WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000111111223458899999999999999999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.80 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=189.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++. +....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEEE
Confidence 467999999999999999999964 689999999975533 33467899999999999999999999987 44589999
Q ss_pred EeecCCCChhhhccCCC--CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 457 YELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~--~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||++ |+|.+++.... .....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 69999885321 11235889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc------
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR------ 607 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~------ 607 (726)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ + ........
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--L-KLIFDIMGTPNESL 232 (317)
T ss_dssp TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCSCCTTT
T ss_pred cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCChhH
Confidence 653322 1234578999999999876 4689999999999999999999999975432111 1 00000000
Q ss_pred --c---------------hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 --D---------------KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 --~---------------~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ...+.....+..... ....+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000011111111111 22358899999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.78 Aligned_cols=255 Identities=21% Similarity=0.364 Sum_probs=202.8
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++.++ +||||+++++++. +....+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCCEEE
Confidence 57999999999999999999975 5889999999754322 234678899999988 8999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999964 345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc--hhhhhhhhhccchhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLVTWARPILRDKDRL 612 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~l 612 (726)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... .
T Consensus 160 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------~ 228 (345)
T 3a8x_A 160 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------F 228 (345)
T ss_dssp SCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH---------H
T ss_pred ccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH---------H
Confidence 433221 234567999999999999999999999999999999999999999643221110 001111 1
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm------~EVl~~ 656 (726)
..+..... .++......+.+++.+||+.||++||++ .|++++
T Consensus 229 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 229 QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11111111 2233344568899999999999999995 677765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.03 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=197.0
Q ss_pred CcccceeeeecCcEEEEEEEEC--CC--cEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~--~g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.|++.+.||+|+||.||+|++. ++ ..||||.+..... ...+.|.+|++++++++||||++++++|.. .....++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCCCeEE
Confidence 4677899999999999999863 22 4689999875432 335679999999999999999999998753 3347899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999752 235889999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCcc--cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 536 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 536 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...... .......+|..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .. ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~-~~-- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQ-GR-- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HT-TC--
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---Hc-CC--
Confidence 443211 11234567889999999999999999999999999999999 677776433221 11111 00 00
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 665 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~ 665 (726)
....+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001122233468899999999999999999999999999877544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=356.79 Aligned_cols=257 Identities=16% Similarity=0.167 Sum_probs=205.0
Q ss_pred HHhcCcccceeeeecCcEEEEEEE------ECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc---cCceeEEEEEeec
Q 004869 377 EATNNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSS 447 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~------l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~ 447 (726)
...++|.+.+.||+|+||+||+|+ ..+++.||||++.. ....++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 44688999999974 34567888999888886 9999999999874
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCC-CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC------
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN------ 520 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~-~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~------ 520 (726)
....++||||+++|+|.++++.... ....++|..++.++.|+++||+|||+.+ |+||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 4588999999999999999963211 2346999999999999999999999998 999999999999998
Q ss_pred -----CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 004869 521 -----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 595 (726)
Q Consensus 521 -----~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~ 595 (726)
++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999976543322333455679999999999999999999999999999999999999985321110
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHHh
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR-PTMGEVVQSLKMVQRV 663 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~R-PTm~EVl~~L~~i~~~ 663 (726)
| . ....+. .++ ....+.+++..|++.+|.+| |+++++.+.|+.+...
T Consensus 293 -----~---------~----~~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 -----C---------K----PEGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----E---------E----ECSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----e---------e----echhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 0 001111 111 13356789999999999999 6888888888876553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=357.85 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=204.2
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEEEE
Confidence 57999999999999999999975 68999999986432 234567899999999999999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 119 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999974 245899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~--------- 251 (350)
T 1rdq_E 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV--------- 251 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH---------
T ss_pred cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH---------
Confidence 432 2345799999999999999999999999999999999999999974321 11111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 657 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~L 657 (726)
.... .++......+.+++.+||+.||++||+ ++||+++-
T Consensus 252 -~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 252 -SGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -HCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -cCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 1111 123333456889999999999999998 89998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.33 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=191.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeec------CCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSS------RDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~------~~~ 450 (726)
..+|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.++. ||||+++++++.. .+.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999964 68999999997665555678999999999996 9999999999842 233
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+++|||+. |+|.+++.... ....+++..++.++.|++.||+|||+.+. +|+||||||+|||+++++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecCc
Confidence 45789999995 79999886311 13358999999999999999999998763 39999999999999999999999999
Q ss_pred ccccCCCCCccc----------ccccccccccccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 004869 531 LAKQAPEGRTNY----------LSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597 (726)
Q Consensus 531 la~~~~~~~~~~----------~~~~~~GT~~Y~APE~l---~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~ 597 (726)
+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765432211 11134689999999998 56678999999999999999999999996432110
Q ss_pred hhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 598 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
. .. ..............+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 261 ---~----~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 ---I----VN----------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---h----hc----------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 00 00000111111223778999999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=343.10 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=199.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCce
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~ 453 (726)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+..+.++ +||||+++++++.. ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 3567999999999999999999975 78999999997543 23356789999999999 99999999999874 4589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-------------
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN------------- 520 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~------------- 520 (726)
++||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999742222245899999999999999999999999 999999999999984
Q ss_pred ------CCcEEEEecCccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 004869 521 ------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 593 (726)
Q Consensus 521 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~ 593 (726)
...+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|||++|..++...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--- 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---
Confidence 4479999999998765432 23589999999999866 6678999999999999999998776421
Q ss_pred ccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 594 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... +..... ...+......+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~--------------~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 --DQWHE--------------IRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HHHHH--------------HHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --hHHHH--------------HHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111 111111 11222333468899999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.11 Aligned_cols=268 Identities=22% Similarity=0.342 Sum_probs=194.1
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCc
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~ 452 (726)
...++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.++. |+||+++++++...+...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999964 68999999986432 223456889999999997 999999999997666667
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 699999863 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC-------------------cccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 004869 533 KQAPEGR-------------------TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592 (726)
Q Consensus 533 ~~~~~~~-------------------~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~ 592 (726)
+...... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8654311 0112334679999999999886 6789999999999999999999999975432
Q ss_pred Cccchhhhhhhhhccc--hhhhhhhc------------------CCccCCCC------------ChhhHHHHHHHHHHcc
Q 004869 593 SGQENLVTWARPILRD--KDRLEELA------------------DPRLGGKY------------PKEDFIRVCTIAAACV 640 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~--~~~l~~i~------------------d~~l~~~~------------~~e~~~~l~~Li~~CL 640 (726)
..+. .... ..+.. ...+..+. .......+ .......+.+|+.+||
T Consensus 237 ~~~~--~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQL--ERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHH--HHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHHH--HHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 2111 1000 00000 00000000 00000000 0022345889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004869 641 APEANQRPTMGEVVQS 656 (726)
Q Consensus 641 ~~dP~~RPTm~EVl~~ 656 (726)
+.||++|||++|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=368.63 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=203.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++. +....+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEE
Confidence 457899999999999999999986 46899999999754322 2456899999999999999999999987 456899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec---CCCcEEEEecCc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL 531 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd---~~~~vKL~DFGl 531 (726)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999874 345899999999999999999999999 99999999999998 467899999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..+.....
T Consensus 160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~~~~- 230 (444)
T 3soa_A 160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLY---QQIKAGAY- 230 (444)
T ss_dssp CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHTCC-
T ss_pred eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHH---HHHHhCCC-
Confidence 987654332 22346799999999999999999999999999999999999999964321 1111 11111000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
+ ............+.+++.+||+.||++|||+.|++++-
T Consensus 231 -----~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 231 -----D--FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp -----C--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred -----C--CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 0 00000112234588999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=347.33 Aligned_cols=268 Identities=25% Similarity=0.306 Sum_probs=200.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-----CCchhHHHHHHHHHHhcc---cCceeEEEEEeecC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSR 448 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~ 448 (726)
..++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 568999999986432 122356788888888775 99999999998754
Q ss_pred CCC---ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 449 DSS---QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 449 ~~~---~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
... ..++||||+. |+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 322 4789999997 69999997532 234899999999999999999999999 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 605 (726)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.......
T Consensus 161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHH
T ss_pred EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 99999998765432 2345679999999999999999999999999999999999999997543211 111110000
Q ss_pred cc-------chhhhh-hhcCCccC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 606 LR-------DKDRLE-ELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 606 ~~-------~~~~l~-~i~d~~l~---~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
-. ....+. ....+... .....+....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 000000 00000000 00011223468899999999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.80 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=204.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++. +....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCeEEEE
Confidence 3467999999999999999999975 47789999998665666788999999999999999999999987 45589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~ 533 (726)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999864 345899999999999999999999999 9999999999999 788999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... .....||+.|+|||++.+. ++.++||||||+++|||++|+.||...... ..... +..
T Consensus 158 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~------ 221 (277)
T 3f3z_A 158 RFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLK----IRE------ 221 (277)
T ss_dssp ECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHH------
T ss_pred eccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHh------
Confidence 7654332 2345699999999987654 899999999999999999999999743211 10000 100
Q ss_pred hhcCCccCCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPK----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 614 ~i~d~~l~~~~~~----e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
... ..+. .....+.+++.+||+.||++|||+.|++++-+.
T Consensus 222 ----~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 222 ----GTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp ----CCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ----CCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 000 1111 123458899999999999999999999987443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=357.81 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=203.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~ 452 (726)
..++|++.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|.+++..+ +||||+++++++. +...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCCE
Confidence 3578999999999999999999976 4789999998743 223456788999999988 7999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999974 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~------ 234 (353)
T 2i0e_A 169 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM------ 234 (353)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH------
T ss_pred cccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH------
Confidence 86433221 23456799999999999999999999999999999999999999974321 11111111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
.... .++......+.+++.+||+.||++||+ ++||+++
T Consensus 235 ----~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 ----EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----HCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----hCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 223334456889999999999999995 5888776
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.38 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
..+|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 36899999999999999999996 57899999998642 12234578999999999999999999999874 45899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+ +|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999999 7899998864 345899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+....... ...+.
T Consensus 158 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~~~i~------- 221 (336)
T 3h4j_B 158 MTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------FKKVN------- 221 (336)
T ss_dssp TTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------BCCCC-------
T ss_pred ccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------HHHHH-------
Confidence 65432 2234579999999999988776 6899999999999999999999974321110 00000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.. ....+......+.+++.+||+.||.+|||++|++++-+.
T Consensus 222 ---~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 222 ---SC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp ---SS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred ---cC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 00 011222334458899999999999999999999988554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.99 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=195.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++.. ....+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 467999999999999999999964 6899999998743 33344678899999999999999999999874 45799
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+ |+||||||+||||+.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999999964 3468999999999999999999998 78 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. ....+..
T Consensus 298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~---~~~~i~~------ 363 (446)
T 4ejn_A 298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK---LFELILM------ 363 (446)
T ss_dssp TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---HHHHHHH------
T ss_pred eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HH---HHHHHHh------
Confidence 6443222 23456799999999999999999999999999999999999999964321 11 1111111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 657 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L 657 (726)
... .++......+.+++.+||+.||++|| +++|++++-
T Consensus 364 ----~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 364 ----EEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ----CCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 111 12333345688999999999999999 999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.06 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=196.7
Q ss_pred ccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeecC
Q 004869 383 EPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++. +....+|||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEEeCCC
Confidence 33678999999999999964 68999999998665555678999999999999999999999987 4458999999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee--cCCCcEEEEecCccccCCCCC
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL--d~~~~vKL~DFGla~~~~~~~ 539 (726)
+|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 170 GGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999998632 345899999999999999999999999 9999999999999 567899999999998765433
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. +....... ...
T Consensus 244 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~----i~~~~~~~----~~~ 310 (373)
T 2x4f_A 244 K---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNN----ILACRWDL----EDE 310 (373)
T ss_dssp B---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHHTCCCS----CSG
T ss_pred c---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhccCCC----Chh
Confidence 2 23346999999999999999999999999999999999999999743211 11111 11100000 000
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
. .......+.+++.+||+.||++|||+.|++++-+
T Consensus 311 ~----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 311 E----FQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp G----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred h----hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 0 0112345889999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=359.55 Aligned_cols=269 Identities=16% Similarity=0.225 Sum_probs=202.2
Q ss_pred hcCcccceeeeec--CcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEG--GFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G--~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+| +||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++.. ....
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 4579999999999 99999999976 6899999999754322 23568889999999999999999999874 4589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999997432 245899999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCc-----ccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 534 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 534 ~~~~~~~-----~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||........ +........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 254 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 254 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCC
Confidence 5432211 111223478999999999987 6789999999999999999999999975432211 111000000
Q ss_pred cc----h----hh-------------hhhhc---CC------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 RD----K----DR-------------LEELA---DP------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 ~~----~----~~-------------l~~i~---d~------~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. . .. +.... .+ ......+......+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0 00 00000 00 00001122233468899999999999999999999977
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.26 Aligned_cols=267 Identities=17% Similarity=0.209 Sum_probs=197.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCCCC-----------chhHHHHHHHHHHhcccCceeEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHRNLVKLVG 443 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpNIV~llg 443 (726)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+..++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5788999998754321 1234677888999999999999999
Q ss_pred Eeec--CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC
Q 004869 444 YYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 521 (726)
Q Consensus 444 ~~~~--~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~ 521 (726)
++.. .+....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9875 2255789999999 9999999974 236999999999999999999999998 9999999999999988
Q ss_pred C--cEEEEecCccccCCCCCc-----ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 004869 522 F--HAKVADFGLAKQAPEGRT-----NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 594 (726)
Q Consensus 522 ~--~vKL~DFGla~~~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~ 594 (726)
+ .+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643211 111234579999999999999999999999999999999999999996322111
Q ss_pred cchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 595 ~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
............ .+......... .......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 268 -~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 -VAVQTAKTNLLD---ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHHHHHHHHHHH---TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHHHHHHHhhcc---cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111110000 00000000000 002233588999999999999999999999988764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.78 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=197.8
Q ss_pred cCcccc-eeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~-~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV 456 (726)
+.|++. +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.. ....++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEE
Confidence 567774 7899999999999995 47899999999876656677899999999985 79999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc---EEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~---vKL~DFGla~ 533 (726)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999974 345899999999999999999999998 999999999999988766 9999999997
Q ss_pred cCCCCCc-----ccccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 534 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 534 ~~~~~~~-----~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6543211 111223469999999999875 567899999999999999999999997654322110000000
Q ss_pred hhccchhhhhhhcCCccCCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPK----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~----e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .......+..... ..+. .....+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 0000111111111 1111 123458899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=383.83 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred eeeeecCcEEEEEEEEC---CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
+.||+|+||.||+|.+. +++.||||+++.... ...++|.+|+++|++++|||||+++++|.. ...++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 57999999999999753 467899999975432 235789999999999999999999999862 3588999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 452 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 452 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999964 345899999999999999999999999 99999999999999999999999999987754432
Q ss_pred c-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 541 N-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
. .......+|..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.. .+..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~--------------~i~~ 587 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA--------------MLEK 587 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH--------------HHHT
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------HHHc
Confidence 2 12234457889999999999999999999999999999998 99999643211 1111 1111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
......+......+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111223334455689999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.39 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++. +..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--NRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCC
Confidence 457999999999999999999975 6899999999754322 2467999999999999999999999987 445
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC----cEEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 527 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~ 527 (726)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 89999999999999999975 345899999999999999999999999 99999999999999887 79999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+..
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~---~~~i~~ 232 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANITS 232 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHT
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHh
Confidence 9999987654322 23456999999999999999999999999999999999999999643211 11 111100
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... .++.. .......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSYD----FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCC----CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccc----cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000 01122357899999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.99 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=203.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++|+||+++++++. +....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEEE
Confidence 578999999999999999999965 589999999875432 23467889999999999999999999987 4557899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc---EEEEecCcc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLA 532 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~---vKL~DFGla 532 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 83 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999998864 345899999999999999999999999 999999999999976655 999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..... ......
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~---~~~~~~--- 223 (284)
T 3kk8_A 156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYA---QIKAGA--- 223 (284)
T ss_dssp EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTC---
T ss_pred EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHH---HHHhcc---
Confidence 87654332 2345799999999999999999999999999999999999999964321 11111 000000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ............+.+++.+||+.||++|||+.|++++-+
T Consensus 224 ---~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 224 ---YD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp ---CC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred ---cc--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 00 000001122345889999999999999999999998744
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.15 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=196.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|.+.+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++. +....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee--cCCeEEEE
Confidence 357999999999999999999964 68899999987543 334578999999999999999999999987 45589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~ 533 (726)
|||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998642222356899999999999999999999999 9999999999999 456889999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
...... ......||..|+|||++. +.++.++||||||+++|||++|+.||...... ..... ..
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~---~~------- 238 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQK---AT------- 238 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HH-------
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhh---hc-------
Confidence 665432 224457999999999875 56899999999999999999999999743211 11100 00
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+..... .......+.+++.+||+.||++|||+.||+++
T Consensus 239 -~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 239 -YKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -HCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111000 00122357899999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.98 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=197.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--CCc--EEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--DGT--AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--~g~--~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|++++++++|+||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 467999999999999999999853 233 68999987542 23346789999999999999999999998632
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++|+||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence 489999999999999999742 245899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccch
Q 004869 532 AKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 532 a~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+ ...+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---~~~~~--- 238 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQI---LHKID--- 238 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH---HHHHH---
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHH---HHHHH---
Confidence 98775543221 2234567889999999999899999999999999999999 9999964321 111 11111
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
........+......+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 239 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 239 -------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111222334568899999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.12 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=178.8
Q ss_pred ceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEEeecCC
Q 004869 385 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
.+.||+|+||.||+|+.. +|+.||||++.. .....+.+|++++.++. ||||+++++++. +....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEEEEEEccCC
Confidence 378999999999999975 689999999963 34567889999999997 999999999987 45588999999999
Q ss_pred CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC---cEEEEecCccccCCCCC
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQAPEGR 539 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~---~vKL~DFGla~~~~~~~ 539 (726)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999975 346899999999999999999999999 99999999999997665 89999999998665433
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +..+...
T Consensus 164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----------~~~i~~~ 231 (325)
T 3kn6_A 164 Q--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI----------MKKIKKG 231 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH----------HHHHTTT
T ss_pred C--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH----------HHHHHcC
Confidence 2 223457899999999999999999999999999999999999999754322111 11111 1111111
Q ss_pred ccCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~--~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... ........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11000 001223468899999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.18 Aligned_cols=258 Identities=24% Similarity=0.261 Sum_probs=195.3
Q ss_pred hcCcccc-eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeec--CCCCce
Q 004869 379 TNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS--RDSSQH 453 (726)
Q Consensus 379 t~~f~~~-~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~--~~~~~~ 453 (726)
.++|.+. ++||+|+||+||+++.. +|+.||||++.. ...+.+|++++.++ +|+||+++++++.. .+....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3467766 78999999999999965 689999999862 35678899988554 89999999998763 234568
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFG 530 (726)
+|||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999997522 345899999999999999999999998 999999999999997 7899999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~ 609 (726)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +...
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~- 282 (400)
T 1nxk_A 210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMG- 282 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHT-
T ss_pred cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcC-
Confidence 998765332 224567899999999999999999999999999999999999999754322111 01000 0000
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.. .............+.+|+.+||+.||++|||+.|++++-+..
T Consensus 283 ----~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 283 ----QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp ----CC---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ----cc---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00 000000112234588999999999999999999999986654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=340.50 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=183.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE--DSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE--CSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc--cCCeEE
Confidence 46799999999999999999996 478999999986432 223467899999999999999999999987 455889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999999999999752 246899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . .
T Consensus 162 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~----------~ 223 (278)
T 3cok_A 162 LKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------N----------K 223 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred ccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------H----------H
Confidence 6533221 22356899999999999989999999999999999999999999753321110 0 0
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+..... ..+......+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000000 1122233458899999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=355.11 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+.|+..+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|++++++++||||+++++++.. ....++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence 4589999999999999999996 578999999997554332 2568899999999999999999999874 458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+. |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 132 v~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 999997 6888887531 246899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+...
T Consensus 205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~---- 268 (348)
T 1u5q_A 205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN---- 268 (348)
T ss_dssp SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS----
T ss_pred CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc----
Confidence 432 2357999999999985 56789999999999999999999999964321 1111111111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..+.. .+......+.+++.+||+.||++|||++|++++.+.
T Consensus 269 ---~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 269 ---ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ---CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 01111 111223457899999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.68 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=177.0
Q ss_pred cCHHHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-----cCceeEEEE
Q 004869 370 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----HRNLVKLVG 443 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV~llg 443 (726)
+++.+.....++|++.++||+|+||.||+|+. .+++.||||++... ....+.+..|++++++++ |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444445578999999999999999999997 46889999999632 233456788999999986 999999999
Q ss_pred EeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---
Q 004869 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--- 520 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--- 520 (726)
++.. ....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~--~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 104 KFMY--YDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEE--TTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred eeeE--CCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9874 45899999999 999999997422 235899999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHH
Q 004869 521 ----------------------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 578 (726)
Q Consensus 521 ----------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ 578 (726)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998654322 3457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 004869 579 ELLTGRKPVDMS 590 (726)
Q Consensus 579 ELltG~~Pf~~~ 590 (726)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.15 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=207.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.+.|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence 457999999999999999999864 68999999997553 3345789999999999999999999999874 4588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecC
Confidence 999999999999963 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.||...... ..... +....
T Consensus 171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----------~~~~~ 235 (303)
T 3a7i_A 171 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----------IPKNN 235 (303)
T ss_dssp TTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----------HHHSC
T ss_pred cccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----------hhcCC
Confidence 4321 223457999999999999999999999999999999999999999643211 11110 00111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.+.+...+ ...+.+++.+||+.||++|||+.|++++.....
T Consensus 236 ~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 236 PPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCCCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred CCCCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 11222223 345889999999999999999999998866543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.57 Aligned_cols=259 Identities=19% Similarity=0.296 Sum_probs=202.5
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||+|+. .+++.||||++.. ...+.+.+|++++++++ |+||+++++++........++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999985 5789999999973 34678999999999997 99999999999865567889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 536 (726)
||+++++|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999985 3788999999999999999999999 99999999999999766 89999999998765
Q ss_pred CCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch------
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------ 609 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 609 (726)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..... .....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~-~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAK-VLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHH-HHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHH-hcCCchhhhHH
Confidence 4332 234578999999999877 678999999999999999999999995432211 11111100 00000
Q ss_pred --------hhhhhhcCCc--------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 --------DRLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 --------~~l~~i~d~~--------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+.... ............+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000110000 0011111234568999999999999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.60 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe--cCCEEE
Confidence 468999999999999999999865 57799999985421 223467899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999964 245899999999999999999999998 99999999999999999999999999865
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+ ..
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-------~~ 221 (279)
T 3fdn_A 159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRI-------SR 221 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-------HH
T ss_pred CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHH-------Hh
Confidence 54322 23457899999999999999999999999999999999999999743211 110000 00
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.....+......+.+++.+||+.||++|||+.|++++-+.
T Consensus 222 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 222 -----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp -----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred -----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 0112223334468899999999999999999999998554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.86 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=206.3
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEee
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 446 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~ 446 (726)
.++++....++|++.+.||+|+||+||+++.. +|+.||||++.... ....+.+.+|.+++.+++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999975 68999999996421 122346889999999999999999999987
Q ss_pred cCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEE
Q 004869 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
+....||||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||
T Consensus 132 --~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 132 --DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred --eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence 455899999999999999999642 235899999999999999999999999 999999999999999999999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 204 ~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------ 276 (412)
T 2vd5_A 204 ADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ 276 (412)
T ss_dssp CCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred eechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------
Confidence 99999987654332 1223467999999999987 357899999999999999999999999753211
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR---PTMGEVVQS 656 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~R---PTm~EVl~~ 656 (726)
.....+..... .+..+.....+ ...+.+++.+||+ +|++| |+++||++|
T Consensus 277 ~~~~~i~~~~~---~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 ETYGKIVHYKE---HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHHHTHHH---HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHHHhccc---CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111111110 11111111122 3458899999999 99998 699999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.05 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC----CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999986432 2345679999999999999999999999865566689
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++| |.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777765322 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
...............||..|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~----- 226 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIG----- 226 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHh-----
Confidence 765433332334557999999999987654 3789999999999999999999997432 111111111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
.... ..+......+.+++.+||+.||++|||+.|++++-+.
T Consensus 227 -----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 227 -----KGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -----HCCC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -----cCCC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 0000 1222333458899999999999999999999987443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.31 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC------chhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
++|++.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|++++++++||||+++++++. +...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE--NKTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec--CCCe
Confidence 57999999999999999999976 6899999998754321 3567999999999999999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC----cEEEEe
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVAD 528 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~D 528 (726)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999964 345899999999999999999999998 99999999999998877 899999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+...
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~ 226 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETL---TNISAV 226 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHTT
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHH---HHhHhc
Confidence 999987654322 23456999999999999999999999999999999999999999643211 110 000000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. ..............+.+++.+||+.||++|||+.|++++-
T Consensus 227 ~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 227 N--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp C--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred c--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 0 0000000011234578999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.88 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=202.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|.+.+.||+|+||.||+++.. +|+.||+|.+........+.+.+|++++++++||||+++++++. +....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE--STTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc--cCCEEEEE
Confidence 3467999999999999999999975 68999999998655545567999999999999999999999987 45588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 533 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~ 533 (726)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999864 345899999999999999999999998 9999999999999 788999999999997
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. ..+.....
T Consensus 158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~---~~i~~~~~--- 224 (304)
T 2jam_A 158 MEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLF---EKIKEGYY--- 224 (304)
T ss_dssp CCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHCCC---
T ss_pred ecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHcCCC---
Confidence 65432 22345699999999999999999999999999999999999999964321 1111 11111000
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.............+.+++.+||+.||++|||+.|++++-+
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 225 -----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred -----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0011111223346889999999999999999999998744
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.18 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=204.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++. +....+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH--DRKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE--cCCEEE
Confidence 367999999999999999999975 57889999986431 233467899999999999999999999987 445889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999999964 235899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... .....||..|+|||++.+..++.++||||||+++|||++|+.||...... .... .
T Consensus 164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~----------~ 223 (284)
T 2vgo_A 164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHR----------R 223 (284)
T ss_dssp CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH----------H
T ss_pred Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHH----------H
Confidence 54322 23456899999999999999999999999999999999999999743211 1111 1
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
+..... .++......+.+++.+||+.||++|||+.|++++-+.
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 224 IVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred Hhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 111111 1223334468899999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.48 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=193.0
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--------CCchhHHHHHHHHHHhcccCceeEEEEEeec
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--------QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~ 447 (726)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999964 57999999986431 112235889999999999999999999975
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC---CcE
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHA 524 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~---~~v 524 (726)
....++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 211 --~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 --AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp --SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred --cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 2358999999999999999875 346899999999999999999999998 9999999999999654 459
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 601 (726)
||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...
T Consensus 282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~ 356 (419)
T 3i6u_A 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ 356 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH
T ss_pred EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH
Confidence 999999998765432 234567999999999985 3678899999999999999999999997433211 11111
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
...... ..... . .......+.+++.+||+.||++|||+.|++++-
T Consensus 357 i~~~~~--~~~~~-----~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 357 ITSGKY--NFIPE-----V----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHTTCC--CCCHH-----H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HhcCCC--CCCch-----h----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 100000 00000 0 011234588999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=354.08 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=202.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~L 455 (726)
..++|++.+.||+|+||.||+++.. +|+.||||++..... .+.+|++++.++ +||||+++++++. +....++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEEE
Confidence 3567999999999999999999975 688999999975432 346789999888 7999999999987 4568999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC----CcEEEEecCc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAKVADFGL 531 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~----~~vKL~DFGl 531 (726)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+.++ +.+||+|||+
T Consensus 94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999975 345899999999999999999999999 9999999999998432 3599999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. ..+....
T Consensus 167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~~-- 239 (342)
T 2qr7_A 167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSGK-- 239 (342)
T ss_dssp CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHCC--
T ss_pred cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccCC--
Confidence 987654322 223457899999999998888999999999999999999999999753222111111 1111100
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..+...........+.+++.+||+.||++|||+.|++++-+.
T Consensus 240 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 240 ------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 011111122334468899999999999999999999998665
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=366.66 Aligned_cols=197 Identities=25% Similarity=0.388 Sum_probs=155.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecC---CCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~---~~~~ 452 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|+|||++++++... +...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999864 6899999999654322 346789999999999999999999998532 2357
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.|+||||+ +|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5799999975 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-------------------------cccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 004869 533 KQAPEGRTN-------------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTG 583 (726)
Q Consensus 533 ~~~~~~~~~-------------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELltG 583 (726)
+........ ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876432110 123446789999999976 466799999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.82 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEE
Confidence 367999999999999999999975 689999999975532 224678999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|||+++|+|.++++. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999974 33588999999999999999999985 7 999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh--------------
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW-------------- 601 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~-------------- 601 (726)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 321 12345799999999999999999999999999999999999999975332111000000
Q ss_pred --------hhh----hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 602 --------ARP----ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 602 --------~~~----~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
... .......+..+................+.+++.+||+.||++|||++|++++-+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 000 0000001111111111111111223468899999999999999999999988554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=353.25 Aligned_cols=269 Identities=15% Similarity=0.187 Sum_probs=207.3
Q ss_pred hcCcccceeeeecCcEEEEEEEECC---------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeE---------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK--------- 440 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~--------- 440 (726)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999753 789999998743 46889999999999999988
Q ss_pred ------EEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcc
Q 004869 441 ------LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 514 (726)
Q Consensus 441 ------llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~ 514 (726)
+++++.. +....++||||+ +|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 5666653 346889999999 99999999742 1356999999999999999999999998 999999999
Q ss_pred ceeecCCC--cEEEEecCccccCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 004869 515 NILLENNF--HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587 (726)
Q Consensus 515 NILLd~~~--~vKL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf 587 (726)
|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 9999999999866432211 1123457999999999999999999999999999999999999999
Q ss_pred CCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhc
Q 004869 588 DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 666 (726)
Q Consensus 588 ~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~~~ 666 (726)
....... ..+......... ....+.+.... .......+.+++.+||+.||++|||++||++.|+.+.+....
T Consensus 269 ~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 269 TNCLPNT-EDIMKQKQKFVD---KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGGTTCH-HHHHHHHHHHHH---SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCCcCH-HHHHHHHHhccC---Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 7543211 111111111110 00111111000 011234588999999999999999999999999998776543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=352.38 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=202.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--------chhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 457899999999999999999995 46889999999755321 2346788999999999999999999987
Q ss_pred CCCceEEEEeecCCC-ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 449 DSSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~G-sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
+....++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 455889999999877 99999975 335899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~- 236 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------T- 236 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------G-
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------H-
Confidence 9999987654432 234579999999999988776 8899999999999999999999963110 0
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... .. ..+......+.+++.+||+.||++|||+.|++++-
T Consensus 237 -----~~~----~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -----VEA----AI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -----TTT----CC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -----Hhh----cc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000 00 11111234588999999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.41 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=197.7
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
+|....+||+|+||.||+|+. .+++.||||.+........+.+.+|++++++++|+||+++++++.. ....++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEe
Confidence 445556999999999999996 4688999999987666666789999999999999999999999874 4588999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEecCccccCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~DFGla~~~~~~ 538 (726)
+++++|.+++....+ ...+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999975321 234678889999999999999999998 999999999999987 899999999999876543
Q ss_pred CcccccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.. ......||..|+|||++.+.. ++.++||||||+++|||++|+.||...... ....+.. .....
T Consensus 177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~--------~~~~~ 243 (295)
T 2clq_A 177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKV--------GMFKV 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHH--------HHHCC
T ss_pred CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhh--------ccccc
Confidence 21 223457899999999987653 789999999999999999999999632211 0000000 00001
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+ ..+......+.+++.+||+.||++||++.|++++
T Consensus 244 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 2233334568899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=366.53 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=204.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 93 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFM 93 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 57999999999999999999975 78999999986432 2234678999999999999999999999874 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999974 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.... ..... .
T Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~----------~ 227 (476)
T 2y94_A 167 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFK----------K 227 (476)
T ss_dssp CTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHH----------H
T ss_pred ccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHH----------H
Confidence 54322 234579999999999988765 6899999999999999999999974321 11111 1
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+.+... ..+......+.+++.+||+.||++|||+.|++++-+
T Consensus 228 i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 228 ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 111111 112223345889999999999999999999998744
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.94 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=198.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecC--CCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--~~~~~~ 454 (726)
+.|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++... +....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788899999999999999964 678999999875432 2346789999999999999999999987642 245689
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEEEEecCccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK 533 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~ 533 (726)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+. +|+||||||+|||++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999964 3458999999999999999999998863 499999999999997 78999999999997
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
...... .....||+.|+|||++. +.++.++||||||+++|||++|+.||...... ..........
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~----- 245 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG----- 245 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT-----
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhcc-----
Confidence 654332 23456999999999876 45899999999999999999999999643211 1111111100
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
......+......+.+++.+||+.||++|||+.|++++
T Consensus 246 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 -----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00001111222458899999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=342.19 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=187.2
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc-h-hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++....... . +.+.++...++.++||||+++++++. +....++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCCEEE
Confidence 46899999999999999999996 478999999997543221 2 23444555578889999999999987 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
||||++ |+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999997 588888753222345699999999999999999999998 8 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
...... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..+.
T Consensus 160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----------- 224 (290)
T 3fme_A 160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLK----------- 224 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHH-----------
T ss_pred cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHH-----------
Confidence 654322 2334699999999996 56678999999999999999999999996432111 0110
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..................+.+++.+||+.||++|||+.|++++-+.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 225 ---QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp ---HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ---HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 1111111111112233458899999999999999999999986443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.47 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE----CCCcEEEEEEcccCC----CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
.++|++.+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 36799999999999999999997 368999999986432 22345678899999999 69999999999874
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 4588999999999999999974 345899999999999999999999998 999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|+++....... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..........
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK 280 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc
Confidence 99986643322 12334679999999999985 3578999999999999999999999975432211 1111111111
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLKM 659 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~L~~ 659 (726)
. . ..++.+....+.+++.+||+.||++|| +++|++++...
T Consensus 281 ~--------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 281 S--------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp C--------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred c--------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 0 1 122333445688999999999999999 99999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.38 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=200.8
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.+.++....++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344445678999999999999999999997 468999999987543 3457899999999999 799999999998753
Q ss_pred C----CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 449 D----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 449 ~----~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
. ....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 2 457899999999999999997421 346889999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
||+|||++........ ......||..|+|||++. +..++.++|||||||++|||++|+.||....... .+.
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~ 244 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALF 244 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHH
Confidence 9999999986643221 123457999999999987 5678999999999999999999999996432110 000
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.... ...+.. ........+.+++.+||+.||++||++.|++++-
T Consensus 245 ----~~~~-------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 245 ----LIPR-------NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp ----HHHH-------SCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred ----Hhhc-------CccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 0000 001111 1112234588999999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.53 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec--cCCEEE
Confidence 367999999999999999999975 578999999865422 23457889999999999999999999987 445889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999999864 346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~--------- 227 (294)
T 2rku_A 165 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI--------- 227 (294)
T ss_dssp CCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH---------
T ss_pred cccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH---------
Confidence 653322 123457999999999999989999999999999999999999999743211 100001
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..... ..+......+.+++.+||+.||++|||++|++++-..
T Consensus 228 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 228 -KKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp -HTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -hhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 11110 1222333458899999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.13 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=194.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++|+||+++++++. +....++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe--eCCEEEEEe
Confidence 57999999999999999999975 68999999997543222 235668999999999999999999987 445789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp ECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 9997 5999988642 235889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc---------
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR--------- 607 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~--------- 607 (726)
... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTT
T ss_pred Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchh
Confidence 322 2234578999999999876 5689999999999999999999999975432211 111111000
Q ss_pred --chhhhhhhcCCccCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 608 --DKDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 608 --~~~~l~~i~d~~l~~~----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
..........+..... ........+.+++.+||+.||++|||++|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000001100000000 0011234578999999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=350.91 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=191.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
..++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.. ....+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 4578999999999999999999854 6899999999754332 23567899999999999999999999874 45899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee-----cCCCcEEEEec
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----ENNFHAKVADF 529 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL-----d~~~~vKL~DF 529 (726)
+||||++ |+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999997 599999974 235899999999999999999999999 9999999999999 45566999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc-
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR- 607 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~- 607 (726)
|+++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......-.
T Consensus 182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~ 257 (329)
T 3gbz_A 182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLP 257 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCC
T ss_pred CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCC
Confidence 99987643322 22345689999999999874 58999999999999999999999997543211 11111000000
Q ss_pred ch------hhhhhhcC--CccCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DK------DRLEELAD--PRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~------~~l~~i~d--~~l~~~-----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ........ +..... ........+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 00000000 000000 001123467899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.29 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=200.1
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcc--cCceeEEEEEeecCCC
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS 450 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~--HpNIV~llg~~~~~~~ 450 (726)
+....++|++.+.||+|+||.||+++..+++.||||++...... ..+.+.+|++++.+++ |+||+++++++.. .
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--D 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--S
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--C
Confidence 33456789999999999999999999888999999999754322 3467899999999997 5999999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||| +.+++|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 57899999 568899999974 235889999999999999999999998 999999999999965 899999999
Q ss_pred ccccCCCCCcccccccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~- 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I- 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H-
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----H-
Confidence 9987654433323345579999999999875 46888999999999999999999999643211 0
Q ss_pred hhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 600 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..+..+.++......+......+.+++.+||+.||++||++.|++++-+.
T Consensus 247 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 247 ----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp ----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ----------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 11122223332223333334568899999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.64 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=203.1
Q ss_pred HHHHHHHhcCcccc-eeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcc-cCceeEEEEEee
Q 004869 372 YEELKEATNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYS 446 (726)
Q Consensus 372 ~~el~~~t~~f~~~-~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~ 446 (726)
+.......++|.+. +.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++.+++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444556678777 89999999999999965 68999999987543 233568999999999994 699999999987
Q ss_pred cCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCc
Q 004869 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFH 523 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~ 523 (726)
+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 100 --~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 100 --NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp --CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred --eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 455899999999999999999642 2346899999999999999999999999 999999999999987 789
Q ss_pred EEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhh
Q 004869 524 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603 (726)
Q Consensus 524 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 603 (726)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~--- 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLN--- 244 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHH---
Confidence 99999999987654322 234579999999999999999999999999999999999999996432111 0000
Q ss_pred hhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.. . ...............+.+++.+||+.||++|||++|++++
T Consensus 245 -i~~-------~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 -ISQ-------V-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -HHH-------T-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -HHh-------c-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0 0001111112233458899999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.92 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=196.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|++++++++||||+++++++.. ....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 478999999999999999999975 68899999997543222 3678999999999999999999999874 45889
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 111 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999974 345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
....... ......||..|+|||++.+..++.++||||||+++|||++|+.||...... .+ ...+....
T Consensus 184 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~~~~~~---- 251 (309)
T 2h34_A 184 TTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM----GAHINQAI---- 251 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH----HHHHHSCC----
T ss_pred ccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH----HHHhccCC----
Confidence 6543221 223456999999999999999999999999999999999999999743211 11 11111000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 662 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-Tm~EVl~~L~~i~~ 662 (726)
..+ ...+......+.+++.+||+.||++|| +++++++.|+.+..
T Consensus 252 -~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 -PRP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -CCG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -CCc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 000 011112223588999999999999999 99999998877644
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.64 Aligned_cols=258 Identities=14% Similarity=0.095 Sum_probs=185.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC---chhHHHHHHHHHHhc--ccCceeEEE-------EEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL--HHRNLVKLV-------GYY 445 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L--~HpNIV~ll-------g~~ 445 (726)
..+|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999965 7899999999865432 234677886655555 599988855 333
Q ss_pred ecCCC---------------CceEEEEeecCCCChhhhccCCCCCcccCChhhh------HHHHHHHHHHHHHHHhCCCC
Q 004869 446 SSRDS---------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR------MKIALDAARGLAYLHEDSQP 504 (726)
Q Consensus 446 ~~~~~---------------~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~------~~ia~qIa~gL~yLH~~~~p 504 (726)
..... ...+|||||++ |+|.+++... ...+.+..+ +.++.|+++||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 32111 34799999998 8999999742 234566667 788899999999999999
Q ss_pred ceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHh
Q 004869 505 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 505 ~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELlt 582 (726)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999876432 124467799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 583 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 583 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
|+.||....+..... |.... ....................+.+++.+||+.||++|||+.|++++-
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPS------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCC------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCCcCcccccc---hhhhh------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 999997553322111 10000 0000011111111123344688999999999999999999998763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=363.99 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=196.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~ 451 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|+.++||||+++++++...+ ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 6899999999754 2223467889999999999999999999986432 24
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999976 56666642 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh---------hhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TWA 602 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~~ 602 (726)
++...... ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||.......+...+ .+.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98765432 234568999999999999999999999999999999999999999754321111000 000
Q ss_pred hhhccchhhhhhhcCCccC-CCC------C-----------hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLG-GKY------P-----------KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~-~~~------~-----------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
... . .......+.... ... + ......+.+|+.+||+.||++|||++|+++|-
T Consensus 288 ~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 288 KKL-Q--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TTS-C--HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHc-c--hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 0 001111110000 000 0 11145688999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.82 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=190.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHH-HHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~i-L~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|..+ ++.++||||+++++++. +....
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CSSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eCCEE
Confidence 357999999999999999999975 578999999975432 233456777776 57789999999999987 44589
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 115 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999964 345888999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~------- 252 (373)
T 2r5t_A 188 ENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNIL------- 252 (373)
T ss_dssp GGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHH-------
T ss_pred ccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-------
Confidence 6433221 23456799999999999999999999999999999999999999964321 11111111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~E 652 (726)
...+ .++......+.+++.+||+.||++||++.+
T Consensus 253 ---~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 253 ---NKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---HSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---hccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1111 122233345889999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.36 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=195.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|.+.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++|+||+++++++. +....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS--TPTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCCeEE
Confidence 368999999999999999999975 68999999986432 233467899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999964 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ..+. ..+..
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~~~~------ 225 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLF---KKIRG------ 225 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHH------
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH---HHhhc------
Confidence 654321 234568999999999987765 6899999999999999999999964321 1111 11100
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ...+......+.+++.+||+.||++|||+.|++++-+
T Consensus 226 ----~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 226 ----GV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ----CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ----Cc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 00 0112223345889999999999999999999998743
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.42 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=204.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEE
Confidence 357999999999999999999975 578999999864422 23467899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++++|.+++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 118 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999999864 346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~------ 256 (335)
T 2owb_A 191 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKN------ 256 (335)
T ss_dssp CCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT------
T ss_pred cccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcC------
Confidence 653322 22345799999999999999999999999999999999999999964321 1111111000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ..+......+.+++.+||+.||++|||+.|++++-.
T Consensus 257 --~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 257 --EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred --CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 01 112223345789999999999999999999998744
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=346.19 Aligned_cols=271 Identities=22% Similarity=0.323 Sum_probs=200.6
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCC------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 449 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~------ 449 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++|+||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 4789999999865432 22457889999999999999999999987533
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 777777642 235899999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCCc--ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh--
Q 004869 530 GLAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-- 604 (726)
Q Consensus 530 Gla~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~-- 604 (726)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 112344678999999998876 5689999999999999999999999975432211111100000
Q ss_pred ---hccchhhhhhhcCCcc--CCCCC-hhh------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ---ILRDKDRLEELADPRL--GGKYP-KED------FIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ---~~~~~~~l~~i~d~~l--~~~~~-~e~------~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+...........-.. ..... .+. ...+.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000 00000 011 2347899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=346.63 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=196.7
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-----chhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
...++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|+||+++++++. +.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HK 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eC
Confidence 44578999999999999999999965 5899999999753322 1357889999999999999999999987 45
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 588999999976 899888642 345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+...........
T Consensus 158 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 158 LAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPT 233 (346)
T ss_dssp GGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCC
T ss_pred cceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCC
Confidence 9987654322 23445789999999998764 5899999999999999999999998654311 11111111000000
Q ss_pred -h---hhhhhcCCccC---CCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 610 -D---RLEELADPRLG---GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 610 -~---~l~~i~d~~l~---~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
. ....+.+.... ...+ ......+.+++.+||+.||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 00000000000 0001 12235688999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.52 Aligned_cols=273 Identities=23% Similarity=0.300 Sum_probs=201.6
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc-----------hhHHHHHHHHHHhcccCcee
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLV 439 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV 439 (726)
...++....++|++.+.||+|+||.||+|+..+|+.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999998889999999986432221 26789999999999999999
Q ss_pred EEEEEeecC---CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 440 KLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 440 ~llg~~~~~---~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
++++++... .....++||||++ |+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999998542 3346799999997 6888888742 346899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~ 595 (726)
|++.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999998554332 2234578999999999876 6789999999999999999999999975431111
Q ss_pred chhhhhhhhhccc----------hhhhhhhcCCccCCC-------CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 596 ENLVTWARPILRD----------KDRLEELADPRLGGK-------YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 596 ~~l~~~~~~~~~~----------~~~l~~i~d~~l~~~-------~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.... ..... ............... ........+.+++.+||+.||++|||+.|++++
T Consensus 243 --~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 --LNKIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp --HHHHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000 00000 000011111111000 011223458899999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=353.98 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=198.0
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC-----
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----- 448 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----- 448 (726)
+....++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+|+++++.++|+||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345568999999999999999999996 578999999997442 2334799999999999999999998542
Q ss_pred -------------------------------CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHH
Q 004869 449 -------------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497 (726)
Q Consensus 449 -------------------------------~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~y 497 (726)
+....++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 2234789999998 58887775322224568999999999999999999
Q ss_pred HHhCCCCceeecCCCccceeec-CCCcEEEEecCccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHH
Q 004869 498 LHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGV 575 (726)
Q Consensus 498 LH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGv 575 (726)
||+.+ |+||||||+|||++ +++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99998 99999999999998 689999999999987654332 2345689999999998765 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-hhh-------hhhcCCccC-----CCCChhhHHHHHHHHHHcccc
Q 004869 576 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRL-------EELADPRLG-----GKYPKEDFIRVCTIAAACVAP 642 (726)
Q Consensus 576 vL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l-------~~i~d~~l~-----~~~~~e~~~~l~~Li~~CL~~ 642 (726)
++|||++|+.||...... ..+.......-... ..+ ....-+... ...+......+.+|+.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999999754321 11111111000000 000 000000000 001222344588999999999
Q ss_pred CCCCCCCHHHHHHH
Q 004869 643 EANQRPTMGEVVQS 656 (726)
Q Consensus 643 dP~~RPTm~EVl~~ 656 (726)
||++|||+.|++++
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=360.04 Aligned_cols=246 Identities=14% Similarity=0.201 Sum_probs=190.4
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHH---HHHHhcccCceeEEE-------EE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEV---EMLSRLHHRNLVKLV-------GY 444 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei---~iL~~L~HpNIV~ll-------g~ 444 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999995 56899999999743 233457789999 455566899999988 55
Q ss_pred eecCCC----------C-----ceEEEEeecCCCChhhhccCCC---CCcccCChhhhHHHHHHHHHHHHHHHhCCCCce
Q 004869 445 YSSRDS----------S-----QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506 (726)
Q Consensus 445 ~~~~~~----------~-----~~~LV~Ey~~~GsL~d~L~~~~---~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~I 506 (726)
+...+. . ..+|||||+ +|+|.+++.... .....++|..++.++.|+++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 543211 1 378999999 689999997421 11234556889999999999999999999 9
Q ss_pred eecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccC-----------CCCcchhHHHHHH
Q 004869 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGV 575 (726)
Q Consensus 507 vHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSfGv 575 (726)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004869 576 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655 (726)
Q Consensus 576 vL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~ 655 (726)
+||||++|+.||......... ..+... ...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999643321110 001110 01223 35889999999999999999999997
Q ss_pred H
Q 004869 656 S 656 (726)
Q Consensus 656 ~ 656 (726)
+
T Consensus 360 h 360 (377)
T 3byv_A 360 T 360 (377)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.38 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=204.0
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhc-ccCceeEEE
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRL-HHRNLVKLV 442 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L-~HpNIV~ll 442 (726)
.......++|++.+.||+|+||.||+|++. +|+.||||++....... .+.+.+|++++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999985 68999999987543211 34678899999999 799999999
Q ss_pred EEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 443 g~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+++.. ....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 167 ~~~~~--~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 167 DSYES--SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEB--SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEee--CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99874 4589999999999999999964 345899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~ 596 (726)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~ 311 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---I 311 (365)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---H
Confidence 999999999987654332 234679999999998864 3578999999999999999999999964321 1
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCC--hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~--~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... .+.. .......+ ......+.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~~---~i~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 LMLR---MIME----------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHH---HHHH----------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH---HHHh----------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 0100 00000000 0112358899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=340.62 Aligned_cols=265 Identities=28% Similarity=0.412 Sum_probs=185.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++.. ....++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 457899999999999999999985 468899999987543 2335678899999999999999999999874 447899
Q ss_pred EEeecCCCChhhhccCC----CCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 456 CYELVPNGSLESWLHGP----LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~----~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
||||+++|+|.+++... ......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998521 112345899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 532 AKQAPEGRT---NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 532 a~~~~~~~~---~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~---~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLT---LQN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH---HTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHH---hcc
Confidence 986644321 112234579999999999876 5689999999999999999999999975432211 1000 000
Q ss_pred chhhh-hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l-~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... ....+......+ ...+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000 011111111222 3458899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=370.73 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+++|++++|||||++++++. +....+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~ 260 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALC 260 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe--eCCEEE
Confidence 467999999999999999999975 6899999998643 2234567899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999999999997522 335899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+..
T Consensus 336 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~------- 403 (576)
T 2acx_A 336 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE------- 403 (576)
T ss_dssp CCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHH-------
T ss_pred cccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhc-------
Confidence 754432 23457999999999999999999999999999999999999999754322111 111110000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
....++......+.+|+.+||+.||++|| +++||++|
T Consensus 404 -----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 -----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01122333345688999999999999999 78999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.39 Aligned_cols=202 Identities=26% Similarity=0.374 Sum_probs=167.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCC---Cc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~---~~ 452 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++|++++|+||+++++++...+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999964 5889999999754322 34678999999999999999999999864322 57
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.|+||||++ |+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 699999975 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--------------------cccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 004869 533 KQAPEGRTN--------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPVD 588 (726)
Q Consensus 533 ~~~~~~~~~--------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELltG~~Pf~ 588 (726)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 123456899999999986 56679999999999999999998665553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=368.59 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=207.5
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE--TKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--eCCEEE
Confidence 367899999999999999999975 68999999996432 233467899999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999999999764433456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.
T Consensus 339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~-------- 406 (543)
T 3c4z_A 339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVL-------- 406 (543)
T ss_dssp CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHH--------
T ss_pred ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHh--------
Confidence 654432 2234579999999999999999999999999999999999999997543211 1111111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm-----~EVl~~ 656 (726)
... ..++......+.+++.+||+.||++||++ +||+++
T Consensus 407 --~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 407 --EQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --HCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --hcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111 12233344568899999999999999975 677654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=350.19 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=199.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++|+||+++++++.. ....++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEE
Confidence 467999999999999999999975 58999999987544332 3567899999999999999999999874 458899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999988764 235899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh----------
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP---------- 604 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~---------- 604 (726)
..... ......||..|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus 175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhh
Confidence 44322 22345789999999998875 78999999999999999999999997543211 11111000
Q ss_pred hccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+...........+......+ ......+.+++.+||+.||++|||+.|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000011111111111111 12235688999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.98 Aligned_cols=264 Identities=18% Similarity=0.265 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc---h--------------hHHHHHHHHHHhcccCceeEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG---D--------------KEFLVEVEMLSRLHHRNLVKL 441 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~---~--------------~~f~~Ei~iL~~L~HpNIV~l 441 (726)
.++|++.+.||+|+||.||+|+. +|+.||||++....... . +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432111 1 789999999999999999999
Q ss_pred EEEeecCCCCceEEEEeecCCCChhhh------ccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCcc
Q 004869 442 VGYYSSRDSSQHLLCYELVPNGSLESW------LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKAS 514 (726)
Q Consensus 442 lg~~~~~~~~~~~LV~Ey~~~GsL~d~------L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~ 514 (726)
++++.. ....++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+
T Consensus 109 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES--SSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999874 4589999999999999999 543 224569999999999999999999999 88 999999999
Q ss_pred ceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCC
Q 004869 515 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLV-KSDVYSYGVVLLELLTGRKPVDMSQP 592 (726)
Q Consensus 515 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~-ksDVwSfGvvL~ELltG~~Pf~~~~~ 592 (726)
|||++.++.+||+|||+++..... ......||..|+|||++.+. .++. ++||||||+++|||++|+.||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999876443 23445799999999999877 6666 99999999999999999999975432
Q ss_pred Cccchhhhhhhhh-ccchhhhhhhcCCcc---CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 593 SGQENLVTWARPI-LRDKDRLEELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 593 ~~~~~l~~~~~~~-~~~~~~l~~i~d~~l---~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. ..+....... ............+.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 258 ~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 L--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp S--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 1111111000 000000000000000 000012233468899999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.14 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=197.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|++++++++||||+++++++.. ....++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEEE
Confidence 468999999999999999999975 588999999987666667889999999999999999999999874 45889999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999998631 235899999999999999999999998 99999999999999999999999999754321
Q ss_pred CCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
.. .......||..|+|||++. ...++.++||||||+++|||++|+.||...... .........
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~---- 237 (302)
T 2j7t_A 170 TL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS---- 237 (302)
T ss_dssp HH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS----
T ss_pred cc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhcc----
Confidence 10 1122346899999999884 567899999999999999999999999743211 111111100
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+. ...+......+.+++.+||+.||++|||+.|++++
T Consensus 238 ---~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 238 ---DPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---CCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---CCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 01122333468899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=351.13 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc--------cCceeEEEEEeecC-
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH--------HRNLVKLVGYYSSR- 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~--------HpNIV~llg~~~~~- 448 (726)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999985 46889999999743 223467899999999996 78899999988632
Q ss_pred -CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCC----
Q 004869 449 -DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNF---- 522 (726)
Q Consensus 449 -~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~---- 522 (726)
+....++||||+ +|+|.+++... ....+++..++.++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 345789999999 66666666432 124589999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------cEEEEecCccccCCCCCcccccccccccccccCcc
Q 004869 523 ---------------------------------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557 (726)
Q Consensus 523 ---------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE 557 (726)
.+||+|||+++..... .....||..|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999876432 23357899999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh---------------------ccchhhhhhhc
Q 004869 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI---------------------LRDKDRLEELA 616 (726)
Q Consensus 558 ~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~---------------------~~~~~~l~~i~ 616 (726)
++.+..++.++|||||||+||||++|+.||.................+ +.....+..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999754432211100000000 00000000000
Q ss_pred CCc---------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPR---------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~---------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+.. -....+.+....+.+|+.+||+.||++|||++|++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0012345666789999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.59 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=196.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC----CCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----~~~~~~ 454 (726)
.+|++.+.||+|+||.||+|+.. +|+.||||++.... +.+.+|+++|++++|+|||++++++... +....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 58999999986432 2345799999999999999999987532 222367
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-CcEEEEecCccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK 533 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-~~vKL~DFGla~ 533 (726)
+||||+++ +|.+.+.........+++..++.++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 666665421122346899999999999999999999998 9999999999999954 678999999998
Q ss_pred cCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-hhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-KDR 611 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~~~ 611 (726)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ...+.......-.. ...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 7654332 2345789999999998765 789999999999999999999999975431 12222222111000 001
Q ss_pred hhhh-------cCCccCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 612 LEEL-------ADPRLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 612 l~~i-------~d~~l~~-----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
+... ..+.+.. .++......+.+|+.+||+.||++|||+.|++++-+
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 1111 0011100 011222356889999999999999999999998743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=338.19 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=199.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||.||+|+.. +|+.||||.+... ...+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 4578999999999999999999975 5899999999753 245789999999999999999999999874 4578999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999862 1345899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... . .... ....
T Consensus 177 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~-------~~~~ 241 (314)
T 3com_A 177 DTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---A---IFMI-------PTNP 241 (314)
T ss_dssp TTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHH-------HHSC
T ss_pred hhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---H---HHHH-------hcCC
Confidence 4321 2234578999999999999999999999999999999999999996432110 0 0000 0000
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.+.. ..+......+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 242 PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 0010 11222334688999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=361.38 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE--DKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEE
Confidence 457999999999999999999975 78999999986543 334577999999999999999999999987 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGL 531 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGl 531 (726)
+||||+.+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999975 345899999999999999999999999 9999999999999 5678999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+.. .+..
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~---- 241 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILK---KVEK---- 241 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH----
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHc----
Confidence 987654432 244579999999998865 6899999999999999999999999753211 1111 1111
Q ss_pred hhhhcCCccCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 612 LEELADPRLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 612 l~~i~d~~l~~~--~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...... ........+.+++.+||+.||++|||+.|++++-+.
T Consensus 242 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 242 ------GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp ------CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ------CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 100000 011233458899999999999999999999988554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.36 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=196.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--------CchhHHHHHHHHHHhcccCceeEEEEEeecC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 448 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~ 448 (726)
..++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999965 578999999864321 1234588999999999999999999998632
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc---EE
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AK 525 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~---vK 525 (726)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ---ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 48999999999999999974 346899999999999999999999999 999999999999987654 99
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
|+|||+++...... ......||..|+|||++. ...++.++|||||||++|||++|+.||....... .+....
T Consensus 158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~ 232 (322)
T 2ycf_A 158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI 232 (322)
T ss_dssp ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH
T ss_pred EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH
Confidence 99999998765432 223457999999999874 5678899999999999999999999997443221 111111
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. .... ..+... ......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~---~~~~----~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TS---GKYN----FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HH---TCCC----CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Hh---Cccc----cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00 0000 000000 1123458899999999999999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.97 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=202.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC---------CchhHHHHHHHHHHhcc-cCceeEEEEEee
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---------QGDKEFLVEVEMLSRLH-HRNLVKLVGYYS 446 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~---------~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~ 446 (726)
..++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 689999999975431 11346789999999996 999999999987
Q ss_pred cCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEE
Q 004869 447 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
+....++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 --TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred --cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 45589999999999999999974 346899999999999999999999999 999999999999999999999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~ 600 (726)
+|||++........ .....||..|+|||++. ...++.++||||||+++|||++|+.||..... ..
T Consensus 166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~--- 236 (298)
T 1phk_A 166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---ML--- 236 (298)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---
T ss_pred ecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HH---
Confidence 99999987654322 23456899999999885 45678999999999999999999999964321 11
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....+.... ..............+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 237 MLRMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111111000 000001112234568899999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=349.08 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCC----CC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~ 451 (726)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999997 46899999999654322 2457889999999999999999999986432 24
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 579999999 8899999873 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh---------hh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TW 601 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~ 601 (726)
++..... .+...||..|+|||++.+ ..++.++|||||||++|||++|+.||.......+.... .+
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876432 234578999999999887 68999999999999999999999999754321111000 00
Q ss_pred hhhhccc--hhhhhhhc---CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 602 ARPILRD--KDRLEELA---DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 602 ~~~~~~~--~~~l~~i~---d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...+... ...+..+. ...+ ..........+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 00000000 0000 01111223468899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.21 Aligned_cols=275 Identities=21% Similarity=0.265 Sum_probs=193.8
Q ss_pred HHHHHHHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCC
Q 004869 372 YEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 372 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~ 450 (726)
.++.....++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556677899999999999999999999974 68999999986543 334567888999999999999999999864321
Q ss_pred -----CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHH--hCCCCceeecCCCccceeecC-CC
Q 004869 451 -----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--EDSQPCVIHRDFKASNILLEN-NF 522 (726)
Q Consensus 451 -----~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH--~~~~p~IvHrDIKp~NILLd~-~~ 522 (726)
...++||||+++ +|.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 227899999986 554444321122446888999999999999999999 887 999999999999997 89
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 601 (726)
.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHH
Confidence 999999999987654332 2345689999999998765 4899999999999999999999999754321 111111
Q ss_pred hhhhccchhhhhhhcCCc----------------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPR----------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~----------------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.............++. ............+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111000000000000000 0011122345678999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.32 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeec----------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---------- 447 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~---------- 447 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 489999999986655556789999999999999999999998742
Q ss_pred --CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcE
Q 004869 448 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHA 524 (726)
Q Consensus 448 --~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~v 524 (726)
.+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 23357899999997 699999963 35889999999999999999999999 99999999999997 57799
Q ss_pred EEEecCccccCCCCCc-ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 525 KVADFGLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 525 KL~DFGla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
||+|||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999987643221 112234567999999998875 6789999999999999999999999975432111 11000
Q ss_pred hhhcc-chhhhhhhcC-------CccC-CC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 603 RPILR-DKDRLEELAD-------PRLG-GK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 603 ~~~~~-~~~~l~~i~d-------~~l~-~~-----~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
...-. ......++.. .... .. ........+.+++.+||+.||++|||+.|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000 0000000000 0000 00 01122345889999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.15 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=199.4
Q ss_pred HHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 374 el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
+.....++|++.+.||+|+||.||+|+..+ .||+|.+.... ....+.|.+|++++++++|+||+++++++.. ..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CC
Confidence 333446789999999999999999999854 49999987543 2334568899999999999999999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 799999999999999999752 235899999999999999999999999 99999999999998 67999999999
Q ss_pred cccCCCCC---cccccccccccccccCcccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh
Q 004869 532 AKQAPEGR---TNYLSTRVMGTFGYVAPEYAMT---------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 599 (726)
Q Consensus 532 a~~~~~~~---~~~~~~~~~GT~~Y~APE~l~~---------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~ 599 (726)
++...... .........||..|+|||++.. ..++.++||||||+++|||++|+.||...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 87653211 1112234568999999999864 45789999999999999999999999743211 111
Q ss_pred hhhhhhccchhhhhhhcCCccC-CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 600 TWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 600 ~~~~~~~~~~~~l~~i~d~~l~-~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
..... -..+... ..++ ..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 253 ---~~~~~-------~~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 ---WQMGT-------GMKPNLSQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---HHHHT-------TCCCCCCCSSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---HHhcc-------CCCCCCCcCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 10100 0111111 1222 2478999999999999999999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.39 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=201.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC--CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
..++|++.+.||+|+||+||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++. +....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE--cCCEEE
Confidence 3467999999999999999999975 6899999998642 2334578999999999999999999999987 456899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec---CCCcEEEEecCc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL 531 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd---~~~~vKL~DFGl 531 (726)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999998864 345899999999999999999999999 99999999999995 466899999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+ ...+.....
T Consensus 171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~- 239 (486)
T 3mwu_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI---LKRVETGKY- 239 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHTCC-
T ss_pred CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC-
Confidence 98765432 2234579999999999875 5899999999999999999999999643211 11 111110000
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.............+.+++.+||+.||++|||+.|++++-+
T Consensus 240 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp -------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred -------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0000001122345889999999999999999999998744
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.05 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE--CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc------eeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l--~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|+| ++++++++.. .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence 46899999999999999999986 36889999999643 223467889999999998765 9999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC----------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---------- 520 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---------- 520 (726)
...++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 5899999999 899999997422 235889999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 521 ---------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 521 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
++.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6789999999998654322 34578999999999999999999999999999999999999997543
Q ss_pred CCccchhhhhhhhh--------ccch-----------------hhhhhhcCCcc-CCCCChhhHHHHHHHHHHccccCCC
Q 004869 592 PSGQENLVTWARPI--------LRDK-----------------DRLEELADPRL-GGKYPKEDFIRVCTIAAACVAPEAN 645 (726)
Q Consensus 592 ~~~~~~l~~~~~~~--------~~~~-----------------~~l~~i~d~~l-~~~~~~e~~~~l~~Li~~CL~~dP~ 645 (726)
.............. .+.. ........+.. ...........+.+++.+||+.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 22111110000000 0000 00000000000 0112334456789999999999999
Q ss_pred CCCCHHHHHHH
Q 004869 646 QRPTMGEVVQS 656 (726)
Q Consensus 646 ~RPTm~EVl~~ 656 (726)
+|||+.|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.07 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=197.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||+||+|+.. ++..||||++.... ......+.+|++++++++||||++++++|. +....++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 457999999999999999999975 68899999997543 333567999999999999999999999997 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecCcc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLA 532 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFGla 532 (726)
||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998864 345899999999999999999999999 999999999999976 455999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...... . ....+......
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~---~~~~i~~~~~~- 255 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---E---ILRKVEKGKYT- 255 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHTCCC-
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHHHhCCCC-
Confidence 8765432 223457999999999876 56899999999999999999999999743211 1 11111110000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+..... .....+.+++.+||+.||++|||+.|++++-+
T Consensus 256 ---~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 256 ---FDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp ---CCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ---CCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 0000001 12345789999999999999999999998744
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.77 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCC---CCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~---~~~~ 453 (726)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++.+++||||+++++++.... ....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 6889999999753322 2367899999999999999999999986432 2468
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599999863 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-cccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-hhhhh------
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARP------ 604 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~~------ 604 (726)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 76543211 11244579999999998754 55899999999999999999999999754422211100 00000
Q ss_pred -hccchhhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 -ILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 -~~~~~~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....................+ ......+.+++.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000111 1123458899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.44 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=193.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCC----CC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~ 451 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+ ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 688999999975432 22357889999999999999999999986433 23
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999997 578888853 3888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchh-h--------hhh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-V--------TWA 602 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l-~--------~~~ 602 (726)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... . .+.
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98664322 22346799999999999999999999999999999999999999975432110000 0 000
Q ss_pred hhh-------ccc-----hhhhhhhcCCccCCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 603 RPI-------LRD-----KDRLEELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 603 ~~~-------~~~-----~~~l~~i~d~~l~~~~---~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... ... ...+............ .......+.+|+.+||+.||++|||++|++++-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000 000 0000000000000000 1122456889999999999999999999998854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=375.54 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=205.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCc
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~ 452 (726)
..++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +|+||+++++++. +...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence 4578999999999999999999965 5789999998743 233456788999999987 7999999999887 4558
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.||||||+++|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999974 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ....
T Consensus 490 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~---------- 551 (674)
T 3pfq_A 490 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELF---------- 551 (674)
T ss_dssp EECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH----------
T ss_pred eccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHH----------
Confidence 86433222 23456899999999999999999999999999999999999999975321 1111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm-----~EVl~~ 656 (726)
..+..... .++.....++.+|+.+||+.||++||++ +||+++
T Consensus 552 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 552 QSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11122111 2334445568999999999999999997 777765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=354.55 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=205.8
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|++++..++|.+.+..+.++.. +....+|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEEEEE
Confidence 46899999999999999999996 5689999998875432 3468999999999987554444444332 445789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee---cCCCcEEEEecCcccc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 534 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL---d~~~~vKL~DFGla~~ 534 (726)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 99999999732 235999999999999999999999999 9999999999999 6889999999999987
Q ss_pred CCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 535 APEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 535 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
....... .......||..|+|||++.+..++.++|||||||+||||++|+.||.................... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-A 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-H
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-c
Confidence 6543321 112356799999999999999999999999999999999999999976543322222111110000 0
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
..++.+. ..++ .++.+++.+||+.||++||++.+|++.|+.+....
T Consensus 235 ~~~~~l~-----~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 235 TSIEALC-----RGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp SCHHHHH-----TTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccHHHHh-----cCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0111111 1233 35889999999999999999999999999886543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.83 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=201.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEE--CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhc---ccCceeEEEEEeec---
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS--- 447 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l--~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~--- 447 (726)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986432 22335678888888777 79999999999862
Q ss_pred CCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEE
Q 004869 448 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 527 (726)
Q Consensus 448 ~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~ 527 (726)
.+....++||||++ |+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 23457899999997 69999997422 234899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+..... ...
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILD-VIG 236 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HcC
Confidence 999998654321 2234578999999999999999999999999999999999999997543211 1110000 000
Q ss_pred ch--hhh-------hhhcCC---ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DK--DRL-------EELADP---RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~--~~l-------~~i~d~---~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ... ...... .............+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000 000000 00001112233457899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=358.95 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=200.3
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-------------CchhHHHHHHHHHHhcccCceeEEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------------QGDKEFLVEVEMLSRLHHRNLVKLVG 443 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNIV~llg 443 (726)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 578999999875431 23467899999999999999999999
Q ss_pred EeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-
Q 004869 444 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF- 522 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~- 522 (726)
++. +....++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~--~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFE--DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEE--CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEE--cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 987 45689999999999999999864 345899999999999999999999999 99999999999998775
Q ss_pred --cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 004869 523 --HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 523 --~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~ 600 (726)
.+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...... .+
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~-- 255 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DI-- 255 (504)
T ss_dssp CSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--
T ss_pred CccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH--
Confidence 69999999998765432 223457999999999876 56899999999999999999999999743211 11
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
...+....... +...... ....+.+++.+||+.||++|||+.|++++-+.
T Consensus 256 -~~~i~~~~~~~----~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 256 -IKKVEKGKYYF----DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp -HHHHHHCCCCC----CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -HHHHHcCCCCC----CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 11111100000 0000011 22458899999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.59 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=194.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC---------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--------- 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--------- 448 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999964 7899999999642 22346789999999999999999999987542
Q ss_pred --CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEE
Q 004869 449 --DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 526 (726)
Q Consensus 449 --~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL 526 (726)
+....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 235689999999999999999742 345788999999999999999999999 999999999999999999999
Q ss_pred EecCccccCCCCCc------------ccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 004869 527 ADFGLAKQAPEGRT------------NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 593 (726)
Q Consensus 527 ~DFGla~~~~~~~~------------~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~ 593 (726)
+|||+++....... ........||..|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 99999986643210 1122345689999999998764 78999999999999999998 44311
Q ss_pred ccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 594 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 594 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.........+.. ........++......+.+++.+||+.||++|||+.|++++
T Consensus 232 --~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111100 01111223344445568899999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.32 Aligned_cols=266 Identities=24% Similarity=0.297 Sum_probs=198.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecC---CCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~---~~~~~ 453 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++|+||+++++++... +....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 6899999999643322 245688999999999999999999987642 23578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 699999863 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccc--------ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh
Q 004869 534 QAPEGRTNY--------LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 534 ~~~~~~~~~--------~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 604 (726)
......... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ +... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLI-FG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH-HH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH-HH
Confidence 765332110 1223578999999998764 7789999999999999999999999975431111 0000 00
Q ss_pred hcc-----------chhhhhhhcCCccC-CCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ILR-----------DKDRLEELADPRLG-GKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~~~-----------~~~~l~~i~d~~l~-~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ......+....... ... .......+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000000000 000 01223457899999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=369.55 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=205.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
...++|++.+.||+|+||.||+|++.. +..||||++...... ..+.|.+|+.++++++||||+++++++. ..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cC
Confidence 345779999999999999999999742 467999998754322 2367999999999999999999999984 24
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999742 235899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ..... +.
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~---i~---- 606 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---IE---- 606 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HH----
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---HH----
Confidence 987654322 22334567889999999999999999999999999999997 99999743211 11111 10
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
+. .....+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 607 ------~~-~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 ------NG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ------HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------cC-CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 00112333345688999999999999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=351.54 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=170.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhc------ccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL------HHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L------~HpNIV~llg~~~~~~~~ 451 (726)
..+|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.+ +|+||+++++++.. ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence 467999999999999999999865 5899999999743 22345788899998887 46799999999874 45
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc--EEEEec
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADF 529 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~--vKL~DF 529 (726)
..++||||+. |+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence 8999999995 69999987532 234899999999999999999999998 999999999999999887 999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
|+++...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 247 G~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9997654322 23578999999999999999999999999999999999999997543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=352.85 Aligned_cols=273 Identities=21% Similarity=0.267 Sum_probs=186.1
Q ss_pred cCccc-ceeeeecCcEEEEEEEEC---CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEP-ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~-~~~LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
+.|++ .++||+|+||+||+|+.. +++.||||++... .....+.+|+++|++++||||+++++++...+....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 468999999999999965 5789999999743 23457899999999999999999999997656678999
Q ss_pred EEeecCCCChhhhccCC-----CCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee----cCCCcEEE
Q 004869 456 CYELVPNGSLESWLHGP-----LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKV 526 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~-----~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL----d~~~~vKL 526 (726)
||||++ |+|.+++... ......+++..++.++.|++.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888877521 111234899999999999999999999999 9999999999999 77899999
Q ss_pred EecCccccCCCCCc-ccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-------ch
Q 004869 527 ADFGLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-------EN 597 (726)
Q Consensus 527 ~DFGla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~-------~~ 597 (726)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654321 112344679999999999987 4589999999999999999999999965432110 00
Q ss_pred hhhhhhhh----------c---cc-hhhhhhhcCCccCCCCC---------hhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 004869 598 LVTWARPI----------L---RD-KDRLEELADPRLGGKYP---------KEDFIRVCTIAAACVAPEANQRPTMGEVV 654 (726)
Q Consensus 598 l~~~~~~~----------~---~~-~~~l~~i~d~~l~~~~~---------~e~~~~l~~Li~~CL~~dP~~RPTm~EVl 654 (726)
+......+ + .. ......+..... .... ......+.+|+.+||+.||++|||++|++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000 0 00 000000000000 0000 00123578999999999999999999999
Q ss_pred HHHHH
Q 004869 655 QSLKM 659 (726)
Q Consensus 655 ~~L~~ 659 (726)
++-+.
T Consensus 333 ~hp~f 337 (405)
T 3rgf_A 333 QDPYF 337 (405)
T ss_dssp TSGGG
T ss_pred cChhh
Confidence 87443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.24 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=194.6
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCC----CCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~~~~L 455 (726)
.+|++.+.||+|+||.||+|+..++..||+|++..... ...+|+++++.++|+||+++++++.... ....++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56999999999999999999987777799999864322 2347999999999999999999986432 223789
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~~ 534 (726)
||||++++.+....+ .......+++..++.++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEEHHHHHHH-HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCccHHHHHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999998754443322 1112346899999999999999999999999 99999999999999 799999999999987
Q ss_pred CCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-hhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRL 612 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l 612 (726)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......-... ..+
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 654332 2345789999999998765 5899999999999999999999999754321 11111111100000 000
Q ss_pred hh----hcC---CccC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EE----LAD---PRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~----i~d---~~l~-----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ... +... ..++......+.+|+.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 000 0000 00111233468899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.19 Aligned_cols=264 Identities=20% Similarity=0.309 Sum_probs=200.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-----------cCceeEEEEEee
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYS 446 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~llg~~~ 446 (726)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999996 46899999999732 223467889999999886 899999999987
Q ss_pred cCC--CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeec----
Q 004869 447 SRD--SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLE---- 519 (726)
Q Consensus 447 ~~~--~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd---- 519 (726)
..+ ....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 432 23688999999 899999997422 23589999999999999999999998 8 99999999999994
Q ss_pred --CCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc-
Q 004869 520 --NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE- 596 (726)
Q Consensus 520 --~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~- 596 (726)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876432 23347899999999999999999999999999999999999999754321110
Q ss_pred ---hhhhhhh-----------------hhccchhh-----------hhhhcCCccCCCCChhhHHHHHHHHHHccccCCC
Q 004869 597 ---NLVTWAR-----------------PILRDKDR-----------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEAN 645 (726)
Q Consensus 597 ---~l~~~~~-----------------~~~~~~~~-----------l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~ 645 (726)
.+..... ..+..... +..+... ...++......+.+|+.+||+.||+
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcc
Confidence 1100000 00000000 0000000 1134556677899999999999999
Q ss_pred CCCCHHHHHHH
Q 004869 646 QRPTMGEVVQS 656 (726)
Q Consensus 646 ~RPTm~EVl~~ 656 (726)
+|||+.|++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=349.22 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=183.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecC----CCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----~~~ 451 (726)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++|+||+++++++... +..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 4689999999975432 2346788999999999999999999998642 225
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++|+||+ +++|.++++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 7899999864 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc--
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-- 608 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-- 608 (726)
++..... .+...||..|+|||++.+ ..++.++|||||||++|||++|+.||.......+ +..... .+..
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~ 250 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILR-LVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCSCC
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCC
Confidence 9865432 234579999999999887 6889999999999999999999999975432111 111000 0000
Q ss_pred --------hhhhhhhcCCccC-CCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 --------KDRLEELADPRLG-GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 --------~~~l~~i~d~~l~-~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
............. .... ......+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000 0000 0112457899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=328.18 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=201.1
Q ss_pred HHhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 377 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 377 ~~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe--CCCeE
Confidence 44578999999999999999999975 68999999986432 334578999999999999999999999987 45588
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC---CcEEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~---~~vKL~DFG 530 (726)
++|+||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998864 235899999999999999999999998 9999999999999754 479999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+++....... .....||..|+|||.+.+ .++.++||||||+++|||++|+.||..... ..+ ...+..
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~---~~~~~~--- 236 (287)
T 2wei_A 170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDI---LKRVET--- 236 (287)
T ss_dssp GGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHH---
T ss_pred cceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHc---
Confidence 9987654322 233468999999998865 489999999999999999999999974321 111 111110
Q ss_pred hhhhhcCCccCCCCC--hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 611 RLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~--~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.......+ ......+.+++.+||+.||++|||+.|++++-
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 237 -------GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -------CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -------CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00000000 11234588999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.24 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=192.8
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC------chhHHHHHHHHHHhc----ccCceeEEEE
Q 004869 375 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRL----HHRNLVKLVG 443 (726)
Q Consensus 375 l~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L----~HpNIV~llg 443 (726)
.....++|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+|++++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 334567899999999999999999986 46889999999754322 234567899999999 8999999999
Q ss_pred EeecCCCCceEEEEee-cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CC
Q 004869 444 YYSSRDSSQHLLCYEL-VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NN 521 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey-~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~ 521 (726)
++.. ....++|+|| +.+++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++
T Consensus 106 ~~~~--~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 106 WFET--QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EC-------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEec--CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9874 4578999999 789999999974 345899999999999999999999999 99999999999999 89
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~- 246 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL- 246 (312)
T ss_dssp TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-
T ss_pred CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh-
Confidence 999999999998765432 234569999999999887766 459999999999999999999996311 000
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .. ...+......+.+++.+||+.||++|||+.|++++
T Consensus 247 ------~----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ------E----------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------H----------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------h----------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 01222233458899999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.78 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=187.6
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|++++.++ +|||||++++++. +....++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEEe
Confidence 44566789999999999877667899999999864 2345688999999987 8999999999886 4558999999
Q ss_pred ecCCCChhhhccCCCCCccc---CChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCC-------------C
Q 004869 459 LVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-------------F 522 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~---Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~-------------~ 522 (726)
|+. |+|.+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 995 6999999754322211 245567889999999999999999 9999999999999754 4
Q ss_pred cEEEEecCccccCCCCCccc--ccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 004869 523 HAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 592 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~ 592 (726)
.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999998776543211 1234579999999999875 678999999999999999999 9999964321
Q ss_pred CccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 593 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.. ......... .+.............+.+++.+||+.||++|||+.||+++
T Consensus 246 ~~----~~i~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE----SNIIRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH----HHHHHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH----HHHhcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11 111110000 0111111233455678999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=336.81 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=199.0
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC------chhHHHHHHHHHHhcc--cCceeEEEE
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVG 443 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~llg 443 (726)
.+.....++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34444567899999999999999999985 46899999999754322 2356788999999996 599999999
Q ss_pred EeecCCCCceEEEEeecCC-CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CC
Q 004869 444 YYSSRDSSQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NN 521 (726)
Q Consensus 444 ~~~~~~~~~~~LV~Ey~~~-GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~ 521 (726)
++. +....++|+||+.+ ++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++
T Consensus 116 ~~~--~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 116 WFE--RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEE--CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred EEe--cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 987 44588999999986 899999964 346899999999999999999999999 99999999999999 78
Q ss_pred CcEEEEecCccccCCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 004869 522 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600 (726)
Q Consensus 522 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~ 600 (726)
+.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~-- 255 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-- 255 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH--
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh--
Confidence 999999999998765432 234569999999999987766 788999999999999999999996311 00
Q ss_pred hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 ~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .......+ ...+.+++.+||+.||++|||++||+++
T Consensus 256 -----~~~--------~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -----IRG--------QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----HHC--------CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----hcc--------cccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00011122 3458899999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.67 Aligned_cols=259 Identities=21% Similarity=0.241 Sum_probs=176.3
Q ss_pred HhcCcccc-eeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHH-HHHHhcccCceeEEEEEeecCC--CCc
Q 004869 378 ATNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEV-EMLSRLHHRNLVKLVGYYSSRD--SSQ 452 (726)
Q Consensus 378 ~t~~f~~~-~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei-~iL~~L~HpNIV~llg~~~~~~--~~~ 452 (726)
..++|.+. ++||+|+||.||+|+.. +|+.||||++... ....+|+ ..+..++|+||+++++++.... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35688885 46999999999999976 6899999998632 2233333 3456678999999999986422 335
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEec
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADF 529 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DF 529 (726)
.++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 799999999999999997532 346899999999999999999999999 999999999999976 456999999
Q ss_pred CccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 530 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 530 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
|+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~-- 247 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRL-- 247 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhc--
Confidence 9998664322 234568999999999998899999999999999999999999996433211100 00000000
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
... .............+.+++.+||+.||++|||+.|++++-+.-
T Consensus 248 ---~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 248 ---GQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred ---ccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 000 000011122334588999999999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.47 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=195.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCCC----
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---- 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~---- 451 (726)
.++|.+.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999964 68999999997543332 46788999999999999999999998743321
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+. |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 3499999997 689888843 3899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh-----
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----- 605 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~----- 605 (726)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcH
Confidence 9865432 234578999999999887 788999999999999999999999997533111 111100000
Q ss_pred -----ccch---hhhhhhcCCccCCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 606 -----LRDK---DRLEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 606 -----~~~~---~~l~~i~d~~l~~~---~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+... .....+.. ..... ........+.+|+.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 00000000 00000 011223468899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=334.59 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=179.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHH-HHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~-iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.. ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEE
Confidence 368999999999999999999975 689999999975432 22345666666 6777899999999999874 458899
Q ss_pred EEeecCCCChhhhccCCC-CCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 456 CYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~-~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
||||+++ +|.+++.... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999975 8887775210 1134588999999999999999999998 8 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
....... .....||..|+|||++ .+..++.++||||||+++|||++|+.||....... .........
T Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~- 245 (327)
T 3aln_A 175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKG- 245 (327)
T ss_dssp C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS-
T ss_pred ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcC-
Confidence 7654321 2334699999999998 45678999999999999999999999997432110 111111110
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 659 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~ 659 (726)
..+.+...........+.+++.+||+.||++|||+.||+++-..
T Consensus 246 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 246 ------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp ------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 00111111112233468899999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.97 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CC-cEEEEEEcccCCCCchhHHHHHHHHHHhcccCc------eeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~llg~~~~~~~ 450 (726)
.++|++.+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|++++++++|+| ++.+.+++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--C
Confidence 468999999999999999999964 34 68999999743 233467889999999998776 8999998874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceee------------
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL------------ 518 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILL------------ 518 (726)
...++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence 5899999999 667777775421 235899999999999999999999998 9999999999999
Q ss_pred -------cCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 004869 519 -------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 591 (726)
Q Consensus 519 -------d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~ 591 (726)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 678899999999998654322 34579999999999999999999999999999999999999997543
Q ss_pred CCccchhhhhhhhhccc-h---------------------------hhhhhhcCCcc-CCCCChhhHHHHHHHHHHcccc
Q 004869 592 PSGQENLVTWARPILRD-K---------------------------DRLEELADPRL-GGKYPKEDFIRVCTIAAACVAP 642 (726)
Q Consensus 592 ~~~~~~l~~~~~~~~~~-~---------------------------~~l~~i~d~~l-~~~~~~e~~~~l~~Li~~CL~~ 642 (726)
.... .......... . ........+.. ...........+.+|+.+||+.
T Consensus 244 ~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 NREH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 2111 1000000000 0 00000000000 0011223345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 004869 643 EANQRPTMGEVVQS 656 (726)
Q Consensus 643 dP~~RPTm~EVl~~ 656 (726)
||++|||+.|++++
T Consensus 321 dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 321 DPAQRITLAEALLH 334 (355)
T ss_dssp STTTSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.48 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=196.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc--hhHHHHHHHHHHhcccCceeEEEEEeecCCC----C
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~----~ 451 (726)
.++|.+.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++...+. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999964 68999999997543322 3578899999999999999999999874332 2
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+. |+|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 4599999997 699888753 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh------
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP------ 604 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~------ 604 (726)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 245 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9865432 234578999999999886 678999999999999999999999997543211 11100000
Q ss_pred ----hccch---hhhhhhcC---CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 ----ILRDK---DRLEELAD---PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ----~~~~~---~~l~~i~d---~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+.+. ..+..+.. ..+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000 000 01112334568899999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.13 Aligned_cols=199 Identities=25% Similarity=0.314 Sum_probs=168.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cC-----ceeEEEEEeecCCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HR-----NLVKLVGYYSSRDS 450 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-Hp-----NIV~llg~~~~~~~ 450 (726)
..++|++.+.||+|+||+||+|+.. +++.||||++... ....+++.+|+++++.++ |+ +|+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence 4578999999999999999999965 6789999999732 222456788999998885 44 49999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh--CCCCceeecCCCccceeec--CCCcEEE
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE--DSQPCVIHRDFKASNILLE--NNFHAKV 526 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~--~~~p~IvHrDIKp~NILLd--~~~~vKL 526 (726)
...++||||++ |+|.+++.... ...+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 58999999996 59999997532 2358999999999999999999995 45 99999999999994 5788999
Q ss_pred EecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 004869 527 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 590 (726)
Q Consensus 527 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~ 590 (726)
+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998764422 3457899999999999999999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.17 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=178.3
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc-h-hHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
.++|++.+.||+|+||.||+|+.. +|+.||||++....... . +.+.++..+++.++|+||+++++++.. ....++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 467999999999999999999975 68999999997543322 2 234445556788899999999999874 458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
||||+ ++.+..++.. ....+++..++.++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999 5555555432 124589999999999999999999985 8 99999999999999999999999999976
Q ss_pred CCCCCcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 609 (726)
...... .....||..|+|||++. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 175 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~ 246 (318)
T 2dyl_A 175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC
T ss_pred ccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC
Confidence 644321 23456999999999984 557889999999999999999999999743211 11111111110
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.+.+. ........+.+++.+||+.||++||++.|++++-.
T Consensus 247 -------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 247 -------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp -------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 01110 01112345889999999999999999999998743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=342.30 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=186.5
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
..+|+..++||+|+||+||.....+|+.||||++.... ...+.+|+++|+++ +|||||++++++. +....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEEEE
Confidence 45689999999999999665556678999999996432 34467899999999 7999999999987 445789999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-----CCcEEEEecCcc
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA 532 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-----~~~vKL~DFGla 532 (726)
||+. |+|.+++.... ..+.+..++.++.|+++||+|||+.+ |+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 69999997532 23556677899999999999999999 999999999999943 346889999999
Q ss_pred ccCCCCCcc-cccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhcc
Q 004869 533 KQAPEGRTN-YLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 533 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
+........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... . .. ....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~-~~---~~~~ 243 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q-AN---ILLG 243 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H-HH---HHTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H-HH---HHhc
Confidence 876543221 2234467999999999987 4567889999999999999999 99998532211 0 00 0000
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.... .. ..........+.+|+.+||+.||++|||+.||+++
T Consensus 244 -~~~~-----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 244 -ACSL-----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -CCCC-----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cCCc-----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 00 01112334457899999999999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=354.35 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=192.8
Q ss_pred hcCcccceeeeecCcEEEEEEEEC--CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC---c
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---Q 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~---~ 452 (726)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.|.+|++++++++||||+++++++...+.. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 589999999874432 2345789999999999999999999998754421 1
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.||||||+++++|.+++.. .++|.+++.++.||++||.|||+.+ |+||||||+|||++++ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999988753 5899999999999999999999999 9999999999999986 8999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+..... ....||++|+|||++.+.. +.++|||||||+||||++|..||....... . ...
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~-~~~--- 287 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------L-PED--- 287 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------C-CTT---
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------c-ccc---
Confidence 876543 3356999999999987664 899999999999999999988875311000 0 000
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSLKMVQR 662 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-m~EVl~~L~~i~~ 662 (726)
.........+.+++.+||+.||++||+ ++++.+.|..+.+
T Consensus 288 ----------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 288 ----------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000111245788999999999999995 6666666766544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.46 Aligned_cols=252 Identities=14% Similarity=0.186 Sum_probs=185.2
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC---chhHHHHHHHHHHhccc-Cce---------------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHH-RNL--------------- 438 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~H-pNI--------------- 438 (726)
+.+|...++||+|+||+||+|+. .+|+.||||++...... ..+.|.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 45688889999999999999995 46899999998743322 25779999999999977 211
Q ss_pred eE------EEEEeecCC---CCceEEEEeecCCCChhhhccCC---CCCcccCChhhhHHHHHHHHHHHHHHHhCCCCce
Q 004869 439 VK------LVGYYSSRD---SSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506 (726)
Q Consensus 439 V~------llg~~~~~~---~~~~~LV~Ey~~~GsL~d~L~~~---~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~I 506 (726)
+. +..++.... ....+++|+++ +++|.+++... ......++|..++.++.|+++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 111111111 22456666665 78999988411 122456889999999999999999999999 9
Q ss_pred eecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCcccc----------ccCCCCcchhHHHHHHH
Q 004869 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA----------MTGHLLVKSDVYSYGVV 576 (726)
Q Consensus 507 vHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~s~ksDVwSfGvv 576 (726)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865432 234567 999999999 55568889999999999
Q ss_pred HHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 577 LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 577 L~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+|||++|+.||........ .. .+.... ..++ ..+.+|+.+||+.||++||++.|++++
T Consensus 307 l~elltg~~Pf~~~~~~~~------~~----------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG------SE----------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC------SG----------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhh------HH----------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999974332111 11 111100 1233 458899999999999999999999776
Q ss_pred --HHHHHH
Q 004869 657 --LKMVQR 662 (726)
Q Consensus 657 --L~~i~~ 662 (726)
++.+.+
T Consensus 365 ~~~~~~~~ 372 (413)
T 3dzo_A 365 PEYEQLRT 372 (413)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.46 Aligned_cols=232 Identities=14% Similarity=0.086 Sum_probs=181.7
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +|+.||||.+....... .+.|.+|++++.+++|+||+++++++.. ....++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 57999999999999999999975 48999999998654332 3679999999999999999999999874 457999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++++|.++++.. ....++.+++.|++.||+|||+.+ |+||||||+|||+++++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999631 345578899999999999999999 9999999999999999999997443
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccch-hhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRLEE 614 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l~~ 614 (726)
|++| ++.++|||||||++|||++|+.||.......... .+....... ....
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~- 226 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEPA- 226 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCCHH-
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCChh-
Confidence 3433 6889999999999999999999997544322110 000000000 0000
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.....+ ...+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 227 ----~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 ----DIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ----HHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ----hcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 011122 2358899999999999999 9999999999886543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=349.34 Aligned_cols=262 Identities=25% Similarity=0.361 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC-CCchhHHHHHHHHHHhcccCceeEEEEEeec----CCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----RDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~----~~~~~~ 453 (726)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|++++++++||||+++++++.. .+....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999996 468999999987542 2234678999999999999999999998754 225578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCc---EEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~---vKL~DFG 530 (726)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 2335899999999999999999999999 999999999999987664 9999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||.... ....|.........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence 9987654332 244679999999999999999999999999999999999999996421 22223222211110
Q ss_pred hhhhhcCCc------------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 004869 611 RLEELADPR------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 654 (726)
Q Consensus 611 ~l~~i~d~~------------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl 654 (726)
. ....... ............+.+++.+||+.||++|||+.|++
T Consensus 242 ~-~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 E-HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred h-hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0000000 01123445667899999999999999999999854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=306.72 Aligned_cols=234 Identities=22% Similarity=0.290 Sum_probs=180.6
Q ss_pred hcCcccc-eeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHH-HhcccCceeEEEEEeec--CCCCce
Q 004869 379 TNNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEML-SRLHHRNLVKLVGYYSS--RDSSQH 453 (726)
Q Consensus 379 t~~f~~~-~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~llg~~~~--~~~~~~ 453 (726)
.++|.+. +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +.++|+||+++++++.. .+....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7899999999999996 4689999999862 35678899998 55589999999999864 224578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFG 530 (726)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999997522 235899999999999999999999999 999999999999998 7899999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+++... +..++.++|||||||++|||++|+.||.......... . ...
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~----~~~--- 212 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G----MKT--- 212 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C----SCC---
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H----HHH---
Confidence 986532 1346779999999999999999999996433211000 0 000
Q ss_pred hhhhhcCCccCCCCC----hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYP----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.... ...+ ......+.+++.+||+.||++|||+.|++++-+..
T Consensus 213 ---~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 213 ---RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp ---SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 000000 0111 11234588999999999999999999999875543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=312.55 Aligned_cols=245 Identities=18% Similarity=0.204 Sum_probs=186.4
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC--------CchhHHHHHHHHHHhcc---------cCceeEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLH---------HRNLVKL 441 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~---------HpNIV~l 441 (726)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|++++++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999998 679999999976532 22377899999999886 8888888
Q ss_pred EEEeecC----------------------------CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHH
Q 004869 442 VGYYSSR----------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493 (726)
Q Consensus 442 lg~~~~~----------------------------~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~ 493 (726)
.+++... +....+|||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 8764311 25689999999999987777743 35899999999999999
Q ss_pred HHHHHH-hCCCCceeecCCCccceeecCCC--------------------cEEEEecCccccCCCCCccccccccccccc
Q 004869 494 GLAYLH-EDSQPCVIHRDFKASNILLENNF--------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552 (726)
Q Consensus 494 gL~yLH-~~~~p~IvHrDIKp~NILLd~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~ 552 (726)
||+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 899 99999999999999887 9999999999866432 3479999
Q ss_pred ccCccccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc-CCccCCCCChhhHH
Q 004869 553 YVAPEYAMTGHLLVKSDVYSYGVV-LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA-DPRLGGKYPKEDFI 630 (726)
Q Consensus 553 Y~APE~l~~~~~s~ksDVwSfGvv-L~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~-d~~l~~~~~~e~~~ 630 (726)
|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|...... ..+.... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTD--KMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHH--HHHHTCCCSSCCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHH--hhhhhhccCcccchhhhhhcCH
Confidence 99999998766 899999998777 7778889998741 112111100 0000000 00000111234556
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH-HH
Q 004869 631 RVCTIAAACVAPEANQRPTMGEVV-QS 656 (726)
Q Consensus 631 ~l~~Li~~CL~~dP~~RPTm~EVl-~~ 656 (726)
.+.+|+.+||+.| |++|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 7899999999976 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-29 Score=285.63 Aligned_cols=185 Identities=18% Similarity=0.129 Sum_probs=129.0
Q ss_pred eeeecCcEEEEEEE-ECCCcEEEEEEcccCCC----------CchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ----------QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 387 ~LG~G~fG~Vykg~-l~~g~~VAVK~l~~~~~----------~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
..+.|++|.+..++ +-.|+.||||.+..... ...++|.+|+++|+++ +|+||++++++++ +....|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEEE
Confidence 45667777776655 33588899999975421 1225699999999999 7999999999987 556899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||||++||+|.++|.. ...++. .+|+.||+.||+|||++| |+||||||+||||++++++||+|||+|+.
T Consensus 319 LVMEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 99999999999999975 234544 358999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 586 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~P 586 (726)
...... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 754432 2345789999999998865 467789999999998888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-26 Score=261.95 Aligned_cols=185 Identities=16% Similarity=0.181 Sum_probs=144.3
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCc--------hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
...++||+|+||.||+|.. .++.+++|+........ .+.|.+|++++++++|+||+++..++.. ....+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccE
Confidence 4467899999999999965 46889999875432221 2358999999999999999955444442 34679
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||||+++|+|.++++. ++.++.|+++||+|||+++ |+||||||+|||+++ ++||+|||+++.
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999973 5689999999999999999 999999999999999 999999999998
Q ss_pred CCCCCccc-----ccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 004869 535 APEGRTNY-----LSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPV 587 (726)
Q Consensus 535 ~~~~~~~~-----~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~Pf 587 (726)
........ ......||+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 75432211 1235689999999999986 66888899999999999988887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=216.95 Aligned_cols=155 Identities=15% Similarity=0.115 Sum_probs=123.6
Q ss_pred CHHHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC------------------chhHHHHHHHHHHh
Q 004869 371 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------------------GDKEFLVEVEMLSR 432 (726)
Q Consensus 371 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~ 432 (726)
....+......|++.+.||+|+||.||+|+..+|+.||||.++..... ....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344455556778888999999999999999977999999999643211 23568999999999
Q ss_pred cccCceeEEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 004869 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 512 (726)
Q Consensus 433 L~HpNIV~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIK 512 (726)
++| +++.+++.. ...++||||+++|+|.+ +.. .....++.|+++||.|||+.+ |+|||||
T Consensus 161 l~~---~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlk 220 (282)
T 1zar_A 161 LQG---LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLS 220 (282)
T ss_dssp TTT---SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred ccC---CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCC
Confidence 984 555555432 35799999999999998 531 345579999999999999999 9999999
Q ss_pred ccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCcccccc
Q 004869 513 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 561 (726)
Q Consensus 513 p~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 561 (726)
|+|||++ ++.+||+|||+++.. ..|+|||++..
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 9999999 999999999998632 34788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=181.35 Aligned_cols=138 Identities=19% Similarity=0.139 Sum_probs=108.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcE--EEEEEcccCCCCc------------------------hhHHHHHHHHHHh
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTA--VAIKRLTCGGQQG------------------------DKEFLVEVEMLSR 432 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ei~iL~~ 432 (726)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+++|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999997 67888 9999875431110 1257889999999
Q ss_pred cccCce--eEEEEEeecCCCCceEEEEeecCC-C----ChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHH-hCCCC
Q 004869 433 LHHRNL--VKLVGYYSSRDSSQHLLCYELVPN-G----SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQP 504 (726)
Q Consensus 433 L~HpNI--V~llg~~~~~~~~~~~LV~Ey~~~-G----sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH-~~~~p 504 (726)
++|+|+ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+
T Consensus 127 l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g-- 191 (258)
T 1zth_A 127 AKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE-- 191 (258)
T ss_dssp HHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred HHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence 998764 344432 256899999942 4 56655431 345678899999999999999 888
Q ss_pred ceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 505 CVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 505 ~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|+||||||+|||+++ .++|+|||+|...
T Consensus 192 -ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 -LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp -EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred -EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.9e-16 Score=169.80 Aligned_cols=144 Identities=15% Similarity=0.178 Sum_probs=105.5
Q ss_pred HHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC-----C---------chhHH--------HHHHHHHH
Q 004869 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-----Q---------GDKEF--------LVEVEMLS 431 (726)
Q Consensus 374 el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~-----~---------~~~~f--------~~Ei~iL~ 431 (726)
.+.....-|++.+.||+|+||.||+|...+|+.||||+++.... . ....+ .+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333445899999999999999999998999999998753210 0 01112 34666677
Q ss_pred hcccCcee--EEEEEeecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeec
Q 004869 432 RLHHRNLV--KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR 509 (726)
Q Consensus 432 ~L~HpNIV--~llg~~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHr 509 (726)
++.+.++. ..+++ ...+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||
T Consensus 169 rL~~~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHr 229 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHG 229 (397)
T ss_dssp HHHHTTCSCCCEEEE------ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhcCCCCCeeeec------cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 76554432 22222 134799999999998776532 344678899999999999998 9999
Q ss_pred CCCccceeecCCC----------cEEEEecCccccCC
Q 004869 510 DFKASNILLENNF----------HAKVADFGLAKQAP 536 (726)
Q Consensus 510 DIKp~NILLd~~~----------~vKL~DFGla~~~~ 536 (726)
||||.|||+++++ .+.|+||+-+....
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999998876 48999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.7e-11 Score=125.95 Aligned_cols=148 Identities=16% Similarity=0.096 Sum_probs=116.0
Q ss_pred HHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCc
Q 004869 374 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 374 el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~ 452 (726)
.+.....+|+....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |.++.++++++.. .+.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~ 84 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCc
Confidence 34555678988899999999999998764 6789999987432233456899999999985 6777888888763 457
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC-------------------------------
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED------------------------------- 501 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~------------------------------- 501 (726)
.++||||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 85 ~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred eEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 899999999999987642 1233457889999999999981
Q ss_pred -------------------------CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 502 -------------------------SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 502 -------------------------~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
..+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11569999999999999887667899998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=122.59 Aligned_cols=138 Identities=19% Similarity=0.124 Sum_probs=101.1
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce--eEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~llg~~~~~~~~~~~LV 456 (726)
..++.+..+.+.|..+.||++...+|..+++|..... ....+.+|+++++.+++.++ .+++++.. +.+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCCEEE
Confidence 3455554444456669999998777888999997643 23568899999999975554 45777765 33468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC----------------------------------
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS---------------------------------- 502 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~---------------------------------- 502 (726)
|||++|.+|. ... .....++.++++.|..||...
T Consensus 94 ~e~i~G~~l~--~~~----------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EECCSSEETT--TSC----------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEecCCcccC--cCc----------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999998884 221 112356777788888888643
Q ss_pred ---------------------CCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 503 ---------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 503 ---------------------~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.+.++|+|+++.|||++++..+.|.|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 2349999999999999887777899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.9e-09 Score=116.22 Aligned_cols=144 Identities=15% Similarity=0.162 Sum_probs=107.2
Q ss_pred cceeeeecCcEEEEEEEECCCcEEEEEEcc--cCCC-CchhHHHHHHHHHHhcc--cCceeEEEEEeecCCC-CceEEEE
Q 004869 384 PASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQ-QGDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS-SQHLLCY 457 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~--~~~~-~~~~~f~~Ei~iL~~L~--HpNIV~llg~~~~~~~-~~~~LV~ 457 (726)
..+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+++++.++ +.++.++++++...+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45788999999999988754 578888875 3321 23457889999999997 4567888888764321 4578999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC-----------------------------------
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS----------------------------------- 502 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~----------------------------------- 502 (726)
||++|..+.+... ..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999988854221 13677888899999999999999731
Q ss_pred --------------------CCceeecCCCccceeecCCCc--EEEEecCcccc
Q 004869 503 --------------------QPCVIHRDFKASNILLENNFH--AKVADFGLAKQ 534 (726)
Q Consensus 503 --------------------~p~IvHrDIKp~NILLd~~~~--vKL~DFGla~~ 534 (726)
.+.++|+|+++.|||++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 357999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.2e-09 Score=115.28 Aligned_cols=189 Identities=21% Similarity=0.271 Sum_probs=122.0
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCc--eeEEEEEeecCCC-CceEEEEeec
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRN--LVKLVGYYSSRDS-SQHLLCYELV 460 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpN--IV~llg~~~~~~~-~~~~LV~Ey~ 460 (726)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+.+.+....+. ...|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 56888886422 23467889999999884 332 3344444322111 2358899999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC---------------------------------------
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--------------------------------------- 501 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~--------------------------------------- 501 (726)
+|.+|.+... ..++..++..++.++++.|+.||..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875332 2356677778888888888888851
Q ss_pred ----------------CCCceeecCCCccceeecC--CCcEEEEecCccccCCCCCcccc------------cccccccc
Q 004869 502 ----------------SQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQAPEGRTNYL------------STRVMGTF 551 (726)
Q Consensus 502 ----------------~~p~IvHrDIKp~NILLd~--~~~vKL~DFGla~~~~~~~~~~~------------~~~~~GT~ 551 (726)
..+.++|+|+++.||++++ +..+.|.||+.+........... ........
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1356899999999999998 56688999999865422110000 00011111
Q ss_pred cccC-ccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 004869 552 GYVA-PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 587 (726)
Q Consensus 552 ~Y~A-PE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf 587 (726)
++.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2222 222211 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2e-06 Score=88.20 Aligned_cols=141 Identities=16% Similarity=0.128 Sum_probs=97.6
Q ss_pred hcCcccceeeeecCcE-EEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEE
Q 004869 379 TNNFEPASILGEGGFG-RVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG-~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~L 455 (726)
...|+. +.+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+-++++++.. ....++
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~l 97 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWL 97 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEE
Confidence 334443 345566655 69987754 466789998652 23457888999999885 3345667777763 357899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC---------------------------------
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--------------------------------- 502 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~--------------------------------- 502 (726)
|||++++.++.+.... .......++.++++.|..||...
T Consensus 98 vme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999887765431 12333455666666666666421
Q ss_pred ----------------------CCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 503 ----------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 503 ----------------------~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 2458999999999999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.3e-06 Score=89.25 Aligned_cols=137 Identities=22% Similarity=0.183 Sum_probs=92.2
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC---ceeEEEEEeecCCCCceEEEEeecC
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDSSQHLLCYELVP 461 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~llg~~~~~~~~~~~LV~Ey~~ 461 (726)
.+.++.|....||+. |..+++|+-. .......+.+|.++|+.+.+. .+.+.+.++.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccC
Confidence 466889999999987 4668888753 112345788999999999752 34556666542 3346789999999
Q ss_pred CCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhC----------------------------------------
Q 004869 462 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------------------------------------- 501 (726)
Q Consensus 462 ~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~---------------------------------------- 501 (726)
|.+|.+.... .++..++..++.++++.|+.||..
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9888763211 123334444444444444444432
Q ss_pred -----------------CCCceeecCCCccceeecC---CCc-EEEEecCcccc
Q 004869 502 -----------------SQPCVIHRDFKASNILLEN---NFH-AKVADFGLAKQ 534 (726)
Q Consensus 502 -----------------~~p~IvHrDIKp~NILLd~---~~~-vKL~DFGla~~ 534 (726)
..+.++|+|+++.|||++. ++. +.|.||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3456899999999999987 455 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3e-06 Score=90.80 Aligned_cols=83 Identities=6% Similarity=-0.060 Sum_probs=57.3
Q ss_pred ceee-eecCcEEEEEEEEC-------CCcEEEEEEcccCC---CCchhHHHHHHHHHHhccc---CceeEEEEEeecCC-
Q 004869 385 ASIL-GEGGFGRVFKGVLS-------DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSRD- 449 (726)
Q Consensus 385 ~~~L-G~G~fG~Vykg~l~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H---pNIV~llg~~~~~~- 449 (726)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+.. -.+.++++++...+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 26678888765322 1123568889999998853 35667777765321
Q ss_pred CCceEEEEeecCCCChhh
Q 004869 450 SSQHLLCYELVPNGSLES 467 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d 467 (726)
.+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 135689999999877764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.4e-05 Score=80.33 Aligned_cols=80 Identities=20% Similarity=0.211 Sum_probs=60.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhccc---CceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~llg~~~~~~~~~~~LV 456 (726)
..+...+.+|.|..+.||+.++.||+.|+||+-..........|..|.+.|+.|.- -.+.+.+++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEE
Confidence 45666788999999999999999999999998765444444568899999998842 2344555542 24789
Q ss_pred EeecCCCCh
Q 004869 457 YELVPNGSL 465 (726)
Q Consensus 457 ~Ey~~~GsL 465 (726)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999988764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=3.4e-05 Score=84.09 Aligned_cols=75 Identities=15% Similarity=0.090 Sum_probs=49.7
Q ss_pred ceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-------CchhHHHHHHHHHHhccc--Cc-eeEEEEEeecCCCCce
Q 004869 385 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------QGDKEFLVEVEMLSRLHH--RN-LVKLVGYYSSRDSSQH 453 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~iL~~L~H--pN-IV~llg~~~~~~~~~~ 453 (726)
.+.||.|.++.||++... +++.++||....... .....+..|.++|+.+.. +. +.+++.+. ....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCcc
Confidence 568999999999999754 467899997643211 123467889999988742 33 33555442 2346
Q ss_pred EEEEeecCCC
Q 004869 454 LLCYELVPNG 463 (726)
Q Consensus 454 ~LV~Ey~~~G 463 (726)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=2.8e-05 Score=81.93 Aligned_cols=143 Identities=22% Similarity=0.308 Sum_probs=80.7
Q ss_pred eeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC--ceeEEEEEe----ecCCCCceEEEEee
Q 004869 386 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYY----SSRDSSQHLLCYEL 459 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~llg~~----~~~~~~~~~LV~Ey 459 (726)
+.|+.|..+.||+....+| .+++|+... .......|.+++..+... .+.+++... .....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999988655 489998864 234455566776666421 233333210 00123467899999
Q ss_pred cCCCChh--------------hhccC-------CCCC---cccCChhhhH------------------------------
Q 004869 460 VPNGSLE--------------SWLHG-------PLGV---NCHLDWETRM------------------------------ 485 (726)
Q Consensus 460 ~~~GsL~--------------d~L~~-------~~~~---~~~Ls~~~~~------------------------------ 485 (726)
++|..+. ..+|. +... ...-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 11111 0000 0011232110
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 486 -KIALDAARGLAYLHE----------DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 486 -~ia~qIa~gL~yLH~----------~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.+...+.+++++|+. ...+.++|+|+++.|||++.++.+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666763 124569999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00035 Score=74.22 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=91.3
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc---cCceeEEEEEeecCCCCceEEEEee
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
...+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.+. ...+.+.++++.. ....++||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEEC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEe
Confidence 3457799999999999876 4677889987532 3567889999999884 2567778877653 3578999999
Q ss_pred cCCCChhh-----------hccCCCC---Cc---------------ccCChhhhH---HHH----------------HHH
Q 004869 460 VPNGSLES-----------WLHGPLG---VN---------------CHLDWETRM---KIA----------------LDA 491 (726)
Q Consensus 460 ~~~GsL~d-----------~L~~~~~---~~---------------~~Ls~~~~~---~ia----------------~qI 491 (726)
+++..+.. .||.... .. ..-+|.... ++. ..+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99987531 1222111 00 011343221 111 111
Q ss_pred HHHH-HHHHh-CCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 492 ARGL-AYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 492 a~gL-~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+ ..|.. ...|+++|+|+.+.|++++.++ +.|.||.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1112 23432 3468899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00059 Score=75.02 Aligned_cols=79 Identities=14% Similarity=0.151 Sum_probs=49.4
Q ss_pred CCCceeecCCCccceeecCCCcEEEEecCccccCCCCCcccccccc-cccccccCccccccC---CCCcchhHHHHHHHH
Q 004869 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-MGTFGYVAPEYAMTG---HLLVKSDVYSYGVVL 577 (726)
Q Consensus 502 ~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~---~~s~ksDVwSfGvvL 577 (726)
..+.++|+|+++.|||++.++ ++|.||+.+........ ..... .-...|++|+..... .-..+.++......+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 356699999999999998876 99999999875432110 00000 012346666655321 112345666888888
Q ss_pred HHHHhC
Q 004869 578 LELLTG 583 (726)
Q Consensus 578 ~ELltG 583 (726)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00065 Score=71.29 Aligned_cols=161 Identities=14% Similarity=0.144 Sum_probs=91.1
Q ss_pred cCHHHHHHHhcCccc-----ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce--eEEE
Q 004869 370 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLV 442 (726)
Q Consensus 370 ~~~~el~~~t~~f~~-----~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI--V~ll 442 (726)
++.+++......|.+ .+.|+.|....+|+....+| .+++|..... .....+..|++++..+...++ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 456677776666754 24566788899999988666 5888987642 123456778888888753332 2232
Q ss_pred EEeec----CCCCceEEEEeecCCCChhh--------------hccCC-CCCc-------ccCChhhhHH----------
Q 004869 443 GYYSS----RDSSQHLLCYELVPNGSLES--------------WLHGP-LGVN-------CHLDWETRMK---------- 486 (726)
Q Consensus 443 g~~~~----~~~~~~~LV~Ey~~~GsL~d--------------~L~~~-~~~~-------~~Ls~~~~~~---------- 486 (726)
..... ...+..+++++|++|..+.. .+|.. .... ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21000 01235689999999866431 01110 0000 0012322110
Q ss_pred --HHHHHHHHHHHHHhC----CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 487 --IALDAARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 487 --ia~qIa~gL~yLH~~----~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+...+.+.+++++.. ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111234455555532 23569999999999999987666899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0014 Score=68.52 Aligned_cols=139 Identities=12% Similarity=0.072 Sum_probs=77.0
Q ss_pred ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEEEEeec-CC
Q 004869 385 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELV-PN 462 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~LV~Ey~-~~ 462 (726)
.+.|+.|....+|+. ..+++|+...... ...+..+|..+++.+...++. ++++++ ...-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~----~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD----PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC----TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE----CCCCEEEEeecCCC
Confidence 578999999999998 4588888764321 122346788888877543333 555542 22357899999 65
Q ss_pred CChhh------------------hccCCCC-CcccCC-hhhhHHHHH--------------HHHHHHH----HHHh-CCC
Q 004869 463 GSLES------------------WLHGPLG-VNCHLD-WETRMKIAL--------------DAARGLA----YLHE-DSQ 503 (726)
Q Consensus 463 GsL~d------------------~L~~~~~-~~~~Ls-~~~~~~ia~--------------qIa~gL~----yLH~-~~~ 503 (726)
.+|.. .||.... .....+ +.....+.. .+.+.+. .|.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44431 1121100 000001 111111100 0111111 1111 234
Q ss_pred CceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 504 PCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 504 p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 56999999999999 5566789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0013 Score=72.93 Aligned_cols=73 Identities=23% Similarity=0.279 Sum_probs=50.8
Q ss_pred ceeeeecCcEEEEEEEECC--------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce-eEEEEEeecCCCCceEE
Q 004869 385 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~~~~~~~~~~~L 455 (726)
.+.|+.|....+|+....+ +..+++|+.... .....+.+|..++..+...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CE
Confidence 4678888899999998753 478888887421 112566789999998864444 46666543 2 38
Q ss_pred EEeecCCCCh
Q 004869 456 CYELVPNGSL 465 (726)
Q Consensus 456 V~Ey~~~GsL 465 (726)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987454
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0052 Score=64.85 Aligned_cols=143 Identities=17% Similarity=0.111 Sum_probs=73.4
Q ss_pred eeeeecCcEE-EEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC--ceeEEEEEeecCCCCceEEEEeecCC
Q 004869 386 SILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 386 ~~LG~G~fG~-Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
+.|+.|+... +|+....+|..+++|...... ...+..|++++..+... .+.+++.+.. +. -+++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~--g~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--AR--GLLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TT--TEEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CC--CEEEEeeCCC
Confidence 4455555444 667665446677777654221 13455677777777432 3445665532 22 2789999987
Q ss_pred CChhhhccCC---------------------CCC-cccCChhhhH-------H-------------HHHHHHHHHHHHH-
Q 004869 463 GSLESWLHGP---------------------LGV-NCHLDWETRM-------K-------------IALDAARGLAYLH- 499 (726)
Q Consensus 463 GsL~d~L~~~---------------------~~~-~~~Ls~~~~~-------~-------------ia~qIa~gL~yLH- 499 (726)
..+.+++... ... ...++..... . ....+.+.++.|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665443210 000 0001110000 0 0001111222221
Q ss_pred --hCCCCceeecCCCccceeecCC----CcEEEEecCccccC
Q 004869 500 --EDSQPCVIHRDFKASNILLENN----FHAKVADFGLAKQA 535 (726)
Q Consensus 500 --~~~~p~IvHrDIKp~NILLd~~----~~vKL~DFGla~~~ 535 (726)
....+.++|+|+.+.||+++.+ ..+.|.||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1234579999999999999874 68999999988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0041 Score=65.33 Aligned_cols=160 Identities=16% Similarity=0.125 Sum_probs=90.0
Q ss_pred cCHHHHHHHhcCccc-----ceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCc--eeEEE
Q 004869 370 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV 442 (726)
Q Consensus 370 ~~~~el~~~t~~f~~-----~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~ll 442 (726)
++.+++....+.|.+ ...++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 455555554444422 24566 88889999887777789999986332 23556778999888885322 33343
Q ss_pred EEeecC----CCCceEEEEeecCCCChhh----h----------ccC-----CCCCcccCChhhh----HHH--------
Q 004869 443 GYYSSR----DSSQHLLCYELVPNGSLES----W----------LHG-----PLGVNCHLDWETR----MKI-------- 487 (726)
Q Consensus 443 g~~~~~----~~~~~~LV~Ey~~~GsL~d----~----------L~~-----~~~~~~~Ls~~~~----~~i-------- 487 (726)
.. ... ..+..+++|+|++|..+.. . +|. .......+++... ..+
T Consensus 89 ~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 89 AF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred ec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 32 100 1235578999998865431 0 111 0000111222111 000
Q ss_pred -------HHHHHHHHHHHHh----CCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 488 -------ALDAARGLAYLHE----DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 488 -------a~qIa~gL~yLH~----~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
...+.+.++.+.. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122233322 1345689999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0051 Score=68.70 Aligned_cols=75 Identities=13% Similarity=0.027 Sum_probs=48.8
Q ss_pred ceeeeecCcEEEEEEEECC-CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce-eEEEEEeecCCCCceEEEEeecCC
Q 004869 385 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLCYELVPN 462 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~~~~~~~~~~~LV~Ey~~~ 462 (726)
.+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..++..+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEEeeCC
Confidence 4678888899999998865 4778888764322 111223689999999875555 45666652 2 259999998
Q ss_pred CChh
Q 004869 463 GSLE 466 (726)
Q Consensus 463 GsL~ 466 (726)
.+|.
T Consensus 186 ~~l~ 189 (458)
T 2qg7_A 186 YALS 189 (458)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.004 Score=66.87 Aligned_cols=74 Identities=14% Similarity=0.097 Sum_probs=45.2
Q ss_pred ceeeeecCcEEEEEEEECC---------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceE
Q 004869 385 ASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHL 454 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~ 454 (726)
.+.|+.|....+|+....+ +..+++|+..... ....+...|.++++.+...+++ ++++.. + -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~---~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF---N---GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T---TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec---C---Cc
Confidence 3567788888999988754 2678888765321 1112346788888888644443 566543 1 26
Q ss_pred EEEeecCCCCh
Q 004869 455 LCYELVPNGSL 465 (726)
Q Consensus 455 LV~Ey~~~GsL 465 (726)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0062 Score=66.38 Aligned_cols=141 Identities=20% Similarity=0.253 Sum_probs=82.5
Q ss_pred eeeeecCcEEEEEEEEC--------CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce-eEEEEEeecCCCCceEEE
Q 004869 386 SILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~~~~~~~~~~~LV 456 (726)
+.|..|-...+|+.... +++.+++|+... .........+|.++++.+.-.++ .++++++. + -+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----ccE
Confidence 56767888889998864 247888988632 22345667799999998853333 45666553 2 289
Q ss_pred EeecCCCChhhh-----------------ccCC-CCCcccC--ChhhhHHHHHHHHH-------------------HHHH
Q 004869 457 YELVPNGSLESW-----------------LHGP-LGVNCHL--DWETRMKIALDAAR-------------------GLAY 497 (726)
Q Consensus 457 ~Ey~~~GsL~d~-----------------L~~~-~~~~~~L--s~~~~~~ia~qIa~-------------------gL~y 497 (726)
|||++|.+|..- ||.- ....... -|.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998665421 1211 0111111 23444444433321 2233
Q ss_pred H----HhC-CCCceeecCCCccceeecCC----CcEEEEecCccc
Q 004869 498 L----HED-SQPCVIHRDFKASNILLENN----FHAKVADFGLAK 533 (726)
Q Consensus 498 L----H~~-~~p~IvHrDIKp~NILLd~~----~~vKL~DFGla~ 533 (726)
| ... ....++|+|+.+.|||++.+ +.+.|.||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3 222 23569999999999999876 789999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.01 Score=63.36 Aligned_cols=32 Identities=22% Similarity=0.302 Sum_probs=28.2
Q ss_pred CCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 503 ~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45699999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.67 E-value=0.044 Score=55.06 Aligned_cols=99 Identities=20% Similarity=0.167 Sum_probs=65.0
Q ss_pred CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCccc
Q 004869 463 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542 (726)
Q Consensus 463 GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 542 (726)
-+|.+.|.. .+.+++++++|.++.|.+.+|.-+-....+ ..+=+.+..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 378888863 356899999999999999998776221111 1233457899999999988764 1111
Q ss_pred ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh
Q 004869 543 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 582 (726)
Q Consensus 543 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt 582 (726)
.....+.+||... ...+.+.=|||+|++||.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888653 455789999999999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.34 E-value=0.048 Score=60.22 Aligned_cols=74 Identities=11% Similarity=0.088 Sum_probs=49.5
Q ss_pred ceeeeecCcEEEEEEEECC--------CcEEEEEEcccCCCCchhHHHHHHHHHHhcccCce-eEEEEEeecCCCCceEE
Q 004869 385 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~llg~~~~~~~~~~~L 455 (726)
.+.|..|-...+|+....+ +..+++|+..... ...-+..+|.++++.+...++ .++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP------EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET------TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------CCE
Confidence 4667778889999998753 5788888864332 222344679999988853333 34555331 278
Q ss_pred EEeecCCCCh
Q 004869 456 CYELVPNGSL 465 (726)
Q Consensus 456 V~Ey~~~GsL 465 (726)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.36 E-value=0.39 Score=52.12 Aligned_cols=29 Identities=28% Similarity=0.430 Sum_probs=24.6
Q ss_pred ceeecCCCccceee------cCCCcEEEEecCccc
Q 004869 505 CVIHRDFKASNILL------ENNFHAKVADFGLAK 533 (726)
Q Consensus 505 ~IvHrDIKp~NILL------d~~~~vKL~DFGla~ 533 (726)
.++|+|+.+.|||+ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46899999999999 456779999998875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.11 Score=38.55 Aligned_cols=27 Identities=19% Similarity=0.148 Sum_probs=14.8
Q ss_pred EEehhHHHHHHHHHHHHHHHHHHHhcc
Q 004869 310 LIFGIGTGLLITAIISVLIICSCAFRG 336 (726)
Q Consensus 310 iii~i~~~v~~~~l~~vl~i~~~~~r~ 336 (726)
++.++++|+++++++++++++++++|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 344555556666665555555554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.21 E-value=0.13 Score=38.16 Aligned_cols=28 Identities=18% Similarity=0.268 Sum_probs=14.6
Q ss_pred EEehhHHHHHHHHHHHHHHHHHHHhccC
Q 004869 310 LIFGIGTGLLITAIISVLIICSCAFRGR 337 (726)
Q Consensus 310 iii~i~~~v~~~~l~~vl~i~~~~~r~r 337 (726)
++.+++.|+++++++++++++++++|++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3444555566655555555555554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.96 E-value=0.19 Score=37.17 Aligned_cols=27 Identities=19% Similarity=0.240 Sum_probs=13.8
Q ss_pred EEehhHHHHHHHHHHHHHHHHHHHhcc
Q 004869 310 LIFGIGTGLLITAIISVLIICSCAFRG 336 (726)
Q Consensus 310 iii~i~~~v~~~~l~~vl~i~~~~~r~ 336 (726)
.|+++++|++++++++++++++.++|+
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHHHHHHHHHhheehhh
Confidence 355555665544444455455544443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 726 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 6e-76
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 24/286 (8%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
+G G FG V+KG AV + +T Q + F EV +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+GY + Q + + SL LH + + IA A+G+ YLH
Sbjct: 68 LFMGYS---TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+IHRD K++NI L + K+ DFGLA ++ ++ G+ ++APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 560 MT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
+SDVY++G+VL EL+TG+ P N ++ +L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDL- 231
Query: 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
++ PK + + A C+ + ++RP +++ S++++ R
Sbjct: 232 -SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-68
Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 28/280 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
+ LG G FG V+ G + T VA+K L G FL E ++ +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L + + E + NGSL +L P G+ L + +A A G+A++
Sbjct: 72 RLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIE 126
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
E IHRD +A+NIL+ + K+ADFGLA+ + + APE
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAI 182
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADP 618
G +KSDV+S+G++L E++T + + + + ++R + EEL
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ- 241
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ C RPT + L+
Sbjct: 242 ----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-67
Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 28/295 (9%)
Query: 388 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 447
+G+G FG V++G G VA+K + ++ E+ L H N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 448 RDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---- 501
+ + Q L + +GSL +L+ + E +K+AL A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 502 -SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEY 558
+P + HRD K+ NIL++ N +AD GLA + +GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 559 AMTGHLL------VKSDVYSYGVVLLELLTGRKP----VDMSQPSGQENLVTWARPILRD 608
+ ++D+Y+ G+V E+ D P + +R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR- 242
Query: 609 KDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
K E+ P + ++ + +R + I C R T + ++L + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 3e-67
Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 26/279 (9%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
+ +G G FG V G + VAIK + G +++F+ E E++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L G + + L +E + +G L +L ET + + LD G+AYL
Sbjct: 64 QLYGVC--LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLE 118
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
E CVIHRD A N L+ N KV+DFG+ + + + ST + +PE
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVF 174
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
KSDV+S+GV++ E+ + K ++ + + ++ D L PR
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPR 225
Query: 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
L + + I C RP +++ L
Sbjct: 226 LASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (547), Expect = 9e-65
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 42/308 (13%)
Query: 372 YEELKEATNNF---------EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCG-GQ 417
+E+ EA F + ++G G FG V G L VAIK L G +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 418 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 477
+ ++FL E ++ + H N++ L S+ ++ E + NGSL+S+L G
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHL--EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
+ + A G+ YL +HRD A NIL+ +N KV+DFGL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 538 GRTNYLSTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 594
++ T + APE SDV+SYG+V+ E+++ + P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 595 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 654
I +D P + + + C + N RP G++V
Sbjct: 236 DMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 655 QSL-KMVQ 661
+L KM++
Sbjct: 285 NTLDKMIR 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-64
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 42/310 (13%)
Query: 374 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLS 431
ELK+ ++FE S LG G G VFK G +A K + + + + E+++L
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
+ +V G + + +C E + GSL+ L + + K+++
Sbjct: 60 ECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
+GL YL + ++HRD K SNIL+ + K+ DFG++ Q + +GT
Sbjct: 114 IKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 167
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD----------------------M 589
Y++PE H V+SD++S G+ L+E+ GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 590 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA----AACVAPEAN 645
+P ++ R + EL D + PK C+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 646 QRPTMGEVVQ 655
+R + +++
Sbjct: 288 ERADLKQLMV 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-64
Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 28/280 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
+ LG G FG V G VAIK + G + EF+ E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L G + + E + NG L ++L + +++ D + YL
Sbjct: 63 QLYGVCT--KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE 117
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+HRD A N L+ + KV+DFGL++ + S + PE
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVL 173
Query: 560 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618
M KSD++++GV++ E+ + G+ P + S + + R E++
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT- 232
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
I +C +A++RPT ++ ++
Sbjct: 233 ----------------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 28/282 (9%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRN 437
++E +G G +GR K SDG + K L G + + + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+V+ R ++ + E G L S + +LD E +++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 498 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
H D V+HRD K +N+ L+ + K+ DFGLA+ + + +GT Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMS 182
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
PE KSD++S G +L EL P + A I K
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGK------ 230
Query: 616 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
R+ +Y E + I + + RP++ E+++
Sbjct: 231 -FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 8e-63
Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 30/283 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
+ +G+G FG V G G VA+K + + FL E ++++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 440 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 499
+L+G + + E + GSL +L L + +K +LD + YL
Sbjct: 64 QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 500 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+HRD A N+L+ + AKV+DFGL K+A + + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
KSDV+S+G++L E+ + + P + L + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGY-------KMD 220
Query: 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662
P V + C +A RP+ ++ + L+ ++
Sbjct: 221 APDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-62
Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 33/293 (11%)
Query: 373 EELKEATNNFEPASI-LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGD-KEFLVEV 427
++L +N A I LG G FG V +GV VAIK L G ++ D +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
+++ +L + +V+L+G + +L E+ G L +L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAEL 114
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTR 546
+ G+ YL + +HRD A N+LL N +AK++DFGL+K + Y +
Sbjct: 115 LHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPI 605
+ APE +SDV+SYGV + E L+ G+KP + + + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ EL + + C + RP V Q ++
Sbjct: 232 ECPPECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-61
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 387 ILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 441
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 442 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+G R L+ + +G L +++ + + + L A+G+ +L
Sbjct: 94 LGICL-RSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLA-- 147
Query: 502 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP--EGRTNYLSTRVMGTFGYVAPEYA 559
+HRD A N +L+ F KVADFGLA+ E + + T ++A E
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
T KSDV+S+GV+L EL+T P P N +L+ + L+
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ------ 255
Query: 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
P+ + + C P+A RP+ E+V +
Sbjct: 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (521), Expect = 5e-61
Identities = 68/314 (21%), Positives = 107/314 (34%), Gaps = 48/314 (15%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFL 424
L+ NN E +GEG FGRVF+ T VA+K L +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------- 471
E +++ + N+VK L +E + G L +L
Sbjct: 65 REAALMAEFDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 472 -------PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524
L ++ IA A G+AYL E +HRD N L+ N
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 584
K+ADFGL++ ++ PE +SDV++YGVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 585 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 644
P + RD + L P+ + + + C +
Sbjct: 240 LQ-----PYYGMAHEEVIYYV-RDGNILA----------CPENCPLELYNLMRLCWSKLP 283
Query: 645 NQRPTMGEVVQSLK 658
RP+ + + L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 5e-61
Identities = 79/293 (26%), Positives = 120/293 (40%), Gaps = 26/293 (8%)
Query: 366 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 425
T+ LA + + + LG+G FG V+ G + T VAIK L G + FL
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQ 61
Query: 426 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 485
E +++ +L H LV+L S + E + GSL +L G G +
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLR--LPQLV 116
Query: 486 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 545
+A A G+AY+ + +HRD +A+NIL+ N KVADFGLA+ +
Sbjct: 117 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 172
Query: 546 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 605
+ APE A+ G +KSDV+S+G++L EL T + P +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQV 227
Query: 606 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
R P E + + C E +RPT + L+
Sbjct: 228 ERGYRM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 7e-61
Identities = 71/303 (23%), Positives = 114/303 (37%), Gaps = 46/303 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 432
N LG G FG+V + VA+K L ++E + E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 433 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------- 478
L +H N+V L+G + L+ E G L ++L
Sbjct: 83 LGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 479 -LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
LD E + + A+G+A+L IHRD A NILL + K+ DFGLA+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE- 596
+ ++APE +SDV+SYG+ L EL + P +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 597 -NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
++ +L + E+ D I C + +RPT ++VQ
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 300
Query: 656 SLK 658
++
Sbjct: 301 LIE 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 34/278 (12%)
Query: 388 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLV 442
LG G FG V KG VA+K L E L E ++ +L + +V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 443 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
G ++ +L E+ G L +L N H+ + +++ + G+ YL
Sbjct: 75 GIC---EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 503 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL-STRVMGTFGYVAPEYAMT 561
+ +HRD A N+LL +AK++DFGL+K Y T + APE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 562 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 620
KSDV+S+GV++ E + G+KP + S ++ + E+ D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD--- 241
Query: 621 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ C + RP V L+
Sbjct: 242 --------------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 47/306 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 432
N E +LG G FG+V VA+K L ++E + E++M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 433 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG----------------- 474
L H N+V L+G S L +E G L ++L
Sbjct: 97 LGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 475 --VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532
L +E + A A+G+ +L +HRD A N+L+ + K+ DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 592
+ + ++APE G +KSDV+SYG++L E+ + P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----P 266
Query: 593 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
+ ++++ +++ P + I +C A ++ +RP+
Sbjct: 267 YPGIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 653 VVQSLK 658
+ L
Sbjct: 317 LTSFLG 322
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 3e-60
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 26/298 (8%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEML 430
Y++ + + LG G +G V++GV VA+K L + +EFL E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVM 67
Query: 431 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
+ H NLV+L+G + + E + G+L +L + + +A
Sbjct: 68 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQ 123
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
+ + YL + IHRD A N L+ N KVADFGL++ G T
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
+ APE +KSDV+++GV+L E+ T D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 223
Query: 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668
++ EL + + P+ +V + AC + RP+ E+ Q+ + + + D
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-60
Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 35/277 (12%)
Query: 387 ILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVG 443
+G G F V+KG+ ++ VA L + + F E EML L H N+V+
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 444 YYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 501
+ S + + EL+ +G+L+++L + + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 502 SQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
+ P +IHRD K NI + K+ D GLA V+GT ++APE
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM-Y 185
Query: 561 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARPILRDKDRLEELADP 618
DVY++G+ +LE+ T P Q + Q + + +P DK + E+ +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244
Query: 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
I C+ ++R ++ +++
Sbjct: 245 ----------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 5e-60
Identities = 72/280 (25%), Positives = 111/280 (39%), Gaps = 35/280 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHH 435
+FE LG+G FG V+ +A+K L + + EVE+ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
N+++L GY+ D+++ L E P G++ L D + + A L
Sbjct: 66 PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 119
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
+Y H VIHRD K N+LL + K+ADFG + AP R + GT Y+
Sbjct: 120 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 172
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
PE K D++S GV+ E L G+ P + + I R + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDF 226
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
D I + +QRP + EV++
Sbjct: 227 VTEGA------RDLIS------RLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-59
Identities = 77/290 (26%), Positives = 113/290 (38%), Gaps = 32/290 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSR 432
+ LG+G FG V +G +VA+K L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
L HRNL++L G + + EL P GSL L G H T + A+ A
Sbjct: 68 LDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVA 121
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTF 551
G+ YL IHRD A N+LL K+ DFGL + P+ +Y + F
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611
+ APE T SD + +GV L E+ T + P N I ++ +R
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER 233
Query: 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661
L D P++ + + C A + RPT + L Q
Sbjct: 234 LPRPED------CPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-58
Identities = 64/291 (21%), Positives = 118/291 (40%), Gaps = 31/291 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDK-EFLVEVEMLSRL 433
+ ++G G FG V+KG+L + VAIK L G + + +FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 434 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
H N+++L G ++ E + NG+L+ +L + + + A
Sbjct: 67 SHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 121
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 552
G+ YL +HRD A NIL+ +N KV+DFGL++ + Y ++
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612
+ APE SDV+S+G+V+ E++T + + + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222
Query: 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663
+ + P + + + C E +RP ++V L + R
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 42/323 (13%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRL-H 434
N+ + ++GEG FG+V K + AIKR+ + ++F E+E+L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------PLGVNCHLDWE 482
H N++ L+G R L E P+G+L +L L +
Sbjct: 70 HPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 483 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 542
+ A D ARG+ YL Q IHRD A NIL+ N+ AK+ADFGL++
Sbjct: 128 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-- 182
Query: 543 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602
T ++A E SDV+SYGV+L E+++ P
Sbjct: 183 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY 236
Query: 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 661
+ + RLE P V + C + +RP+ +++ SL +M++
Sbjct: 237 EKLPQGY-RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 662 RVIECQDPTLTSSNNRANLRQSS 684
+ TL A + S+
Sbjct: 286 ERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-58
Identities = 65/294 (22%), Positives = 120/294 (40%), Gaps = 36/294 (12%)
Query: 372 YEELKEATN---NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 427
YE + N +E LG+G FG+V+K A K + ++ ++++VE+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 428 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 487
++L+ H N+VKL+ + + + E G++++ + L +
Sbjct: 61 DILASCDHPNIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVV 115
Query: 488 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 547
L YLH++ +IHRD KA NIL + K+ADFG++ +
Sbjct: 116 CKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 548 MGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTW 601
+GT ++APE M K+DV+S G+ L+E+ P +++ +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230
Query: 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
P L R +DF++ C+ + R T +++Q
Sbjct: 231 EPPTLAQPSRWSSNF----------KDFLK------KCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 5e-58
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 40/282 (14%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRN 437
F +G G FG V+ + + VAIK+++ G+Q + ++ + EV L +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
++ G Y L E + + L + A +GLAY
Sbjct: 77 TIQYRGCY--LREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAY 130
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
LH + +IHRD KA NILL K+ DFG A + +GT ++APE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 181
Query: 558 YAMT---GHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 613
+ G K DV+S G+ +EL + P +M+ S ++ P L+ E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ +C+ RPT +++
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 64/280 (22%), Positives = 106/280 (37%), Gaps = 29/280 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 437
+++ LGEG +G V V AVA+K + + E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+VK G+ R+ + L E G L + + + + G+ Y
Sbjct: 65 VVKFYGHR--REGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVY 118
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
LH + HRD K N+LL+ + K++DFGLA L ++ GT YVAPE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 558 YAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEEL 615
DV+S G+VL +L G P D S QE + + L +++
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ + + R T+ ++ +
Sbjct: 236 P----------LALLH------KILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 9e-57
Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLH 434
E +GEG FG V +G+ AVAIK +E FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
H ++VKL+G + + EL G L S+L LD + + A +
Sbjct: 67 HPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTA 120
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
LAYL +HRD A N+L+ +N K+ DFGL++ + T Y +++ ++
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWM 176
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 613
APE SDV+ +GV + E+L G KP + + + + +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660
L + C A + ++RP E+ L +
Sbjct: 237 TLYS-----------------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 74/333 (22%), Positives = 135/333 (40%), Gaps = 41/333 (12%)
Query: 382 FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH 435
F+ +LG G FG V+KG+ VAIK L + +KE L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
++ +L+G + L +L+P G L ++ ++ + + + A+G+
Sbjct: 71 PHVCRLLGICLTST---VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 124
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
YL ++HRD A N+L++ H K+ DFGLAK Y + ++A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
E + +SDV+SYGV + EL+T G KP D S +++ + + +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241
Query: 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR------VIECQD 668
+ I C +A+ RP E++ + R VI+ +
Sbjct: 242 VYM-----------------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 669 PTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPY 701
S +N ++ D + + + Y
Sbjct: 285 RMHLPSPTDSNFYRALM--DEEDMDDVVDADEY 315
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 58/279 (20%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 437
+ +G+G G V+ + ++ G VAI+++ Q + + E+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+V + Y + + E + GSL + +D + + + L +
Sbjct: 79 IVNYLDSY--LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
LH + VIHRD K+ NILL + K+ DFG Q ++ + ++GT ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELA 616
K D++S G++ +E++ G P ++ + + T P L++ ++L +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
DF+ C+ + +R + E++Q
Sbjct: 247 ----------RDFLN------RCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 38/302 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 432
+ + LG G FG+V + + VA+K L G + + + E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLD 480
+ H V + ++ ++ E G+L ++L L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
E + + A+G+ +L IHRD A NILL K+ DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 600
++APE ++SDV+S+GV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 601 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 659
L++ R+ P + C E +QRPT E+V+ L +
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 660 VQ 661
+Q
Sbjct: 295 LQ 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 7e-53
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 34/292 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSR 432
+ LG+G FG V++GV T VAIK + + EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------GPLGVNCHLDWETRMK 486
+ ++V+L+G S L+ EL+ G L+S+L V ++
Sbjct: 80 FNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 487 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 546
+A + A G+AYL+ +HRD A N ++ +F K+ DFG+ + E +
Sbjct: 138 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 547 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606
+ +++PE G SDV+S+GVVL E+ T + P + R ++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVM 249
Query: 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
P + + C RP+ E++ S+K
Sbjct: 250 EGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 7e-52
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 43/303 (14%)
Query: 380 NNFEPASILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGD-KEFLVEVEML 430
+ LGEG FG+V + T VA+K L + D + + E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 431 SRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------------GPLGVNC 477
+ H+N++ L+G + + E G+L +L
Sbjct: 73 KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 478 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537
L + + A ARG+ YL IHRD A N+L+ + K+ADFGLA+
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 538 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
+T ++APE +SDV+S+GV+L E+ T P
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 242
Query: 598 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657
V +L++ R++ P + + C +QRPT ++V+ L
Sbjct: 243 -VEELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 658 KMV 660
+
Sbjct: 292 DRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 66/282 (23%), Positives = 104/282 (36%), Gaps = 31/282 (10%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLS 431
K+ +F+ ILGEG F V L+ AIK L + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 432 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 491
RL H VKL + +D + NG L ++ D +
Sbjct: 64 RLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEI 117
Query: 492 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 551
L YLH +IHRD K NILL + H ++ DFG AK + +GT
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611
YV+PE SD+++ G ++ +L+ G P N + I++ +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYD 228
Query: 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 653
E P+ D + + +A +R E+
Sbjct: 229 FPEKFFPKA------RDLVE------KLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 4e-51
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
++++ LG G FG V + + G A K + + + E++ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
V L + D ++ ++ YE + G L + + + ++ +GL ++
Sbjct: 86 VNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHM 140
Query: 499 HEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
HE +H D K NI+ + + K+ DFGL ++ GT + AP
Sbjct: 141 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAP 194
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
E A + +D++S GV+ LL+G P EN R + +++ A
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWNMDDSA 248
Query: 617 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ ++ DFIR + + N R T+ + ++
Sbjct: 249 FSGI----SEDGKDFIR------KLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 3e-50
Identities = 65/315 (20%), Positives = 121/315 (38%), Gaps = 34/315 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
+ ++ LG G FG V + V + G K + E+ ++++LHH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
+ L + D + +L E + G L + + + + A GL ++
Sbjct: 89 INLHDAF--EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHM 143
Query: 499 HEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
HE ++H D K NI+ E K+ DFGLA + T + AP
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAP 197
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616
E + +D+++ GV+ LL+G P G+++L T + R +E A
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQN-VKRCDWEFDEDA 251
Query: 617 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS--LKMVQRVIECQDPTLT 672
+ E DFI+ + E +R T+ + ++ LK + + P+
Sbjct: 252 FSSV----SPEAKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301
Query: 673 SSNNRANLRQSSTTF 687
+ R +++ +
Sbjct: 302 YNKIRQKIKEKYADW 316
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (437), Expect = 2e-49
Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 33/294 (11%)
Query: 379 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH 434
++ +E ILG GG V L VA+K L F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 435 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
H +V + + + L E V +L +H + + +++ DA
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTF 551
+ L + H+ +IHRD K +NI++ KV DFG+A+ A G + + V+GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 552 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611
Y++PE A + +SDVYS G VL E+LTG P ++ V+ A +R+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPI 232
Query: 612 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 662
L + + +A R T E+ L V
Sbjct: 233 PPSARHEGL----SADLDAVVL------KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (433), Expect = 1e-48
Identities = 52/288 (18%), Positives = 103/288 (35%), Gaps = 29/288 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
N + +G G FG ++ G ++ G VAIK + + +E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
+ + + + + +++ EL+ + + + +T + +A + Y+
Sbjct: 65 IPTIRWCGA-EGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYI 119
Query: 499 HEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRTN-----YLSTRVMGT 550
H IHRD K N L + + DFGLAK+ + RT+ + + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
Y + + + D+ S G VL+ G P + + + R +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISE 230
Query: 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
+ L YP E T C + + +P + Q +
Sbjct: 231 KKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (430), Expect = 2e-48
Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 47/294 (15%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---------QQGDKEFLVEVEML 430
N+EP ILG G V + + A+K + G Q+ + L EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 431 SRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
++ H N+++L Y ++ L ++L+ G L +L L + KI
Sbjct: 64 RKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMR 117
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ LH+ ++HRD K NILL+++ + K+ DFG + Q G V G
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 171
Query: 550 TFGYVAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 603
T Y+APE + D++S GV++ LL G P + R
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLR 225
Query: 604 PILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
I+ + Y D + + + +R T E +
Sbjct: 226 MIMSGNYQFGSPEWD----DYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (437), Expect = 2e-48
Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH- 434
N+F I+G GGFG V+ +D G A+K L +QG+ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 435 --HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
+V + + + +L+ G L L + A +
Sbjct: 64 GDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEII 117
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
GL ++H V++RD K +NILL+ + H +++D GLA + + + +GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 170
Query: 553 YVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611
Y+APE G +D +S G +L +LL G P + + + DR
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DR 219
Query: 612 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 652
+ L + E + + + N+R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLE------GLLQRDVNRRLGCLG 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 2e-47
Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 29/288 (10%)
Query: 372 YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEM 429
+++ ++ + ++ +LG G F V VAIK + +G + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 430 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 489
L ++ H N+V L Y L +LV G L + ++
Sbjct: 61 LHKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIF 114
Query: 490 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ YLH+ + L+ + ++DFGL+K G + G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609
T GYVAPE D +S GV+ LL G P EN IL+ +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE 225
Query: 610 DRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ + DFIR + + +R T + +Q
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR------HLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 65/337 (19%), Positives = 117/337 (34%), Gaps = 37/337 (10%)
Query: 376 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 434
KE + A LG G FG V + V S K + G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
HRN++ L + S + + ++ +E + + ++ L+ +
Sbjct: 60 HRNILHLHESFESME--ELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114
Query: 495 LAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
L +LH + H D + NI+ + K+ +FG A+Q G +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612
Y APE + +D++S G ++ LL+G P E I+ +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYTF 222
Query: 613 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 670
+E A + E DF+ + E R T E +Q +++ IE
Sbjct: 223 DEEAFKEI----SIEAMDFVD------RLLVKERKSRMTASEALQH-PWLKQKIERVSTK 271
Query: 671 LTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAF 707
+ + R+ T + + S+ S A
Sbjct: 272 VIRTLKH---RRYYHTLIKKDLNMVVSAARISCGGAI 305
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 27/298 (9%)
Query: 377 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 434
+ + S +GEG +G V + VAIK+++ Q + L E+++L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 435 HRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
H N++ + + Q Y + L L HL +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQIL 119
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTF 551
RGL Y+H V+HRD K SN+LL K+ DFGLA+ A P+ T + T
Sbjct: 120 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 552 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--RPILRD 608
Y APE + KS D++S G +L E+L+ R Q N + P D
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAA-----------ACVAPEANQRPTMGEVVQ 655
+ + L P ++ + + + ++R + + +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSR-LH 434
+F +LG+G FG+VF AIK L D + +VE +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 435 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 494
H L + + +++ E + G L + D A + G
Sbjct: 62 HPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILG 115
Query: 495 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
L +LH +++RD K NILL+ + H K+ADFG+ K+ G GT Y+
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614
APE + D +S+GV+L E+L G+ P ++ I D
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPR 224
Query: 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 650
+ +D + E +R +
Sbjct: 225 WLEKEA------KDLLV------KLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-46
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 22/294 (7%)
Query: 378 ATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL 433
A +E + +GEG +G+VFK + + G VA+KR+ G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 434 ---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
H N+V+L + + + + + + + + ET +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 551 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610
Y APE + D++S G + E+ + S Q + + ++D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 611 RLEELADPRLG----GKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 655
++A PR P E F+ C+ +R + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (400), Expect = 7e-44
Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 36/274 (13%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 435
+F+ LG G FGRV +G A+K L + + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
++++ G + +D+ Q + + + G L S L + A + L
Sbjct: 64 PFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLAL 117
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
YLH +I+RD K NILL+ N H K+ DFG AK P+ GT Y+A
Sbjct: 118 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIA 169
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
PE T D +S+G+++ E+L G P N + IL + R
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELRFPPF 223
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT 649
+ + +D + + + +QR
Sbjct: 224 FNEDV------KDLLS------RLITRDLSQRLG 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (398), Expect = 7e-44
Identities = 48/290 (16%), Positives = 93/290 (32%), Gaps = 31/290 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 438
+++ +GEG FG +F+G L + VAIK + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 439 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 498
+ V Y+ + ++L +L+ + +T A + +
Sbjct: 63 IPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSI 117
Query: 499 HEDSQPCVIHRDFKASNILL-----ENNFHAKVADFGLAKQAPEGRTN-----YLSTRVM 548
H + +++RD K N L+ +N V DFG+ K + T +
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
GT Y++ + + D+ + G V + L G P + T + R
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------ATNKQKYERI 228
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658
++ + L +P+E + P +
Sbjct: 229 GEKKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 9e-44
Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 437
+ +GEG +G V+K + G A+K RL + + E+ +L L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+VKL + +L +E + + L+ T L G+AY
Sbjct: 62 IVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAY 115
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
H+ V+HRD K N+L+ K+ADFGLA+ Y + ++ +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDV 171
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617
+ D++S G + E++ G + Q + K+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 618 PRLGGKY------PKEDFIRVCTIAAA-----CVAPEANQRPTMGEVVQ 655
P+ + P E F++ + + + NQR T + ++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 35/320 (10%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 444
+LG G G+V + A+K L Q + EVE+ R ++V++V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 445 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 502
Y + + + L E + G L S + + +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 503 QPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 559
+ HRD K N+L N K+ DFG AK+ + T YVAPE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 560 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619
D++S GV++ LL G P G I +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 620 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 677
+ +E IR + E QR T+ E + + + + L +S
Sbjct: 244 V----SEEVKMLIR------NLLKTEPTQRMTITEFMNH-PWIMQSTKVPQTPLHTSRVL 292
Query: 678 ANLRQSSTTFDSDGTSSMFS 697
++ + TS++ +
Sbjct: 293 KEDKERWEDVKEEMTSALAT 312
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 68/286 (23%), Positives = 105/286 (36%), Gaps = 28/286 (9%)
Query: 387 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLHHRNLVK 440
LGEG F V+K + VAIK++ G + K+ L E+++L L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 500
L+ + S L ++ + + L L +GL YLH+
Sbjct: 65 LLDAF--GHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 501 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 560
++HRD K +N+LL+ N K+ADFGLAK Y T + T Y APE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLF 173
Query: 561 TGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDKDRLEE 614
+ V D+++ G +L ELL + Q E L T D L +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 615 LADPRLGGKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 655
+ P R T + ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)
Query: 381 NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 437
NF+ +GEG +G V+K G VA+K RL + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
+VKL+ ++ L +E + + L + +GLA+
Sbjct: 63 IVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAF 117
Query: 498 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 557
H V+HRD K N+L+ K+ADFGLA+ Y + V+ +
Sbjct: 118 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEI 173
Query: 558 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617
+ D++S G + E++T R Q + + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 618 PRLGGKYPK---EDFIRVCTIAAA--------CVAPEANQRPTMGEVVQ 655
P +PK +DF +V + + N+R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 67/292 (22%), Positives = 103/292 (35%), Gaps = 27/292 (9%)
Query: 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 439
++ ++G G FG V++ L G VAIK++ Q + E++++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 440 KLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
+L ++ S + L + VP H L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSL 135
Query: 496 AYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 554
AY+H + HRD K N+LL + K+ DFG AKQ G N + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 555 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDK 609
DV+S G VL ELL G+ Q + L T R +R+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 610 DRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEVVQ 655
+ +P R T A + R T E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 69/289 (23%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD------KEFLVEVEMLSR 432
+ ++ LG G F V K S G A K + + ++ EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 433 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
+ H N++ L Y + + +L ELV G L +L L E +
Sbjct: 70 IQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQIL 123
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 548
G+ YLH + H D K NI+L K+ DFGLA + G +
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 549 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
GT +VAPE L +++D++S GV+ LL+G P V+ D
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 609 K--DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 655
+ LA +DFIR + + +R T+ + +Q
Sbjct: 238 EYFSNTSALA----------KDFIR------RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 61/277 (22%), Positives = 96/277 (34%), Gaps = 33/277 (11%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 435
N+F+ +LG+G FG+V + G A+K L + + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
L L Y+ + + E G L L E + L
Sbjct: 65 PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSAL 118
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
YLH V++RD K N++L+ + H K+ DFGL K+ GT Y+A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615
PE D + GVV+ E++ GR P ++ IL ++ R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFELILMEEIRFPRT 227
Query: 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
P + + + + QR G
Sbjct: 228 LSPEA------KSLLA------GLLKKDPKQRLGGGP 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 48/302 (15%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLVEVEMLSR 432
+ ++ +LG GGFG V+ G+ +SD VAIK + G +EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 433 LH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
+ +++L+ ++ DS +L E + L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDF---ITERGALQEELARSFFWQ 118
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
+ + H V+HRD K NIL+ N K+ DFG + T G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDG 171
Query: 550 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
T Y PE+ +S V+S G++L +++ G P + + I+R
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 668
+ + + IR C+A + RPT E+ +Q V+ Q+
Sbjct: 220 QVFFRQRVSSEC------QHLIR------WCLALRPSDRPTFEEIQNH-PWMQDVLLPQE 266
Query: 669 PT 670
Sbjct: 267 TA 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 59/302 (19%), Positives = 117/302 (38%), Gaps = 33/302 (10%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHR 436
+ +E + +G+G FG VFK G VA+K++ ++ L E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 437 NLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
N+V L+ ++ S + L ++ + + V ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRVM 548
GL Y+H ++HRD KA+N+L+ + K+ADFGLA+ + + + T +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 549 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT------- 600
T Y PE + D++ G ++ E+ T + + Q L++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 601 -WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEV 653
P + + + E+L + + K+ A + + QR +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 654 VQ 655
+
Sbjct: 303 LN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-39
Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 29/304 (9%)
Query: 372 YEELKEAT----NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFL 424
+E+ + + +G G +G V V G VAIK+L + K
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 425 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 484
E+ +L + H N++ L+ ++ ++ + LV G L + L +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGEDRI 123
Query: 485 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 544
+ +GL Y+H +IHRD K N+ + + K+ DFGLA+QA T
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---- 176
Query: 545 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----- 599
V+ + D++S G ++ E++TG+ S Q +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 600 ----TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAA----ACVAPEANQRPTMG 651
+ + + D+ + P L K +A + +A QR T G
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 652 EVVQ 655
E +
Sbjct: 297 EALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 2e-38
Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 25/291 (8%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 436
+E +GEG +G VFK VA+K RL + L E+ +L L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 437 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 496
N+V+L S LV + N LD E +GL
Sbjct: 62 NIVRLHDVLHSDK------KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 497 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
+ H V+HRD K N+L+ N K+A+FGLA+ Y S V+ +
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171
Query: 557 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG---QENLVTWARPILRDKDRLE 613
D++S G + EL +P+ + P +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 614 ELADPRLGGKYPKEDFIRVCT---------IAAACVAPEANQRPTMGEVVQ 655
+L D + YP + + + QR + E +Q
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-35
Identities = 53/306 (17%), Positives = 110/306 (35%), Gaps = 52/306 (16%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRN 437
++++ LG G + VF+ + +++ V +K L K+ E+++L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPN 91
Query: 438 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 497
++ L S L +E V N + L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 498 LHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 556
H ++HRD K N+++++ + ++ D+GLA+ G+ + + + P
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198
Query: 557 EYAMTGHLL-VKSDVYSYGVVLLELLTGRKP-----------VDMSQPSGQENLVTWARP 604
E + + D++S G +L ++ ++P V +++ G E+L +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 605 ILRDKD-------------RLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 649
+ D R E E DF+ + + R T
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD------KLLRYDHQSRLT 312
Query: 650 MGEVVQ 655
E ++
Sbjct: 313 AREAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 2e-35
Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 18/234 (7%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHH 435
+ F+ LG G FGRV G A+K L K+ L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 436 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 495
LVKL + + +V + L A
Sbjct: 101 PFLVKLEFSF------KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 496 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 555
YLH +I+RD K N+L++ + +V DFG AK+ GT +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALA 206
Query: 556 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 609
PE ++ D ++ GV++ E+ G P QP + +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-35
Identities = 65/284 (22%), Positives = 110/284 (38%), Gaps = 35/284 (12%)
Query: 380 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL----TCGGQQGDKEFLVEVEMLS 431
NFE +LG G +G+VF G A+K L + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 432 RL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 490
+ LV L +Y+ + ++ L + + G L + L +
Sbjct: 84 HIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGE 137
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 550
L +LH+ +I+RD K NILL++N H + DFGL+K+ T + GT
Sbjct: 138 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 193
Query: 551 FGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608
Y+AP+ G D +S GV++ ELLTG P + + + +R IL+
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251
Query: 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 652
+ + +D I+ + + +R G
Sbjct: 252 EPPYPQEMSALA------KDLIQ------RLLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-35
Identities = 58/307 (18%), Positives = 113/307 (36%), Gaps = 44/307 (14%)
Query: 380 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 436
++ +G G G V VAIK+L Q K E+ ++ ++H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 437 NLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 492
N++ L+ ++ + + + L EL+ + LD E +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQML 129
Query: 493 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 552
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ----------------E 596
Y APE + D++S G ++ E++ + Q +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--------CVAPEANQRP 648
L R + ++ + L P+L + A+ + + +R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 649 TMGEVVQ 655
++ + +Q
Sbjct: 304 SVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 25/308 (8%)
Query: 364 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-- 420
PT R + + E ++ S +G G +G V G VA+K+L+ Q
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 421 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 480
K E+ +L + H N++ L+ ++ S + LV + + + L
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLT 119
Query: 481 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540
+ + RGL Y+H +IHRD K SN+ + + K+ DFGLA+ + T
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 541 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ----- 595
V + H D++S G ++ ELLTGR + Q
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA--------AACVAPEANQR 647
+ T +L+ + + PK +F V A + ++++R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 648 PTMGEVVQ 655
T + +
Sbjct: 293 ITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 2e-29
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 15/228 (6%)
Query: 382 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 440
+ LG G F V+ + + T VA+K + G + + E+++L R++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 441 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL----------DWETRMKIALD 490
++ PNG + LG N +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 491 AARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMG 549
GL Y+H + +IH D K N+L+E + + +A + T +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 550 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 597
T Y +PE + +D++S ++ EL+TG + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 5e-24
Identities = 35/207 (16%), Positives = 60/207 (28%), Gaps = 34/207 (16%)
Query: 386 SILGEGGFGRVFKGVLSDGTAVAIKRL----------TCGGQQGDKEFLVEVEMLSRLHH 435
++GEG VF +K GD F V +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 436 RNLVKLVGYYSSR--DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 493
R L KL G + + + EL+ + E ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDA-----------KELYRVRVENPDEVLDMILE 114
Query: 494 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFG 552
+A + ++H D N+L+ + DF + + EG L V
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 553 YVAPEYAMTGHLLVKSDVYSYGVVLLE 579
Y + Y + D+ S +L+
Sbjct: 171 YFSRTYRT------EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 726 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.29 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=425.89 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=201.3
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.. ....++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEEEEe
Confidence 5789999999999999999999888999999997543 446789999999999999999999999874 4578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++... ...++|..++.++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998753 345899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCCc
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 619 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 619 (726)
.. ......||..|||||++.+..++.|+|||||||++|||+|+..|+..... ...+..... . .
T Consensus 156 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~---~-----------~ 218 (263)
T d1sm2a_ 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIS---T-----------G 218 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHH---H-----------T
T ss_pred ce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHH---h-----------c
Confidence 22 23346799999999999999999999999999999999996544432211 111111110 0 0
Q ss_pred cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 620 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 620 l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.....+.....++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11122333345689999999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=430.08 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=205.0
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||+++|++. ....++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEEEEE
Confidence 4678999999999999999998753 59999997543 334578999999999999999999999975 2468999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++|+.. ...++|..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999742 245999999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
............||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .+... ....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~----~~~~---- 225 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFM----VGRG---- 225 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHH----HHHT----
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHH----HhcC----
Confidence 5444334456789999999999864 358999999999999999999999997543211 11111 1100
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
...+.+ ...+......+.+|+.+||+.||++|||++||+++|+.+.+.+
T Consensus 226 -~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 226 -YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 011111 0112223346889999999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=423.62 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=210.6
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.. ...++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEE
Confidence 46789999999999999999999888999999997543 446789999999999999999999998752 36799999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ....++|..+++++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.....
T Consensus 88 y~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999988642 2345999999999999999999999998 999999999999999999999999999987654
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. .......||+.|||||++.++.++.++|||||||+||||+||..|+..... ...+.... ..
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i----~~---------- 225 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNL----ER---------- 225 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HT----------
T ss_pred cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHH----Hh----------
Confidence 32 233456799999999999999999999999999999999997666542211 11111111 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+......+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11112233334568899999999999999999999999988654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-50 Score=426.66 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEECC-C---cEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~-g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.++||+|+||+||+|++.. | ..||||++..... ...++|.+|+++|++++|||||+++|+|. +....+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCEEE
Confidence 456778999999999999999752 2 3689999875433 33467999999999999999999999987 445899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++... ...++|.++++++.||++||+|||+.+ |+||||||+||||++++++||+|||+++.
T Consensus 104 iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999998753 335999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccc---ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 535 APEGRTNY---LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 535 ~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+...+ .
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i---~---- 247 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI---E---- 247 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---H----
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH---H----
Confidence 65433221 1223468999999999999999999999999999999998 8999964321 1111111 0
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.......+.+....+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 248 -------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 -------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111112334445568999999999999999999999999988765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=420.33 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=204.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||+||+|+.. +|+.||||++..... +..+.+.+|+++|++++|||||++++++.. ....+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEE
Confidence 57999999999999999999974 689999999975432 334679999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+++|+|.++|.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999974 346999999999999999999999999 99999999999999999999999999997755
Q ss_pred CCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.......+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... +..+.
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~-------------- 220 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------------- 220 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH--------------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh--------------
Confidence 443334456789999999999988776 67899999999999999999999754322111 11110
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...............+.+|+.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000001112223457899999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=412.35 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=211.8
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|. +....++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCceEEEEEc
Confidence 6899999999999999999999888899999998654 34678999999999999999999999987 44589999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.+++... ...+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999998642 346899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......||..|+|||++.+..++.|+|||||||++|||+| |+.||...... .+. ..+ ..
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~---~~i-~~---------- 216 (258)
T d1k2pa_ 155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EHI-AQ---------- 216 (258)
T ss_dssp CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HHH-HT----------
T ss_pred ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH---HHH-Hh----------
Confidence 22 2344679999999999999999999999999999999998 89999744311 111 111 11
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
......+.....++.+++.+||+.||++|||++||+++|.+|
T Consensus 217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111123334445689999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-50 Score=421.88 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=212.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
..++|++.+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|. +....++|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeEEE
Confidence 3568999999999999999999975 58899999997543 44678999999999999999999999987 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|.++|... ....++|..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999999642 2346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhc
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 616 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 616 (726)
.... .......||+.|||||++.+..++.|+|||||||++|||++|..|+..... ...+. +.+
T Consensus 167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~--------------~~i 229 (287)
T d1opja_ 167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY--------------ELL 229 (287)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH--------------HHH
T ss_pred CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH--------------HHH
Confidence 4432 223445689999999999999999999999999999999998777643221 11111 111
Q ss_pred CCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 617 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 617 d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
........+.....++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111222333444456899999999999999999999999887653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=422.71 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=196.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||+||+|+.. +|+.||||.+...... ..+.|.+|+++|++++|||||++++++........++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999964 6899999999765432 23568999999999999999999999875556678999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCC--CceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ--PCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~--p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+. ..|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999996433334569999999999999999999998652 3499999999999999999999999999997
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||..... ..+. ..+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~---~~i--------- 226 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GKI--------- 226 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHH---------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH---HHH---------
Confidence 754322 23456899999999999999999999999999999999999999974321 1111 111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+... ...+.....++.+|+.+||+.||++|||++|++++
T Consensus 227 -~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 -REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111 11222334468899999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=414.48 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=210.3
Q ss_pred hcCccccee-eeecCcEEEEEEEEC---CCcEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASI-LGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~-LG~G~fG~Vykg~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++..... ..++|.+|+++|++++|||||+++|+|.. ...
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 356777775 999999999999864 3557999999754332 34679999999999999999999999863 368
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
+|||||+++|+|.+++... ...+++..+++++.|+++||+|||+.+ |+||||||+||||++++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence 9999999999999998642 346999999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCcc-cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 534 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 534 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||..... ..+... +...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~----i~~~-- 228 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF----IEQG-- 228 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH----HHTT--
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcC--
Confidence 77654322 22334578999999999999999999999999999999998 9999974321 111111 1111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.....+.....++.+|+.+||+.||++||||.+|++.|+.+...+
T Consensus 229 --------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 229 --------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111233344456889999999999999999999999998776543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=422.65 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=207.2
Q ss_pred hcCcccceeeeecCcEEEEEEEECC-C-----cEEEEEEcccCC-CCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD-G-----TAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~-g-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.++||+|+||+||+|++.. + ..||||++.... ......|.+|+++|.++ +|||||+++|+|. +.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--LS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--eC
Confidence 4689999999999999999999643 2 369999986543 33456799999999998 8999999999987 44
Q ss_pred CceEEEEeecCCCChhhhccCCCC-------------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG-------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 511 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~-------------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDI 511 (726)
...++||||+++|+|.++|+.... ....++|..++.++.||++||+|||+.+ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 588999999999999999975432 1235899999999999999999999998 999999
Q ss_pred CccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 004869 512 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS 590 (726)
Q Consensus 512 Kp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~ 590 (726)
||+|||++.++++||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665444334455678999999999999999999999999999999998 89999743
Q ss_pred CCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 591 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 591 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... ..+.. .+.. ......+......+.+|+.+||+.||++|||++||+++|.
T Consensus 271 ~~~--~~~~~----~~~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD--ANFYK----LIQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS--HHHHH----HHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH--HHHHH----HHhc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 11111 1111 1112233344456899999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=413.61 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=202.1
Q ss_pred cCcccceeeeecCcEEEEEEEECCC-----cEEEEEEcccCCCC-chhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g-----~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
+.|+..++||+|+||.||+|.++++ ..||||++...... ..++|.+|++++++++|||||+++|+|. +....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe--cCCce
Confidence 4688899999999999999997542 47999999754332 3457999999999999999999999987 44578
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+.+|+|.+++... ...++|.++++++.|+++||+|||+.+ |+||||||+||||++++.+||+|||+++
T Consensus 85 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999988642 346999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc-ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... ........||+.|||||++.++.++.++|||||||+||||++|..|+...... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~------------ 224 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMK------------ 224 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH------------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHH------------
Confidence 7654332 22234457899999999999999999999999999999999977665432211 11111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+........+.+....+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 225 --~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 225 --AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111122233444556789999999999999999999999999887763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=416.77 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=207.9
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.. ....|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEE
Confidence 4799999999999999999995 4689999999986666667789999999999999999999999884 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+|+.....
T Consensus 98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999999998863 35899999999999999999999999 999999999999999999999999999877543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||....... ......... .+
T Consensus 170 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-------~~ 234 (293)
T d1yhwa1 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-------TP 234 (293)
T ss_dssp TC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-------SC
T ss_pred cc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence 32 2345679999999999999999999999999999999999999996432111 111111100 00
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. -..+......+.+++.+||+.||++|||++|+++|
T Consensus 235 ~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp C--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11223334568899999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=410.29 Aligned_cols=247 Identities=29% Similarity=0.429 Sum_probs=206.1
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++. +....++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE--ECCEEEE
Confidence 57999999999999999999975 6899999998632 2334567899999999999999999999988 4558999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 84 vmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999974 346899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+.+
T Consensus 157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~-------- 218 (263)
T d2j4za1 157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISR-------- 218 (263)
T ss_dssp CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT--------
T ss_pred CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHc--------
Confidence 5432 2346799999999999999999999999999999999999999964321 111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.. ...+.....++.+++.+||+.||++|||++|++++=
T Consensus 219 --~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 219 --VE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp --TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred --CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 11 112333345688999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=409.55 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=199.0
Q ss_pred eeeeecCcEEEEEEEECC---CcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEeec
Q 004869 386 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 460 (726)
Q Consensus 386 ~~LG~G~fG~Vykg~l~~---g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey~ 460 (726)
++||+|+||+||+|.+.+ ++.||||+++..... ..++|.+|+++|++++|||||+++|+|.. ...+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 579999999999998643 468999999754322 24679999999999999999999999853 3578999999
Q ss_pred CCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCCc
Q 004869 461 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 540 (726)
Q Consensus 461 ~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 540 (726)
++|+|.++++. ...++|..+++++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999974 346999999999999999999999998 99999999999999999999999999987755433
Q ss_pred cc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 541 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 541 ~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. ......||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..+.. .+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~----~i~~~--------- 226 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKG--------- 226 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTT---------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHH----HHHcC---------
Confidence 22 2334679999999999999999999999999999999998 8999974321 11111 11111
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
.....+.....++.+|+.+||+.||++|||++||++.|+...
T Consensus 227 -~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 227 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 111233334456889999999999999999999998887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=410.66 Aligned_cols=257 Identities=29% Similarity=0.417 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.. ...++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEE
Confidence 3679999999999999999999988889999999754 3446789999999999999999999999852 36799999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ....++|.+++.++.||++||+|||+.+ |+||||||+||||++++++||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999998642 2345999999999999999999999998 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
.. .......||+.|+|||++..+.++.++|||||||+||||++|..|+..... ...+..++. .
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~--------------~ 229 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE--------------R 229 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------------T
T ss_pred Cc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH--------------h
Confidence 32 233446799999999999999999999999999999999997776643221 111111111 1
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
......+.....++.+++.+||+.||++||+|++|++.|+...
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1111233444456899999999999999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=412.70 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=205.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
+.|++.+.||+|+||+||+|+.. +|+.||||++........+.|.+|+++|++++|||||++++++.. ....+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEe
Confidence 46899999999999999999964 689999999987766667889999999999999999999999874 458999999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 538 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 538 (726)
|+++|+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999998631 245899999999999999999999999 999999999999999999999999999765322
Q ss_pred CcccccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 539 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 539 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
. .......||+.|||||++. ...++.++|||||||+||||++|+.||....... . ...+....
T Consensus 164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~----~~~i~~~~---- 231 (288)
T d2jfla1 164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--V----LLKIAKSE---- 231 (288)
T ss_dssp H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H----HHHHHHSC----
T ss_pred c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--H----HHHHHcCC----
Confidence 1 1233467999999999984 4568899999999999999999999997543211 1 11111110
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.+. ...+......+.+|+.+||+.||++|||++|++++
T Consensus 232 ---~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 ---PPT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 11223334568899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=420.59 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+++|++++|||||+++++|. +....++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence 578999999999999999999964 689999999975533 33467899999999999999999999998 44589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
|||+++|+|.+++.+ ...+++..+..++.|+++||.|||+ ++ |+||||||+||||++++++||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999974 3468999999999999999999997 47 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc---------
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL--------- 606 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~--------- 606 (726)
... ..+..+||+.|||||++.+..++.++||||+||++|||++|+.||........... +.....
T Consensus 156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPR 229 (322)
T ss_dssp HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C--------------
T ss_pred CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHhcCCcccCCcc
Confidence 432 22356899999999999999999999999999999999999999975432211000 000000
Q ss_pred -------------------cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 -------------------RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 -------------------~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
........+...............++.+++.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000111111100000011123468899999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=412.11 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=211.5
Q ss_pred HHHHHhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEee
Q 004869 374 ELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYS 446 (726)
Q Consensus 374 el~~~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~ 446 (726)
+++..+++|++.+.||+|+||+||+|++. +++.||||+++...... .++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999964 35789999997544332 467999999999999999999999987
Q ss_pred cCCCCceEEEEeecCCCChhhhccCCC--------------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCce
Q 004869 447 SRDSSQHLLCYELVPNGSLESWLHGPL--------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 506 (726)
Q Consensus 447 ~~~~~~~~LV~Ey~~~GsL~d~L~~~~--------------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~I 506 (726)
+....+++|||+++|+|.++|+... .....++|..++.++.|++.||+|||+.+ |
T Consensus 87 --~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 87 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred --cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 4458999999999999999996321 11235899999999999999999999999 9
Q ss_pred eecCCCccceeecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-C
Q 004869 507 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-K 585 (726)
Q Consensus 507 vHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~-~ 585 (726)
+||||||+||||+.++++||+|||+++...........+...||+.|+|||++.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998765544333445567999999999999999999999999999999999986 5
Q ss_pred CCCCCCCCccchhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 004869 586 PVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 661 (726)
Q Consensus 586 Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~ 661 (726)
||..... ..+... +.+.. ....+.....++.+|+.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~---~e~~~~-------------v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAH---EEVIYY-------------VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCH---HHHHHH-------------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCH---HHHHHH-------------HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6653321 111111 11111 11223344456899999999999999999999999998763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=405.28 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred cccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecC--CCCceEEE
Q 004869 382 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLLC 456 (726)
Q Consensus 382 f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~--~~~~~~LV 456 (726)
|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.|.+|+++|++++|||||++++++... +....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999975 688999999875432 2345789999999999999999999998642 34467999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec-CCCcEEEEecCccccC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQA 535 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd-~~~~vKL~DFGla~~~ 535 (726)
|||+++|+|.+++.. ...+++..++.++.||++||+|||+++. +|+||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999964 3468999999999999999999998763 499999999999996 5889999999999865
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... .....||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+. ..+....
T Consensus 166 ~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~---~~i~~~~------ 229 (270)
T d1t4ha_ 166 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY---RRVTSGV------ 229 (270)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH---HHHTTTC------
T ss_pred cCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHH---HHHHcCC------
Confidence 4332 345689999999998865 5999999999999999999999999643211 1111 1111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ..+.....++.+|+.+||+.||++|||++|+++|
T Consensus 230 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCc----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 000 1111223357899999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=411.84 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=204.4
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++. +....|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE--ECCEEEE
Confidence 5799999999999999999997 46899999998642 2334567999999999999999999999987 4458999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 86 vmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999864 346899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.............||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+..
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~-------- 224 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIK-------- 224 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHT--------
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHc--------
Confidence 654433344556799999999999999999999999999999999999999974321 111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
.. ..++.....++.+|+.+||+.||++|||++|++++.+
T Consensus 225 --~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 225 --LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp --TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred --CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 11 1223334456889999999999999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=411.59 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=205.4
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc----EEEEEEcccC-CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.+|++.++||+|+||+||+|++. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.. ...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 46999999999999999999964 343 6899998643 33456789999999999999999999999973 357
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++++||+.+|+|.+++... ...++|..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 8999999999999988642 346899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
...............||+.|||||++.++.++.++|||||||+||||+| |+.||+..... .+.. .+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~----~i~~~--- 229 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKG--- 229 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHH----HHHHT---
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcC---
Confidence 8766554444455679999999999999999999999999999999998 78888643311 1111 11111
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.....+......+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 230 -------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11123344455689999999999999999999999999887653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=409.82 Aligned_cols=266 Identities=25% Similarity=0.398 Sum_probs=203.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhc-ccCceeEEEEEeecCC
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 449 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~ 449 (726)
..++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|.+++.++ +|+|||.+++++.. +
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-T
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-C
Confidence 3478999999999999999999853 246899999975433 3346788899988887 68999999998764 3
Q ss_pred CCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCcccee
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 517 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NIL 517 (726)
....++||||+++|+|.++|+.... ....++|.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4578999999999999999964321 1235899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCccc
Q 004869 518 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQE 596 (726)
Q Consensus 518 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~-~Pf~~~~~~~~~ 596 (726)
|++++.+||+|||+|+...........+...||+.|||||++.+..++.++|||||||++|||+||. .||...... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~ 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 9999999999999998776554444455678999999999999999999999999999999999975 567533211 1
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
.+ ...+.... ....+.....++.+++.+||+.||++|||++||+++|+.+.+.
T Consensus 245 ~~----~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EF----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 11111111 1122333445688999999999999999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=399.54 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++|||||+++|+|.. +....++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe-cCCcEEEEEec
Confidence 57889999999999999999995 688999999743 345789999999999999999999999853 23467999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.++|+.. ....++|..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999641 1235899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhhhhhcCC
Q 004869 540 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 618 (726)
Q Consensus 540 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 618 (726)
....+|..|+|||++.++.++.++|||||||++|||+| |+.||.... ...+..++. .
T Consensus 158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i~--------------~ 215 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE--------------K 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHT--------------T
T ss_pred -----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH--------------c
Confidence 33468899999999999999999999999999999998 677775432 112222211 1
Q ss_pred ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 619 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 619 ~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
......+.....++.+|+.+||+.||++||||.||+++|+.++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11122334444568999999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=398.95 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=198.5
Q ss_pred hcCcccceeeeecCcEEEEEEEECC----CcEEEEEEcccCCCCc-hhHHHHHHHHHHhcccCceeEEEEEeecCCCCce
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~ 453 (726)
.++|++.+.||+|+||.||+|++.. +..||||.++...... .+.|.+|++++++++|||||+++|++. ....
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeE
Confidence 4689999999999999999998642 3578999986543332 467999999999999999999999985 2478
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999987642 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 534 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 534 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
....... ...+...||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+... + ....
T Consensus 157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~---i-~~~~-- 226 (273)
T d1mp8a_ 157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---I-ENGE-- 226 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---H-HTTC--
T ss_pred eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH---H-HcCC--
Confidence 7654322 23445678999999999999999999999999999999998 89998754321 11111 1 1110
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
....+......+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 227 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0122333445689999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=408.30 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=199.4
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
.|+..+.||+|+||+||+|+. .+|+.||||++....... .+.|.+|+++|++++|||||++++++.. ....++|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 489999999999999999996 468899999997654333 2468999999999999999999999874 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+++|+|..++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999999877653 346999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcccccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 613 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 613 (726)
.. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... .....+...
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~----- 229 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN----- 229 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-----
T ss_pred CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-----
Confidence 32 33579999999999864 46899999999999999999999999643211 111111111
Q ss_pred hhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 614 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 614 ~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.+ .+......+.+|+.+||+.||++|||++|+++|
T Consensus 230 --~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 --ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 01111 112223458899999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=406.26 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=190.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 378 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 378 ~t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
..+.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++. +....||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEE
Confidence 3467999999999999999999975 689999999975432 23456889999999999999999999987 4568999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec---CCCcEEEEecCcc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLA 532 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd---~~~~vKL~DFGla 532 (726)
||||+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||++
T Consensus 85 vmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999975 346999999999999999999999999 99999999999994 5789999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 612 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 612 (726)
+...... .....+||+.|||||++.+..++.++|||||||+||||++|+.||..... ..+. ..+....
T Consensus 158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~---~~i~~~~--- 225 (307)
T d1a06a_ 158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLF---EQILKAE--- 225 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHTTC---
T ss_pred EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHH---HHHhccC---
Confidence 8665432 22346799999999999999999999999999999999999999974321 1111 1111110
Q ss_pred hhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..............+.+|+.+||+.||++|||++|++++
T Consensus 226 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 -----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011111122333468899999999999999999999876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-47 Score=410.17 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=207.0
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.. ....+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 358999999999999999999964 689999999986655556789999999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec--CCCcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd--~~~~vKL~DFGla~~~ 535 (726)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 103 E~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999999642 345999999999999999999999999 99999999999995 4678999999999877
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~----- 242 (350)
T d1koaa2 177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW----- 242 (350)
T ss_dssp CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-----
T ss_pred ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----
Confidence 54432 3456799999999999999999999999999999999999999964321 111111111100
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.............+.+|+.+||+.||++|||++|++++
T Consensus 243 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111223458899999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=398.79 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEECC--C--cEEEEEEcccCC---CCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSD--G--TAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~--g--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
++|++.+.||+|+||.||+|++.. + ..||||+++... ....++|.+|+++|++++|||||+++|+|.. ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 579999999999999999998642 2 378999987542 2234679999999999999999999999863 36
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.++||||+++|+|.+++.. ....+++..+++++.|+++||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred hheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 7899999999999998864 2346999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccc-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 533 KQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 533 ~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... .... ..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~---~~i~~~-- 230 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQIL---HKIDKE-- 230 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---HHHHTS--
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHH---HHHHhC--
Confidence 9876544322 2334568899999999999999999999999999999998 8999964321 1111 111111
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
......+......+.+|+.+||+.||++||||.||++.|++.
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122233334688999999999999999999999888764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=396.31 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC------CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++. +..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECC
Confidence 46799999999999999999997 4789999999865422 12467999999999999999999999987 456
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC----cEEEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 527 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~----~vKL~ 527 (726)
..+|||||+++|+|.++|.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 89999999999999999964 346999999999999999999999999 99999999999998776 59999
Q ss_pred ecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 528 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 528 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
|||+++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...... .. ...+..
T Consensus 160 DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~ 230 (293)
T d1jksa_ 160 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANVSA 230 (293)
T ss_dssp CCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHT
T ss_pred chhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HH---HHHHHh
Confidence 9999987754432 23457999999999999999999999999999999999999999743211 11 111111
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....... ..+......+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VNYEFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TCCCCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCCc--------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1000000 0011123457899999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=399.14 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=207.9
Q ss_pred hcCcccceeeeecCcEEEEEEEECC--------CcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~~--------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~ 448 (726)
.++|++.+.||+|+||.||+|+..+ +..||||+++..... ...++.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 3688999999999999999998532 347999999765432 346789999999998 7999999999997
Q ss_pred CCCceEEEEeecCCCChhhhccCCCC------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
+....++||||+++|+|.++|..... ....+++.++++++.|+++||+|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 44589999999999999999975321 2346899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 595 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~Pf~~~~~~~~ 595 (726)
|++.++.+||+|||+++...............||+.|+|||.+.++.++.|+|||||||++|||++ |+.||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999987765544444456779999999999999999999999999999999998 6888764321
Q ss_pred chhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 596 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 596 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
..+.. .+... .....+......+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 244 ~~~~~----~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELFK----LLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHH----HHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----HHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 11111 1112233344568999999999999999999999999988865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=400.87 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCc--EEEEEEcccC-CCCchhHHHHHHHHHHhc-ccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCG-GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~--~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.++||+|+||+||+|++. +|. .||||++... .....++|.+|+++|+++ +|||||+++|+|.. ....+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeE
Confidence 67889999999999999999975 343 5788888643 333456899999999999 79999999999984 45899
Q ss_pred EEEeecCCCChhhhccCCC------------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC
Q 004869 455 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 522 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~------------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~ 522 (726)
+||||+++|+|.++|+... .....++|..+++++.||++||.|||+.+ |+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence 9999999999999997532 22356999999999999999999999998 99999999999999999
Q ss_pred cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCccchhhhh
Q 004869 523 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK-PVDMSQPSGQENLVTW 601 (726)
Q Consensus 523 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~-Pf~~~~~~~~~~l~~~ 601 (726)
.+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ...+...
T Consensus 165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~ 238 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEK 238 (309)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH
T ss_pred ceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHH
Confidence 999999999986543322 234568999999999999999999999999999999999765 564322 1111111
Q ss_pred hhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 602 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 602 ~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
+ . .. .....+.....++.+|+.+||+.||++||||+||+++|+.+.+
T Consensus 239 i---~-~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 L---P-QG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp G---G-GT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---H-hc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 1 11 1112333444568999999999999999999999999988765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=400.31 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=211.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCCC-chhHHHHHHHHHHhc-ccCceeEEEEEeecCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 450 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~~~~ 450 (726)
.++|++.++||+|+||.||+|++. +++.||||+++..... ...+|.+|+++++++ +|||||+++|+|. +.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--IG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--eC
Confidence 468999999999999999999852 4578999999755433 345799999999999 6999999999997 44
Q ss_pred CceEEEEeecCCCChhhhccCCCC--------------CcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccce
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 516 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~--------------~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NI 516 (726)
...++||||+++|+|.++|+.... ....+++..+++++.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 578999999999999999964321 2235899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 004869 517 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 596 (726)
Q Consensus 517 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~ 596 (726)
|++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+..|+....... .
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-S 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-H
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-H
Confidence 999999999999999998776554445556789999999999999999999999999999999999555443222111 1
Q ss_pred hhhhhhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 597 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 597 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
.+. .+++.......+......+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 256 ~~~--------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 KFY--------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHH--------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111 1111111222233344568999999999999999999999999987644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-46 Score=407.29 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=207.4
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++. +....||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEE
Confidence 35799999999999999999996 479999999998665555667899999999999999999999987 456899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec--CCCcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd--~~~~vKL~DFGla~~~ 535 (726)
||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+..
T Consensus 106 E~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 106 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceec
Confidence 999999999987642 345999999999999999999999999 99999999999997 6789999999999987
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
.... ......||+.|||||++.+..++.++|||||||+||||+||+.||...... .+ ...+...
T Consensus 180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~------- 243 (352)
T d1koba_ 180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET---LQNVKRC------- 243 (352)
T ss_dssp CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHHC-------
T ss_pred CCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhC-------
Confidence 6543 234567999999999999999999999999999999999999999643211 11 1111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
+..............+.+|+.+||+.||++|||++|+++|
T Consensus 244 -~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 -DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111122233458899999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=399.45 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=204.1
Q ss_pred ceeeeecCcEEEEEEEECCC----cEEEEEEcccC-CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEee
Q 004869 385 ASILGEGGFGRVFKGVLSDG----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 459 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~Ey 459 (726)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|... ....++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 57899999999999997532 36899999743 233346799999999999999999999998643 3578999999
Q ss_pred cCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCCCC
Q 004869 460 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 539 (726)
Q Consensus 460 ~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 539 (726)
+++|+|.++++.. ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999753 335788899999999999999999998 9999999999999999999999999998765443
Q ss_pred cc--cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhhcC
Q 004869 540 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 617 (726)
Q Consensus 540 ~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 617 (726)
.. .......||..|+|||++.+..++.++||||||+++|||+||+.||...... ..+..+ +... .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~---i~~g-~------- 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQG-R------- 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTT-C-------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcC-C-------
Confidence 22 2233467999999999999999999999999999999999988887643211 111111 1111 1
Q ss_pred CccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 618 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 618 ~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
....+......+.+|+.+||+.||++||+|.||+++|+.+.+.
T Consensus 252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0112223344688999999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=396.64 Aligned_cols=274 Identities=23% Similarity=0.348 Sum_probs=203.2
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHH--HHHhcccCceeEEEEEeecCCC--CceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSRLHHRNLVKLVGYYSSRDS--SQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~--iL~~L~HpNIV~llg~~~~~~~--~~~~L 455 (726)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+++..|.+ .+.+++|||||+++|+|...+. ..+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4678889999999999999998 5789999998632 3344544544 5567899999999999875443 35789
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC-----CCceeecCCCccceeecCCCcEEEEecC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-----QPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~-----~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
||||+++|+|.++|++ ..++|..+++++.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999974 35899999999999999999999741 2349999999999999999999999999
Q ss_pred ccccCCCCCcc--cccccccccccccCccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 531 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 531 la~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~------~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
+++........ .......||+.|||||++.+.. ++.|+|||||||+||||+||..|+......... .....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhcc
Confidence 99876543321 1234567999999999987543 578999999999999999999887533221111 00000
Q ss_pred hhhccchhhhhhhcCCccCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 004869 603 RPILRDKDRLEELADPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 663 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~ 663 (726)
............+.+..+.... +.+....+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0000000111122222222222 223456789999999999999999999999999988753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-46 Score=388.53 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc---hhHHHHHHHHHHhcccCceeEEEEEeecCCC--Cc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--SQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~--~~ 452 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.....+ .+.|.+|++++++++|||||++++++...+. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 478999999997554332 3468999999999999999999999875443 34
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.||||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998864 346999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+....... ........||+.|||||++.+..++.++|||||||++|||+||+.||..... .......++....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 76544322 2233456799999999999999999999999999999999999999974321 1111111211111
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ 661 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-Tm~EVl~~L~~i~ 661 (726)
... . ........+.+++.+||+.||++|| |++++++.|..++
T Consensus 233 ~~~----~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPS----A----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGG----G----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCc----h----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 1 1112234588999999999999999 8999998887764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=399.81 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++. +....|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec--cccccc
Confidence 35799999999999999999996 47899999998643 2334577899999999999999999999988 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 82 iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccc
Confidence 99999999999999974 346888999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... .....+||+.|||||++.+..++.++||||+||++|||++|+.||..... . .....+...
T Consensus 155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~---~~~~~i~~~------ 220 (337)
T d1o6la_ 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---RLFELILME------ 220 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHC------
T ss_pred cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---H---HHHHHHhcC------
Confidence 654322 23456899999999999999999999999999999999999999975331 1 111111111
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
. ..++.....++.+|+.+||+.||++|++ +.|+++|
T Consensus 221 ----~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ----E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----C--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 1223334456889999999999999994 8898876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=398.26 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=208.9
Q ss_pred hcCcccceeeeecCcEEEEEEEEC------CCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCCCC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~ 451 (726)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|.. ..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--CC
Confidence 468899999999999999999863 257899999975432 233568999999999999999999999873 45
Q ss_pred ceEEEEeecCCCChhhhccCCC------CCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEE
Q 004869 452 QHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 525 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~------~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vK 525 (726)
..++||||+++|+|.++++... .....++|..+.+++.|+++||.|||+.+ |+||||||+|||+++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 7899999999999999986321 11234789999999999999999999998 99999999999999999999
Q ss_pred EEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCccchhhhhhhh
Q 004869 526 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARP 604 (726)
Q Consensus 526 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~-~Pf~~~~~~~~~~l~~~~~~ 604 (726)
|+|||+++...............||+.|+|||.+.++.++.++||||||++||||+||. .||.... ...+..
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~- 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLR- 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHH-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHH-
Confidence 99999998776554444445567999999999999999999999999999999999985 5664321 111111
Q ss_pred hccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 004869 605 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 660 (726)
Q Consensus 605 ~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i 660 (726)
.+.+... ...+......+.+++.+||+.||++||||+||+++|+..
T Consensus 247 ---------~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 ---------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---------HHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 122333445689999999999999999999999988765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-46 Score=395.48 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=204.2
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe--eCCeeee
Confidence 5799999999999999999996 46899999998643 2334577999999999999999999999987 4568999
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 vmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999874 345788899999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+...
T Consensus 155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~------- 216 (316)
T d1fota_ 155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA------- 216 (316)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-------
T ss_pred ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcC-------
Confidence 543 2346799999999999999999999999999999999999999974321 1111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
. ..++......+.+++.+||+.||++|+ |++|+++|
T Consensus 217 ---~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ---E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---C--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 122233344588999999999999996 89999886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-45 Score=383.79 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=203.4
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc---------hhHHHHHHHHHHhcc-cCceeEEEEEeecC
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLH-HRNLVKLVGYYSSR 448 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~ 448 (726)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|++++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 6899999999999999999996 478999999997543221 235889999999997 999999999997
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
+....||||||+++|+|.++|+. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 45689999999999999999964 446999999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 602 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 602 (726)
||+++....... .+...||..|+|||++.+ ..++.++||||+||+||||++|+.||....... . .
T Consensus 154 FG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~---~ 224 (277)
T d1phka_ 154 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M---L 224 (277)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H
T ss_pred chheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---H---H
Confidence 999998765432 244679999999998863 356889999999999999999999997533111 0 1
Q ss_pred hhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 603 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 603 ~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..+.... .............++.+++.+||+.||++|||++||+++
T Consensus 225 ~~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111110 001111112334568899999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-45 Score=395.64 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=203.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 455 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~L 455 (726)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc--ccccccc
Confidence 57999999999999999999974 6999999998632 2234567899999999999999999999987 4558899
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccC
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 535 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~ 535 (726)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 119 v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999964 346899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
... .....||+.|||||++.+..++.++|||||||+||||+||+.||..... ......+..
T Consensus 192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~-------- 252 (350)
T d1rdqe_ 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVS-------- 252 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--------
T ss_pred ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhc--------
Confidence 532 2346799999999999999999999999999999999999999964321 111111111
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
... ..+......+.+++.+||+.||++|+ |++|+++|
T Consensus 253 --~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 --GKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111 12223344588999999999999994 89999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-45 Score=397.96 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=198.6
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCC---CCchhHHHHH---HHHHHhcccCceeEEEEEeecCCCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~llg~~~~~~~~~ 452 (726)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++. +...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE--ECCE
Confidence 68999999999999999999965 68999999985321 1223344555 56667778999999999987 4458
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.|+||||+++|+|.++|.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 82 ~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999964 345889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 611 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 611 (726)
+...... .....||+.|||||++.. ..++.++|||||||+||||+||+.||..........+. +...
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~----- 222 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL----- 222 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSS-----
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhcc-----
Confidence 8765443 234579999999999875 56899999999999999999999999754332211111 1010
Q ss_pred hhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004869 612 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPT-----m~EVl~~ 656 (726)
.. ....+.....++.+|+.+||+.||++||| ++|+++|
T Consensus 223 -----~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 -----TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----SC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----cC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 01122233345889999999999999999 6888876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=382.94 Aligned_cols=260 Identities=25% Similarity=0.289 Sum_probs=194.0
Q ss_pred cceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCc-----hhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 384 PASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-----DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 384 ~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~-----~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+++|++++|||||++++++. +....+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCceeehh
Confidence 468999999999999996 468999999997543221 356899999999999999999999987 445799999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 80 E~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 80 DFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp ECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred hhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCC
Confidence 99999888777653 346899999999999999999999999 99999999999999999999999999987655
Q ss_pred CCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhh-------ccch
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------LRDK 609 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~-------~~~~ 609 (726)
... ......||+.|+|||++... .++.++|||||||++|||++|+.||......+. +....... +.+.
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 153 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSST
T ss_pred Ccc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhcCCCChhhccch
Confidence 432 22345799999999998754 579999999999999999999999975432111 11100000 0000
Q ss_pred hhhhhhcCCccCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
........-......+ ......+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000000011 1123468899999999999999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=392.00 Aligned_cols=256 Identities=24% Similarity=0.257 Sum_probs=199.9
Q ss_pred hcCcccce-eeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhc-ccCceeEEEEEeec--CCCCce
Q 004869 379 TNNFEPAS-ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS--RDSSQH 453 (726)
Q Consensus 379 t~~f~~~~-~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~llg~~~~--~~~~~~ 453 (726)
.++|++.. +||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.. ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 699999999999996 5789999999862 45678899997765 89999999999864 234568
Q ss_pred EEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC---CCcEEEEecC
Q 004869 454 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 530 (726)
Q Consensus 454 ~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~---~~~vKL~DFG 530 (726)
|+|||||+||+|.++|... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999752 2346999999999999999999999999 999999999999975 5679999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchh
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 610 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 610 (726)
+|+....... .....||+.|||||++.+..++.++|||||||+||||+||+.||.......... .....+....
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~~~~~i~~~~- 233 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQ- 233 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS-
T ss_pred eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--HHHHHHhcCC-
Confidence 9987755432 244679999999999999999999999999999999999999996433221100 0000000000
Q ss_pred hhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004869 611 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 657 (726)
Q Consensus 611 ~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L 657 (726)
.............++.+|+.+||+.||++|||+.|++++=
T Consensus 234 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 234 -------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp -------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred -------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 0000000112334688999999999999999999999873
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=388.79 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=204.6
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||.++... .....+.+|+++|++++|||||++++++.. ....||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 468999999999999999999975 68899999997543 234568899999999999999999999874 45899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC--CCcEEEEecCccccC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 535 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~--~~~vKL~DFGla~~~ 535 (726)
||+++|+|.++|... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 81 E~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999999742 235899999999999999999999999 999999999999985 458999999999876
Q ss_pred CCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhhh
Q 004869 536 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 615 (726)
Q Consensus 536 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 615 (726)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....+..........
T Consensus 155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHH
T ss_pred ccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCChh
Confidence 54332 34467999999999999999999999999999999999999999753211 1111111111000000
Q ss_pred cCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 004869 616 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 658 (726)
Q Consensus 616 ~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~ 658 (726)
... ....++.+|+.+||+.||++|||++|+++|=+
T Consensus 226 ----~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 226 ----AFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ----HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----hcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000 12235789999999999999999999998743
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=391.13 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=202.5
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccC---CCCchhHHHHHHHHHH-hcccCceeEEEEEeecCCCCceE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLS-RLHHRNLVKLVGYYSSRDSSQHL 454 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~-~L~HpNIV~llg~~~~~~~~~~~ 454 (726)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|..++. .++|||||++++++. +....|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCcee
Confidence 68999999999999999999964 6899999999643 2334456778888776 689999999999987 455899
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
|||||+++|+|.++++. ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 80 ivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999999974 345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccchhhhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 614 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 614 (726)
...... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+...
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~~~------ 218 (320)
T d1xjda_ 153 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FHSIRMD------ 218 (320)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHC------
T ss_pred cccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHcC------
Confidence 654332 234567999999999999999999999999999999999999999743211 11 1111110
Q ss_pred hcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 004869 615 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 656 (726)
Q Consensus 615 i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~-EVl~~ 656 (726)
.+ .++......+.+|+.+||+.||++||++. |+++|
T Consensus 219 --~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 --NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11 22333344588999999999999999995 78764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=381.57 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=197.5
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. ....++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 6899999999999999999996 5789999999965432 235689999999999999999999999974 4589999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
|||+.++ +.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EECCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EeecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 9999765 4444432 12346999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-h---hh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-K---DR 611 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~---~~ 611 (726)
.... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... .+.......... . ..
T Consensus 154 ~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 154 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp CCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred CCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccc
Confidence 4332 234457999999999877655 5789999999999999999999997543211 111000000000 0 00
Q ss_pred hhhhcCCc--cCC--CC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 612 LEELADPR--LGG--KY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 612 l~~i~d~~--l~~--~~-----~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.....+.. ... .. .......+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000 00 01122457899999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=376.39 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.+.||+|+||+||+|+.++|+.||||++..... ...+.+.+|+++|++++|||||++++++. +....++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCceeEEE
Confidence 68999999999999999999999999999999975432 23568999999999999999999999988 455899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 537 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 537 (726)
||+.++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp ECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99988777777653 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhh-------hccch
Q 004869 538 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-------ILRDK 609 (726)
Q Consensus 538 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~-------~~~~~ 609 (726)
... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +...... .+...
T Consensus 153 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTG
T ss_pred Ccc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccch
Confidence 322 2334568999999999875 4568999999999999999999999975432111 1100000 00000
Q ss_pred hhhhhhcCCccC-------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 610 DRLEELADPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 610 ~~l~~i~d~~l~-------~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
...... +.... ..........+.+++.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKY-DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTC-CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhc-ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000 01112223468899999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=377.16 Aligned_cols=240 Identities=23% Similarity=0.387 Sum_probs=195.5
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC------chhHHHHHHHHHHhcc--cCceeEEEEEeecCCC
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS 450 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~llg~~~~~~~ 450 (726)
++|++.++||+|+||+||+|+. .+|+.||||++...... ....+.+|+++|++++ |||||++++++. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence 5799999999999999999996 47899999998743221 1245778999999997 899999999987 44
Q ss_pred CceEEEEeecCC-CChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-CCcEEEEe
Q 004869 451 SQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD 528 (726)
Q Consensus 451 ~~~~LV~Ey~~~-GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-~~~vKL~D 528 (726)
...++||||+.+ +++.+++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 589999999976 678888764 346899999999999999999999999 999999999999985 57999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhcc
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 607 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 607 (726)
||+|+...... .+...||+.|||||++.+..+ +.++|||||||++|||++|+.||.... .+ .+
T Consensus 155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~ 218 (273)
T d1xwsa_ 155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IR 218 (273)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HH
T ss_pred cccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hh
Confidence 99998764432 345679999999999987765 677999999999999999999996321 11 01
Q ss_pred chhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 608 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 608 ~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .......++ .++.+++.+||+.||++|||++|++++
T Consensus 219 ~--------~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 G--------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--------CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--------ccCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 001112233 458899999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=377.14 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=199.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CC-CcEEEEEEcccCC--CCchhHHHHHHHHHHhc---ccCceeEEEEEeec---C
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---R 448 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~llg~~~~---~ 448 (726)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+++|+.+ +||||++++++|.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 6779999986432 23345677888887776 79999999999853 2
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEe
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 528 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~D 528 (726)
.....+++|||+++|++...... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 33468999999998877655442 2345889999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-h-------
Q 004869 529 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-T------- 600 (726)
Q Consensus 529 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~------- 600 (726)
||+++...... ......||+.|||||++.+..++.++||||+||++|||++|+.||............ .
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99988654322 234568999999999999999999999999999999999999999754322111000 0
Q ss_pred --hhhhhccchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 601 --WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 601 --~~~~~~~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
|.............. ...............+.+|+.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccc-cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000000 0000001112223457889999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-42 Score=367.66 Aligned_cols=261 Identities=17% Similarity=0.266 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCCceEEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 457 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~~~~LV~ 457 (726)
++|++.++||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+++|++++ ||||+++++++........++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 5789999999973 34578899999999995 99999999998866667899999
Q ss_pred eecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCccccCC
Q 004869 458 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 536 (726)
Q Consensus 458 Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 536 (726)
||+.+|+|.++.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987653 4889999999999999999999999 99999999999998654 69999999998765
Q ss_pred CCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccch--h---------hhhhhh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN--L---------VTWARP 604 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~--l---------~~~~~~ 604 (726)
.... .....||..|+|||.+.+. .++.++||||+||++|||++|+.||.......... + ..|...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 2445789999999998765 57999999999999999999999997543221110 0 000000
Q ss_pred h-ccchhhhhhhcCCc--------cCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 605 I-LRDKDRLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 605 ~-~~~~~~l~~i~d~~--------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
. .............. ...........++.+|+.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000000 0001111223457899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=366.62 Aligned_cols=271 Identities=21% Similarity=0.288 Sum_probs=195.6
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCC--CCchhHHHHHHHHHHhcccCceeEEEEEeecCC------
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 449 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~------ 449 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 479999999986543 233567899999999999999999999875422
Q ss_pred CCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEec
Q 004869 450 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 529 (726)
Q Consensus 450 ~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DF 529 (726)
....++||||+.++.+..+... ...++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3468999999988877765543 345788899999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCCcc--cccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 530 GLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 530 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
|+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543221 122335799999999998765 68999999999999999999999997533211111110000000
Q ss_pred cch-------hhhhhhcCCccCCCCC-hh------hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 607 RDK-------DRLEELADPRLGGKYP-KE------DFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 607 ~~~-------~~l~~i~d~~l~~~~~-~e------~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ................ .+ ....+.+|+.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0000000000000000 01 12346789999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-42 Score=361.43 Aligned_cols=262 Identities=20% Similarity=0.296 Sum_probs=199.1
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEEEe
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 458 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV~E 458 (726)
++|++.+.||+|+||+||+|+. .+|+.||||.+.... ..+++..|++++++++|+|++..++.+.. +....++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEEEE
Confidence 5799999999999999999996 468999999987543 23568899999999988776666655543 4457899999
Q ss_pred ecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeec---CCCcEEEEecCccccC
Q 004869 459 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQA 535 (726)
Q Consensus 459 y~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd---~~~~vKL~DFGla~~~ 535 (726)
|+ +|+|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 55676666432 346899999999999999999999999 99999999999975 4567999999999977
Q ss_pred CCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh-hhhhhhccch
Q 004869 536 PEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDK 609 (726)
Q Consensus 536 ~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~~~~~~~ 609 (726)
...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--
Confidence 554321 1234567999999999999999999999999999999999999999754432221111 11110000
Q ss_pred hhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 004869 610 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 662 (726)
Q Consensus 610 ~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~ 662 (726)
...+.+...++ .++.+++..||+.||++||+++++.+.|+.+..
T Consensus 235 -----~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 -----TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----SCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00011112333 348899999999999999999999988887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=369.48 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=198.0
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC-CchhHHHHHHHHHHhcccCceeEEEEEeecCC--CCceE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD--SSQHL 454 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~--~~~~~ 454 (726)
+++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+++|+++|++++||||+++++++.... ....+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 5799999999975432 23457899999999999999999999986432 12345
Q ss_pred EEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcccc
Q 004869 455 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 455 LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||||++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55677789999999963 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc-ccccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc----
Q 004869 535 APEGRT-NYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---- 608 (726)
Q Consensus 535 ~~~~~~-~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~---- 608 (726)
...... .......+||+.|+|||++. ...++.++||||+||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 644322 12234567999999999985 456789999999999999999999999755432211111000000000
Q ss_pred -----hhhhhhhcCCccCCCCCh-----hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 609 -----KDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 609 -----~~~l~~i~d~~l~~~~~~-----e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
.........+.. ...+. ....++.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 01111 112357899999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=372.00 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=194.1
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecCC----CC
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 451 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~----~~ 451 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 6999999999754332 2457899999999999999999999987533 23
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCc
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 531 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGl 531 (726)
..++||||+ +++|..+++ ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 667877775 245999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhh---------h
Q 004869 532 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------W 601 (726)
Q Consensus 532 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~---------~ 601 (726)
++...... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||............. +
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 345799999999998764 56899999999999999999999997543211110000 0
Q ss_pred hhhhccc-hhhhhhhcCCccCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 602 ARPILRD-KDRLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 602 ~~~~~~~-~~~l~~i~d~~l~~----~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
....... ........ +.... .........+.+|+.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00000000 00000 0111223457899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=357.98 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=202.7
Q ss_pred cCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCC--CchhHHHHHHHHHHhcccCceeEEEEEeecCCCCceEEE
Q 004869 380 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~~~~~~~LV 456 (726)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|+||+++++++. +....+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc--cccceeEE
Confidence 5799999999999999999996 4789999999975433 23468899999999999999999999997 45588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCccccCC
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 536 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~~~~ 536 (726)
+|++.+++|..++.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 80 ~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999988864 346889999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCcccccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-----hh
Q 004869 537 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-----KD 610 (726)
Q Consensus 537 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-----~~ 610 (726)
.... ......++..|+|||.+.... ++.++|||||||++|||++|+.||.......+ ...-+...... ..
T Consensus 153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCT
T ss_pred CCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhh
Confidence 5432 223446788999999887665 68999999999999999999999754322111 10000000000 00
Q ss_pred hhhhhcCC---------ccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 611 RLEELADP---------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 611 ~l~~i~d~---------~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
......+. .............+.+|+.+||+.||++|||++||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00011122333467899999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=370.46 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=194.0
Q ss_pred CcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCceeEEEEEeecC----CCCceEE
Q 004869 381 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQHLL 455 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----~~~~~~L 455 (726)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|+|||+++++|... +....+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999975 689999999975432 335799999999999999999998532 3345789
Q ss_pred EEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCC-cEEEEecCcccc
Q 004869 456 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQ 534 (726)
Q Consensus 456 V~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~-~vKL~DFGla~~ 534 (726)
||||+++|.+..+.+. ......+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999987644443321 122346999999999999999999999998 99999999999999765 899999999987
Q ss_pred CCCCCcccccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc-hhhh
Q 004869 535 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-KDRL 612 (726)
Q Consensus 535 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~~~l 612 (726)
...... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+....+..-.. ....
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhh
Confidence 654432 234579999999998775 578999999999999999999999997543211 111111000000 0000
Q ss_pred hhh----cC---CccC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 613 EEL----AD---PRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 613 ~~i----~d---~~l~-----~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... .+ +... ..........+.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 0000 00111223458899999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.9e-41 Score=354.89 Aligned_cols=265 Identities=19% Similarity=0.222 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCCchhHHHHHHHHHHhccc-CceeEEEEEeecCCCCceEEE
Q 004869 379 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC 456 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~llg~~~~~~~~~~~LV 456 (726)
.++|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++. +....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEE
Confidence 368999999999999999999964 68999999886432 34567889999999975 89999999876 44588999
Q ss_pred EeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecC-----CCcEEEEecCc
Q 004869 457 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGL 531 (726)
Q Consensus 457 ~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~-----~~~vKL~DFGl 531 (726)
|||+ +|+|.++++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence 9999 78999998642 235899999999999999999999999 999999999999964 57899999999
Q ss_pred cccCCCCCcc-----cccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhc
Q 004869 532 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 606 (726)
Q Consensus 532 a~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 606 (726)
|+........ .......||+.|||||++.+..++.++|||||||++|||++|+.||..................
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~- 231 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK- 231 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-
Confidence 9876543221 1233467999999999999999999999999999999999999999754433222111111000
Q ss_pred cchhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 004869 607 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 664 (726)
Q Consensus 607 ~~~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~L~~i~~~~ 664 (726)
.......+ +...+| .++.+++..|++.+|++||+++.+.+.|+.+.+..
T Consensus 232 ~~~~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 232 KQSTPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHSCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000111 112334 34888999999999999999999999888876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=363.20 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC----CCcEEEEEEcccCC----CCchhHHHHHHHHHHhccc-CceeEEEEEeecCCC
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDS 450 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~H-pNIV~llg~~~~~~~ 450 (726)
++|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+++|++++| |||+++++++.. .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence 67999999999999999999852 47899999986432 2335678899999999976 899999999874 4
Q ss_pred CceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecC
Q 004869 451 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 530 (726)
Q Consensus 451 ~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFG 530 (726)
...+++|||+.+|+|.+++.. ...+.......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 589999999999999999964 335677889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhhhhhccc
Q 004869 531 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 608 (726)
Q Consensus 531 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 608 (726)
+++........ ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ......
T Consensus 175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~-- 249 (322)
T d1vzoa_ 175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRIL-- 249 (322)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHH--
T ss_pred chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcc--
Confidence 99876543322 23446799999999998754 468899999999999999999999975543322111 111000
Q ss_pred hhhhhhhcCCccCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004869 609 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 656 (726)
Q Consensus 609 ~~~l~~i~d~~l~~~~~~e~~~~l~~Li~~CL~~dP~~RP-----Tm~EVl~~ 656 (726)
... ...+.....++.+++.+||+.||++|| |++|+++|
T Consensus 250 --------~~~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 --------KSE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------cCC--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000 122334455689999999999999999 58899875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=361.93 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=190.3
Q ss_pred cCcccceeeeecCcEEEEEEEEC-CCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecC----CCCc
Q 004869 380 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ 452 (726)
Q Consensus 380 ~~f~~~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~----~~~~ 452 (726)
++|++.++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++... +...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999965 6999999999754332 235688999999999999999999998643 3367
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.|+||||+.++.+. .+. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999765554 443 24789999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhh---------hhhh
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TWAR 603 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~~~ 603 (726)
+...... ..+...||+.|+|||++.+..++.++||||+||+++||++|+.||............ .+..
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8665433 234567999999999999999999999999999999999999999644311110000 0000
Q ss_pred hhc-------cch-----hhhhhhcCCccCCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PIL-------RDK-----DRLEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~-------~~~-----~~l~~i~d~~l~~~---~~~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
... ... .............. ........+.+|+.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 00000010000000 112234568899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=360.28 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=195.5
Q ss_pred hcCcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCC--chhHHHHHHHHHHhcccCceeEEEEEeecC---CCCc
Q 004869 379 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ 452 (726)
Q Consensus 379 t~~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~llg~~~~~---~~~~ 452 (726)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|+|+|++++++... +...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 57999999999755332 235788999999999999999999988642 2334
Q ss_pred eEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcEEEEecCcc
Q 004869 453 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 532 (726)
Q Consensus 453 ~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~vKL~DFGla 532 (726)
.+++++|+.+|+|.++++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 5677888899999999963 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccchhhhhh--------h
Q 004869 533 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--------R 603 (726)
Q Consensus 533 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~~l~~~~--------~ 603 (726)
..... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+... .
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 75532 22345799999999987765 4689999999999999999999999754321111100000 0
Q ss_pred hhccchhhhhhhcCCccC-CCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004869 604 PILRDKDRLEELADPRLG-GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 656 (726)
Q Consensus 604 ~~~~~~~~l~~i~d~~l~-~~~~-----~e~~~~l~~Li~~CL~~dP~~RPTm~EVl~~ 656 (726)
..... ............ .... ......+.+|+.+||+.||++|||++|+++|
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCC-HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccc-hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 000000000000 0000 1122457899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-37 Score=332.26 Aligned_cols=266 Identities=20% Similarity=0.234 Sum_probs=192.7
Q ss_pred CcccceeeeecCcEEEEEEEE-CCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-----------cCceeEEEEEeecC
Q 004869 381 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYSSR 448 (726)
Q Consensus 381 ~f~~~~~LG~G~fG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~llg~~~~~ 448 (726)
+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999996 579999999997432 22457788999988875 57899999988765
Q ss_pred CCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHh-CCCCceeecCCCccceeecCCC-----
Q 004869 449 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNF----- 522 (726)
Q Consensus 449 ~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~-~~~p~IvHrDIKp~NILLd~~~----- 522 (726)
.....+++++++..+........ ......+++..+..++.||++||+|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 55677777877766554333221 1223467889999999999999999998 77 99999999999998655
Q ss_pred -cEEEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccc----h
Q 004869 523 -HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE----N 597 (726)
Q Consensus 523 -~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~Pf~~~~~~~~~----~ 597 (726)
.+|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||......... .
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 4999999999865432 23457999999999999999999999999999999999999999643321111 1
Q ss_pred hhhhhhhh-------ccchhhhhhhcCC-----c--------------cCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 004869 598 LVTWARPI-------LRDKDRLEELADP-----R--------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 651 (726)
Q Consensus 598 l~~~~~~~-------~~~~~~l~~i~d~-----~--------------l~~~~~~e~~~~l~~Li~~CL~~dP~~RPTm~ 651 (726)
+......+ ...........+. . ............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11111000 0000000000000 0 01123455667899999999999999999999
Q ss_pred HHHHH
Q 004869 652 EVVQS 656 (726)
Q Consensus 652 EVl~~ 656 (726)
|+++|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6.1e-23 Score=201.19 Aligned_cols=169 Identities=15% Similarity=0.137 Sum_probs=122.9
Q ss_pred ccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCC------------------chhHHHHHHHHHHhcccCceeEEEEE
Q 004869 383 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------------------GDKEFLVEVEMLSRLHHRNLVKLVGY 444 (726)
Q Consensus 383 ~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~L~HpNIV~llg~ 444 (726)
.+.++||+|+||+||+|+..+|+.||||.++.+... ......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999987532110 01234568889999999999998766
Q ss_pred eecCCCCceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCCCCceeecCCCccceeecCCCcE
Q 004869 445 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 524 (726)
Q Consensus 445 ~~~~~~~~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~~p~IvHrDIKp~NILLd~~~~v 524 (726)
. ..+++|||++++.+.+ +++.....++.|++++|+|||+.+ |+||||||+|||++++ .+
T Consensus 83 ~------~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 E------GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp E------TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred c------CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 3 2379999998765543 445667789999999999999999 9999999999999976 48
Q ss_pred EEEecCccccCCCCCcccccccccccccccCccccccCCCCcchhHHHHHHHH
Q 004869 525 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 577 (726)
Q Consensus 525 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSfGvvL 577 (726)
+|+|||+|+............+.+. .+ .| ...+.|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~---~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVR---NI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHH---HH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHH---HH-HH-HHcCCCCCcccHHHHHHHH
Confidence 9999999987653322111000000 00 01 1235678899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2.3e-07 Score=92.46 Aligned_cols=149 Identities=15% Similarity=0.091 Sum_probs=103.1
Q ss_pred HHHHHHhcCcccceeeeecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcc-cCceeEEEEEeecCCCC
Q 004869 373 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSS 451 (726)
Q Consensus 373 ~el~~~t~~f~~~~~LG~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~llg~~~~~~~~ 451 (726)
.++....+.|+..+..+-++.+.||+... ++..+++|+...........+.+|..++..+. +--+-+++.+.. +.+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCC
Confidence 46777778888766655555678999765 45667889886554445556888999988774 433556666655 335
Q ss_pred ceEEEEeecCCCChhhhccCCCCCcccCChhhhHHHHHHHHHHHHHHHhCC-----------------------------
Q 004869 452 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS----------------------------- 502 (726)
Q Consensus 452 ~~~LV~Ey~~~GsL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL~yLH~~~----------------------------- 502 (726)
..++||+++++.++.+.... ......++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred ceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 78999999999888654421 1122334555555555555421
Q ss_pred ---------------------------CCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 503 ---------------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 503 ---------------------------~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
.++++|+|+.+.|||++++...-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 2358999999999999987777799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=7.1e-06 Score=80.79 Aligned_cols=130 Identities=21% Similarity=0.146 Sum_probs=84.1
Q ss_pred eeeecCc-EEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccC--ceeEEEEEeecCCCCceEEEEeecCCC
Q 004869 387 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRDSSQHLLCYELVPNG 463 (726)
Q Consensus 387 ~LG~G~f-G~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~llg~~~~~~~~~~~LV~Ey~~~G 463 (726)
.+..|.. ..||+...+++..+++|...... ...+..|.+.++.+... .+.+++++.. +....++||+|++|-
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeecc
Confidence 4455553 67999988888888999765332 34577888888877533 3455666655 445789999999987
Q ss_pred ChhhhccCCCCCcccCChhhhHHHHHHHHHHH------------------------------------------------
Q 004869 464 SLESWLHGPLGVNCHLDWETRMKIALDAARGL------------------------------------------------ 495 (726)
Q Consensus 464 sL~d~L~~~~~~~~~Ls~~~~~~ia~qIa~gL------------------------------------------------ 495 (726)
++.+.... ....+.++++.|
T Consensus 92 ~~~~~~~~------------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSHLA------------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSCCC------------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc------------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 76542100 011112222222
Q ss_pred ---HHHHhC----CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 496 ---AYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 496 ---~yLH~~----~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
..+... ..+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 222221 23458999999999999988777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.00037 Score=73.60 Aligned_cols=77 Identities=17% Similarity=0.135 Sum_probs=48.5
Q ss_pred ceeeeecCcEEEEEEEEC-CCcEEEEEEccc----CC---CCchhHHHHHHHHHHhcc-c--CceeEEEEEeecCCCCce
Q 004869 385 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTC----GG---QQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRDSSQH 453 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~-~g~~VAVK~l~~----~~---~~~~~~f~~Ei~iL~~L~-H--pNIV~llg~~~~~~~~~~ 453 (726)
.+.||.|....||+.... +++.|+||.-.. .. .........|.+.|+.+. + ..+.+++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCC
Confidence 356899999999999865 467899996421 11 112234566888887663 2 3455666553 2356
Q ss_pred EEEEeecCCCCh
Q 004869 454 LLCYELVPNGSL 465 (726)
Q Consensus 454 ~LV~Ey~~~GsL 465 (726)
++|||++++..+
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEeccCCccc
Confidence 899999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.00083 Score=68.77 Aligned_cols=139 Identities=15% Similarity=0.129 Sum_probs=78.2
Q ss_pred cEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee--EEEEE---eecCCCCceEEEEeecCCCChhh
Q 004869 393 FGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV--KLVGY---YSSRDSSQHLLCYELVPNGSLES 467 (726)
Q Consensus 393 fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV--~llg~---~~~~~~~~~~LV~Ey~~~GsL~d 467 (726)
--.||+++..+|+.|++|....+ ....+++..|.+.+..|...++. ..+.. .........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999987643 33457788899998888643321 11111 00012345788899998744321
Q ss_pred ----h----------cc----CC-CCCcccCChh-------------------hhHHHHHHHHHHHHHHHh----CCCCc
Q 004869 468 ----W----------LH----GP-LGVNCHLDWE-------------------TRMKIALDAARGLAYLHE----DSQPC 505 (726)
Q Consensus 468 ----~----------L~----~~-~~~~~~Ls~~-------------------~~~~ia~qIa~gL~yLH~----~~~p~ 505 (726)
. +| .. ......+++. .+..+...+.+.++.+.. .....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 01 00 0001111111 111122222223333322 23456
Q ss_pred eeecCCCccceeecCCCcEEEEecCcccc
Q 004869 506 VIHRDFKASNILLENNFHAKVADFGLAKQ 534 (726)
Q Consensus 506 IvHrDIKp~NILLd~~~~vKL~DFGla~~ 534 (726)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45789998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0027 Score=66.54 Aligned_cols=74 Identities=23% Similarity=0.278 Sum_probs=50.1
Q ss_pred ceeeeecCcEEEEEEEECCC--------cEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee-EEEEEeecCCCCceEE
Q 004869 385 ASILGEGGFGRVFKGVLSDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLL 455 (726)
Q Consensus 385 ~~~LG~G~fG~Vykg~l~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~llg~~~~~~~~~~~L 455 (726)
.+.|+-|-.-.+|+....++ +.|.+++.- . ........+|.++++.+.-.+++ ++++++. + .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C----ce
Confidence 36788889999999987543 445655543 2 23345567899999988644444 6777653 2 68
Q ss_pred EEeecCCCChh
Q 004869 456 CYELVPNGSLE 466 (726)
Q Consensus 456 V~Ey~~~GsL~ 466 (726)
|+||+++..|.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeccccCC
Confidence 89999875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.29 E-value=0.0089 Score=60.03 Aligned_cols=161 Identities=14% Similarity=0.052 Sum_probs=85.3
Q ss_pred cCHHHHHHHhcCcccceee-----eecCcEEEEEEEECCCcEEEEEEcccCCCCchhHHHHHHHHHHhcccCcee--EEE
Q 004869 370 LAYEELKEATNNFEPASIL-----GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV--KLV 442 (726)
Q Consensus 370 ~~~~el~~~t~~f~~~~~L-----G~G~fG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV--~ll 442 (726)
++.+|+.....+|.+.+.. ..|---+.|+...++|+ +++|+..... ..++...|++++..+...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 5678888888899775444 35556789999887665 8899875432 234556677777777533221 111
Q ss_pred EE----eecCCCCceEEEEeecCCCChhhhc--------------c---CCC---CCccc-----------------CCh
Q 004869 443 GY----YSSRDSSQHLLCYELVPNGSLESWL--------------H---GPL---GVNCH-----------------LDW 481 (726)
Q Consensus 443 g~----~~~~~~~~~~LV~Ey~~~GsL~d~L--------------~---~~~---~~~~~-----------------Ls~ 481 (726)
.. ....-......++.+..+......- + ... ..... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 00 0000122345566666654332110 0 000 00000 001
Q ss_pred hhhHHHHHHHHHHHHHHHhC-CCCceeecCCCccceeecCCCcEEEEecCccc
Q 004869 482 ETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK 533 (726)
Q Consensus 482 ~~~~~ia~qIa~gL~yLH~~-~~p~IvHrDIKp~NILLd~~~~vKL~DFGla~ 533 (726)
......+..+...+.-.+.. -+-++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222333333221 23359999999999999998877899999875
|